<SEC-DOCUMENT>0001833141-23-000013.txt : 20230914
<SEC-HEADER>0001833141-23-000013.hdr.sgml : 20230914
<ACCEPTANCE-DATETIME>20230914145848
ACCESSION NUMBER:		0001833141-23-000013
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		22
CONFORMED PERIOD OF REPORT:	20230914
FILED AS OF DATE:		20230914
DATE AS OF CHANGE:		20230914

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CYBIN INC.
		CENTRAL INDEX KEY:			0001833141
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40673
		FILM NUMBER:		231254916

	BUSINESS ADDRESS:	
		STREET 1:		100 KING STREET WEST
		STREET 2:		SUITE 5600
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5X 1C9
		BUSINESS PHONE:		(908) 764-8385

	MAIL ADDRESS:	
		STREET 1:		100 KING STREET WEST
		STREET 2:		SUITE 5600
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5X 1C9
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a6-kxcybininformationcircu.htm
<DESCRIPTION>6-K
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i41e748e71316416fa36e602a529b51db_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">UNITED STATES<br>SECURITIES AND EXCHANGE COMMISSION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Washington, D.C. 20549</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form 6-K</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16<br>UNDER THE SECURITIES EXCHANGE ACT OF 1934</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the month of September, 2023.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission File Number&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">001-40673</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Cybin Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Exact Name of Registrant as Specified in Charter)<br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices) </font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form 20-F  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:100%">&#9633;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Form 40-F </font><font style="color:#000000;font-family:'Cambria Math',serif;font-size:10pt;font-weight:400;line-height:100%">&#8864;</font></div><div><font><br></font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCORPORATION BY REFERENCE</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 99.1 of this Form 6-K of Cybin Inc. (the &#8220;Company&#8221;) is hereby incorporated by reference into the Registration Statement on Form F-10 (File No. 333-272706) of the Company, as amended or supplemented.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SIGNATURE</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.<br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:5.048%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.696%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.507%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CYBIN INC.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 14, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Doug Drysdale&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Doug Drysdale</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT INDEX</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="cybin-informationcircularx.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Annual and Special Meeting of Shareholders and Management Information Circular</a><a href="cybin-informationcircularx.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> </a><a href="cybin-informationcircularx.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">dated September 13, 2023</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="noticeofmeeting.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Annual and Special Meeting of Shareholder</a><a href="noticeofmeeting.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">s</a><a href="noticeofmeeting.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> dated September 13, 2023</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="cybin-finalproxyformasm2.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Form of Proxy</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="a23-19847x2_472766xcybin.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Statement Request Form</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="abridgementcertificatecybin.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Abridgement Certificate</a><a href="abridgementcertificatecybin.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> </a><a href="abridgementcertificatecybin.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">dated September 1</a><a href="abridgementcertificatecybin.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">4, 20</a><a href="abridgementcertificatecybin.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">23</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="a10122023asm-cybinincxno.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Meeting and Record Date</a></font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>cybin-informationcircularx.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i03495151b60d4686a1ed76df16c56576_1"></div><div style="min-height:59.76pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><img alt="image_11.jpg" src="image_11.jpg" style="height:226px;margin-bottom:5pt;vertical-align:text-bottom;width:388px"></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">CYBIN INC.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AND</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT INFORMATION CIRCULAR</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 13, 2023</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_4"></div><hr style="page-break-after:always"><div style="min-height:89.28pt;width:100%"><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</font></div><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.554%"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS&#160;&#160;&#160;&#160;1</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">QUESTIONS &#38; ANSWERS REGARDING THE ARRANGEMENT AND THE MEETING&#160;&#160;&#160;&#160;3</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Questions Regarding the Arrangement&#160;&#160;&#160;&#160;3</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Questions Regarding the Meeting&#160;&#160;&#160;&#160;5</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MANAGEMENT INFORMATION CIRCULAR&#160;&#160;&#160;&#160;8</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General Matters&#160;&#160;&#160;&#160;8</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Glossary of Terms&#160;&#160;&#160;&#160;8</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Information Contained in this Circular&#160;&#160;&#160;&#160;18</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward-Looking Statements&#160;&#160;&#160;&#160;18</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and Industry Data&#160;&#160;&#160;&#160;21</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Note to U.S. Shareholders&#160;&#160;&#160;&#160;21</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">THE MEETING&#160;&#160;&#160;&#160;22</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Solicitation of Proxies&#160;&#160;&#160;&#160;22</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Voting at the Meeting&#160;&#160;&#160;&#160;22</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appointment and Revocation of Proxies&#160;&#160;&#160;&#160;22</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of Discretion by Proxies&#160;&#160;&#160;&#160;23</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Legal Proxy &#8211; U.S. Cybin Beneficial Shareholders&#160;&#160;&#160;&#160;23</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">How Do I Attend and Participate at the Meeting&#63;&#160;&#160;&#160;&#160;23</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Advice to Beneficial Shareholders&#160;&#160;&#160;&#160;24</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Note to Non-Objecting Beneficial Owners&#160;&#160;&#160;&#160;24</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">VOTING SECURITIES AND PRINCIPAL HOLDERS THEREOF&#160;&#160;&#160;&#160;25</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SUMMARY&#160;&#160;&#160;&#160;26</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Meeting&#160;&#160;&#160;&#160;26</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Parties to the Arrangement&#160;&#160;&#160;&#160;26</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Background to the Arrangement&#160;&#160;&#160;&#160;27</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recommendation of the Board&#160;&#160;&#160;&#160;27</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reasons for the Arrangement&#160;&#160;&#160;&#160;27</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Arrangement&#160;&#160;&#160;&#160;27</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Required Approvals&#160;&#160;&#160;&#160;28</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock Exchange Listings&#160;&#160;&#160;&#160;29</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Securities Laws Matters&#160;&#160;&#160;&#160;29</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Arrangement Agreement&#160;&#160;&#160;&#160;30</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Support and Voting Agreements&#160;&#160;&#160;&#160;30</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk Factors&#160;&#160;&#160;&#160;30</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">THE ARRANGEMENT&#160;&#160;&#160;&#160;32</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Background to the Arrangement &#38; Recommendations&#160;&#160;&#160;&#160;32</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Arrangement&#160;&#160;&#160;&#160;37</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan of Arrangement&#160;&#160;&#160;&#160;38</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Directors&#160;&#160;&#160;&#160;39</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Timing&#160;&#160;&#160;&#160;40</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest of Directors and Executive Officers in the Arrangement&#160;&#160;&#160;&#160;40</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Required Approvals&#160;&#160;&#160;&#160;40</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock Exchange Listings&#160;&#160;&#160;&#160;41</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Securities Laws Matters&#160;&#160;&#160;&#160;42</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Arrangement Agreement&#160;&#160;&#160;&#160;43</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk Factors&#160;&#160;&#160;&#160;57</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Information Concerning Cybin&#160;&#160;&#160;&#160;61</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Information Concerning Small Pharma&#160;&#160;&#160;&#160;61</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Information Concerning Post-Arrangement Cybin&#160;&#160;&#160;&#160;61</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Material Changes&#160;&#160;&#160;&#160;62</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OTHER MATTERS TO BE ACTED UPON&#160;&#160;&#160;&#160;62</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial Statements&#160;&#160;&#160;&#160;62</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appointment and Remuneration of Auditors&#160;&#160;&#160;&#160;62</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Election of Directors&#160;&#160;&#160;&#160;62</font></div></div><div style="display:inline-block;max-width:2.890%;min-width:1.890%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.556%"><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Cease Trade Orders&#160;&#160;&#160;&#160;66</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EXECUTIVE COMPENSATION&#160;&#160;&#160;&#160;67</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation Discussion and Analysis&#160;&#160;&#160;&#160;67</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Management Contracts&#160;&#160;&#160;&#160;67</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Elements of Compensation&#160;&#160;&#160;&#160;68</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation of Directors&#160;&#160;&#160;&#160;72</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation Risk&#160;&#160;&#160;&#160;72</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial Instruments&#160;&#160;&#160;&#160;72</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation Governance&#160;&#160;&#160;&#160;72</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation Governance&#160;&#160;&#160;&#160;73</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance Graph&#160;&#160;&#160;&#160;73</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Summary Compensation Table&#160;&#160;&#160;&#160;74</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incentive Plan Awards&#160;&#160;&#160;&#160;76</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director Compensation&#160;&#160;&#160;&#160;77</font></div><div style="padding-left:58.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Securities Authorized for Issuance Under Equity Compensation Plans&#160;&#160;&#160;&#160;78</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">INDEBTEDNESS OF DIRECTORS AND EXECUTIVE OFFICERS&#160;&#160;&#160;&#160;79</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">STATEMENT OF CORPORATE GOVERNANCE PRACTICES&#160;&#160;&#160;&#160;79</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AUDIT COMMITTEE DISCLOSURE&#160;&#160;&#160;&#160;79</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Audit Committee&#8217;s Charter&#160;&#160;&#160;&#160;79</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Composition of Audit Committee&#160;&#160;&#160;&#160;79</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">INTERESTS OF INFORMED PERSONS IN MATERIAL TRANSACTIONS&#160;&#160;&#160;&#160;80</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">INTEREST OF CERTAIN PERSONS IN MATTERS TO BE ACTED UPON&#160;&#160;&#160;&#160;81</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">INTERESTS OF EXPERTS&#160;&#160;&#160;&#160;81</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Experts of Cybin&#160;&#160;&#160;&#160;81</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Experts of Small Pharma&#160;&#160;&#160;&#160;81</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ADDITIONAL INFORMATION&#160;&#160;&#160;&#160;81</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">APPROVAL OF BOARD OF DIRECTORS&#160;&#160;&#160;&#160;81</font></div><div style="margin-bottom:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Schedule A Form of Acquisition Resolution&#160;&#160;&#160;&#160;A-1</font></div><div style="margin-bottom:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Schedule B Plan of Arrangement&#160;&#160;&#160;&#160;B-1</font></div><div style="margin-bottom:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Schedule C Information Concerning Cybin&#160;&#160;&#160;&#160;C-1</font></div><div style="margin-bottom:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Schedule D Information Concerning Small Pharma&#160;&#160;&#160;&#160;D-1</font></div><div style="margin-bottom:6pt;padding-left:22.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Schedule E Information Concerning Post-Arrangement Cybin&#160;&#160;&#160;&#160;E-1</font></div><div style="margin-bottom:6pt;padding-left:22.5pt;padding-right:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Schedule F Unaudited Pro Forma Financial Statements of Post-Arrangement Cybin &#160;&#160;&#160;&#160;F-1</font></div><div style="margin-bottom:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Schedule G Statement of Corporate Governance Practices&#160;&#160;&#160;&#160;G-1</font></div><div style="margin-bottom:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Schedule H Audit Committee Charter&#160;&#160;&#160;&#160;H-1</font></div><div style="margin-bottom:6pt;padding-left:36pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Schedule I Directors&#8217; Mandate&#160;&#160;&#160;&#160;I-1</font></div></div></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i</font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_7"></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September 13, 2023</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fellow Shareholders&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On behalf of the board of directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and management of Cybin Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), I write in connection with the annual and special meeting (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of the holders (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of common shares (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of Cybin. The Meeting will be held in a virtual-only format via live audio webcast on Thursday, October 12, 2023 at 1&#58;00 p.m. (Toronto time). To attend the Meeting, you must register at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;register.proxypush.com&#47;cybn</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon completing your registration, you will receive further instructions via email, including a unique link that will allow you access to the Meeting and to vote and submit questions during the Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying management information circular (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Circular</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and notice of annual and special meeting of Cybin Shareholders (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notice of Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) contain important information regarding how to vote at the Meeting, the Arrangement (as defined below), the Acquisition Resolution (as defined below), the directors nominated for election, our corporate governance practices and how we compensate our executives and directors. Cybin Shareholders are urged to read this information carefully and, if they require assistance, to consult their tax, financial, legal and other professional advisors.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">The Arrangement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 28, 2023, Cybin entered into an arrangement agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Arrangement Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) with Small Pharma Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) whereby, subject to the terms and conditions of the Arrangement Agreement, pursuant to a statutory plan of arrangement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) under the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Corporations Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (British Columbia), Cybin will acquire all of the issued and outstanding common shares of Small Pharma (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) on the basis of 0.2409 Cybin Shares per Small Pharma Share outstanding. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately following completion of the Arrangement, Small Pharma will become a wholly-owned subsidiary of Cybin and, following the issuance of Cybin Shares pursuant to the Arrangement at the effective time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effective Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), it is anticipated that current holders of Cybin Shares and former holders of Small Pharma Shares will own approximately 75.3% and 25.7% of the combined entity.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Reasons for the Arrangement</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10pt">Highly Complementary and Diversified Asset Portfolio. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combination creates an international, clinical-stage leader, with an expanded portfolio of clinical-stage psychedelic assets (CYB003 &#8211; Cybin&#8217;s proprietary deuterated psilocybin analog, CYB004 &#8211; Cybin&#8217;s proprietary deuterated DMT molecule, SPL028 &#8211; Small Pharma&#8217;s deuterated DMT, and SPL026 &#8211; Small Pharma&#8217;s first generation DMT) and pre-clinical assets that are highly complementary. Post-Arrangement Cybin&#8217;s combined DMT programs will constitute a significantly expanded dataset of systematic research on these short-duration psychedelic molecules, strengthening Post-Arrangement Cybin&#8217;s ability to make informed, data-driven strategic decisions for its development programs, increasing the likelihood of success.</font></div><div style="margin-bottom:0.12pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10pt">Enhanced and Diversified Development Potential. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Post-Arrangement Cybin will be able to pursue an expanded development portfolio, with multiple milestones anticipated to be initiated and&#47;or completed over the next 12 to 18 months. This includes, but is not limited to&#58; (i) determining safety and efficacy interactions of DMT in patients with major depressive disorder on selective serotonin reuptake inhibitors (SSRIs)&#59; (ii) first in-human readouts of deuterated DMT compounds using intravenous (CYB004 and SPL028) and intramuscular (SPL028) routes of administration&#59; (iii) efficacy, safety and tolerability readout of CYB003 in major depressive disorder patients&#59; and, (iv) subject to the availability of financing and applicable regulatory approvals&#58; (a) initiation of a pivotal efficacy study of CYB003&#59; and (b) initiation of an efficacy study on a deuterated DMT compound. The addition of Small Pharma&#8217;s experience and expertise in the United Kingdom and Europe will increase Cybin&#8217;s ability to advance research and development activities in those markets.</font></div><div style="margin-bottom:0.12pt;text-align:justify;text-indent:4.5pt"><font><br></font></div><div style="margin-bottom:0.12pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10pt">Strengthened Intellectual Property Portfolio.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Post-Arrangement Cybin will hold the most impressive intellectual property portfolio in the psychedelic drug development sector. Based on patents and patent applications held by Cybin and Small Pharma as of the date of this Circular, Post-Arrangement Cybin will hold 160 pending patent applications, including five allowed applications, as well as 30 granted patents protecting its clinical and preclinical </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:0.12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">molecules. This extensive intellectual property portfolio creates an unmatched opportunity for Post-Arrangement Cybin to develop next-generation novel compounds for a number of mental health disorders that may be amenable to treatment with psychedelic therapies.</font></div><div style="margin-bottom:0.12pt;text-align:justify;text-indent:4.5pt"><font><br></font></div><div style="margin-bottom:0.12pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10pt">Operational and Financial Synergies.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Post-Arrangement Cybin is expected to benefit from significant operational and financial synergies through the combination of the Parties&#8217; research and development portfolios, and corporate general and administrative cost savings.</font></div><div style="margin-bottom:0.12pt;text-align:justify;text-indent:4.5pt"><font><br></font></div><div style="margin-bottom:0.12pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10pt">Improved Financial Position. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Post-Arrangement Cybin will have, on a pro forma basis as at June 30, 2023, estimated cash of approximately $17.66 million, as well as access to two accessible financing arrangements, including (i) an at-the-market equity program that allows Cybin to issue and sell up to US$35 million of Cybin Shares, from time to time, which was renewed by Cybin in August 2023&#59; and (ii) a common share purchase agreement with Lincoln Park Capital Fund, LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LPC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) dated May 30, 2023 whereby Cybin has the right to sell, and LPC is obligated to purchase, up to US$30 million of Cybin Shares over a 36-month period (of which US$29.5 million remains unsold as at the date of this Circular).</font></div><div style="margin-bottom:0.12pt;text-align:justify;text-indent:4.5pt"><font><br></font></div><div style="margin-bottom:0.12pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10pt">Strong Research and Development and Leadership Teams.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Stakeholders will benefit from the combination of two experienced biotechnology teams with a proven track record of success across the biotechnology and pharmaceutical sectors. George Tziras, Small Pharma&#8217;s Chief Executive Officer, will also be joining the Cybin Board.</font></div><div style="margin-bottom:0.12pt;text-align:justify;text-indent:4.5pt"><font><br></font></div><div style="margin-bottom:0.12pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10pt">Consideration of Alternatives.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Taking into account the degree to which Small Pharma&#8217;s assets and operations complement those of Cybin, organic growth opportunities currently available to Cybin, and other potential acquisition opportunities, management of Cybin and the Cybin Board have assessed the alternatives reasonably available. The completion of the Arrangement is consistent with Cybin&#8217;s strategic objectives, which include the development of its existing clinical- and pre-clinical-stage assets, and the pursuit through acquisition of additional clinical and pre-clinical-stage assets that contribute to corporate growth. Cybin believes that Post-Arrangement Cybin will be better positioned to pursue a value maximizing strategy as a result of the anticipated benefits of the Arrangement.</font></div><div style="margin-bottom:0.12pt;text-align:justify;text-indent:4.5pt"><font><br></font></div><div style="margin-bottom:0.12pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10pt">Strong Director, Officer and Shareholder Support.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Arrangement has strong director, officer, and shareholder support. All of the directors and senior officers of Cybin, and certain shareholders of Cybin, who collectively hold approximately 17% of the issued and outstanding Cybin Shares as at the record date of August 30, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Record Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) have entered into support and voting agreements with Small Pharma concurrently with the execution of the Arrangement Agreement pursuant to which they have agreed, among other things, to vote their Cybin Shares in favour of the Acquisition Resolution at the Meeting and otherwise support the Arrangement. </font></div><div style="margin-bottom:0.12pt;text-align:justify;text-indent:4.5pt"><font><br></font></div><div style="margin-bottom:0.12pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">In addition, each of the directors and executive officers of Small Pharma who owns Small Pharma Shares, and Small Pharma&#8217;s largest shareholder, who collectively hold or exercise control or direction over approximately 28.8%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the issued and outstanding Small Pharma Shares as at the date of the Arrangement Agreement, have entered into support and voting agreements with Cybin concurrently with the execution of the Arrangement Agreement pursuant to which they have agreed, among other things, to support the Arrangement and vote their Small Pharma Shares in favour of the resolution to approve the Arrangement at the annual and special meeting of Small Pharma shareholders to be held on October 12, 2023 (as it may be adjourned or postponed). See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Support and Voting Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the Circular.</font></div><div style="margin-bottom:0.12pt;text-align:justify;text-indent:4.5pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Shareholder Vote</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition Resolution</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the Meeting, Cybin Shareholders will be asked to consider, and if deemed advisable, to approve, with or without variation, an ordinary resolution (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition Resolution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) approving the Arrangement, the full text of which is attached as Schedule A to the Circular.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To be effective, the Acquisition Resolution must be approved at the Meeting by a simple majority of the votes cast on the Acquisition Resolution by the Cybin Shareholders present (virtually) or represented by proxy at the Meeting.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recommendation</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybin Board, after careful consideration, including a thorough review of the Arrangement Agreement and receiving the advice of its legal counsel, in addition to considering other matters, each as described in the Circular, has unanimously determined that the Arrangement is in the best interests of Cybin and unanimously recommends that Cybin Shareholders </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VOTE FOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Acquisition Resolution. The determination of the Cybin Board is based on various factors described more fully under the heading &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background to the Arrangement &#38; Recommendations &#8211; Reasons for the Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and elsewhere in the Circular.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Vote your Cybin Shares today FOR the Acquisition Resolution</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Your vote is important regardless of how many Cybin Shares you own. Cybin Shareholders are strongly encouraged to submit their votes in advance of the Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the internet, by telephone, or by submitting a completed form of proxy or voting instruction form, as applicable. To be effective, the enclosed form of proxy must be received by Cybin&#8217;s transfer agent, Odyssey Trust Company (according to the instructions on the proxy), not later than 1&#58;00 p.m. (Toronto time) on Tuesday, October 10, 2023, or not later than 48 hours (excluding Saturdays, Sundays or holidays) before the time of the Meeting (as it may be adjourned or postponed from time to time). The deadline for the deposit of proxies may be waived or extended by the Chair of the Meeting at his discretion, without notice.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you hold your Cybin Shares through a broker, custodian, nominee or other intermediary, you should follow the instructions provided by such intermediary to ensure your vote is counted at the Meeting.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Conditions</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to obtaining the requisite approvals of the Cybin Shareholders, the Small Pharma shareholders and the Supreme Court of British Columbia, it is anticipated that the Arrangement will be completed as soon as practicable following&#58; (i) receipt of the final order of the Supreme Court of British Columbia, which is expected to be obtained on or about October 17, 2023&#59; and (ii) the satisfaction or waiver of all other conditions precedent to the Arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On behalf of Cybin, we would like to thank all Cybin Shareholders for their continuing support.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sincerely,</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.739%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Eric So&#8221;</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eric So </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chair and President</font></div></td></tr></table></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_10"></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CYBIN INC.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTICE IS HEREBY GIVEN</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that an annual and special meeting (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of the holders (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of common shares (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in the capital of Cybin Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) will be held in a virtual-only format via live audio webcast on Thursday, October 12, 2023 at 1&#58;00 p.m. (Toronto time), to conduct the following business&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to consider, and if deemed advisable, to approve, with or without variation, an ordinary resolution (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition Resolution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) authorizing and approving the acquisition of Small Pharma Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) by way of a proposed plan of arrangement under the Business Corporations Act (British Columbia) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) involving Cybin and Small Pharma, pursuant to the terms and subject to the conditions of the arrangement agreement dated August 28, 2023 between Cybin and Small Pharma (for further information, please see the sections entitled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background to the Arrangement &#38; Recommendations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the Circular (as defined herein))&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to receive the audited consolidated financial statements of Cybin as at and for the years ended March 31, 2023 and 2022, together with the report of the auditors thereon&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to appoint Zeifmans LLP as Cybin&#8217;s auditors and to authorize the directors to fix their remuneration (for further information, please see the section entitled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Matters to be Acted Upon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Appointment and Remuneration of Auditors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the Circular)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to determine the number of directors to be elected to be six (for further information, please see the section entitled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Matters to be Acted Upon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Election of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the Circular)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to elect directors to Cybin&#8217;s board of directors (for further information, please see the section entitled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Matters to be Acted Upon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Election of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the Circular) (items 3 to 5 being, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Annual Resolutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accompanying this Notice of Annual and Special Meeting of Shareholders is the management information circular of Cybin dated September 13, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Circular</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), which provides specific details of the business to be considered at the Meeting, a form of proxy for Cybin Shareholders and a financial statement request card. The full text of the Acquisition Resolution is set out in Schedule A to the Circular. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If the Arrangement is not completed, the Cybin Shares referred to in the Acquisition Resolution will not be issued, even if the Acquisition Resolution is approved at the Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The board of directors of Cybin unanimously recommends that Cybin Shareholders </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">VOTE FOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Acquisition Resolution and the Cybin Annual Resolutions. It is a condition to the completion of the Arrangement that the Acquisition Resolution be approved at the Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Meeting will be held in a virtual meeting format only via live webcast online. You must register at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;register.proxypush.com&#47;cybn</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon completing your registration, you will receive further instructions via email, including a unique link that will allow you access to the Meeting. Cybin Shareholders and duly appointed proxyholders will be able to attend the Meeting (virtually), submit questions and vote by online ballot, provided they are connected to the internet and follow the instructions in the Circular. On the day of the meeting, Cybin Shareholders may begin to log in to the virtual-only Meeting 15 minutes prior to the Meeting. The Meeting will begin promptly at 1&#58;00 p.m. (Toronto time).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Cybin Shareholder wishing to be represented by proxy at the Meeting or any adjournment thereof must deposit their duly executed form of proxy with Cybin&#8217;s transfer agent and registrar, Odyssey Trust Company, (a) by mail at Attn&#58; Proxy Department, 67 Yonge Street, Suite 702, Toronto, Ontario M5E 1J8, or (b) by voting online at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;vote.odysseytrust.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and entering their 12 digit control number by no later than 1&#58;00 p.m. (Toronto time) on Tuesday, October 10, 2023 or if the Meeting is adjourned, not less than 24 hours (excluding Saturdays, Sundays and holidays) before the time set for any reconvened meeting at which the proxy is to be used.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Shareholders who wish to appoint a person other than the management nominees identified in the form of proxy to participate at the Meeting as their proxy and vote their Cybin Shares, must deposit their proxy appointing such third party proxyholder AND complete the additional step of registering the proxyholder by emailing Odyssey Trust Company at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">appointee&#64;odysseytrust.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> by no later than 1&#58;00 p.m. (Toronto time) on Tuesday, October 10, 2023, or if the Meeting is adjourned, not less than 24 hours (excluding Saturdays, Sundays and holidays) before the time set for any reconvened meeting at which the proxy is to be used, and provide Odyssey Trust Company with the required proxyholder contact information, the number of Cybin Shares appointed and the name in which the Cybin Shares are registered, so that Odyssey Trust Company may provide the proxyholder with credentials via email. Failure to register the proxyholder with Odyssey Trust Company will result in the proxyholder not receiving login credentials to participate at the Meeting and not being able to attend, participate or vote at the Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The record date for the purposes of determining the Cybin Shareholders entitled to receive notice of and to vote at the Meeting and any adjournment(s) or postponement(s) is the close of business on August 30, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Record Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The Cybin Shareholders of record as of the close of business on the Record Date will be entitled to receive this Notice of the Annual and Special Meeting of Shareholders and the accompanying Circular and to (virtually) attend and vote at the Meeting and any adjournment(s) or postponement(s) thereof. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DATED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> at Toronto, Ontario on September 13, 2023.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="padding-left:270.8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.739%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BY ORDER OF THE BOARD</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Eric So&#8221;</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eric So </font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chair and President</font></div></td></tr></table></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_13"></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUESTIONS &#38; ANSWERS REGARDING THE ARRANGEMENT AND THE MEETING</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All capitalized terms used herein but not otherwise defined have the meanings set forth under &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management Information Circular</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Glossary of Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in this Circular.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Circular is provided to you in connection with the solicitation by or on behalf of management of Cybin of proxies to be used at the Meeting to be held in a virtual-only format via live audio webcast on Thursday, October 12, 2023 at 1&#58;00 p.m. (Toronto time) for the purposes indicated in the Notice of Meeting. You will not be able to attend the Meeting in person. Registration is required online at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;register.proxypush.com&#47;cybn. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Your vote is very important. Cybin Shareholders are strongly encouraged to submit their votes in advance of the Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The questions and answers below give general information regarding the Arrangement and guidance for voting your Cybin Shares and related matters. Unless otherwise noted, all answers relate to both Cybin Registered Shareholders and Cybin Beneficial Shareholders.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Questions Regarding the Arrangement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;Why is the Meeting being held&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to annual shareholder matters, the Meeting is being held because Cybin and Small Pharma have entered into the Arrangement Agreement, pursuant to which Cybin has agreed to acquire all of the issued and outstanding Small Pharma Shares by way of the Arrangement in exchange for the issuance of 0.2409 Cybin Shares for each issued and outstanding Small Pharma Share. Cybin expects to issue approximately 81,010,487 Cybin Shares to Former Small Pharma Shareholders, representing approximately 34.5% of the 234,683,234 Cybin Shares issued and outstanding (on a non-diluted basis) as at the date of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the policies of the Cboe Canada, because the total number of Cybin Shares issuable pursuant to the Arrangement is more than 25% of the total number of Cybin Shares issued and outstanding, the Arrangement must be approved by Cybin Shareholders.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arrangement cannot proceed unless a number of conditions are satisfied, including the approval of the Acquisition Resolution by Cybin Shareholders. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;What are Cybin Shareholders being asked to vote on&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the Meeting, Cybin Shareholders will be asked to approve the Arrangement. The full text of the Acquisition Resolution is attached as Schedule A to the Circular. Also see &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Required Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shareholder Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Meeting is also an annual shareholder meeting. Cybin Shareholders will receive Cybin&#8217;s audited consolidated financial statements as at and for the years ended March 31, 2023 and 2022, and the report of the auditors on such financial statements, and will be asked to vote to&#58; (i) appoint Cybin&#8217;s auditors for the ensuing year and to authorize the directors to fix their remuneration&#59; (ii) determine the number of directors to be elected to be six&#59; and (iii) elect directors for the ensuing year. Details regarding annual shareholder matters to be considered at the Meeting are provided under the heading &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Matters to be Acted Upon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;What approvals are being sought at the Meeting&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to be effective, the Acquisition Resolution must be approved by a simple majority of the votes cast thereon by the Cybin Shareholders present (virtually) or represented by proxy at the Meeting. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Required Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shareholder Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Cybin Shareholders will be asked to approve each of the annual matters to be considered at the Meeting, including the appointment of the auditors of Cybin, setting the number of directors to be elected at six and electing the directors of Cybin for the ensuing year. In connection with the election of directors, Cybin has adopted a majority voting </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">policy as described under &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Matters to be Acted Upon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Election of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Majority Voting Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the Circular.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;What other approvals are required for the Arrangement&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to approval of the Acquisition Resolution by Cybin Shareholders, the Arrangement requires a number of additional approvals to become effective, including&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Arrangement Resolution must be approved by Small Pharma Shareholders at the Small Pharma Meeting by at least 66 &#8532;% of the votes cast on the Arrangement Resolution by the Small Pharma Shareholders present in person (virtually) or represented by proxy at the Small Pharma Meeting&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Court must grant the Final Order approving the Arrangement&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Cboe Canada and the NYSE American must have conditionally approved the listing of the Consideration Shares, subject to satisfaction of standard listing conditions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Required Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;Does the Cybin Board support the Arrangement&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Yes.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Cybin Board, based upon careful consideration, has unanimously determined that the Arrangement and the entry into the Arrangement Agreement are in the best interests of Cybin, and approved the Arrangement Agreement and the transactions contemplated thereby.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Cybin Board unanimously recommends that Cybin Shareholders </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">VOTE FOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> the Acquisition Resolution.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In making its recommendation, the Cybin Board considered a number of factors as described in this Circular under the heading &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background to the Arrangement &#38; Recommendations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reasons for the Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;Why is Cybin proposing to acquire Small Pharma&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combination of Cybin and Small Pharma creates an international, clinical-stage leader, holding a significantly expanded portfolio of clinical-and pre-clinical stage psychedelic assets that are highly complementary. Post-Arrangement Cybin&#8217;s combined DMT programs will constitute a significantly expanded dataset of systematic research on these short-duration psychedelic molecules, which will better enable Post-Arrangement Cybin&#8217;s to make informed, data-driven strategic decisions for its development programs, increasing the likelihood of success.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;What will happen to Small Pharma Options under the Arrangement&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Plan of Arrangement, each In-the-Money Small Pharma Option outstanding immediately prior to the Effective Time (whether vested or unvested) shall be deemed to be, exercised and surrendered to Small Pharma for cancellation and the holders thereof shall receive, in respect of each such surrendered In-the-Money Small Pharma Option, the Option Consideration. Each Out-of-the-Money Small Pharma Option outstanding at the Effective Time, shall be, and shall be deemed to be, surrendered to Small Pharma for cancellation and the holders thereof shall receive, in respect of each such surrendered Out-of-the-Money Small Pharma Option, a cash payment from the Small Pharma equal to $0.001 per Out-of-the-Money Small Pharma Option.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is expected that 11,828,850 Small Pharma Options will be exercised prior to the Effective Time. Following such exercises, no Small Pharma Options are expected to be In-the-Money Small Pharma Options, assuming that the Small Pharma Share Value will be approximately $0.10 per Small Pharma Share.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;How many Cybin Shares are expected to be issued at the Effective Time&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Plan of Arrangement, Small Pharma Shareholders will receive, for each Small Pharma Share held, 0.2409 Cybin Shares. As at the date of this Circular, there are 324,453,787 Small Pharma Shares outstanding. It is expected that </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">approximately 81,010,487 Cybin Shares will be issued as Consideration for the Small Pharma Shares, subject to certain assumptions, including that (i) no Small Pharma Shareholders will exercise Dissent Rights&#59; (ii) 11,828,850 Small Pharma Options will be exercised prior to the Effective Time&#59; and (iii) no other Small Pharma Options will be Small Pharma In-the-Money Options at the Effective Time. In such circumstances, current Cybin Shareholders and former Small Pharma Shareholders will own approximately 74.3% and 25.7% of the outstanding Cybin Shares, respectively, as at the date of the Arrangement Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effects of the Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background to the Arrangement &#38; Recommendations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reasons for the Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;Have any Cybin Shareholders or Small Pharma Shareholders agreed to vote in favour of the Arrangement&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Yes. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the directors, senior officers of Cybin, and certain significant shareholders of Cybin who collectively hold approximately 17% of the issued and outstanding Cybin Shares as of the Record Date, have entered into support and voting agreements with Small Pharma, whereby such Cybin Shareholders have agreed to, among other things, support the Arrangement and vote their Cybin Shares in favour of the Acquisition Resolution, subject to certain exceptions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Cybin has entered into support and voting agreements with the Small Pharma Supporting Shareholders, which include each of the directors and executive officers of Small Pharma who own Small Pharma Shares, as well as Small Pharma&#8217;s largest shareholder, pursuant to which such Small Pharma Supporting Shareholders have agreed to, among other things, vote all their Small Pharma Shares in favour of the Arrangement Resolution. The Small Pharma Supporting Shareholders collectively own, or exercise control or direction over, approximately 28.8% of the issued and outstanding Small Pharma Shares as at the date of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Support and Voting Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for more information.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;When will the Arrangement become effective&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is currently expected that the Effective Date will occur on or about October 17, 2023, and in no event will completion of the Arrangement occur later than November 30, 2023, unless extended by mutual agreement of the Parties in accordance with the terms of the Arrangement Agreement. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Timing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;What will happen if the Acquisition Resolution is not approved by Cybin Shareholders or the Arrangement is not completed for any reason&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Acquisition Resolution is not approved by Cybin Shareholders, the Arrangement Agreement may be terminated. In the event the Arrangement Agreement is terminated (i) by Small Pharma or Cybin in the event that the Acquisition Resolution is not approved by Cybin Shareholders or (ii) by Small Pharma as a result of Cybin&#8217;s breach of representations and warranties, then, in certain circumstances, Small Pharma will be entitled to receive from Cybin an expense reimbursement of $400,000. In addition, Cybin may be required to pay a termination fee of $2,000,000 to Small Pharma in certain circumstances. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expenses and Termination Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Questions Regarding the Meeting</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;Who is entitled to attend and vote at the Meeting&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin Shareholders of record as of the close of business on August 30, 2023, the Record Date for the Meeting, are entitled to receive notice of and to attend and vote at, the Meeting or any adjournment(s) or postponement(s) thereof.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;When will the Meeting be held and how can I attend&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Meeting will be held on Thursday, October 12, 2023 commencing at 1&#58;00 p.m. (Toronto time), subject to any adjournment(s) or postponement(s) thereof. The Meeting will be hosted online by way of a live audio webcast and Cybin Shareholders will not be able to attend the Meeting in person. To attend the Meeting, Cybin Shareholders and duly appointed proxyholders must register at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;register.proxypush.com&#47;cybn</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon completing your registration, you will </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receive further instructions via email, including a unique link that will allow you access to the Meeting and to vote and submit questions during the Meeting. On the day of the meeting, Cybin Shareholders may begin to log in to the virtual-only meeting 15 minutes prior to the Meeting. The Meeting will begin promptly at 1&#58;00 p.m. (Toronto time).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you log in to the Meeting, you will not be revoking any previously submitted proxies. However, if you vote on a ballot you will be revoking any and all previously submitted Proxies. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If you DO NOT wish to revoke your previously submitted Proxies, do not vote at the Meeting.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> You may also choose to enter the Meeting as a guest. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the Circular.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Voting during the Meeting will only be available for registered Cybin Shareholders and duly appointed proxyholders (including Cybin Beneficial Shareholders who have appointed themselves as proxyholder). Cybin Beneficial Shareholders who have not appointed themselves as their proxyholder may attend the Meeting by registering as a guest at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;register.proxypush.com&#47;cybn</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon completing your registration, you will receive further instructions via email, including a unique link that will allow you access to the Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Shareholders who wish to appoint a third party proxyholder to represent them at the virtual Meeting must submit their proxy or VIF (as applicable) and register their proxyholder with Odyssey Trust Company, Cybin&#8217;s transfer agent. Registering the proxyholder is an additional step once a Cybin Shareholder has submitted their proxy or VIF. Failure to register a duly appointed proxyholder will result in the proxyholder not receiving credentials to participate at the Meeting. To register a proxyholder, Cybin Shareholders MUST email Odyssey Trust Company at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">appointee&#64;odysseytrust.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> by no later than 1&#58;00 p.m. (Toronto time) on Tuesday, October 10, 2023, or if the Meeting is adjourned, not less than 24 hours (excluding Saturdays, Sundays and holidays) before the time set for any reconvened meeting at which the proxy is to be used, and provide Odyssey Trust Company with the required proxyholder contact information, the number of Cybin Shares appointed and the name in which the Cybin Shares are registered, so that Odyssey Trust Company may provide the proxyholder with credentials via email. Failure to register the proxyholder with Odyssey Trust Company will result in the proxyholder not receiving login credentials to participate at the Meeting and not being able to attend, participate or vote at the Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;What if I encounter technical difficulties while attending the Meeting&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you participate in the virtual Meeting, it is important that you are connected to the internet at all times during the Meeting in order to vote when the applicable balloting commences. It is your responsibility to ensure connectivity for the duration of the Meeting. You should allow ample time to login to the virtual Meeting and complete the above procedure.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Meeting participants must use the latest versions of Chrome, Safari, Microsoft Edge, or Firefox. As internal network security protocols, such as firewalls or VPN connections may block access to the virtual meeting platform, please ensure that you use a network that is not restricted by the security settings of your organization or that you have disabled your VPN settings. Should you encounter any difficulties accessing the virtual-only Meeting platform, including any difficulties voting or submitting questions, you may call the technical support number that will be posted in your instructional email.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;Can I ask questions at the Meeting&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin Registered Shareholders and duly appointed proxyholders may ask questions during the Meeting. While logged in for the Meeting you will be able to submit questions online by clicking on the button.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Guests, including Cybin Beneficial Shareholders who have not appointed themselves as proxyholder, will be permitted to attend and to listen to the Meeting however, they will not be able to vote or submit questions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;How can a Registered Cybin Shareholder vote&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You are a Registered Cybin Shareholder if you hold any Cybin Shares in your own name, as recorded in the shareholder register of Cybin maintained by Odyssey Trust Company.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you are a Registered Cybin Shareholder, you can vote your Cybin Shares in the following manner&#58;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Online</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;vote.odysseytrust.com </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mail</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; Using the envelope accompanying your proxy&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If you want to attend the Meeting and vote online during the Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Register at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;register.proxypush.com&#47;cybn</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Upon completing your registration, you will receive further instructions via email, including a unique link that will allow you access to the Meeting and to vote and submit questions during the Meeting&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;On the day of the Meeting, October 12, 2023, stockholders may begin to log in to the virtual-only Meeting 15 minutes prior to the Meeting&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;VOTE.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;How can a Cybin Beneficial Shareholder vote&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you are a Cybin Beneficial Shareholder, you can vote your Cybin Shares in the following manner&#58;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mail</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; Using the envelope accompanying your VIF&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Phone&#47;Fax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; Using the number(s) listed on your VIF&#59; or</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If you want to attend the Meeting and vote online during the Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;appoint yourself as proxyholder in accordance with the instructions provided in your VIF (see &#8220;How can I attend the Meeting&#8221; above)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;register at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;register.proxypush.com&#47;cybn</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;upon completing your registration, you will receive further instructions via email, including a unique link that will allow you access to the Meeting and to vote and submit questions during the Meeting&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;VOTE.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin Beneficial Shareholders should carefully follow the instructions of their Intermediaries and their service companies, including instructions regarding when and where the VIF or proxy form is to be delivered. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Advice to Beneficial Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for additional information.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;Should I send in my proxy now&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Yes.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To ensure your vote is counted, Cybin Shareholders should immediately complete and submit the enclosed proxy or VIF, or vote by internet or telephone in accordance with the instructions provided therein. You are encouraged to vote well in advance of the proxy deadline to ensure that your Cybin Shares are voted at the Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;When is the proxy voting deadline&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proxies will not be valid unless the completed, dated and signed proxy is received by Odyssey Trust Company, 67 Yonge Street, Suite 702, Toronto, Ontario M5E 1J8 not later than 1&#58;00 p.m. (Toronto time) on Tuesday, October 10, 2023 or not later than 48 hours (excluding Saturdays, Sundays and holidays) before the time of the Meeting as it may be adjourned or postponed from time to time. The deadline for the deposit of proxies may be waived or extended by the Chair of the Meeting at his sole discretion, without notice.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q&#58;&#160;&#160;&#160;&#160;Do I have dissent rights&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cybin Shareholders are not entitled to exercise dissent rights in respect of the Acquisition Resolution.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_16"></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT INFORMATION CIRCULAR</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Matters</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated, all information contained in this Circular is given as of September 13, 2023.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All dollar amounts set forth in this Circular are in Canadian. dollars, except where otherwise indicated.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Circular contains references to U.S. dollars and Canadian dollars. All dollar amounts referenced in this Circular are expressed in Canadian dollars or &#8220;$&#8221;, unless otherwise indicated. References to U.S. dollars or &#8220;US$&#8221; refer to the legal tender of the United States. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets out the average exchange rates for each period indicated according to information published by the Bank of Canada</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:32.39pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.156%"><tr><td style="width:1.0%"></td><td style="width:41.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.070%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.070%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.073%"></td><td style="width:0.1%"></td></tr><tr style="height:17pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31</font></td></tr><tr style="height:17pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">One Canadian dollar in U.S. dollars</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7685</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7978</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7454</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">One U.S. dollar in Canadian dollars</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3013</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2535</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3415</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br>On September 12, 2023, being the last business day before the date of this Circular, the daily exchange rate as quoted by the Bank of Canada for Canadian dollars into U.S. dollars was $1.00 &#61; US$, and Canadian dollars in terms of the U.S. dollar, as, was US$1.00 &#61; $1.3560.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of Cybin and Small Pharma that are incorporated by reference in this Circular are reported in Canadian dollars and are prepared in accordance with IFRS. The pro forma financial statements of Post-Arrangement Cybin that are included as Schedule F to this Circular are reported in Canadian dollars.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Glossary of Terms</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a glossary of certain terms used in this Circular including Schedule C, Schedule D and Schedule E. Terms and abbreviations used in the other schedules to this Circular are defined separately and the terms and abbreviations defined below are not used therein, except where otherwise indicated.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020 EMI Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Rules of the Small Pharma Ltd 2020 Employee Share Option Plan, as adopted by the board of directors of Small Pharma Ltd. (a predecessor to, and now a subsidiary of, Small Pharma) on March 24, 2020.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition Proposal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, other than the Arrangement and the transactions required for the Parties to effect the Arrangement under the Arrangement Agreement, any proposal, inquiry or offer (written or oral) made by any Person, alone or with others, other than a Party or one or more of its affiliates, relating to (in each case whether in one transaction or a series of transactions, and whether directly or indirectly)&#58; (i) an issuance or acquisition of 20% or more of any class of voting or equity securities (and&#47;or securities convertible into or exchangeable or exercisable for voting or equity securities, assuming, if applicable, the conversion, exchange or exercise of such securities) of a Party or any of its Subsidiaries (except, with respect to Cybin, a Cybin Permitted Financing)&#59; (ii) a take-over bid, tender offer, exchange offer, or other transaction that, if consummated, would result in a Person, together with any Persons acting jointly or in concert, beneficially owning, or exercising control or direction over, 20% or more of any class of voting or equity securities (and&#47;or securities convertible into or exchangeable or exercisable for voting or equity securities, assuming, if applicable, the conversion, exchange or exercise of such securities) of a Party or any of its Subsidiaries&#59; (iii) a direct or indirect acquisition or sale, disposition or joint venture (or a lease, long-term supply agreement or other arrangement having a similar economic effect as a sale or disposition) of assets that represent 20% or more of the consolidated assets of a Party and its Subsidiaries (based on the financial statements of the Party most recently filed on SEDAR+ before the date of the proposal, inquiry or offer), as determined in good faith by the board of directors of such Party following consultation with its financial advisor&#59; (iv) an amalgamation, arrangement, merger, business combination or consolidation involving a Party or any of its Subsidiaries&#59; (v) a recapitalization, issuer bid, liquidation, dissolution, reorganization or similar transaction involving a Party or any of its </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsidiaries&#59; or (vi) any other transaction, the consummation of which would or could reasonably be expected to interfere with, prevent or materially delay the transactions contemplated by the Arrangement Agreement or the Arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition Resolution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the ordinary resolution approving the Arrangement, to be considered at the Meeting, in the form set out in Schedule A.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in the Securities Act.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aird &#38; Berlis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Aird &#38; Berlis LLP.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Annual Cybin MD&#38;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Cybin&#8217;s management&#8217;s discussion and analysis for the year ended March 31, 2023.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the arrangement under section 288 of the BCBCA on the terms and subject to the conditions set out in the Plan of Arrangement, subject to any amendments or variations thereto in accordance with the Arrangement Agreement or the Plan of Arrangement or at the direction of the Court in the Final Order with the prior written consent of Small Pharma and Cybin, each acting reasonably.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Arrangement Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Arrangement Agreement among Cybin and Small Pharma dated August 28, 2023 as the same may be amended, supplemented or otherwise modified from time to time in accordance with its terms&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Arrangement Resolution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the special resolution of the Small Pharma Shareholders approving the Arrangement to be considered at the Small Pharma Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Audit Committee of the Cybin Board.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation &#8211; Elements of Compensation &#8211; Cybin Equity Incentive Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BCBCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Business Corporations Act (British Columbia).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Nominee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Matters to be Acted Upon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Election of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Broadridge</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Meeting &#8211; Advice to Beneficial Shareholders&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any day excluding a Saturday, Sunday or statutory holiday in the Province of British Columbia or the Province of Ontario, and also excluding any day on which the principal chartered banks located in the Cities of Toronto or Vancouver are not open for business during normal banking hours or any day on which the Court is not sitting during normal hours.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cashless Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation &#8211; Elements of Compensation &#8211; Cybin Equity Incentive Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Type of Awards &#8211; Cybin Options&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Canadian Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Securities Act, together with all other applicable provincial securities laws, rules and regulations and published policies thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cboe Canada</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Cboe Canada exchange (formerly the NEO Exchange).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CEO Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation &#8211; Management Contracts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Change in Recommendation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means circumstances where, in the case of Small Pharma&#58; (a) the Small Pharma Board fails to include the Small Pharma Board Recommendation in the Circular&#59; (b) the Small Pharma Board withdraws, modifies, qualifies, or publicly proposes or states an intention to withdraw, modify, or qualify, the Small Pharma Board Recommendation&#59; (c) the Small Pharma Board accepts, approves, endorses or recommends, or publicly proposes to accept, approve, endorse or recommend an Acquisition Proposal, or takes no position or remains neutral with respect to a publicly </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disclosed Acquisition Proposal for more than five Business Days (or beyond the third Business Day prior to the date of the Meeting, if sooner)&#59; or (d) the Small Pharma Board fails to reaffirm the Small Pharma Board Recommendation, by press release, upon the written request by Cybin, promptly after any Acquisition Proposal that is publicly disclosed is determined not to be (or no longer to be) a Superior Proposal, within three Business Days of Cybin&#8217;s request (or, if the Meeting is scheduled to occur within that three Business Day period, before the Meeting)&#59; or in the case of Cybin&#58; (a) the Cybin Board fails to include the Cybin Board Recommendation in the Cybin Circular&#59; (b) the Cybin Board withdraws, modifies, qualifies, or publicly proposes or states an intention to withdraw, modify, or qualify, the Cybin Board Recommendation&#59; (c) the Cybin Board accepts, approves, endorses or recommends, or publicly proposes to accept, approve, endorse or recommend an Acquisition Proposal, or takes no position or remains neutral with respect to a publicly disclosed Acquisition Proposal for more than five Business Days (or beyond the third Business Day prior to the date of the Cybin Meeting, if sooner)&#59; or (d) the Cybin Board fails to reaffirm the Cybin Board Recommendation, by press release, upon the written request by Small Pharma, promptly after any Acquisition Proposal that is publicly disclosed is determined not to be (or no longer to be) a Cybin Superior Proposal, within three Business Days of Small Pharma&#8217;s request (or, if the Cybin Meeting is scheduled to occur within that three Business Day period, before the Cybin Meeting).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Circular</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means this management information circular.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Compensation Committee of the Cybin Board.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the consideration to be received by the Small Pharma Shareholders pursuant to the Plan of Arrangement as consideration for the Small Pharma Shares, consisting of 0.2409 Cybin Share for each Small Pharma Share.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consideration Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Cybin Shares to be issued to the Small Pharma Shareholders as part of the Consideration pursuant to the Arrangement. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Court</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Supreme Court of British Columbia.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the coronavirus disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and&#47;or any other virus or disease developing from or arising as a result of SARS-CoV-2 and&#47;or COVID-19.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Cybin Inc., a corporation existing under the laws of Ontario.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin AIF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the annual information form of Cybin for the year ended March 31, 2023, dated June 27, 2023.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Beneficial Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Meeting &#8211; Advice to Beneficial Shareholders&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the board of directors of Cybin.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Board Recommendation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background to the Arrangement &#38; Recommendations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recommendation of the Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Equity Incentive Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Cybin&#8217;s omnibus equity incentive plan adopted by the Cybin Board on November 5, 2020.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Dividend Equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation &#8211; Elements of Compensation &#8211; Cybin Equity Incentive Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an option to purchase Cybin Shares issued pursuant to the Cybin Equity Incentive Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Performance Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation &#8211; Elements of Compensation &#8211; Cybin Equity Incentive Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Permitted Financing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means one or more offerings of Cybin Shares (and&#47;or securities convertible into or exchangeable or exercisable for Cybin Shares) for aggregate gross proceeds of up to US$50 million.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Privateco</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reverse Takeover Transaction&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Registered Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; are Cybin Shareholders whose names appear directly on the list of Cybin Shareholders maintained by Cybin&#8217;s registrar. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin RSU</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation &#8211; Elements of Compensation &#8211; Cybin Equity Incentive Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation &#8211; Elements of Compensation &#8211; Cybin Equity Incentive Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Share Based Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation &#8211; Elements of Compensation &#8211; Cybin Equity Incentive Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Shareholder Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the approval of the Acquisition Resolution by a simple majority of the votes cast in respect of the Acquisition Resolution by Cybin Shareholders present in person (virtually) or represented by proxy at the Meeting, as required by the Cboe Canada.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the holders of outstanding Cybin Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means common shares in the capital of Cybin.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Support and Voting Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the support and voting agreements (including all amendments thereto) between Small Pharma and the Cybin Supporting Shareholders setting forth the terms and conditions upon which the Cybin Supporting Shareholders agree to vote their Cybin Shares in favour of the Acquisition Resolution.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Supporting Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means each of the senior officers and directors of Cybin.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Termination Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a fee of $2,000,000, payable by Cybin to Small Pharma under certain circumstances if the Arrangement Agreement is terminated.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Warrants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Cybin Share purchase warrants exercisable to acquire one Cybin Share at a price of US$0.40 per Cybin Share until August 4, 2028.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Depositary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any trust company, bank or financial institution agreed to in writing between Cybin and Small Pharma for the purpose of, among other things, exchanging certificates representing Small Pharma Shares for certificates representing Consideration Shares and paying the cash consideration forming part of the Consideration in connection with the Arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dissent Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the rights of dissent granted in favour of Small Pharma Shareholders in respect of the Arrangement, as described in the Plan of Arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dissent Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in the Plan of Arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dissenting Shareholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a registered holder of Small Pharma Shares who has duly and validly exercised their Dissent Rights in strict compliance with the dissent procedures set out under Division 2 of Part 8 of the BCBCA, as modified by the Plan of Arrangement, the Interim Order and the Final Order and who has not withdrawn or been deemed to have withdrawn such exercise of Dissent Rights.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DMT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means N, N-dimethyltryptamine.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EDGAR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Electronic Data Gathering, Analysis, and Retrieval system under the U.S. Securities Act and available for public view at www.sec.gov. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date upon which the Arrangement becomes effective.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effective Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the beginning of the day (Vancouver time) on the Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMI Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (i) the 2020 EMI Plan&#59; and (ii) Schedule C (EMI Overseas Sub-Plan) to the Rolling Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exchange Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means 0.2409 Cybin Shares for each Small Pharma Share.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exchanges</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Cboe Canada, the NYSE American and the TSXV, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expense Reimbursement Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a payment of $400,000, payable by Cybin to Small Pharma under certain circumstances if the Arrangement Agreement is terminated.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Final Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the final order of the Court, after being informed of the intention to rely upon the Section 3(a)(10) Exemption and similar exemptions from applicable securities laws of any state of the United States with respect to the issuance of the Consideration Shares to be issued pursuant to the Arrangement to Small Pharma Securityholders in the United States, in a form acceptable to the Parties, acting reasonably, approving the Arrangement as that order may be amended by the Court at any time before the Effective Time with the consent of the Parties, acting reasonably, or, if appealed then, unless that appeal is withdrawn or denied, as affirmed or amended on appeal, provided that any such amendment is acceptable to the Parties, acting reasonably.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Former Small Pharma Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, at and following the Effective Time, the holders of Small Pharma Shares immediately prior to the Effective Time including, for greater certainty, recipient holders of Option Consideration.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">forward-looking statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-Looking Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Canadian generally accepted accounting principles applicable to publicly accountable enterprises under Part I of the CPA Canada Handbook of the Chartered Professional Accountants of Canada.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governmental Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means&#58; (i) any federal, provincial, state, local, municipal, regional, territorial, aboriginal, or other government, governmental or public department, branch, ministry, or court, domestic or foreign, including any district, agency, commission, board, arbitration panel or authority and any subdivision of any of them exercising or entitled to exercise any administrative, executive, judicial, ministerial, prerogative, legislative, regulatory, or taxing authority or power of any nature&#59; (ii) any quasi-governmental or private body exercising any regulatory, expropriation or taxing authority under or for the account of any of them, and any subdivision of any of them&#59; and (iii) any stock exchange, including the Cboe Canada, TSXV, and NYSE American.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gowling WLG</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Gowling WLG (Canada) LLP.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IFRS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means International Financial Reporting Standards, at the relevant time, prepared on a consistent basis.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IM</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means intramuscular. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In-the-Money Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation &#8211; Elements of Compensation &#8211; Cybin Equity Incentive Plan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Types of Awards &#8211; Cybin Options&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In-the-Money Small Pharma Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Small Pharma Option where the exercise price of such Small Pharma Option is less than the Small Pharma Share Value.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In-the-Money Small Pharma Option Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in respect of a Small Pharma Option means the amount, if any, by which the total fair market value (determined immediately before the Effective Time) of the Small Pharma Shares that a holder is entitled to acquire on exercise of the Small Pharma Option immediately before the Effective Time exceeds the amount payable to acquire such shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interim Cybin MD&#38;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Cybin&#8217;s management&#8217;s discussion and analysis for the three months ended June 30, 2023.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interim Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the interim order of the Court, after being informed of the intention to rely upon the Section 3(a)(10) Exemption and similar exemptions from applicable securities laws of any state of the United States with respect to </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the issuance of the Consideration Shares to be issued pursuant to the Arrangement to Small Pharma Securityholders in the United States, in a form acceptable to the Parties, acting reasonably, providing for, among other things, the calling and holding of the Small Pharma Meeting, as the same may be amended, supplemented or varied by the Court, with the consent of the Parties, acting reasonably.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intermediary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an intermediary through which a Cybin Beneficial Shareholder holds its Cybin Shares, including banks, trust companies, securities dealers or brokers and trustees or administrators of self-directed trusts governed by RRSPs, RRIFs, RESPs (each as defined in the Tax Act) and similar plans, and such Intermediary&#8217;s nominees.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investment Canada Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Canada Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Canada) and the regulations thereunder, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means all laws, statutes, codes, ordinances, decrees, rules, regulations, by-laws, statutory rules, principles of law, published policies and guidelines, judicial or arbitral or administrative or ministerial or departmental or regulatory judgments, orders (including the Interim Order and the Final Order), decisions, rulings or awards, including general principles of common and civil law, and the applicable terms and conditions of any grant of approval, permission, authority or licence of any Governmental Authority or self-regulatory authority, and the term &#8220;applicable&#8221; with respect to Law and in a context that refers to one or more Persons, means such Laws as are binding upon such Person or its assets.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Letter of Transmittal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in the Plan of Arrangement. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lock-up Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the lock-up agreements to be entered into between Cybin and each of the Small Pharma Supporting Shareholders at the Effective Time, in accordance with the terms of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lock-up Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to it in &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lock-up Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Locked-up Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to it in &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lock-up Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LottoGopher</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Matters to be Acted Upon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Election of Directors &#8211; Corporate Cease Trade Orders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LPC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Lincoln Park Capital Fund, LLC.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Match Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement Agreement &#8211; Non-Solicitation Covenants and Right to Match</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to a Party, any effect, event, change, occurrence or state of facts that, individually or in the aggregate with other effects, events, changes, occurrences or states of facts, is, or would reasonably be expected to be, material and adverse to the business, condition (financial or otherwise), properties, assets (tangible or intangible), liabilities (contingent or otherwise), capitalization, operations, prospects or results of operations of that Party and its subsidiaries, on a consolidated basis, other than&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any effect, event, change, occurrence or state of facts resulting from or arising in connection with&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any change affecting the psychedelic or pharmaceutical industries generally&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any change in GAAP or its interpretation by any Governmental Authority&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any change or proposed change in Law, or the interpretation, application or non-application of Law by any Governmental Authority&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any change in general economic or political conditions in Canada, the United Kingdom, the United States, or the European Union or any of its member states&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any change in financial, credit, or securities markets in general&#59; </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vi)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any natural disaster or calamity&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any pandemic, epidemic or similar health emergency&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(viii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">war, armed hostilities or acts of terrorism&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unless it relates primarily to (or has the effect of relating primarily to) that Party and its subsidiaries, on a consolidated basis, or adversely affects that Party and its subsidiaries disproportionately, compared to other businesses operating in the same industry and geographic areas as that Party&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any effect, event, change, occurrence or state of facts resulting from or arising in connection with&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any change the trading price or trading volume of any securities of that Party on the Cboe Canada or NYSE American (in the case of the Cybin Shares) or the TSXV (in the case of the Small Pharma Shares) (but the state of facts underlying that change may be considered to determine whether a Material Adverse Effect has occurred if such underlying cause does not otherwise fall within any of the exceptions to this definition)&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the announcement or pending consummation of the Arrangement Agreement or the Arrangement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any action taken (or not taken) by a Party that is required to be taken (or not taken) under the Arrangement Agreement or that is consented to by the Other Party in writing&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and provided that references in the Arrangement Agreement to dollar amounts are not intended to be, and will not be deemed to be, illustrative or interpretive for purposes of determining whether a Material Adverse Effect has occurred. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MDD</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means major depressive disorder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the annual and special meeting of Cybin Shareholders to be held at 1&#58;00 p.m. (Toronto time) on Thursday, October 12, 2023 or any adjournment(s) or postponement(s) thereof for the purposes set forth in the accompanying Notice of Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Meeting Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, collectively, the Notice of Meeting, this Circular and a form of proxy or voting instruction form (if applicable).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MI 61-101</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Multilateral Instrument 61-101 &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Protection of Minority Security Holders in Special Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NEO Exchange Listing Manual</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the policy manual of that governs companies listed on the Cboe Canada.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NI 51-102</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means National Instrument 51-102 &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Continuous Disclosure Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NI 52-110</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means National Instrument 52-110 &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Audit Committees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NI 58-101</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means National Instrument 58-101 &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure of Corporate Governance Practices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notice of Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the notice of the annual and special meeting of Cybin Shareholders which accompanies this Circular.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NYSE American</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the NYSE American exchange. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OBCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Corporations Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Ontario) and the regulations thereunder, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Option Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, subject to any withholding pursuant to section 5.03 of the Plan of Arrangement, in respect of an In-the-Money Small Pharma Option, such number of Small Pharma Shares obtained by dividing&#58; (i) In-the-Money </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Small Pharma Option Amount in respect of such In-the-Money Small Pharma Option, by (ii) the Small Pharma Share Value, with the result rounded down to the nearest whole number of Small Pharma Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Matters to be Acted Upon &#8211; Election of Directors &#8211; Corporate Cease Trade Orders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (a) with respect to Cybin, Small Pharma, and (b) with respect to Small Pharma, Cybin.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTCQB Market</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the OTCQB Venture Market.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Out-of-the-Money Small Pharma Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Small Pharma Option where the exercise price of such Small Pharma Option is greater than the Small Pharma Share Value.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outside Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means November 30, 2023, or such later date as the Parties may agree in writing.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation &#8211; Elements of Compensation &#8211; Cybin Equity Incentive Plan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any of Small Pharma or Cybin, as the case may be, and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means both of them, collectively.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means authorizations, registrations, permits, certificates of approval, approvals, grants, licences, quotas, consents, commitments, rights or privileges issued or granted by any Governmental Authority.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan of Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the plan of arrangement, substantially in the form of Schedule B, and any amendments or variations thereto made in accordance with the Arrangement Agreement, the Plan of Arrangement or at the direction of the Court.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Post-Arrangement Cybin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Cybin and all of its subsidiaries (including Small Pharma) immediately </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rands Support and Voting Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the support and voting agreement (including all amendments thereto) between Cybin and Peter Rands setting forth the terms and conditions upon which Mr. Rands agrees to vote or cause to be voted all Small Pharma Shares he beneficially owns, or over which he exercises control or direction, in favour of the Arrangement Resolution.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Record Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date for the determination of Cybin Shareholders entitled to receive notice of and to vote at the Meeting or any adjournment(s) or postponement(s) thereof, being August 30, 2023.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registered Cybin Shareholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the registered holder of Cybin Shares as recorded in the shareholder register of Cybin.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means approvals, consents, waivers, sanctions, rulings, determinations, clearances, permissions of Governmental Authorities (including the lapse, without objection, of a prescribed time under a statute or regulation that states that a transaction may be implemented if the prescribed time has lapsed without an objection being made following the giving of notice) or written confirmations of no intention to initiate legal proceedings from Governmental Authorities, in each case required or desirable to consummate the transactions contemplated by the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulation S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Regulation S under the U.S. Securities Act.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Representatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to a Person, its subsidiaries, and its and their directors, officers, employees, consultants, financial advisors, legal counsel, agents or other representatives.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rolling Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Small Pharma&#8217;s 10% rolling stock option plan most recently approved by the Small Pharma Shareholders on July 19, 2022, including the Small Pharma Overseas Sub-Plans.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RTO Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning given to such term in the section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reverse Takeover Transaction&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rule 144</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Rule 144 under the U.S. Securities Act.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the United States Securities and Exchange Commission.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 3(a)(10) Exemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the exemption from the registration requirements of the U.S. Securities Act provided by section 3(a)(10) thereof.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (British Columbia) and the rules, regulations and published policies made thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, collectively, Canadian Securities Laws, the U.S. Securities Act and the U.S. Exchange Act with all other applicable securities laws, rules and regulations and published policies thereunder&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SEDAR+</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the System for Electronic Document Analysis and Retrieval described in National Instrument 13-101 &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">System for Electronic Document Analysis and Retrieval of the Canadian Securities Administrators</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and available for public view at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sedarplus.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Small Pharma Inc., a company existing under the laws of British Columbia.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma AIF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the annual information form of Small Pharma for the year ended February 28, 2023, dated September 12, 2023.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the board of directors of Small Pharma.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma Board Recommendation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Small Pharma Board&#8217;s unanimous&#58; (i) determination that the Arrangement and the entry into the Arrangement Agreement are in the best interests of Small Pharma&#59; (ii) determination that the Arrangement is fair to the Small Pharma Securityholders&#59; (iii) approval of the Arrangement Agreement and the transactions contemplated thereby&#59; and (iv) resolution to recommend that Small Pharma Securityholders vote in favour of the Arrangement Resolution.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the annual and special meeting of Small Pharma Shareholders to be held at 1&#58;00 p.m. (Toronto time) on October 12, 2023 or any adjournment(s) or postponement(s) thereof, to be held in accordance with the Interim Order to consider the Arrangement Resolution, among other things.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma Option Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, collectively, the Rolling Plan and the EMI Plans.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma Optionholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the holder of one or more Small Pharma Options.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the options to purchase Small Pharma Shares granted under the Small Pharma Stock Option Plans.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma Overseas Sub-Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (i) CSOP Small Pharma Overseas Sub-Plan, and (ii) EMI Small Pharma Overseas Sub-Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma Special Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the special committee established by the Small Pharma Board in connection with the transactions contemplated by the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma Securityholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Small Pharma Shareholders and, as applicable, holders of Small Pharma Options.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma Share Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the volume weighted average trading price of the Small Pharma Shares on the TSXV for the five trading days immediately preceding the Effective Time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma Shareholder Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given to such term in section titled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Required Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shareholder Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the holders of Small Pharma Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means common shares in the authorized share structure of Small Pharma.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma Supporting Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means each of the directors and senior officers of Small Pharma who own Small Pharma Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma Termination Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a fee of $2,000,000, payable by Small Pharma to Cybin under certain circumstances if the Arrangement Agreement is terminated.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma Support and Voting Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the support and voting agreements (including all amendments thereto) between Cybin and the Small Pharma Supporting Shareholders setting forth the terms and conditions upon which the Small Pharma Supporting Shareholders agree to vote their Small Pharma Shares in favour of the Arrangement Resolution.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SSRI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means selective serotonin reuptake inhibitor.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Superior Proposal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any unsolicited bona fide written Acquisition Proposal received by a Party after the date of the Arrangement Agreement that&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">did not result from or involve a breach of the Arrangement Agreement by the Party or any of its Representatives&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">complies with Laws&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is for&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the acquisition of all of the voting securities of the Party (that are not already owned by the Person making the Acquisition Proposal and any joint actors and any of their respective affiliates)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the acquisition of all or substantially all of the assets of the Party on a consolidated basis&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is not subject to any financing condition, and in respect of which it has been demonstrated to the satisfaction of the board of directors of the Party, acting in good faith and after consulting with the Party&#8217;s financial advisors and outside legal counsel, that adequate arrangements have been made in respect of any financing required&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is not subject to any due diligence or access condition&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is on terms that the Party, acting in good faith, reasonably believes, after consulting with the Party&#8217;s financial advisors and outside legal counsel&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is reasonably capable of being completed without undue delay relative to the Arrangement, taking into account all legal, financial, regulatory and other aspects of that proposal and the Person making that proposal&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">would, if consummated in accordance with its terms, result in a transaction more favourable to the Party&#8217;s shareholders from a financial perspective than the Arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Canada) and the regulations thereunder, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Termination Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, in the case of Cybin, the Cybin Termination Fee, and in the case of Small Pharma, the Small Pharma Termination Fee.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TSXV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the TSX Venture Exchange.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UK NSIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the National Security and Investment Act 2021 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United Kingdom</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;UK Secretary of State in the Cabinet Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Secretary of State in the Cabinet Office acting as decision maker for the purposes of the UK NSIA.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the United States Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the United States Securities Act of 1933, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, collectively, the U.S. Securities Act and the U.S. Exchange Act with all other applicable securities laws, rules and regulations and published policies thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">United States</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the United States of America, its territories and possessions, any State of the United States and the District of Columbia.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Support and Voting Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, collectively, the Cybin Support and Voting Agreements and the Small Pharma Support and Voting Agreements.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise requires, words importing the singular include the plural and vice versa, words importing any gender include all genders, and references to &#8220;persons&#8221; include natural persons, as well as corporations, companies, partnerships, other organizations and entities, and Governmental Authorities.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Contained in this Circular</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Circular describes the business of the Meeting, items to be voted upon and the voting process. In particular, it contains a detailed description of the Arrangement and the matters to be considered at the Meeting, as well as detailed information regarding Cybin and Small Pharma and certain unaudited pro forma financial information regarding Post-Arrangement Cybin. It also includes certain risk factors relating to the completion of the Arrangement and the other transactions contemplated by the Arrangement Agreement. Additionally, this Circular provides information about annual meeting matters, including Cybin&#8217;s directors, auditors, executive and director compensation, corporate governance and other matters. Please give this material your careful consideration and, if you require assistance, consult your financial, tax or other professional advisors.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Circular does not constitute an offer to sell or a solicitation of an offer to purchase any securities or the solicitation of a proxy by any person in any jurisdiction in which such an offer or solicitation is not authorized or in which the person making such offer or solicitation is not qualified to do so or to any person to whom it is unlawful to make such an offer or solicitation of an offer or a proxy solicitation.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information concerning Small Pharma contained in this Circular has been provided by Small Pharma. Although Cybin has no knowledge that would indicate that any of such information is untrue or incomplete, Cybin does not assume any responsibility for the accuracy or completeness of such information or the failure by Small Pharma to disclose events which may have occurred or may affect the completeness or accuracy of such information but which are unknown to Cybin.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Descriptions of the terms of the Arrangement Agreement and the Plan of Arrangement in this Circular are summaries of the key terms of those documents and are qualified in their entirety by the full text of such agreements. Cybin Shareholders should refer to the full text of each of the Arrangement Agreement and the Plan of Arrangement for complete details of those documents. The full text of the Arrangement Agreement is available under Cybin&#8217;s SEDAR+ profile at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sedarplus.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and on EDGAR at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Plan of Arrangement is attached as a schedule to the Arrangement Agreement, and is attached as Schedule B to this Circular.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements contained in this Circular, and in certain documents incorporated by reference herein, constitute &#8220;forward-looking information&#8221; and &#8220;forward-looking statements&#8221;, within the meaning of applicable Securities Laws </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">forward-looking statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). All statements other than statements of historical fact, including, without limitation, those regarding future financial position, business strategy, budgets, research and development, plans and objectives of management for future operations, and any statements preceded by, followed by or that include the words &#8220;expect&#8221;, &#8220;likely&#8221;, &#8220;may&#8221;, &#8220;will&#8221;, &#8220;should&#8221;, &#8220;intend&#8221;, or &#8220;anticipate&#8221;, &#8220;potential&#8221;, &#8220;proposed&#8221;, &#8220;estimate&#8221;, &#8220;pro forma&#8221;, and &#8220;post-Arrangement&#8221; and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions &#8220;may&#8221; or &#8220;will&#8221; happen, or by discussions of strategy, are forward-looking statements.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In particular, and without limitation, this Circular contains forward-looking statements concerning&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the expected benefits of the Arrangement and attributes of Post-Arrangement Cybin, including potential growth opportunities and operational, competitive and portfolio synergies&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the structure and effect of the Arrangement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the timing of the Meeting, the Small Pharma Meeting and the Final Order&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the anticipated Effective Date&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the anticipated number of Cybin Shares to be issued pursuant to the Arrangement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the anticipated receipt of all required Regulatory Approvals for the Arrangement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the ability of Cybin and Small Pharma to satisfy other conditions to, and to complete, the Arrangement&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the potential costs of the Arrangement to Cybin, including in the event the Arrangement is not completed.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements reflect management&#8217;s current beliefs and are based on information currently available to management, as well as certain expectations and assumptions with respect to the Arrangement, including&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the structure and expected benefits of the Arrangement are based upon a number of factors, including the terms and conditions of the Arrangement Agreement and current industry, economic and market conditions&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certain steps in, and timing of, the Arrangement and the Effective Date, as well as the number of Cybin Shares to be issued pursuant to the Arrangement, are based upon the terms of the Arrangement and advice received from counsel to Cybin relating to timing and expectations&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the listing of the Consideration Shares on the Cboe Canada and the NYSE American, as well as the delisting of the Small Pharma Shares from the TSXV and removal from quotation on the OTCQB, is based on anticipated receipt of all required approvals from such stock exchanges and markets, as applicable&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the approval of the Acquisition Resolution by Cybin Shareholders and the approval of the Arrangement Resolution by Small Pharma Shareholders&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the ability of Cybin and Small Pharma to satisfy the other closing conditions in all material respects in accordance with the terms of the Arrangement Agreement, and in a timely manner, is based upon management&#8217;s current expectations regarding timing and the ability of Cybin and Small Pharma to satisfy their respective obligations under the Arrangement Agreement&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">management&#8217;s current expectations regarding the completion of the Arrangement, the ability to realize operational synergies and clinical development for psychedelic-based treatment options.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the forward-looking statements contained in this Circular are based upon assumptions that management currently believes to be reasonable based on information available to management as at the date of this Circular, there can be no assurance that actual results, performance or achievements will be consistent with these forward looking statements. </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements involve significant risks and uncertainties. A number of factors could cause actual results to differ materially from those anticipated in such forward-looking statements including&#58; (i) changes in general economic and market conditions&#59; (ii) uncertainties related to research &#38; development of product candidates, which are at early stages of development, including the possibility that actual capital and operating costs and economic returns will differ significantly from estimates&#59; (iii) uncertainties related to clinical trials&#59; (iv) Cybin may be unable to adequately protect or defend its intellectual property against infringement&#59; (v) adverse changes in economic, political or social conditions or in applicable laws, rules and regulations&#59; (vi) Cybin may not maintain &#8220;foreign private issuer&#8221; status under the U.S. Securities Laws&#59; (vii) inability to raise additional funding to support operations&#59; (viii) risks associated with Cybin&#8217;s reliance on third parties to plan, conduct and monitor preclinical studies and clinical trials&#59; (ix) Cybin&#8217;s product candidates may fail to demonstrate safety and efficacy to the satisfaction of regulatory authorities or may not otherwise produce positive results&#59; (x) investigational new drug applications to commence clinical trials may not be approved&#59; (xi) Cybin may be unable to complete clinical trials due to difficulties enrolling patients when expected, or at all&#59; (xii) Cybin may fail to successfully compete against other biotechnology and pharmaceutical companies&#59; (xiii) risks associated with Cybin&#8217;s reliance on the capabilities and experience of key executives and scientists&#59; (xiv) the risk of patent-related or other litigation&#59; (xv) adverse changes to the laws or regulations in the United States, the United Kingdom, Canada, the Netherlands, Ireland and other jurisdictions in which Cybin operates may occur&#59; (xvi) fluctuations in foreign exchange rates&#59; and (xvii) Cybin may become subject to environmental costs, events or liability claims.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are also risks inherent in the nature of the Arrangement, including&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin and Small Pharma may fail to realize the anticipated benefits of the Arrangement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the conditions to completion of the Arrangement, including receipt of all required Regulatory Approvals and Court approval may not be satisfied or waived by the Outside Date, or at all, which may result in the Arrangement not being completed&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the timing of the Meeting, the Small Pharma Meeting and Final Order and the anticipated Effective Date may be changed or delayed&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin and Small Pharma will incur significant costs relating to the Arrangement, regardless of whether the Arrangement is completed or not completed&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Arrangement Agreement could be terminated by either Party under certain circumstances&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">if the Arrangement is not completed, Cybin Shareholders will not realize the benefits of the Arrangement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">risks and unforeseen difficulties related to the integration of Cybin&#8217;s and Small Pharma&#8217;s existing businesses, including that Cybin Shareholders may be exposed to additional business risks not previously applicable to their investments in Cybin Shares&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">if there are a significant number of Dissenting Shareholders, a substantial cash payment may be required to be made to such Dissenting Shareholders that could have an adverse effect on Cybin&#8217;s financial condition and cash resources if the Arrangement is completed&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other risks and uncertainties discussed under the heading &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Readers are cautioned that the foregoing lists of factors are not exhaustive and there may be other factors that could affect Cybin, Small Pharma or Post-Arrangement Cybin. Accordingly, undue reliance should not be placed on forward-looking statements. With regard to the forward-looking statements in Cybin&#8217;s and Small Pharma&#8217;s documents incorporated by reference herein, please refer to the forward-looking statements advisories in such documents in respect of the forward-looking statements contained therein, the assumptions upon which they are based and the risk factors in respect of such forward-looking statements.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as required by Law, Cybin and Small Pharma do not undertake any obligation to publicly update or revise any forward-looking statements. All forward-looking statements contained in this Circular are expressly qualified by this </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cautionary statement and those made in each of Cybin&#8217;s filings with Canadian and United States securities regulatory authorities, and Small Pharma&#8217;s filings with the Canadian securities regulatory authorities, that are expressly incorporated by reference herein.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market and Industry Data</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market and industry data contained in the Circular or incorporated by reference in this Circular concerning economic and industry trends is based upon good faith estimates of Cybin&#8217;s management or derived from information provided by industry sources. Cybin believes that such market and industry data is accurate and that the sources from which it has been obtained are reliable. However, Cybin cannot guarantee the accuracy of such information and we have not independently verified the assumptions upon which projections of future trends are based. While Cybin is not aware of any misstatements regarding the industry data presented herein, Cybin&#8217;s estimates involve risks and uncertainties and are subject to change based on various factors, including those discussed under &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in this Circular and in the Cybin AIF.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note to U.S. Shareholders</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE CONSIDERATION SHARES ISSUABLE PURSUANT TO THE ARRANGEMENT HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR THE SECURITIES REGULATORY AUTHORITY OF ANY STATE OF THE UNITED STATES, NOR HAS THE SEC OR ANY SUCH STATE SECURITIES REGULATORY AUTHORITY PASSED UPON THE ACCURACY OR ADEQUACY OF THIS CIRCULAR. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENCE.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance of the Cybin Shares to Small Pharma Securityholders in exchange for Small Pharma Shares (including Small Pharma Shares issued upon the exchange for In-the-Money Small Pharma Options pursuant to the Plan of Arrangement) has not been and will not be registered under the U.S. Securities Act or the securities laws of any state of the United States. Such securities will be issued in reliance upon the Section 3(a)(10) Exemption and exemptions from applicable U.S. Securities Laws. The Section 3(a)(10) Exemption exempts the issuance of securities issued in exchange for one or more bona fide outstanding securities from the general requirement of registration under the U.S. Securities Act where the terms and conditions of the issuance and exchange of such securities have been determined to be substantively and procedurally fair to the persons to whom the securities will be issued by a court of competent jurisdiction, expressly authorized by Law to grant such approval, after a hearing upon the fairness of the terms and conditions of the issuance and exchange at which all persons to whom the securities will be issued have the right to appear and receive timely and adequate notice thereof. The Court is authorized to conduct a hearing at which the fairness of the terms and conditions of the Arrangement will be considered. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Required Approvals </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Court Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. The issuance of the Consideration Shares to Small Pharma Securityholders in exchange for the Small Pharma Shares or In-the-Money Small Pharma Options, in each case pursuant to the Arrangement, will, therefore, be exempt from registration under the U.S. Securities Act pursuant to the Section 3(a)(10) Exemption and will be freely transferable under United States federal securities laws, except that the U.S. Securities Act imposes restrictions on the resale of securities received pursuant to the Arrangement by persons who are, or within the 90 days immediately before the Effective Date were, &#8220;affiliates&#8221; (as defined in Rule 144 under the U.S. Securities Act) of the issuer of those securities. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Securities Laws Matters </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> U.S. Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of Cybin and Small Pharma is a &#8220;foreign private issuer&#8221; as defined in Rule 3b-4 under the U.S. Exchange Act, and this Circular has been prepared in accordance with the disclosure requirements of applicable Canadian Securities Laws. Accordingly, the solicitation of proxies for the Meeting is not subject to the requirements of section 14(a) of the U.S. Exchange Act. As such, the solicitations and transactions contemplated in this Circular are made in the United States for securities of a Canadian issuer in accordance with Ontario corporate Laws and Canadian Securities Laws, and this Circular has been prepared solely in accordance with disclosure requirements applicable in Canada. Cybin Shareholders should be aware that such requirements are different from those of the United States applicable to registration statements under the U.S. Securities Act and proxy statements under the U.S. Exchange Act. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The enforcement by investors of civil liabilities under the U.S. Securities Laws may be affected adversely by the fact that Cybin is organized under the laws of a jurisdiction other than the U.S., that some or all of its officers and directors are residents of countries other than the U.S., that some or all of the experts named in this Circular and the documents incorporated by reference herein may be residents of countries other than the U.S., and that all or a substantial portion of the assets of Cybin, Small Pharma and such persons are located outside the U.S. As a result, it may be difficult or impossible for Cybin Shareholders resident in the U.S. to effect service of process within the U.S. upon Cybin or Small Pharma, their </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respective officers and directors or the experts named in this Circular and any documents incorporated by reference herein, or to realize, against them, upon judgments of courts in the U.S. predicated upon civil liabilities under U.S. Securities Laws. In addition, Cybin Shareholders resident in the U.S. should not assume that Canadian courts&#58; (i) would enforce judgments of U.S. courts obtained in actions against such persons predicated upon civil liabilities under U.S. Securities Laws or the state-specific &#8220;blue sky&#8221; securities laws of any state within the U.S.&#59; or (ii) would enforce, in original actions, liabilities against such persons predicated upon civil liabilities under U.S. Securities Laws or &#8220;blue sky&#8221; laws of any state within the United States.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE MEETING</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Circular is furnished in connection with the solicitation of proxies by and on behalf of the management of Cybin for use at the Meeting to be held in a virtual-only format via live audio webcast on Thursday, October 12, 2023 at 1&#58;00 p.m. (Toronto time) and any adjournment or postponement thereof, for the purposes set forth in the Notice of Meeting. To attend the Meeting, you must register at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;register.proxypush.com&#47;cybn</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Solicitation of Proxies</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While it is expected that the solicitation of proxies will be primarily by mail, to encourage your vote, you may be contacted by Cybin&#8217;s directors, officers, employees or agents by telephone, email, internet, facsimile, or by other means of communication. The solicitation of proxies will primarily be made by sending proxy materials to Cybin Shareholders by mail, but proxies may also be solicited personally or by telephone by regular employees of Cybin. The cost of solicitation will be borne by Cybin. Except as otherwise stated, the information contained herein is given as of September 13, 2023.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as noted below, Cybin has distributed or made available for distribution, the Meeting Materials to Intermediaries for distribution to Cybin Beneficial Shareholders (as defined below) whose Cybin Shares are held by or in custody of such Intermediaries. Such Intermediaries are required to forward such documents to Cybin Beneficial Shareholders unless a Cybin Beneficial Shareholders has waived the right to receive them. Cybin has elected to pay for the delivery of the Meeting Materials to objecting Cybin Beneficial Shareholders by the Intermediaries. Cybin is sending proxy-related materials directly to non-objecting Cybin Beneficial Shareholders, through the services of its transfer agent and registrar, Odyssey Trust Company. The solicitation of proxies from Cybin Beneficial Shareholders will be carried out by the Intermediaries or by Cybin if the names and addresses of the Cybin Beneficial Shareholders are provided by Intermediaries. Cybin will pay the permitted fees and costs of Intermediaries incurred in connection with the distribution of the Meeting Materials. Cybin is not relying on the notice-and-access provisions of Canadian Securities Laws for delivery of the Meeting Materials to registered Shareholders or Cybin Beneficial Shareholders.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Voting at the Meeting</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin Registered Shareholders may vote at the Meeting by completing a ballot online during the Meeting, as further described below. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Appointment and Revocation of Proxies</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A registered Cybin Shareholder can vote by proxy whether or not they attend the Meeting. The persons named in the enclosed form of proxy are officers and&#47;or directors of Cybin. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A registered Cybin Shareholder desiring to appoint some other person (who need not be a Cybin Shareholder) to represent him, her or it at the Meeting may do so either by inserting such person&#8217;s name in the blank space provided in the applicable form of proxy or by completing another proper form of proxy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In either case, a registered Cybin Shareholder can vote by proxy by delivering the completed proxy to Cybin&#8217;s transfer agent and registrar, Odyssey Trust Company, (i) by mail to Attn&#58; Proxy Department, 67 Yonge Street, Suite 702, Toronto, Ontario M5E 1J8 in the prepaid addressed envelope provided for that purpose, or (ii) by voting online at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;vote.odysseytrust.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by no later than 1&#58;00 p.m. (Toronto time) on Tuesday, October 10, 2023, or if the Meeting is adjourned, not less than 24 hours (excluding Saturdays, Sundays and holidays) before the time set for any reconvened meeting at which the proxy is to be used.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Shareholders who wish to appoint a person, other than the management nominees identified on the form of proxy, to attend and participate at the Meeting as their proxy and vote their Cybin Shares, must submit their proxy appointing such third party proxyholder AND complete the additional step of registering the proxyholder by </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">emailing Odyssey Trust Company at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">appointee&#64;odysseytrust.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> by no later than 1&#58;00 p.m. (Toronto time) on Tuesday, October 10, 2023, or if the Meeting is adjourned, not less than 24 hours (excluding Saturdays, Sundays and holidays) before the time set for any reconvened meeting at which the proxy is to be used, and provide Odyssey Trust Company with the required proxyholder contact information, the number of Cybin Shares appointed and the name in which the Cybin Shares are registered, so that Odyssey Trust Company may provide the proxyholder with a username via email. Failure to register the proxyholder with Odyssey Trust Company will result in the proxyholder not receiving login credentials to participate at the Meeting and not being able to attend, participate or vote at the Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Cybin Shareholder has the right to revoke a proxy that has been submitted. To revoke a proxy, the Cybin Shareholder may deliver a written notice to the registered office of Cybin at any time up to and including the last business day before the Meeting or any adjournment of the Meeting. The proxy may also be revoked on the day of the Meeting or any adjournment of the Meeting by delivering written notice to the chair of the Meeting. In addition, the proxy may be revoked by any other method permitted by law. The written notice of revocation may be executed by the Cybin Shareholder or by an attorney who has the Cybin Shareholder&#8217;s written authorization. If the Cybin Shareholder is a corporation, the written notice must be executed by its duly authorized officer or attorney.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exercise of Discretion by Proxies</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The persons named in the accompanying form of proxy will vote the Cybin Shares in respect of which they are appointed in accordance with the direction of the Shareholders appointing them. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In the absence of such direction, such Cybin Shares will be voted in favour of the passing of the matters set out in the Notice of Meeting. The form of proxy confers discretionary authority upon the persons named therein with respect to amendments or variations to matters identified in the Notice of Meeting and with respect to other matters which may properly come before the Meeting or any adjournment thereof</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At the time of the printing of this Circular, the management of Cybin knows of no such amendments, variations or other matters to come before the Meeting other than the matters referred to in the Notice of Meeting. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">However, if any other matters which at present are not known to the management of Cybin should properly come before the Meeting, the proxy will be voted on such matters in accordance with the best judgment of the named proxies.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proxy &#8211; U.S. Cybin Beneficial Shareholders</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you are a Cybin Beneficial Shareholder located in the United States and wish to attend, participate or vote at the Meeting or, if permitted, appoint a third party as your proxyholder, in addition to the steps described herein you must obtain a valid legal proxy from your intermediary. Follow the instructions from your Intermediary included with the legal proxy form and the voting information form sent to you, or contact your Intermediary to request a legal proxy form or a legal proxy if you have not received one. After obtaining a valid legal proxy from your Intermediary, you must then submit such legal proxy to Odyssey Trust Company. Requests for registration from Cybin Beneficial Shareholders located in the United States that wish to attend, participate or vote at the Meeting or, if permitted, appoint a third party as their proxyholder must be sent by e-mail to </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">appointee&#64;odysseytrust.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and received by 1&#58;00 p.m. (Toronto) on Tuesday, October 10, 2023.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How Do I Attend and Participate at the Meeting&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin is holding the Meeting as a completely virtual meeting, which will be conducted via live webcast. Cybin Shareholders will not be able to attend the Meeting in person.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin Registered Shareholders and duly appointed proxyholders will be able to attend, participate and vote at the Meeting. Registration is required online at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;register.proxypush.com&#47;cybn</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon completing your registration, you will receive further instructions via email, including a unique link that will allow you access to the Meeting and to vote and submit questions during the Meeting&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Registered Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; Your control number is located on the form of proxy. If you are using your control number to login to the Meeting and you have previously voted, you do not need to vote again when the polls open. By voting at the Meeting, you will revoke your previous voting instructions received prior to voting cut-off.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Duly appointed proxyholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; Odyssey Trust Company will provide the proxyholder with a credentials by email after the voting deadline has passed. Cybin Registered Shareholders and duly appointed proxyholders will be entitled to attend, participate and vote at the Meeting. Cybin Shareholders who wish to appoint a third party proxy-holder to represent them at the Meeting MUST submit their duly completed proxy AND register the proxyholder. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Appointment and Revocation of Proxies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advice to Beneficial Shareholders</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Shareholders should note that only proxies deposited by Cybin Shareholders whose names appear on the records of Cybin as the registered holders of Cybin Shares, or non-objecting beneficial owners whose names has been provided to Cybin&#8217;s registrar and transfer agent, can be recognized and acted upon at the Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The information set forth in this section is therefore of significant importance to a substantial number of Cybin Shareholders who do not hold their Cybin Shares in their own name (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Beneficial Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). If Cybin Shares are listed in an account statement provided to a Shareholder by an Intermediary, then in almost all cases those Cybin Shares will not be registered in such Cybin Shareholder&#8217;s name on the records of Cybin. Such Cybin Shares will more likely be registered under the name of the Shareholder&#8217;s Intermediary or an agent of that Intermediary. In Canada, the vast majority of such Cybin Shares are registered under the name of CDS &#38; Co., as nominee for CDS Clearing and Depository Services Inc., which acts as a depository for many Canadian Intermediaries. Cybin Shares held by Intermediaries or their nominees can only be voted for or against resolutions upon the instructions of the Cybin Beneficial Shareholders. Without specific instructions, Intermediaries are prohibited from voting Cybin Shares for their clients.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Applicable regulatory policy requires Intermediaries to seek voting instructions from Cybin Beneficial Shareholders in advance of shareholders&#8217; meetings. Every Intermediary has its own mailing procedures and provides its own return instructions, which should be carefully followed by Cybin Beneficial Shareholders in order to ensure that their Cybin Shares are voted at the Meeting. Often the form of proxy supplied to a Cybin Beneficial Shareholders by its Intermediary is identical to the form of proxy provided by Cybin to the Intermediaries. However, its purpose is limited to instructing the Intermediary how to vote on behalf of the Cybin Beneficial Shareholders. The majority of Intermediaries now delegate responsibility for obtaining instructions from clients to Broadridge Financial Solutions, Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Broadridge</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Broadridge typically mails the voting instruction forms or proxy forms to the Cybin Beneficial Shareholders and asks the Cybin Beneficial Shareholders to return the voting instruction forms or proxy forms to Broadridge. Broadridge then tabulates the results of all instructions received and provides appropriate instructions respecting the voting of Cybin Shares to be represented at the Meeting. A Cybin Beneficial Shareholders receiving a proxy or voting instruction form from Broadridge cannot use that proxy to vote Cybin Shares directly at the Meeting. The proxy must be returned to Broadridge well in advance of the Meeting in order to have the Cybin Shares voted.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although Cybin Beneficial Shareholders may not be recognized directly at the Meeting for the purposes of voting Cybin Shares registered in the name of their Intermediary, a Cybin Beneficial Shareholders may attend the Meeting as proxyholder for the Intermediary and vote their Cybin Shares in that capacity. Cybin Beneficial Shareholders who wish to attend the Meeting and indirectly vote their own Cybin Shares as proxyholder for the Intermediary should enter their own names in the blank space on the management form of proxy or voting instruction form provided to them and return the same to their Intermediary (or the agent of such Intermediary) in accordance with the instructions provided by such Intermediary or agent well in advance of the Meeting. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Beneficial Shareholders should carefully follow the instructions of their Intermediaries and their service companies.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All references to Cybin Shareholders at the Meeting are to Cybin Shareholders as of the Record Date unless specifically stated otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note to Non-Objecting Beneficial Owners</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Meeting Materials are being sent to both registered and Cybin Beneficial Shareholders. If you are a Cybin Beneficial Shareholder, and Cybin or its transfer agent and registrar, Odyssey Trust Company, has sent the Meeting Materials directly to you, your name and address and information about your holdings of Cybin Shares, have been obtained in accordance with applicable securities regulatory requirements from the Intermediary holding on your behalf. By choosing to send the Meeting Materials to you directly, Cybin (and not the Intermediary holding on your behalf) has assumed responsibility for (i) delivering the Meeting Materials to you, and (ii) executing your proper voting instructions. Please return your voting instructions as specified in the request for voting instructions.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VOTING SECURITIES AND PRINCIPAL HOLDERS THEREOF</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin has fixed the close of business on August 30, 2023, as the record date, for the purposes of determining Shareholders entitled to receive the Notice of Meeting and vote at the Meeting. As at the Record Date, 234,683,234 Cybin Shares, each carrying the right to one vote per share at the Meeting, were issued and outstanding.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the knowledge of the directors and executive officers of Cybin, as at the Record Date, no person beneficially owns, or controls or directs, directly or indirectly, voting securities of Cybin carrying 10% or more of the voting rights attached to the Cybin Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_19"></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This summary should be read together with and is qualified in its entirety by the more detailed information and financial data and statements contained elsewhere in this Circular, including the schedules hereto and documents incorporated into this Circular by reference.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Meeting</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Meeting will be held via live audio webcast on Thursday, October 12, 2023 at 1&#58;00 p.m. (Toronto time). Cybin Shareholders and duly appointed proxyholders (including Cybin Beneficial Shareholders who have appointed themselves as proxyholder) can attend the Meeting online and participate, vote, and submit questions during the Meeting. To attend the Meeting, you must register at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;register.proxypush.com&#47;cybn</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon completing your registration, you will receive further instructions via email, including a unique link that will allow you access to the Meeting and to vote and submit questions during the Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Record Date for determining the Cybin Shareholders entitled to receive notice of and to vote at the Meeting was August 30, 2023. Only Cybin Shareholders of record as of the close of business (Toronto time) on the Record Date are entitled to receive notice of and to vote at the Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Parties to the Arrangement </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cybin</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin&#8217;s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. Cybin is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybin Shares are listed on Cboe Canada and the NYSE American under the symbol &#8220;CYBN&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Schedule C for additional information regarding Cybin.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Small Pharma</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Small Pharma is a biotechnology company progressing a pipeline of short-duration psychedelic-assisted therapies for the treatment of mental health conditions. Small Pharma has a portfolio of clinical-stage DMT-based assets, SPL026 and SPL028. Small Pharma was granted an Innovation Passport designation for SPL026 from the U.K. Medicines and Healthcare products Regulatory Agency and has a pipeline of proprietary preclinical assets.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Small Pharma Shares are listed on the TSXV under the symbol &#8220;DMT&#8221; and are quoted on the OTCQB under the symbol &#8220;DMTFF&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Schedule D for additional information regarding Small Pharma.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Post-Arrangement Cybin</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Arrangement, Small Pharma will become a wholly-owned subsidiary of Cybin. For further information concerning the business and operations of Post-Arrangement Cybin see Schedule E.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Background to the Arrangement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arrangement and the provisions of the Arrangement Agreement are the result of arm&#8217;s length negotiations among representatives of Small Pharma and Cybin and their respective financial and legal advisors. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background to the Arrangement &#38; Recommendations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for a detailed summary of the background to the Arrangement and the events leading up to the execution of the Arrangement Agreement and the public announcement of the proposed Arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation of the Board</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After careful consideration, the Cybin Board determined, in consultation with its legal advisors, that the Arrangement is in the best interests of Cybin, and unanimously recommends that Cybin Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"> VOTE FOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Acquisition Resolution. The determination of the Cybin Board is based on various factors described more fully in the Circular. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background to the Arrangement &#38; Recommendations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reasons for the Arrangement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In unanimously determining that the Arrangement is in the best interests of Cybin, and in supporting the Arrangement generally, the Cybin Board considered and relied on a number of principal factors, including, among others, factors relating to&#58; (i) the highly complementary combined product candidate portfolio of Post-Arrangement Cybin&#59; (ii) enhanced and diversified development potential&#59; (iii) the strengthening of Cybin&#8217;s IP portfolio&#59; (iv) operational and financial synergies&#59; (v) improved financial position following the Arrangement&#59; (vi) strong combined research and development and leadership teams&#59; (vii) consideration of alternatives&#59; and (viii) support for the Arrangement from the directors, officers, and significant shareholders of Cybin and Small Pharma. In the course of its deliberations, the Cybin Board also considered the various procedural and qualitative safeguards provided by the terms of the Arrangement Agreement to protect the interests of Cybin and Cybin Shareholders.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background to the Arrangement &#38; Recommendations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reasons for the Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for a more detailed description of these and other factors and procedural safeguards.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Arrangement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of the Arrangement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the Arrangement is to effect the business combination of Cybin and Small Pharma. The Arrangement is to be carried out pursuant to the Arrangement Agreement and the Plan of Arrangement. Upon completion of the Arrangement, among other things, Cybin will acquire all of the issued and outstanding Small Pharma Shares and Small Pharma will become a wholly- owned subsidiary of Cybin. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Small Pharma Shares</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Arrangement, each Small Pharma Share outstanding at the Effective Time (other than Small Pharma Shares held by Dissenting Shareholders) will be deemed to be transferred to Cybin in exchange for the Consideration. The Exchange Ratio implies a consideration of approximately $0.10 per Small Pharma Share based on the closing price of the Cybin Shares of $0.415 on the Cboe Canada on August 25, 2023 (being the last trading day prior to the announcement of the Arrangement).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Small Pharma Share held by Dissenting Shareholders will be deemed to have been transferred to Small Pharma (free and clear of any encumbrances), without any further act or formality, and such Dissenting Shareholders will cease to have any rights as a Small Pharma Shareholder other than the right to be paid the fair value for their Small Pharma Shares by Small Pharma.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Small Pharma Options</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Plan of Arrangement, each In-the-Money Small Pharma Option outstanding immediately prior to the Effective Time (whether vested or unvested) shall be and shall be deemed to be, exercised and surrendered to Small Pharma </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for cancellation and the holders thereof shall receive, in respect of each such surrendered In-the-Money Small Pharma Option, the Option Consideration. Each Out-of-the-Money Small Pharma Option outstanding at the Effective Time, shall be, and shall be deemed to be, surrendered to Small Pharma for cancellation and the holders thereof shall receive, in respect of each such surrendered Out-of-the-Money Small Pharma Option, a cash payment from the Small Pharma equal to $0.001 per Out-of-the-Money Small Pharma Option.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cybin Shares</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Arrangement is completed, the actual number of Cybin Shares that will be issued on the Effective Date will depend on (i) the number of Small Pharma Shares issued and outstanding on the Effective Date, which may be affected by the number of Small Pharma Options that are exercised prior to the Effective Date, and (ii) the number of Small Pharma Shares held by Dissenting Shareholders. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin anticipates that immediately following the completion of the Arrangement, current Cybin Shareholders and Former Small Pharma Shareholders will own approximately 74.3% and 25.7% of the outstanding Cybin Shares, respectively, based on the number of Cybin Shares outstanding upon execution of the Arrangement Agreement, and assuming that&#58; (i) no Small Pharma Shareholders will exercise Dissent Rights&#59; (ii) 11,828,850 Small Pharma Options will be exercised prior to the Effective Time&#59; (iii) no other Small Pharma Options will be Small Pharma In-the-Money Options at the Effective Time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Procedural Steps</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arrangement is proposed to be carried out pursuant to Part 9, Division 5 of the BCBCA. The following procedural steps must be taken in order for the Arrangement to become effective&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the Arrangement Resolution must be approved by Small Pharma Shareholders at the Small Pharma Meeting in the manner set forth in the Interim Order&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Acquisition Resolution must be approved by Cybin Shareholders at the Meeting in the manner required by the Cboe Canada&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;the Court must grant the Final Order approving the Arrangement&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;all other conditions precedent to the Arrangement must be satisfied or waived by the appropriate Party.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">There is no assurance that the conditions set out in the Arrangement Agreement will be satisfied or waived on a timely basis or at all.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Required Approvals</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholder Approvals</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cybin Shareholder Approval</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to subsection 10.11(1)(b) of the NEO Exchange Listings Manual, the Cboe Canada requires shareholder approval of an acquisition in circumstances where the total number of securities issuable by a listed issuer pursuant to an acquisition is more than 25% of the total number of securities of the listed issuer outstanding (calculated on a non-diluted basis). Pursuant to the Arrangement, Cybin expects to issue 81,010,487 Cybin Shares to Former Small Pharma Shareholders, representing approximately 34.5% of the 234,683,234 Cybin Shares issued and outstanding (on a non-diluted basis) as at the date of the Arrangement Agreement. Accordingly, at the Meeting, Cybin Shareholders will be asked to approve the Acquisition Resolution authorizing the Arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cboe Canada requires that the Acquisition Resolution must be approved at the Meeting by a simple majority of the votes cast on the Acquisition Resolution by Cybin Shareholders present (virtually) or represented by proxy at the Meeting. If the Acquisition Resolution is not approved by Cybin Shareholders, Cybin will not be able to satisfy the listing requirements of Cboe Canada, and the Arrangement will not proceed.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Cybin Board unanimously recommends that Cybin Shareholders </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">VOTE FOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> the Acquisition Resolution.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full text of the Acquisition Resolution is set out in Schedule A. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Small Pharma Shareholder Approval</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is a condition to the completion of the Arrangement that the Arrangement Resolution be approved at the Small Pharma Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the Interim Order, the Arrangement Resolution must, subject to further order of the Court, be approved by at least 66 &#8532;% of the votes cast on the Arrangement Resolution by the Small Pharma Shareholders present in person (virtually) or represented by proxy at the Small Pharma Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Court Approvals</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 13, 2023, the Court granted the Interim Order providing for the calling and holding of the Small Pharma Meeting and other procedural matters.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The BCBCA provides that a plan of arrangement requires Court approval. Subject to the terms of the Arrangement Agreement, if the Acquisition Resolution and the Arrangement Resolution are approved at the Meeting and the Small Pharma Meeting, respectively, Small Pharma intends to make an application to the Court for the Final Order. The Court hearing in respect of the Final Order is expected to take place on or about October 17, 2023 via teleconference at 9&#58;45 a.m. (Vancouver time), or as soon thereafter as counsel may be heard.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Exchange Listings</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As soon as practicable following completion of the Arrangement, Cybin intends to apply to applicable Canadian securities regulators to have Small Pharma cease to be a reporting issuer and to have the Small Pharma Shares delisted from the TSXV and removed from quotation on the OTCQB Market.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin has applied to or will apply to list the Consideration Shares on the Cboe Canada and NYSE American. It is a condition to completion of the Arrangement that the Cboe Canada and the NYSE American will have conditionally approved the listing of the Consideration Shares, subject to satisfaction of standard listing conditions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Laws Matters</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Canadian Securities Laws</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybin Shares distributed pursuant to the Arrangement will be issued in reliance on exemptions from the prospectus requirements of applicable Canadian Securities Laws, will generally be &#8220;freely tradable&#8221; and the resale of such Cybin Shares will be exempt from the prospectus requirements (and not subject to any &#8220;restricted period&#8221; or &#8220;hold period&#8221;) under applicable Canadian Securities Laws if the following conditions are met&#58; (i) the trade is not a control distribution (as defined under applicable Canadian Securities Laws)&#59; (ii) no unusual effort is made to prepare the market or to create a demand for Cybin Shares&#59; (iii) no extraordinary commission or consideration is paid to a person or company in respect of the trade&#59; and (iv) if the selling shareholder is an insider or an officer of Cybin, the selling securityholder has no reasonable grounds to believe that Cybin is in default of securities legislation.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Securities Laws</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A general overview of certain requirements of U.S. Securities Laws that may be applicable to Small Pharma Securityholders is set out in this Circular under the heading &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Securities Laws Matters </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> U.S. Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. All holders of such securities are urged to consult with counsel to ensure that the resale of their securities complies with applicable U.S. Securities Laws.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to obtaining the Final Order, the issuance of the Consideration Shares to Small Pharma Shareholders in exchange for the Small Pharma Shares, in each case pursuant to the Arrangement, will be exempt from registration under the U.S. Securities Act pursuant to the Section 3(a)(10) Exemption. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Arrangement Agreement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arrangement will be effected in accordance with the Arrangement Agreement and the Plan of Arrangement. A copy of the Arrangement Agreement, including the Plan of Arrangement, can be found under Cybin&#8217;s SEDAR+ profile at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sedarplus.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and on EDGAR at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Plan of Arrangement is also attached as Schedule B to this Circular. Summaries of certain key terms of the Arrangement Agreement and the Plan of Arrangement are provided under &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. Such summaries are qualified in their entirety by reference to the full text of the Arrangement Agreement and the Plan of Arrangement. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to certain covenants, representations and warranties made by each of Small Pharma and Cybin in the Arrangement Agreement, each Party has provided certain non-solicitation covenants, agreeing not to solicit, promote, facilitate or knowingly encourage an Acquisition Proposal from any third party. However, a Party may, prior to obtaining the Cybin Shareholder Approval or the Small Pharma Shareholder Approval, as applicable, respond to an Acquisition Proposal that constitutes or could reasonably be expected to lead to a Superior Proposal, subject to the other Party&#8217;s right to match any such Superior Proposal within five Business Days.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arrangement Agreement may be terminated by mutual written consent of Small Pharma and Cybin and by each Party in certain circumstances as more particularly set forth in the Arrangement Agreement, including the failure to obtain the requisite Cybin Shareholder Approval or the Small Pharma Shareholder Approval. Subject to certain limitations, each Party may also terminate the Arrangement Agreement if the Arrangement Agreement is not consummated by the Outside Date, which date can be extended by written agreement of the Parties.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Arrangement Agreement is terminated, in certain circumstances, Small Pharma or Cybin, as applicable, will be required to pay the Other Party a Termination Fee of $2 million, or Cybin may be required to pay to Small Pharma an Expense Reimbursement Amount of $400,000 as a reimbursement for costs and expenses incurred in connection with the Arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for a more detailed summary of the material terms of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Support and Voting Agreements</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cybin Support and Voting Agreements</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the directors and senior officers of Cybin, who collectively hold approximately 17% of the issued and outstanding Cybin Shares as at the Record Date, have entered into a Cybin Support and Voting Agreement with Small Pharma pursuant to which each such individual has agreed to, among other things, vote all Cybin Shares beneficially owned by them in favour of the Acquisition Resolution, subject to the terms and conditions of such agreements.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Small Pharma Support and Voting Agreements</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin has entered into Small Pharma Support and Voting Agreements with each of the directors and senior officers of Small Pharma who own Small Pharma Shares, and Small Pharma&#8217;s largest shareholder, pursuant to which each such individual has agreed to, among other things, vote all Small Pharma Shares beneficially owned by them in favour of the Arrangement Resolution, subject to the terms and conditions of such agreements. As of the date hereof, these directors and senior officers and Small Pharma&#8217;s largest shareholder collectively beneficially owned or exercised control or direction over approximately 28.8% of the issued and outstanding Small Pharma Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factors</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin Shareholders voting in favour of the Acquisition Resolution will be choosing to endorse the proposed acquisition of Small Pharma by Cybin. The Arrangement involves risks. The following is a list of certain risk factors associated </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">specifically with the Arrangement and which Cybin Shareholders should carefully consider in evaluating whether to approve the Acquisition Resolution&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin and Small Pharma may fail to realize the anticipated benefits of the Arrangement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the conditions to completion of the Arrangement, including among other things, the approval of the Arrangement Resolution by Small Pharma Shareholders, approval of the Acquisition Resolution by Cybin Shareholders, the Cboe Canada and NYSE American approval and Court approval, may not be satisfied or waived by the Outside Date, or at all, which may result in the Arrangement not being completed&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">risks related to the integration of Cybin&#8217;s and Small Pharma&#8217;s existing businesses, including that Cybin Shareholders may be exposed to additional business risks not previously applicable to their investments in Cybin Shares&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Arrangement Agreement could be terminated by either Party under certain circumstances&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Termination Fee payable under the Arrangement Agreement in certain circumstances may discourage third parties from proposing a significant business transaction with Cybin&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">completion of the Arrangement will result in a significant number of additional Cybin Shares being issued and available for trading in the public market, which will have a dilutive effect on Cybin Shareholders&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">risks related to the development of psychedelic-based treatment options by Post-Arrangement Cybin.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk factors listed above are an abbreviated list of risk factors summarized elsewhere in this Circular, including under the heading &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Arrangement is completed, Cybin will become subject to certain risks involved with Small Pharma&#8217;s business. In addition, whether or not the Arrangement is completed, Cybin will continue to face many of the risks that it currently faces with respect to its business and affairs. For a description of these risk factors see &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the Small Pharma AIF and the Cybin AIF, respectively, each of which are incorporated by reference in this Circular and are available on SEDAR+ at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sedarplus.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and on EDGAR at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_22"></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE ARRANGEMENT</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Background to the Arrangement &#38; Recommendations</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 28, 2023, Cybin entered into the Arrangement Agreement with Small Pharma, which sets out the terms and conditions for the implementation of the Arrangement, which will be effected by way of the Plan of Arrangement. Pursuant to the Arrangement, Cybin will acquire all of the issued and outstanding Small Pharma Shares in exchange for the Consideration of 0.2409 Cybin Shares for each Small Pharma Share.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background to the Arrangement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arrangement Agreement is the result of arm&#8217;s length negotiations among representatives of Cybin and Small Pharma and their respective financial and legal advisors. The following is a summary of the material events that preceded the execution and public announcement of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin regularly reviews its overall corporate strategy and long-term strategic plan with the goal of maximizing shareholder value, including identifying and evaluating potential strategic transactions, and engaging in preliminary conversations with potential counterparties. Small Pharma has been of interest to Cybin since January 2021, when the companies entered into initial exploratory discussions. Eric So, Chair and President of Cybin and Doug Drysdale, Chief Executive Officer of Cybin, and Small Pharma representatives including Peter Rands, then Chief Executive Officer and a director, and George Tziras, then Chief Business Officer and a director, held meetings in the United Kingdom, the United States and via web conference. Based on those meetings, both parties determined that given their respective stages of development, a strategic transaction would be premature, and discussions were terminated. The Cybin Board was informed that Small Pharma was of interest to Cybin, and that initial exploratory discussions had been attempted.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In mid-June 2023, following significant progress by both Cybin and Small Pharma on their respective development programs, Mr. So, Mr. Drysdale and Mr. Tziras revisited discussions regarding a potential strategic transaction. Management of Cybin concluded that a potential business combination with Small Pharma remained an attractive opportunity to maximize shareholder value, and should be explored further.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 21, 2023, following initial discussions, the Parties entered into a reciprocal confidentiality agreement to facilitate each Party&#8217;s provision of non-public information to the other Party. Later that day, Mr. Drysdale and Mr. So met in person with Mr. Tziras, Chief Executive Officer of Small Pharma, to discuss a potential transaction whereby Cybin would acquire 100% of the issued and outstanding Small Pharma Shares Cybin reviewed Small Pharma&#8217;s capitalization and financial position, and developed a share exchange model to determine the relative valuation of the two companies in a potential business combination, which formed a basis of subsequent negotiations.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2023, Cybin engaged Gowling WLG as its legal counsel to provide advice on the structure and proposed terms of the possible transaction.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2023, Mr. Drysdale presented Mr. Tziras with a non-binding letter of intent outlining the basic terms of a potential transaction, including the proposed share exchange model and the respective valuations of the two companies, and exclusivity obligations during negotiations, among other things. Small Pharma received and reviewed Cybin&#8217;s non-binding letter of intent, in consultation with its financial advisor, Jefferies International Limited, its legal counsel, Aird &#38; Berlis, and the Small Pharma Special Committee.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The non-binding letter of intent was negotiated extensively throughout July 2023 based on different potential acquisition scenarios and valuation approaches. It was determined that in light of market volatility affecting the price for the Cybin Shares and the Small Pharma Shares, it would be preferable to negotiate the consideration for Small Pharma based on a fixed exchange ratio based on the proportionate share of the combined entity resulting from a transaction that would be held by the Cybin Shareholders and Small Pharma Shareholders.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 18, 2023, Jefferies International Limited, on behalf of Small Pharma, delivered an amended draft of the non-binding letter of intent, signalling Small Pharma&#8217;s interest in pursuing a potential transaction, subject to adjustment to various terms including consideration, deal protections, board representation, the terms of the post-transaction lock-up agreements, as well as being subject to ongoing due diligence and finalizing definitive transaction documents.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following further negotiations, including a call on July 25, 2023, between management of Cybin, Small Pharma and its financial advisor, and the Parties&#8217; respective legal counsel, the Parties reached an agreement on the non-binding letter of intent, including an increase in the proportionate share of the combined entity resulting from such a transaction that would be held by the Small Pharma Shareholders.&#160;On July 27, 2023, the Parties entered into the non-binding letter of intent, which provided for a 30-day exclusivity period (subject to extension under certain circumstances) to complete initial due diligence and negotiate the Arrangement Agreement. Management of Cybin subsequently informed the Cybin Board that the non-binding letter of intent had been executed, and that due diligence and negotiations were underway.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2023, Cybin delivered an initial legal due diligence request list to Small Pharma, and on August 2, 2023, Small Pharma delivered an initial legal due diligence request list to Cybin. Pursuant to the terms of the confidentiality agreement, each Party received access to diligence materials of the other Party via a virtual data room.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between July 27, 2023, and August 27, 2023, each of Cybin and Small Pharma, working with their respective financial, technical, and legal advisors, completed detailed reciprocal due diligence. During that time, senior executives of both companies and their respective legal counsel and financial advisors convened multiple meetings and phone calls to discuss certain due diligence matters and negotiate the terms of the Arrangement Agreement and related documentation.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 4, 2023, Cybin and its legal counsel, Gowling WLG, provided a draft arrangement agreement to Small Pharma&#8217;s legal counsel, Aird &#38; Berlis, for its review and comment. Subsequent to the delivery of the draft arrangement agreement, the Parties and their respective legal counsel discussed various structuring matters. On August 11, 2023, Aird &#38; Berlis formally replied to Gowling WLG with revisions to the draft arrangement agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between August 11 and August 28, 2023, the Cybin and Small Pharma transaction teams, assisted by their respective legal and financial advisors, negotiated the terms of the Arrangement Agreement as well as the forms ancillary documents including the Plan of Arrangement, Lock-up Agreement, and Voting Support Agreements, with a view to completing negotiations and, if desirable, seeking final approvals of the Cybin Board and Small Pharma Board. Over this period, representatives of Small Pharma, Cybin and their respective legal and financial advisors held numerous internal and&#47;or all-party conference calls to discuss the progress of business and legal due diligence and to negotiate the Arrangement Agreement and ancillary documents. Numerous drafts of the Arrangement Agreement and ancillary documents were exchanged by the Parties and their legal advisors.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 25, 2023, management of Cybin notified the Cybin Board that it appeared that a transaction with Small Pharma could be accomplished, and provided an update on the terms of the Arrangement Agreement that had been negotiated, the strategic rationale of the transaction, and preliminary due diligence findings. On August 27, 2023, the directors and executive officers of Cybin were presented with the Small Pharma Voting Support Agreement, and the directors and executive officers of Small Pharma were presented with the Cybin Voting Support Agreement, for their respective consideration and execution.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 27, 2023, with the approval of Small Pharma&#8217;s management, Mr. Tziras and Mr. Drysdale approached Peter Rands, a significant Small Pharma Shareholder, in connection with the proposed Arrangement. Mr. Drysdale presented Mr. Rands with a form of Cybin Voting Support Agreement and Lock-up Agreement, and requested that he and the beneficial owner of any other Small Pharma Shares over which he had control or direction execute a Cybin Voting Support Agreement. Mr. Rands, Mr. Drysdale and Mr. Tziras negotiated the terms of such agreements until the early morning of August 28, 2023.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 27, 2023, the Cybin Board met formally to consider the merits of the Arrangement and final terms and conditions of the Arrangement Agreement and ancillary documents. The Cybin Board members were joined by representatives of Gowling WLG, and members of management. During this meeting, Cybin management presented to the Cybin Board its conclusions and analyses of the potential benefits and risks of the Arrangement, including key transaction terms and conditions, and the results of their due diligence investigation. Representatives of Gowling WLG provided an overview of the specific terms and conditions of the Arrangement Agreement and other ancillary documents, and answered questions from the Cybin Board. The Cybin Board carefully considered management&#8217;s advice on the potential synergies that could come from the Arrangement, the consideration and share exchange ratio, the amount of the Termination Fees, provisions requiring Cybin to reimburse Small Pharma&#8217;s expenses under certain circumstances, the other proposed terms of the Arrangement Agreement and Plan of Arrangement, as well as the other the factors set out below under &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reasons for the Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. The Cybin Board also considered each Party&#8217;s shareholder approval requirements, the Voting Support </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreements to be entered into by the Cybin Supporting Shareholders and the Small Pharma Supporting Shareholders, and the Lock-Up Agreements to be entered into by the Small Pharma Supporting Shareholders on the Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After duly considering the transaction terms, the benefits and risks associated with the Arrangement, and other considerations such as potential impacts of the Arrangement on the Cybin Shareholders and other stakeholders, and the timing of the Arrangement, the Cybin Board, among other things, unanimously&#58; (i) determined that the Arrangement is in the best interests of Cybin&#59; (ii) approved the Arrangement Agreement, and (iii) and resolved to recommend that Cybin Shareholders vote in favour of the Acquisition Resolution. The Cybin Board also authorized management to finalize the form of the Arrangement Agreement the related transaction documents, and execute and deliver them on behalf of Cybin. The determinations of the Cybin Board were confirmed by a written resolution early in the morning on August 28, 2023. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arrangement Agreement, the Small Pharma Voting Support Agreements, and the Cybin Voting Support Agreements were entered into early in the morning on August 28, 2023. Following a brief halt in trading of the Cybin Shares and the Small Pharma Shares, the execution of the Arrangement Agreement was publicly announced by joint press release. Later in the morning on August 28, 2023, the Parties provided a webcast presentation regarding the proposed Arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recommendation of the Board</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybin Board, after careful consideration, including a thorough review of the Arrangement Agreement, as well as a thorough review of other matters, including those discussed in this Circular, has unanimously&#58; (i) determined that the Arrangement and the entry into the Arrangement Agreement are in the best interests of Cybin&#59; (ii) approved the Arrangement Agreement and the transactions contemplated thereby&#59; and (iii) resolved to recommend that Cybin Shareholders vote in favour of the Acquisition Resolution (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Board Recommendation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Cybin Board unanimously recommends that Cybin Shareholders </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">VOTE FOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> the Acquisition Resolution.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In coming to its conclusion and recommendations the Cybin Board considered, among others, the following factors&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the purpose and anticipated benefits of the Arrangement as outlined under &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background to the Arrangement &#38; Recommendations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reasons for the Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and elsewhere in this Circular&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;information concerning the financial condition, results of operations, business plans and prospects of Cybin, and the resulting potential for the enhancement of the business efficiency, management effectiveness and financial results of Post-Arrangement Cybin&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;the alternatives available to Cybin&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;the potential risks and negative factors relating to the Arrangement, as outlined under &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background to the Arrangement &#38; Recommendations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reasons for the Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and elsewhere in this Circular.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing discussion of the information and factors considered by the Cybin Board is not intended to be exhaustive. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reasons for the Arrangement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the course of its evaluation of the Arrangement and in reaching the Cybin Board Recommendation, the Cybin Board consulted with Cybin&#8217;s senior management, and its legal counsel, and considered a number of strategic, financial and operational factors and potential benefits and risks of the Arrangement, including, without limitation, those listed below, and in light of the Cybin Board&#8217;s knowledge of the business, financial condition and prospects of Cybin.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of certain primary factors considered and relied upon by the Cybin Board in reaching its unanimous recommendation that Cybin Shareholders </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">VOTE FOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Acquisition Resolution&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Highly Complementary and Diversified Asset Portfolio. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combination creates an international, clinical-stage leader, with an expanded portfolio of clinical-stage psychedelic assets (CYB003 &#8211; Cybin&#8217;s proprietary deuterated psilocybin analog, CYB004 &#8211; Cybin&#8217;s proprietary deuterated DMT molecule, SPL028 &#8211; Small Pharma&#8217;s </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deuterated DMT, and SPL026 &#8211; Small Pharma&#8217;s first generation DMT) and pre-clinical assets that are highly complementary. Post-Arrangement Cybin&#8217;s combined DMT programs will constitute a significantly expanded dataset of systematic research on these short-duration psychedelic molecules, strengthening Post-Arrangement Cybin&#8217;s ability to make informed, data-driven strategic decisions for its development programs, increasing the likelihood of success.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Enhanced and Diversified Development Potential. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Post-Arrangement Cybin will be able to pursue an expanded development portfolio, with multiple milestones anticipated to be initiated and&#47;or completed over the next 12 to 18 months. This includes, but is not limited to&#58; (i) determining safety and efficacy interactions of DMT in patients with MDD on SSRIs&#59; (ii) first in-human readouts of deuterated DMT compounds using IV (CYB004 and SPL028) and IM (SPL028) routes of administration&#59; (iii) efficacy, safety and tolerability readout of CYB003 in MDD patients&#59; and, (iv) subject to the availability of financing and applicable regulatory approvals&#58; (a) initiation of a pivotal efficacy study of CYB003&#59; and (b) initiation of an efficacy study on a deuterated DMT compound. The addition of Small Pharma&#8217;s experience and expertise in the United Kingdom and Europe will increase Cybin&#8217;s ability to advance research and development activities in those markets.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strengthened Intellectual Property Portfolio.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Post-Arrangement Cybin will hold the most impressive intellectual property portfolio in the psychedelic drug development sector. Based on patents and patent applications held by Cybin and Small Pharma as of the date of this Circular, Post-Arrangement Cybin will hold 160 pending patent applications, including five allowed applications, as well as 30 granted patents protecting its clinical and preclinical molecules. This extensive intellectual property portfolio creates an unmatched opportunity for Post-Arrangement Cybin to develop next-generation novel compounds for a number of mental health disorders that may be amenable to treatment with psychedelic therapies.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operational and Financial Synergies.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Post-Arrangement Cybin is expected to benefit from significant operational and financial synergies through the combination of the Parties&#8217; research and development portfolios, and corporate general and administrative cost savings.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Improved Financial Position. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Post-Arrangement Cybin will have, on a pro forma basis as at June 30, 2023, estimated cash of approximately $17.66 million, as well as access to two accessible financing arrangements, including (i) an at-the-market equity program that allows Cybin to issue and sell up to US$35 million of Cybin Shares, from time to time, which was renewed by Cybin in August 2023&#59; and (ii) a common share purchase agreement with LPC dated May 30, 2023 whereby Cybin has the right to sell, and LPC is obligated to purchase, up to US$30 million of Cybin Shares over a 36-month period (of which US$29.5 million remains unsold as at the date of this Circular).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strong Research and Development and Leadership Teams.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Stakeholders will benefit from the combination of two experienced biotechnology teams with a proven track record of success across the biotechnology and pharmaceutical sectors. George Tziras, Small Pharma&#8217;s Chief Executive Officer, will also be joining the Cybin Board.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consideration of Alternatives.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Taking into account the degree to which Small Pharma&#8217;s assets and operations complement those of Cybin, organic growth opportunities currently available to Cybin, and other potential acquisition opportunities, management of Cybin and the Cybin Board have assessed the alternatives reasonably available. The completion of the Arrangement is consistent with Cybin&#8217;s strategic objectives, which include the development of its existing clinical- and pre-clinical-stage assets, and the pursuit through acquisition of additional clinical and pre-clinical-stage assets that contribute to corporate growth. Cybin believes that Post-Arrangement Cybin will be better positioned to pursue a value maximizing strategy as a result of the anticipated benefits of the Arrangement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strong Director, Officer and Shareholder Support.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Arrangement has strong director, officer, and shareholder support. All of the directors and senior officers of Cybin, and certain shareholders of Cybin, who collectively hold approximately 17% of the issued and outstanding Cybin Shares as at the record date of August 30, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Record Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) have entered into support and voting agreements with Small Pharma concurrently </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with the execution of the Arrangement Agreement pursuant to which they have agreed, among other things, to vote their Cybin Shares in favour of the Acquisition Resolution at the Meeting and otherwise support the Arrangement. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, each of the directors and executive officers of Small Pharma who owns Small Pharma Shares, and Small Pharma&#8217;s largest shareholder, who collectively hold or exercise control or direction over approximately 28.8%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the issued and outstanding Small Pharma Shares as at the date of the Arrangement Agreement, have entered into support and voting agreements with Cybin concurrently with the execution of the Arrangement Agreement pursuant to which they have agreed, among other things, to support the Arrangement and vote their Small Pharma Shares in favour of the resolution to approve the Arrangement at the Small Pharma Meeting. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Support and Voting Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the course of its deliberations, the Cybin Board also considered the various procedural and qualitative safeguards provided by the terms of the Arrangement Agreement to protect the interests of Cybin and Cybin Shareholders, including&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholder Approval.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Acquisition Resolution must be approved by a simple majority of the votes cast on the Acquisition Resolution by Cybin Shareholders present (virtually) or represented by proxy at the Meeting. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Required Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shareholder Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Detailed Due Diligence.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cybin, including its management and legal and finance teams, with assistance from outside legal advisors, completed a detailed diligence review of Small Pharma, including its material intellectual property and clinical trials.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deal Protections and Right to Match.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Arrangement Agreement provides express limitations on Small Pharma&#8217;s ability to solicit interest from third parties, and in addition, provides that Cybin shall have the right to match any unsolicited Acquisition Proposal received prior to the approval of the Arrangement Resolution and Acquisition Resolution by Small Pharma Shareholders and Cybin Shareholders, respectively, that constitutes a Superior Proposal for the Small Pharma Shares. In the event of a termination of the Arrangement Agreement by Small Pharma in response to a Superior Proposal received by Small Pharma, the amount of the Termination Fee payable to Cybin is reasonable in the circumstances. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Solicitation Covenants and Right to Match</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement Agreement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expenses and Termination Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybin Board also considered a number of potential risks in respect of the Arrangement, including&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk of Non-Completion.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The risks to Cybin if the Arrangement is not completed, including the costs to Cybin in resources and management attention in pursuing the Arrangement and the restrictions on Cybin&#8217;s conduct of its business prior to the completion of the Arrangement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Termination Rights.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The right of Small Pharma to terminate the Arrangement Agreement under certain limited circumstances.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Required Approvals.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The potential risk of not obtaining certain consents from third parties required to complete the Arrangement, including from the Court, Small Pharma Shareholders, Cybin Shareholders or any other third party whose consent is required including, without limitation, Regulatory Approvals.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Termination Fee and Expense Reimbursement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Termination Fee payable to Small Pharma in certain circumstances, including if Cybin enters into an agreement with a third party to acquire Cybin that constitutes a Superior Proposal. Additionally, in certain circumstances, the Expense Reimbursement Amount may be payable to Small Pharma.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybin Board&#8217;s reasons for recommending the Arrangement include certain assumptions relating to forward-looking statements, and such information and assumptions are subject to various risks. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-Looking Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in this Circular.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information and factors described above and considered by the Cybin Board in reaching the Cybin Board Recommendation are not intended to be exhaustive, but include material factors considered by the Cybin Board. In its </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">evaluation of the Arrangement and in reaching the Cybin Board Recommendation, the Cybin Board did not quantify or otherwise attempt to assign any relative or specific weights to the foregoing factors, and individual directors may have assigned different weightings to different factors.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybin Board realized that there are risks associated with the Arrangement, including that some of the potential benefits set forth above may not be realized or that there may be significant costs associated with realizing such benefits. The Cybin Board believes that the factors in favour of the Arrangement outweigh the risks and potential disadvantages, although there can be no assurance in this regard. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Arrangement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Procedural Steps</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arrangement is proposed to be carried out pursuant to section 288 of the BCBCA. The following procedural steps must be taken in order for the Arrangement to become effective&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the Arrangement Resolution must be approved by Small Pharma Shareholders at the Small Pharma Meeting in the manner set forth the Interim Order&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Acquisition Resolution must be approved by Cybin Shareholders at the Meeting&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;the Court must grant the Final Order approving the Arrangement&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Cybin must deposit or cause to be deposited with the Depositary in escrow the Consideration Shares and cash required to effect payment in full of the aggregate consideration to be paid pursuant to the Arrangement&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;all other conditions precedent to the Arrangement must be satisfied or waived by the appropriate Party&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;the Parties must implement the Arrangement in accordance with the Final Order.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no assurance that the conditions set out in the Arrangement Agreement will be satisfied or waived on a timely basis or at all.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of the Arrangement</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the Arrangement is to effect the business combination of Cybin and Small Pharma through the acquisition of all of the issued and outstanding Small Pharma Shares by Cybin. The Arrangement will be implemented by way of a Court-approved plan of arrangement under the BCBCA in accordance with the terms of the Arrangement Agreement and the Plan of Arrangement. For a detailed description of the steps which will occur under the Plan of Arrangement on the Effective Date, assuming all conditions to the implementation of the Arrangement have been satisfied or waived, please see the full text of the Plan of Arrangement attached as Schedule B to this Circular.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arrangement will result in the issuance of 0.2409 Cybin Shares to each Small Pharma Shareholder (excluding Dissenting Shareholders) for each Small Pharma Share held immediately prior to the Effective Time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No fractional Cybin Shares will be issued in connection with the Arrangement. Instead, in the event that a former Small Pharma Securityholder would otherwise be entitled to a fractional Consideration Share, the number of Cybin Shares to be issued to such Small Pharma Securityholder will be rounded down to the nearest whole Cybin Share, without additional compensation.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance of the Cybin Shares pursuant to the Arrangement, and the Arrangement itself, will not result in a material impact on the control or direction over Cybin.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Small Pharma Shares</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at the date of the Arrangement Agreement and as at the date of this Circular, there are 324,453,787 Small Pharma Shares outstanding. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Arrangement, each Small Pharma Share outstanding at the Effective Time (other than Small Pharma Shares held by Dissenting Shareholders) will be deemed to be transferred to Cybin in exchange for the Consideration. The Exchange Ratio implies a consideration of approximately $0.10 per Small Pharma Share based on the closing price of the Cybin Shares of $0.415 on the Cboe Canada on August 25, 2023 (being the last trading day prior to the signing of the Arrangement Agreement).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Small Pharma Share held by Dissenting Shareholders will be deemed to have been transferred to Small Pharma (free and clear of any encumbrances), without any further act or formality, and such Dissenting Shareholders will cease to have any rights as a Small Pharma Shareholder other than the right to be paid the fair value for their Small Pharma Shares by Small Pharma.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan of Arrangement provides that Small Pharma Shares not deposited together with a duly completed Letter of Transmittal and all other required documents on or before the sixth anniversary of the Effective Date will be automatically cancelled without any repayment of capital in respect thereof. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Small Pharma Options</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Arrangement, all of the Small Pharma Options outstanding immediately prior to the Effective Time will cease to exists on the following basis&#58; (i) each In-the-Money Small Pharma Option outstanding immediately prior to the Effective Time (whether vested or unvested) shall be and shall be deemed to be, exercised and surrendered to Small Pharma for cancellation and the holders thereof shall receive, in respect of each such surrendered In-the-Money Small Pharma Option, the Option Consideration&#59; and (ii) each Out-of-the-Money Small Pharma Option outstanding at the Effective Time, shall be, and shall be deemed to be, surrendered to Small Pharma for cancellation and the holders thereof shall receive, in respect of each such surrendered Out-of-the-Money Small Pharma Option, a cash payment from the Small Pharma equal to $0.001 per Out-of-the-Money Small Pharma Option.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at the date of the Arrangement Agreement and as at the date of this Circular, there are 22,211,350 Small Pharma Options outstanding. At the Effective Time, assuming that the Small Pharma Share Value will be approximately $0.10 per Small Pharma Share, 11,828,850 Small Pharma Options would be In-the-Money Small Pharma Options. All such Small Pharma Options are expected to be exercised prior to the Effective Time. Accordingly, no Cybin Shares are expected to be issued upon the deemed exercise and surrender of In-the-Money Small Pharma Options pursuant to the Plan of Arrangement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cybin Shares</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at the date of the Arrangement Agreement and as at the Record Date, there are 234,683,234 Cybin Shares outstanding.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Arrangement is completed, approximately 81,010,487 Cybin Shares are expected to be issued to Small Pharma Shareholders. Immediately following the completion of the Arrangement, current Cybin Shareholders and Former Small Pharma Shareholders are expected to own approximately 74.3% and 25.7% of the outstanding Cybin Shares, respectively, as at the date of the Arrangement Agreement, and assuming that&#58; (i) no Small Pharma Shareholders will exercise Dissent Rights&#59; (ii) 11,828,850 Small Pharma Options will be exercised prior to the Effective Time&#59; (iii) no other Small Pharma Options will be Small Pharma In-the-Money Options at the Effective Time, and (iv) no Cybin Shares will be issued prior to the Effective Time. The actual number of Cybin Shares that will be issued on the Effective Date will depend on the number of Small Pharma Shares issued and outstanding on the Effective Date. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan of Arrangement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan of Arrangement sets out the steps and actions by which the Arrangement will be effected. The following is a summary only of the steps that will occur under the Plan of Arrangement on the Effective Date if all conditions to the completion of the Arrangement have been satisfied or waived. The following description of steps is qualified in its entirety by reference to the full text of the Plan of Arrangement, which is attached as Schedule B to this Circular.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Plan of Arrangement, commencing at the Effective Time, the following will occur and will be deemed to occur in the following order without any further authorization, act or formality&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;notwithstanding any vesting or exercise or other provisions to which a Small Pharma Option might otherwise be subject (whether by contract, the conditions of grant, applicable Law or the terms of the Small Pharma Option Plans), each Small Pharma Option outstanding immediately prior to the Effective Time (whether vested or unvested) shall be deemed to be vested and exercisable, and without any further action by or on behalf of a Small Pharma Optionholder&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;each In-the-Money Small Pharma Option outstanding at the Effective Time, shall be, and shall be deemed to be, exercised and surrendered to Small Pharma for cancellation and the holders thereof shall receive, in respect of each such surrendered In-the-Money Small Pharma Option, the Option Consideration&#59; the Small Pharma Shares comprising the Option Consideration will have an issue price per share equal to the Small Pharma Share Value and shall be issued as fully paid and non-assessable common shares in authorized share structure of Small Pharma, and such Small Pharma Shares will be added to Small Pharma&#8217;s central securities register in the name of such Small Pharma Optionholder&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;each Out-of-the-Money Small Pharma Option outstanding at the Effective Time, shall be, and shall be deemed to be, surrendered to Small Pharma for cancellation and the holders thereof shall receive, in respect of each such surrendered Out-of-the-Money Small Pharma Option, a cash payment from Small Pharma equal to $0.001 per Out-of-the-Money Small Pharma Option, less any amount that may be withheld pursuant to the Plan of Arrangement&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;each Small Pharma Option holder will cease to be the holder of Small Pharma Options or to have any rights in respect of any Small Pharma Option (other than the right to receive the Option Consideration pursuant to paragraph (i) above or cash payment pursuant to paragraph (ii) above) or under any Small Pharma Option Plan and the name of such Small Pharma Option holder will be removed from the applicable securities register of the Small Pharma with respect to all Small Pharma Options&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Small Pharma Option Plans and all agreements, arrangements and understandings relating to any and all Small Pharma Options shall be terminated and shall be of no further force and effect&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;each Dissent Share held by a Dissenting Shareholder shall be, and shall be deemed to be, surrendered to Small Pharma by the holder thereof, without any further act or formality by such Dissenting Shareholder, free and clear of all encumbrances, and each such Dissent Share so surrendered shall be cancelled and thereupon each Dissenting Shareholder shall cease to have any rights as a holder of such Dissent Shares other than a claim against Small Pharma in an amount determined and payable in accordance with Article 4 of the Plan of Arrangement and the name of such Dissenting Shareholder shall be removed from the central securities register of holders of Small Pharma Shares&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;each Small Pharma Share outstanding immediately prior to the Effective Time including, for greater certainty Small Pharma Shares issued at the Effective Time pursuant to paragraph (a)(i) above, other than Dissent Shares or Small Pharma Shares held by Cybin, shall be transferred to Cybin without any further act or formality by such former Small Pharma Shareholder free and clear of any encumbrances, and each such Former Small Pharma Shareholder shall be removed from Small Pharma&#8217;s central securities register of holders of Small Pharma Shares, and in consideration thereof, each such Former Small Pharma Shareholders shall receive the Share Consideration, subject to any withholding pursuant to the Plan of Arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No fractional Cybin Shares will be issued in connection with the Plan of Arrangement. The number of Cybin Shares to be issued will be rounded down to the nearest whole number of Cybin Shares in the event that any person would otherwise be entitled to a fractional Cybin Share.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the completion of the Arrangement, it is expected that the board of directors of Post-Arrangement Cybin will be led by the current Chair of the Cybin Board, Eric So, and that the board of directors will be comprised of seven directors, </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including the six current directors of Cybin, being Theresa Firestone, Grant Froese, Paul Glavine, Eric Hoskins, Mark Lawson, and Eric So, together with George Tziras, a current director of Small Pharma. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin has agreed to make all commercially reasonable best efforts to ensure that, with effect as and from the Effective Time, Mr. Tziras will be appointed to the Cybin Board and that at each meeting of the Cybin Shareholders, held to consider the election of directors following the Effective Date until and including the annual meeting of Cybin Shareholders that occurs in 2025, Mr. Tziras will be nominated by management of Cybin for election as a director of Cybin&#59; provided that (i) at all relevant times Mr. Tziras is and remains qualified and eligible to act as a director of Cybin under applicable laws, (ii) Mr. Tziras has delivered to Cybin a consent to act as a director of Cybin, and (iii) Cybin and Mr. Tziras will have entered into and remain parties to a director nominee agreement. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Officers and Directors of Post-Arrangement Cybin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in Schedule E to this Circular. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Timing</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Acquisition Resolution and the Arrangement Resolution are passed at the Meeting and the Small Pharma Meeting, respectively, Small Pharma will apply for the Final Order. The Court hearing in respect of the Final Order is scheduled to take place on or about October 17, 2023 at 12&#58;45 p.m. (Toronto time) (9&#58;45 a.m. Vancouver time), or as soon thereafter as the hearing of the Final Order can be heard or at such other date and time as the Court may direct. If the Final Order is obtained in form and substance satisfactory to Cybin and Small Pharma, and all other conditions set forth in the Arrangement Agreement are satisfied or waived, the Arrangement will become effective at the beginning of the day (Vancouver time) on the Effective Date. It is currently expected that the Effective Date will occur on or about October 17, 2023, and in no event will completion of the Arrangement occur later than November 30, 2023, unless extended by mutual agreement of the Parties in accordance with the terms of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest of Directors and Executive Officers in the Arrangement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the knowledge of Cybin, none of the directors and executive officers of Cybin, or any of their respective affiliates, have any material interest in the Arrangement or the Acquisition Resolution that differs from the interests of Cybin Shareholders generally. As at September 12, 2023, the last trading day prior to the date of this Circular, neither Cybin, nor any of Cybin&#8217;s directors, executive officers, or any of their respective affiliates and associates, beneficially owned or exercised control or direction over, directly or indirectly, any Small Pharma Shares. Also see &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest of Certain Persons in Matters to be Acted Upon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Required Approvals</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholder Approvals</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cybin Shareholder Approval</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cboe Canada requires shareholder approval of an acquisition in circumstances where the total number of securities issuable by a listed issuer pursuant to the acquisition is more than 25% of the total number of securities of the listed issuer outstanding (calculated on a non-diluted basis). Pursuant to the Arrangement, Cybin expects to issue 81,010,487 Cybin Shares to Former Small Pharma Shareholders, representing approximately 34.5% of the 234,683,234 issued and outstanding Cybin Shares on a non-diluted basis as at the date of the Arrangement Agreement. Accordingly, at the Meeting, Cybin Shareholders will be asked to approve the Acquisition Resolution.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full text of the Acquisition Resolution is set out in Schedule A. Also, see &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effects of the Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Acquisition Resolution must be approved at the Meeting by a simple majority of the votes cast on the Acquisition Resolution by Cybin Shareholders present (virtually) or represented by proxy at the Meeting. If the Acquisition Resolution is not approved by Cybin Shareholders, Cybin will not be able to satisfy the listing requirements of the Cboe Canada, and the Arrangement will not proceed.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Recommendation&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> The Cybin Board unanimously recommends that Cybin Shareholders </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">VOTE FOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> the Acquisition Resolution.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Proxies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#58; Unless otherwise instructed, proxies in favour of the management designees will be </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">VOTED FOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> the Acquisition Resolution.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the approval of the Acquisition Resolution by Cybin Shareholders at the Meeting, the Acquisition Resolution authorizes the Cybin Board, without further notice to or approval of the Cybin Shareholders, to elect not to proceed with the Arrangement or to revoke and not give effect to the Acquisition Resolution.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Small Pharma Shareholder Approval</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is a condition to the completion of the Arrangement that the Arrangement Resolution be approved at the Small Pharma Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the Interim Order, the Arrangement Resolution must, subject to further order of the Court, be approved by at least 66 &#8532;% of the votes cast on the Arrangement Resolution by the Small Pharma Shareholders present in person (virtually) or represented by proxy at the Small Pharma Meeting (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma Shareholder Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Court Approvals</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interim Order</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 13, 2023, the Court granted the Interim Order which provides for the calling and holding of the Small Pharma Meeting and other procedural matters.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Final Order</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The BCBCA provides that a plan of arrangement requires Court approval. Subject to the terms of the Arrangement Agreement, if the Acquisition Resolution and the Arrangement Resolution are approved at the Meeting and the Small Pharma Meeting, respectively, Small Pharma intends to make an application to the Court for the Final Order.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Court hearing in respect of the Final Order is expected to take place on or about October 17, 2023 via teleconference at 9&#58;45 a.m. (Vancouver time), or as soon thereafter as counsel may be heard. At the Final Order hearing, the Court will consider, among other things, the fairness of the terms and conditions of the Arrangement and the rights and interests of every person affected. The Court may approve the Arrangement in any manner the Court may direct, subject to compliance with such terms and conditions, if any, as the Court deems fit. There can be no assurance that the Court will approve the Arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Exchange Listings</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Small Pharma is a reporting issuer under the securities Laws of each province and territory of Canada. The Small Pharma Shares are listed and posted for trading on the TSXV under the symbol &#8220;DMT&#8221; and are quoted on the OTCQB under the symbol &#8220;DMTFF&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 25, 2023, the last trading day prior to announcement of the Arrangement, the closing price of the Small Pharma Shares on the TSXV was $0.085. On September 12, 2023, the last trading day prior to the date of this Circular, the closing price of the Small Pharma Shares on the TSXV was $0.09.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As soon as practicable following completion of the Arrangement, Cybin intends to apply to applicable Canadian securities regulators to have Small Pharma cease to be a reporting issuer and to have the Small Pharma Shares delisted from the TSXV and removed from quotation on the OTCQB.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin is a reporting issuer under the securities Laws of each province and territory of Canada. The Cybin Shares are listed on the Cboe Canada under the trading symbol &#8220;CYBN&#8221; and on the NYSE American under the symbol &#8220;CYBN&#8221;.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is a condition to the completion of the Arrangement that the Cboe Canada and NYSE American will have conditionally approved the listing of the Consideration Shares, subject only to customary conditions. The Cboe Canada has approved the Arrangement (including the listing of the Consideration Shares), subject to approval of the Cybin Shareholders, and Cybin has applied to the NYSE American to list the Consideration Shares. The NYSE American has not conditionally approved the listing of the Consideration shares as at the date of this Circular. Listing will be conditional on Cybin satisfying the standard listing conditions imposed by each exchange.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information with respect to the trading history of the Cybin Shares and the Small Pharma Shares, see &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Price Range and Trading Volumes of Cybin Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Market for Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trading Price and Volume&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Schedule C of this Circular and in the Small Pharma AIF, respectively.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Laws Matters</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Canadian Securities Laws</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybin Shares distributed pursuant to the Arrangement will be issued in reliance on exemptions from the prospectus requirements of applicable Canadian Securities Laws, will generally be &#8220;freely tradable&#8221; and the resale of such Cybin Shares will be exempt from the prospectus requirements (and not subject to any &#8220;restricted period&#8221; or &#8220;hold period&#8221;) under applicable Canadian Securities Laws if the following conditions are met&#58; (i) the trade is not a control distribution (as defined under applicable Canadian Securities Laws)&#59; (ii) no unusual effort is made to prepare the market or to create a demand for Cybin Shares&#59; (iii) no extraordinary commission or consideration is paid to a person or company in respect of the trade&#59; and (iv) if the selling shareholder is an insider or an officer of Cybin, the selling securityholder has no reasonable grounds to believe that Cybin is in default of securities legislation.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Securities Laws</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance of the Cybin Shares to Small Pharma Securityholders in exchange for Small Pharma Shares (including Small Pharma Shares issued upon the exchange for In-the-Money Small Pharma Options pursuant to the Plan of Arrangement) has not been and will not be registered under the U.S. Securities Act or the securities laws of any state of the United States. Such securities will be issued in reliance upon the Section 3(a)(10) Exemption and exemptions from applicable U.S. Securities Laws. The Section 3(a)(10) Exemption exempts the issuance of securities issued in exchange for one or more bona fide outstanding securities from the general requirement of registration under the U.S. Securities Act where the terms and conditions of the issuance and exchange of such securities have been determined to be substantively and procedurally fair to the persons to whom the securities will be issued by a court of competent jurisdiction, expressly authorized by Law to grant such approval, after a hearing upon the fairness of the terms and conditions of the issuance and exchange at which all persons to whom the securities will be issued have the right to appear and receive timely and adequate notice thereof. The Court is authorized to conduct a hearing at which the fairness of the terms and conditions of the Arrangement will be considered. The Court granted the Interim Order on September 13, 2023 and, subject to the approval of the Arrangement Resolution by Small Pharma Shareholders and of the Acquisition Resolution by Cybin Shareholders, a hearing on the Arrangement will be held on or about October 17, 2023 by the Court. Accordingly, the Final Order, if granted, will constitute a basis for the Section 3(a)(10) Exemption from the registration requirement of the U.S. Securities Act. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Required Approvals </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Court Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. The issuance of the Consideration Shares to Small Pharma Securityholders in exchange for the Small Pharma Shares or In-the-Money Small Pharma Options, in each case pursuant to the Arrangement, will, therefore, be exempt from registration under the U.S. Securities Act pursuant to the Section 3(a)(10) Exemption.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consideration Shares to be received by Small Pharma Securityholders pursuant to the Arrangement may be resold without restriction under the U.S. Securities Act, except by persons who are &#8220;affiliates&#8221; (as defined in Rule 144) of Cybin after the Effective Date or who have been affiliates of Cybin within 90 days before the Effective Date. Persons who may be deemed to be affiliates of an issuer generally include individuals or entities that control, are controlled by, or are under common control with, the issuer, whether through the ownership of voting securities, by contract or otherwise, and generally include executive officers and directors of the issuer as well as principal shareholders of the issuer. Any resale of Consideration Shares by such an affiliate (or, if applicable, former affiliate) may be subject to the registration requirements of the U.S. Securities Act, absent an exemption therefrom. Subject to certain limitations, such affiliates (and former affiliates) may immediately resell such Consideration Shares outside the United States without registration under the U.S. </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities Act pursuant to and in accordance with Regulation S. Such Consideration Shares may also be resold in transactions completed in accordance with Rule 144 under the U.S. Securities Act, if available.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing discussion is only a general overview of certain requirements of certain requirements of United States federal securities Laws that may be applicable to the resale of Cybin Shares to be received upon completion of the Arrangement. All holders of such securities are urged to consult with counsel to ensure that the resale of their securities complies with applicable Securities Laws. The foregoing discussion does not address the Canadian Securities Laws that will apply to the issue to, or the resale within Canada of, the Cybin Shares by U.S. shareholders. U.S. shareholders reselling their Cybin Shares in Canada must comply with Canadian Securities Laws, as outlined above under &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Securities Laws Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canadian Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Arrangement Agreement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The following is a summary of certain terms of the Arrangement Agreement and is qualified in its entirety by the full text of the Arrangement Agreement, a copy of which can be found under Cybin&#8217;s SEDAR+ profile at www.sedarplus.com and on EDGAR at www.sec.gov, and the Plan of Arrangement, the full text of which is attached a schedule to the Arrangement Agreement, and is attached as Schedule B to this Circular. Cybin Shareholders are encouraged to read the Arrangement Agreement and Plan of Arrangement in their entirety.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In reviewing the Arrangement Agreement and this summary, readers are advised that this summary has been included to provide Cybin Shareholders with information regarding the key terms of the Arrangement Agreement and is not intended to provide any other factual information about Cybin, Small Pharma or any of their respective subsidiaries or affiliates. The Arrangement Agreement contains representations and warranties and covenants by each of Cybin and Small Pharma, which are summarized below. These representations and warranties have been made solely for the benefit of the Other Party and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are not intended as statements of fact to investors, but rather, as a means of allocating risks between the Parties if those statements prove to be inaccurate, in certain circumstances subject to materiality&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have been qualified by certain confidential disclosures that were made to the Other Party in connection with the negotiation of the Arrangement Agreement, which disclosures are not reflected in the Arrangement Agreement&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">may apply standards of materiality that are different from what may be viewed as material by Cybin Shareholders, Small Pharma Shareholders or other investors.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, information concerning the subject matter of the representations and warranties in the Arrangement Agreement and as described below may have changed since the date of the Arrangement Agreement and subsequent developments may have been included in this Circular. Accordingly, the representations and warranties and other provisions of the Arrangement Agreement should not be read on their own, but instead with the information contained elsewhere in this Circular and the documents incorporated by reference into this Circular.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Representations and Warranties</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Representations and Warranties of Small Pharma </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arrangement Agreement contains certain customary representations and warranties of Small Pharma relating to, among other things&#58; (i) corporate existence of Small Pharma&#59; (ii) the charter documents of Small Pharma&#59; (iii) the capacity and power of Small Pharma to carry on its business&#59; (iv) the qualification and registration of Small Pharma to conduct its business in each jurisdiction that is required to do so&#59; (v) the requisite corporate power, authority and capacity of Small Pharma to perform its obligations under the Arrangement Agreement&#59; (vi) the receipt of the Small Pharma Board approval of the Arrangement Agreement&#59; (vii) absence of conflicts&#59; (viii) regulatory approvals&#59; (ix) consents of third parties&#59; (x) the Small Pharma Board Recommendation&#59; (xi) the receipt of a fairness opinion&#59; (xii) brokers&#59; (xiii) ownership of subsidiaries&#59; (xiv) corporate existence of subsidiaries&#59; (xv) available funds&#59; (xvi) capitalization of Small Pharma&#59; (xvii) convertible securities&#59; (xviii) rights of outstanding securities (xix) options on assets&#59; (xx) Small Pharma&#8217;s TSXV listing&#59; (xxi) compliance with MI 61-101&#59; (xxii) reporting issuer status&#59; (xxiii) corporate records&#59; (xxiv) books and records&#59; (xxv) material changes&#59; (xxvi) conduct of business&#59; (xxvii) public disclosure record&#59; (xxviii) financial statements&#59; (xxix) absence </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of undisclosed liabilities&#59; (xxx) compliance with Laws and permits&#59; (xxxi) United States Laws&#59; (xxxii) material contracts&#59; (xxxiii) restrictions on business activities&#59; (xxxiv) related party transactions&#59; (xxxv) litigation&#59; (xxxvi) shareholder rights plans&#59; (xxxvii) tax&#59; (xxxviii) employment matters&#59; (xxxix)&#59; employee benefit plans&#59; (xl) insurance&#59; (xli) environmental laws&#59; (xlii) title and rights regarding assets&#59; (xliii) intellectual property&#59; (xliv) patents and patent applications&#59; (xlv) healthcare laws&#59; (xlvi) healthcare regulatory compliance&#59; (xlvii) suppliers&#59; (xlviii) anti-corruption&#59; (xlix) anti-money laundering and&#59; (l) customs, trade laws and sanctions. The representations and warranties made by Small Pharma are, in certain cases, subject to specified exceptions or qualifications. For the complete text of the applicable provisions, see section 3.1 of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Representations and Warranties of Cybin </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arrangement Agreement contains certain customary representations and warranties of Cybin relating to, among other things&#58; (i) corporate existence of Cybin&#59; (ii) the charter documents of Cybin&#59; (iii) the capacity and power of Cybin to carry on its business&#59; (iv) the qualification and registration of Cybin to conduct its business in each jurisdiction that is required to do so&#59; (v) the requisite corporate power, authority and capacity of Cybin to perform its obligations under the Arrangement Agreement&#59; (vi) the receipt of the Cybin Board approval of the Arrangement Agreement&#59; (vii) absence of conflicts&#59; (viii) regulatory approvals&#59; (ix) consents of third parties&#59; (x) the Cybin Board Recommendation&#59; (xi) ownership of subsidiaries&#59; (xii) available funds&#59; (xiii) capitalization of Cybin&#59; (xiv) the issuance of the Consideration Shares&#59; (xv) convertible securities&#59; (xvi) rights of outstanding securities&#59; (xvii) options on assets&#59; (xviii) Cybin&#8217;s Cboe Canada and NYSE American listings&#59; (xix) reporting issuer status&#59; (xx) corporate records&#59; (xxi) material changes&#59; (xxii) conduct of business&#59; (xxiii) public disclosure record&#59; (xxiv) financial statements&#59; (xxv) internal controls&#59; (xxvi) disclosure controls and procedures&#59; (xxvii) absence of undisclosed liabilities&#59; (xxviii) compliance with Laws and permits&#59; (xxix) Investment Canada Act matters (xxx) United States Laws&#59; (xxxi) material contracts (xxxii) restrictions on business activities&#59; (xxxiii) related party transactions&#59; (xxxiv) litigation&#59; (xxxv) tax&#59; (xxxvi) employment matters&#59; (xxxvii) employee benefit plans&#59; (xxxviii) insurance&#59; (xxxix)&#59; title and rights regarding assets&#59; (xl) environmental laws&#59; (xli) intellectual property&#59; (xlii) patents and patent application&#59; (xliii) healthcare laws&#59; (xliv) healthcare regulatory compliance&#59; (xlv) anti-corruption&#59; (xlvi) anti-money laundering and&#59; (xlvii) directors and officers. The representations and warranties made by Cybin are, in certain cases, subject to specified exceptions or qualifications. For the complete text of the applicable provisions, see section 3.2 of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Covenants</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Arrangement Agreement, each of Cybin and Small Pharma has agreed to certain covenants, including customary positive and negative covenants relating to conducting their respective businesses, and using commercially reasonable efforts to satisfy conditions precedent to their respective obligations under the Arrangement Agreement. In addition, each of Cybin and Small Pharma agreed to certain covenants in relation to the preparation of this Circular and the circular of Small Pharma with respect to the Small Pharma Meeting as well as the convening and conducting of the Meeting and the Small Pharma Meeting, respectively.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Arrangement Agreement, each of Cybin and Small Pharma has covenanted, among other things, until the earlier of the completion of the Arrangement or the termination of the Arrangement Agreement, to maintain and preserve their respective businesses and refrain from taking certain actions outside the ordinary course.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Covenants Regarding the Conduct of Business of Small Pharma</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In particular, Small Pharma, directly or indirectly, has agreed to, among other things and subject to certain qualifications, not to (i) adopt a plan of liquidation, dissolution, merger, consolidation or reorganization&#59; (ii) make any changes to its existing accounting policies or adopt any new accounting policies, except, in each case, as required by applicable Laws or GAAP, (iii) (A) make, change or revoke any material tax election or designation&#59; (B) settle or compromise any material tax claim, assessment, reassessment, liability, action, suit, proceeding, hearing or controversy&#59; (C) filing any materially amended tax return&#59; (D) enter into any material agreement with a Governmental Authority with respect to taxes&#59; (E) enter into or change any material tax sharing, tax advance pricing agreement, tax allocation or tax indemnification agreement&#59; (F) surrender any right to claim a material tax abatement, reduction, deduction, exemption, credit or refund&#59; (G) consent to the extension or waiver of the limitation period applicable to any material tax matter&#59; (H) make a request for a tax ruling to any Governmental Authority&#59; or (I) materially amend or change any of its methods of reporting income, deductions or accounting for tax purposes, other than as may be required by Law (iv) declaring or paying any dividends or other </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">distribution or payment&#59; (v) pay the Small Pharma Optionholders any amount of consideration for the Small Pharma Options (other than in accordance with the Plan of Arrangement)&#59; (vi) redeem, purchase or otherwise acquire any shares of its capital stock or any of its outstanding securities&#59; (vii) amend the Small Pharma constating documents or the constating documents of any of its subsidiaries&#59; (viii) split, consolidate, exchange or reclassify any securities of Small Pharma or any of its subsidiaries or undertake any other capital reorganization of Small Pharma or any of its subsidiaries&#59; (ix) amend the Small Pharma Option Plans, or the terms of any securities of Small Pharma or any of its subsidiaries (x) reduce the stated capital of the Small Pharma Shares or otherwise enter into any transaction that would reduce the &#8220;paid-up capital&#8221; (within the meaning of the Tax Act) of the Small Pharma Shares&#59; (xi) reorganize, amalgamate, merge or otherwise combine Small Pharma or any of its subsidiaries with any Person, other than pursuant to the Arrangement Agreement&#59; (xii) acquire (by amalgamation, merger, plan of arrangement, consolidation, exchange, acquisition of shares or assets, lease, license, or otherwise) any Person or division of that Person, or make any investment in that Person or division by purchase of securities, contributions of capital, property transfer or otherwise&#59; (xiii) allot, issue or grant any securities of Small Pharma or any of its subsidiaries (including securities convertible into, exchangeable for, or that carry a right to acquire, directly or indirectly, any securities of Small Pharma or any of its subsidiaries)&#59; (xiv) grant any waiver of, or relinquish or change, any rights that are, individually or in the aggregate, material to Small Pharma&#59; (xv) release any director or officer of Small Pharma or any of its subsidiaries from any fiduciary duty owed by that Person&#59; (xvi) sell, lease, pledge, transfer, mortgage, grant a license in, surrender, abandon or otherwise dispose of or encumber any of its property or assets, real or personal&#59; (xvii) (A) sell, transfer, assign or dispose of any right held in any intellectual property, (B) lease or grant a license of any right in any intellectual property&#59; or (C) assign or grant a license of any material right in any intellectual property&#59; (xviii)&#160;&#160;&#160;&#160;(A) waive, amend or voluntarily terminate any inbound license in favour of Small Pharma or any of its subsidiaries with respect to intellectual property, (B) amend any contract with respect to the use of any intellectual property or (C) amend or waive any rights under any material contract, or enter into any contract that would be a material contract if in effect on the date hereof&#59; (xix) commence (other than planning) or terminate any phase I, phase II, phase III or phase IV human clinical trial&#59; (xx) (A) waive or materially amend the Small Pharma&#8217;s rights in or to any intellectual property that is registered or the subject of an application for registration&#59; or (B) fail to use reasonable efforts to prosecute or maintain any intellectual property that is registered&#59; (xxi) (A) waive, release or condition any non-compete, non-solicit, non disclosure, confidentiality or other restrictive covenant owed to Small Pharma or its subsidiaries&#59; or (B) enter into any contract which creates any non-competition or material non-solicit obligations for Small Pharma or any of its subsidiaries&#59; (xxii) make any loan to any Person, other than in respect of accounts payable to trade creditors or accrued liabilities incurred in the ordinary course&#59; (xxiii) prepay any indebtedness before its scheduled maturity&#59; (xxiv) increase, incur, or otherwise become liable for any indebtedness for borrowed money in excess of $250,000 (in aggregate)&#59; or assume, guarantee or otherwise become responsible for any liability or obligation of any other Person&#59; (xxv) pay, discharge, settle or satisfy any material claims, liabilities or obligations other than as reflected or reserved against in Small Pharma&#8217;s financial statements&#59; (xxvi) amend, modify or terminate any material contract, or enter into any contract that would be a material contract if it was in existence on the date of the Arrangement Agreement (xxvii) enter into any Contract with a term of greater than 12 months&#59; (xxviii) incur capital expenditures in excess of $100,000 (in aggregate)&#59; (xxix) enter into or adopt any shareholder rights plan or similar agreement or arrangement&#59; (xxx) enter into any new lease for real property, or amend or extend the terms of any existing lease for real property&#59; (xxxi)&#160;&#160;&#160;&#160;enter into any agreement or arrangement that limits or otherwise restricts, in any material respect, the business of Small Pharma or any of its subsidiaries, or that may in the future limit or restrict, in any material respect, Small Pharma, any of its subsidiaries, or their successors from carrying on business, acquiring or operating any properties or assets or competing in any manner&#59; (xxxii) enter into or amend, in any material respect, any contract with any broker, finder or investment banker in connection with the Arrangement and the transactions contemplated by Arrangement Agreement&#59; (xxxiii) take any action or fail to take any action which action or failure to act would result in the material loss, expiration or surrender of, or the loss of any material benefit under, or reasonably be expected to cause any Governmental Authority to institute proceedings for the suspension, revocation or limitation of rights under, any material permit necessary to conduct Small Pharma&#8217;s and its subsidiaries&#8217; businesses as now conducted or as proposed to be conducted, or fail to pursue, with commercially reasonable efforts and due diligence, any pending application to any Governmental Authorities for any material permit&#59; (xxxiv) enter into any transaction with a &#8220;related party&#8221; (as defined in MI 61-101), other than expense reimbursements, expense accounts, payments and advances in the ordinary course, or agree to provide any &#8220;collateral benefit&#8221; (as defined in MI 61-101) to a &#8220;related party&#8221;&#59; (xxxv) other than as required by the terms of any employee plan or written employment Contract in existence on the date of the Arrangement Agreement&#58; (A) grant to any officer or director of Small Pharma or any of its subsidiaries an increase in compensation in any form, other than in the ordinary course&#59; (B) grant any general increase in the rate of wages, salaries, bonuses or other remuneration of employees or independent contractors&#59; (C) adopt or otherwise implement any new bonus, profit sharing distribution, employee or executive bonus or retention plan or similar plan or program&#59; (D) grant or increase any severance, change of control or termination pay or similar compensation or benefits payable to (or amend any existing Contract with) any director or officer </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of Small Pharma or, other than in the ordinary course, any employee (other than a director or officer), independent contractor or consultant&#59; (E) enter into any employment, deferred compensation, independent contractor, consulting, bonus, retention, or other similar contract (or amend any such existing contract) with any director or officer of Small Pharma or any of its subsidiaries or, other than in the ordinary course, any employee (other than a director or officer), independent contractor or consultant&#59; (F) provide for accelerated vesting or removal of restrictions on exercise of any Small Pharma Options upon a change of control occurring on or prior to the Effective Time&#59; (G) loan or advance money or other property by Small Pharma or its subsidiaries to any of their present or former directors, officers or employees (other than expense reimbursements, expense accounts and advances in the ordinary course)&#59; (H) terminate any employee plan, amend or modify, in a material way, any employee plan, or adopt any plan, agreement, program, policy, trust, fund or other arrangement that would be an employee plan if it were in existence as of the date of the Arrangement Agreement&#59; or (I) increase, or agree to increase, any funding obligation or accelerate, or agree to accelerate, the timing of any funding contribution or vesting under any employee plan&#59; (xxxvi) commence waive, release, assign, settle, compromise or settle any litigation, proceeding, claim or investigation affecting Small Pharma or any of its subsidiaries&#59; (xxxvii)&#160;&#160;&#160;&#160;take any action that might reasonably be expected to, directly or indirectly, interfere with, prevent or materially delay the completion of the Arrangement, or which would render, or which may reasonably be expected to render, untrue or inaccurate in any material respect any of the representations and warranties of Small Pharma set forth in the Arrangement Agreement&#59; or (xxxviii) announce an intention, propose, authorize or enter into any agreement, or otherwise make a commitment to do action prohibited by the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the complete text of the applicable conduct of business provisions, see section 4.1 of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Covenants Regarding the Conduct of Business of Cybin</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In particular, Cybin, directly or indirectly, has agreed to, among other things and subject to certain qualifications, not to (i) adopt a plan of liquidation, dissolution, merger, consolidation or reorganization&#59; (ii) split, consolidate, exchange or reclassify the Cybin Shares, or undertake any other capital reorganization of Cybin&#59; (iii) amend the Cybin Articles or by-laws of Cybin&#59; (iv) declare or pay any dividends or other distribution or payment (whether in cash, shares or property) in respect of any shares of its capital stock&#59; (v) redeem, purchase or otherwise acquire any shares of its capital stock or any of its outstanding securities, other than in connection with the exercise of outstanding Cybin Options from time to time in accordance with their terms&#59; (vi) allot, issue or grant any securities of Cybin or any of its subsidiaries (including securities convertible into, exchangeable for, or that carry a right to acquire, directly or indirectly, any securities of Cybin or any of its subsidiaries), other than&#58; (A) Cybin Shares issuable upon exercise of convertible securities of Cybin issued before the date of the Arrangement Agreement&#59; or (B) pursuant to a Cybin Permitted Financing&#59; (vii) (A) sell, transfer, assign or dispose of any material right in any material intellectual property, (B), lease or grant a license of any material right in any material intellectual property or (C) assign or grant a license of any material right in any other material intellectual property&#59; (viii) substantially discontinue or materially change the nature of the business of the Cybin and its subsidiaries&#59; (ix) take any action that might reasonably be expected to, directly or indirectly, interfere with, prevent or materially delay the completion of the Arrangement, or which would render, or which may reasonably be expected to render, untrue or inaccurate in any material respect any of the representations and warranties of Cybin set forth in the Arrangement Agreement&#59; or (x) announce an intention, propose, authorize or enter into any agreement, or otherwise make a commitment to do action prohibited by the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the complete text of the applicable conduct of business provisions, see section 4.2 of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Covenants Regarding the Arrangement Agreement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of Cybin and Small Pharma has made certain customary covenants in respect of the Arrangement, including that each Party will&#58; (i) use commercially reasonable efforts to obtain all third party consents, approvals and provide any notices required under material contracts&#59; (ii) use commercially reasonable efforts obtain (and maintain) all required or advisable regulatory approvals (iii) perform all such acts and things as may be reasonably necessary or desirable in order to consummate, as soon as reasonably practicable, the transactions contemplated by the Arrangement Agreement&#59; (iv) use commercially reasonable efforts to ensure that the Section 3(a)(10) Exemption is available for the issuance of Consideration Shares to Small Pharma Securityholders in exchange for their Small Pharma Shares&#59; and (v) promptly notify the Other Party of (A) any circumstance or development that, to the knowledge of such Party, is or would reasonably be expected to constitute a material change (within the meaning of Canadian Securities Laws) or Material Adverse Effect with respect to such notifying Party&#59; (B) any notice or other communication from any Person alleging that the consent (or waiver, permit, </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exemption, order, approval, agreement or confirmation) of that Person (or another Person) is or may be required in connection with the Arrangement Agreement or the Arrangement&#59; (C) any notice or other communication from any material business partner to the effect that such material business partner is terminating, may terminate or is otherwise materially adversely modifying or may materially adversely modify its relationship with such notifying Party or any of its subsidiaries as a result of the Arrangement Agreement or the Arrangement&#59; (D) any notice or other communication received from any Governmental Authority in connection with the Arrangement Agreement (and such notifying Party shall contemporaneously provide a copy of any such written notice or communication to where not prohibited by Law)&#59; and (E) any claims commenced or, to the knowledge of such Party, threatened, that relate to or involve such notifying Party, the Arrangement Agreement or the Arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin has all covenanted to make and make all commercially reasonable efforts to obtain, approval of the Cboe Canada and NYSE American to list the Consideration Shares that will be issuable to Small Pharma Shareholders under the Arrangement (subject to customary listing conditions).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the complete text of the applicable provisions, see sections 4.3, 4.4 and 4.5 of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conditions</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mutual Conditions</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The respective obligations of Cybin and Small Pharma to complete the Arrangement are subject to the satisfaction, on or before the Effective Time, of each of the following conditions precedent, each of which may only be waived with the mutual consent of the Parties, in whole or in part, at any time and from time to time, without prejudice on any other rights that the Parties may have&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interim Order.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Interim Order will have been granted and will not have been set aside or modified in a manner unacceptable to either of the Parties, acting reasonably, on appeal or otherwise.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Arrangement Resolution.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Arrangement Resolution will have been approved by the Small Pharma Shareholders in accordance with the requirements of the BCBCA and the Interim Order and in form and substance satisfactory to each of the Parties, acting reasonably, and will be in full force and effect, unamended.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition Resolution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Acquisition Resolution will have been approved by the Cybin Shareholders in accordance with the requirements of the OBCA, in form and substance satisfactory to each of the Parties, acting reasonably, and will be in full force and effect, unamended.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Final Order.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Final Order will have been granted and will not have been set aside or modified in a manner unacceptable to either of the Parties, acting reasonably, on appeal or otherwise.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. Exemption.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Consideration Shares to be issued to the holders of Small Pharma Shares (including Small Pharma Shares issued upon the exchange for In-the-Money Small Pharma Options pursuant to the Plan of Arrangement) under the Arrangement will be (i) exempt from the registration requirements of the U.S. Securities Act under the Section 3(a)(10) Exemption and exemptions from applicable U.S. state securities Laws (or will otherwise be exempt from, or not subject to, registration requirements), and (ii) freely tradeable under United States Securities Laws (other than as applicable to persons who are, have been within 90 days of the Effective Time, or, at the Effective Time become, &#8220;affiliates&#8221; of Cybin, as such term is defined in Rule 144 under the U.S. Securities Act).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Illegality.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There will not be in effect any Law that makes the consummation of the Arrangement illegal or otherwise prohibits or enjoins Cybin or Small Pharma from consummating the Arrangement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Each of the Cboe Canada and NYSE American will have approved the listing of all of the Consideration Shares issuable under the Arrangement, subject only to customary conditions.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;If required by the rules of the TSXV, the TSXV will have accepted notice for filing of the Arrangement, subject only to customary conditions.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;Following the notification of any transaction contemplated by the Arrangement, to the extent required by the UK NSIA, either&#58;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;the UK Secretary of State in the Cabinet Office will have confirmed to Cybin in accordance with section 14(8)(b)(ii) of the UK NSIA that no further action will be taken in relation to the transaction&#59; or</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;in the event that a call-in notice is given in relation to the transaction pursuant to section 14(8)(b)(i) of the UK NSIA, the UK Secretary of State in the Cabinet Office will have either&#58;</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;given a final notification pursuant to section 26(1)(b) of the UK NSIA confirming that no further action will be taken in relation to the transaction&#59; or</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;made a final order pursuant to section 26(1)(a) of the UK NSIA permitting the transaction to proceed subject to such remedies or requirements that are in all respects satisfactory to the Parties, each acting reasonably, and such order not being revoked or varied before completion of the Arrangement.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;All other regulatory approvals will have been obtained and will remain in effect on terms satisfactory to each Party, acting reasonably.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Canadian Exemptions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The distribution of the Consideration Shares pursuant to the Arrangement shall be exempt from the prospectus requirements of applicable Canadian Securities Laws by virtue of applicable prospectus exemptions under Canadian Securities Laws, and there shall be no resale restrictions on such Consideration Shares under applicable Canadian Securities Laws, except in respect of those holders who are subject to restrictions on resale as a result of being a &#8220;control person&#8221; under applicable Canadian Securities Laws.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conditions to the Obligations of Cybin</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations of Cybin to complete the Arrangement are subject to the satisfaction of the following conditions precedent&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Covenants.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> All covenants of Small Pharma under the Arrangement Agreement to be performed on or before the Effective Time which have not been waived by Cybin shall have been duly performed by Small Pharma in all material respects.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Representations and Warranties.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (i) the representations and warranties of Small Pharma regarding its organization, constating documents, power, authority and capacity to carry on its business, qualification and authorization to enter into the Arrangement Agreement, as well as to the absence of any violation of, and the existence of its subsidiaries shall be true and correct in all respects as of the Effective Time as if made at and as of such time&#59; (ii) the representations and warranties of Small Pharma regarding its capitalization and convertible securities shall be true and correct in all respects (except for </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de minimis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> inaccuracies) as of the date of the Arrangement Agreement&#59; and (iii) all other representations and warranties of Small Pharma under the Arrangement Agreement will be true and correct in all respects as of the date of the Arrangement Agreement and as of the Effective Date as if made on and as of that date (except for representations and warranties made as of a specified date, the accuracy of which will be determined as of that specified date), except for inaccuracies of representations and warranties the circumstances giving rise to which, individually or in the aggregate, do not have and would not reasonably be expected to have a Material Adverse Effect with respect to Small Pharma.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No Material Adverse Effect.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Since the date of the Arrangement Agreement, there shall not have occurred any Material Adverse Effect with respect to Small Pharma.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Officers&#8217; Certificate.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cybin will have received a certificates of Small Pharma addressed to Cybin and dated the Effective Date, signed, without personal liability, on behalf of Small Pharma, by two senior officers of Small Pharma, confirming the matters set out in paragraphs (a), (b), and (c) above, as at the Effective Date.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dissent Rights.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Holders of no more than 5% of the Small Pharma Shares shall have validly exercised Dissent Rights in respect of the Arrangement that have not been withdrawn as of the Effective Date.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Resignations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Each of the officers and directors of Small Pharma in connection with whom a resignation request has been made by Cybin will have resigned without compensation (other than amounts set out in the disclosure letter delivered by Small Pharma in connection with the Arrangement Agreement) and will have executed a resignation and release.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consents.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Small Pharma will have obtained all consents, approvals and waivers required to complete the transactions contemplated by the Arrangement Agreement, on terms satisfactory to Cybin, acting reasonably&#58; (i) under all material contracts&#59; (ii) under any other contracts to which Small Pharma is a party, except to the extent that the failure to obtain those consents, approvals and waivers (individually or in the aggregate) would not reasonably be expected to have a Material Adverse Effect with respect to Small Pharma&#59; and (iii) under all permits owned, possessed or obtained by Small Pharma, except to the extent that the failure to obtain any of those consents, approvals and waivers (individually or in the aggregate) would not reasonably be expected to have a Material Adverse Effect with respect to Small Pharma.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No Adverse Legal Action.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No order of any Governmental Authority will be in force, and no action or proceeding will be pending or threatened by any Person&#58; (i) to restrain, prohibit or impose material limitations on the Arrangement or the transactions contemplated by the Arrangement Agreement&#59; (ii) to restrict Cybin&#8217;s ability to exercise full rights of ownership in the Small Pharma Shares (including the ability to vote and receive dividends)&#59; (iii) that would have a Material Adverse Effect with respect to Small Pharma or Cybin if the Arrangement is consummated&#59; or (iv) that would, or would reasonably be expected to, result in a judgment or assessment of material damages against Small Pharma or Cybin relating to the transactions contemplated by the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lock-Up Agreements.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Each of the Small Pharma Supporting Shareholders will have executed and delivered to Cybin a Lock-Up Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing conditions are for the exclusive benefit of Cybin and may be waived by Cybin, in its sole discretion, in whole or in part, at any time and from time to time without prejudice to any other rights which Cybin may have.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conditions to the Obligations of Small Pharma</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations of Small Pharma to complete the Arrangement are subject to the satisfaction of the following conditions precedent&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Covenants.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> All covenants of Cybin under the Arrangement Agreement to be performed on or before the Effective Time which have not been waived by Small Pharma shall have been duly performed by Cybin in all material respects.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Representations and Warranties.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (i) the representations and warranties of Cybin regarding its organization, constating documents, power, authority and capacity to carry on its business, qualification and authorization to enter into the Arrangement Agreement, its obligations under the Arrangement Agreement, as well as to the absence of any violation of, and the issuance of the Considerations shall be true and correct in all respects as of the Effective Time as if made at and as of such time&#59; (ii) the representations and warranties of Cybin regarding its convertible securities (except for de minimis inaccuracies) as of the date of the Arrangement Agreement&#59; and (iii) all other representations and warranties of Cybin under the Arrangement Agreement will be true and correct in all respects as of the date of the Arrangement Agreement and as of the Effective Date as if made on and as of that date (except </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for representations and warranties made as of a specified date, the accuracy of which will be determined as of that specified date), except for inaccuracies of representations and warranties the circumstances giving rise to which, individually or in the aggregate, do not have and would not reasonably be expected to have a Material Adverse Effect with respect to Cybin.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No Material Adverse Effect.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Since the date of the Arrangement Agreement, there shall not have occurred any Material Adverse Effect with respect to Cybin.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Officers&#8217; Certificate.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Small Pharma will have received a certificate of Cybin addressed to Small Pharma and dated the Effective Date, signed, without personal liability, on behalf of Cybin, by two senior officers of Cybin, confirming the matters set out in paragraphs (a), (b), and (c) above, as at the Effective Date.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deposit of Consideration.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cybin will have deposited or caused to be deposited with the Depositary in escrow the Consideration Shares required to effect payment in full of the aggregate consideration to be paid pursuant to the Arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing conditions are for the exclusive benefit of Small Pharma and may be waived by Small Pharma, in its sole discretion, in whole or in part, at any time and from time to time without prejudice to any other rights which Cybin may have.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Solicitation Covenants and Right to Match</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Solicitation Covenants</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Arrangement Agreement, each Party has agreed to certain non-solicitation covenants, including that such Party shall not, except as expressly provided in the Arrangement Agreement, directly or indirectly, including through any Representative&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;make, solicit, initiate, facilitate, encourage or promote (including by way of providing access to or disclosure of any non-public information relating to such Party or its subsidiaries, providing access to any properties, facilities, books or records of such Party or its subsidiaries, or entering into any form of agreement, arrangement or understanding) any proposal, inquiry or offer that constitutes, or may reasonably be expected to constitute or lead to, an Acquisition Proposal, or agree to or endorse any of the foregoing&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;enter into or otherwise engage or participate in any discussions or negotiations with any Person (other than the Other Party) regarding any proposal, inquiry or offer that constitutes, or may reasonably be expected to constitute or lead to, an Acquisition Proposal&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;accept, approve, endorse or recommend, or propose publicly to accept, approve, endorse or recommend, any Acquisition Proposal&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;make a Change in Recommendation&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;enter into, or publicly propose to enter into, any letter of intent, agreement in principle, agreement, arrangement, understanding or undertaking related to any Acquisition Proposal (other than a confidentiality and standstill agreement as contemplated in Section 5.4(b)(v)(A) of the Arrangement Agreement).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Party has covenanted to the Other Party that it will cause its subsidiaries and representatives to immediately cease and cause to be terminated any existing solicitation, encouragement, discussion or negotiation with any persons commenced prior to the date of the Arrangement Agreement, its subsidiaries or any representatives with respect to any Acquisition Proposal, and, in connection therewith, such Party will discontinue access to any of its confidential information (and not establish or allow access to any of its confidential information, or any data room, virtual or otherwise) and shall as soon as possible request, to the extent that it is entitled to do so (and exercise all rights it has to require), the return or destruction of all confidential information regarding such Party and its subsidiaries previously provided to any such person or any other </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">person and will request, to the extent it is entitled to do so (and exercise all rights it has to require), the destruction of all material including or incorporating or otherwise reflecting any material confidential information regarding such Party and its subsidiaries. Each Party has agreed that neither it nor any of its subsidiaries, shall terminate, waive, amend or modify any provision of any existing confidentiality agreement relating to an Acquisition Proposal or any standstill agreement to which it or any of its subsidiaries is a party or becomes party to in accordance with the Arrangement Agreement, and each Party has undertaken to enforce all standstill, non-disclosure, non-disturbance, non-solicitation and similar covenants that it or any of its subsidiaries have entered into prior to the date of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing restrictions are subject to &#8220;fiduciary out&#8221; provisions, which provide that if at any time following the date of the Arrangement Agreement and prior to obtaining the Cybin Shareholder Approval or the Small Pharma Shareholder Approval, as applicable&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;a Party receives a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">bona fide</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, written Acquisition Proposal that did not result from a breach of the Arrangement Agreement and that the Cybin Board or the Small Pharma Board, as applicable, determines in good faith, after consultation with its financial advisors and outside legal counsel, constitutes or, if consummated in accordance with its terms, could reasonably be expected to lead to a Superior Proposal, then such Party may in response to a request made by the person making such Acquisition Proposal, provided it is in compliance with the Arrangement Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;furnish non-public information with respect to the Party and its subsidiaries to the person making such Acquisition Proposal&#59; and&#47;or </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;enter into, participate, facilitate and maintain discussions or negotiations with, and otherwise cooperate with or assist, the person making such Acquisition Proposal,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provided that such Party shall not, and shall not allow its representatives to, under any circumstances waive any confidentiality or standstill provision or agreement that would otherwise prohibit such person from making such Acquisition Proposal or disclose any non-public information to such person&#58; (i) if such non-public information has not been previously provided to, or is not concurrently provided to the Other Party&#59; and (ii) unless prior to disclosing any such information, the Party shall enter into a confidentiality agreement (on terms deemed acceptable under the Arrangement Agreement) with such person&#59; provided, however, that any such agreement shall not preclude such person from making a Superior Proposal and no such agreement shall be required if such person is already party to a confidentiality agreement with such Party&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;a Party receives an Acquisition Proposal that did not result in a breach of the Arrangement Agreement and which the Cybin Board or the Small Pharma Board, as applicable, concludes in good faith, after consultation with its financial advisors and outside legal counsel, constitutes a Superior Proposal, it may, subject to the right to match provisions of the Arrangement Agreement and compliance with the procedures and payment of fees set forth in the Arrangement Agreement, terminate the Arrangement Agreement to enter into a definitive agreement with respect to such Superior Proposal.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, nothing contained in the Arrangement Agreement prohibits a Party from taking any action or making a Change in Recommendation or from making any disclosure to any of its securityholders prior to the Effective Time, if, in the good faith judgment of the Cybin Board or the Small Pharma Board, as applicable, after consultation with outside legal counsel, failure to take such action or make such disclosure would be inconsistent with such board of directors&#8217; exercise of its fiduciary duties or such action or disclosure is otherwise required under applicable Law (including by responding to an Acquisition Proposal under a directors&#8217; circular or otherwise as required under Securities Laws).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Arrangement Agreement, each Party has agreed to promptly notify the Other Party, at first orally and then in writing within 24 hours of receipt of any Acquisition Proposal, including a description of the material terms and conditions thereof, and the identity of the person or persons making the Acquisition Proposal, and shall provide the Other Party with a copy of any such proposal, inquiry, offer or request, and a copy of any agreement entered into in accordance with the Arrangement Agreement. Such Party shall thereafter also provide such other details of such proposal, inquiry, offer or request, or any amendment to any of the foregoing, as the Other Party may reasonably request and shall keep the Other Party promptly informed as to the status, including any changes to the material terms, of such proposal, inquiry, offer or </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">request, or any amendment to any of the foregoing, and shall respond promptly to all reasonable inquiries from the Other Party with respect thereto.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the complete text of the applicable provisions, see section 5.2 and 5.3 of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cybin Right to Match</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arrangement Agreement provides that, if at any time following the date of the Arrangement Agreement and prior to Small Pharma obtaining the Small Pharma Shareholder Approval at the Small Pharma Meeting, Small Pharma receives an Acquisition Proposal that the Small Pharma Board, concludes in good faith, after consultation with its financial advisors and outside legal counsel, constitutes a Superior Proposal, it may enter into an Acquisition Agreement in respect of such Superior Proposal, provided that&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Small Pharma has complied in all material respects with its obligations under the Arrangement Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the person making the Acquisition Proposal was not restricted from doing so under any existing confidentiality, standstill or similar agreement with Small Pharma or any of its Subsidiaries&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Small Pharma has delivered to Cybin&#58; (i) written notice that the Small Pharma Board has determined (A) that the Acquisition Proposal constitutes a Superior Proposal, and (B) subject to Cybin&#8217;s rights under Section 5.5(c) of the Arrangement Agreement to enter into the Acquisition Agreements&#59; (ii) written notice of the cash value, or range of values, ascribed by the Small Pharma Board to any non-cash consideration offered in the Superior Proposal (iii) a copy of the Acquisition Agreement (in final form, but unexecuted by Small Pharma)&#59; and (iv) all documents required to be delivered by Small Pharma under Section 5.5(c) of the Arrangement Agreement&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;a period of five Business Days (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Match Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), or more, has elapsed from the date on which all documents required by paragraph (b)(iv) above have been delivered&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Small Pharma has complied with its obligations under pursuant to the Match Period and the Small Pharma Board has determined in good faith, after consulting with its financial advisors and outside legal counsel, that the Acquisition Proposal still constitutes a Superior Proposal&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;Small Pharma has paid or concurrently pays to Cybin the Small Pharma Termination Fee and Small Pharma terminates the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the Match Period, Cybin will have the right, but not the obligation, to offer to amend the Arrangement Agreement and the Plan of Arrangement, including modification of the Consideration. In the event Cybin exercises this right to match, the Arrangement Agreement provides as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the Small Pharma Board will review any such offer by Cybin in good faith in order to determine whether the Acquisition Proposal to which Small Pharma is responding would continue to be a Superior Proposal when assessed against Cybin&#8217;s amended offer&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Small Pharma will (and will cause its financial and legal advisors to) negotiate in good faith with Cybin (and its financial and legal advisors) to make any adjustments to the terms and conditions of the Arrangement Agreement that would result in the Acquisition Proposal ceasing to be a Superior Proposal.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the complete text of the applicable provisions, see section 5.5 of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expenses and Termination Fees</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Parties have agreed that all fees, costs and expenses incurred in connection with the Arrangement Agreement and the Plan of Arrangement shall be paid by the Party incurring such fees, costs or expenses, except in the circumstances described below.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Termination Fee</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Arrangement Agreement is terminated as a result of a Party entering into an agreement, understanding or arrangement to effect an Acquisition Proposal that is a Superior Proposal, subject to certain limitations, a Change in Recommendation in respect of the Arrangement or the material breach of such Party&#8217;s non-solicitation covenants, then such Party will pay the applicable Termination Fee to the Other Party.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the foregoing, if the Arrangement Agreement is terminated by either of the Parties as a result of (i) the Effective Time not occurring on or before the Outside Date or (ii) the Small Pharma Meeting is held and the Arrangement Resolution is voted on by the Small Pharma Shareholders and not approved as required by the Interim Order, if an Acquisition Proposal in respect of Small Pharma is made, proposed or publicly announced after the execution of Arrangement Agreement, before the termination of the Arrangement Agreement, and before the Small Pharma Meeting is held, and such Acquisition Proposal has not been withdrawn at least five Business Days before the Small Pharma Meeting, and either&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Arrangement is submitted to the Small Pharma Shareholders for approval and the Pharma Shareholders do not approve the Arrangement Resolution as required in the Interim Order&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Arrangement is not submitted for the approval of the Small Pharma Shareholders, </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within 12 months after the date of the termination of the Arrangement Agreement, any Acquisition Proposal in respect of Small Pharma is completed (regardless of whether it is the Acquisition Proposal), or Small Pharma or any of its subsidiaries, directly or indirectly, in one or more transactions, accepts, approves, or enters into a contract in respect of such Acquisition Proposal, and such Acquisition Proposal is later completed, whether or not within such 12 month period, provided that, in such circumstance, the term &#8220;Acquisition Proposal&#8221; shall have the meaning given to it in the Arrangement Agreement, except that references to &#8220;20%&#8221; shall be deemed to be &#8220;50%&#8221;, then Small Pharma will pay to Cybin the Small Pharma Termination Fee.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expense Reimbursement </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event the Arrangement Agreement is terminated (i) by Small Pharma or Cybin in the event that the Acquisition Resolution is not approved by Cybin Shareholders or (ii) by Small Pharma as a result of Cybin&#8217;s breach of representations and warranties than Cybin will pay to Small Pharma the Expense Reimbursement Amount provided that the Expense Reimbursement Amount will not be payable if (i) prior to the Cybin Meeting, a Material Adverse Effect with respect to Small Pharma has occurred, or (ii) the Small Pharma Meeting is held, and the Arrangement Resolution is also not approved. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the complete text of the applicable provisions, see section 8.6 of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Termination</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to payment of the Termination Fee and Expense Reimbursement Amount, where applicable, the Arrangement Agreement may be terminated and the Arrangement abandoned at any time prior to the Effective Time&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;by mutual written agreement of Small Pharma and Cybin&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;by Small Pharma, upon written notice to Cybin&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;if any of the mutual conditions precedent or conditions precedent to the obligations of Small Pharma that have not been waived by Small Pharma and are not capable of being satisfied by the Outside Date, provided that the failure to satisfy that condition is not the result, directly or indirectly, of Small Pharma&#8217;s breach of the Arrangement Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;if a breach of any representation, warranty or covenant of Cybin has occurred that would cause the condition set out in Section 6.3(a) or 6.3(b) of the Arrangement Agreement not be satisfied, and that breach is incapable of being cured or is not, and provided that Small Pharma is not then in breach of the Arrangement Agreement so as to cause any condition in Section 6.2(a) (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Small </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharma Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or Section 6.2(b) (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Small Pharma Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) not to be satisfied&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;if Small Pharma (or the Small Pharma Board) accepts, approves, endorses or recommends a Superior Proposal, or enters into an Acquisition Agreement, in each case in accordance with Arrangement Agreement, and that before or concurrent with that termination Small Pharma pays the Small Pharma Termination Fee&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;if (A) the Cybin Board fails to include the Cybin Board Recommendation in the Cybin Circular, (B) the Cybin Board withdraws, modifies, qualifies, or publicly proposes or states an intention to withdraw, modify, or qualify, the Cybin Board Recommendation, (C) the Cybin Board accepts, approves, endorses or recommends, or publicly proposes to accept, approve, endorse or recommend an Acquisition Proposal, or takes no position or remains neutral with respect to a publicly disclosed Acquisition Proposal for more than five Business Days (or beyond the third Business Day prior to the date of the Cybin Meeting, if sooner), or (D) the Cybin Board fails to reaffirm the Cybin Board Recommendation, by press release, upon the written request by Small Pharma, promptly after any Acquisition Proposal that is publicly disclosed is determined not to be (or no longer to be) a Superior Proposal, within three Business Days of Small Pharma&#96;s request (or, if the Cybin Meeting is scheduled to occur within that three Business Day period, before the Cybin Meeting).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;by Cybin, upon written notice to Small Pharma&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;if any of the mutual conditions precedent or conditions precedent to the obligations of Cybin that have not been waived by Cybin and are not capable of being satisfied by the Outside Date, provided that the failure to satisfy that condition is not the result, directly or indirectly, of Cybin&#8217;s breach of the Arrangement Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;if a breach of any representation, warranty or covenant of Small Pharma has occurred that would cause the condition set out in Section 6.2(a) or 6.2(b) of the Arrangement Agreement not be satisfied, and that breach is incapable of being cured or is not, and provided that Cybin is not then in breach of the Arrangement Agreement so as to cause any condition in Section 6.3(a) (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cybin Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or Section 6.3(b) (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cybin Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) not to be satisfied&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;if Cybin (or the Cybin Board) accepts, approves, endorses or recommends a Superior Proposal, or enters into an Acquisition Agreement, in each case in accordance with Arrangement Agreement, and that before or concurrent with that termination Cybin pays the Cybin Termination Fee&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;if (A) the Small Pharma Board fails to include the Small Pharma Board Recommendation in the Small Pharma Circular, (B) the Small Pharma Board withdraws, modifies, qualifies, or publicly proposes or states an intention to withdraw, modify, or qualify, the Small Pharma Board Recommendation, (C) the Small Pharma Board accepts, approves, endorses or recommends, or publicly proposes to accept, approve, endorse or recommend an Acquisition Proposal, or takes no position or remains neutral with respect to a publicly disclosed Acquisition Proposal for more than five Business Days (or beyond the third Business Day prior to the date of the Small Pharma Meeting, if sooner), or (D) the Small Pharma Board fails to reaffirm the Small Pharma Board Recommendation, by press release, upon the written request by Small Pharma, promptly after any Acquisition Proposal that is publicly disclosed is determined not to be (or no longer to be) a Superior Proposal, within three Business Days of Cybin&#8217;s request (or, if the Small Pharma Meeting is scheduled to occur within that three Business Day period, before the Small Pharma Meeting).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;by either Small Pharma or Cybin if&#58;</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;the Effective Time shall not have occurred on or before the Outside Date, provided that such termination right shall not be available a Party if the failure of the Effective Time to occur on or before the Outside Date is the result, directly or indirectly, of that Party&#8217;s breach of the Arrangement Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;if the Small Pharma Meeting is held and the Arrangement Resolution is voted on by the Small Pharma Shareholders and not approved as required by the Interim Order, or if the Cybin Meeting is held and the Acquisition Resolution is not approved, provided that a Party may not terminate the Arrangement Agreement if such occurrence is the result, directly or indirectly, of that Party&#8217;s breach of the Arrangement Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;if there has occurred a Material Adverse Effect with respect to the Other Party that is incapable of being cured prior to the Outside Date&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;if there shall be enacted or made any Law (or any such Law shall have been amended) that makes consummation of the Arrangement illegal or otherwise prohibited or enjoins Cybin or the Small Pharma from consummating the Arrangement and such Law (if applicable) or enjoinment shall have become final and non-appealable&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;if the Other Party intentionally or materially breaches certain non-solicitation covenants. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the complete text of the applicable provisions, see section 7.1 of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amendments</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arrangement Agreement and the Plan of Arrangement may, at any time and from time to time before or after the holding of the Small Pharma Meeting but not later than the Effective Time, be amended by mutual written agreement of the Parties, without further notice to or authorization on the part of Small Pharma&#8217;s Securityholders and any such amendment may, subject to the Interim Order and the Final Order and applicable Law, without limitation&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;change the time for performance of any of the obligations or acts of the Parties&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;modify any representation or warranty contained in the Arrangement Agreement or in any document delivered pursuant to the Arrangement Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;modify any of the covenants contained in the Arrangement Agreement and waive or modify performance of any of the obligations of the Parties&#59; and&#47;or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;modify any mutual conditions contained in the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the complete text of the applicable provisions, see section 9.1 of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Support and Voting Agreements</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cybin Support and Voting Agreements</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective August 28, 2023, each of the directors and senior officers of Cybin and certain significant shareholders of Cybin, who, in the aggregate, beneficially owned or exercised control or direction over, directly or indirectly, approximately 17% of the outstanding Cybin Shares as at the date of the Arrangement Agreement (on a non-diluted basis), have entered into a Cybin Support and Voting Agreement with Small Pharma pursuant to which they agreed, among other things, to vote, or cause to be voted, all of such Cybin Supporting Shareholders&#8217; Cybin Shares&#58; (i) in favour of the approval of the Acquisition Resolution, any other transactions contemplated in the Arrangement Agreement and any other matter necessary for the consummation of the Arrangement&#59; (ii) against any Acquisition Proposal of Cybin&#59; (iii) against any action, agreement, transaction or proposal that would result in a material breach of any representation, warranty, covenant, agreement or other obligation of Cybin in the Arrangement Agreement or of the Cybin Supporting Shareholder under the Cybin Support and Voting Agreement&#59; and (iv) against any matter that could reasonably be expected to delay, prevent, impede or frustrate the </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">successful completion of the Arrangement or any of the transactions contemplated by the Arrangement Agreement. Additionally, each Cybin Supporting Shareholder has agreed to a number of customary negative covenants in furtherance of the consummation of the Arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Cybin Support and Voting Agreement may be terminated&#58; (i) by Small Pharma, at any time by written notice to the Shareholder&#59; (ii) by the applicable Cybin Supporting Shareholder if (A) Small Pharma breaches or is in default of any of the covenants or obligations of Small Pharma under the applicable Cybin Support and Voting Agreement and such breach or such default has or may reasonably be expected to have an adverse effect on the consummation of the transactions contemplated by the Arrangement Agreement&#59; or (B) any of the representations or warranties of Small Pharma under the applicable Cybin Support and Voting Agreement shall have been at the date of the applicable agreement, or subsequently become, untrue or incorrect, except to the extent any such failure to be true or correct would not preclude Small Pharma from consummating the Arrangement&#59; provided in (A) and (B) that the applicable Cybin Supporting Shareholder has notified Small Pharma in writing of any of the foregoing events and the same has not been cured by Small Pharma within ten Business Days of the date such notice was received by Small Pharma&#59; or (iii) by mutual agreement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Small Pharma Support and Voting Agreements</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective August 28, 2023, each of the directors and senior officers of Small Pharma who hold Small Pharma Shares, who beneficially owned or exercised control or direction over, directly or indirectly, approximately 2.5% of the outstanding Small Pharma Shares as at the date of the Arrangement Agreement (on a non-diluted basis) have entered into a Small Pharma Support and Voting Agreement with Cybin pursuant to which they agreed, among other things, to vote, or cause to be voted, all of the Small Pharma Supporting Shareholders&#8217; securities of Small Pharma which have a right to be voted at the Small Pharma Meeting&#58; (i) in favour of the approval of the Arrangement Resolution, any other transactions contemplated in the Arrangement Agreement and any other matter necessary for the consummation of the Arrangement&#59; (ii) against any Acquisition Proposal for Small Pharma&#59; (iii) against any action, agreement, transaction or proposal that would result in a material breach of any representation, warranty, covenant, agreement or other obligation of Small Pharma in the Arrangement Agreement or of the Shareholder under the Small Pharma Support and Voting Agreement&#59; and (iv) against any matter that could reasonably be expected to delay, prevent, impede or frustrate the successful completion of the Arrangement or any of the transactions contemplated by the Arrangement Agreement. Additionally, each Small Pharma Supporting Shareholder has agreed to a number of customary negative covenants in furtherance of the consummation of the Arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Small Pharma Support and Voting Agreement may be terminated&#58; (i) by Cybin at any time upon written notice of to the applicable Small Pharma Supporting Shareholder&#59; (ii) by the applicable Small Pharma Supporting Shareholder if (A) Cybin breaches or is in default of any of the covenants or obligations of Cybin under the applicable Small Pharma Support and Voting Agreement and such breach or such default has or may reasonably be expected to have an adverse effect on the consummation of the transactions contemplated by the Arrangement Agreement or (B) any of the representations or warranties of Cybin under the applicable Small Pharma Support and Voting Agreement shall have been at of the date of the agreement, or subsequently become, untrue or incorrect, except to the extent any such failure to be true or correct would not preclude Cybin from consummating the Arrangement&#59; provided in each case that the Small Pharma Supporting Shareholder has notified Cybin in writing of any of the foregoing events and the same has not been cured by Cybin within ten business days of the date such notice was received by Cybin&#59; or (iii) by mutual agreement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rands Support and Voting Agreement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective August 28, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Peter Rands, who beneficially owned or exercised control or direction over, directly or indirectly, approximately 26.3% of the outstanding Small Pharma Shares as of the date of the Arrangement Agreement (on a non-diluted basis) has entered into the Rands Support and Voting Agreement with Cybin on substantially similar terms to the Small Pharma Support and Voting Agreement, except that during the period starting on the first trading day following the date on which Small Pharma files an information circular on SEDAR+ in respect of the Arrangement and ending on the Effective Date, Mr. Rands may offer for sale and sell up to an aggregate of 8,500,000 Small Pharma Shares through the facilities of the TSXV.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lock-up Agreements</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a condition to closing the Arrangement and pursuant to the terms of the Arrangement Agreement, each Small Pharma Supporting Shareholder will be required to enter into a Lock-up Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Small Pharma Supporting Shareholder other than Mr. Rands will enter into a Lock-up Agreement that provides that without the prior written consent of Cybin, during the period commencing on the Effective Date and expiring on the date that is 12 months after the Effective Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lock-up Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Small Pharma Supporting Shareholder will not directly or indirectly&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;offer, sell, contract to sell, lend, sell or grant any option or contract to purchase, purchase any option or contract to sell, pledge, grant a security interest in, or otherwise transfer, dispose of or deal with any of the Cybin Shares issued to the applicable Small Pharma Supporting Shareholder (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Locked-Up Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), or announce any intention to take any of the foregoing actions&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;enter into any swap or other similar arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Locked-Up Shares (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lock-up Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the Lock-up Period, Locked-Up Share will be released from the Lock-up Restrictions as to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (one sixth) of the total number of Locked-Up Shares (rounding down any fractional shares) on each one-month anniversary of the Effective Date, starting on the date that is six months after the Effective Date until the expiry of the Lock-up Period.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Rands will enter into a Lock-Up Agreement on substantially similar terms, except that at the Effective Time, the Lock-up Restrictions will be released with respect to 2,047,650 Locked-Up Shares minus the number of Cybin Shares that is equal to the number of Small Pharma Shares sold or transferred by Mr. Rands between the date of the Arrangement Agreement and the Effective Date multiplied by the Exchange Ratio (rounding down any fractional shares). In addition, during the Lock-Up Period, if Mr. Rands or Ms. Knox proposes to sell any Buyer Shares during any 30-day period a number of Buyer Shares that exceeds 3% of the trading volume of the Buyer Shares on the NYSE American during the 20 trading days ended on the last trading day preceding such 30-day period, they will give Cybin a sale notice setting out the terms of the proposed sale, and Cybin will have the right, for a period of five business days, to elect to purchase or designate the purchasers for all or any part of such Cybin Shares at the price and on the terms set out in the sale notice. If, and to the extent that, Cybin does not, or its designated purchasers do not, confirm an intent to purchase all of the Cybin Shares referred to in the sale notice within such five business day period, or if Cybin or its designated purchasers do not complete the purchase of all of the Cybin Shares within 10 business days from the date on which Cybin received the sale notice, whichever occurs first, the applicable shareholder will have the right, for a period of 15 business days, to sell, without further notice to Cybin, the remaining Cybin Shares at a price not less, and on terms no more favorable, than the price and terms set out in the sale notice.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factors</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin Shareholders voting in favour of the Acquisition Resolution will be choosing to endorse the proposed acquisition of Small Pharma by Cybin. In addition to the risk factors present in each of Cybin&#8217;s and Small Pharma&#8217;s businesses, described under the heading &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the Cybin AIF and Small Pharma AIF, which are incorporated by reference into this Circular, Cybin Shareholders should carefully consider the following risk factors specifically associated with the Arrangement in evaluating whether to approve the Acquisition Resolution. Readers are cautioned that such risk factors are not exhaustive. These risk factors should be considered in conjunction with the other information included in this Circular, including the documents incorporated by reference herein and documents filed by Cybin and Small Pharma pursuant to applicable Securities Laws from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Factors Relating to the Arrangement</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arrangement may not be completed</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of Cybin and Small Pharma has the right to terminate the Arrangement Agreement in certain circumstances. Accordingly, there is no certainty that the Arrangement will be completed in accordance with the terms of the Arrangement Agreement or the Plan of Arrangement, or at all.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the completion of the Arrangement is subject to a number of conditions precedent, certain of which are outside of the control of Cybin or Small Pharma. Among other things, the Arrangement is conditional upon the approval of the Arrangement Resolution by Small Pharma Shareholders, approval of the Acquisition Resolution by Cybin Shareholders, the Cboe Canada and NYSE American approval and Court approval. There can be no assurance that any or all such approvals will be obtained, or that Cybin will be able to satisfy the requirements under subsection 10.11(1)(b) of the NEO Exchange Listing Manual. A substantial delay in obtaining satisfactory approvals or the imposition of unfavourable terms or conditions in any approvals could have an adverse effect on the business, financial condition or results of operations of Small Pharma, Cybin or Post-Arrangement Cybin.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arrangement Agreement may be terminated</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of Cybin and Small Pharma has the right to terminate the Arrangement Agreement in certain circumstances. Accordingly, there is no certainty, nor can Cybin provide any assurance, that the Arrangement Agreement will not be terminated before the completion of the Arrangement. For instance, either Cybin or Small Pharma has the right, in certain circumstances, to terminate the Arrangement Agreement if changes occur that have a Material Adverse Effect on the Other Party. There is no assurance that a Material Adverse Effect will not occur before the Effective Date, in which case Cybin or Small Pharma could elect to terminate the Arrangement Agreement and the Arrangement would not proceed.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin may be subject to a number of material risks relating to the Arrangement not being completed, including the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;certain costs related to the Arrangement, such as legal, financial advisory and accounting fees must be paid by Cybin even if the Arrangement is not completed&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;if the Arrangement is not completed, the market price of Cybin Shares may be adversely affected&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Cybin may be required to pay the Cybin Termination Fee or the Expense Reimbursement Amount in certain circumstances.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restrictions on Cybin prior to closing</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arrangement Agreement restricts Cybin from taking specified actions until the Arrangement is completed, without the consent of Small Pharma. These restrictions may prevent Cybin from pursuing attractive business opportunities that may arise prior to completion of the Arrangement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fixed share consideration</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Exchange Ratio for the Consideration is fixed and will not increase or decrease due to fluctuations in the market price of Cybin Shares or Small Pharma Shares. The market price of Cybin Shares or Small Pharma Shares could each fluctuate significantly prior to the Effective Date in response to various factors and events, including, without limitation, the differences between Cybin&#8217;s and Small Pharma&#8217;s actual financial or operating results and those expected by investors and analysts, changes in analysts&#8217; projections or recommendations, changes in general economic or market conditions, and broad market fluctuations. As a result of such fluctuations, historical market prices are not indicative of future market prices or the market value of the Consideration Shares to be issued on the Effective Date. There can also be no assurance that the trading price of the Cybin Shares will not decline following the completion of the Arrangement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks related to Small Pharma&#8217;s business</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While Cybin has completed due diligence investigations with respect to Small Pharma, certain risks may materialize, may not have been uncovered or are not known at this time. Such risks may have an adverse impact on Cybin and the combined assets of Cybin and Small Pharma following the Arrangement and may have a negative impact on the value of the Cybin Shares.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cybin may become liable to pay the Termination Fee or the Expense Reimbursement Amount</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Arrangement Agreement is terminated under certain circumstances, Cybin will be required to pay the Cybin Termination Fee to Small Pharma. The Cybin Termination Fee may discourage third parties from attempting to propose a significant business transaction with Cybin, even if a different transaction could provide better value than the Arrangement to Cybin Shareholders. If Cybin is required to pay the Termination Fee under the Arrangement Agreement, Cybin&#8217;s financial condition may be materially adversely affected. In addition, if the Arrangement Agreement is terminated in certain circumstances where the Cybin Shareholders have not approved the Acquisition Resolution, or if Cybin fails to comply with its representations, warranties, or covenants under the Arrangement Agreement, Cybin will be obligated to pay the Expense Reimbursement Amount to Small Pharma. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Small Pharma Shareholders may exercise Dissent Rights</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Small Pharma Shareholders have the right to exercise Dissent Rights and demand payment equal to the fair value of their Small Pharma Shares in cash. Cybin&#8217;s obligation to complete the Arrangement is conditional upon Dissent Rights not being exercised by Small Pharma Shareholders holding more than 5% of the issued and outstanding Small Pharma Shares. Accordingly, the Arrangement may not be completed if Small Pharma Shareholders exercise Dissent Rights in respect of more than 5% of the issued and outstanding Small Pharma Shares and Cybin does not waive this condition to its obligation to complete the Arrangement. If Dissent Rights are exercised in respect of a significant number of Small Pharma Shares, a substantial cash payment may be required to be made to such Small Pharma Shareholders, which could have an adverse effect on Post-Arrangement Cybin&#8217;s financial condition and cash resources.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin and Small Pharma may be the target of securities class actions and derivative lawsuits which could result in substantial costs and may delay or prevent the Arrangement from being completed. Securities class action lawsuits and derivative lawsuits are often brought against companies that have entered into an agreement to acquire a public company or to be acquired. Third parties may also attempt to bring claims against Cybin and Small Pharma seeking to restrain the Arrangement or seeking monetary compensation or other remedies. Even if the lawsuits are without merit, defending against these claims can result in substantial costs and divert management time and resources. Additionally, if a plaintiff is successful in obtaining an injunction prohibiting consummation of the Arrangement, then that injunction may delay or prevent the Arrangement from being completed.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diversion of management attention</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pending Arrangement could cause the attention of Cybin&#8217;s management to be diverted from the day-to-day operations of Cybin. These disruptions could be exacerbated by a delay in the completion of the Arrangement and could result in lost opportunities or negative impacts on performance, which could have a material and adverse effect on the business, financial condition and results of operations or prospects of Cybin if the Arrangement is not completed, and on the business of Cybin following the Effective Date.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unknown or undisclosed risks or liabilities of Small Pharma</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While Cybin conducted due diligence with respect to Small Pharma prior to entering into the Arrangement Agreement, there are risks inherent in any transaction. Specifically, there could be unknown or undisclosed risks or liabilities of Small Pharma for which Cybin is not permitted to terminate the Arrangement Agreement. Any such unknown or undisclosed risks or liabilities could materially and adversely affect Cybin&#8217;s financial performance and results of operations. Cybin could encounter additional transaction and enforcement-related costs and may fail to realize any or all of the potential benefits from the Arrangement Agreement. Any of the foregoing risks and uncertainties could have a material adverse effect on Cybin&#8217;s business, financial condition and results of operations.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reliance on Small Pharma with respect to information regarding Small Pharma included in, or which may have been omitted from, this Circular.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated, all historical information regarding Small Pharma contained in this Circular, including all Small Pharma financial information and all pro forma financial information reflecting the pro forma effects of the acquisition of </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Small Pharma by Cybin, has been derived from Small Pharma&#8217;s publicly disclosed information or provided by Small Pharma. Although Cybin has no reason to doubt the accuracy or completeness of such information, any inaccuracy or material omission in Small Pharma&#8217;s publicly disclosed information, including the information about or relating to Small Pharma contained in this Circular, could result in unanticipated liabilities or expenses, increase the cost of integrating the companies or adversely affect Cybin&#8217;s operational and development plans and Cybin&#8217;s business, financial condition and results of operations.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Factors Relating to Post-Arrangement Cybin</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Possible failure to realize anticipated benefits of the Arrangement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin and Small Pharma are proposing to complete the Arrangement for a variety of reasons, including to strengthen the position of each entity in the clinical-stage biopharmaceutical industries and to combine the assets of both companies to realize certain benefits, including those set forth in this Circular under the heading &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background to the Arrangement &#38; Recommendations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reasons for the Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. Achieving the anticipated benefits of the Arrangement depends in part on the ability of Cybin to effectively fund and develop Post-Arrangement Cybin&#8217;s key projects, to realize the anticipated capital and operating synergies and to maximize the potential of its improved growth opportunities and anticipated capital funding opportunities. A variety of factors, including those risk factors set forth in this Circular and in the documents incorporated by reference herein, may adversely affect the ability of Post-Arrangement Cybin to achieve the anticipated benefits of the Arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks related to the integration of Cybin and Small Pharma</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Post-Arrangement Cybin&#8217;s ability to realize the benefits of the Arrangement will depend in part on successfully consolidating functions and integrating operations, procedures and personnel in a timely and efficient manner, as well as on Post-Arrangement Cybin&#8217;s ability to realize the anticipated growth opportunities and synergies from integrating Small Pharma&#8217;s business following completion of the Arrangement. This integration will require the dedication of management effort, time and resources which may divert management&#8217;s focus and resources from other strategic opportunities available to Post-Arrangement Cybin, and from operational matters during this process.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the integration process could result in disruption of existing relationships with suppliers, employees, customers and other constituencies of Cybin and Small Pharma. There can be no assurance that management will be able to integrate the operations of each of the businesses successfully or achieve any of the synergies or other benefits that are anticipated to result from the Arrangement. The integration process is in the planning phase, and although most operational and strategic decisions have yet to be made, key decisions with respect to selected senior staffing positions and organization structure are progressing. These decisions and the integration of Cybin and Small Pharma will present challenges to management, including the integration of systems and personnel of the two geographically-separated companies, unanticipated liabilities and unanticipated costs. It is possible that the integration process could result in the loss of key employees, the disruption of the respective ongoing businesses or inconsistencies in standards, controls, procedures and policies that adversely affect the ability of management to maintain relationships with customers, suppliers, employees or to achieve the anticipated benefits of the Arrangement. The performance of Post-Arrangement Cybin&#8217;s operations could be adversely affected if it cannot retain key employees to assist in the integration and operation of Cybin and Small Pharma.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any inability of management to successfully integrate the operations could have a Material Adverse Effect on the business, financial condition and results of operations of Post-Arrangement Cybin.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, Post-Arrangement Cybin will face the same risks that each of Cybin and Small Pharma currently face, in addition to other risks.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adverse effects on Cybin Shares</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On completion of the Arrangement, a significant number of additional Cybin Shares will be issued and available for trading in the public market. The increase in the number of Cybin Shares may lead to sales of such shares or the perception that such sales may occur (commonly referred to as &#8220;market overhang&#8221;), either of which may adversely affect the market for, and the market price of, the Cybin Shares.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dilution</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the issuance of Cybin Shares in connection with the Arrangement, the ownership and voting interests of Cybin Shareholders in Cybin will be diluted, relative to current proportional ownership and voting interests.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pro forma financial statements may not be indicative of the financial condition or results of operations of Post-Arrangement Cybin</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma consolidated financial statements contained in this Circular are presented for illustrative purposes only as of their respective dates and may not be an indication of the financial condition or results of operations of Post-Arrangement Cybin for several reasons. For example, the unaudited pro forma consolidated financial statements have been derived from the respective historical financial statements of Cybin and Small Pharma, and certain adjustments and assumptions made as of the dates indicated therein may not be relevant in regards to Cybin following the Arrangement and other adjustments and assumptions have been made to give effect to the Arrangement and the other respective relevant transactions which may not, with the passage of time, turn out to be relevant or correct. The information upon which these adjustments and assumptions have been made is preliminary, and adjustments and assumptions of this nature require the exercise of judgement and are difficult to make with complete accuracy. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management Information Circular</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-Looking Statements.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Outbreaks of communicable diseases</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging infectious diseases or the threat of outbreaks of contagious diseases, including the COVID-19 outbreak, could lead to disruptions in many aspects of Post-Arrangement Cybin&#8217;s business operations (including as a result of government regulation and prevention measures), labour shortages and shutdowns, social unrest, breach of material contracts, increased insurance premiums, delays in permitting or approvals, governmental disruptions, capital markets volatility, and other unknown but potentially significant impacts, all of which could result in the closure of research facilities, warehouses, and supply chains upon which Post-Arrangement Cybin relies. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Post-Arrangement Cybin&#8217;s business could be adversely impacted by the effects of a health epidemic or other outbreaks of communicable disease. In particular, such an event could materially and adversely impact Cybin&#8217;s business including without limitation, employee health, workforce productivity, increased insurance premiums, limitations on travel, the availability of industry experts and personnel, restrictions to research programs and other factors that will depend on future developments beyond Cybin&#8217;s control, which could have a material and adverse effect on its business, financial condition and results of operations. In addition, the inability of Governmental Authorities to control the spread and impact of a pandemic could adversely affect global economies and financial markets resulting in an economic downturn that could have an adverse effect on Post-Arrangement Cybin&#8217;s future prospects. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Concerning Cybin</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. See Schedule C for additional information regarding Cybin.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Concerning Small Pharma</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Small Pharma is a biotechnology company progressing a pipeline of short-duration psychedelic-assisted therapies for the treatment of mental health conditions. See Schedule D for additional information regarding Small Pharma.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Concerning Post-Arrangement Cybin</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Arrangement, Small Pharma will become a wholly-owned subsidiary of Cybin. For further information concerning the business and operations of Post-Arrangement Cybin, see Schedule E. See Schedule F for selected pro forma financial information for Post-Arrangement Cybin as at and for the three months ended June 30, 2023, and for the year ended March 31, 2023.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Material Changes</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as disclosed in this Circular, Cybin is not aware of any plans or proposals for material changes in the business or affairs of Cybin, or the affairs of Small Pharma which may have a significant effect on the financial performance and financial position of Cybin, Small Pharma, or Post-Arrangement Cybin. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER MATTERS TO BE ACTED UPON</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the knowledge of the Cybin Board, the only other matters to be brought before the Meeting, in addition to the Acquisition Resolution, are those matters set forth in the Notice of Meeting, as set forth below in more detail.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statements</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin&#8217;s audited consolidated financial statements as at and for the years ended March 31, 2023 and 2022, and the report of the auditors on such financial statements, will be placed before the Meeting, and will be open to inspection. Such financial statements are also available on SEDAR+ under Cybin&#8217;s profile at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sedarplus.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and on EDGAR at www.sec.gov. No formal action will, or is required to, be taken in respect of Cybin&#8217;s audited consolidated financial statements at the Meeting. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Appointment and Remuneration of Auditors</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management proposes to nominate Zeifmans LLP, which firm has been auditor of Cybin since November 2020, as auditor of Cybin, to hold office until the close of the next annual meeting of Cybin Shareholders. </font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Recommendation&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Management of Cybin recommends that Cybin Shareholders </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">VOTE FOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> the appointment of Zeifmans LLP as Cybin&#8217;s auditors and authorizing the directors to fix their remuneration.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Proxies&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Unless otherwise instructed, proxies in favour of the management designees will be </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">VOTED FOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> the appointment of Zeifmans LLP as Cybin&#8217;s auditors and authorizing the directors to fix their remuneration.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Election of Directors</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybin Board presently consists of six directors. At the Meeting, the Cybin Shareholders will be asked to elect the six nominees set forth below, namely, Theresa Firestone, Grant Froese, Paul Glavine, Eric Hoskins, Mark Lawson and Eric So (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Nominees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Nominee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) as directors of Cybin. Each Board Nominee elected will hold office until the next annual meeting of shareholders or until his or her successor is duly elected or appointed pursuant to the by-laws of Cybin. The enclosed form of proxy permits Cybin Shareholders to vote for all the Board Nominees together or for each Board Nominee on an individual basis.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin Shares represented by proxies in favour of management will be </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">VOTED FOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> each of the Board Nominees, unless the Cybin Shareholder who has given such proxy has directed that the Cybin Shares are to be withheld from voting in respect of any particular Board Nominee or Board Nominees. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management does not contemplate that any of the Board Nominees will be unable to serve as directors. However, if for any reason, any of the Board Nominees do not stand for election or are determined to be ineligible to serve as a director of Cybin, the persons named in the form of proxy reserve the right to vote for other nominee(s) that may be proposed for election at the Meeting at their discretion.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Majority Voting Policy</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin Shareholders will vote for the election of each individual proposed director nominee separately. Cybin has adopted a majority voting policy for the election of directors whereby any nominee director (in an uncontested election) who receives more &#8220;withheld&#8221; votes than &#8220;for&#8221; votes at any meeting where Cybin Shareholders vote on the election, the director will be expected to submit to the Cybin Board his or her resignation, to take effect upon acceptance by the Cybin Board. The Cybin Board will then have 90 days to accept the resignation, during which time an alternate Cybin Board member may be appointed. The Cybin Board shall be expected to accept the resignation absent exceptional circumstances that would </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">warrant the applicable director to continue to serve on the Cybin Board. In determining whether to accept the resignation, the Cybin Board will consider various matters including the results of the vote of Cybin Shareholders, the contribution of the director to the Cybin Board and committee discussions, the expressed reasons (if any) for which the withheld votes have been given, the merits of such reasons, and the ability to address the underlying concerns. The Cybin Board will promptly disclose the results of the vote director by director and will promptly issue a news release disclosing the Board&#8217;s decision. If the Cybin Board determines not to accept a resignation, the news release shall fully state the reasons for that decision.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The director under consideration will not participate in any Cybin Board or committee deliberations relating to his or her potential resignation. Subject to any corporate law restrictions, the Cybin Board may (i) leave a resultant vacancy unfilled until the next annual meeting of Cybin Shareholders&#59; (ii) fill the vacancy through the appointment of a new director whom the Cybin Board considers to merit the confidence of Cybin Shareholders&#59; or (iii) call a special meeting of Cybin Shareholders at which there will be presented individuals to fill the vacant position or positions. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advance Notice Requirement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin&#8217;s By-Law No. 1, contains a requirement providing for advance notice of nominations of directors in certain circumstances where nominations for election to the Board are made by Cybin Shareholders. For an annual meeting of Cybin Shareholders, notice to Cybin must be provided not less than 30 and not more than 65 days prior to the date of the annual meeting&#59; save and except where the annual meeting is to be held on a date less than 50 days after the date on which the first public announcement of the date of such annual meeting was made, in which event notice may be given not later than the close of business on the 10th day following such public announcement. For a special meeting of Cybin Shareholders (that is not also an annual meeting), notice to Cybin must be given not later than the close of business on the 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> day following the day on which the first public announcement of the date of such special meeting was made. Cybin&#8217;s By-Law No. 1 is available under Cybin&#8217;s profile on SEDAR+ at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sedarplus.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set out certain information as of the date of this Circular (unless otherwise indicated) with respect to the persons being nominated at the Meeting for election as directors. Information regarding Cybin Shares owned by each director of Cybin is presented to the best knowledge of management of Cybin and has been furnished to management of Cybin by such directors. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">THERESA FIRESTONE</font></td><td colspan="9" style="background-color:#d9d9d9;border-bottom:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal Occupation and Biographical Information</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ontario, Canada</font></div><div style="padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director Since&#58; August 16, 2021</font></div><div style="margin-bottom:6pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LEAD INDEPENDENT</font></div><div style="padding-left:3.1pt;padding-right:3.1pt;text-align:center"><img alt="image_1.jpg" src="image_1.jpg" style="height:171px;margin-bottom:5pt;vertical-align:text-bottom;width:169px"></div></td><td colspan="9" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Theresa Firestone is a senior healthcare executive with retail, pharmaceutical, health &#38; wellness, government and global restructuring expertise. She spent 15 years in senior roles at Pfizer Inc., 14 years in government and 7 years in the retail and health and wellness sector. Ms. Firestone has international experience in executive leadership roles in Canada, Europe and Asia and extensive P&#38;L experience. At Pfizer, Ms. Firestone was Regional President of Emerging Markets Asia and had responsibility for a P&#38;L of $1.4B and oversaw 9 markets in Asia. Ms. Firestone was most recently Senior Vice President with Shoppers Drug Mart where she led health and wellness initiatives including new growth strategies and the development and launch of health clinics and the PC Health App.</font></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current Board&#47;Committee Membership</font></td><td colspan="6" style="background-color:#bfbfbf;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 Attendance (Total)</font></td><td colspan="3" style="background-color:#bfbfbf;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Public Board Memberships</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member of the Cybin Board</font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member of the Audit Committee</font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member of the Corporate Governance and Nominating Committee</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:3.1pt;padding-right:3.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 of 5</font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:3.1pt;padding-right:3.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 of 5</font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:3.1pt;padding-right:3.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 of 1</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:3.1pt;padding-right:3.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:3.1pt;padding-right:3.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:3.1pt;padding-right:3.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aurora Cannabis Inc. (TSX&#58; ACB)</font></td></tr><tr><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Cybin Shares Beneficially Owned, Controlled or Directed</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:3.1pt;padding-right:3.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,250</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:434.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Note&#58;</font></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;Also holds 390,000 Cybin Options.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GRANT FROESE</font></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal Occupation and Biographical Information</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ontario, Canada</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director Since&#58; November 5, 2020</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INDEPENDENT</font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><img alt="image_2.jpg" src="image_2.jpg" style="height:170px;margin-bottom:5pt;vertical-align:text-bottom;width:170px"></div></td><td colspan="9" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Grant Froese is a retail industry veteran with 38 years of experience at Loblaw Companies Limited, Canada&#8217;s largest food retailer, with his most recent position being Chief Operating Officer. Mr. Froese also served as the Chief Executive Officer of Marquee Health Group, a late-stage applicant under the Access to Cannabis for Medical Purposes Regulation and as Chief Executive Officer of Harvest One Cannabis Inc. (now Delivra Health Brands Inc.), a global cannabis company that develops and provides innovative lifestyle and wellness products to consumers and patients in regulated markets around the world where he gained valuable industry experience and insight. Mr. Froese has extensive experience in supply chain management, digital&#47;ecommerce businesses, marketing, brand management, and merchandising and operations management.</font></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current Board&#47;Committee Membership</font></td><td colspan="6" style="background-color:#bfbfbf;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 Attendance (Total)</font></td><td colspan="3" style="background-color:#bfbfbf;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Public Board Memberships</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member of the Cybin Board</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member of the Audit Committee</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member of the Compensation Committee</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 of 5</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 of 5</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 of 2</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100% </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">None.</font></td></tr><tr><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Cybin Shares Beneficially Owned, Controlled or Directed</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nil</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:434.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Note&#58;</font></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;Also holds 390,000 Cybin Options and warrants exercisable to purchase 750,000 Cybin Shares.</font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.951%"><tr><td style="width:1.0%"></td><td style="width:33.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.419%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PAUL GLAVINE</font></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal Occupation and Biographical Information</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ontario, Canada</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director Since&#58; November 5, 2020</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NOT INDEPENDENT</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><img alt="image_3.jpg" src="image_3.jpg" style="height:170px;margin-bottom:5pt;vertical-align:text-bottom;width:170px"></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div></td><td colspan="9" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Paul Glavine is a Co-founder and the Chief Growth Officer of Cybin. He is a serial entrepreneur and investor with vast experience in the biotech, mining and life science sectors. He was the Co-founder of TruVerra, which was acquired by Supreme Cannabis Company (later acquired by Canopy Growth). He has completed financings and M&#38;A transactions in excess of $180 million in the past 4 years for his businesses.</font></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current Board&#47;Committee Membership</font></td><td colspan="6" style="background-color:#bfbfbf;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 Attendance (Total)</font></td><td colspan="3" style="background-color:#bfbfbf;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Public Board Memberships</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member of the Cybin Board</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 of 5</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">None.</font></td></tr><tr><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Cybin Shares Beneficially Owned, Controlled or Directed</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,242,407</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(2)</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:434.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notes&#58;</font></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;Includes 750,000 Cybin Shares held by Mr. Glavine&#8217;s spouse, 1,716,666</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cybin Shares held directly by Mr. Glavine and 8,775,741 Cybin Shares held by the PLG Family Trust, controlled by Mr. Glavine. </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;Also holds 2,324,000 Cybin Options and warrants exercisable to purchase 4,000,000 Cybin Shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ERIC HOSKINS</font></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal Occupation and Biographical Information</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ontario, Canada</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director Since&#58; November 5, 2020</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INDEPENDENT</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><img alt="image_4.jpg" src="image_4.jpg" style="height:170px;margin-bottom:5pt;vertical-align:text-bottom;width:170px"></div></td><td colspan="9" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Eric Hoskins is a Partner at Maverix Private Equity. He is the former Ontario Health Minister (2014-2018) responsible for one of the largest health care systems in North America. He is a former elected Member of Ontario Provincial Parliament holding Cabinet positions in Health, Economic Development and Trade, Children and Youth Services, and Immigration. Dr. Hoskins is a physician and public health specialist with more than thirty years&#8217; experience in health care and public policy.</font></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current Board&#47;Committee Membership</font></td><td colspan="6" style="background-color:#bfbfbf;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 Attendance (Total)</font></td><td colspan="3" style="background-color:#bfbfbf;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Public Board Memberships</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member of the Cybin Board</font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member of the Audit Committee</font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member of the Governance and Nominating Committee </font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 of 5</font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 of 5</font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 of 1</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80% </font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80%</font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Think Research Corporation (TSXV&#58; THNK)</font></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">FSD Pharma Inc. (Nasdaq&#58; HUGE) (CSE&#58; HUGE)</font></div></td></tr><tr><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Cybin Shares Beneficially Owned, Controlled or Directed</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(2)</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:434.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notes&#58;</font></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;Includes 50,000 Cybin Shares held by Dr. Hoskin&#8217;s spouse, and 50,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cybin Shares held directly by Dr. Hoskin. </font></div><div style="margin-bottom:30pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;Also holds 390,000 Cybin Options, and warrants exercisable to purchase 1,150,000 Cybin Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.480%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MARK LAWSON</font></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal Occupation and Biographical Information</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ontario, Canada</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director Since&#58; November 5, 2020</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INDEPENDENT</font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><img alt="image_5.jpg" src="image_5.jpg" style="height:170px;margin-bottom:5pt;vertical-align:text-bottom;width:170px"></div></td><td colspan="9" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Mark Lawson is a private equity and investment banking executive with over 20 years of experience in Canada, the United States, and in the emerging markets. From 2008 to present Mr. Lawson has been the Managing Partner of Clermont Capital Partners, a Toronto based merchant bank and advisory firm focused on the technology and healthcare sectors. From 2004 to 2008 he was an investment banker with Morgan Stanley in New York, where he was involved in the execution of over $6 billion worth of mergers and acquisitions, $8 billion worth of debt offerings and $500 million of equity financings in the healthcare, technology, and telecom sectors. Mr. Lawson is also currently a director of various publicly traded companies in North America. Mr. Lawson received his Bachelor of Arts in Statistical Sciences from The University of Western Ontario, Canada and his MBA from The Richard Ivey School of Business, University of Western Ontario, Canada. Mr. Lawson is a member of the Economic Club of New York and is a Director of the Hugh and Ilene Lawson Charitable Organization.</font></div></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current Board&#47;Committee Membership</font></td><td colspan="6" style="background-color:#bfbfbf;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 Attendance (Total)</font></td><td colspan="3" style="background-color:#bfbfbf;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Public Board Memberships</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member of the Cybin Board</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member of the Audit Committee</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member of the Compensation Committee</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member of the Corporate Governance and Nominating Committee</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 of 5</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 of 5</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 of 2</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 of 1</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Claren Energy Corp. (CEN-TSXV)</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Armm Inc. (ARMM &#8211; OTCQB)</font></div></td></tr><tr><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Cybin Shares Beneficially Owned, Controlled or Directed</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114,996</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:434.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Note&#58;</font></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;Also holds 420,000 Cybin Options. </font></div><div style="text-align:justify"><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.035%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ERIC SO</font></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal Occupation and Biographical Information</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ontario, Canada</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director Since&#58; November 5, 2020</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NOT INDEPENDENT</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><img alt="image_6.jpg" src="image_6.jpg" style="height:170px;margin-bottom:5pt;vertical-align:text-bottom;width:170px"></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font><br></font></div></td><td colspan="9" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eric So is a Co-founder, Chair, and President of Cybin. He is a veteran owner and operator of various public and private companies over the last 15 years and has led C-level corporate strategy, development and finance at all stages of the business life cycle from start-up to high growth and multinational. He began his career practicing in the areas of corporate commercial, securities, finance and mergers and acquisitions at Torys LLP.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></div></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current Board&#47;Committee Membership</font></td><td colspan="6" style="background-color:#bfbfbf;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 Attendance (Total)</font></td><td colspan="3" style="background-color:#bfbfbf;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Public Board Memberships</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member of the Cybin Board</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member of the Compensation Committee</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member of the Corporate Governance and Nominating Committee</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 of 5</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 of 2</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 of 1</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">None.</font></td></tr><tr><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Cybin Shares Beneficially Owned, Controlled or Directed</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,572,411</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(2)</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:434.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notes&#58;</font></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;Includes 2,000,000 Cybin Shares held by Mr. So&#8217;s spouse, 1,716,667</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cybin Shares held directly by Mr. So and 7,855,744 Cybin Shares held by the So Family Trust &#8211; 2017, controlled by Mr. So. </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;Also holds 2,324,000 Cybin Options and warrants exercisable to purchase 4,000,000 Cybin Shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Cease Trade Orders</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as disclosed below, no proposed director is, as at the date of this Circular, or has been, within 10 years before the date of this Circular, a director, chief executive officer or chief financial officer of any company (including Cybin) that&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;was subject to a cease trade order, an order similar to a cease trade order, or an order that denied the relevant company access to any exemption under applicable securities legislation, and which in all cases was in effect for a period of more than 30 consecutive days (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), which Order was issued while the proposed director was acting in the capacity as director, chief executive officer or chief financial officer of such company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;was subject to an Order that was issued after the proposed director ceased to be a director, chief executive officer or chief financial officer and which resulted from an event that occurred while that person was acting in the capacity as director, chief executive officer or chief financial officer of such company</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greg Cavers was the interim Chief Financial Officer of LottoGopher Holdings Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LottoGopher</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), a CSE-listed company, until January 2020. Preceding his position, LottoGopher has been subject to a cease trade order on December 5, 2018 for failing to file interim financial report, management&#8217;s discussion and analysis and certification of the filings pursuant to National Instrument 52-109 &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certification of Disclosure in Issuers&#8217; Annual and Interim Filings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing information, not being within the knowledge of Cybin, has been furnished by the proposed directors.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bankruptcies, or Penalties or Sanctions </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the knowledge of Cybin, no proposed director&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;is, as at the date of this Circular, or has been within 10 years before the date of this Circular, a director or executive officer of any company (including Cybin) that, while that person was acting in that capacity, or within a year of that person ceasing to act in that capacity, became bankrupt, made a proposal under any </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">legislation relating to bankruptcy or insolvency or was subject to or instituted any proceedings, arrangement or compromise with creditors or had a receiver, receiver manager or trustee appointed to hold its assets&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;has within 10 years before the date of this Circular, become bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency or become subject to or instituted any proceedings, arrangement or compromise with creditors or had a receiver, receiver manager or trustee appointed to hold his assets&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;has been subject to any penalties or sanctions imposed by a court relating to securities legislation or by a securities regulatory authority or has entered into a settlement agreement with a securities regulatory authority&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;has been subject to any penalties or sanctions imposed by a court or regulatory body that would likely be considered important to a reasonable securityholder in deciding whether to vote for a proposed director.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing information, not being within the knowledge of Cybin, has been furnished by the proposed directors.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Discussion and Analysis</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The general objectives of Cybin&#8217;s compensation strategy are to&#58; (a) compensate management in a manner that encourages and rewards a high level of performance and outstanding results with a view to increasing long-term shareholder value&#59; (b) align management&#8217;s interests with the long-term interests of shareholders&#59; and (c) attract and retain highly qualified executive officers. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management Contracts</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of the management contracts for the Named Executive Officers (as defined below)&#58; </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Doug Drysdale</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Doug Drysdale currently receives a base salary of US$500,000 per annum for his services as Chief Executive Officer of Cybin. He has entered into an employment agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CEO Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) with Cybin which is for an indefinite term and includes provisions relating to, among other things, base salary, eligibility for benefits, an annual performance bonus and equity awards. As per the CEO Employment Agreement, Mr. Drysdale is eligible to be considered for an annual performance bonus, currently for up to 65% of Mr. Drysdale&#8217;s base salary and shall be based on criteria established by the Cybin Board and the Compensation Committee.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that the CEO Employment Agreement is terminated without cause, Cybin will pay to Mr. Drysdale a cash severance payment equal to six (6) months base salary. Mr. Drysdale may terminate the CEO Employment Agreement by providing 30 days&#8217; written notice to Cybin. Assuming termination without cause occurred on the date of this Circular, the estimated severance payment to Mr. Drysdale would have been approximately US$250,000.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Greg Cavers, Eric So, Paul Glavine, and Aaron Bartlone</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Named Executive Officers, serving in the following capacities, currently receive the following annual salaries&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greg Cavers currently receives $250,000 per annum for his services as Chief Financial Officer of Cybin&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eric So currently receives $480,000 per annum for his services as President of Cybin&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Paul Glavine currently receives $480,000 per annum for his services as Chief Growth Officer of Cybin&#59; and</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aaron Bartlone currently receives US$300,000 per annum for his services as Chief Operating Officer of a subsidiary of Cybin.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of such Named Executive Officers has entered into an agreement with Cybin, which is for an indefinite term and includes standard provisions relating to, among other things, base salary, eligibility for employee benefits, equity awards and confidentiality and intellectual property rights.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Cavers&#8217; employment agreement provides that Cybin may terminate his employment without cause provided, however, that if Cybin terminates his employment without cause, Cybin will provide Mr. Cavers with three months&#8217; notice of termination (or pay in lieu), plus an additional one months&#8217; notice (or pay in lieu) for each year of completed service with Cybin. Assuming termination without cause occurred on the date of this Circular, the estimated severance payment to Mr. Cavers would have been approximately $125,000.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. So and Mr. Glavine&#8217;s consulting agreements provide that their respective agreements may be terminated on 24 months&#8217; notice and upon payment of all accrued fees and other fees that would be due during such 24 month period. The agreements do not contain severance or change of control provisions. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Bartlone&#8217;s agreement provides that Cybin may terminate his employment without cause provided, however, that if Cybin terminates his employment without cause, Cybin will provide Mr. Bartlone with eight months&#8217; notice of termination (or pay in lieu), plus an additional one months&#8217; notice (or pay in lieu) for each year of completed service with Cybin, up to a maximum of 12 months. Assuming termination without cause occurred on the date of this Circular, the estimated severance payment to Mr. Bartlone would have been approximately US$250,000.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Elements of Compensation</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation of Named Executive Officers is comprised of the following elements&#58; (a) base salary&#59; and (b) long-term equity incentives, consisting of Awards granted under the Cybin Equity Incentive Plan. These principal elements of compensation are described in further detail below. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Base Salary</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Named Executive Officer receives a base salary, which constitutes a significant portion of the Named Executive Officer&#8217;s compensation package. Base salary is provided in recognition for discharging day-to-day duties and responsibilities and reflects the Named Executive Officer&#8217;s performance over time, as well as that individual&#8217;s particular experience and qualifications. A Named Executive Officer&#8217;s base salary is reviewed by the Cybin Board or the Compensation Committee on an annual basis and may be adjusted to take into account performance contributions for the year and to reflect sustained performance contributions over a number of years. At the discretion of the Cybin Board or the Compensation Committee, each of the Named Executive Officers is eligible to receive performance bonuses, which are contingent on the Named Executive Officer achieving certain performance objectives set annually by the Compensation Committee. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cybin Equity Incentive Plan</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 13, 2020, Cybin received Cybin Shareholder approval of the Cybin Equity Incentive Plan and on November 5, 2020, it was adopted by the Cybin Board. On August 16, 2021, certain amendments to the Cybin Equity Incentive Plan were approved to better align the Cybin Equity Incentive Plan with policies of the Cboe Canada. The Cybin Equity Incentive Plan permits the granting of Cybin Options, stock appreciation rights (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), restricted share unit awards (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), performance share units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), dividend equivalents (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and other share-based awards (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin Share Based Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and collectively with Cybin Options, Cybin SARs, Cybin RSUs, Cybin Performance Awards and Cybin Dividend Equivalents, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Awards are granted by either the Cybin Board or the Compensation Committee.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybin Equity Incentive Plan is intended to promote the interests of Cybin and its shareholders by aiding Cybin in attracting and retaining employees, officers, consultants, advisors and non-employee directors capable of assuring the future success of Cybin, to offer such persons incentives to put forth maximum efforts for the success of Cybin&#8217;s business and to </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compensate such persons through various share and cash based arrangements and provide them with opportunities for share ownership in Cybin, thereby aligning the interests of such persons with the Cybin Shareholders.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shares Subject to the Cybin Equity Incentive Plan</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybin Equity Incentive Plan is a rolling plan which, subject to the adjustment provisions provided for therein (including a subdivision or consolidation of the Cybin Shares), provides that the aggregate maximum number of Cybin Shares that may be issued under all Awards under the Cybin Equity Incentive Plan shall not exceed 20% of Cybin&#8217;s issued and outstanding Cybin Shares from time to time, such number being 46,936,646 as at the date of this Circular. Notwithstanding the foregoing, the aggregate number of Cybin Shares that may be issued pursuant to awards of Cybin Options shall not exceed 22,266,002.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybin Equity Incentive Plan is considered an &#8220;evergreen&#8221; plan, since the Cybin Shares covered by Awards which have been exercised, settled or terminated shall be available for subsequent grants under the Cybin Equity Incentive Plan and the number of Awards available to grant increases as the number of issued and outstanding Cybin Shares increases.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at the date of this Circular, a total of 40,676,675 Cybin Shares are issuable pursuant to Cybin Options granted under the Cybin Equity Incentive Plan, representing approximately 17.3% of Cybin&#8217;s issued and outstanding Cybin Shares. An aggregate of 6,259,971 Cybin Shares (plus any Awards forfeited or cancelled) are available for issuance under the Cybin Equity Incentive Plan, representing approximately 2.7% of Cybin&#8217;s issued and outstanding Cybin Shares as at the date of this Circular. As of the date of this Circular, a total of 12,835,400 Cybin Shares are issuable pursuant to Cybin Incentive Stock Options (as such term is defined in the Cybin Equity Incentive Plan) granted under the Cybin Equity Incentive Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eligibility</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of Cybin&#8217;s employees, officers, consultants, advisors and non-employee directors or any affiliate or person to whom an offer of employment or engagement with Cybin is extended, are eligible to participate in the Cybin Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The basis of participation of an individual under the Cybin Equity Incentive Plan, and the type and amount of any Award that an individual will be entitled to receive under the Cybin Equity Incentive Plan, will be determined by the Compensation Committee based on its judgment as to the best interests of Cybin and Cybin Shareholders, and therefore cannot be determined in advance.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a Participant ceases to be an Eligible Person (as such term is defined in the Cybin Equity Incentive Plan) Cybin for any reason, whether for cause or otherwise, the Participant may, within 90 days following the date on which it ceased to be an Eligible Person, an investor relations person or holder of Cybin Options, exercise any Cybin Option that was exercisable on the date the Participant ceased to be an Eligible Person. The Compensation Committee may extend such 90 day period subject to obtaining any approval required by the Cboe Canada and subject to a maximum extension to the original expiry date of such Cybin Options. Any Cybin Option that was not exercisable on the date the Participant ceased to be an Eligible Person will be deemed to expire on such date, unless extended pursuant to the Cybin Equity Incentive Plan. Any Cybin Option that was exercisable on the date the Participant ceased to be an Eligible Person will be deemed to expire immediately following the 90 day period unless extended pursuant to the Cybin Equity Incentive Plan.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Administration of the Cybin Equity Incentive Plan</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybin Equity Incentive Plan shall be administered by the Compensation Committee. The Compensation Committee shall have full power and authority to designate a Participant, the time or times at which awards may be granted, the conditions under which awards may be granted or forfeited to Cybin, the number of Cybin Shares to be covered by any Award, the exercise price of any Award, whether restrictions or limitations are to be imposed on the Cybin Shares issuable pursuant to grants of any Award, and the nature of any such restrictions or limitations, any acceleration of exercisability or vesting, or waiver of termination regarding any award, based on such factors as the Compensation Committee may determine.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Compensation Committee interprets the Cybin Equity Incentive Plan and may adopt guidelines and other rules and regulations relating to the Cybin Equity Incentive Plan, and make all other determinations and take all other actions necessary or advisable for the implementation and administration of the Equity Incentive Plan.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Types of Awards</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cybin Options</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Cybin Equity Incentive Plan, unless the Compensation Committee determines otherwise in the case of an Cybin Option substituted for another Cybin Option in connection with a corporate transaction, the exercise price of the Cybin Options may not be lower than the greater of the closing market price of the Cybin Shares on the Cboe Canada on (a) the trading day prior to the date of grant of the Cybin Options and (b) the date of grant of the Cybin Options. Cybin Options granted under the Cybin Equity Incentive Plan will be subject to such terms, including the exercise price and the conditions and timing of exercise, as may be determined by the Compensation Committee and specified in the applicable award agreement. The maximum term of a Cybin Option granted under the Cybin Equity Incentive Plan will be ten years from the date of grant. Payment in respect of the exercise of a Cybin Option may not be made, in whole or in part, with a promissory note.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise specified by the Compensation Committee the time of granting an Cybin Option and set forth in the particular Award Agreement (as such term is defined in the Cybin Equity Incentive Plan), an exercise notice must be accompanied by payment of the exercise price. A participant may, in lieu of exercising an Cybin Option pursuant to an exercise notice, elect to surrender such Cybin Option to Cybin (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cashless Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in consideration for an amount from Cybin equal to (i) the Fair Market Value (as defined in the Equity Incentive Plan) of the Cybin Shares issuable on the exercise of such Cybin Option (or portion thereof) as of the date such Cybin Option (or portion thereof) is exercised, less (ii) the aggregate exercise price of the Cybin Option (or portion thereof) surrendered relating to such Cybin Shares (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In-the-Money Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) by written notice to Cybin indicating the number of Cybin Options such participant wishes to exercise using the Cashless Exercise, and such other information that Cybin may require. Subject to the provisions of the Cybin Equity Incentive Plan, Cybin will satisfy payment of the In-the-Money Amount by delivering to the participant such number of Cybin Shares having a fair market value equal to the In-the-Money Amount.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cybin RSUs</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards of Cybin RSUs shall be subject to such restrictions as the Compensation Committee may impose (including, without limitation, any limitation on the right to vote or the right to receive any dividend or other right or property with respect thereto), which restrictions may lapse separately or in combination at such time or times, in such installments or otherwise as the Compensation Committee may deem appropriate. Upon a Participant&#8217;s termination of employment or service or resignation or removal as a director (in either case, as determined under criteria established by the Compensation Committee) during the applicable restriction period, all Cybin RSUs held by such Participant at such time shall be forfeited and reacquired by Cybin for cancellation at no cost to Cybin&#59; provided, however, that the Compensation Committee may waive in whole or in part any or all remaining restrictions with respect to Cybin RSUs. Pursuant to the policies of the Cboe Canada, the value ascribed to the Cybin Shares covered by the Cybin RSU may not be lower than the greater of the closing market price of the Cybin Shares on (a) the trading day prior to the date of grant of the Cybin RSU, and (b) the date of grant of the Cybin RSU. Any Cybin RSU granted under the Cybin Equity Incentive Plan shall be issued at the time such Awards are granted and may be evidenced in such manner as the Compensation Committee may deem appropriate.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Appreciation Rights</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Cybin SAR granted under the Cybin Equity Incentive Plan shall confer on the Participant a right to receive upon exercise, the excess of (i) the Fair Market Value (as such term is defined in the Cybin Equity Incentive Plan) of one (1) Cybin Share on the date of exercise over (ii) the grant price of the Cybin SAR as specified by the Compensation Committee (which price shall not be less than 100% of the Fair Market Value of one (1) Cybin Share on the date of grant of the Cybin SAR)&#59; provided, however, that, subject to applicable law and stock exchange rules, the Compensation Committee may designate a grant price below Fair Market Value on the date of grant if the Cybin SAR is granted in substitution for a stock appreciation right previously granted by an entity that is acquired by or merged with Cybin or an Affiliate. Notwithstanding the foregoing, pursuant to the rules of the Cboe Canada, Cybin Shares issued in connection with SARs may not be priced lower than the greater of the closing market prices of the Cybin Shares on (a) the trading day prior to the date of grant of the Cybin SAR, and (b) the date of grant of the Cybin SAR. Subject to the terms of the Cybin Equity Incentive Plan, the policies of the Cboe Canada and any applicable Award Agreement, the grant price, term, methods of exercise, dates of exercise, methods of settlement, equity compensation and any other terms and conditions of any Cybin SAR shall be as determined by the </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation Committee. The Compensation Committee may impose such conditions or restrictions on the exercise of any Cybin SAR as it may deem appropriate. No Cybin SAR may be exercised more than ten years from the grant date.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Share Units</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Cybin Performance Award granted under the Cybin Equity Incentive Plan (i) may be denominated or payable in cash, Cybin Shares (including without limitation, Cybin RSUs), other securities, other Awards or other property and (ii) shall confer on the holder thereof the right to receive payments, in whole or in part, upon the achievement of one or more objective performance goals during such performance periods as the Compensation Committee shall establish. Notwithstanding the foregoing, pursuant to the rules of the Cboe Canada, Cybin Performance Awards may not be priced lower than the greater of the closing market prices of the Cybin Shares on (a) the trading day prior to the date of grant of the Cybin Performance Award, and (b) the date of grant of the Cybin Performance Award. Subject to the terms of the Cybin Equity Incentive Plan and the policies of the Cboe Canada, the performance goals to be achieved during any performance period, the length of any performance period, the amount of any Cybin Performance Award granted, the amount of any payment or transfer to be made pursuant to any Cybin Performance Award and any other terms and conditions of any Cybin Performance Award shall be determined by the Compensation Committee.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Equivalents</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Cybin Dividend Equivalent granted under the Cybin Equity Incentive Plan allows Participants to receive payments (in cash, Cybin Shares, other securities, other Awards or other property as determined in the discretion of the Compensation Committee) equivalent to the amount of cash dividends paid by Cybin to holders of Cybin Shares with respect to a number of Cybin Shares as determined by the Compensation Committee. Subject to the terms of the Cybin Equity Incentive Plan, the policies of the Cboe Canada and any applicable Award Agreement, such Dividend Equivalents may have such terms and conditions as the Compensation Committee shall determine. Notwithstanding the foregoing, (i) the Compensation Committee may not grant Cybin Dividend Equivalents to Eligible Persons in connection with grants of Cybin Options, Cybin SARs or other Awards the value of which is based solely on an increase in the value of the Cybin Shares after the date of grant of such Award, and (ii) dividend and Cybin Dividend Equivalent amounts may be accrued but shall not be paid unless and until the date on which all conditions or restrictions relating to such Award have been satisfied, waived or lapsed. Subject to the terms of the Cybin Equity Incentive Plan, the policies of the Cboe Canada and any applicable Award Agreement, such Cybin Dividend Equivalents may have such terms and conditions as the Compensation Committee shall determine, provided that pursuant to the rules of the Cboe Canada, Dividend Equivalents may not be priced lower than the greater of the closing market prices of the Cybin Shares on (a) the trading day prior to the date of grant of the Cybin Dividend Equivalent, and (b) the date of grant of the Cybin Dividend Equivalent.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Share-Based Awards</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Awards may be granted under the Cybin Equity Incentive Plan that are denominated or payable in, valued in whole or in part by reference to, or otherwise based on or related to, Cybin Shares (including, without limitation, securities convertible into Cybin Shares), as are deemed by the Compensation Committee to be consistent with the purpose of the Equity Incentive Plan in accordance with applicable regulations, provided that pursuant to the rules of the Cboe Canada, such Awards may not be priced lower than the greater of the closing market prices of the Cybin Shares on (a) the trading day prior to the date of grant of the Award, and (b) the date of grant of the Award. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Term</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Cybin Equity Incentive Plan does not stipulate a specific term for Awards granted thereunder, Awards may not expire beyond 10 years from its date of grant, except where Cybin Shareholder approval is received or where an expiry date would have fallen within a blackout period of Cybin. All Awards must vest and settle in accordance with the provisions of the Cybin Equity Incentive Plan and any applicable award agreement, which award agreement may include an expiry date for a specific award.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event an Award expires, at a time when a scheduled blackout is in place or an undisclosed material change or material fact in the affairs of Cybin exists, the expiry of such Award will be the date that is ten Business Days after which such scheduled blackout terminates or there is no longer such undisclosed material change or material fact.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Non-Transferability of Awards</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No Award and no right under any such Award shall be transferable by a Participant other than by will or by the laws of descent and distribution, and no Award (other than fully vested and unrestricted Cybin Shares issued pursuant to any Award) or right under any such Award may be pledged, alienated, attached or otherwise encumbered, and any purported pledge, alienation, attachment or encumbrance thereof shall be void and unenforceable against Cybin or any Affiliate. The Compensation Committee may also establish procedures as it deems appropriate for a Participant to designate a person or persons, as beneficiary or beneficiaries, to exercise the rights of the Participant and receive any property distributable with respect to any Award in the event of the Participant&#8217;s death. In the event of a Participant&#8217;s death, any unexercised, options issued to such Participant shall be exercisable within a period of one (1) year next succeeding the year in which the Participant died, unless such exercise period is extended by the Compensation Committee and approval is obtained from the stock exchange on which the Cybin Shares then trade, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation of Directors</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Independent members of the Cybin Board are paid $50,000 annually, which amount is paid quarterly. In addition, the independent lead director receives an additional annual cash fee of $15,000. Directors of Cybin are also compensated for their services through the granting of Cybin Options and other Awards, and may also be reimbursed for out-of-pocket expenses incurred in carrying out their duties as directors.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Officers of Cybin who also act as directors will not receive any additional compensation for services rendered in such capacity, other than as paid by Cybin in their capacity as officers.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Risk</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybin Board and, as applicable, the Compensation Committee, considers and assesses the implications of risks associated with Cybin&#8217;s compensation policies and practices and devotes such time and resources as is believed to be necessary in the circumstances. Cybin&#8217;s practice of compensating its officers primarily through a mix of salary, bonus and stock options is designed to mitigate risk by&#58; (i) ensuring that Cybin retains such officers&#59; and (ii) aligning the interests of its officers with the short-term and long-term objectives of Cybin and its shareholders. As at the date of this Circular, the Cybin Board had not identified risks arising from Cybin&#8217;s compensation policies and practices that are reasonably likely to have a material adverse effect on Cybin.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of Cybin&#8217;s Insider Trading Policy, Cybin&#8217;s officers and directors are prohibited from purchasing financial instruments, such as prepaid variable forward contracts, equity swaps, collars or units of exchange funds, that are designed to hedge or offset a decrease in market value of equity securities granted as compensation or held, directly or indirectly, by an officer or director.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Governance</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to assist the Cybin Board in fulfilling its oversight responsibilities with respect to compensation matters, the Board has established the Compensation Committee and has reviewed and approved the Compensation Committee&#8217;s Charter. The Compensation Committee is composed of Eric So, Mark Lawson and Grant Froese. Mr. So is not considered &#8220;independent&#8221;, as such term is defined in NI 58-101.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee meets on compensation matters as and when required with respect to executive compensation. The primary goal of the Compensation Committee as it relates to compensation matters is to ensure that the compensation provided to the Named Executive Officers and Cybin&#8217;s other executive officers is determined with regard to Cybin&#8217;s business strategies and objectives, such that the financial interest of the executive officers is aligned with the financial interest of shareholders, and to ensure that their compensation is fair and reasonable and sufficient to attract and retain qualified and experienced executives. The Compensation Committee is given the authority to engage and compensate any outside advisor that it determines to be necessary to carry out its duties. </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a whole, the members of the Compensation Committee have direct experience and skills relevant to their responsibilities in executive compensation, including with respect to enabling the Compensation Committee in making informed decisions on the suitability of Cybin&#8217;s compensation policies and practices. All three members have experience on the board of directors and related committees of other public companies, as described under &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Matters to be Acted Upon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Election of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in this Circular. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Governance</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybin Board has adopted a Clawback Policy, which provides that the Cybin Board may seek recovery of erroneously awarded Awards received by certain executive officers on a full or partial basis in situations where Cybin is required to prepare an accounting restatement of its financial statements due to Cybin&#8217;s material non-compliance with any financial reporting requirements under applicable Securities Laws.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Graph</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph compares the percentage change in the cumulative Cybin Shareholder return on the Cybin Shares compared to the cumulative total return of the S&#38;P&#47;TSX Composite Index for the period commencing on December 31, 2018 to March 31, 2023 based on the price of the Cybin Shares, assuming a $100 investment on December 31, 2018 and reinvestment of dividends. From December 31, 2018 to June 29, 2020 (the date the Cybin Shares were halted in connection with the announcement of the RTO Transaction), the performance reflected is that of Clarmin Explorations Inc., Cybin&#8217;s predecessor business, and is not reflective of Cybin&#8217;s business or performance since the completion of the RTO Transaction on November 5, 2020 and the listing of its Cybin Shares on the Cboe Canada on November 10, 2020. </font></div><div style="margin-bottom:12pt;text-align:justify"><img alt="image_7.jpg" src="image_7.jpg" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:622px"></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin&#8217;s total shareholder return for the period from the completion of the RTO Transaction to March 31, 2023 was -44%. Between 2020 and 2023, Cybin completed a series of financings that provided it with a net cash position as at March 31, 2023 of $16.6 million. The Cybin Board has not, as of the date of the Circular, determined any incentive payments based on Cybin&#8217;s results for 2023, including its total shareholders&#8217; return, but it is anticipated that as part of the compensation and governance review, the Cybin Board will consider and approve incentive payments that take into account these factors. As the completion of the RTO Transaction marked the beginning of the current business of Cybin, Cybin considers its share performance since completion of the RTO Transaction to be pertinent to its Cybin Shareholders. Therefore, the next graph compares the percentage change in the cumulative Shareholder return on the Cybin Shares commencing with the listing of the Cybin Shares on the Cboe Canada on November 10, 2020 to March 31, 2023, compared to the cumulative total return of the S&#38;P&#47;TSX Composite Index for the same period, assuming a $100 investment on November 10, 2020 and reinvestment of dividends.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><img alt="image_8.jpg" src="image_8.jpg" style="height:281px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary Compensation Table</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Circular, a &#8220;Named Executive Officer&#8221; means&#58; (a) a Chief Executive Officer&#59; (b) a Chief Financial Officer&#59; (c) each of Cybin&#8217;s three next most highly compensated executive officers at the end of the financial year ended March 31, 2023 whose total compensation, individually, was greater than $150,000&#59; and (d) each individual who would be a Named Executive Officer but for the fact that the individual was neither an executive officer of Cybin or its subsidiaries, nor serving in a similar capacity, at the end of the financial year ended March 31, 2023. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the financial year ended March 31, 2023, Cybin had the following Named Executive Officers&#58; (a) Doug Drysdale, Chief Executive Officer&#59; (b) Greg Cavers, Chief Financial Officer&#59; (c) Eric So, Chair and President&#59; (d) Paul Glavine, Chief Growth Officer&#59; and (e) Aaron Bartlone, Chief Operating Officer. The following table presents the compensation earned by the Named Executive Officers for the years ended March 31, 2023, 2022 and 2021. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.951%"><tr><td style="width:1.0%"></td><td style="width:13.056%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.802%"></td><td style="width:0.1%"></td></tr><tr style="height:30pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name and principal position</font></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary&#47;Fee <br>($)</font></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based awards<br>($)</font></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option-based awards<br>($)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-equity incentive plan compensation<br>($)</font></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension value<br>($)</font></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All other compensation<br>($)</font></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total compensation<br>($)</font></td></tr><tr style="height:39pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Annual incentive plans</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term incentive plans</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Doug Drysdale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">661,600</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">549,319</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276,648</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,805,921</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,607,422</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">340,832</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,573</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">834,173</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,505,240</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,224,902</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greg Cavers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223,750</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,670</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">478,212</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229,432</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,200</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,800</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329,200</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">744,762</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">438,102</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eric So</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chair and President</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,000</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">534,533</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">804,435</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">999,722</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(9)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">624,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,164,533</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,094,157</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Paul Glavine</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Growth Officer and a director</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,000</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">534,533</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">804,435</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">999,722</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(9)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">624,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,164,533</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,094,157</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aaron Bartlone</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Operating Officer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">396,960</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">374,880</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,169</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">523,936</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">612,464</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,573</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,249</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">515,533</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">901,065</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">703,633</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:434.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notes&#58;</font></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Calculated based on the Black-Scholes model for option valuation.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Mr. Drysdale commenced employment with Cybin Privateco in August 2020 and was appointed as Chief Executive Officer of Cybin effective November 5, 2020. Mr. Drysdale&#8217;s salary is paid in U.S. dollars and has been converted to Canadian dollars for the purpose of this Circular using the Bank of Canada daily exchange rate as of March 31. For the period ended March 31, 2023, an exchange rate of US$1.00 &#61; $1.3232 was applied.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;The period of compensation during the 2021 financial year for Mr. Drysdale was less than 12 months&#59; on an annualized basis, his base salary would have been $385,631.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;Prior to November 5, 2020, Mr. Cavers was the Chief Financial Officer of Cybin Privateco. In connection with the RTO Transaction, Cybin Privateco became a wholly-owned subsidiary of Cybin. The salaries above include those paid to Mr. Cavers by both Cybin and Cybin Privateco. Mr. Cavers was appointed as Chief Financial Officer of Cybin effective November 5, 2020.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;Prior to November 5, 2020, Mr. So was the President of Cybin Privateco. In connection with the RTO Transaction, Cybin Privateco became a wholly-owned subsidiary of Cybin. The salaries above include those paid to Mr. So by both Cybin and Cybin Privateco. Mr. So was appointed as President of Cybin effective November 5, 2020. Mr. So&#8217;s compensation was received solely in capacity as an officer of Cybin.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;Prior to November 5, 2020, Mr. Glavine was the Chief Operating Officer of Cybin Privateco. In connection with the RTO Transaction, Cybin Privateco became a wholly-owned subsidiary of Cybin. The salaries above include those paid to Mr. Glavine by both Cybin and Cybin Privateco. Mr. Glavine was appointed as Chief Operating Officer of Cybin effective November 5, 2020. On March 29, 2021, Mr. Glavine ceased to be the Chief Operating Officer and was appointed as Chief Growth Officer of Cybin. Mr. Glavine&#8217;s compensation was received solely in capacity as an officer of Cybin.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)&#160;&#160;&#160;&#160;Mr. Bartlone commenced employment with Cybin Privateco in December 2020 and was appointed Chief Operating Officer of a subsidiary of Cybin on March 25, 2021. Mr. Bartlone&#8217;s salary is paid in U.S. dollars and has been converted to Canadian dollars for the purpose of this Circular using the Bank of Canada daily exchange rate as of March 31. For the period ended March 31, 2023, an exchange rate of US$1.00 &#61; $1.3232 was applied.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)&#160;&#160;&#160;&#160;The period of compensation during the 2021 financial year for Mr. Bartlone was less than 12 months&#59; on an annualized basis, his base salary would have been $304,944, applying the Bank of Canada daily exchange rate as of March 31, 2021 of US$1.00 &#61; $1.2575.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(9)&#160;&#160;&#160;&#160;Amount includes $724,722 related to warrants issued on June 15, 2020 with an exercise price of $0.25. The warrants vested on issuance and expire on June 15, 2025. Fair value calculated based on the Black-Scholes model for warrant valuation. The fair value of the warrants has been calculated based on the following weighted average assumptions (the grant date fair value equals the accounting fair value for stock options)&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:126pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.771%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 15, 2020</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Risk free interest rate</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.82%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividend yield</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Volatility factor</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average expected life</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value (rounded)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$0.18</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Incentive Plan Awards</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Outstanding Share-Based Awards and Option-Based Awards</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth all share-based and option-based awards outstanding for the Named Executive Officers as of March 31, 2023&#58; </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.951%"><tr><td style="width:1.0%"></td><td style="width:9.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.153%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.157%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option-Based Awards</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-Based Awards</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of securities underlying unexercised options<br>(#)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option exercise price<br>($)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option expiration date</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Value of unexercised in-the-money options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><br>($)</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of shares or units of shares that have not vested<br>(#)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Market or payout value of share based awards that have not vested<br>($)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Market or payout value of vested share-based awards not paid out or distributed<br>($)</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Doug Drysdale</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,000,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,000</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.75</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2.90</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.13</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 12, 2025</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 28, 2026</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 4, 2027</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greg Cavers</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.25</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.89</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2.90</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.13</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 15, 2025</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 28, 2025</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 28, 2026</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 4, 2027</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eric So</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chair and President</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,000</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.75</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2.90</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.13</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 4, 2025</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 28, 2026</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 4, 2027</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Paul Glavine</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Growth Officer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,000</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.75</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2.90</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.13</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 4, 2025</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 28, 2026</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 4, 2027</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aaron Bartlone</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Operating Officer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,000</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.89</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.36</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2.48</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.13</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2, 2026</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 28, 2026</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 18, 2026</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 4, 2027</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:434.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Note&#58;</font></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The &#8220;value of unexercised in-the-money options&#8221; is calculated based on the difference between the closing price of $0.53 for the Cybin Shares on the Cboe Canada on the last trading day of the year ended March 31, 2023 and the exercise price of the options, multiplied by the number of unexercised options.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Incentive Plan Awards &#8211; Value Vested or Earned During the Year</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the value of all incentive plan awards vested or earned for each Named Executive Officer during the year ended March 31, 2023&#58; </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.837%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option-based awards &#8211; Value vested during the year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">($)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based awards &#8211; Value vested during the year</font></div><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">($)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-equity incentive plan compensation &#8211; Value earned during the year</font></div><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">($)</font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Doug Drysdale</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greg Cavers</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eric So</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chair and President</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,625</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Paul Glavine</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Growth Officer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,625</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aaron Bartlone</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Operating Officer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,000</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:434.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br>Note&#58;</font></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The &#8220;value vested during the year&#8221; is calculated as the aggregate dollar value that would have been realized if the options under the option-based award had been exercised on the vesting date based on the difference between the closing price for the Cybin Shares on the Cboe Canada, as applicable, as of the date of vesting (or the most recent closing price on the exchange, if applicable) and the exercise price of the options, multiplied by the number of vested options.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Compensation</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Director Compensation Table</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth all amounts of compensation provided to the directors of Cybin (other than directors who are also Named Executive Officers) during the financial year ended March 31, 2023&#58; </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.103%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fees</font></div><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earned</font></div><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">($)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based awards<br>($)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option-based awards<br>($)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All other compensation<br>($)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br>($)</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Grant Froese</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eric Hoskins</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mark Lawson</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Theresa Firestone</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,000</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Incentive Plan Awards - Outstanding Share-Based Awards and Option-Based Awards</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth all awards outstanding for each of the directors of Cybin (other than directors who are also Named Executive Officers) as of March 31, 2023&#58; </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.951%"><tr><td style="width:1.0%"></td><td style="width:15.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.195%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.404%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option-Based Awards</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-Based Awards</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of securities underlying unexercised options<br>(#)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option exercise price<br>($)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option expiration <br>date</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Value of unexercised in-the-money options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><br>($)</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of shares or units of shares that have not vested<br>(#)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Market or payout value of share based awards that have not vested</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><br>($)</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Market or payout value of vested share-based awards not paid out or distributed<br>($)</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Grant Froese</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195,000</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.89</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 28, 2025</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eric Hoskins</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.89</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 28, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mark Lawson</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.89</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 28, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Theresa Firestone</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2.87</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 27, 2026</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:434.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br>Notes&#58;</font></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The &#8220;value of unexercised in-the-money options&#8221; is calculated based on the difference between the closing price of $0.53 for the Cybin Shares on the Cboe Canada on the last trading day of the year ended March 31, 2023 and the exercise price of the options, multiplied by the number of unexercised options.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The &#8220;market or payout value of share-based awards that have not vested&#8221; is calculated based on the closing price of $0.53 for the Cybin Shares on the Cboe Canada on the last trading day of the year ended March 31, 2023 multiplied by the number of Cybin Shares that have not vested.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Incentive Plan Awards &#8211; Value Vested or Earned During the Year</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the value of all incentive plan awards vested or earned by each director of Cybin (other than directors who are also named Executive Officers) during the year ended March 31, 2023&#58; </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.237%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.138%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option-based awards &#8211; Value vested during the year<br>($)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;padding-left:3.1pt;padding-right:3.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based awards &#8211; Value vested during <br>the year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><br>($)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-equity incentive plan compensation &#8211; Value earned during the year<br>($)</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Grant Froese</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eric Hoskins</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mark Lawson</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Theresa Firestone</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:434.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br>Note&#58;</font></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The &#8220;value vested during the year&#8221; is calculated based on the difference between the closing price for the Cybin Shares on the Cboe Canada as of the date of vesting (or the most recent closing price on the Cboe Canada) and the exercise price of the options, multiplied by the number of vested options.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Authorized for Issuance Under Equity Compensation Plans</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.829%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plan Category</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Cybin Shares to be issued upon exercise of outstanding options</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-average exercise price of outstanding options</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Cybin Shares remaining available for future issuance under equity compensation plans</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity compensation plans approved by security holders</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,569,800</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.36</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,495,946</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity compensation plans not approved by security holders</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,569,800</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.36</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,495,946</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEBTEDNESS OF DIRECTORS AND EXECUTIVE OFFICERS</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at the date of this Circular, no individual who is an executive officer, director, employee or former executive officer, director or employee of Cybin or any of its subsidiaries is indebted to Cybin or any of its subsidiaries pursuant to the purchase of securities or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No individual who is, or at any time during the financial year ended March 31, 2023 was, a director or executive officer of Cybin, a proposed management nominee for election as a director of Cybin, or an associate of any such director, executive officer or proposed nominee, was indebted to Cybin or any of its subsidiaries during the financial year ended March 31, 2023 or as at the date of this Circular in connection with security purchase programs or other programs.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STATEMENT OF CORPORATE GOVERNANCE PRACTICES</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maintaining a high standard of corporate governance is a priority for the Cybin Board and Cybin&#8217;s management as both believe that effective corporate governance will help create and maintain shareholder value in the long term. A description of Cybin&#8217;s corporate governance practices, which addresses the matters set out in NI 58-101, is set out in Schedule G to this Circular.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AUDIT COMMITTEE DISCLOSURE</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit Committee&#8217;s Charter</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charter of the Audit Committee is attached as Schedule H to this Circular.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Composition of Audit Committee</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As at the date of this Circular, the Audit Committee is composed of Mark Lawson (Chair), Theresa Firestone, Eric Hoskins, and Grant Froese, each of whom is a director of Cybin.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the members of the Audit Committee are &#8220;independent&#8221; as such term is defined in NI 52-110. Cybin is of the opinion that all four members of the Audit Committee are &#8220;financially literate&#8221; as such term is defined in NI 52-110.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Relevant Education and Experience</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All the members of the Audit Committee have the education and&#47;or practical experience required to understand and evaluate financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of issues that can reasonably be expected to be raised by Cybin&#8217;s financial statements.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Theresa Firestone</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Ms. Firestone is a senior healthcare executive with retail, pharmaceutical, health &#38; wellness, government and global restructuring expertise. She spent 15 years in senior roles at Pfizer Inc., 14 years in government and 7 years in the retail and health and wellness sector. Ms. Firestone has international experience in executive leadership roles in Canada, Europe and Asia and extensive P&#38;L experience. At Pfizer, Ms. Firestone was Regional President of Emerging Markets Asia and had responsibility for a profit and loss account of $1.4 billon and oversaw 9 markets in Asia. Ms. Firestone was most recently Senior Vice President with Shoppers Drug Mart where she led health and wellness initiatives including new growth strategies. Ms. Firestone has a Bachelor of Applied Science from the University of Guelph.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Grant Froese</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Grant Froese completed a 38-year career with Canadian retail giant Loblaw Companies Limited where he last served as Chief Operating Officer until his retirement. During his career at Loblaw, he led operations, merchandising and had oversight of supply chain, ecommerce, and marketing functions. Most recently, Grant was the Chief Executive Officer of Harvest One Cannabis Inc. (now Delivra Health Brands Inc.), where he was responsible for oversight of all aspects of the company&#8217;s production, operations and financial matters including, the review and approval of quarterly and annual financial statements, annual information forms, management&#8217;s discussion and analysis, and related corporate disclosures. Mr. Froese is the principal consultant at Grey Wolf Management Services Inc. and sits on the board of several companies. Mr. Froese has a Diploma in Business Administration. </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eric Hoskins</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Mr. Hoskins served as the Minister of Health for Ontario for 4 years and was responsible for creating, overseeing and administering a $55 billion budget. He was also a member of the Ontario government Cabinet for ten years regularly reviewing and commenting on budgets and financial statements. Mr. Hoskins was the Chief Financial Officer of War Child Canada, a $20 million charity, for 8 years. He also has a degree in Health Economics. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mark Lawson</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Mr. Lawson was previously an investment banker with Morgan Stanley in New York where he was involved in the execution of over $6 billion worth of mergers and acquisitions, $8 billion worth of debt offerings and $500 million of equity financings in the healthcare, energy, technology, and media &#38; telecom sector. Mr. Lawson is currently the Head of Carbon Acquisition for Invert, a company that funds global carbon reduction and removal projects, and is building a platform that puts the power to fight climate change in your hands. He received his Bachelor of Arts in Statistical Sciences from The University of Western Ontario, Canada, and his MBA in Finance from The Richard Ivey School of Business, University of Western Ontario, Canada. Mr. Lawson was previously the Chief Financial Officer of a TSX-V listed company.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit Committee Oversight</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At no time since the commencement of Cybin&#8217;s most recently completed financial year have any recommendations by the Audit Committee respecting the nomination and&#47;or compensation of Cybin&#8217;s external auditors not been adopted by the Cybin Board.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reliance on Certain Exemptions</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At no time since the commencement of Cybin&#8217;s most recently completed financial year has Cybin relied on exemptions in relation to &#8220;De Minimis Non-audit Services&#8221; or any exemption provided by Part 8 of NI 52-110.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pre-Approval Policies and Procedures</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the Audit Committee Charter, the Audit Committee shall pre-approve all non-audit services to be provided to Cybin or its subsidiary entities by Cybin&#8217;s external auditor.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">External Auditor Service Fees (By Category)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate fees billed by Cybin&#8217;s external auditors during the financial years ended March 31, 2023 and March 31, 2022 were as follows&#58;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.344%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financial Period Ended March 31</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Audit Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">($)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Audited-Related Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">($)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</font></div><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">($)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All Other Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</font></div><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">($)</font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">359,500</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nil</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,600</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,500</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">335,376</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nil</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,300</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nil</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:434.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notes&#58;</font></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;&#8220;Audit Fees&#8221; includes fees necessary to perform the annual audit of Cybin&#8217;s financial statements. These services include reviewing interim financial statements and disclosure documents related to financings and other attest services required by legislation or regulation, such as comfort letters, consents, reviews of securities filings and statutory audits. </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;&#8220;Audit-Related Fees&#8221; include services that are traditionally performed by the auditor.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;&#8220;Tax Fees&#8221; include fees for all tax services other than those included in &#8220;Audit Fees&#8221; and &#8220;Audit-Related Fees&#8221;. This category includes fees for tax compliance, tax planning and tax advice. Tax planning and tax advice includes assistance with tax audits and appeals, tax advice related to mergers and acquisitions, and requests for rulings or technical advice from tax authorities.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;&#8220;All Other Fees&#8221; include all other non-audit services, the aggregate fees billed for products and services, other than the services reported under notes (1), (2) and (3) above.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTERESTS OF INFORMED PERSONS IN MATERIAL TRANSACTIONS</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No &#8220;informed person&#8221; (as such term is defined in NI 51-102) or proposed nominee for election as a director of Cybin or any associate or affiliate of the foregoing has any material interest, direct or indirect, in any transaction in which Cybin has participated since the commencement of Cybin&#8217;s most recently completed financial year or in any proposed transaction </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which has materially affected or will materially affect Cybin. Small Pharma is not an informed person, associate or affiliate of Cybin.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEREST OF CERTAIN PERSONS IN MATTERS TO BE ACTED UPON</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No person or company who has been a director or executive officer of Cybin at any time since the beginning of Cybin&#8217;s last completed financial year, no proposed nominee for election as a director of Cybin and no associate or affiliate of any of the foregoing persons has any material interest, direct or indirect, by way of beneficial ownership of securities or otherwise, in any matter to be acted upon at the Meeting other than the election of directors.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTERESTS OF EXPERTS</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Experts of Cybin</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The audited consolidated financial statements of Cybin as at and for the years ended March 31, 2023 and 2022, incorporated by reference in this Circular have been audited by Zeifmans LLP, as set forth in their report of independent registered public accounting firm thereon, and incorporated herein by reference. Zeifmans LLP is independent of Cybin within the meaning of the relevant rules and related interpretations prescribed by the relevant professional bodies in Canada and any applicable legislation or regulations and are independent accountants with respect to Cybin under all relevant U.S. professional and regulatory standards.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Experts of Small Pharma</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The audited consolidated financial statements of Small Pharma as at February 28, 2023 and 2022, incorporated by reference in this Circular, have been audited by MNP LLP, as set forth in their report thereon, included therein and incorporated herein by reference. MNP LLP has advised that it is independent of Small Pharma within the meaning of the relevant rules and related interpretations prescribed by the relevant professional bodies in Canada and any applicable legislation or regulations.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADDITIONAL INFORMATION</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information relating to Cybin is available under Cybin&#8217;s profile on SEDAR+ at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sedarplus.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and on EDGAR at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Financial information relating to Cybin is provided in the audited consolidated financial statements of Cybin as at and for the financial years ended March 31, 2023 and 2022, and the Annual Cybin MD&#38;A. Copies of Cybin&#8217;s annual financial statements, the management&#8217;s discussion and analysis, and this Circular may be obtained upon request to Cybin. Cybin may require the payment of a reasonable charge if the request is made by a person who is not a shareholder of Cybin.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APPROVAL OF BOARD OF DIRECTORS</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contents and sending of this Circular have been approved by the Cybin Board.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dated</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; September 13, 2023. </font></div><div style="padding-left:300.45pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.739%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Eric So&#8221;</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eric So </font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chair and President</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81</font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_25"></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE A<br>FORM OF ACQUISITION RESOLUTION</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESOLVED THAT&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The acquisition by Cybin Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of Small Pharma Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Target</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) by way of an arrangement under Division 5 of Part 9 of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Corporations Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (British Columbia), as more particularly described in the management information circular of the Corporation dated as of September 13, 2023 (as the same may have been amended or supplemented, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Circular</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), as the arrangement may be or have been amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and all transactions contemplated by the Arrangement, is authorized and approved.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The arrangement agreement between the Corporation and the Target dated August 28, 2023 (as the same may be amended, restated, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Arrangement Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and the actions of the directors of the Corporation in approving the Arrangement Agreement, and the actions of the directors and officers of the Corporation in executing and delivering the Arrangement Agreement (and any modifications, supplements or amendments thereto), and causing the performance by the Corporation of its obligations thereunder, are ratified and approved.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Despite this resolution having been passed by the shareholders of the Corporation or the Arrangement having been approved by the Supreme Court of British Columbia, the directors of the Corporation are authorized and empowered, without further notice to or approval of the holders of securities of the Corporation, </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1&#160;&#160;&#160;&#160;to amend the Arrangement Agreement or the plan of arrangement implementing the Arrangement, to the extent permitted by their respective terms&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2&#160;&#160;&#160;&#160;subject to the terms of the Arrangement Agreement, not to proceed with the Arrangement and related transactions.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Any one or more officers or directors of the Corporation is authorized and directed for and on behalf of and in the name of the Corporation to execute or cause to be executed, and to deliver or cause to be delivered, all documents and instruments and to perform or cause to be performed all other acts and things that that person determines may be necessary or desirable to give full effect to this resolution and the matters authorized by it, that determination to be conclusively evidenced by the execution and delivery of that document or instrument or the doing of that act or thing.&#8221;</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A-1</font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_28"></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE B<br>PLAN OF ARRANGEMENT</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNDER SECTION 288 OF THE <br>BUSINESS CORPORATIONS ACT (BRITISH COLUMBIA) </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE&#160;1<br>DEFINITIONS AND INTERPRETATION </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 1.01&#160;&#160;&#160;&#160;Definitions </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Plan of Arrangement, unless the context otherwise requires, the following words and terms with the initial letter or letters thereof capitalized shall have the meanings ascribed to them below&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the arrangement under section 288 of the BCBCA on the terms and subject to the conditions set out in this Plan of Arrangement, subject to any amendments or variations thereto made in accordance with Section 9.1 of the Arrangement Agreement, this Plan of Arrangement or at the direction of the Court&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Arrangement Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the arrangement agreement dated as of August 28, 2023 between the Buyer and the Target together with the Target Disclosure Letter and the Buyer Disclosure Letter, as the same may be amended, supplemented or otherwise modified from time to time in accordance with the terms thereof&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Arrangement Resolution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the special resolution approving the Plan of Arrangement to be considered at the Target Meeting, to be substantially in the form and content of Schedule B to the Arrangement Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BCBCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Corporations Act </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(British Columbia) and the regulations made thereunder, as promulgated or amended from time to time&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any day other than a Saturday, a Sunday or a statutory or civic holiday in Vancouver, British Columbia or Toronto, Ontario&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Buyer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Cybin Inc., a corporation existing under the laws of the Province of Ontario&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Buyer Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a common share in the capital of the Buyer&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Court</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Supreme Court of British Columbia&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Depositary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Odyssey Trust Company, or any other person that may be appointed by Target with the consent of the Buyer, acting reasonably, to act as depositary in connection with the Arrangement&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dissent Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall have the meaning ascribed to such term in Section 4.01&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dissent Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Target Shares held by a Dissenting Target Shareholder in respect of which the Dissenting Target Shareholder has validly exercised Dissent Rights&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dissenting Target Shareholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a registered Target Shareholder who has properly and validly dissented in respect of the Arrangement Resolution in strict compliance with the Dissent Rights, who has not withdrawn or been deemed to have withdrawn such dissent and who is ultimately determined to be entitled to be paid fair value for its Dissent Shares&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the third (3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) Business Day following the date upon which all of the conditions to the completion of the Arrangement set forth in Article VI of the Arrangement Agreement (other than the delivery of items to be delivered on the Effective Date and the satisfaction of those conditions that, by </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B-1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">their terms, cannot be satisfied until immediately prior to the Effective Date) have been satisfied or waived (subject to applicable Laws) or such other date as the Parties may agree&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(n)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effective Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the beginning of the day (Vancouver time) on the Effective Date or such other time as the Buyer and the Target may agree upon in writing prior to the Effective Date. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(o)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Encumbrance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any mortgage, hypothec, pledge, assignment, charge, lien, claim, security interest, adverse interest, other third person interest or encumbrance of any kind, whether contingent or absolute, and any agreement, option, right or privilege (whether by law, contract or otherwise) capable of becoming any of the foregoing&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(p)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Final Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the order of the Court approving the Arrangement under Section 291 of the BCBCA, after being informed of the intention to rely upon the Section 3(a)(10) Exemption and similar exemptions from applicable state securities law with respect to the issuance of the Buyer Shares to be issued pursuant to the Arrangement to Target Securityholders, in a form acceptable to the Target and the Buyer, each acting reasonably, as such order may be amended by the Court (with the consent of both the Target and the Buyer, each acting reasonably) at any time prior to the Effective Date or, if appealed, then, unless such appeal is withdrawn or denied, as affirmed or as amended (provided that any such amendment is acceptable to both the Target and the Buyer, each acting reasonably) on appeal&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(q)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Former Target Shareholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, at and following the Effective Time, the holders of Target Shares immediately prior to the Effective Time including, for greater certainty, recipient holders of Option Consideration pursuant to Section 3.01(a)(i)&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(r)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In-the-Money Option Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, in respect of an In-the-Money Target Option, the amount by which the aggregate Target Share Value of the Target Shares that a holder is entitled to acquire on exercise of such In-the-Money Target Option exceeds the aggregate exercise price to acquire such Target Shares&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(s)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In-the-Money Target Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Target Option where the exercise price of such Target Option is less than the Target Share Value&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(t)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interim Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the interim order of the Court in a form acceptable to the Target and the Buyer, each acting reasonably, after being informed of the intention to rely upon the Section 3(a)(10) Exemption and similar exemptions from applicable state securities law with respect to the issuance of the Buyer Shares to be issued pursuant to the Arrangement to Target Securityholders, providing for, among other things, the calling and holding of the Target Meeting, as the same may be amended by the Court with the consent of the Target and the Buyer, each acting reasonably&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(u)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning ascribed to it in the Arrangement Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Letter of Transmittal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the letter of transmittal to be sent to holders of Target Shares for use in connection with the Arrangement&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(w)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Option Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, subject to any withholding pursuant to Section 5.03, in respect of an In-the-Money Target Option, such number of Target Shares obtained by dividing&#58; (i) In-the-Money Option Amount in respect of such In-the-Money Target Option, by (ii) the Target Share Value, with the result rounded down to the nearest whole number of Target Shares&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(x)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Out-of-the-Money Target Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Target Option where the exercise price of such Target Option is greater than the Target Share Value&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(y)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means collectively, the Target and the Buyer, and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any of them&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(z)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan of Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means this plan of arrangement, as amended, modified or supplemented from time to time in accordance with Article 8 of the Arrangement Agreement or Article&#160;6 hereof, in each case </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B-2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with the written consent of the Buyer and the Target, each acting reasonably, or at the direction of the Court in the Final Order&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(aa)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 3(a)(10) Exemption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the exemption from the registration requirements of the U.S. Securities Act pursuant to Section 3(a)(10) thereof&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(bb)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means 0.2409 of a Buyer Share in exchange for each Target Share outstanding at the Effective Time including, for greater certainty, any Target Shares issued and outstanding at the Effective Time as Option Consideration&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(cc)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Target</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Small Pharma Inc., a company incorporated under the laws of the Province of British Columbia&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dd)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Target Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the annual and special meeting of shareholders of the Target, and any adjournment or postponement thereof, to be called and held in accordance with the Interim Order to consider the Arrangement Resolution&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ee)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Target Option Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, collectively, the 10% rolling stock option plan of Target most recently approved by Target Shareholders on July 19, 2022, and the Rules of the Small Pharma Ltd 2020 Employee Share Option Plan, as adopted by the board of directors of Small Pharma Ltd on March 24, 2020&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ff)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Target Optionholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a holder of one or more Target</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(gg)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Target Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an option to purchase one or more Target Shares&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(hh)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Target Securityholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, collectively, the Target Shareholders and Target Optionholders&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Target Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a common share in the authorized share structure of Target&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(jj)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Target Share Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the volume weighted average trading price of the Target Shares on the TSX Venture Exchange Inc. for the five trading days immediately preceding the Effective Time&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(kk)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Target Shareholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a holder of one or more Target Shares&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ll)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Canada), R.S.C. 1985 (5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Supp.) c.1, and the regulations thereunder, as amended&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(mm)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the United States Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any capitalized term used in this Plan of Arrangement and not otherwise defined herein shall have the meaning ascribed thereto in the Arrangement Agreement. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 1.02&#160;&#160;&#160;&#160;Interpretation Not Affected by Headings </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The division of this Plan of Arrangement into articles, sections, paragraphs and subparagraphs and the insertion of headings herein are for convenience of reference only and shall not affect the construction or interpretation of this Plan of Arrangement. The terms &#8220;this Plan of Arrangement&#8221;, &#8220;hereof&#8221;, &#8220;herein&#8221;, &#8220;hereto&#8221;, &#8220;hereunder&#8221; and similar expressions refer to this Plan of Arrangement and not to any particular article, section or other portion hereof and include any instrument supplementary or ancillary hereto. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 1.03&#160;&#160;&#160;&#160;Number, Gender and Persons </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Plan of Arrangement, unless the context otherwise requires, words importing the singular shall include the plural and vice versa, words importing the use of either gender shall include both genders and neuter and the word person and words </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B-3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">importing persons shall include a natural person, firm, trust, partnership, association, corporation, joint venture or government (including any governmental agency, political subdivision or instrumentality thereof) and any other entity or group of persons of any kind or nature whatsoever. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 1.04&#160;&#160;&#160;&#160;Date for any Action </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the date on which any action is required to be taken hereunder is not a Business Day, such action shall be required to be taken on the next succeeding day which is a Business Day. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 1.05&#160;&#160;&#160;&#160;Statutory References </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any reference in this Plan of Arrangement to a statute includes all regulations made thereunder, all amendments to such statute or regulation in force from time to time and any statute or regulation that supplements or supersedes such statute or regulation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 1.06&#160;&#160;&#160;&#160;Currency</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, all references in this Plan of Arrangement to sums of money are expressed in lawful money of Canada and &#8220;$&#8221; refers to Canadian dollars.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 1.07&#160;&#160;&#160;&#160;Governing Law </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Plan of Arrangement shall be governed, including as to validity, interpretation and effect, by the laws of the Province of British Columbia and the laws of Canada applicable therein. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE&#160;2<br>ARRANGEMENT AGREEMENT AND BINDING EFFECT </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 2.01&#160;&#160;&#160;&#160;Arrangement Agreement </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Plan of Arrangement is made pursuant to, and subject to the provisions of, the Arrangement Agreement. If there is any inconsistency or conflict between the provisions of this Plan of Arrangement and the provisions of the Arrangement Agreement, the provisions of this Plan of Arrangement shall govern.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 2.02&#160;&#160;&#160;&#160;Binding Effect </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of and from the Effective Time, this Plan of Arrangement shall be binding upon the Target and the Buyer, the Target Shareholders (including Dissenting Target Shareholders), the Target Optionholders, the Depositary and the registrar and transfer agent of the Target, without any further act or formality required on the part of any person except as expressly provided herein.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 2.03&#160;&#160;&#160;&#160;Effective Date and Time </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exchanges, issuances and cancellations provided for in Section 3.01 shall be deemed to occur on the Effective Date at the time and in the order specified, notwithstanding that certain of the procedures related thereto are not completed until after the Effective Date. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 2.04&#160;&#160;&#160;&#160;U.S. Securities Law</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any provision herein to the contrary, each of the parties to the Arrangement agree that the Arrangement will be carried out with the intention that Buyer Shares to be issued to the Target Securityholders in connection with the Arrangement shall be exempt pursuant to the Section 3(a)(10) Exemption and similar exemptions from applicable state securities laws, and the Buyer Shares to be distributed pursuant to the Arrangement shall not be subject to resale restrictions in the United States under the U.S. Securities Act other than as may be prescribed by Rule 144 under the U.S. Securities Act.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B-4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE&#160;3<br>ARRANGEMENT </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 3.01&#160;&#160;&#160;&#160;Arrangement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the Effective Time, unless otherwise specifically provided in this Section 3.01, the following events or transactions shall occur and shall be deemed to occur sequentially in the following order without any further act or formality&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;notwithstanding any vesting or exercise or other provisions to which a Target Option might otherwise be subject (whether by contract, the conditions of grant, applicable Law or the terms of the Target Option Plans), each Target Option outstanding immediately prior to the Effective Time (whether vested or unvested) shall be deemed to be vested and exercisable, and without any further action by or on behalf of a Target Optionholder&#58; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-21.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">each In-the-Money Target Option outstanding at the Effective Time, shall be, and shall be deemed to be, exercised and surrendered to the Target for cancellation and the holders thereof shall receive, in respect of each such surrendered In-the-Money Target Option, the Option Consideration&#59; the Target Shares comprising the Option Consideration will have an issue price per share equal to the Target Share Value and shall be issued as fully paid and non-assessable common shares in the authorized share structure of the Target, and such Target Shares will be added to the Target&#8217;s central securities register in the name of such Target Optionholder&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-21.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">each Out-of-the-Money Target Option outstanding at the Effective Time, shall be, and shall be deemed to be, surrendered to the Target for cancellation and the holders thereof shall receive, in respect of each such surrendered Out-of-the-Money Target Option, a cash payment from the Target equal to $0.001 per Out-of-the-Money Target Option, less any amount that may be withheld pursuant to Section 5.03&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-21.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">each Target Optionholder will cease to be the holder of Target Options or to have any rights in respect of any Target Option (other than the right to receive the Option Consideration pursuant to Section 3.01(a)(i) or cash payment pursuant to Section 3.01(a)(ii)) or under any Target Option Plan and the name of such Target Optionholder will be removed from the applicable securities register of the Target with respect to all Target Options&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Target Option Plans and all agreements, arrangements and understandings relating to any and all Target Options shall be terminated and shall be of no further force and effect&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;each Dissent Share held by a Dissenting Target Shareholder shall be, and shall be deemed to be, surrendered to the Target by the holder thereof, without any further act or formality by such Dissenting Target Shareholder, free and clear of all Encumbrances, and each such Dissent Share so surrendered shall be cancelled and thereupon each Dissenting Target Shareholder shall cease to have any rights as a holder of such Dissent Shares other than a claim against Target in an amount determined and payable in accordance with Article&#160;4 and the name of such Dissenting Target Shareholder shall be removed from the central securities register of holders of Target Shares&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;each Target Share outstanding immediately prior to the Effective Time including, for greater certainty Target Shares issued at the Effective Time pursuant to Section 3.01(a)(i), other than Dissent Shares or Target Shares held by the Buyer, shall be transferred to the Buyer without any further act or formality by such Former Target Shareholder free and clear of any Encumbrances, and each such Former Target Shareholder shall be removed from Target&#8217;s central securities register of holders of Target Shares, and in consideration thereof, each such Former Target Shareholder shall receive the Share Consideration, subject to any withholding pursuant to Section 5.03.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B-5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 3.02&#160;&#160;&#160;&#160;Effective Time Procedures </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the provisions of Article&#160;5, on the Effective Date, the Former Target Shareholders shall be entitled to receive delivery of the certificates representing the Buyer Shares to which they are entitled pursuant to Section 3.01(d).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 3.03&#160;&#160;&#160;&#160;No Fractional Shares and Rounding</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;In no event shall any holder of Target Shares be entitled to receive a fractional Buyer Share under this Plan of Arrangement. Where the aggregate number of Buyer Shares to be issued to a Target Shareholder as consideration under this Plan of Arrangement would result in a fraction of a Buyer Share being issuable the number of Buyer Shares to be issued to such Target Shareholder shall be rounded down to the closest whole number.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;If the aggregate cash amount a Target Securityholder is entitled to receive under this Plan of Arrangement would otherwise include a fraction of $0.01, then the aggregate cash amount such Target Securityholder shall be entitled to receive shall be rounded down to the nearest whole $0.01.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 3.04&#160;&#160;&#160;&#160;Adjustments to the Share Consideration </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that, after the date of the Arrangement Agreement and prior to the Effective Date, the Buyer or the Target changes the number of Buyer Shares or Target Shares, respectively, issued and outstanding as a result of a reclassification, stock split (including a reverse stock split), stock dividend or stock distribution, recapitalization, subdivision, or other similar transaction, the Share Consideration shall be equitably adjusted to eliminate the effects of such event on the Share Consideration.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 3.05&#160;&#160;&#160;&#160;Deemed Fully Paid and Non-Assessable Shares</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Target Shares and Buyer Shares issued pursuant to this Plan of Arrangement shall be deemed to be validly issued and outstanding as fully paid and non-assessable shares.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 3.06&#160;&#160;&#160;&#160;Target Option Plan Matters</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Parties acknowledge and agree that the outstanding Target Options shall be treated in accordance with the provisions this Plan of Arrangement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Parties acknowledge that no deduction will be claimed by the Target or by any person not dealing at arm&#8217;s length with the Target in respect of any the Option Consideration, or any portion there of that is made, or deemed to have been made, to a holder of Target Options who is resident of Canada or who is employed in Canada (all within the meaning of the Tax Act) in computing the Target&#8217;s, or any person not dealing at arm&#8217;s length with Target, taxable income under the Tax Act and the Buyer shall cause the Target to&#58; (i) where applicable, make an election pursuant to subsection 110(1.1) of the Tax Act in respect of the In-the-Money Target Options that were exercised and surrendered to the Target for cancellation in exchange for the Option Consideration, and (ii) the Target (or a person not dealing at arm&#8217;s length with Target) will provide evidence in writing of the election to holders of the In-the-Money Target Options&#59; and (iii) the Target (or a person not dealing at arm&#8217;s length with the Target) will make the appropriate notation on the T4 slips issued to such holders, or in such other manner as may be prescribed under the Tax Act.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE&#160;4<br>DISSENT RIGHTS </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 4.01&#160;&#160;&#160;&#160;Dissent Rights </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Pursuant to the Interim Order, registered Target Shareholders may exercise Dissent Rights under Division 2 of Part 8 of the BCBCA, as modified by this Article&#160;4, the Interim Order and the Final Order, with respect to all (but not less than all) of the Target Shares held, provided that the Notice of Dissent </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B-6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contemplated by Section 242 of the BCBCA must be received by the Target at least two (2) Business Days before the Target Meeting (or any date to which the Target Meeting may be postponed or adjourned), and provided further that holders who exercise such Dissent Rights and who&#58; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-21.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are ultimately entitled to be paid fair value for their Dissent Shares (which fair value shall, notwithstanding anything in the BCBCA, be the fair value of such Dissent Shares immediately before the passing by the Target Shareholders of the Arrangement Resolution) shall be paid an amount in cash equal to such fair value by the Target (including any successor or successors to the Target by amalgamation) to the extent available, with Target funds not directly or indirectly provided by Buyer or its affiliates&#59; and </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-21.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are ultimately not entitled, for any reason, to be paid fair value for their Target Shares shall be deemed to have participated in the Arrangement, as of the Effective Time, on the same basis as non-dissenting registered Target Shareholders and shall be entitled to only the Share Consideration pursuant to Section 3.01(d) that such holder would have received pursuant to the Arrangement if such holder had not exercised Dissent Rights. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In no case shall the Target, the Buyer or any other person be required to recognize&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-21.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a person exercising Dissent Rights unless such person is the registered holder of those Target Shares in respect of which such rights are sought to be exercised&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-21.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Target Shareholders who exercise Dissent Rights as Target Shareholders after the time that is immediately prior to the Effective Time, and the names of the Dissenting Target Shareholders shall be deleted from the central securities register as holders of Target Shares at the Effective Time and their Target Shares shall be deemed to be surrendered to the Target and cancelled. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;For greater certainty, (i) no holder of Target Options shall be entitled to Dissent Rights in respect of such holder&#8217;s Target Options, and (ii) in addition to any other restrictions under the Interim Order and section 238 of the BCBCA, no holders of Target Shares who vote or have instructed a proxyholder to vote such Target Shares in favour of the Arrangement Resolution shall be entitled to exercise Dissent Rights.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE&#160;5<br>DELIVERY OF SHARE CONSIDERATION </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 5.01&#160;&#160;&#160;&#160;Delivery of Share Consideration</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Following receipt of the Final Order and in any event no later than the Business Day prior to the Effective Date, the Buyer shall deposit, or arrange to be deposited for the benefit of Target Shareholders (excluding Dissenting Target Shareholders, and the Buyer, if applicable) such number of Buyer Shares necessary to satisfy the Share Consideration payable to Target Shareholders as required by this Plan of Arrangement, which Buyer Shares shall be held by the Depositary in escrow as agent and nominee for such Target Shareholders.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Upon surrender to the Depositary for cancellation of a certificate which immediately prior to the Effective Time represented outstanding Target Shares that were transferred pursuant to Section 3.01(d), together with a duly completed and executed Letter of Transmittal and such additional documents and instruments as the Depositary may reasonably require, the registered holder of the Target Shares represented by such surrendered certificate shall be entitled to receive in exchange therefor, and the Depositary shall deliver to such holder, the Share Consideration which such holder has the right to receive under this Plan of Arrangement for such Target Shares, without interest, less any amounts withheld pursuant to Section 5.03, and any certificate so surrendered shall forthwith be cancelled.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;As soon as practicable after the Effective Date, the Target shall deliver, or cause to be delivered, to each holder of Out-of-the-Money Target Options as reflected on the register maintained by or on behalf of the Target immediately prior to the Effective Time, a cheque or cash payment (or process the payment </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B-7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">through the Target&#8217;s payroll systems or such other means as the Target may elect) representing the amount, if any, which such holder of Out-of-the-Money Target Options has the right to receive pursuant to Section 3.01(a)(ii) of this Plan of Arrangement for such Out-of-the-Money Target Options, less any amount withheld pursuant to Section 5.03.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Until surrendered as contemplated by this Section 5.01, each certificate or other evidence of registered ownership that immediately prior to the Effective Time represented Target Shares, shall be deemed after the Effective Time to represent only the right to receive upon such surrender the Share Consideration which the holder is entitled to receive in lieu of such certificate as contemplated in this Section 5.01, less any amounts withheld pursuant to Section 5.03. Any such certificate formerly representing Target Shares not duly surrendered on or before the sixth (6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) anniversary of the Effective Date shall cease to represent a claim by or interest of any former holder of Target Shares of any kind or nature against or in the Target or the Buyer. On such date, all Share Consideration to which such former holder was entitled shall be deemed to have been surrendered to the Buyer, and shall be paid over by the Depositary to the Buyer or as directed by the Buyer.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Any payment made by the Depositary (or the Target or any of its subsidiaries, as applicable) pursuant to this Plan of Arrangement that has not been deposited or has been returned to the Depositary (or the Target or any of its subsidiaries, as applicable) or that otherwise remains unclaimed, in each case, on or before the sixth (6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) anniversary of the Effective Time, and any right or claim to payment hereunder that remains outstanding on the sixth (6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) anniversary of the Effective Time shall cease to represent a right or claim of any kind or nature and the right of the holder to receive the applicable consideration for the Target Shares and the Out-of-the-Money Target Options pursuant to this Plan of Arrangement shall terminate and be deemed to be surrendered and forfeited to the Buyer or the Target, as applicable, for no consideration.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;No holder of Target Shares or In-the-Money Target Options shall be entitled to receive any Share Consideration with respect to Target Shares other than the Share Consideration which such holder is entitled to receive in accordance with Section 3.01(d) and this Section 5.01 and, for greater certainty, no such holder will be entitled to receive any interest, dividends, premium or other payment in connection therewith other than, in respect of Target Shares, any declared but unpaid dividends with a record date prior to the Effective Date. No dividend or other distribution declared or made after the Effective Time with respect to any securities of the Target with a record date on or after the Effective Date shall be delivered to the holder of any unsurrendered certificate which, immediately prior to the Effective Date, represented outstanding Target Shares that were transferred pursuant to Section 3.01.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;No holder of Out-of-the-Money Target Options shall be entitled to receive any cash payment other than, subject to Section 3.03, the cash payment which such holder is entitled to receive in accordance with Section 3.01(a)(ii) and this Section 5.01 and, for greater certainty, no such holder will be entitled to receive any interest or other payment in connection therewith.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;No dividend or other distribution declared or made after the Effective Time with respect to Buyer Shares with a record date after the Effective Time shall be delivered to the holder of any unsurrendered certificate that, immediately prior to the Effective Time, represented outstanding Target Shares that were transferred pursuant to Section 3.01, unless and until the holder of such certificate shall have complied with the provisions of this Section 5.01. Subject to applicable Law and to this Section 5.01 at the time of such compliance, there shall, in addition to the delivery of the Share Consideration to which such holder is thereby entitled, be delivered to such holder, without interest, the amount of the dividend or other distribution with a record date after the Effective Time theretofore paid with respect to the Buyer Shares to which such holder is entitled in respect of such holder&#8217;s Share Consideration, net of any applicable withholding and other taxes</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 5.02&#160;&#160;&#160;&#160;Lost Certificates </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event any certificate which immediately prior to the Effective Time represented one or more outstanding Target Shares that were transferred pursuant to Section 3.01 shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the person claiming such certificate to be lost, stolen or destroyed and who was listed immediately </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B-8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prior to the Effective Time as the registered holder thereof on the central securities register of holders of Target Shares maintained by or on behalf of the Target, the Depositary will issue in exchange for such lost, stolen or destroyed certificate, the Share Consideration which such holder is entitled to receive for such Target Shares under this Plan of Arrangement. When authorizing such issuance of Share Consideration in exchange for any lost, stolen or destroyed certificate, the person to whom such Share Consideration is to be delivered shall, as a condition precedent to the delivery of such Share Consideration, give a bond satisfactory to the Buyer and the Depositary (each acting reasonably) in such sum as the Buyer may direct (acting reasonably), or otherwise indemnify the Buyer and the Target in a manner satisfactory to the Buyer, acting reasonably, against any claim that may be made against the Buyer and the Target with respect to the certificate alleged to have been lost, stolen or destroyed. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 5.03&#160;&#160;&#160;&#160;Withholding Rights </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Buyer, the Target and the Depositary, as applicable, shall be entitled to deduct and withhold from any consideration otherwise payable or deliverable to any person under this Plan of Arrangement (including any amounts payable pursuant to Section 4.01), such amounts as the Buyer, the Target or the Depositary, as applicable, are required to deduct and withhold, or reasonably believe to be required to deduct and withhold, from such amount otherwise payable or deliverable under any provision of any Laws in respect of Taxes. Any such amounts will be deducted, withheld and remitted from the amount otherwise payable or deliverable pursuant to this Plan of Arrangement and shall be treated for all purposes under this Plan of Arrangement as having been paid to the person in respect of which such deduction, withholding and remittance was made&#59; provided that such deducted and withheld amounts are actually remitted to the appropriate Governmental Authority. The Buyer will (i) promptly notify the Target if it becomes aware of any such deduction or withholding, and (ii) remit any withheld or deducted amounts to the appropriate Governmental Authority within the time required by applicable Law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Buyer, the Target or the Depositary that delivers Share Consideration to any Former Target Shareholder under this Plan of Arrangement shall be authorized to sell or otherwise dispose of such portion of Buyer Shares otherwise issuable to such Former Target Shareholder (if any) as is necessary to provide sufficient funds to enable it to comply with its deducting or withholding requirements and such Party shall notify the applicable Target Shareholder and remit any unapplied balance of the net proceeds of such sale to such Former Target Shareholder (after deduction for (x) the amounts required to satisfy the required withholding under the Plan of Arrangement in respect of such person, (y) reasonable commissions payable to the broker effecting the sale of Buyer Shares on the instruction of the Buyer, the Target or the Depositary, and (z) other reasonable costs and expenses). None of the Buyer, the Target or the Depositary will be liable for any loss arising out of any sale of such Buyer Shares, including any loss relating to the manner or timing of such sales, the prices at which the Buyer Shares are sold or otherwise.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 5.04&#160;&#160;&#160;&#160;Limitation and Proscription </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that a Former Target Shareholder shall not have complied with the provisions of Section 5.01 or Section 5.02 on or before the date that is six years after the Effective Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">final proscription date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), then the Share Consideration that such Former Target Shareholder was entitled to receive shall be automatically cancelled without any repayment of capital in respect thereof and the interest of the Former Target Shareholder in such Share Consideration to which it was entitled shall be terminated as of such final proscription date. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE&#160;6<br>AMENDMENTS </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 6.01&#160;&#160;&#160;&#160;Amendments to Plan of Arrangement </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Buyer and the Target reserve the right to amend, modify or supplement this Plan of Arrangement at any time and from time to time, provided that each such amendment, modification or supplement must be (i)&#160;set out in writing, (ii)&#160;agreed to in writing by the Target and the Buyer, (iii)&#160;filed with the Court and, if made following the Target Meeting, approved by the Court, and (iv) communicated to Target Securityholders, if and as required by the Court. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any amendment, modification or supplement to this Plan of Arrangement may be proposed by the Buyer at any time prior to the Target Meeting provided that Target shall have consented thereto in writing, with or without any other prior notice or communication, and, if so proposed and accepted by the persons </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B-9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">voting at the Target Meeting (other than as may be required under the Interim Order), shall become part of this Plan of Arrangement for all purposes. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Any amendment, modification or supplement to this Plan of Arrangement may be proposed by the Target at any time prior to the Target Meeting provided that the Buyer shall have consented thereto in writing, with or without any other prior notice or communication, and, if so proposed and accepted by the persons voting at the Target Meeting (other than as may be required under the Interim Order), shall become part of this Plan of Arrangement for all purposes. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Any amendment, modification or supplement to this Plan of Arrangement that is approved by the Court following the Target Meeting shall be effective only if&#58; (i)&#160;it is consented to in writing by each of the Target and the Buyer&#59; and (ii)&#160;if required by the Court, it is consented to by the Target Securityholders or, voting in the manner directed by the Court.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B-10</font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_31"></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE C<br>INFORMATION CONCERNING CYBIN</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized terms used but otherwise not defined in this Schedule C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall have the meaning given to them under the heading &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Glossary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in this Circular.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Structure</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin was incorporated under the BCBCA on October 13, 2016 under the name &#8220;Clarmin Explorations Inc.&#8221; The Cybin Shares commenced trading on the TSXV on January 8, 2018. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2020, Cybin consolidated its outstanding common shares on the basis of 6.672 pre-consolidation Cybin Shares for one post-consolidation Cybin Share.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 5, 2020, Cybin Corp. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Privateco</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) amalgamated with 2762898 Ontario Inc. and Cybin acquired all of the issued and outstanding common shares in the capital of Cybin Privateco in exchange for Cybin Shares on the basis of one Cybin Share for every one common share of Cybin Privateco then issued and outstanding, (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RTO Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). In connection with the closing of the RTO Transaction, (i) Cybin and Cybin Privateco completed a series of transactions resulting in a reorganization of Cybin Privateco and Cybin, and pursuant to which Cybin became the direct parent and sole shareholder of Cybin Privateco&#59; (ii) Cybin changed its financial year end from July 31 to March 31, and (iii) Cybin was continued under the OBCA and changed its name to &#8220;Cybin Inc.&#8221; Effective November 9, 2020, the Cybin Shares were delisted from trading on the TSXV. On November 10, 2020, the Cybin Shares began trading on the Cboe Canada exchange (previously, the NEO Exchange). The RTO Transaction constituted a reverse takeover of Cybin by Cybin Privateco, with Cybin Privateco as the reverse takeover acquirer under applicable Securities Laws and for accounting purposes under IFRS.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin&#8217;s registered office and head office is located at 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9. The following diagram sets forth the corporate structure of Cybin, as at the date of this Circular.</font></div><div style="text-align:center"><img alt="image_9.jpg" src="image_9.jpg" style="height:370px;margin-bottom:5pt;vertical-align:text-bottom;width:480px"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:434.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Note&#58; </font></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Pursuant to a contribution agreement entered into on December 4, 2020, as amended on September 24, 2021, with Cybin, Cybin US Holdings Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cybin U.S.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;), and all of the shareholders (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Adelia Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;) of Adelia Therapeutics Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Adelia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;), the Adelia Shareholders hold certain non-voting securities of Cybin U.S.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C-1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of the Business</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin&#8217;s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. Cybin&#8217;s research and development work focuses on a three-pillar strategy that leverages Cybin&#8217;s core competencies in preclinical innovation and clinical development. This strategy supports the creation of intellectual property focused on developing the Cybin&#8217;s platform technology, the progression of clinical development programs including CYB003, a deuterated psilocybin analog, CYB004, a deuterated version of DMT, CYB005, phenethylamine derivatives, and an expansive list of preclinical molecules to facilitate future drug development opportunities.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further information regarding Cybin, the development of its business and its business activities, see the Cybin AIF which is incorporated by reference in this Circular.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Developments</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 28, 2023, Cybin entered into the Arrangement Agreement with Small Pharma pursuant to which Cybin has agreed to acquire all of the issued and outstanding Small Pharma Shares by way of the Arrangement. As consideration under the Arrangement, Small Pharma Shareholders (other than Dissenting Shareholders) will receive 0.2409 of a Cybin Share for each Small Pharma Share held. Immediately following completion of the Arrangement, Small Pharma will become a wholly- owned subsidiary of Cybin and, assuming that no Cybin Shares are issued in settlement of Small Pharma Incentive Awards and that there are no Dissenting Shareholders, it is anticipated that Former Small Pharma Shareholders and current Cybin Shareholders will own approximately 74.3% and 25.7% of Post-Arrangement Cybin. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effects of the Arrangement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cybin Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 5, 2023, Cybin announced that the United States Patent and Trademark Office has granted U.S. patent 11,746,088, covering composition of matter for deuterated tryptamine compounds and pharmaceutical compositions thereof, with exclusivity until 2041. The newly granted U.S. patent covers deuterated 5-methoxy-dimethyltryptamine analogs in Cybin&#8217;s pre-clinical deuterated tryptamine portfolio.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of Capital Structure</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cybin Shares</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin&#8217;s authorized share capital consists of an unlimited number of Cybin Shares without par value. Holders of Cybin Shares are entitled to one vote for each Cybin Share held at all meetings of shareholders of Cybin, to receive dividends if, as and when declared by the Cybin Board, and to participate rateably in any distribution of property or assets upon the liquidation, winding-up or other dissolution of Cybin. The Cybin Shares carry no pre-emptive rights, conversion or exchange rights, or redemption, retraction, repurchase, sinking fund or purchase fund provisions. There are no provisions requiring a holder of Cybin Shares to contribute additional capital, and no restrictions on the issuance of additional securities by Cybin. There are no restrictions on the repurchase or redemption of Cybin Shares by Cybin except to the extent that any such repurchase or redemption would render Cybin insolvent.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Cybin Shares rank equally as to dividends, voting powers and participation in assets and in all other respects. The holders of Cybin Shares are entitled to receive notice of, attend and vote at any meeting of the shareholders of Cybin. Each Cybin Share carries one vote per share. There are no voting right ceilings attached to the Cybin Shares. The holders of Cybin Shares are entitled to receive on a pro-rata basis such dividends as the Cybin Board from time to time may declare, out of funds legally available therefor. In the event of a liquidation, winding-up or dissolution of Cybin, whether voluntary or involuntary or for the purpose of a reorganization or otherwise or upon any distribution of capital, the holders of Cybin Shares have the right to receive on a pro-rata basis all of the assets of Cybin remaining after payment of all of Cybin&#8217;s </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C-2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liabilities. No pre-emptive, redemption, retraction, exchange, sinking fund or conversion rights are attached to the Cybin Shares, and the Cybin Shares, when fully paid, will not be liable to further call or assessment. No other class of shares may be created without the approval of the holders of Cybin Shares.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividend History</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin has paid no dividends on the Cybin Shares since incorporation and does not anticipate paying dividends in the immediate future. Cybin does not currently intend to declare any dividends payable to the holders of the Cybin Shares. Cybin has no restrictions on paying dividends, but if Cybin generates earnings in the foreseeable future, it expects that they will be retained to finance growth. The Cybin Board will determine if and when dividends should be declared and paid in the future based upon the Cybin&#8217;s financial position at the relevant time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market for Securities</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Price Range and Trading Volumes of Cybin Shares</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybin Shares are listed on the Cboe Canada and the NYSE under the symbol &#8220;CYBN&#8221;. The following table sets forth, for the periods indicated, the reported high and low prices and the trading volume of the Cybin Shares on the Cboe Canada and the NYSE American&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cboe Canada</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.833%"><tr><td style="width:1.0%"></td><td style="width:47.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Month</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">High ($)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Low ($)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Volume</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2022</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.49</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.64</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,061,741</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.89</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.61</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,200,569</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.67</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.49</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,706,993</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.51</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.375</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,307,124</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.83</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.40</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,313,804</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.82</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.52</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,039,711</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.69</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.48</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,147,215</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.55</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.40</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,906,116</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.46</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.35</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,899,880</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.52</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.30</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,778,524</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.70</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.49</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,373,988</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.48</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.36</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,902,686</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 1-12, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.50</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.41</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,015,309</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NYSE American </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.833%"><tr><td style="width:1.0%"></td><td style="width:47.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Month</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">High (US$)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Low (US$)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Volume</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2022</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.14</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.47</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,585,300</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.66</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.45</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,602,731</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.48</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.36</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,969,352</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.39</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.26</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,739,104</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.62</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.30</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,677,475</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.60</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.39</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,754,753</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.50</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.35</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,943,897</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.40</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.29</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,366,468</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.35</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.26</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,443,776</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.39</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.21</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,472,709</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.53</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.37</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,877,677</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.37</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.28</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,425,653</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 1-12, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.33</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.30</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,166,198</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C-3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 25, 2023, the last trading day prior to the announcement that Small Pharma and Cybin had entered into the Arrangement Agreement, the closing prices of the Cybin Shares on the Cboe Canada and NYSE American were $0.415 and US$0.30, respectively. On September 12, 2023, the last trading day prior to the date of this Circular, the closing price of the Cybin Shares on the Cboe Canada was $0.43 and the closing price of the Cybin Shares on the NYSE American was US$0.33.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prior Sales</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the issuances by Cybin of the Cybin Shares, or securities convertible into the Cybin Shares, within the 12 months preceding the date of this Circular&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cybin Shares</font></div><div style="padding-left:84.48pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.233%"><tr><td style="width:1.0%"></td><td style="width:41.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.765%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Issuance</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of <br>Cybin Shares Issued</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Issuance Price Per Cybin Share (C$)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 13, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,000</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.14</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 14, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.08</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 15, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.98</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 16, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.92</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 19, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.89</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 20, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">461,421</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.84</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 21, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.84</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 22, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380,896</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.88</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 23, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.85</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 26, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,214</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.85</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 27, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.77</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 28, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227,831</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.72</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 29, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">328,900</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.71</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">366,300</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.69</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 3, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.66</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 4, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,452</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.66</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 7, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">912,572</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.82</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 17, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131,700</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.80</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 18, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,600</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.79</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 19, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,512</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.76</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 20, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.75</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 21, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.70</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 24, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.70</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 25, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.67</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 26, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.64</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 27, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.64</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 28, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">236,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.63</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 31, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323,900</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.64</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 1, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">372,300</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.64</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,600</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.62</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 3, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,600</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.64</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 4, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,465</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.63</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 7, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,584</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.62</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 8, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">293,648</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.62</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 10, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">344,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.60</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 14, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,339</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.59</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 15, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,400</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.59</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 15, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222,437</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.58</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 30, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,574</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.55</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 1, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,300</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.55</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 5, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102,928</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.49</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 6, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.48</font></td></tr></table></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C-4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="padding-left:84.48pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.233%"><tr><td style="width:1.0%"></td><td style="width:41.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.765%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 7, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">293,644</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.47</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 8, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192,600</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.46</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 8, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,922</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.47</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 12, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.68</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 12, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,089,648</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.63</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 17, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,200,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.57</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 18, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.57</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 19, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.59</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 20, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.57</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 23, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171,900</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.57</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 24, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">286,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.53</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 26, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.51</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 30, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.52</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 31, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.52</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 1, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124,600</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.51</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,400</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.51</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 6, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">212,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.59</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 7, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.57</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 8, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.58</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 9, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.58</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 10, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">580,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.59</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 13, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.58</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123,400</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.66</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 6, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">884,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.61</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 7, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.60</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 8, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.60</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 9, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">620,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.55</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 13, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,837</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.55</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 14, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">446,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.54</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 14, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,387,222</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.52</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 16, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.53</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 17, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.52</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 20, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">254,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.51</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 21, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.51</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 22, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.50</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 28, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">439,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.52</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 29, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,300</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.51</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 19, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.49</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 20, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.48</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 21, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.49</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 26, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,600</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.47</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 4, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.43</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 5, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.42</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 9, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.41</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 10, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.40</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 11, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.41</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 12, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">392,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.40</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 16, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">400,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.40</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 17, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,836</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.39</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.40</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 19, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.40</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 23, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">387,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.39</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 23, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">429,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.38</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 24, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.37</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 25, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">463,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.38</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 26, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">400,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.37</font></td></tr></table></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C-5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="padding-left:84.48pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.233%"><tr><td style="width:1.0%"></td><td style="width:41.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.765%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 30, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248,400</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.37</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 30, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,538,844</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.40</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 31, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.34</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 1, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.38</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 1, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.34</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">337,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.36</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.34</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 5, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">245,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.35</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 5, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.34</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 6, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,733</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.35</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 7, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.35</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 7, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.31</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 8, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">451,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.33</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 8, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.30</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 9, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167,500</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.33</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 9, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.29</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 12, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.31</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 14, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162,200</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.31</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 26, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.38</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 7, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,602</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.69</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 10, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.62</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 11, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.61</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 12, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341,080</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.58</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 17, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">618,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.59</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 18, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">485,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.56</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 4, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,264,706</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.45</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:434.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notes&#58;</font></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;Certain amounts have been converted from U.S. dollars to Canadian dollars based on the average exchange rate posted by the Bank of Canada for the year ended December 31, 2022, being US$1.00 &#61; C$1.3282.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;Cybin Shares issued in connection with Cybin&#8217;s prior at-the-market equity program (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior ATM Program</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8221;) under Cybin&#8217;s short form base shelf prospectus dated July 5, 2021, which qualified Cybin to issue and sell up to US$35,000,000 of Cybin Shares to the public, from time to time, at its discretion. The Prior ATM Program was qualified by the prospectus supplement dated August 8, 2022.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;Cybin Shares issued in exchange for class B common shares in the capital of Cybin U.S. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8221;). Such Class B Shares were issued in connection with the acquisition of Adelia to Adelia Shareholders. The Class B Shares are exchangeable at the holder&#8217;s option for Cybin Shares on the basis of 10 Cybin Shares for 1 Class B Share, subject to customary adjustments.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;Cybin Shares issued to LPC on May 30, 2023 pursuant to the terms of the purchase agreement entered into between LPC and Cybin on May 30, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LPC Purchase Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8221;). </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)&#160;&#160;&#160;&#160;Cybin Shares issued pursuant to the LPC Purchase Agreement. </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6)&#160;&#160;&#160;&#160;The Cybin Shares were issued in connection with an overnight marketed public offering of units of Cybin on August 4, 2023, qualified pursuant to a prospectus supplement to Cybin&#8217;s short form base shelf prospectus dated July 5, 2021. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cybin Options</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.571%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date Granted</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Cybin Options</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise Price ($)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expiry Date</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 28, 2022</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,000</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.00</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 27, 2027</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 28, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.75</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 27, 2025</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.75</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2025</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.00</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2027</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 16, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.91</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 15, 2025</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 16, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.75</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 15, 2025</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 28, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,615,000</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.44</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 30, 2028</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cybin Warrants</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.751%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date Granted</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Cybin Warrants</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise Price ($)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expiry Date</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 4, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,264,706</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US$0.40</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 4, 2028</font></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:434.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#58;</font></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;The Cybin Warrants were issued in connection with an overnight marketed public offering of units of Cybin on August 4, 2023, qualified pursuant to a prospectus supplement to Cybin&#8217;s short form base shelf prospectus dated July 5, 2021. </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C-6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Capitalization</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following table sets out the consolidated capitalization of Cybin as at June 30, 2023, and September 1, 2023.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.801%"><tr><td style="width:1.0%"></td><td style="width:38.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.916%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Class of Security</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As at June 30, 2023</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As at September 1, 2023</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cybin Shares</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208,325,846</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234,683,234</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cybin Options</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,980,425</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,676,675</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Underwriters warrants</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">868,740</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">868,740</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cybin Warrants</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,230,485</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,836,331</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Class B Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530,542.1</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530,542.1</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:434.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Note&#58;</font></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;Exchangeable for Cybin Shares on the basis of 10 Cybin Shares for each Class B Share, at the option of the holder thereof, subject to customary adjustments.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings and Regulatory Actions</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To Cybin&#8217;s knowledge, Cybin is not a party to, nor is any of its property the subject of, any material legal proceedings, and there are no material legal proceedings known by Cybin to be contemplated. Cybin has not&#58; (i) received any penalties or sanctions imposed against it by a court relating to securities legislation or by a securities regulatory authority during the financial year ended March 31, 2023&#59; (ii) received any other penalties or sanctions imposed by a court or regulatory body that would likely be considered important to a reasonable investor in making an investment decision&#59; or (iii) entered any settlement agreements with a court relating to securities legislation or with a securities regulatory authority during the financial year ended March 31, 2023.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transfer Agent, Registrar and Auditor</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin&#8217;s transfer agent and registrar for the Cybin Shares is Odyssey Trust Company of Canada at its principal office in Calgary, Alberta.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The auditors of Cybin are Zeifmans LLP of Toronto, Ontario.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Documents Incorporated by Reference</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information has been incorporated by reference in this Schedule C from documents filed with securities commissions or similar authorities in Canada</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Copies of the documents incorporated herein by reference may be obtained on request without charge from Cybin at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ir&#64;cybin.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or by telephone&#58; 1-866-292-4601. In addition, copies of the documents incorporated herein by reference may be obtained by accessing the disclosure documents available through the Internet on Cybin&#8217;s issuer profile on SEDAR+ at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sedarplus.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents of Cybin filed with the various securities commissions or similar authorities in the provinces of Canada are specifically incorporated by reference into and form an integral part of this Schedule C&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the Cybin AIF&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the audited consolidated financial statements of Cybin as at and for the years ended March 31, 2023 and 2022&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;the Annual Cybin MD&#38;A&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Cybin&#8217;s unaudited condensed interim consolidated financial statements as at and for the three months ended June 30, 2023 and 2022&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;the Interim Cybin MD&#38;A&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;Cybin&#8217;s management information circular dated July 13, 2022 in respect of the annual general meeting of Cybin Shareholders held on August 15, 2022&#59; </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C-7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;Cybin&#8217;s material change report dated May 31, 2023 with respect to its purchase agreement with LPC&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;Cybin&#8217;s material change report dated August 8, 2023 with respect to its overnight marketed public offering for aggregate gross proceeds of US$8,250,000&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Cybin&#8217;s material change report dated August 23, 2023 with respect to the filing of a prospectus supplement and entry into an equity distribution agreement&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;Cybin&#8217;s material change report dated September 7, 2023 with respect to the entering into of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any documents of the type required by National Instrument 44-101 &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short Form Prospectus Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to be incorporated by reference into a short form prospectus, including any material change reports (excluding confidential reports), comparative interim financial statements, comparative annual financial statements and the auditor&#8217;s report thereon, management&#8217;s discussion and analysis of financial condition and results of operations, information circulars, annual information forms and business acquisition reports filed by Cybin with the securities commissions or similar authorities in Canada subsequent to the date of this Circular and before the Effective Date, are deemed to be incorporated by reference in this Circular and this Schedule C. Cybin Shareholders should refer to these documents for important information concerning Cybin.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for the purposes of this Schedule C to the extent that a statement contained herein or in any other subsequently filed document which also is, or is deemed to be, incorporated by reference herein modifies or supersedes such statement. The modifying or superseding statement need not state that it has modified or superseded a prior statement or include any other information set forth in the document that it modifies or supersedes. The making of a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation, an untrue statement of a material fact or an omission to state a material fact that is required to be stated or that is necessary to make a statement not misleading in light of the circumstances in which it was made. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute part of this Schedule C.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information contained or otherwise accessed through Cybin&#8217;s website, </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.cybin.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or any website, other than those documents specifically incorporated by reference herein and filed on SEDAR+ under Cybin&#8217;s profile at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sedarplus.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> does not form part of this Circular.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factors</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The business and operations of Cybin are subject to risks. In addition to considering the other information in this Circular, Cybin Shareholders should consider carefully the factors set forth in the Cybin AIF, the Annual Cybin MD&#38;A and the Interim Cybin MD&#38;A, each of which are incorporated by reference in this Circular.</font></div><div><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C-8</font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_34"></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE D<br>INFORMATION CONCERNING SMALL PHARMA</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information about Small Pharma should be read in conjunction with the documents incorporated by reference into this Schedule D and the information concerning Small Pharma appearing elsewhere in this Circular. </font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of the Business</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Small Pharma is a biotechnology company progressing short-duration psychedelic-assisted therapies for the treatment of mental health conditions. Small Pharma has initiated programs across its &#8220;first-generation&#8221; and &#8220;second-generation&#8221; psychedelics portfolio. It is focused on the development of pharmaceutical psychedelic assets with the inclusion of support therapy, anticipating this treatment paradigm to be important for optimizing beneficial patient outcomes.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Small Pharma is focused on the research and development of pharmaceutical drugs, with an intention to further advance its current portfolio into and through clinical trials towards commercialization. This progression may also extend to the sales and marketing of any of its assets that receive marketing authorization. In addition, Small Pharma may expand its research and development pipeline by initiating additional development programs. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this Circular, Small Pharma has initiated and progressed its research and development efforts on four therapeutic candidates across its psychedelic and non-psychedelic compounds, discussed in detail below. In line with its business model, Small Pharma has ensured an intellectual property strategy is embedded in the development of all its therapeutic candidates. Across its lead psychedelic-focused development programs, SPL026 and SPL028, Small Pharma has 17 patents granted and 77 patent applications pending and is actively continuing to expand its portfolio. Small Pharma also has additional patents granted and applications pending across its preclinical pipeline, SPL029 and SPL801B programs, as further described below.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Small Pharma&#8217;s research and development strategy is targeted around the following core target value proposition&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rapid and durable efficacy&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A treatment course that has the potential to result in rapid symptom relief, with improvements in patient health outcomes that extend for at least a few months.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strong commercial proposition&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Short (&#126;less than&#60;&#126;2.5hr) in-clinic treatments (includes dosing and support therapy) provided on an episodic &#8220;as required&#8221; basis in order to maximize convenience for both patients and physicians, as well as provide economic benefits for payers.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Robust intellectual property protection&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Progressing a multi-layered intellectual property strategy for each asset, including targeting Composition of Matter protection within the second-generation portfolio, in multiple jurisdictions.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SPL026&#58; First-Generation DMT Asset</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Small Pharma has advanced its first-generation short-duration psychedelic clinical program, SPL026, with the positive completion of a proof-of-concept study for an IV formulation of SPL026, as well as exploratory studies to evaluate additional formulations and treatment populations.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Small Pharma&#8217;s IV SPL026 Phase I&#47;IIa study completed in Q1 2023 with positive results demonstrated the safety, tolerability and efficacy of DMT with support therapy for the treatment of MDD. To further inform the patient recruitment of future trials and ultimately facilitate broadening the treatable MDD populations, in H2 2022, Small Pharma initiated a Phase I drug interaction study in the United Kingdom to investigate the potential interactions between SSRI antidepressants and IV SPL026 therapy in patients with MDD. The study completed dosing in July 2023 with data anticipated in Q3 2023.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, Small Pharma is investigating additional routes of administration that may offer improved treatment convenience to patients. Small Pharma initiated a Phase I IM&#47;IV SPL026 study in Q4 2022 to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics profiles of IM compared to IV SPL026 administration. The study completed in Q2 2023 and demonstrated that IM SPL026 meets the target treatment length, demonstrating the potential for IM administration as a convenient route for patients and physicians.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">D-1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SPL028&#58; Proprietary Second-Generation Deuterated DMT Asset</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SPL028 is Small Pharma&#8217;s novel deuterated second-generation DMT compound targeting an extended DMT psychedelic experience. It offers a unique short-duration DMT drug profile that could provide optimized dose formulations for different administration routes and distinct therapeutic benefits for patients. Small Pharma initiated a Phase I IV and IM healthy volunteer study in Q1 2023 to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of both administration routes. Data regarding the volunteer study is anticipated in Q4 2023. </font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Small Pharma files reports and other information with the each of the securities regulators in the provinces and territories of Canada. These reports containing additional information with respect to Small Pharma&#8217;s business and operations are available to the public free of charge on Small Pharma&#8217;s issuer profile on SEDAR+ at </font><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sedarplus.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and on Small Pharma&#8217;s website at www.smallpharma.co.uk. Information contained on Small Pharma&#8217;s website is not and is not deemed to be a part of this Circular or incorporated by reference herein and should not be relied upon by Cybin Shareholders for the purpose of determining whether to approve the Acquisition Resolution.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Documents Incorporated by Reference</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in documents of Small Pharma incorporated by reference herein, contains forward-looking information about Small Pharma. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-Looking Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in this Circular in respect of forward-looking information that is included in the documents incorporated by reference herein.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents, filed by Small Pharma with the securities commissions or similar regulatory authorities in each of the provinces and territories of Canada are specifically incorporated by reference into, and form an integral part of, this Circular as of the date of this Circular.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the Small Pharma AIF&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the audited consolidated financial statements for the financial years ended February 28, 2023 and 2022, together with the independent auditor&#8217;s report thereon and the notes thereto&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;the management&#8217;s discussion and analysis for the financial year ended February 28, 2023&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;the unaudited interim condensed consolidated financial statements for the three months ended May 31, 2023 and 2022&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;the management&#8217;s discussion and analysis for the three months ended May 31, 2023 and 2022&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;the material change report dated September 7, 2023 regarding the Arrangement&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;the material change report dated January 30, 2023 regarding the results of Small Pharma&#8217;s Phase IIa Trial of SPL026&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;the management information circular dated June 20, 2022 in connection with the annual and special meeting of the shareholders of Small Pharma held on July 19, 2022.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any documents of the type required by National Instrument 44-101 &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short Form Prospectus Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to be incorporated by reference into a short form prospectus, including any material change reports (excluding confidential reports), comparative interim financial statements, comparative annual financial statements and the auditor&#8217;s report thereon, management&#8217;s discussion and analysis of financial condition and results of operations, information circulars, annual information forms and business acquisition reports filed by Small Pharma with the securities commissions or similar authorities in Canada subsequent to the date of this Circular and before the Effective Date, are deemed to be incorporated by reference in this Circular and this Schedule D. Cybin Shareholders should refer to these documents for important information concerning Small Pharma.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">D-2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for the purposes of this Schedule D to the extent that a statement contained herein or in any other subsequently filed document which also is, or is deemed to be, incorporated by reference herein modifies or supersedes such statement. The modifying or superseding statement need not state that it has modified or superseded a prior statement or include any other information set forth in the document that it modifies or supersedes. The making of a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation, an untrue statement of a material fact or an omission to state a material fact that is required to be stated or that is necessary to make a statement not misleading in light of the circumstances in which it was made. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute part of this Schedule D.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References to Small Pharma&#8217;s website in any documents that are incorporated by reference into this Circular, do not incorporate by reference the information on such website, and Small Pharma disclaims any such incorporation by reference.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factors</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The business and operations of Small Pharma are subject to risks. In addition to considering the other information in this Circular, Cybin Shareholders should consider carefully the factors set forth in the Small Pharma AIF, Small Pharma&#8217;s management&#8217;s discussion and analysis for the financial year ended February 28, 2023, and Small Pharma&#8217;s management&#8217;s discussion and analysis for the three months ended May 31, 2023 and 2022, each of which are incorporated by reference in this Circular.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">D-3</font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_37"></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div style="margin-bottom:12pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE E<br>INFORMATION CONCERNING POST-ARRANGEMENT CYBIN</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized terms used in this Schedule E but not otherwise defined herein have the meanings set forth in the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General Matters &#8211; Glossary of Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in this Circular.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate Structure</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On completion of the Arrangement, Post-Arrangement Cybin will continue the current operations of Cybin and Small Pharma under the name &#8220;Cybin Inc.&#8221;, and be governed by the laws of the Province of British Columbia. The Arrangement will result in the acquisition of all of the Small Pharma Shares by Cybin and will result in Small Pharm being a wholly-owned subsidiary of Cybin.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is expected that the management head and registered office of Post-Arrangement Cybin will continue to be located at 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following diagram sets forth the corporate structure of Post-Arrangement Cybin.</font></div><div style="margin-bottom:12pt;text-align:center"><img alt="image_10.jpg" src="image_10.jpg" style="height:386px;margin-bottom:5pt;vertical-align:text-bottom;width:514px"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:434.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Note&#58; </font></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Pursuant to a contribution agreement entered into on December 4, 2020, as amended on September 24, 2021, with Cybin, Cybin US Holdings Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cybin U.S.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;), and all of the shareholders (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Adelia Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;) of Adelia Therapeutics Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Adelia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;), the Adelia Shareholders hold certain non-voting securities of Cybin U.S.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><br>Description of the Business</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Post-Arrangement Cybin will carry on the business operated by Cybin and Small Pharma and it will continue to engage in clinical-stage biopharmaceutical company research.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Post-Arrangement Cybin&#8217;s research programs will include&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a combined deuterated DMT program consisting of&#58; (a) CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder&#59; and (b) SPL028, a proprietary deuterated DMT molecule targeting longer-duration psychedelic effects&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CYB005, focused on the development of therapeutic phenethylamine derivatives&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SPL026, a proprietary DMT molecule for the treatment of major depressive disorder targeting short-duration psychedelic effects&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an extensive list of preclinical molecules to facilitate future drug development opportunities.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of Capital Structure</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authorized share structure of Post-Arrangement Cybin will be the same as the currently authorized share capital of Cybin and there will be no change in the rights associated with the Cybin Shares. The authorized share capital of Cybin consists of an unlimited number of Cybin Shares without par value. See &#8220;Description of Capital Structure&#8221; in the Cybin AIF, which is incorporated by reference in this Circular.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is anticipated that there will be 315,693,721 Cybin Shares issued and outstanding upon completion of the Arrangement, based on the number of issued and outstanding Cybin Shares and Small Pharma Shares as at the date of the Arrangement Agreement, and assuming that (i) no Small Pharma Shareholders will exercise Dissent Rights&#59; (ii) 11,828,850 Small Pharma Options will be exercised prior to the Effective Time&#59; and (iii) no other Small Pharma Options will be Small Pharma In-the-Money Options at the Effective Time.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of Capital Structure</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unaudited Pro Forma Financial Information</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma consolidated financial statements of Post-Arrangement Cybin following completion of the Arrangement have been compiled from the underlying financial statements of Cybin and Small Pharma, which have each been prepared in accordance with IFRS, to illustrate the effect of the Arrangement. The unaudited pro forma</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements of Post-Arrangement Cybin and accompanying notes are included in Schedule F to this Circular.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pro Forma Consolidated Capitalization</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the approximate capitalization of Cybin as at June 30, 2023, and as at September 1, 2023, both before and after giving effect to the Arrangement. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.068%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.721%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Class of Security</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As at <br>June 30, 2023</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As at <br>September 1, 2023</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As at September 1, 2023, after giving effect to the Arrangement</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cybin Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208,325,846</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234,683,234</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315,693,721</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cybin Options</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,980,425</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,676,675</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,676,675</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Underwriters warrants</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">868,740</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">868,740</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">868,740</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cybin Warrants</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,230,485</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,836,331</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,836,331</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Class B Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530,542.1</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530,542.1</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530,542.1</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:434.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notes&#58;</font></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Assumes 81,010,487 Cybin Shares will be issued pursuant to the Arrangement.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Exchangeable for Cybin Shares on the basis of 10 Cybin Shares for each Class B Share, at the option of the holder thereof, subject to customary adjustments.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There will be no restrictions in Post-Arrangement Cybin&#8217;s articles or elsewhere, other than customary general solvency requirements, which would prevent Post-Arrangement Cybin from paying dividends following completion of the Arrangement. However, Cybin has not paid any dividends on the Cybin Shares since incorporation and does not anticipate that any dividends will be paid on the Cybin Shares in the immediate future, as management anticipates that all available funds will be invested to finance further clinical trials and research programs. Any decision to pay dividends on the Cybin Shares in the future will be made by the Cybin Board on the basis of the earnings, financial requirements and other conditions existing at such time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Officers and Directors of Post-Arrangement Cybin</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Officers</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the completion of the Arrangement, it is expected that the executive officers of Post-Arrangement Cybin will be the current executive officers of Cybin, which include the following individuals&#58; (i) Doug Drysdale (Chief Executive Officer)&#59; (ii) Greg Cavers (Chief Financial Officer)&#59; (iii) Eric So (Chair and President) (iv) Gabriel Fahel (Chief Legal Officer and Corporate Secretary)&#59; (v) Paul Glavine (Chief Growth Officer and Director)&#59; and (vii) and Aaron Bartlone (Chief Operating Officer).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following completion of the Arrangement, Small Pharma&#8217;s executive officers will continue their employment as executive officers or senior officers, as applicable, of Small Pharma (or an affiliate of Small Pharma or Cybin) and will report directly to the Chief Executive Officer of Cybin.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Directors</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the completion of the Arrangement, it is expected that the board of directors of Post-Arrangement Cybin will be led by the current Chair of the Cybin Board, Eric So, and that the board of directors will be comprised of seven directors, including the six current directors of Cybin, being Eric So, Theresa Firestone, Grant Froese, Eric Hoskins, Paul Glavine and Mark Lawson, and George Tziras, a current director of Small Pharma, who has indicated his willingness to be appointed to the Cybin Board, and whom Cybin has agreed to appoint upon the completion of the Arrangement pursuant to the terms of the Arrangement Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Tziras is the Chief Executive Officer of Small Pharma, having previously served as its Chief Business Officer from 2021 through July 2022. He has served as a director of Small Pharma since April 29, 2021, and Small Pharma&#8217;s operating subsidiary, Small Pharma Ltd., since 2015. Mr. Tziras has over 15 years of experience in investment banking and international capital markets having worked at a number of global financial institutions including Goldman Sachs, Credit Suisse, Nomura, Lehman Brothers and CIBC. He has worked on a broad range of transactions including debt and equity financings&#59; mergers, disposals and acquisitions&#59; private equity buyouts and debt restructurings. He has also worked across a number of industries, including healthcare. Mr. Tziras holds a BA degree from the University of Oxford and a MA degree from the Johns Hopkins School of Advanced International Studies.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The directors of Post-Arrangement Cybin will hold office until the next annual meeting of the shareholders of Post-Arrangement Cybin or until their respective successors have been duly elected or appointed, unless their office is earlier vacated in accordance with the articles of Post-Arrangement Cybin or the OBCA. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After giving effect to the Arrangement, it is expected the proposed directors and executive officers of Post-Arrangement Cybin and their associates or affiliates, will beneficially own, or exercise control or direction over an aggregate of approximately 25,372,264 Cybin Shares, representing approximately 8.04% of the Cybin Shares expected to be outstanding a non-diluted basis following completion of the Arrangement.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation of Executive Officers</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the completion of the Arrangement, it is expected that Post-Arrangement Cybin will maintain the current policies of Cybin with respect to executive and director compensation. See &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the Circular.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:59.76pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transfer Agent, Registrar and Auditor</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is expected that following completion of the Arrangement, the transfer agent and registrar for the Cybin Shares will continue be Odyssey Trust Company at its principal office in Calgary, Alberta.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is expected that the auditors for Post-Arrangement Cybin will continue to be Zeifmans LLP of Toronto, Ontario.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factors</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The business and operations of Post-Arrangement Cybin will continue to be subject to the risks currently faced by Cybin and Small Pharma, including those set out under the heading &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the Circular. Readers should also carefully consider the risk factors relating to Cybin described in the documents incorporated by reference in Schedule C, and the risk factors relating to Small Pharma described in the documents incorporated by reference in Schedule D.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-4</font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_40"></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SCHEDULE F<br>UNAUDITED PRO FORMA FINANCIAL STATEMENTS OF POST-ARRANGEMENT CYBIN</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See attached. </font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#2a1c42;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-1</font></div><div><font><br></font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_43"></div><hr style="page-break-after:always"><div style="min-height:87.12pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><img alt="image_11.jpg" src="image_11.jpg" style="height:144px;margin-bottom:5pt;vertical-align:text-bottom;width:247px"></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:17.5pt;font-weight:700;line-height:100%">CYBIN INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:17.5pt;font-weight:700;line-height:100%">UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS</font></div><div><font><br></font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-2</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:87.12pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CYBIN INC.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">UNAUDITED PRO FORMA CONSOLIDATED STATEMENT OF FINANCIAL POSITION</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">As at June 30, 2023</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Expressed in thousands of Canadian dollars)</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.693%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cybin Inc.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Small Pharma Inc.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">May 31, 2023</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pro Forma Adjustments</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unaudited       Pro Forma Consolidated</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,349</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,152</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,250)</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6(a)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,662</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,211</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,837</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,174</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Current Assets</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,647</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,652</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,839)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,460</font></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,401</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,401</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,255</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,201</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,456</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Non-Current Assets</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30,044</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">590</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,201</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51,835</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL ASSETS</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45,691</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,242</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,362</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77,295</font></td></tr><tr style="height:7pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,999</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,687</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,686</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease Liabilities</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Current Liabilities</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,999</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,002</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,001</font></td></tr><tr style="height:4pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease Liabilities</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Non-Current Liabilities</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">233</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">233</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL LIABILITIES</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,999</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,235</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,234</font></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SHAREHOLDERS' EQUITY</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share capital</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,682</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,723</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,723)</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6(b)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,619</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,301</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contributed surplus</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,277</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,277</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payment reserve</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,233</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,233)</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">7</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options reserve</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,383</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,383</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants reserve</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,873</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,873</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive deficit</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(858)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,665)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,665</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6(b)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(858)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deficit</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162,665)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,284)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,284</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6(b)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,250)</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6(a)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167,915)</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL SHAREHOLDERS' EQUITY</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39,692</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,007</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,362</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68,061</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45,691</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,242</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,362</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77,295</font></td></tr></table></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-3</font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_46"></div><hr style="page-break-after:always"><div style="min-height:100.08pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CYBIN INC.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">UNAUDITED PRO FORMA CONSOLIDATED STATEMENT OF LOSS AND COMPRENSIVE LOSS</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">For the three months ended June 30, 2023</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Expressed in thousands of Canadian dollars)</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.183%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.749%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cybin Inc.</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Small Pharma Inc.</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pro Forma Adjustments</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unaudited Pro Forma Consolidated</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended June 30, 2023</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended May 31, 2023</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXPENSES</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,384</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,494</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(i)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(l)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,333</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative costs</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,048</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(a)-(h)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,131</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(l)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,729</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(k)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investor and public relations</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(a)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consulting fees</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(b)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(c)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Directors&#8217; fees</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(d)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange loss</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(j)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office and miscellaneous</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(e)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(933)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(f)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Occupancy costs</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(g)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,494</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,494)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(i)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and benefits</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,586</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,586)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(l)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payment expense</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(k)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer agent and filing fees</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(h)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL EXPENSES</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,707</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,749</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,452</font></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INCOME (EXPENSES)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation gain (loss)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,891)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211;</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(j)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,895)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL OTHER INCOME (EXPENSES)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,807)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">105</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,706)</font></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET LOSS FOR THE PERIOD</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14,514)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,644)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(20,158)</font></td></tr><tr style="height:4pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER COMPREHENSIVE LOSS</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation differences for foreign operations</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,555</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMPREHENSIVE LOSS FOR THE PERIOD</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(13,337)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,266)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18,603)</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic loss per share for the period attributable to common shareholders</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.07)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.07)</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average number of common shares outstanding - basic</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">206,157,780</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">80,367,585</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">286,525,365</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-4</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:100.08pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CYBIN INC.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">UNAUDITED PRO FORMA CONSOLIDATED STATEMENT OF LOSS AND COMPRENSIVE LOSS</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">For the twelve months ended March 31, 2023</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Expressed in thousands of Canadian dollars)</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.639%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.943%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.946%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cybin Inc.</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Small Pharma Inc.</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pro Forma Adjustments</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unaudited Pro Forma Consolidated</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended March 31, 2023</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended February 28, 2023</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></div></td><td colspan="6" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXPENSES</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,491</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,382</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(u)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,008</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(x)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,881</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative costs</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,341</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,255</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(m)-(t)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,867</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(x)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,250</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6(a)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,713</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,686</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,189</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(w)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,875</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investor and public relations</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,241)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(m)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consulting fees</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(482)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(n)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(o)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Directors&#8217; fees</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(p)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange loss</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(v)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office and miscellaneous</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(864)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(q)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,898</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,898)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(r)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Occupancy costs</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(s)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,382</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,382)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(u)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and benefits</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,875</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,875)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(x)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payment expense</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,189</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,189)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(w)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer agent and filing fees</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(t)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL EXPENSES</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51,518</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,742</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,209</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">81,469</font></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INCOME (EXPENSES)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation gain (loss)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,027</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3(v)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,986</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of investments measured at fair value through profit or loss</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration accretion</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL OTHER INCOME (EXPENSES)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,028</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,008</font></td></tr><tr style="height:4pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET LOSS FOR THE PERIOD BEFORE INCOME TAX</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(47,490)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24,721)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,250)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(77,461)</font></td></tr><tr style="height:4pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax recovery</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,885</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,885</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET LOSS FOR THE PERIOD</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(47,490)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(22,836)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,250)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(75,576)</font></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER COMPREHENSIVE LOSS</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation differences for foreign operations</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,669)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,849)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,518)</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMPREHENSIVE LOSS FOR THE PERIOD</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(49,159)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24,685)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,250)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(79,094)</font></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic loss per share for the period attributable to common shareholders</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.26)</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.28)</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average number of common shares outstanding - basic</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">185,428,767</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">80,367,585</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">265,796,352</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-5</font></div><div><font><br></font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_49"></div><hr style="page-break-after:always"><div style="min-height:92.16pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CYBIN INC.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NOTES TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Expressed in thousands of Canadian dollars except for share and option amounts and share and option prices)</font></div><div><font><br></font></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;ACQUISITION OF SMALL PHARMA</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybin Inc. (&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybin</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options. On August 29, 2023, Cybin entered into a definitive agreement with Small Pharma Inc. (&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Small Pharma</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), in which Cybin is to acquire Small Pharma in an all-shares transaction (the &#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transaction</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Transaction, Cybin is to acquire all of the issued and outstanding common shares of Small Pharma at a fixed exchange ratio of 0.2409 Cybin common shares for each Small Pharma common share.  The exchange ratio implies a 43.6% premium to Small Pharma&#8217;s 30-day volume weighted average closing share price for the 30-day period ended August 25, 2023.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;BASIS OF PRESENTATION </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited pro forma consolidated financial statements (the &#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pro Forma Consolidated Financial Statements</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of Cybin have been prepared from information derived from, and should be read in conjunction with the following&#58;</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:90pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.02pt">the audited annual consolidated financial statements of Cybin, together with the notes thereto, as at and for the year ended March 31, 2023 as filed on SEDAR&#59;</font></div><div style="padding-left:90pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.02pt">the unaudited interim consolidated financial statements of Cybin, together with the notes thereto, as at and for the three-month periods ended June 30, 2023 and 2022 as filed on SEDAR&#59;</font></div><div style="padding-left:90pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.02pt">the audited annual consolidated financial statements of Small Pharma, together with the notes thereto, as at and for the year ended February 28, 2023 as filed on SEDAR, and </font></div><div style="padding-left:90pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.02pt">the unaudited interim consolidated financial statements of Small Pharma, together with the notes thereto, as at and for the three-month periods ended May 31, 2023 and 2022 as filed on SEDAR&#59;</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pro Forma Consolidated Financial Statements are based on Cybin&#8217;s historical consolidated financial statements as well as Small Pharma&#8217;s historical consolidated financial statements, as adjusted to give effect to the Transaction. </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited pro forma consolidated statement of financial position as at June 30, 2023 has been prepared as if the acquisition of Small Pharma has occurred on June 30, 2023. The unaudited pro forma consolidated statements of income and loss for the year ended March 31, 2023, and three-month period ended June 30, 2023, have been prepared to give effect to the acquisition of Small Pharma as if it had occurred on April 1, 2022.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The historical consolidated financial information of Cybin and Small Pharma are presented in accordance with the International Financial Reporting Standards (&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IFRS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and therefore, there were no significant adjustments to Small Pharma&#8217;s consolidated financial statements to conform to Cybin&#8217;s accounting framework. The assumptions and estimates underlying the adjustments to the Pro Forma Consolidated Financial Statements are described in the accompanying notes, which should be read together with the Pro Forma Consolidated Financial Statements. These Pro Forma Consolidated Financial Statements have been prepared by Management of Cybin in accordance with IFRS on a consistent basis with those disclosed in Note 2 of Cybin&#8217;s consolidated financial statements as at and for the year ended March 31, 2023 and Note 2 to Cybin&#8217;s condensed interim consolidated financial statements as at and for the three-month period ended June 30, 2023.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing the Pro Forma Consolidated Financial Statements, Management reviewed Small Pharma&#8217;s accounting policies and financial statement presentation to identify any differences between Cybin&#8217;s and Small Pharma&#8217;s IFRS accounting policies and financial statement presentation. Certain historical balances have been reclassified to conform to Cybin&#8217;s financial statement presentation and for the purposes of the pro forma presentation. Additional accounting policy and financial statement presentation differences may be identified after the filing of this circular as more information is obtained by Cybin, and therefore these adjustments are subject to change. </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:92.16pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CYBIN INC.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NOTES TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Expressed in thousands of Canadian dollars except for share and option amounts and share and option prices)</font></div><div><font><br></font></div></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is management&#8217;s opinion that the Pro Forma Consolidated Financial Statements have been prepared within acceptable limits of materiality, using accounting policies consistent with IFRS appropriate in the circumstances. The Pro Forma Consolidated Financial Statements are not intended to reflect the consolidated financial position and consolidated financial performance of the companies which would have actually resulted had the Transaction been affected on the dates indicated. Actual amounts recorded upon consummation of the Transaction will differ from those recorded in the Pro Forma Consolidated Financial Statements and the differences may be material.  Management has not made any fair value adjustment allocation to the value of the acquired assets and liabilities on the balance sheet of Small Pharma due to the uncertainty with respect to the measurement of amounts at this time.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;ADJUSTMENTS TO SMALL PHARMA&#8217;S FINANCIAL STATEMENTS</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassifications to Small Pharma&#8217;s consolidated income statement for three-month period ending June 30, 2023 include&#58;</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Presentation of investor and public relations as general and administrative costs</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Presentation of consulting fees as general and administrative costs</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Presentation of depreciation as general and administrative costs</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Presentation of directors&#8217; fees as general and administrative costs</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e)&#160;&#160;&#160;&#160;Presentation of office and miscellaneous as general and administrative costs</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f)&#160;&#160;&#160;&#160;Presentation of professional fees as general and administrative costs</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g)&#160;&#160;&#160;&#160;Presentation of occupancy costs as general and administrative costs</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h)&#160;&#160;&#160;&#160;Presentation of transfer agent and filing fees as general and administrative costs</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i)&#160;&#160;&#160;&#160;Presentation of research and development as research</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">j)&#160;&#160;&#160;&#160;Presentation of foreign exchange loss as foreign currency translation gain (loss)</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">k)&#160;&#160;&#160;&#160;Presentation of share-based payment expense to share-based compensation</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l)&#160;&#160;&#160;&#160;Presentation of salaries and benefits as follows&#58;</font></div><div style="padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.&#160;&#160;&#160;&#160;General and administrative costs&#58; $1,131</font></div><div style="padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.&#160;&#160;&#160;&#160;Research&#58; $455</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassifications to the Small Pharma&#8217;s consolidated income statement for the twelve-month period ended March 31, 2023 include&#58;</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">m)&#160;&#160;&#160;&#160;Presentation of investor and public relations as general and administrative costs</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n)&#160;&#160;&#160;&#160;Presentation of consulting fees as general and administrative costs</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o)&#160;&#160;&#160;&#160;Presentation of depreciation as general and administrative costs</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">p)&#160;&#160;&#160;&#160;Presentation of directors&#8217; fees as general and administrative costs</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">q)&#160;&#160;&#160;&#160;Presentation of office and miscellaneous as general and administrative costs</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r)&#160;&#160;&#160;&#160;Presentation of professional fees as general and administrative costs</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s)&#160;&#160;&#160;&#160;Presentation of occupancy costs as general and administrative costs</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t)&#160;&#160;&#160;&#160;Presentation of transfer agent and filing fees as general and administrative costs</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">u)&#160;&#160;&#160;&#160;Presentation of research and development as research</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v)&#160;&#160;&#160;&#160;Presentation of foreign exchange loss as foreign currency translation gain (loss)</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">w)&#160;&#160;&#160;&#160;Presentation of share-based payment expense to share-based compensation</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x)&#160;&#160;&#160;&#160;Presentation of salaries and benefits as follows&#58;</font></div><div style="padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.&#160;&#160;&#160;&#160;General and administrative costs&#58; $3,867</font></div><div style="padding-left:90pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.&#160;&#160;&#160;&#160;Research&#58; $2,008</font></div><div><font><br></font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:92.16pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CYBIN INC.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NOTES TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Expressed in thousands of Canadian dollars except for share and option amounts and share and option prices)</font></div><div><font><br></font></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;FAIR VALUE OF CONSIDERATION TRANSFERRED</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is an estimate of the number of Cybin common shares that are to be issued in exchange for Small Pharma common shares&#58;</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.489%"><tr><td style="width:1.0%"></td><td style="width:54.126%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.674%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Small Pharma common shares outstanding as at May 31, 2023</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,562,487</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Small Pharma options exercised prior to the Transaction</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1,2</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,720,150</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Small Pharma common shares to be converted</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336,282,637</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion Ratio</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2409</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cybin common shares to be issued</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,010,487</font></td></tr></table></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Refer to note 7 for additional details surrounding Small Pharma&#8217;s options.</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">As of the date of the circular, 2,891,300 of the 14,720,150 Small Pharma options have already been exercised, leaving an estimated 11,828,850 Small Pharma options remaining to be exercised prior to the Transaction. </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purpose of determining the number of Small Pharma options exercised prior to the Transaction, the implied consideration of $0.10 per Small Pharma common share based on the quoted fair market value of the Cybin common shares on August 25, 2023 was used. Based on the exercise price of the assumed Small Pharma options exercised prior to the Transaction, Small Pharma will receive $411 in cash proceeds. The final number of Cybin common shares to be issued is to be determined as of the closing date of the Transaction.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the purchase price for the Transaction&#58;</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.489%"><tr><td style="width:1.0%"></td><td style="width:48.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cybin common shares to be issued</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,010,487</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of Cybin common shares</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.415</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated purchase price</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$33,619</font></td></tr></table></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Cybin&#8217;s common shares for the purpose of this exercise is based on their quoted fair market value as at August 25, 2023. The final purchase price is to be determined as of the closing date of the Transaction. </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;PRELIMINARY PURCHASE PRICE ALLOCATION</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the preliminary allocation of the purchase price consideration to reflect value of the assets</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">acquired and liabilities assumed at June 30, 2023&#58;</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets acquired and liabilities assumed</font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.693%"><tr><td style="width:1.0%"></td><td style="width:54.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.276%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,563</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Current Assets</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,063</font></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Non-Current Assets</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">590</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL ASSETS</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,653</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:92.16pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CYBIN INC.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NOTES TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Expressed in thousands of Canadian dollars except for share and option amounts and share and option prices)</font></div><div><font><br></font></div></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.693%"><tr><td style="width:1.0%"></td><td style="width:54.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.276%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,687</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease Liabilities</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Current Liabilities</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,002</font></td></tr><tr style="height:4pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease Liabilities</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Non-Current Liabilities</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">233</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL LIABILITIES</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,235</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Assets assumed excluding intangible assets&#47;goodwill</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,418</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangibles&#47;Goodwill on acquisition</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,201</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated purchase price</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,619</font></td></tr></table></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Adjusted to include $411 related to the exercise of Small Pharma options prior to the close of the Transaction</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">For the purpose of the pro forma statements, this amount has been allocated to &#8220;Goodwill&#8221; on the statement of financial position. The split between &#8220;Goodwill&#8221; and &#8220;Intangible Assets&#8221; will be determined upon completion of the fair value assessment and the purchase price allocation.  </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Transaction is to be accounted for as a business combination using the acquisition method of accounting in accordance with IFRS 3. Under this method, the assets acquired, and liabilities assumed are to be recorded based on their fair values as of the closing date of the Transaction. In accordance with IFRS 3, the final purchase price allocation will be completed within one year. For the purposes of these Pro Forma Consolidated Financial Statements, Cybin has not made any fair value adjustment allocation to the value of the acquired assets and liabilities on the balance sheet of Small Pharma given the uncertainty with respect to the measurement of fair value amounts at this time. Therefore, the difference between the purchase price and the net assets has been allocated to intangible assets and goodwill on acquisition. Cybin expects that a significant portion of the unallocated purchase price will be allocated among intangible assets and goodwill. Intangible assets acquired primarily include in-process research and development and patents, and goodwill is calculated as the excess of the preliminary estimate of the acquisition-date fair value of the consideration transferred, over the preliminary estimate of the fair values assigned to the identifiable assets acquired and liabilities assumed. The actual purchase accounting adjustments are to be finalized once Cybin has completed detailed valuations and necessary calculations and may differ materially from the adjustment reflected in the Ppro Forma Consolidated Financial Statements.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;PRO FORMA ADJUSTMENTS</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Additional Transaction costs of $5,250 have been charged to deficit and presented as a reduction of cash. These are comprised as follows&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;Cybin Inc. professional fees of $400&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;Small Pharma professional fees of $2,350&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;Additional closing costs of $2,500</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Reflects the elimination of historical equity balances of Small Pharma as at June 30, 2023.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:92.16pt;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CYBIN INC.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NOTES TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Expressed in thousands of Canadian dollars except for share and option amounts and share and option prices)</font></div><div><font><br></font></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;PRO FORMA OPTIONS RESERVE </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.640%"><tr><td style="width:1.0%"></td><td style="width:63.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.920%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Options</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cybin option reserve as at June 30, 2023</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,980,425</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,383</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Small Pharma option reserve as at May 31, 2023</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,596,400</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,233</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma adjustment for Small Pharma options exercised and cancelled</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,596,400)</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,233)</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pro forma consolidated option reserve as at June 30, 2023</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40,980,425</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28,383</font></td></tr></table></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately prior to the closing of the Transaction, each in-the-money Small Pharma option outstanding (whether vested or unvested) are to be deemed to be exercised and surrendered to Small Pharma for cancellation and the holders thereof are to receive common shares of Cybin for each option at the conversion ratio of 0.2409. Each out-of-the-money Small Pharma option outstanding immediately prior to the closing of the Transaction, is to be, and is to be deemed to be, surrendered to Small Pharma for cancellation and the holders thereof are to receive, in respect of each such surrendered out-of-the-money Small Pharma option, a cash payment from the Small Pharma equal to $0.001 per out-of-the-money Small Pharma option.&#160;</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:18pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-10</font></div><div><font><br></font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_52"></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SCHEDULE G<br>STATEMENT OF CORPORATE GOVERNANCE PRACTICES</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.690%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Governance Disclosure Requirement Under the Corporate Governance National Instrument 58-101 (&#8220;NI 58-101&#8221;)</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comments</font></td></tr><tr><td colspan="6" style="background-color:#dbdbdb;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Board of Directors</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:13.5pt;padding-right:2.75pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:6.75pt">Board of Directors&#8212;Disclose how the Cybin Board of facilitates its exercise of independent supervision over management, including (i) the identity of directors that are independent, and (ii) the identity of directors who are not independent, and the basis for that determination.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Cybin Board currently consists of a total of six directors of which Messrs. Eric Hoskins, Grant Froese, Mark Lawson and Ms. Theresa Firestone are considered &#8220;independent&#8221; as such term is defined in NI 58-101. </font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Messrs. Eric So and Paul Glavine are not considered independent as they are executive officers of Cybin.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.  Directorships&#8212;If a director is presently a director of any other issuer that is a reporting issuer (or the equivalent) in a jurisdiction or a foreign jurisdiction, identify both the director and the other issuer.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Please refer to the Circular under the heading &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Other Matters to be Acted Upon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Election of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8221; in the Circular.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.  Disclose whether or not the independent directors hold regularly scheduled meetings at which non-independent directors and members of management are not in attendance. If the independent directors hold such meetings, disclose the number of meetings held since the beginning of Corporation&#8217;s most recently completed financial year. If the independent directors do not hold such meetings, describe what the Cybin Board does to facilitate open and candid discussion among its independent directors.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">As of 2022, the independent directors hold at least two meetings annually at which non-independent directors and members of management are not in attendance. During the financial year ended March 31, 2023, three meetings were held. In addition, the independent directors hold an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">in camera</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> session at most meetings of the Cybin Board. </font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior to 2022, as part of their regularly scheduled meetings, the Cybin Board and Audit Committee typically held </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">in camera</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> sessions without management present in order to facilitate open and candid discussion.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.  Disclose whether or not the Chair of the Cybin Board is an independent director. If the Cybin Board has a Chair who is an independent director, disclose the identity of the independent Chair, and describe his or her role and responsibilities.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eric So is the Chair of the Cybin Board and is not considered &#8220;independent&#8221;, as such term is defined in NI 58-101, as he is an executive officer of Cybin.</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Theresa Firestone is the Lead Director of the Cybin Board, and is &#8220;independent&#8221; as such term is defined in NI 58-101.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.  Disclose the attendance record of each director for all Board meetings held since the beginning of Cybin&#8217;s most recently completed financial year.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Please refer to the Circular under the heading &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Other Matters to be Acted Upon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Election of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8221;.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.  Disclose the text of the Cybin Board&#8217;s written mandate. If the Cybin Board does not have a written mandate, describe how the Cybin Board delineates its role and responsibilities.</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The directors of the Cybin Board have adopted a formal written mandate which provides that the directors of the Cybin Board are responsible for the overall stewardship of Cybin, establishing the overall policies and standards of Cybin and approving its strategic plans. A copy of the Directors&#8217; Mandate can be found as Schedule I to the Circular.</font></td></tr><tr><td colspan="6" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Position Descriptions</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.  Disclose whether or not the Cybin Board has developed written position descriptions for the Chair and the Chair of each Board committee. If the Cybin Board has not developed written position descriptions for the Chair of each Board committee, briefly describe how the Cybin Board delineates the role and responsibilities of each such position.</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The directors of the Cybin Board have adopted a formal written mandate for the Chair of the Cybin Board and the Lead Director of the Cybin Board, which outlines their respective roles and responsibilities. The Cybin Board has not adopted a formal written mandate for the Chair of the Audit Committee or the Chair of the Corporate Governance and Nominating Committee. The Cybin Board looks to the Chair to lead such committee in accordance with such committee&#8217;s written mandate. &#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.  Describe whether or not the Cybin Board and CEO have developed a written position description for the CEO. If the Cybin Board and the CEO have not developed such a position description, briefly describe how the Cybin Board delineates the role and responsibilities of the CEO.</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Cybin Board has adopted a formal mandate for the CEO which outlines the roles and responsibilities of the CEO, including management of the strategic and operational agenda of Cybin and for execution of the directives and policies of the Cybin Board.</font></td></tr></table></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">G-1</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.690%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Orientation and Continuing Education</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.  Describe what steps, if any, the Cybin Board takes to orient new directors regarding the role of the Cybin Board, its committees, and its directors, and the nature and operation of Cybin&#8217;s business, and describe any measures the Cybin Board takes to provide continuing education for directors.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New members of the Cybin Board participate in an initial program pursuant to which they are provided with&#58; (i) information respecting the functioning of the Cybin Board and its committees and a copy of Cybin&#8217;s corporate governance documents&#59; (ii) access to Cybin&#8217;s documents, including those that are confidential&#59; and (iii) access to management and senior employees of Cybin. The initial orientation program addresses Cybin&#8217;s business, operations, key risks, corporate structure, and matters relevant to Cybin&#8217;s business. Cybin Board members are encouraged to&#58; (i) communicate with management and Cybin&#8217;s auditors&#59; (ii) remain abreast of industry trends and developments, and changes in legislation, with management&#8217;s assistance&#59; and (iii) visit Cybin&#8217;s operations.</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">While each director ultimately assumes responsibility for remaining informed about Cybin&#8217;s business and relevant developments, management assists the directors by providing them with regular updates on relevant developments and other information that management considers of interest to the Cybin Board. Directors may also attend the meetings of committees of the Cybin Board of which they are not active members to broaden their knowledge base and receive additional information on Cybin&#8217;s business and developments in areas where they are not commonly exposed, provided that such attendance would not compromise the independence of such committees.</font></div></td></tr><tr><td colspan="6" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ethical Business Conduct</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.  Disclose whether or not the Cybin Board has adopted a written code for the directors, officers and employees. If the Cybin Board has adopted a written code&#58; (i) disclose how a person or company may obtain a copy of the code, (ii) describe how the Cybin Board monitors compliance with its code, or if the Cybin Board, and (iii) provide a cross-reference to any material change report filed since the beginning of Cybin&#8217;s most recently completed financial year that pertains to any conduct of a director or executive officer that constitutes a departure from the code.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Cybin Board has adopted a formal Code of Business Conduct (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8221;) which highlights key issues and identifies policies and resources to help employees, officers and directors of Cybin reach appropriate and ethical decisions. Cybin&#8217;s compliance officer is responsible for investigating all reported complaints under the Code. A copy of the Code can be obtained by contacting Cybin.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.  Describe the steps the Cybin Board takes to ensure directors exercise independent judgement in considering transactions and agreement in respect of which a director or executive officer has a material interest, and any other steps the Cybin Board takes to encourage and promote a culture of ethical business conduct.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Cybin Board is responsible for promoting an ethical business culture. The Cybin Board monitors compliance, including through receipt by the Audit Committee of reports of unethical behaviour. To ensure that an ethical business culture is maintained and promoted, directors are encouraged to exercise their independent judgment. If a director has a material interest in any transaction or agreement that Cybin proposes to enter into, such director is expected to disclose such interest to the Cybin Board in compliance with the applicable laws, rules and policies which govern conflicts of interest in connection with such transaction or agreement. Further, any director who has a material interest in any proposed transaction or agreement will be excluded from the portion of the Cybin Board meeting concerning such matters and will be further precluded from voting on such matters.</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cybin has appointed an independent Lead Director to provide leadership to the independent directors. In addition to separate meetings of the independent directors, held at least twice annually, the independent directors hold an in camera session at most meetings of the Cybin Board.</font></div></td></tr><tr><td colspan="6" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nomination of Directors</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.  Disclose the process by which the Cybin Board identifies new candidates for Board nomination, including&#58; (i) who identifies new candidates, (ii) the process of identifying new candidates, and (iii) whether or not the Cybin Board has a nominating committee composed entirely of independent directors, and the responsibilities, powers, and operation of such nominating committee.</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Corporate Governance and Nominating Committee is responsible for the identification and assessment of potential directors. While no formal nomination procedures are in place to identify new candidates, the Corporate Governance and Nominating Committee does review the experience and performance of nominees for election to the Cybin Board. Members of the Corporate Governance and Nominating Committee are canvassed with respect to the qualifications of a prospective candidate and each candidate is evaluated with respect to his or her experience and expertise, with particular attention paid to those areas of expertise that could complement and enhance current management. The Corporate Governance and Nominating Committee also assesses any potential conflicts, independence or time commitment concerns that the candidate may present.</font></td></tr></table></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">G-2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.690%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensation</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.  Disclose what steps, if any, are taken to determine compensation for the directors and officers, including&#58; (i) who determines compensation, (ii) the process of determining compensation, and (iii) if the Cybin Board has a compensation committee, the responsibilities, powers, and operation of the compensation committee.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The process undertaken by the Cybin Board and the Compensation Committee in respect of compensation is more fully described in the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Compensation Discussion and Analysis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8221; in the Circular.</font></div></td></tr><tr><td colspan="6" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Board Committees</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.  If the Cybin Board has standing committees other than the audit, compensation and nominating committees, identify the committees and describe their function.</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Cybin Board does not have any standing committees other than the Corporate Governance and Nominating Committee, the Compensation Committee and the Audit Committee.</font></td></tr><tr><td colspan="6" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assessments</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.  Disclose whether or not the Cybin Board, its committees and individual directors are regularly assessed with respect to their effectiveness and contribution. If assessments are regularly conducted, describe the process used for the assessments. If assessments are not regularly conducted, describe how the Cybin Board satisfies itself that the Cybin Board, its committees, and its individual Trustees are performing effectively.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The entire Board will evaluate the effectiveness of the Cybin Board, its committees and individual directors on an annual basis. To facilitate this evaluation, each committee will conduct an annual assessment of its performance, consisting of a review of its charter, the performance of the committee as a whole and the performance of the committee Chair. </font></div></td></tr><tr><td colspan="6" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director Term Limits and Other Mechanisms of Board Renewal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.  Disclose whether Cybin has adopted term limits for the directors on its Board or other mechanisms for Board renewal and, if so, include a description of those director term limits or other mechanisms of Board renewal. If Cybin has not adopted director term limits or other mechanisms of Board renewal, disclose why it has not done so.</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Cybin Board has not adopted a term limit for directors. The Cybin Board believes that the imposition of term limits on a director implicitly discounts the value of experience and continuity amongst Board members and runs the risk of excluding experienced and potentially valuable Board members as a result of an arbitrary determination. The notional objective of term limits is to encourage board turnover, introduce new perspectives and retain independence. Cybin has achieved a satisfactory mix and turnover in directors over its short history, and the Cybin Board believes that it can strike the right balance between continuity and fresh perspectives without mandated term limits.</font></td></tr><tr><td colspan="6" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Policies Regarding the Representation of Women on the Cybin Board</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.  Disclose whether Cybin has adopted a written policy relating to the identification and nomination of women directors. If Cybin has not adopted such a policy, disclose why it has not done so. If Cybin has adopted a policy, disclose a short summary of its objectives and key provisions, the measures taken to ensure that the policy has been effectively implemented, annual and cumulative progress by the issuer in achieving the objectives of the policy, and whether and, if so, how the Cybin Board or its nominating committee measures the effectiveness of the policy.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cybin adopted a written diversity policy (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diversity Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8221;) in 2021 to formalize its approach to diversity. The Diversity Policy sets out the many characteristics of diversity, including gender, age, visible minorities, Indigenous peoples, persons with disabilities, sexual orientation and other personal characteristics. </font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Further, Cybin amended its written corporate governance and nominating committee charter (the &#8220;Corporate Governance and Nominating Committee Charter&#8221;) in June 2022 to affirm Cybin&#8217;s commitment to actively consider all aspects of diversity, including gender, when the Corporate Governance and Nominating Committee makes recommendations to the Cybin Board for the appointment or nomination of new directors.</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cybin has not adopted a specific target regarding the representation of women on the Cybin Board or in executive officer positions however, it is an objective of the Diversity Policy and Corporate Governance and Nominating Committee Charter that diversity be considered in determining the optimal composition of the Cybin Board. The Diversity Policy and Corporate Governance and Nominating Committee Charter sets out guidelines for the Corporate Governance and Nominating Committee to find the best qualified candidates for Board positions recognizing that the Cybin Board&#8217;s background should represent a variety of backgrounds, experiences and skills. </font></div></td></tr></table></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">G-3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.690%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consideration of the Representation of Women in the Director Identification and Selection Process</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.  Disclose whether and, if so, how the Cybin Board or nominating committee considers the level of representation of women on the Cybin Board in identifying and nominating candidates for election or re-election to the Cybin Board. If Cybin does not consider the representation of women on the Cybin Board in identifying and nominating candidates for election or re-election to the Cybin Board, disclose Cybin&#8217;s reasons for not doing so.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">It is an objective of the Diversity Policy and Corporate Governance and Nominating Committee Charter that diversity be considered in connection with the identification and nomination of female Board members. Gender diversity is an important factor that is taken into account in identifying and selecting Board members. The Cybin Board believes that diversity is important to ensure that directors provide a wide range of perspectives, experience and expertise required to achieve effective stewardship of Cybin.</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Diversity Policy and Corporate Governance and Nominating Committee Charter do not include a target number or percentage of women on the Cybin Board. The Corporate Governance and Nominating Committee does not believe that targets are appropriate since gender diversity is only one of several characteristics considered during the selection process for Board nominees. Instead, the Corporate Governance and Nominating Committee believes that a method for reviewing Board nominees on a variety of factors, including diversity, is more appropriate. </font></div></td></tr><tr><td colspan="6" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consideration Given to the Representation of Women in Executive Officer Appointments</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.  Disclose whether and, if so, how the issuer considers the level of representation of women in executive officer positions when making executive officer appointments. If Cybin does not consider the level of representation of women in executive officer positions when making executive officer appointments, disclose Cybin&#8217;s reasons for not doing so.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">It is an objective of the Diversity Policy that diversity be considered in connection with the identification and nomination of female candidates for executive positions. Gender diversity is an important factor that is taken into account in considering the hiring, promotion and appointment of executive officers. The Cybin Board believes that diversity is important to ensure that executives provide a wide range of perspectives, experience and expertise required to achieve effective stewardship of Cybin.</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Diversity Policy does not include a target number or percentage of women in executive management positions. The Corporate Governance and Nominating Committee does not believe that targets are appropriate since gender diversity is only one of several characteristics considered during the selection process for executive officers. Instead, the Corporate Governance and Nominating Committee believes that a method for reviewing executive officers on a variety of factors, including diversity, is more appropriate.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20. Disclose whether Cybin has adopted a target regarding women on the Cybin Board or in executive officer positions. If Cybin has not adopted a target, disclose why it has not done so. If Cybin has adopted a target, disclose the target, and the annual and cumulative progress of Cybin in achieving the target.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cybin has not adopted a target regarding women on the Cybin Board or in executive officer positions. </font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Diversity Policy does not include a target number or percentage of women in executive management positions. The Corporate Governance and Nominating Committee does not believe that targets are appropriate since gender diversity is only one of several characteristics considered during the selection process for executive officers. Instead, the Corporate Governance and Nominating Committee believes that a method for reviewing executive officers on a variety of factors, including diversity, is more appropriate.</font></div></td></tr><tr><td colspan="6" style="background-color:#dbdbdb;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Women on the Cybin Board and in Executive Officer Positions</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:14.95pt;padding-right:2.75pt;text-indent:-12.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21. Disclose the number and proportion (in percentage terms) of (i) directors on Cybin&#8217;s Board, and (ii) executive officers of Cybin, who are women.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currently, one (17%) of the six directors of the Cybin Board identifies as a woman and one (11%) of nine executive officers of Cybin identifies as a woman.</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">G-4</font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_55"></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE H<br>AUDIT COMMITTEE CHARTER</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Implemented pursuant to National Instrument 52-110 &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Audit Committees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">National Instrument 52-110 &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Audit Committees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Instrument</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) relating to the composition and function of audit committees was implemented for reporting issuers and, accordingly, applies to every NEO Exchange listed company, including Cybin. The Instrument requires all affected issuers to have a written audit committee charter which must be disclosed, as stipulated by Form 52-110F2, in the management information circular of the Corporation wherein management solicits proxies from the security holders of the Corporation for the purpose of electing directors to the board of directors.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Charter has been adopted by the board of directors in order to comply with the Instrument and to more properly define the role of the Committee in the oversight of the financial reporting process of the Corporation. Nothing in this Charter is intended to restrict the ability of the board of directors or Committee to alter or vary procedures in order to comply more fully with the Instrument, as amended from time to time.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PART 1</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.1&#160;&#160;&#160;&#160;Purpose&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the Committee is to&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;improve the quality of the Corporation&#8217;s financial reporting&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;assist the board of directors to properly and fully discharge its responsibilities&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;provide an avenue of enhanced communication between the directors and external auditors&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;enhance the external auditor&#8217;s independence&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;increase the credibility and objectivity of financial reports&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;strengthen the role of the directors by facilitating in depth discussions between directors, management and external auditors.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.2&#160;&#160;&#160;&#160;Definitions</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">accounting principles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning ascribed to it in National Instrument 52-107 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acceptable Accounting Principles and Auditing Standards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Corporation that is a subsidiary of another Corporation or companies that are controlled by the same entity&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">audit services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the professional services rendered by the Corporation&#8217;s external auditor for the audit and review of the Corporation&#8217;s financial statements or services that are normally provided by the external auditor in connection with statutory and regulatory filings or engagements&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Charter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means this audit committee charter&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the committee established by and among certain members of the board of directors for the purpose of overseeing the accounting and financial reporting processes of the Corporation and audits of the financial statements of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Control Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any individual or company that holds or is one of a combination of individuals or companies that holds a sufficient number of any of the securities of the Corporation so as to affect materially the control of the Corporation, </font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">H-1</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or that holds more than 20% of the outstanding voting shares of the Corporation except where there is evidence showing that the holder of those securities does not materially affect the control of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">financially literate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Section 1.3&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">immediate family member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an individual&#8217;s spouse, parent, child, sibling, mother or father-in-law, son or daughter-in-law, brother or sister-in-law, and anyone (other than an employee of either the individual or the individual&#8217;s immediate family member) who shares the individual&#8217;s home&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">independent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means independent only as determined by both the Instrument and the NEO Exchange Listing Manual&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Instrument</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means National Instrument 52-110 &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Audit Committees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MD&#38;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning ascribed to it in National Instrument 51-102&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a member of the Committee&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">National Instrument 51-102</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means National Instrument 51-102 &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Continuous Disclosure Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">non-audit services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means services other than audit services.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.3&#160;&#160;&#160;&#160;Meaning of Financially Literate</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of this Charter, an individual is financially literate if he or she has the ability to read and understand a set of financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of the issues that can reasonably be expected to be raised by the Corporation&#8217;s financial statements.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PART 2</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.1&#160;&#160;&#160;&#160;Audit Committee</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The board of directors has hereby established the Committee for, among other purposes, compliance with the Instrument.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.2&#160;&#160;&#160;&#160;Relationship with External Auditors</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporation will require its external auditor to report directly to the Committee and the Members shall ensure that such is the case.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.3&#160;&#160;&#160;&#160;Committee Responsibilities</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Committee shall be responsible for making the following recommendations to the board of directors&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the external auditor to be nominated for the purpose of preparing or issuing an auditor&#8217;s report or performing other audit, review or attest services for the Corporation&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the compensation of the external auditor.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The Committee shall be directly responsible for overseeing the work of the external auditor engaged for the purpose of preparing or issuing an auditor&#8217;s report or performing other audit, review or attest services for the Corporation, including the resolution of disagreements between management and the external auditor regarding financial reporting. This responsibility shall include&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;reviewing the audit plan with management and the external auditor&#59;</font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">H-2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;reviewing with management and the external auditor any proposed changes in major accounting policies, the presentation and impact of significant risks and uncertainties, and key estimates and judgements of management that may be material to financial reporting&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;questioning management and the external auditor regarding significant financial reporting issues discussed during the fiscal period and the method of resolution&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;reviewing any problems experienced by the external auditor in performing the audit, including any restrictions imposed by management or significant accounting issues on which there was a disagreement with management&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;reviewing audited annual financial statements, in conjunction with the report of the external auditor, and obtaining an explanation from management of all significant variances between comparative reporting periods&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;reviewing the post-audit or management letter, containing the recommendations of the external auditor, and management&#8217;s response and subsequent follow up to any identified weakness&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;reviewing interim unaudited financial statements before release to the public&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;reviewing all public disclosure documents containing audited or unaudited financial information before release, including any prospectus, the annual report and management&#8217;s discussion and analysis&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;reviewing the evaluation of internal controls by the external auditor, together with management&#8217;s response&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;reviewing the terms of reference of the internal auditor, if any&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;reviewing the reports issued by the internal auditor, if any, and management&#8217;s response and subsequent follow up to any identified weaknesses&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;reviewing the appointments of the chief financial officer and any key financial executives involved in the financial reporting process, as applicable.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;The Committee shall pre-approve all non-audit services to be provided to the Corporation or its subsidiary entities by the issuer&#8217;s external auditor.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;The Committee shall review the Corporation&#8217;s financial statements, MD&#38;A, and annual and interim earnings press releases before the Corporation publicly discloses this information.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;The Committee shall ensure that adequate procedures are in place for the review of the Corporation&#8217;s public disclosure of financial information extracted or derived from the Corporation&#8217;s financial statements, and shall periodically assess the adequacy of those procedures.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;When there is to be a change of auditor, the Committee shall review all issues related to the change, including the information to be included in the notice of change of auditor called for under National Instrument 51-102, and the planned steps for an orderly transition.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)&#160;&#160;&#160;&#160;The Committee shall review all reportable events, including disagreements, unresolved issues and consultations, as defined in National Instrument 51-102, on a routine basis, whether or not there is to be a change of auditor.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)&#160;&#160;&#160;&#160;The Committee shall, as applicable, establish procedures for&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the receipt, retention and treatment of complaints received by the issuer regarding accounting, internal accounting controls, or auditing matters&#59; and</font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">H-3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the confidential, anonymous submission by employees of the issuer of concerns regarding questionable accounting or auditing matters.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)&#160;&#160;&#160;&#160;As applicable, the Committee shall establish, periodically review and approve the Corporation&#8217;s hiring policies regarding partners, employees and former partners and employees of the present and former external auditor of the issuer.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)&#160;&#160;&#160;&#160;The responsibilities outlined in this Charter are not intended to be exhaustive. Members should consider any additional areas which may require oversight when discharging their responsibilities.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.4&#160;&#160;&#160;&#160;De Minimis Non-Audit Services</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee shall satisfy the pre-approval requirement in subsection 2.3(3) if&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the aggregate amount of all the non-audit services that were not pre-approved is reasonably expected to constitute no more than five per cent of the total amount of fees paid by the issuer and its subsidiary entities to the issuer&#8217;s external auditor during the financial year in which the services are provided&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Corporation or the subsidiary of the Corporation, as the case may be, did not recognize the services as non-audit services at the time of the engagement&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;the services are promptly brought to the attention of the Committee and approved by the Committee or by one or more of its Members to whom authority to grant such approvals has been delegated by the Committee, prior to the completion of the audit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.5&#160;&#160;&#160;&#160;Delegation of Pre-Approval Function</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Committee may delegate to one or more independent Members the authority to pre-approve non-audit services in satisfaction of the requirement in subsection 2.3(3).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The pre-approval of non-audit services by any Member to whom authority has been delegated pursuant to subsection 2.5(1) must be presented to the Committee at its first scheduled meeting following such pre-approval.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PART 3</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.1&#160;&#160;&#160;&#160;Composition </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Committee shall be composed of a minimum of three Members.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Every Member shall be a director of the issuer.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Every Member shall be independent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;Every Member shall be financially literate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;The board of directors of the Corporation shall appoint or re-appoint the Members after each annual meeting of shareholders of the Corporation.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PART 4</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.1&#160;&#160;&#160;&#160;Authority</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the replacement of this Charter, the Committee shall have the authority to&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;engage independent counsel and other advisors as it determines necessary to carry out its duties&#59;</font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">H-4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;set and pay the compensation for any advisors employed by the Committee&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;communicate directly with the internal and external auditors&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;recommend the amendment or approval of audited and interim financial statements to the board of directors.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PART 5</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.1&#160;&#160;&#160;&#160;Required Disclosure</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporation must include in its Annual Information Form the disclosure required by Form 52-110F1.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.2&#160;&#160;&#160;&#160;Disclosure in Information Circular</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If management of the Corporation solicits proxies from the security holders of the Corporation for the purpose of electing directors to the board of directors, the Corporation shall include in its management information circular a cross-reference to the sections in the Corporation&#8217;s Annual Information Form that contain the information required by section 5.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PART 6</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.1&#160;&#160;&#160;&#160;Meetings</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Meetings of the Committee shall be scheduled to take place at regular intervals and, in any event, not less frequently than quarterly.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Opportunities shall be afforded periodically to the external auditor, the internal auditor and to members of senior management to meet separately with the Members.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Minutes shall be kept of all meetings of the Committee.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">H-5</font></div></div></div><div id="i03495151b60d4686a1ed76df16c56576_58"></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE I<br>DIRECTORS&#8217; MANDATE</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CYBIN INC.<br>(the &#8220;Corporation&#8221;)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DIRECTORS&#8217; MANDATE</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">November 2020</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors&#8217; Responsibilities</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The board of directors of the Corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) are responsible for the stewardship of the Corporation. To discharge this obligation, the Directors, directly and through the applicable committees of the Directors, should assume responsibility in the following areas&#58; </font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strategic Planning Process</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provide input to management on emerging trends and issues.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adopt, review and approve, if appropriate, management&#8217;s strategic plans on an annual basis.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Review and approve the Corporation&#8217;s financial objectives, plans and actions, including significant capital allocations and expenditures.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Monitoring Tactical Progress</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Monitor corporate performance against the strategic and business plans, including assessing operating results to evaluate whether the business is being properly managed.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Assessment</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identify the principal risks of the Corporation&#8217;s businesses and ensure that appropriate systems are in place to manage these risks.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Level Staffing</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Select, monitor and evaluate the Chief Executive Officer and approve the appointment of other senior executives, and ensure the adoption of a management succession plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approve a position description for the Chief Executive Officer including limits to management&#8217;s responsibilities and corporate objectives which the Chief Executive Officer is responsible for meeting, all upon recommendation from the Corporate Governance and Nominating Committee.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Satisfy itself as to the integrity of the Chief Executive Officer and other executive officers.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Satisfy itself that the Chief Executive Officer and other executive officers create, maintain and foster a culture of integrity throughout the Corporation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Engage in succession planning including, identifying, training and monitoring future senior management.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Integrity</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ensure the integrity of the Corporation&#8217;s internal control and management information systems.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ensure ethical behaviour and compliance with laws and regulations, audit and accounting principles, and the Corporation&#8217;s own governing documents.</font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I-1</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:56.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Satisfy itself as to the integrity of the Chief Executive Officer and other executive officers and that the Chief Executive Offer and other executive officers create a culture of integrity throughout the organization.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Material Transactions</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Review and approve material transactions not in the ordinary course of business, including without limitation, stock issuances, acquisitions, loans and leases.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Monitoring Directors&#8217; Effectiveness</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assess their own effectiveness in fulfilling the above and Directors&#8217; responsibilities, including monitoring the effectiveness of individual Directors.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Policy and Code of Business Conduct</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adopt, monitor and periodically review the effectiveness of a corporate disclosure policy and a code of business conduct.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Make determinations with respect to waiving compliance with the code of business conduct by Directors and executive officers.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Directors may delegate responsibility for making determinations with respect to waiving compliance with the code of business conduct to a committee of the Directors. </font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Feedback from Shareholders</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Develop measures for the receipt, by the Directors, of feedback from shareholders.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expectations of Directors</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directors are expected to attend all meetings.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The specific dates of Board meetings to approve interim and annual financial results shall be scheduled at the commencement of each fiscal year.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional meetings of the Directors shall be called on an as-required basis.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directors are expected to review materials to be presented at the meetings of the Directors prior to such meetings. Such materials are to be circulated with sufficient advanced notice to allow the Directors adequate review time. However, for unscheduled meetings, shorter notice may be necessary.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Governance</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Develop the Corporation&#8217;s approach to corporate governance, including developing a set of corporate governance principles and guidelines that are specifically applicable to the Corporation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#183;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Directors may delegate this responsibility to a committee of the Directors, which committee shall have a majority of &#8220;Independent&#8221; directors (as such term is defined in National Policy 58-201 &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Governance Guidelines</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and the remaining members of which, if any, shall be &#8220;non-management&#8221; directors.</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Perform such other functions as prescribed by law or assigned to the Directors in the Corporation&#8217;s constating documents, policies and guideline.</font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I-2</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>noticeofmeeting.htm
<DESCRIPTION>EX-99.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i7f5235bdbf2d45d78e9f9420c974be59_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CYBIN INC.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NOTICE IS HEREBY GIVEN</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> that an annual and special meeting (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) of the holders (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cybin Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) of common shares (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cybin Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) in the capital of Cybin Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cybin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) will be held in a virtual-only format via live audio webcast on Thursday, October 12, 2023 at 1&#58;00 p.m. (Toronto time), to conduct the following business&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to consider, and if deemed advisable, to approve, with or without variation, an ordinary resolution (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Acquisition Resolution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) authorizing and approving the acquisition of Small Pharma Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Small Pharma</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) by way of a proposed plan of arrangement under the Business Corporations Act (British Columbia) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) involving Cybin and Small Pharma, pursuant to the terms and subject to the conditions of the arrangement agreement dated August 28, 2023 between Cybin and Small Pharma (for further information, please see the sections entitled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Background to the Arrangement &#38; Recommendations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">The Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">The Arrangement Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; in the Circular (as defined herein))&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to receive the audited consolidated financial statements of Cybin as at and for the years ended March 31, 2023 and 2022, together with the report of the auditors thereon&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to appoint Zeifmans LLP as Cybin&#8217;s auditors and to authorize the directors to fix their remuneration (for further information, please see the section entitled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Matters to be Acted Upon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Appointment and Remuneration of Auditors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; in the Circular)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to determine the number of directors to be elected to be six (for further information, please see the section entitled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Matters to be Acted Upon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Election of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; in the Circular)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to elect directors to Cybin&#8217;s board of directors (for further information, please see the section entitled &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Matters to be Acted Upon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Election of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; in the Circular) (items 3 to 5 being, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cybin Annual Resolutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accompanying this Notice of Annual and Special Meeting of Shareholders is the management information circular of Cybin dated September 13, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Circular</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), which provides specific details of the business to be considered at the Meeting, a form of proxy for Cybin Shareholders and a financial statement request card. The full text of the Acquisition Resolution is set out in Schedule A to the Circular. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">If the Arrangement is not completed, the Cybin Shares referred to in the Acquisition Resolution will not be issued, even if the Acquisition Resolution is approved at the Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The board of directors of Cybin unanimously recommends that Cybin Shareholders </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">VOTE FOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> the Acquisition Resolution and the Cybin Annual Resolutions. It is a condition to the completion of the Arrangement that the Acquisition Resolution be approved at the Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Meeting will be held in a virtual meeting format only via live webcast online. You must register at https&#58;&#47;&#47;register.proxypush.com&#47;cybn. Upon completing your registration, you will receive further instructions via email, including a unique link that will allow you access to the Meeting. Cybin Shareholders and duly appointed proxyholders will be able to attend the Meeting (virtually), submit questions and vote by online ballot, provided they are connected to the internet and follow the instructions in the Circular. On the day of the meeting, Cybin Shareholders may begin to log in to the virtual-only Meeting 15 minutes prior to the Meeting. The Meeting will begin promptly at 1&#58;00 p.m. (Toronto time).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A Cybin Shareholder wishing to be represented by proxy at the Meeting or any adjournment thereof must deposit their duly executed form of proxy with Cybin&#8217;s transfer agent and registrar, Odyssey Trust Company, (a) by mail at Attn&#58; Proxy Department, 67 Yonge Street, Suite 702, Toronto, Ontario M5E 1J8, or (b) by voting online at http&#58;&#47;&#47;vote.odysseytrust.com, and entering their 12 digit control number by no later than 1&#58;00 p.m. (Toronto time) on Tuesday, October 10, 2023 or if the Meeting is adjourned, not less than 24 hours (excluding Saturdays, Sundays and holidays) before the time set for any reconvened meeting at which the proxy is to be used.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cybin Shareholders who wish to appoint a person other than the management nominees identified in the form of proxy to participate at the Meeting as their proxy and vote their Cybin Shares, must deposit their proxy appointing such third party proxyholder AND complete the additional step of registering the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">proxyholder by emailing Odyssey Trust Company at appointee&#64;odysseytrust.com by no later than 1&#58;00 p.m. (Toronto time) on Tuesday, October 10, 2023, or if the Meeting is adjourned, not less than 24 hours (excluding Saturdays, Sundays and holidays) before the time set for any reconvened meeting at which the proxy is to be used, and provide Odyssey Trust Company with the required proxyholder contact information, the number of Cybin Shares appointed and the name in which the Cybin Shares are registered, so that Odyssey Trust Company may provide the proxyholder with credentials via email. Failure to register the proxyholder with Odyssey Trust Company will result in the proxyholder not receiving login credentials to participate at the Meeting and not being able to attend, participate or vote at the Meeting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The record date for the purposes of determining the Cybin Shareholders entitled to receive notice of and to vote at the Meeting and any adjournment(s) or postponement(s) is the close of business on August 30, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Record Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). The Cybin Shareholders of record as of the close of business on the Record Date will be entitled to receive this Notice of the Annual and Special Meeting of Shareholders and the accompanying Circular and to (virtually) attend and vote at the Meeting and any adjournment(s) or postponement(s) thereof. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DATED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> at Toronto, Ontario on September 13, 2023.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="padding-left:270.8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.307%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BY ORDER OF THE BOARD</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Eric So&#8221;</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eric So </font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chair and President</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>cybin-finalproxyformasm2.htm
<DESCRIPTION>EX-99.3
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>cybin-finalproxyformasm2</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1365;"><!-- cybin-finalproxyformasm2001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="cybin-finalproxyformasm2001.jpg" title="slide1" width="1365" height="1055">
<DIV><FONT size="1" style="font-size:1pt;color:white">CYBIN INC.  Form of Proxy &#8211; Annual and Special Meeting to be held on October 12, 2023 Trader&#8217;s Bank Building 702, 67 Yonge Street Toronto ON M5E 1J8  Appointment of Proxyholder  I/We being the undersigned holder(s) of common shares of Cybin Inc. (&#8220;Cybin&#8221;) hereby  appoint Eric So, Chair and President, or failing this person, Gabriel Fahel, Chief Legal  Officer (the &#8220;Management Nominees&#8221;) OR  Print the name of the person you are appointing if this person is  someone other than the Management Nominees listed herein then  register the proxy appointment by emailing  appointee@odysseytrust.com:  as my/our proxyholder with full power of substitution and to attend, act, and to vote for and on behalf of the holder in accordance with the following direction (or if no directions have  been given, as the proxyholder sees fit) and all other matters that may properly come before the Annual and Special Meeting of Cybin to be held virtually via live audio webcast on  Thursday, October 12, 2023  at 1:00 p.m. (Toronto Time) or at any adjournment thereof (the &#8220;Meeting&#8221;). Registration is required online at https://register.proxypush.com/cybn.  1. Acquisition Resolution. To consider, and if deemed advisable, to approve, with or without variation, an ordinary resolution (the &#8220;Acquisition Resolution&#8221;) authorizing and approving the acquisition of Small Pharma Inc. (&#8220;Small Pharma&#8221;) by way of a proposed plan of arrangement under the Business Corporations  Act (British Columbia), pursuant to the terms and subject to the conditions of the arrangement agreement between Cybin and Small Pharma dated August 28, 2023. The full text of the Acquisition Resolution is set out as Schedule &#8220;A&#8221; to the management information circular of Cybin dated September 13, 2023. For    Against 2. Appointment of Auditors. To appoint Zeifmans LLP as Cybin&#8217;s auditors and to authorize the directors to fix their remuneration. For    Withhold 3. Number of Directors.  To fix the number of directors at six (6). For    Against 4. Election of Directors. For     Withhold For     Withhold For     Withhold  a. Theresa Firestone b. Grant Froese c. Paul Glavine d. Eric Hoskins e. Mark Lawson f. Eric So Authorized Signature(s) &#8211; This section must be completed for your instructions  to be executed.  I/we authorize you to act in accordance with my/our instructions set out above.  I/We hereby  revoke any proxy previously given with respect to the Meeting.  If no voting instructions are  indicated above, this Proxy will be voted as recommended by Management.  Signature(s): Date  MM / DD / YY  Interim Financial Statements &#8211; Check the box to the right if you would like to  receive interim financial statements and accompanying Management&#8217;s Discussion  &amp; Analysis by mail. See reverse for instructions to sign up for delivery by email.  Annual Financial Statements &#8211; Check the box to the right if you would like to RECEIVE  the Annual Financial Statements and accompanying Management&#8217;s Discussion and Analysis  by mail. See reverse for instructions to sign up for delivery by email.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- cybin-finalproxyformasm2002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="cybin-finalproxyformasm2002.jpg" title="slide2" width="1365" height="1055">
<DIV><FONT size="1" style="font-size:1pt;color:white">INSTEAD OF MAILING THIS PROXY, YOU MAY SUBMIT YOUR  PROXY USING SECURE ONLINE VOTING AVAILABLE ANYTIME: This form of proxy is solicited by and on behalf of Management. Proxies must be received by 1:00 p.m., Toronto Time, on Tuesday,  October 10, 2023. Notes to Proxy 1. Each holder has the right to appoint a person, who need not be a holder, to attend and  represent them at the Meeting. If you wish to appoint a person other than the Management  Nominees, please insert the name of your chosen proxyholder in the space provided on the  reverse. 2. If the securities are registered in the name of more than one holder (for example, joint  ownership, trustees, executors, etc.) then all of the registered owners must sign this proxy in  the space provided on the reverse. If you are voting on behalf of a corporation or another  individual, you may be required to provide documentation evidencing your power to sign this  proxy with signing capacity stated. 3. This proxy should be signed in the exact manner as the name appears on the proxy. 4. If this proxy is not dated, it will be deemed to bear the date on which it is mailed by  Management to the holder. 5. The securities represented by this proxy will be voted as directed by the holder; however, if  such a direction is not made in respect of any matter, and the holder appoints the  Management Nominees, this proxy will be voted as recommended by Management. 6. The securities represented by this proxy will be voted or withheld from voting, in accordance  with the instructions of the holder, on any ballot that may be called for and, if the holder has  specified a choice with respect to any matter to be acted on, the securities will be voted  accordingly. 7. This proxy confers discretionary authority in respect of amendments to matters identified in  the Notice of Meeting and other matters that may properly come before the Meeting. 8. This proxy should be read in conjunction with the accompanying documentation provided by  Management. To Vote Your Proxy Online please visit: https://login.odysseytrust.com/pxlogin You will require the CONTROL NUMBER printed with your address to  the right. To attend the Meeting, you must register at https://register.proxypush.com/cybn. Upon  completing your registration, you will receive further instructions via email, including a  unique link that will allow you access to the Meeting and to vote and submit questions  during the Meeting. As part of the registration process, you must enter the control number  located on your proxy card. If you vote by Internet, do not mail this proxy. To request the receipt of future documents via email and/or to sign up for Securityholder Online  services, you may contact Odyssey Trust Company at https://odysseytrust.com/ca-en/help/.  Voting by mail may be the only method for securities held in the name of a corporation or securities  being voted on behalf of another individual. A return envelope has been enclosed for voting by mail. </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>5
<FILENAME>a23-19847x2_472766xcybin.htm
<DESCRIPTION>EX-99.4
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>a23-19847x2_472766xcybin</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1048;"><!-- a23-19847x2_472766xcybin001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a23-19847x2_472766xcybin001.jpg" title="slide1" width="1048" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">(the &#8220;Issuer&#8221;)  Request for Financial Statements  In accordance with National Instrument 51-102 &#8211; Continuous Disclosure Obligations, registered and  beneficial shareholders may elect annually to receive interim (quarterly) financial statements and  corresponding management discussion and analysis (&#8220;MD&amp;A&#8221;) and/or annual financial statements and  MD&amp;A. If you wish to receive these documents by mail or email, please return this completed form to:  c/o Odyssey Trust Company  350 &#8211; 409 Granville St  Vancouver, BC V6C 1T2  Canada  Rather than receiving the financial statements by mail, you may choose to view these documents on the  SEDAR+ website at www.sedarplus.com.  SHAREHOLDER REGISTRATION (Please provide the name in which your shares are currently registered)  Street Address  City Prov/State Postal/Zip Code  Country (if not Canada or the USA) Email Address  If this is an Address Change, please check the box below and provide your former address.  Please send me the following:  Annual Financial Statements with MD&amp;A  (Mark this box if you would like to receive the Annual Financial Statements and related MD&amp;A) Interim Financial Statements with MD&amp;A  (Mark this box if you would like to receive the Interim Financial Statements and related MD&amp;A)  I HEREBY CERTIFY that I am a registered and/or beneficial holder of the Corporation, and as such, request that my  name be placed on the Issuer&#8217;s Mailing List in respect to its annual and/or interim financial statements and MD&amp;A for  the current financial year. If I have provided my email address above, I hereby consent to its use for the delivery by the  Issuer or its agent of annual and/or interim financial statements by email.  SIGNED: ____________________________  DATE:   (Signature of Shareholder)  PRIVACY NOTICE:  At Odyssey Trust Company, we take your privacy seriously.  In the course of providing services to you we receive  non-public, personal information about you.  We receive this information through transactions we perform for you and through other  communications with you.  We may also receive information about you by virtue of your transactions with affiliates of Odyssey Trust  Company or other parties.  This information may include your name, social insurance number, stock/unit ownership information and  other financial information. With respect to both to current and former securityholders, Odyssey Trust Company does not share non- public personal information with any non-affiliated third party except as necessary to process a transaction, service your account or  as permitted by law.  Our affiliates and outside service providers with whom we share information are legally bound not to disclose  the information in any manner, unless permitted by law or other governmental process.  We strive to restrict access to your personal  information to those employees who need to know the information to provide our services to you, and we maintain physical, electronic  and procedural safeguards to protect your personal information. Odyssey Trust Company realizes that you entrust us with confidential  personal and financial information and we take that trust very seriously.  By providing your personal information to us and signing this  form, we will assume, unless we hear from you to the contrary, that you have consented and are consenting to this use and disclosure.  A complete copy of our Privacy Code may be accessed at www.odysseytrust.com or you may request a copy in writing to Chief Privacy  Officer, 350 &#8211; 409 Granville St, Vancouver, BC V6C 1T2.  Cybin Inc Cybin Inc </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>6
<FILENAME>abridgementcertificatecybin.htm
<DESCRIPTION>EX-99.5
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i80819851d70d44338f4283edf6c90bee_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CYBIN INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CERTIFICATE</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Pursuant to Section 2.20 of National Instrument 54-101</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Reference is made to the annual meeting of the shareholders (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Cybin Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) scheduled to be held on October 12, 2023.  I, Douglas Drysdale, as the duly appointed Chief Executive Officer of the Corporation, hereby certify on behalf of the Corporation and not in my personal capacity as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.75pt">All proxy-related materials in connection with the Meeting have been sent in compliance with National Instrument 54-101 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Communication with Beneficial Owners of Securities of a Reporting Issuer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NI 54-101</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to all beneficial owners of the Corporation at least 21 days before the date fixed for the Meeting.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.75pt">The Corporation has arranged to carry out all of the requirements of NI 54-101 in addition to those described in item 1 above in connection with the Meeting.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.75pt">The Corporation is relying upon Section 2.20 of NI 54-101 in connection with the abridgement of the time periods specified in Subsections 2.2(1) and 2.5(1) of NI 54-101 in respect of the Meeting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The term &#8220;beneficial owner&#8221; as used in this Certificate has the meaning given to it in NI 54-101.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DATED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> as of September 14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, 2023. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CYBIN INC.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:108pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> (s) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Douglas Drysdale&#8221;&#160;&#160;&#160;&#160;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Douglas Drysdale </font></div><div style="padding-left:180pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chief Executive Officer </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.6
<SEQUENCE>7
<FILENAME>a10122023asm-cybinincxno.htm
<DESCRIPTION>EX-99.6
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>a10122023asm-cybinincxno</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- a10122023asm-cybinincxno001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a10122023asm-cybinincxno001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">To All Applicable Exchanges and Securities Administrators Subject: Cybin Inc (the &quot;Issuer&quot;) Amended Notice of Meeting and Record Date  Dear Sir/Madam: Annual Special Meeting October 12, 2023 August 30, 2023 August 30, 2023 August 30, 2023 Common Shares CA23256X1006 No Yes No No Yours truly, Odyssey Trust Company as agent for Cybin Inc August 28, 2023 Notice and Access for Beneficial Holders: Issuer sending proxy materials directly to NOBOs: Issuer paying for delivery to OBOs: Notice and Access for Registered Holders: We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of  securityholders: Filed via SEDAR Meeting Type: Meeting Date: Record Date for Notice of Meeting: Record Date for Voting (if applicable): In accordance with applicable securities regulations we are filing this information with you  in our capacity as agent of the Issuer. Beneficial Ownership Determination Date: Class of Securities Entitled to Vote: ISIN: </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>a10122023asm-cybinincxno001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 a10122023asm-cybinincxno001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HH!!&0<T4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[M_M44-@BL?)XQ(2S*H4YP,GGM6'X>N+>P;X@+?NB-#J4MQ-O.,0M!&4)]L
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MW<VD;J?<$J1^@_.N]^!%ZL_@N[M,CS+>\;(']UE4@G\0WY5O_$CP./&FA)'
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M:NT45(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% 'FGC'1;RPU?0VM?$_B")=5U<6\T:WN%1&21R$&WC!4 =>*Z&?4$\'6]CI,
M3:KKFI7TK_9HIIE>5PH!8L[;0J*,<GU'6IO%>C7FK7OAN6T566PU5+J?<V,1
MB.121ZG+#BHO$NE:G_PD&C^(=)MX[R:P2:":T>41F6*4+DJQX# H#@\$9Y%
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M<A(9/WB+M&V/!).><L!56/X<WEA97&CQ^%M-OW:=_(U6XNV$?E.Y;,D0(8L
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M6"!+BY-LR*(4?)09=AN8@$A1VJ/X;ZE<ZOX!TV_NYY9IIFF)>4_,0)G SGT
M _"L^WTKQ!X;UN[O]-TR'4HM2M;9)8S<B%H)HDV9)(Y0C'3D$'@UL^!-)O\
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&YM+:]C6.ZMXIXU=9
MLJ!@&4Y4X/<$ @U-10 R:&*X@DAFC22*12CHXRK*1@@@]0:(HHX(4AAC6.*-
M0J(@P% X  ["GT4 %%%% !1110 4444 %%%% !1110 4444 %(0&4JP!!&"#
MWI:* ,K3?#.@Z/=276F:-86=Q(,/+;VZ(Q'ID#I6K110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% 'D.M^.?$%YX^U;P_I^NZ+X>33@@A&I)EKQF7/!/ '
M3IS@CKVZW2_%]SIOA33K[QO;QZ7?7-R+0+#^]25VSL*["V P'<\8^E<?XN\^
M7Q)J5MXM^'\_B#3VQ_9E[I5H6E5.?D=@=P//J.A..:P1X1\4V?P@L(Y-,NY9
MK/7DU&'3@?,FAM0" @'<Y)./>@#V+4?%&GVVHWFBQ7/_ !.(K![Y83&V/+&0
M&W8V]>V<UQG@GXOZ-J'A_2%\0:G'%J]VS1R%;=UB5][!5+8VJ2NT]>]4;=-7
MU[XHZAKO_"/:I8V$WAR2VA:[@V,S[\X(!.UB<X4\X&>]<G%IOB*]^$>G> ?^
M$.U2'4I;@.+N2#;!&GFER[/U5L';@C./J!0!Z]:^(ROCG7]/N]7L_L6GVL<Y
MM_*='MP5!9WD(VD=3P>*?H/Q%\+^)=2&GZ9J)>Y92\220O'YRCJ4+ !NAZ>E
M><:MHEYKGCWXCZ/8ONNYM'M4C).-[!$.">V<8_&D\(:)?ZAX@\+)>:;XMC?1
MHB7EU#RH;:U8(%*QXCS(K8QP1QCWH ] N/BEX.MM9;2Y=743)-Y#R")S$DG]
MTR8V@_CBJ.E?$VSU/XH:CX2"JD=N/*@D\MRTTR@F0'C"A<,!GKC()R*XWPW_
M &]X4\.3^#9O MUJ]_\ V@SQSS0!K&9"P/F/(<@$ =QQQ]*Z33(=1TGXZ:S/
M/H]^]EJUK D-Y!"6@C*1C.]_X>5('?IZT =SH/B'3/$VGM?:3<FXMEE:(N8V
M3YEZC# &M2L;PSJ<NK:6UQ+HUQI#"9T^SW";6('\6,#@ULT %<)XW\6:Q9^(
M-(\*>&8K8ZSJ:M*9[H$QV\2YRQ ZGAL?3OFN[KS;QWI6L:;XZT/QQI&FRZHM
ME"]I>6<'^M,;;L,@[D%SQ[#W( +FC:GXVT/5;V#Q;':WVCPVC70U:RCVE-N2
M4:/JQP#]T$].N>-R7QQX=AT"PUQM0SI^H2K#:R+$[&1V) 4*!NS\I[=JQ?#?
MB+Q1XH\4322Z!/I/AF.WV%-3@V7$TI/89X&#[CCWX\^\):!>-\44\(38?1O"
MUY/J4/.?]8%,*GW4G=_WU0!U&E?%RQLM8\2VGB:]6);'5)+>V$-L[E858C<^
MT' S@9/6NFOO$N?%_ABUL=8LQ8ZI%+*(3$[O=*$W*4<#:H'7DC-><P'6M ?X
MAVTO@[5[U=<OKE;.:WMMRONW ;^X3Y@0V".M:&C^$M:TCQ!\,8KBSFD&FVET
M+R5%+) SH2%9AP.3M_"@#K9_B[X)MR=^KMA93#(PMI2(F!Q\QV_*,^O6NPGG
M L)+B%E8"(NC#D'C(->*6OAC5U^"GC+3VT>[%_=ZI)+# 8#YDJ[XB& QDC@_
MD:];TZ":/PA:6[QNLRV"(R$?,&\L#&/7- '&>#_B=:OX TG6_%M_#;7%_/+"
MCK"P0E6([ XX'>NGT'QUX=\2?;O[.O\ +6(W7*SQ-"T:]=Q#@<<=:\DT7PKK
M:>#_ (=6MQHUX)+/7C-=1/ V88_-SN<8X&.<FNCUCPKJ^J^/?'8M[6:*+4M$
M2WM[EE*QR2;5&W=T[8- '6Z/\3?"6NZO'IEAJA>YF+"#?!(B3$==C, #5GQ[
MXE?PIX0O-2@027AVPVD9&=TSG:OUQG/T%<9X1U75Y(?"WAZ3P%=12Z9&L5W>
MZA;A(K<(H!>%^=S-C/&/ZUI_&:-E\)Z;?D$P:?J]K=7'M&&*D_FPH ;>?$E=
M"\=:+X1U&1)97MT%]=B%\F=E&U551@ D@YY SCC%4=&^+MA9W_B.#Q1?+%]B
MU>:UMQ#;.VR%6VAGV@XYXR>M6?%46H6'QB\-Z]%I&H7VG_8GM'DLX?,\MF8X
M+>B_,#D]L]<5C67AS54\(?%&%]*N1<:AJ%V]JAA.ZX0Y*E/[PYXQ0!Z%KGCK
MP[X>M[*:^U $7R[[5((VE>5<9W!5!.,'KTK4T;6M.\0Z7#J6E7275I+G9(F1
MTX((/((]#7BU[X=UW2M0\':XUKKZVT/A^&PN/[(A5[JVE5<D%'4\'.#QV/X^
M@_"W1I-'\+SM+9:A9/>WDET8-0E1Y1N &2%10N<9VXXH Q-<U[XBV]WXA33M
M.\R*VO[6*P/V0MYD+AO,8'^+'R9/;FM+3_',T7CKQG9:Q=00:/HL4$B2%,%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]2M/MLHN Q$49V!?ND=68C\*[[5O&&@^'K:UDUO5+:R>Y4,B2-RWJ0!DX]Z
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.4,I4[0#QVP!U%9NCZ3/=6WP@BN=/F>.WDO?M"R0G$9#*5W CCD<9]*]^HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKC9?&>KS:[JNFZ3
MX5FU!=-E6&687L4669 _ ?'9JV/#GB2V\1VEPZ03VEU:3&"[M+D 202 9P<$
M@@@@@@X(H VJ*B@N8+E2T$T<J@X)C8, ?3BD2[MI)V@2XB:9/O1JX++]10!-
M148N(&E$0FC,A!(0,,\<'BL/Q!XFDTG4++2]/TR74]4O%>2.W258E6-,;G=V
MX RP'0DYH Z"BN6T_P 775S_ &I9W>ASVFLV%N+C[$TZ,LZ$':4E^[@E2.<8
M/6NA2\B\F)IWC@DD"YC:09#,.%]SU^N* +%%<5XI^(<?AE-2D&ERWB6,]O;'
MRY "\LJEMH&.R[#[[_:MC6?%5EI'@^3Q(%:XMO(26%$.&EWX"*/<E@/QH W:
M*RM'UVVU3PWI^M2;;2&\MXYPLK@;-R@@$].]:7G1>3YWFIY6-V_<-N/7/I0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML\EO=L4,,JDAXVV [NV"!WYH ]4HKS-+Z#P3<:A''HD,-UIWAUKYD@OI)(F
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M56)+#&0?08-=Y10!Y_:^"-:T*#PY-H]_9W-[I5I-9RK?;UCE21E;Y2N2NTJ
M!SQQ4!^'6I3Z3=&[O;";5#K1UB%F@+6Y8HJF-T/.TC<.I/0]:]'HH \^E\$Z
MOJ&DZ]#<C1+"2_L&L[>WT^WQ&A/5WD*AV)XX   '0GFNX6WD731;),8Y1#Y8
ME0 E3C&X \<=>:LT4 >>6?@?5Y?$.D:EJ:Z)%/ITIDDU"PB9+F^^4KB08 4'
M.6&6Z<8KH_%VA7>N:=9_V?/##?6-[%>VYG!,;,A/RMCD @GD5T%% 'EGBK0=
M;BT3QAX@UFXL6>YT%K58+0/MBV%VQEOO?>SGCKC'%;ECH&OZQ<Z'/X@NM/>R
MTS]_$MJK[[F4QE%9]W"8#,<#.2>M=L0""" 0>QI: .%TKPQXHTK3[/P_;:I9
M1:-:3*4NXP_VMH%;<(BN-H./E+9Z=LU"_@_Q':Z-J/AK3;_3DT2]>;;/*KFX
MMXYF+.BJ/E8_,V"2.O2O0** .7TGPHVDZQK-Q%*GV6[LK6TMTYW((4=?F_[Z
M'3T-4[?P9>0^&_!^F&Y@,FAW,$TSC.) D;H0O'7+#K7:44 <-'X(O4N8)3=6
M^(_$DNL$<\QNCJ$Z?>^8>U0>,?#4;+XGUB_NGBL[FRM51[>(R20/!(SB0KW
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M :[MXGACD+'A'(+#&<'.T=1VH \P\+M-X:\)> ]92^NSILR);7\4MPSQJ)E
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&\FMIT$D4BZI<X=2,@C]YZ4 =W17%_\ "J?"/_/I??\ @SN?_CE'_"J?"/\
MSZ7W_@SN?_CE ':45Y7J^@?"O0;YK+5+Z2TN54,8Y-5N@0#T/WZL:)X2^&GB
M1IET>>>], !D$6J71VYSC/S^QH ],HKB_P#A5/A'_GTOO_!G<_\ QRC_ (53
MX1_Y]+[_ ,&=S_\ '* .THKB_P#A5/A'_GTOO_!G<_\ QRC_ (53X1_Y]+[_
M ,&=S_\ '* .THKB_P#A5/A'_GTOO_!G<_\ QRC_ (53X1_Y]+[_ ,&=S_\
M'* .THKB_P#A5/A'_GTOO_!G<_\ QRC_ (53X1_Y]+[_ ,&=S_\ '* .THKB
M_P#A5/A'_GTOO_!G<_\ QRC_ (53X1_Y]+[_ ,&=S_\ '* .THKB_P#A5/A'
M_GTOO_!G<_\ QRC_ (53X1_Y]+[_ ,&=S_\ '* .THKB_P#A5/A'_GTOO_!G
M<_\ QRC_ (53X1_Y]+[_ ,&=S_\ '* .THKB_P#A5/A'_GTOO_!G<_\ QRC_
M (53X1_Y]+[_ ,&=S_\ '* .THKB_P#A5/A'_GTOO_!G<_\ QRC_ (53X1_Y
M]+[_ ,&=S_\ '* .THKB_P#A5/A'_GTOO_!G<_\ QRC_ (53X1_Y]+[_ ,&=
MS_\ '* .THKB_P#A5/A'_GTOO_!G<_\ QRC_ (53X1_Y]+[_ ,&=S_\ '* .
MTHKB_P#A5/A'_GTOO_!G<_\ QRC_ (53X1_Y]+[_ ,&=S_\ '* .THKB_P#A
M5/A'_GTOO_!G<_\ QRC_ (53X1_Y]+[_ ,&=S_\ '* .THKB_P#A5/A'_GTO
MO_!G<_\ QRC_ (53X1_Y]+[_ ,&=S_\ '* .THKB_P#A5/A'_GTOO_!G<_\
MQRC_ (53X1_Y]+[_ ,&=S_\ '* .THKB_P#A5/A'_GTOO_!G<_\ QRC_ (53
MX1_Y]+[_ ,&=S_\ '* .THKB_P#A5/A'_GTOO_!G<_\ QRC_ (53X1_Y]+[_
M ,&=S_\ '* .THKB_P#A5/A'_GTOO_!G<_\ QRC_ (53X1_Y]+[_ ,&=S_\
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M- 'H%%<7_P *I\(_\^E]_P"#.Y_^.4?\*I\(_P#/I??^#.Y_^.4 =I17%_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6SF([?WK%2S%B#G!&T&NMMOAWIENUK#_ &AJDNF6DPGM],DN ;>-E.5XV[B
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MF\5<2S1Q^6KMZA<G'YT <K_PK>#_ *&KQ;_X-WH_X5O!_P!#5XM_\&[UVE%
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MC3[:9T&GRWF+Z:-&*EU&< G!*H0<C'/- '1?\*W@_P"AJ\6_^#=Z/^%;P?\
M0U>+?_!N]+;>)==U;QG>:9I5MIW]F6/V:6>YN&?>\<J;L(!QNQGD\=/6NDUF
MUU"]TY[?3=0%A.Y -QY0D9%[[03C=CH3D#T- ',_\*X@/3Q5XL_\&[T#X<6Y
MZ>*O%G_@W>J'@C2)=3^%#Z2FI75NTMU>1-=JV9<?:I-QSZD @GWS4>D:9I-M
M\2;:'PA:);6>GV\L>LR6^1#(Y \N,]FD!RQ/4#@GG% &I_PK>#_H:O%O_@W>
MD_X5Q;YQ_P )5XLR?^HN]=K7F7C7P]H=C9ZG=7Z2:IXCU65UTH<_:(WQB-(<
M'Y%0X)88[DT ;!^'%N.OBKQ9_P"#=Z/^%<0#_F:O%G_@W>LRST9/$WC&ZTSQ
M1&FHKH^DV:>5)S&T\H<R2X_O?( #V[4S0-(M_$'AB&#7;YY=+T+4;VWEBN'_
M '=S'$[+&96)Y"#UX..: -;_ (5Q ?\ F:O%G_@W>@?#BW/3Q5XL_P#!N]9/
MA;0H=<T[Q'#ISW>G>%K^XB_L](6,>Y% \YHP>4CD(QQCC)&,T[PK'::;\2[V
MPL-,ET&R?3ODL9%VK>.LG,R!25^4<'G<=PR.* -7_A6\'_0U>+?_  ;O1_PK
M>#_H:O%O_@W>NTHH XO_ (5O!_T-7BW_ ,&[T?\ "MX/^AJ\6_\ @W>NTHH
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M2AI:!@,,@96W'W^0?G6=_P (/K?_ $/^O?\ ?,'_ ,11_P (/K?_ $/^O?\
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M/R& /IPE '=45Q7_  @^M_\ 0_Z]_P!\P?\ Q%'_  A&M?\ 0_Z]_P!\P?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%E8LS8DQP" H.3QFK-OX:U>]FG/B/6H[RVDM'M/L=G;FWB97&&=P78LV.!R
M,G YJOIWA+68?[-LM0\1?:=)T['E0PVYAEG 4JJS.'(90#R HW$#- &5_P )
MGXEB\,P>,KBUTT:%*4E:R57^TQV[L '\S=M+8(8KM''&:L_\)=KO]J^([AHM
M.CT+0)7%PQ5S/,JPB3"\[01GJ>N>@QR+\/\ 43I$/AN;7DD\-0NI%O\ 9,7#
M1*P986EW8VC &0H) Q6[:>%8(E\1Q74WVBWUR=I)(]FW8K1+&5SDYX7.>.M
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M>4A&D"R$LJ$L"H/=3TKTOQ#9ZQ<V]K-H=[';W=M.)3%/GRKA,$&-R 2!SD$
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MQBMO_0)*[6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9;B*5,C,AA7<2OU[9H SO^$<\<_]#_'_ ."2+_XNC_A'/'/_ $/\?_@DB_\
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MO_A'/'/_ $/\?_@DB_\ BZ/^$<\<_P#0_P ?_@DB_P#BZ[2B@#B_^$<\<_\
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M7J!"BK(#P@P<G!.2.U)]D^)7_05\,?\ @%-_\<H^R?$K_H*^&/\ P"F_^.4
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MD:02;>X!*G'HIK'TS5+_ ,1_$;PU(=:TC58K"&YEF_LE6,<0:,(&D8L<,Q.
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M =I17%_9/B5_T%?#'_@%-_\ '*/LGQ*_Z"OAC_P"F_\ CE ':45Q?V3XE?\
M05\,?^ 4W_QRC[)\2O\ H*^&/_ *;_XY0!VE%<7]D^)7_05\,?\ @%-_\<H^
MR?$K_H*^&/\ P"F_^.4 =I17%_9/B5_T%?#'_@%-_P#'*/LGQ*_Z"OAC_P
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M/LGQ*_Z"OAC_ , IO_CE ':45Q?V3XE?]!7PQ_X!3?\ QRC[)\2O^@KX8_\
M *;_ ..4 =I17%_9/B5_T%?#'_@%-_\ '*/LGQ*_Z"OAC_P"F_\ CE ':45Q
M?V3XE?\ 05\,?^ 4W_QRC[)\2O\ H*^&/_ *;_XY0!VE%<7]D^)7_05\,?\
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MN;D,PNE=?,C9F.XEPBG<>/>K^HVFL>*O$-I>7NBW&CZ9%IE]:S2W,T1=&E5
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M4 %%%% !1110 4444 %%%% '%?$+_CY\'_\ 8Q6W_H$E=K7%?$+_ (^?!_\
MV,5M_P"@25VM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7GOQ ;4T\9^"6T>*UEOQ->>4ET[)&?W!SDJ"1QGMUQ7H5<5XI_Y*/X
M#_Z[WO\ Z3F@ ^U?$S_H%^%__ R?_P"(H^U?$S_H%^%__ R?_P"(J&%M3\:>
M(=:BCUF\TO1]*N?L2)8E4EGF"JSLSD$A1N  '7J:KZV_B?PUX4OUN=6^TK'J
M%HEC>\"=H7FC5UE 4+D9(R.H/:@"]]J^)G_0+\+_ /@9/_\ $4?:OB9_T"_"
M_P#X&3__ !%7-4\:C3[B_2WT'5=0@T[_ (_+BW2,)'\NX@;W4N0""=H-%SXW
MM_M%K;Z5IE_J\T]DFH;+41KL@?[K'S&7DX. ,GB@"G]J^)G_ $"_"_\ X&3_
M /Q%'VKXF?\ 0+\+_P#@9/\ _$5=G\;6^W3([#2]1OKS4;=KF*T1$BD2-2 Q
M?S&4+@L!C/7\ZV=&U6/6M,COH[>YM@Y96ANH]DD;*2"&'U'8D'M0!S/VKXF?
M] OPO_X&3_\ Q%'VKXF?] OPO_X&3_\ Q%6+WQ];6T^H&WT?5+ZQTV0QWM[;
M1H8X6498 %@S[?XMH.*Q[G7+[6?B?INGVC:JFCI8)?))9R1+'<;G&)');<8L
M?+C .<\8YH T/M7Q,_Z!?A?_ ,#)_P#XBC[5\3/^@7X7_P# R?\ ^(J;XAZI
M?Z7I%E):W%Q9V<EXD>H7UM#YLEM!AB648..0HW8.,]*I^$KGSM66;1O&2Z]H
MC0,;F.[N$DGMY.-K*54'!&00V,=10!-]J^)G_0+\+_\ @9/_ /$4?:OB9_T"
M_"__ (&3_P#Q%2P?$*RG%O=G2]2CT:YF$$.JNB"!V9MJG&[>$)P Q4#D5)J'
MCNWL[K4%M](U._M=-;9?7=K&AC@8 $C!8,Y4$$A0<4 5OM7Q,_Z!?A?_ ,#)
M_P#XBC[5\3/^@7X7_P# R?\ ^(K?T_Q%9ZGJ6IV5NLI?3UB:1V "N)$WKMYS
MT]0*P6^)-@]MH\EGI&JWLVKVK7=K;P1(7VJ5!#9? .&SUQQUS@$ 3[5\3/\
MH%^%_P#P,G_^(H^U?$S_ *!?A?\ \#)__B*R=7\9WNGV]Q)ID6IW4O\ PD4-
ME,DJ0_N@1$6B3+ 88-@$]R<D#!K:'BZQTVZ\17%Y+J+?9)[:(VCQHQ622)"L
M4(4Y8DL,Y_B)YQS0!']J^)G_ $"_"_\ X&3_ /Q%'VKXF?\ 0+\+_P#@9/\
M_$5=A\;VB/>1:OI]]I$]K:/?&*["-O@7[S*8V8''&1G(R.*ET;Q8=5OK>VFT
M/5+ 74)GMIKA(VCE08/5';:<$'#8H S?M7Q,_P"@7X7_ / R?_XBHXF^(T&_
MR=&\*1[W+OLNIAN8]2<1\D^M'Q-U273+/0@NLRZ1;7.JI!=7<3JA6(QR$\L"
M!R!VIOA>?1KC7(Q8?$.]UN9$9C9/=P2*PQC)"(#QD'K0!-]J^)G_ $"_"_\
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M1KUWKNJ^)VN%NHH[>^2*&VN5"O /)0LN!D?>W'()!SD'% $?VKXF?] OPO\
M^!D__P 11]J^)G_0+\+_ /@9/_\ $4@\87-MX]US3[^UGAT?3[".X-PPCV1C
M]X6D8AMQ!"@  9RIR!U-NP\=07-W81W>CZIIUOJ3;+&ZNT0),Q&0IVL2A(!(
M# 9^O% %7[5\3/\ H%^%_P#P,G_^(H^U?$S_ *!?A?\ \#)__B*M^/+^_P!&
MTBUUNSGD2'3[N.6]B7D2VQ.V08]@V[_@-'BC4KN35?#^B:7<M%/J%SY\TL>,
MK:Q#=)SVW$HN?]J@"I]J^)G_ $"_"_\ X&3_ /Q%'VKXF?\ 0+\+_P#@9/\
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M+\+_ /@9/_\ $4?:OB9_T"_"_P#X&3__ !%=K10!Q7VKXF?] OPO_P"!D_\
M\11]J^)G_0+\+_\ @9/_ /$5VM% 'D'CVX\>-H]@-1T_P_'%_:EH4,%U*Q,G
MFC:#E!\N<9/I75?:OB9_T"_"_P#X&3__ !%'Q._Y &F?]AJQ_P#1RU/K.KZO
MJ'BP>&-!N(+)X;47=[?2Q>:8U9BJ(B9 +'!.3P .] $'VKXF?] OPO\ ^!D_
M_P 12&Y^)9&#I?A<@_\ 3Y/_ /$5H:2_B/2M2N[?7KJWOM*2W\^/5-B0-&0?
MFCD0''3Y@P & <T[3?'6AZI?6UK#)=1F[S]DEN+22*.YP,GRW90&XY]QTH Y
M#3_"GBC2]06_LO"G@^&X0L8V6[N"(R>NQ2F$S[ 5O?:OB9_T"_"__@9/_P#$
M5._Q+\,1.2]U<+ D[6TMT;23R(90Q7:\FW:IR.Y[@]"*NZ?XTT?47OHT:Z@E
MLX/M,L=U:20N8>?WBJP!9>#TH R_M7Q,_P"@7X7_ / R?_XBC[5\3/\ H%^%
M_P#P,G_^(J:/XF^&9#"1/>".Y0M;2FQF"7)&,K$=OSMSC S5^U\::'<Z-?:J
M]R]K;V#F.[6ZA>*2%N#AD89R<C''.1B@#*^U?$S_ *!?A?\ \#)__B*/M7Q,
M_P"@7X7_ / R?_XBM73O&>D:C/-;@W=M<Q0&Y\B\M)('>(=74.!N'TJMI_Q#
M\/:G<V,5O-=>7?D):W,EI*D,KD9V+(5VEN#QGJ".M %/[5\3/^@7X7_\#)__
M (BD6?XE(H5=*\+*HZ 7<P _\<K8\::W<^'?"&HZM9PK+/;H"H<$JN6"EV Y
M*J"6..P-8>DW7B1KJPO++Q)IWB?3II1'>)##%$8$(/[Q&5N<'&5.21TYH E^
MU?$S_H%^%_\ P,G_ /B*/M7Q,_Z!?A?_ ,#)_P#XBJEA\2+2TN=>BUI[DK8:
MG+!YMO92/';P#;M,C*I YW<GFNBU3Q?I6EW:6A%W>73PB?R;&UDN&6(G <[
M< XXSU[4 9'VKXF?] OPO_X&3_\ Q%'VKXF?] OPO_X&3_\ Q%7KGQ_X=MM,
MT[4/M<LL&I!_L@AMW=Y2O#*% SNSQ@C/7TI;OQYHEHZQG[=-)Y"7,R06,LC6
M\;#(,H53LXYP>?:@"A]J^)G_ $"_"_\ X&3_ /Q%'VKXF?\ 0+\+_P#@9/\
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M* .*^U?$S_H%^%__  ,G_P#B*/M7Q,_Z!?A?_P #)_\ XBNUHH XK[5\3/\
MH%^%_P#P,G_^(H^U?$S_ *!?A?\ \#)__B*[6B@#BOM7Q,_Z!?A?_P #)_\
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M@1?^#N+_ .(H R;#PQK'AUM!UFRT6WDGMHKF&\TVTN#E5F<.&1Y6PS J-V2
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MHKB_^$C\=?\ 0@1?^#N+_P"(H_X2/QU_T($7_@[B_P#B* .THKB_^$C\=?\
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M.4FCFE9EE\S&T*%?))/&TBIGT?0_#OC#7I/$VD27UM?P0&RF-D]RK!8A')&
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MGS692PQ@?W03GIB@#FO^$VUS_H0-=_[^0?\ Q='_  FVN?\ 0@:[_P!_(/\
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MQA7D"[%/(X)'6MZ66."%YI76.-%+.[' 4#DDGL* .._X3;7/^A UW_OY!_\
M%T?\)MKG_0@:[_W\@_\ BZCF^(FGWNO^']/T6Z2=;^Z:.;S;>1"T0B=@\98
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MW-CINF:?<-:&ZN;=IY+B9/O[5#*%0$XSDDD&@!W_  FVN?\ 0@:[_P!_(/\
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MXF\1:EJVK>$8+OPOJ>EQKKUNXFNFB*L=KC;\K$YY)_ UZM7%?$+_ (^?!_\
MV,5M_P"@25VM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!VEV,V1QG(P3USQ71?\ "R(?^A3\7?\ @H?_ !H_X61#_P!"GXN_\%#_ .-
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MZ%/Q=_X*'_QH [6BN*_X61#_ -"GXN_\%#_XT?\ "R(?^A3\7?\ @H?_ !H
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M_#PSVQ;R3JS_ #I]QO,X/L?2EU6QE34O$,XLY9=.M/$]G>WD$<1;?"($WL$
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M44 <5\0O^/GP?_V,5M_Z!)7:UQ7Q"_X^?!__ &,5M_Z!)7:T %%%% !1110
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MJ^_\%=S_ /&Z/^%K>$O^?J^_\%=S_P#&ZV[/7A=>*-6T8P>6-.@MYC.7SO\
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M+_GZOO\ P5W/_P ;KM** .+_ .%K>$O^?J^_\%=S_P#&Z/\ A:WA+_GZOO\
MP5W/_P ;KM** .+_ .%K>$O^?J^_\%=S_P#&Z/\ A:WA+_GZOO\ P5W/_P ;
MKM** .+_ .%K>$O^?J^_\%=S_P#&Z/\ A:WA+_GZOO\ P5W/_P ;KM** .+_
M .%K>$O^?J^_\%=S_P#&Z/\ A:WA+_GZOO\ P5W/_P ;KM** .+_ .%K>$O^
M?J^_\%=S_P#&Z/\ A:WA+_GZOO\ P5W/_P ;KM** .+_ .%K>$O^?J^_\%=S
M_P#&Z/\ A:WA+_GZOO\ P5W/_P ;KM** .+_ .%K>$O^?J^_\%=S_P#&Z/\
MA:WA+_GZOO\ P5W/_P ;KM** .+_ .%K>$O^?J^_\%=S_P#&Z/\ A:WA+_GZ
MOO\ P5W/_P ;KM** .+_ .%K>$O^?J^_\%=S_P#&Z/\ A:WA+_GZOO\ P5W/
M_P ;KM** .+_ .%K>$O^?J^_\%=S_P#&Z/\ A:WA+_GZOO\ P5W/_P ;KM**
M .+_ .%K>$O^?J^_\%=S_P#&Z/\ A:WA+_GZOO\ P5W/_P ;KM** .+_ .%K
M>$O^?J^_\%=S_P#&Z/\ A:WA+_GZOO\ P5W/_P ;KM** .+_ .%K>$O^?J^_
M\%=S_P#&Z/\ A:WA+_GZOO\ P5W/_P ;KM** /*?$WC?0O$>K>$;/39[EYDU
MZWD(ELYHAM"N.KJ!U(XKU:N*^(7_ !\^#_\ L8K;_P! DKM: "BBB@ HHHH
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M'\/6NW'Q+\ +;_9QX@TP0[=OEC[N/3&,8I(?B5\/[:'R8-?TR*+^XGRK^0%
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M6'(/O5E?B7X 5E*^(=-!4D@@]">O;O3G^)_@.0J7\1Z<VT[ERV<'U'% '/\
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M/P-_T,UA_P!]G_"@#KZ*Y#_A:?@;_H9K#_OL_P"%'_"T_ W_ $,UA_WV?\*
M.OHKD/\ A:?@;_H9K#_OL_X4?\+3\#?]#-8?]]G_  H Z^BN0_X6GX&_Z&:P
M_P"^S_A1_P +3\#?]#-8?]]G_"@#KZ*Y#_A:?@;_ *&:P_[[/^%'_"T_ W_0
MS6'_ 'V?\* .OHKD/^%I^!O^AFL/^^S_ (4?\+3\#?\ 0S6'_?9_PH Z^BN0
M_P"%I^!O^AFL/^^S_A1_PM/P-_T,UA_WV?\ "@#KZ*Y#_A:?@;_H9K#_ +[/
M^%'_  M/P-_T,UA_WV?\* .OHKD/^%I^!O\ H9K#_OL_X4?\+3\#?]#-8?\
M?9_PH Z^BN0_X6GX&_Z&:P_[[/\ A1_PM/P-_P!#-8?]]G_"@#KZ*Y#_ (6G
MX&_Z&:P_[[/^%'_"T_ W_0S6'_?9_P * .OHKD/^%I^!O^AFL/\ OL_X4?\
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ME[>UO+SP?<ZY=MX?M=7%VYEU:XN9OMUO<"4@)M6,D8X41C@KCCF@#WHV]J"
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M4 1?9;?_ )X1?]\"C[+;_P#/"+_O@5+10!%]EM_^>$7_ 'P*/LMO_P \(O\
MO@5+10!%]EM_^>$7_? H^RV__/"+_O@5+10!%]EM_P#GA%_WP*/LMO\ \\(O
M^^!4M% $7V6W_P">$7_? H^RV_\ SPB_[X%2T4 1?9;?_GA%_P!\"C[+;_\
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M.@N@FL>'5%V2USBY@'G$C&7Y^;CCFKO_  B'AG_H7=(_\ H__B:/^$0\,_\
M0NZ1_P" 4?\ \30!FZ9J_P /]%61=*U+PU8K(<N+:X@CW'WVD9I+35OA]I[(
MUGJ/AFW:-WD0PSP(59@ Q&#P2  3WP*T_P#A$/#/_0NZ1_X!1_\ Q-'_  B'
MAG_H7=(_\ H__B: ,N'4_AY;ZJ^J0W_AB/4'SNNDG@$ISURV<\TV74/AU-JJ
MZI+>^%WU!2"+IIK<R@CH=V<YK6_X1#PS_P!"[I'_ (!1_P#Q-'_"(>&?^A=T
MC_P"C_\ B: (I/%_A*:)XI?$6B21NI5D:]B(8'J"-W(K,LKSX;Z;M^PW7A6V
M*R"53#+;IAP" PP>N"1GW-;'_"(>&?\ H7=(_P# */\ ^)H_X1#PS_T+ND?^
M 4?_ ,30!1_M_P "_8#8?VOX=^QD[C;_ &F#R\[MV=N<?>Y^O-17VJ_#[4[N
M&[O]0\,W5S#_ *J:>>!W3Z$G(K3_ .$0\,_]"[I'_@%'_P#$T?\ "(>&?^A=
MTC_P"C_^)H JIXG\%QV(L4US0%M!'Y0@%W"(PF,;=N<8QQBI(/%OA"V@C@@\
M0Z'%#&H1(X[V)550,   \ 5-_P (AX9_Z%W2/_ */_XFC_A$/#/_ $+ND?\
M@%'_ /$T 9-QJ'PZN['[#<7OA>6T\PR^0\UN4WGDMMSC)R>:EFUCP!<:6NES
M:GX:DT]0 MJ]Q 8@!TPN<"M'_A$/#/\ T+ND?^ 4?_Q-'_"(>&?^A=TC_P
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M09XU=7"RWD+ ,IR#@GJ#R#5G_A$/#/\ T+ND?^ 4?_Q-'_"(>&?^A=TC_P
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M_P )GX6_Z&71O_ ^+_XJC_A,_"W_ $,NC?\ @?%_\53_ /A$/#/_ $+ND?\
M@%'_ /$T?\(AX9_Z%W2/_ */_P")H 9_PF?A;_H9=&_\#XO_ (JC_A,_"W_0
MRZ-_X'Q?_%4__A$/#/\ T+ND?^ 4?_Q-'_"(>&?^A=TC_P  H_\ XF@!G_"9
M^%O^AET;_P #XO\ XJC_ (3/PM_T,NC?^!\7_P 53_\ A$/#/_0NZ1_X!1__
M !-'_"(>&?\ H7=(_P# */\ ^)H 9_PF?A;_ *&71O\ P/B_^*H_X3/PM_T,
MNC?^!\7_ ,53_P#A$/#/_0NZ1_X!1_\ Q-'_  B'AG_H7=(_\ H__B: &?\
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MA;_H9=&_\#XO_BJ/^$S\+?\ 0RZ-_P"!\7_Q5/\ ^$0\,_\ 0NZ1_P" 4?\
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MDY&&''7(%/\ [;\4:-%)?^(;#3WTU+.6YFDL'8-:E%W;6#GY\C(!7'(Z8YH
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M)R@9EB&0509QN.>>W% 'I5%<#8^.M0\4'2;?PU;6D5Q=V!O[B2^+.D"!S'L
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)22#YK!F;<X(&.PY]:<OA?7-4(@\2:Y%<V"6TML8+&%H/M/F)L+RY=@2 3@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6S3/)C\XS>6GFE=A?:-VWKC/I3Z "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOAO9ZRLSVD^MO'"LQ(9[4E0 >^",CZ8QQBM,>$=!?Q+\4;8Z;#]FTVQ62SA
M^2!V@9BRKT!RHY[4 >]R75O$5$D\2%@64,X&0!DD?04D%U;W4 GMYXIH3G$D
M;AE_,<5\Z7,VERVWPF?Q$^[33:3K<&0G;M&T -C^'A<]L9SQ5N'4-(TJW^)5
MQI%E)?\ @\+;)';VTSQQ-*V%?8Z\A<DYQVP.F* /?;74;*^+BTO+>X*??\J5
M7V_7!XI!J=@7A07ML6FSY2^:N7Q_=YY_"O!O!9L[?XOZ0NGR:&L<VE2K)'HN
M[RA\I8*[,3O?@$GCMFN>30=-B_9W3Q"EJHU>.^!CN\GS$ FV@*>PZG'J<]:
M/J!)X99)(XY8W>,X=58$K]1VHAGAN(_,@E25,XW(P8?F*\4^(U_=> /&-]K5
MC&YC\2Z4UKB,?=NT "/_ -\D?K7J'@GP\OA;P9I>C@ 26\ \XCO(WS.?^^B:
M -^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
IBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>a23-19847x2_472766xcybin001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 a23-19847x2_472766xcybin001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(]QR(UX&0HP,ULT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX]ZQN-0U*YE6^AEW#HJH3C/IUYSTH ^L*\Z_X6C"^C#4$2T43ZV=*A$DK8B
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT:** .4^(.@ZCXI\.+H=BR1PWES$MY,S8,< ;<Q4=V. ,?6NGM[>*TMHK:!
MD,2"-%'15 P!^5244 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%(KJXRK!ATR#F@!:*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BF[TW[-R[L9VYYIU !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJDUQ+#J+7B*NUUVD;.I8@ #.,$\\<T =7<_%5AX:\.7=EHK76L^(,BTTY9P
MN#@EG(Z#CM_+-3:?\3S'!X@M_$.C2:;JVAV_VF>UCE$HEC(R&1AQW ]LCGKC
MC=4^&6MS>$/!<YTB*_O=&C:*]TJ2X"><C-G"N#@$?7O[8.UX3\'ZM:IK^H6_
M@_1="FN+4V]C;7,KW+2 X++,0Y4H2O8 \^@Y +_AGXD:_KUUITI\*Q/I=\P'
MVBQU!+A[8'H94 &WWS@CGOQ6/HGB?Q5<_'K6-/FTV62SBB6$VYO5V6D.4(F
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MYT_XC:LOCC3_  [K_AAM*&IQM)9R_:EE/ )PX P#QZ\$CZU4N_BCK-Y?ZO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#,G\.Z5=>(;77IK-7U2TC
M,4%QO;**<@C&<'[QZCO6G110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !16'X>\21:]9W=P81:BWOY[(!
MY =YC<KD<#KC.*UK>[MKQ"]M<13J#M+1.& /IQ0!-115<W]F+O[(;N#[3_SQ
M\P;_ /OGK0!8HJ">\M;5HUN+F&%I#A!(X4L?09ZTMS=VUF@>ZN(H$)P&E<*"
M?3F@":BHIKJWMH#///%%"/\ EI(X5?S-*+B Q)*)HS&^-C[AAL],'O0!)154
MZE8K;+<M>VPMV.U93*NTGT!SBL_0_$,6LPZI*T0MTL+^:S9FD!#>7CY\X& <
M]* -JBH(+ZTN8&G@NH)85SNDCD#*,=<D41WMK+<-;QW,+S*-S1K("P'J1UH
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MFHZ2(KQLK(PR&4Y!%87B;Q'-H3Z;;V>F/J5]J$[0PVR3+$3M1G9MS<8 7]:
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M $=>10!-14-M>6MXA>UN89T!P6B<, ?3BIJ "BHY9X8%W32I&.>78#H,GK[
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M;Q&>-2B2E!N53U /4#VJ.33+"6WN+>2QMGAN6+SQM$I65CCEAC#'@<GT% '
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MZV\"QAOJ% S2VNCZ98F,VFG6EN8]VSR8%3;NQNQ@<9P,^N!0!P&G7^F:'?\
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M/WC_ !9![ >@KWFLY] T:2\EO)-)L'N9<>9,ULA=\$$9;&3R ?PK1H ****
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M!R%;@$L,C/( QSD*/B(UMH=[/J&E>5JMKJ*Z7]BCN R2SL%*;9"  I#9R1P
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MF,/$_(RCC!^5AD$]1G-<+9^ M1-SK5U%IFE:$M[I4UB+*PN&>.:5QQ*_R*%
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M8))VX'&*[BW,S6T37*(DY0&1(VW*K8Y ) R,]\"@"GK6H7&F:7)<VFGS:A<
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MX>CD*F;[<!=-&&VF58=N-O!."V2.<5K+XMU.]\97>AZ7HD=Q;V+6[75Z]V$
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M:(ER@4@NH. ,\Y/([V?#GCK4?$3V=W;:-:R:7=2F,M;WXDN+8<X::+: HXY
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MAHHFE59&![84MSVZUS\OA[0] ^)W@]='40>;#>%X%E9E8"(8DP2>3TW=_?%
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M%)[/Q3')-;6W]FKX>BTUA%PA=9&+*JDE@N#QG/UKM** //?!W@K4K%-537)
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M(XU)"X8[MQ"],8K.L/A[>VVF6>B2^$-/EGA=(Y-6FO"T$D2M]_R@P?>5'W<
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M7D81KG5KJZCPP.8WD)4\=..U='10!YYKWA+5=5UWQ5:K;J-/U_3X8DO1*O\
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M!<12O'C>J."4R,C([9%<]XJ\5'1/[+6R-M<27.KV^GW"LV3$LA.3@'AN.,T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT2R.B-#=P7,&JW+0),DGRH%5B6/'8@+CCEJT_$NO1^'=(-XT#W,SRI;VULA
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>Z@1=N5DVL<*Q(P5(R5Z5TGPY@AM_ASX>$#.P?3X';=*SX8QJ2!DG SV' Z
M"@#IZS;'0M/T[4[W48(G-W>$>=+)*TAP"2%7<3M7))VC YK2HH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0D#&2!GCFDD6-XF255:-A
MM96&00>,&L'QKH\VM^%;N"TXOX=MU9-W6>,AT_,C'T)K!NM4A\;W?A.RMQFT
MG1=9O$_NI'CRXV^LI''_ $S- '6:5X>T70VE;2M*LK)I?]8;>!4+>QP.GM3;
M#PWH>EWLM[I^D6-K=2Y#S0P*C'/)Y [UPVI_$'4=.OGD^WZ-,D=^EL^FV\,D
MLJQM*(]S3JVQ7P0=I7 Z9S5K4O%?BA(?%.H62Z2MEX?G=?+FBD:2Y5(DD8;@
MX"'#'!P<G' QR =BGA[18]8;5TTJR74FSFZ$"B0Y&"=V,YQQFM*N-?7O$&M:
MQJ%IX>_LZWCTZ&%W-[$\AGED3>$&UEV *5RW/)Z<4BZUXGUC5KZPTN/3+"33
M88?M(O$>??/)&'\M2K+A0"!NYSGI0!V=1W%O#=VTMM<Q)-!*A22.10RNI&""
M#U!%<CX6\:3^)-5M(?LL<$$^DK>LO)=)?.:-ESG!4%3CBH-$\:7]VV@SZA%:
MQV6J->6YDC5E\N>*1M@R6(PT<;_B/?% '5:CHFE:O9I9ZCIUK=VT9!2*:)65
M2.!@'IQ27.A:3=Z4FEW&F6DM@@ 2V:%3&N.F%Q@8]JX2?XBW[6NDX-G9-JS7
M%S!<36TLRQ6B,!&2B'+.X93U  -.7QYKEWI=G'8P6+:A-K/]F&>6&5()$,32
M"9%)##H,J2>C#/(- 'H-C86>F6<=I86L-K;1C"10H$5?H!575]&T;6HD@UBP
MLKQ%.46YB5]I]1GI^%6[);M;&!;Z2&2["#S7@0JA;OM!)('U->9^++&WOOBN
M$N/"H\0JNAQD0YB'E'SY/F_>,![<4 >A0:!HUMIATVWTJRCL&()MD@41L<@Y
M*XP3D _A3-1T70M>F3^T=/L+^2W)"^?$LACSU'/3/I7EMI=SVGA.^T6'[1I+
M7/B.&RELO,._3;>8I\JOTPPR05.!YG'2NZ?P+X:TVXT^^T^WAT:XM)E*W%J%
MB:8'@QR$_?#9QSD^AS0!O0:/I5I+$\&GVD,D;N\92%5*L_WR,#@MCGUJ3^S[
M!8;F'[);B*\9C<)Y8Q,S#:2P_B)  .>H%<_\0+.9_#JZK9H7OM&G348%'5A'
M_K$_X%&7&/<5GZG?1^(/%6G-:D3Z?H]D=8?'*O+(I6 ?]\^8W_?- '7_ -GV
M&RUA%I;[;,AK9/+7$.%*@H/X< D<=CBHTT_2K%K9DM+.!H=ZVY$:KLWG+A?3
M<>3CK7D_AD)'8^%O$.IZ"T+WMS$6UN.['VJ6>7C]ZNW_ %+,VT#<<#;P*Z3P
MOH&E>+H]6UGQ#86^I7DNHW-LJW:"06T4<A18T!X7A<DC!).: .NL?#6A:;?R
M7]CH]A;7<F=T\-NJN<]>0._?UJ[>V5GJ-J]I?6T%S;RC#0SH'5OJ#P:I>'=.
M@TC2$TZUOY;R&W=T1I9!(T8W'$9/^S]WGGBN7U+3[J#XK>'+RYU.>Y6<7@BM
M]H6*!!&,  =6.3EB?3I0!U&E:'H.@I+'I6G6%B)/]8((E3=]<=:L:?I^FZ19
M_9].M;:SMBQ81P(J)N/4X'&:X'QEX.\-MXK\,2'1+$O?ZK)]K;R1F?,,K'=Z
M_, ?K6EK_ASP?HEO#>ZI9Q2:?;PFVLM)\D/%YKN6/E18YE8G'X=N30!W-%<]
MX'T^_P!,\':?::F&6Y0.?*:3>849V9(RW?:I5<^U=#0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM[K4)K^92=UQ,B*S9.1D( O'3@=JMT44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !17,M\1/!JS&%O$VEK(K;2&N5&#[YKI(Y(YHDEB=7C=0RNIR&!
MZ$'N* '45'-/#;JK32I&&8(I=@,L3@ 9[D\ 5!;ZI876H7=A!=Q27=GM^T0J
MV6BW#*[AVR.: +=%%% !115:XU&RM8[EY[J&-;6+SI]SC]TF"=S>@^5N?8T
M6:*AM+NWOK2&[M9DFMYD$D<B'*NI&00?2IJ "BBB@ HHHH **** "BJG]J6'
M]K?V5]KB_M#R?M'V;=\_EYV[L>F>,U;H **J:;JECK-BE[IMW%=6KDA98FW*
M2#@\_45;H ***0D $DX ZDT +15!M:TM+FQMS?V_G7X8VB"0$SA1EBGK@$'B
MK] !115;4-0L]*L9;Z_N8K:UA&Z2:5@JJ.G)/OQ0!9HK(TOQ1H6MS1PZ9JMK
M=2R0FX1(GRQC#;"V/3<,?6M>@ HHHH ***J7>J6%C=6EM=7<4,]VY2WC=L&5
MAR0H[F@"W1152TU2PO[FZM[2[BFFM'\NX1&R8F]&]#0!;HHJ.>>*V@>>>5(H
MD&YY)&"JH]23TH DHHZU')/#"\:2RHC2MMC#, 7.,X'J< G\* )**** "BBB
M@ HHJ,SPBX%N94\]D+B/<-Q4$ G'7&2.?>@"2BBF2RQP0O-*X2-%+,S'@ <D
MF@!]%5["_M-4L8KVQN([BUF&Z.6-LJPZ<&K% !1110 444'@9H **R;?Q1H5
MVEB]OJMI(M^[1VA60'SF7[P7U(K6H **** "BBB@ HHHH **** "BBB@ HJ.
MXN(;2VEN;B18X8D,DCL<!5 R2?8"F6=Y;:A9PWEG.D]M,H>.6,Y5U/0@T 3T
M444 %%%% !114<T\-NF^>5(D+!=SL%&2< <]R>* )**** "BBJDNJ6$&IV^F
MRW<27MPK/# S8=U7J0.^* +=%%% !114<L\,&SSI4CWL$3>P&YCT ]3[4 24
M54L]4L-0GNH+2[BGEM)/*N$1LF)_[K>AJW0 4444 %%%% !152#5+"YU&ZTZ
M&[BDO+4*9X%;+QAAE=P[9%6Z "BBB@ HHHH **** "BHVGA2:.%Y4660$HA8
M!FQUP.^*DH **** "BBB@ HJ,SPK<+;F5!,REUC+#<5! ) ZX!(Y]Q4&FZI8
MZS8I>Z;=Q75JY(66)MRD@X//U% %NBBB@ HHHH **** "BBB@ HHHH ****
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MCJ.>GMG:]XR\67_B;Q*FCW6HPQZ,4CM8;.SBEAD;;DF9W.0&QQCMSVY]!O\
MX9^$M3UJ35;O2@]Q+()95$KK'*XZ,\8.UC]1SWJ36OAUX7U_4WU#4-.9KB55
M6<QSR1K.%Z!U5@&Q@=?2@#C;C5/$&K^.S:6;IIVHW'@];N,"",O%<F0?+O92
M=N>,9QWQGFG^$O'6K>-=?\/6EI<M#%9Z<]QK@$:_/-GRQ&<CY?F4M@8X->AQ
M>&])@UY-;AM!'?I9BQ1U8A5@#;@@7.T<^V:;H_A?1M O-1N],LEMY]2F\ZZ8
M,Q\Q\DYY/ RQX&!S0!X[H7B?Q'+X-\"16&I164^JZE<6T\D=I$%V[R 0@4+D
M=>,9/7-7;SQOXF\,:+X]M9-3.HW.BW%K%9WD\*!D$_4L% !V]N.OMQ7I%IX"
M\-V-MI-M;V!2+29VN+-?/D/ER,<D\MSR>AS4&N>#;>;3/$3Z1:6?]IZRJ?:#
M?;Y(9BG #+GY>,C*XP2#VH YBPOO$>B_$[P]X?N_%#ZM97EE-<RAX(U8L%..
M5'W<C(_'K75_$:&:?X<>(E@N6MW%A*Y=5#$JJDLO/]X KGMGBN-\$_#?4-*\
M86.LW6EZ9I,%C:O$L5I=27#SR.,%BS\A0.@R<5ZG>6D%_93V=U&);>>-HI4/
M1E88(_(T >"6NG:HS_".WAUF1+F>VNGAN3 A-O&8(_D48P<#(!.>3SFK]WX\
M\3Z+X9UZQ.H/>7]KKZZ5;W[0(9%C8$[MHPK-\I SW:O2M+^'OAO1Y-,DL[*4
M/ICRR6C/<R/Y9D4*_5N1A0,'@=JGF\#>'+BUU:VGTU9(=6G^T7BO(YWR?WAS
M\I_W<4 <]\/]5\1RZ]JFEZM_:-Q8Q1)+;7.HVZ0S*QX9&"'!'.0:J?'B">7X
M974D=V\444T1EB"@B8&10 2>1@X/'I78^'O"&B^%S</I=JZ37)'G3S2O+(^.
M "S$G ]*M:[H.F^)=(ETO5K<SV<I4O&'9,E2".5(/4"@#S&_O]5\/>,-7L$O
MTGEL?!L]TET;2))#*LA(;(7H./E^[QG%1:3K_BRTNO .I7WB![V'Q!^ZN;1K
M>-$4% 05(&=W.2<]?;BO2[WPGHNH:G=:C<VA>ZNK!M-F?S7&ZW8Y*8!P.>XY
M]Z:/!^AB+18OL9V:*0; >:_[H@8]?FX'?- 'DVJ^-M?M]3BU;3=>U"_L&UE;
M0G^SXXK'RRV#&I8[V8?WA^=:6JZQXLO]3^(1L_$DMC;>'D6>VBCMXV+'RF?:
M6(SM^4^_/MBNP;X5>#WEDD.F28>?[0(Q=2A(Y,YW(H;"G([?3I6S_P (GHN_
M6V^R'.N)LU#]Z_[T;2GK\ORL1\N* //8?$WB+Q;K/AC0[?5SH_VS04U6ZN8(
M49YI#\NQ=P( R,\5+>:MJ<6I^ +>YUG3=7FEU">&XO+:&-EDV@8P<'8P[[<5
MUVH_#OPQJFG:=97.GL(]-B$-H\<[I)$F,;=X.XC'J35F#P1X=M8M'CM]-6)-
M'=I+)4D8>6S?>)Y^8G_:S0!Y5J/C;7X-5M=6TW7M0O["76ELR?[/CBL3&6(,
M:$GS&88/S#T/-=A\.O\ D=?B#_V%$_\ 036E_P *J\'^<\G]F2 &?[0L8NI0
MD<F<[D4-A3D=OITKH=-T'3=(OM1O+*W,<^HRB:Z;>S;W QG!.!^&* .8^)E_
MXCL=-T__ (1\S?O+G%VMIY9N6CQTB5\@G/H">GO7FOBK6[O7_@WK:2ZYJ$]Q
MI^H0BXM[ZP2WN$1G 6.3!(.#\VX8/RX(KVSQ!X8TCQ/;0P:K:F402>9#(DC1
MR1-ZJRD$?G6>GP]\,IX>O=#_ +/+V5\XDNO,F=I)7!!#,Y.[(('>@#B_%FJ:
MY87D6C67BC5;B^L],,\T6GZ=$79LG$LSN0BICC:,'OWKGGN]:\5:W\*M4GUA
M[>[O8;H;XX$(1T'S. 1@EUP".@QQBO39?ACX4F>V>2PF9H(/LV?M<H,L><[9
M,-\XR?XL^G2I)_AOX7N-+TO3GL)!;Z4[-9[;F0-%N.6&[=D@GL30!YC%XZ\:
M:C+>:Y8-J4@@U,V\>G)9QFT,*L 4:0G?YF#G/^/&CKNO^+)[_P"($MGXCELK
M;P]Y4MM"EO&VXE-Q5B1G;P?Q/MBN\G^&OA2XUIM5ETO,[SBY>/SG$+RC^-H\
M[2?PJ_)X.T*7^V]]F3_;847_ .]?]Z%!4=_EX)^[B@#SS3O%'B;3/$OA^;4=
M7;4;;6M&FU"6T\A$6%UB\P+&0,^@Y)SS^&=X3\8^,]0NO#^K/+J5Y;ZG=^7=
MV[V4:6D<3,5W1.#N)3&3GKSZ<^L1^%-&COM*O5M")]*MS;6;>8Q\N,KM(QG#
M<<9.36;I_P -O"FEZO'J=IIFR>&1I84,SM%"[=62,G:I^@X[4 >:W_B3QD_A
MGQAXBA\320KH>M2V]O:BUB*N@D0;7)&2 &&/QSG/%^*/5Y_C;?7]MJOES?\
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M-N(T8Y*!R>?J?TJ[J'PZUBV\2:9JWAG7+>P^P:3'I2+<VWG$HA)R>0,]/RH
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ML-(_M"2:0JS27*6\4( SN=VSCVXKS?Q!\5-8U/P-#J6AV'V2X76!IUV4NDD
M(P=J/C#!\XW#ICZ&NU\<^"[OQ1J&BW]I=6:R:9)(_P!EO[<S6\V\ 9901R,<
M?6N>/PFOU\(ZCI"ZS;&ZN-8&K0SBUV(K\94H#P..W2@#MM<U^]T/P5<:])I)
MDNK:V6XFL1./DX!==X!!VC/..<5SG_"V=)_X2K^R/(;[-_9?]H_;/,X_U7F[
M-N.OE_-G/X5TNJ7UKI'A)I?$]PC1>0L-Y+# [*[,-K810S8)/OC-?/\ _8W@
MO_A$?[)_X3"?[=]N\_[;_9-UGR/*\KRL;/[OX=J /4K3XM V4MQJ>B-89T4Z
MQ;J;K?YR;BH3.P8)^4]_O4L'Q9^WZ?H\NFZ$]S>:A:W=S):FYVFW$&<@G8<E
MF4J.!7*^-M1\ >*_[!2#7IK.+3&$;H-+NCYMO\N8_N?[ Q4GA?6/ GASQMKG
MB$Z_-,M_N%M!_9=T/LZNY=U^YW;'3% '5VOQ<TVZUSPSIRVA5-:M!<O.9N+9
MB&PAXY.Y&'4>M=)X.\3'Q=X=3619-:032R+ K2;RZ*Q4/T&,D'C]:\).E^!X
M]%URR@\5S)-=W<<]A+_95U_H:([L$'R>DCCC%=Y9>//#.D6_AW3]*\3R6^F:
M="8;N$Z/<,UR-@"D,8_E(8%CZYH T?#?Q5F\3:O!!9Z'$;.:X:'<NI1FYB )
M&^2 @$+QV)_&HM0^,,-G?:A+%H_G:+IUW]CNKW[8BRAP0K,D)&YU!(YS7 O+
MX:O-?L;S4?%-K*EI?"\^W0^'KB&]FPVX([J@7'OC/%.G;PG'J]^=/\1V*:=?
MWIO)&NO#4MQ<PDG+)&[QD;3CN./SR >C:_\ $"^DU#7=*T#0YM0CTNTWWM['
M=+$82Z%E\M2/G('/4=#6=X;\8ZUIWPS\-7*Z<^K7%U#(T]Y>WZP1Q[6;&^1\
MDD] /:N<U'7/#Z>(=8O= \8FPL];@2*^ADT2YD92JE0T9V  X)Z],YYXQF"7
MPS;6OAD6_BBVGET>WDMVCO\ 0KJ:!M[%O,5-HPPSZ]A0!WW_  M]9?#.B:K:
M:!+<W&J7K6"VB7*Y64<##XPP)QSQUS5J7XA:^FO1>'XO!K2ZT^GB]> :B@2+
MYRI5G*X[#D9Y8#WKS[2[CPGI]CH-J_BMI1I6LMJ6\:/=+YJGG;C9P?TJ36_&
MEI<?%B37M#UPV4 T<6RW-QI=Q+'(_F9,90*&'!W;L8RM '1ZCXYE\1_\(/?6
M#7>G&;7?LE]:"4@AE^]&V,!AT//KTKH)/B6L?A;Q3K?]E$C0=0DL3#]H_P!?
ML95W9V_+G=TP>G6O/;&Y\&6-CX=B'BJ:6XT[56U2[F?2;D?:)&^\  GR] ._
M2J>IW.AW-MXFTNS\:K!H^N7C7SQOH=TTJR,P8KNVXVY [9X[<T >A:U\5FT_
M7!I-EI%O/<+:1W3B[U%+7?O7<$BW#YVQ]*[^WO0^E1WUS$]J#")9(Y""8N,D
M$@D<>U>%>*-6\/:XRQIXEL;BU-FEL(M1\/7$C6Q"X+PNJ!@3UP2>?TW=*\8^
M&=)LM'TB+Q9/-HMI9-:W5O+I%P7N"00&#>7E0,]!VXH Z/0?B'JNO36%W!X0
MO!H%_.T4%^DZNZ@$C>\0&57(/.>/RJG<_%>Y2+4-5LO#%Q=^&M/N3;W&I+<H
MK$@@,R1$9902.<C\.:X[P_KVG:$VG:6GQ G'A[3K@S10Q:-<I/*N21%(^S!7
M).>.?;C%.>ZT%++4= T_QP]OX9U&Y:>6!M$N6GC#$%HT?9C!QU(_KD ]$U7X
MG74.L:EI^C>'FU06-A'J!G^V+$C0LFXGE2<X(P!G/MBFZ1\4IM2U3P^D_AR>
MTTW7@ZV=V]RK,749(:,#@9X!SSUQ7+Q:YX)MM;UV\M_$$B6VHZ2FFPP_V7=$
MPA4V D[.:AL=4\)1Q>![9?$KN_AZ1MW_ !*KH>>6&!CY/E_&@#W2BLS1+75K
M2WN%U?48[Z5[AWA=(1'LB.-J$#J1SSWK3H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-1^*M:OM+UN_.GK;)<)8V?ERR0ACF2Z,9!/4K@GC/4DT =1]BU;_ *&C4_\
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M,4DDRQ'*HWS(-X8=/ND$F@#L7M=3C7<_BK4E7U:*U _]$T[[%JW_ $-&I_\
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M;&PVE!ON#\N/X>GM3[;0K>UBGC3P7JLB3P^1(+BYAF_=?W!OG.U?88%>B44
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MP=<?^BVH UT_U:_04ZFI_JU^@IU !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'_?F7_XJKU% %'[9XG_YZ:1_WYE_^*H^V>)_^>FD?]^9?_BJO44 4?MGB?\
MYZ:1_P!^9?\ XJC[9XG_ .>FD?\ ?F7_ .*J]10!1^V>)_\ GII'_?F7_P"*
MH^V>)_\ GII'_?F7_P"*J]10!1^V>)_^>FD?]^9?_BJ/MGB?_GII'_?F7_XJ
MKU% %'[9XG_YZ:1_WYE_^*H^V>)_^>FD?]^9?_BJO44 4?MGB?\ YZ:1_P!^
M9?\ XJC[9XG_ .>FD?\ ?F7_ .*J]10!1^V>)_\ GII'_?F7_P"*H^V>)_\
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MO44 4?MGB?\ YZ:1_P!^9?\ XJC[9XG_ .>FD?\ ?F7_ .*J]10!1^V>)_\
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M)_\ GII'_?F7_P"*J]10!1^V>)_^>FD?]^9?_BJ/MGB?_GII'_?F7_XJKU%
M%'[9XG_YZ:1_WYE_^*H^V>)_^>FD?]^9?_BJO44 4?MGB?\ YZ:1_P!^9?\
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M31_PDVE?\]IO_ 67_P")KL** ./_ .$FTK_GM-_X"R__ !-'_"3:5_SVF_\
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M)-I7_/:;_P !9?\ XFNPHH X_P#X2;2O^>TW_@++_P#$T?\ "3:5_P ]IO\
MP%E_^)KL** ./_X2;2O^>TW_ ("R_P#Q-'_"3:5_SVF_\!9?_B:["B@#C_\
MA)M*_P">TW_@++_\31_PDVE?\]IO_ 67_P")KL** ./_ .$FTK_GM-_X"R__
M !-'_"3:5_SVF_\  67_ .)KL** ./\ ^$FTK_GM-_X"R_\ Q-'_  DVE?\
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M_ 67_P")KL** ./_ .$FTK_GM-_X"R__ !-'_"3:5_SVF_\  67_ .)KL**
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M>+_^1*U[_L'7'_HMJV:QO%__ ")6O?\ 8.N/_1;4 7TU"RV+_IEOT'_+5?\
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MM"R_Y_+?_OZO^-']H67_ #^6_P#W]7_&N?\ [!T?_H$V/_@.G^%']@Z/_P!
MFQ_\!T_PH Z#^T++_G\M_P#OZO\ C1_:%E_S^6__ ']7_&N?_L'1_P#H$V/_
M (#I_A1_8.C_ /0)L?\ P'3_  H Z#^T++_G\M_^_J_XT?VA9?\ /Y;_ /?U
M?\:Y_P#L'1_^@38_^ Z?X4?V#H__ $";'_P'3_"@#H/[0LO^?RW_ ._J_P"-
M']H67_/Y;_\ ?U?\:Y_^P='_ .@38_\ @.G^%']@Z/\ ] FQ_P# =/\ "@#H
M/[0LO^?RW_[^K_C1_:%E_P _EO\ ]_5_QKG_ .P='_Z!-C_X#I_A1_8.C_\
M0)L?_ =/\* .@_M"R_Y_+?\ [^K_ (T?VA9?\_EO_P!_5_QKG_[!T?\ Z!-C
M_P" Z?X4?V#H_P#T";'_ ,!T_P * .@_M"R_Y_+?_OZO^-']H67_ #^6_P#W
M]7_&N?\ [!T?_H$V/_@.G^%']@Z/_P! FQ_\!T_PH Z#^T++_G\M_P#OZO\
MC1_:%E_S^6__ ']7_&N?_L'1_P#H$V/_ (#I_A1_8.C_ /0)L?\ P'3_  H
MZ#^T++_G\M_^_J_XT?VA9?\ /Y;_ /?U?\:Y_P#L'1_^@38_^ Z?X4?V#H__
M $";'_P'3_"@#H/[0LO^?RW_ ._J_P"-']H67_/Y;_\ ?U?\:Y_^P='_ .@3
M8_\ @.G^%']@Z/\ ] FQ_P# =/\ "@#H/[0LO^?RW_[^K_C1_:%E_P _EO\
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M_P"-']H67_/Y;_\ ?U?\:Y_^P='_ .@38_\ @.G^%']@Z/\ ] FQ_P# =/\
M"@#H/[0LO^?RW_[^K_C1_:%E_P _EO\ ]_5_QKG_ .P='_Z!-C_X#I_A1_8.
MC_\ 0)L?_ =/\* .@_M"R_Y_+?\ [^K_ (T?VA9?\_EO_P!_5_QKG_[!T?\
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MCCAO8YH9L;QE24" @8YY_P#K5W-VOA&PNX[2\71+>YD^Y#,(D=OH#R: .O\
M[0LO^?RW_P"_J_XT?VA9?\_EO_W]7_&N0U!/"6D&,:DFBV9D^X+@11[OIG&:
MS-:U?P?H>I:38W-EII?4V/ER".((B 9WL3T4] >YH ]"_M"R_P"?RW_[^K_C
M1_:%E_S^6_\ W]7_ !KCISX.MM073Y_[#BO6( MY/*60D]/E//-9MO?:'+XL
MUK1)= L8H]+MH[A[DQH=X9<GY=O&/J: /0_[0LO^?RW_ ._J_P"-']H67_/Y
M;_\ ?U?\:\A?6[PZ#::S;_#K39K&:T%W),][!"(@<G!#)G[H4Y]_:G:#XDM=
M;T/3M4/@G3K6.^U%;1%FN(4S&1S*NY!OYR-@&3CB@#US^T++_G\M_P#OZO\
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M0[6:W2*0*?0D9JY_8.C_ /0)L?\ P'3_  H Z#^T++_G\M_^_J_XT?VA9?\
M/Y;_ /?U?\:Y_P#L'1_^@38_^ Z?X4?V#H__ $";'_P'3_"@#H/[0LO^?RW_
M ._J_P"-']H67_/Y;_\ ?U?\:Y_^P='_ .@38_\ @.G^%']@Z/\ ] FQ_P#
M=/\ "@#H/[0LO^?RW_[^K_C1_:%E_P _EO\ ]_5_QKG_ .P='_Z!-C_X#I_A
M1_8.C_\ 0)L?_ =/\* .@_M"R_Y_+?\ [^K_ (T?VA9?\_EO_P!_5_QKG_[!
MT?\ Z!-C_P" Z?X4?V#H_P#T";'_ ,!T_P * .@_M"R_Y_+?_OZO^-']H67_
M #^6_P#W]7_&N?\ [!T?_H$V/_@.G^%']@Z/_P! FQ_\!T_PH Z#^T++_G\M
M_P#OZO\ C1_:%E_S^6__ ']7_&N?_L'1_P#H$V/_ (#I_A1_8.C_ /0)L?\
MP'3_  H Z#^T++_G\M_^_J_XT?VA9?\ /Y;_ /?U?\:Y_P#L'1_^@38_^ Z?
MX4?V#H__ $";'_P'3_"@#H/[0LO^?RW_ ._J_P"-']H67_/Y;_\ ?U?\:Y_^
MP='_ .@38_\ @.G^%']@Z/\ ] FQ_P# =/\ "@#H/[0LO^?RW_[^K_C69X39
M7T65E(93J%\00<@C[5+5+^P='_Z!-C_X#I_A5GP6B1>'3'&JHB7UZJJHP !=
M2X % '04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P#;* +5%5?[#US_ *#MM_X+_P#[91_8>N?]!VV_\%__ -LH M455_L/7/\
MH.VW_@O_ /ME']AZY_T';;_P7_\ VR@"U157^P]<_P"@[;?^"_\ ^V4?V'KG
M_0=MO_!?_P#;* +5%5?[#US_ *#MM_X+_P#[91_8>N?]!VV_\%__ -LH M45
M5_L/7/\ H.VW_@O_ /ME']AZY_T';;_P7_\ VR@"U157^P]<_P"@[;?^"_\
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M_P#;* +5%5?[#US_ *#MM_X+_P#[91_8>N?]!VV_\%__ -LH M455_L/7/\
MH.VW_@O_ /ME']AZY_T';;_P7_\ VR@"U157^P]<_P"@[;?^"_\ ^V4?V'KG
M_0=MO_!?_P#;* *,G_(Y6W_8/F_]&1U#XVBDF\"Z]%$C22/I\ZJBC)8E#@ =
MZ9)H^L?\)?;1_P!LV_F&PE8/]AX \R/C&_Z<UK_V'KG_ $';;_P7_P#VR@#S
MOPC\.+6[T'P]?:QJ6M71@ABN$TZZN/W$,@48 3:",>F?:N=U6UMK&[\;6>O>
M'[N_U;4YY&TNX2S,V]&7$2HX!V[3C/3I[5[-_8>N?]!VV_\ !?\ _;*/[#US
M_H.VW_@O_P#ME 'BFNZ/=Z:=&EU">]MM4CT:.VEEGTP7UK/C_EEQN*OS@G';
MWR;&H6[+8?#W5M:\-);QP--'>6\-D7")_P LP4P2 ?O;3T)->Q_V'KG_ $';
M;_P7_P#VRC^P]<_Z#MM_X+__ +90!X)XUCN]27Q-$FD-:WR:ANCM[?26DDGC
M##$[7!S@$=EQ^1-=)XA6_3Q-XW>UMYRVHV%G9V\@C;#-)M0X/L&)/IBO5_[#
MUS_H.VW_ (+_ /[91_8>N?\ 0=MO_!?_ /;* /)O'=^TNN6'A">SU.+PQ81Q
MM=O:6SR&ZPH*Q@KT4<9]\^@J]X@U*V\0V_A+^QM,OH;:QU^U4QR6C1>6@!Y
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M$E_Y'BU_[!LW_HV*MNL27_D>+7_L&S?^C8JVZ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ K$\*?\@>?_L(WW_I7+6W6)X4_P"0//\ ]A&^_P#2N6@#;HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K&\7_\
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MJVZXU]?1O%$%^--U7R$LI(2?L;YW%T(X^BFM/_A++7_H':M_X!/0!OT5@?\
M"66O_0.U;_P">C_A++7_ *!VK?\ @$] &_16!_PEEK_T#M6_\ GH_P"$LM?^
M@=JW_@$] &_16!_PEEK_ - [5O\ P">C_A++7_H':M_X!/0!OT5@?\)9:_\
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M ,/_ (1#1?\ GWG_ / R;_XNC_A$-%_Y]Y__  ,F_P#BZW** ,/_ (1#1?\
MGWG_ / R;_XNC_A$-%_Y]Y__  ,F_P#BZW** ,/_ (1#1?\ GWG_ / R;_XN
MC_A$-%_Y]Y__  ,F_P#BZW** ,/_ (1#1?\ GWG_ / R;_XNC_A$-%_Y]Y__
M  ,F_P#BZW** ,/_ (1#1?\ GWG_ / R;_XNC_A$-%_Y]Y__  ,F_P#BZW**
M ,/_ (1#1?\ GWG_ / R;_XNC_A$-%_Y]Y__  ,F_P#BZW** ,/_ (1#1?\
MGWG_ / R;_XNC_A$-%_Y]Y__  ,F_P#BZW** ,/_ (1#1?\ GWG_ / R;_XN
MC_A$-%_Y]Y__  ,F_P#BZW** ,/_ (1#1?\ GWG_ / R;_XNC_A$-%_Y]Y__
M  ,F_P#BZW** ,/_ (1#1?\ GWG_ / R;_XNC_A$-%_Y]Y__  ,F_P#BZW**
M ,/_ (1#1?\ GWG_ / R;_XNC_A$-%_Y]Y__  ,F_P#BZW** ,/_ (1#1?\
MGWG_ / R;_XNC_A$-%_Y]Y__  ,F_P#BZW** ,/_ (1#1?\ GWG_ / R;_XN
MC_A$-%_Y]Y__  ,F_P#BZW** ,/_ (1#1?\ GWG_ / R;_XNC_A$-%_Y]Y__
M  ,F_P#BZW** ,/_ (1#1?\ GWG_ / R;_XNC_A$-%_Y]Y__  ,F_P#BZW**
M ,/_ (1#1?\ GWG_ / R;_XNC_A$-%_Y]Y__  ,F_P#BZW** ,/_ (1#1?\
MGWG_ / R;_XNC_A$-%_Y]Y__  ,F_P#BZW** ,/_ (1#1?\ GWG_ / R;_XN
MC_A$-%_Y]Y__  ,F_P#BZW** ,/_ (1#1?\ GWG_ / R;_XNC_A$-%_Y]Y__
M  ,F_P#BZW** ,/_ (1#1?\ GWG_ / R;_XNC_A$-%_Y]Y__  ,F_P#BZW**
M ,/_ (1#1?\ GWG_ / R;_XNC_A$-%_Y]Y__  ,F_P#BZW** ,/_ (1#1?\
MGWG_ / R;_XNC_A$-%_Y]Y__  ,F_P#BZW** ,/_ (1#1?\ GWG_ / R;_XN
MC_A$-%_Y]Y__  ,F_P#BZW** ,/_ (1#1?\ GWG_ / R;_XNC_A$-%_Y]Y__
M  ,F_P#BZW** ,/_ (1#1?\ GWG_ / R;_XNC_A$-%_Y]Y__  ,F_P#BZW**
M ,/_ (1#1?\ GWG_ / R;_XNC_A$-%_Y]Y__  ,F_P#BZW** ,/_ (1#1?\
MGWG_ / R;_XNC_A$-%_Y]Y__  ,F_P#BZW** ,/_ (1#1?\ GWG_ / R;_XN
MC_A$-%_Y]Y__  ,F_P#BZW** ,/_ (1#1?\ GWG_ / R;_XNF^#H4M] >&,$
M1QW]ZB@DD@"ZE Y/)K>K$\*?\@>?_L(WW_I7+0!MT444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C>+_P#D2M>_[!UQ
M_P"BVK9K&\7_ /(E:]_V#KC_ -%M0!KI_JU^@IU-3_5K]!3J "BBB@ HHHH
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MMJMO_:-U?SZ;<:>]Q<7&HVL<:V[JN[>FPY:,XQB@#T;[-K7_ $,=S_X#0_\
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MB#Q#XA\4"U\2KH5MH;(D2-$A0_*27E+#[O!_#]0#M%NKU]3?3%\62&^2(3-
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M_K5[ ^D/Y:DPVSR.&.,8( CZG/WJ]2\::H=%\)7=RNI_V?* L<=R;?SV#$@
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MJ(=4M8[>YMT<_=R3L=B V"0/ITH ]*^S:U_T,=S_ . T/_Q%'V;6O^ACN?\
MP&A_^(KB_A]XANKO6-0TO4M0U8W,<*S+9:M9I%+&N<,PD7 922.H'\Z]$!!
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MVG=_] #5O^_<?_Q==710!RG]IW?_ $ -6_[]Q_\ Q=']IW?_ $ -6_[]Q_\
MQ==710!RG]IW?_0 U;_OW'_\71_:=W_T -6_[]Q__%UU=% '*?VG=_\ 0 U;
M_OW'_P#%T?VG=_\ 0 U;_OW'_P#%UU=% '*?VG=_] #5O^_<?_Q=']IW?_0
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MT5R7]B?]175__ ^3_&C^Q/\ J*ZO_P"!\G^- '6T5R7]B?\ 45U?_P #Y/\
M&C^Q/^HKJ_\ X'R?XT =;17)?V)_U%=7_P# ^3_&C^Q/^HKJ_P#X'R?XT =;
M17)?V)_U%=7_ / ^3_&C^Q/^HKJ__@?)_C0!UM%<!9MI]_K.HZ3;ZUK+7FG>
M7]I0WDH"[UW+@YP>/2M+^Q/^HKJ__@?)_C0!UM%<E_8G_45U?_P/D_QH_L3_
M *BNK_\ @?)_C0!UM%<3J%I9Z5837U_KNJ6]K"NZ2634) %'3U]>*J&;31KE
MMHW]MZS]MN;<W,2?;)<&,=\]!]* /0:*Y+^Q/^HKJ_\ X'R?XT?V)_U%=7_\
M#Y/\: .MHKS:YU+2K;Q+%X?.KZ_)J,BARD5Q,ZQJ>A=APH^M;G]B?]175_\
MP/D_QH ZVBO+KC7] M;74+F77];$6GW8L[@BYF.V4G&!Z_45TG]B?]175_\
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M<E_8G_45U?\ \#Y/\:/[$_ZBNK_^!\G^- '6T5R7]B?]175__ ^3_&C^Q/\
MJ*ZO_P"!\G^- '6T5R7]B?\ 45U?_P #Y/\ &C^Q/^HKJ_\ X'R?XT =;17)
M?V)_U%=7_P# ^3_&C^Q/^HKJ_P#X'R?XT =;17)?V)_U%=7_ / ^3_&C^Q/^
MHKJ__@?)_C0!UM%<E_8G_45U?_P/D_QH_L3_ *BNK_\ @?)_C0!UM%<E_8G_
M %%=7_\  ^3_ !H_L3_J*ZO_ .!\G^- '6T5R7]B?]175_\ P/D_QH_L3_J*
MZO\ ^!\G^- '6T5R7]B?]175_P#P/D_QH_L3_J*ZO_X'R?XT =;17)?V)_U%
M=7_\#Y/\:/[$_P"HKJ__ ('R?XT =;17)?V)_P!175__  /D_P :/[$_ZBNK
M_P#@?)_C0!UM%<E_8G_45U?_ ,#Y/\:/[$_ZBNK_ /@?)_C0!UM%<E_8G_45
MU?\ \#Y/\:/[$_ZBNK_^!\G^- '6T5R7]B?]175__ ^3_&C^Q/\ J*ZO_P"!
M\G^- '6T5R7]B?\ 45U?_P #Y/\ &C^Q/^HKJ_\ X'R?XT =;17)?V)_U%=7
M_P# ^3_&C^Q/^HKJ_P#X'R?XT =;17)?V)_U%=7_ / ^3_&C^Q/^HKJ__@?)
M_C0!UM%<E_8G_45U?_P/D_QH_L3_ *BNK_\ @?)_C0!UM%<E_8G_ %%=7_\
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M6\F4)).MVH=U'0%MF2* /,]6\*R>$=$\*6EQ=+<W5SXL@NIY$3:F]L@A1V&
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M_P#$T :%%9^_Q#_T X?_  .'_P 31O\ $/\ T X?_ X?_$T :%%9^_Q#_P!
M.'_P.'_Q-&_Q#_T X?\ P.'_ ,30!H45G[_$/_0#A_\  X?_ !-&_P 0_P#0
M#A_\#A_\30!H45G[_$/_ $ X?_ X?_$T;_$/_0#A_P# X?\ Q- &A16?O\0_
M] .'_P #A_\ $T;_ !#_ - .'_P.'_Q- &A16?O\0_\ 0#A_\#A_\31O\0_]
M .'_ ,#A_P#$T :%%9^_Q#_T X?_  .'_P 31O\ $/\ T X?_ X?_$T :%%9
M^_Q#_P! .'_P.'_Q-&_Q#_T X?\ P.'_ ,30!H45G[_$/_0#A_\  X?_ !-&
M_P 0_P#0#A_\#A_\30!H45G[_$/_ $ X?_ X?_$T;_$/_0#A_P# X?\ Q- &
MA16?O\0_] .'_P #A_\ $T;_ !#_ - .'_P.'_Q- &A16?O\0_\ 0#A_\#A_
M\31O\0_] .'_ ,#A_P#$T :%%9^_Q#_T X?_  .'_P 31O\ $/\ T X?_ X?
M_$T :%%9^_Q#_P! .'_P.'_Q-&_Q#_T X?\ P.'_ ,30!H45G[_$/_0#A_\
M X?_ !-&_P 0_P#0#A_\#A_\30!H45G[_$/_ $ X?_ X?_$T;_$/_0#A_P#
MX?\ Q- &A16?O\0_] .'_P #A_\ $T;_ !#_ - .'_P.'_Q- &A16?O\0_\
M0#A_\#A_\31O\0_] .'_ ,#A_P#$T :%%9^_Q#_T X?_  .'_P 31O\ $/\
MT X?_ X?_$T :%%9^_Q#_P! .'_P.'_Q-&_Q#_T X?\ P.'_ ,30!H45G[_$
M/_0#A_\  X?_ !-&_P 0_P#0#A_\#A_\30!H45G[_$/_ $ X?_ X?_$T;_$/
M_0#A_P# X?\ Q- &A16?O\0_] .'_P #A_\ $T;_ !#_ - .'_P.'_Q- &A1
M6?O\0_\ 0#A_\#A_\31O\0_] .'_ ,#A_P#$T :%%9^_Q#_T X?_  .'_P 3
M1O\ $/\ T X?_ X?_$T :%%9^_Q#_P! .'_P.'_Q-&_Q#_T X?\ P.'_ ,30
M!H45G[_$/_0#A_\  X?_ !-&_P 0_P#0#A_\#A_\30!H45G[_$/_ $ X?_ X
M?_$T;_$/_0#A_P# X?\ Q- &A16?O\0_] .'_P #A_\ $T;_ !#_ - .'_P.
M'_Q- &A16?O\0_\ 0#A_\#A_\31O\0_] .'_ ,#A_P#$T :%%9^_Q#_T X?_
M  .'_P 31O\ $/\ T X?_ X?_$T :%%9^_Q#_P! .'_P.'_Q-&_Q#_T X?\
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M[R8I#;-GE%4L[<<\#'YUVM>4ZSX=\5>*OBG<:E971T:UT:W6WLKBYLA,L[2
M^8R*Q [[2?0#UH [:P\8Z3<^"[/Q1=74=K83PH[R.>(V8A2I]PQVT_3/&GAO
M6;N[M=.UFTN9K1"\R1OG:HZL/4#U&17CMSX5\3Z9\,_%O@AM/NKX074$^G7$
M,!"3HTB,X0<XVXSCW/I79ZOX?O!\3K6\L]-D%DGAR6U,L<>$#Y;:F1WQC H
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M$WBQ@X6 Y#EB.0,'K3?$_@#2]$^&WB/3_"FCO'/?0KF&%WD:5E88P&)[$]*
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MA5BZ_+NP?[V-WXT =!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1\"_Z[Q5_P!AZX_] CKI_MMI_P _4/\ W\%<OX#97D\4LC!E.O7&"#D'Y(Z
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MALG"QQZ3/Y+1MT B.T@_ES7/^&M+L_\ A95Y>>3_ *0-%LI0Y=OO,9E8]>X
MH ]$HKS_ ,9ZM<^#]?&LP"26+5+)[)(<DJ;Q,M!Q_M9=?P%9UIHUA'XD7P_X
MGO&DMK#1X'M5GN6C2:0L_P!HFZC+!@O/\(/;- 'J-%>3^%M8E&K>%);_ %!S
M:26^J0VUQ<RX\^-9H_*8D_>/EC()Y(YKJ?A[>KJ&GZU<QW'GPOK5WY4@;<"F
M_C!],=* .OHKQ35[K4[6>[T2UGN WA>[GUIL,?WEN&22.,G^(%99EQ_TSJ^L
MZZM<Z/>ZI=2IHGB#5+J>3=*T:.B)LM8V.1A65-^WH3ZT >N50UG5[;0M)GU*
M\W_9X=N[RUR>6"CCZD5Y=<7<>FWE];Z?>N/#]CXATWRY//+1P%B/.0.3]P$K
MD9P"Q%.\8ZE#?W?C=+:[6>&&PTU2$DW*K^>Y/3C.,9H ]4U*_ATO2[O4+C=Y
M%K"\\FT9.U5+' ]<"HY]6MK?09=9??\ 98[4W38'S; N[IZXKR[Q%%I>H:?X
M_N=?O6BU.S:6*T5KED,,/DJ8@BY (<EL\?,20:[35O\ DDM]_P!@*3_T0: +
MMWXLL;+3YK^>WO5M8H8)O-\GY7$K;5"G."0<9';(K>KQ77I9SHGB&-&+;-%T
M5HXV8[=QE;\LX%6-0U#5+/PIXF%W</'XHCNX4U&43,J):/* KPD#*1>62,@;
M@0Q.2* /8JJ/J=I'JT.EM+B\FA>=(]IY1"H8YZ=77\ZX+P?!+8>-C:V\VE6]
MK)IYDFL;"_FN@QWJ$ERR!5/+#KEL]#C-2>)[:"+XFZ?>)&AO_P"Q;MK7<Y&^
M97CV #/)Y/% 'HE%>0Z>=.MM'\':MI.H23>(+^[MDNF^U,\ER'_X^%D0GHHW
M'D?*5&,5UGQ#MQ>0^';)Y9HX;G6H8IO*D*%T,<FY<@@X(XH [*BO'=3L/^*L
MUK2Y8M.&GZ9:P"PCU#5IK;R(2F6ECVJVX[]P+DY&T"K>E>5K6J:39^+=12ZM
M1H,5Q;LTTD,5S(78/+\VTE@@C/(XW$XYH ]7JM+>"*_MK3[/<.9U=A*D9,:;
M<<,W8G/'K@^E>122#5==T^P@N(M3T6/21+8G6M0EMA.?-=7DRJ'S&4! ">BD
M$9SFKFCI<:K)X5T^\U/[9;W5GJT'GV\TC!H]T:I\[JI8J#@/CG&0><T >M45
MY-I^JZUK$+QH96U'PKI=RDZC/[[4,/%'D?Q?+&7_ .VJU3\+B>.]\*7MM>:5
M%/>N//EBU.>YGOU,9,@DC,> P/S9) 4C&1F@#UJ\U.TT^:SAN9=DEY-Y$"[2
M=[[6;''3A6//I4>E:O;:Q%<R6N_;;W4MJ^]<?/&Q5L>V17*?$&RT^?5_!\U^
M$$:ZL8R[R%  8)3C.1_$JUR5QI-M!X2\4^(8VG75+77[E[>=9W'DXNL84 XP
M<G(QSGF@#V>BO&-;-U?ZWXNFU"738I;";;;S7FJ36TEG"(E*21(B$<DELCEC
MD=J](DUMM%\!+K6J2I-+;Z>LTS("HEDV \ @$;FX (!YZ"@"73_%6EZGXBU'
M0[:1S>6 !EW+A6SC.T]]I(!]"16U7C,-MXC\)6F@>(-4TJU@2QN'?5+N.\+R
M2QW3CS2R;!C:Y1OO'&RI]5TN"\T/XA:U+-<F^TZ\G:QE6X=?LY2"-P4 . <G
MGUX% 'K]%>8G1[7Q%XD\5/J;3S"WL;1X4$[HL;M"Q+@*0-V0.>WXFCPGKF-:
MT*ZU;40GVGPE;S-)<2[1(X?+MR<$X()/O0!Z=5#4-7MM-NM.MI]_F:A<?9X=
MJY&_8S\^@PAKR?3;^'5O#_ABP>)M0EN/M]RD5WJ!MK5T6=AND(5F=@"-J@<
MDGH*7PU<M.OA^/SXY8;;Q9<PP^5,TL:(+:4A49N2HR<$]J /3O$7B.U\-V]I
M+<V]W<-=W(MH8K6+S'9RK,!C([*:JVWBT7$%S*?#^O0B! ^V6RPTG(&$ )R>
M<X]*R?B1#<7#>%(;6[:TG?78@DZHKE#Y,W.UN#^-0^+[35]*^'6OO?:]-J$A
MB0Q.8$A,7SC.-@&<Y[^E '?45Y7JFCVVJ7GQ$O+M[EY;':UGMN'46[BS1MZ
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MEKM@S3M-HEI]KO-J9 3;NPISRV.U<(]U'X>\5ZUXLE)6WLM=>UO6 _Y836T
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ML+YKC2Y98)G:(B:V+@ML88Y7K@YJW7CFKZE<:/\ %#QWJ5HRK<VOAM9HBPR
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MEM$/OJC$'D D GN,YK'?Q[XYM?"NHZ]-J6GR1Z)JQTZ:$6>#>8< L3GY/O#
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MB<DD="2><U\Q6OC?38O&4'CQM3/]IS:P\=Q8[6RNGE0B\XVY4#IGTKZD5E=
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MC\,5-10!FZ%H\>AZ3%9+(9I-S233,,&:5V+.Y^K$G';I6E110 4444 %%%%
M!1110 4444 %%%% !1110 5B>%/^0//_ -A&^_\ 2N6MNL3PI_R!Y_\ L(WW
M_I7+0!MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ^!\C?,/4=>>* .RHKSS0O'5^?"_AQ+JQ%WK>I6?VC:URD2-&JKNE=L87)8
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MHHH **** "BBB@ HHHH *Q/"G_('G_["-]_Z5RUMUB>%/^0//_V$;[_TKEH
MVZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*?\ ('G_ .PC??\ I7+6W6)X4_Y \_\ V$;[_P!*Y: -NBBB@ HHHH ****
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M8_\ OD4 9G_"5^'?^@_I?_@9'_C1_P )7X=_Z#^E_P#@9'_C6G]GA_YXQ_\
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M@_I?_@9'_C1_PE?AW_H/Z7_X&1_XUI_9X?\ GC'_ -\BC[/#_P \8_\ OD4
M9G_"5^'?^@_I?_@9'_C1_P )7X=_Z#^E_P#@9'_C6G]GA_YXQ_\ ?(H^SP_\
M\8_^^10!F?\ "5^'?^@_I?\ X&1_XT?\)7X=_P"@_I?_ (&1_P"-:?V>'_GC
M'_WR*/L\/_/&/_OD4 9G_"5^'?\ H/Z7_P"!D?\ C1_PE?AW_H/Z7_X&1_XU
MI_9X?^>,?_?(H^SP_P#/&/\ [Y% &9_PE?AW_H/Z7_X&1_XT?\)7X=_Z#^E_
M^!D?^-:?V>'_ )XQ_P#?(H^SP_\ /&/_ +Y% &9_PE?AW_H/Z7_X&1_XT?\
M"5^'?^@_I?\ X&1_XUI_9X?^>,?_ 'R*/L\/_/&/_OD4 9G_  E?AW_H/Z7_
M .!D?^-'_"5^'?\ H/Z7_P"!D?\ C6G]GA_YXQ_]\BC[/#_SQC_[Y% &9_PE
M?AW_ *#^E_\ @9'_ (T?\)7X=_Z#^E_^!D?^-:?V>'_GC'_WR*/L\/\ SQC_
M .^10!F?\)7X=_Z#^E_^!D?^-'_"5^'?^@_I?_@9'_C6G]GA_P">,?\ WR*/
ML\/_ #QC_P"^10!F?\)7X=_Z#^E_^!D?^-'_  E?AW_H/Z7_ .!D?^-:?V>'
M_GC'_P!\BC[/#_SQC_[Y% &9_P )7X=_Z#^E_P#@9'_C1_PE?AW_ *#^E_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&&);&[(//:O3M-\+:%H]Z]YIVE6MM<."#)'& 0"<D+_=!/88%,A\(^'K:_\
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MGEF,?*_[M222"1C@C%>Q.BR(R,,JPP1ZBLBR\)^']-OH[VRTBT@N8T"1R)&
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MUU*9YXV3AY"0=Y_VL@<^U-M?#6B65I<VEOI=K';W2[;B,1@K*,8^8=^/7UH
MX2TO-3\.:P\D[7D<-MI=Q=W\-_JHNFD"@%)57)V?,"/EP.>G%=-X'T>]L="L
MKW5=4O[W4KBTC,_VB=F1"1G"IT!&<9ZFM"U\)Z!96%W8VVDVT=M=KLN$"9\U
M<8PQ/)&.,5L@ # &!0!YC?W,FI:+XL\17NM7]D=,N+FVL8K:Z:)(##\JDH#B
M1G;G#9!#  5:T"REUCXC3:K?27276G:3:)+$MPZHL\H+R+MSC;A4RO3//6NM
MF\*Z#<:K_:DVDVKWNX.96C!)<=&(Z%AV)Y%7X+&UMKBYN(8$2:Z</.ZCF1@H
M4$_0 #\* ..\364.J_$?P[;RW%S''86UQJ,HCN'C4;=J(< CG+OSZ CIFN7T
MFTNX?#_A[6X]2OX]0UW7%N$B2=DB$4LC2N#&.'S$IY8$^F !7J-YH6EW]_%?
M75C#+=Q1M$DS+\P1@0RY]#D_G3UTG3U%@JVD(%@/]$&W_4_+L^7T^4D?0T >
M4W.J^(-4T_4M=1KR"<W\EOIL@U188("DIC2-H<X<LR_-N!)W<8XKTOQ3/>6_
M@W69[(-]MCL)GAV=1((R1CWS2KX6T%=8.KKI-J+\OYGG^6,[\8+>F[_:ZUKT
M <?IE[X>T'X76$SM&VD?88UVH-YG+J 5 _B9B3QU))K,BB@U2\U]+O4;W2M'
MT!8[6VM[2Z>V\E1"LAE<J06^\  <KA>AS736O@OPU9:D-1MM$LHKL.7618A\
MK'JRCHI]P*FO_"VA:I?B]OM*M;BY 4%Y(\[@.FX=&QVSG% '"Z%+K/B^ZTBV
MU'5+^TB@T&*XOQ:RF!I99G^3<5^Z=L1;C!^8CH2*HVUU>3^#;'Q1!KVHRZE?
MZN!86XNF,1C>YV^28\X8>6&))R1C@C%>F:AI*RV.JFP6*WU"^MS%]H*_Q!2J
M%L=0N:HZ%X+T/0DLI;?3K87MM;I"+D1_,<(%+#T) Y/4]Z .*O[RZO/!>M^+
MY=9U"WU"*XGCTZW@N62.%HY3'%$8@=LC.RC.X'.[C%7YKR:?5/$VNZIJM_;:
M5HGDHMM:2LJ&:.(22$@$;AF0+MR <<YP,=?_ ,(KH/\ :W]J_P!DVOV[S/-\
MWRQG?_?QTW?[77WJXNE6"VUU;"SA\B[9WN(R@*RE^&+#OGO0!YKITNL6/C#P
MW;3RZK#->">:]:]U,3>;"L1))A4E(_G*8*XQTYYJCH$D^EZ'X=N+2YOS+K%Y
M=:Q<JUR[F2"-)'5>2?O;H0?7C.:]+L/">@:7*DUEI-K#+&K(L@3+!6 !7)YQ
M@#CI4NG>&]&TDP&PTZ"W\A72+8OW%<@L!Z E5_(4 <%')?0:%X6\0?VU?7&M
MZO>6I:$7+&"1)2&DC6'.P*D98[@,C;DFJM[+J5]X6U/Q"NM:DMQ<ZT8-(BBN
M62.-?M"P+\H.'!VDX;(QT'))]$T_PKH.E7QO;'2;6WN3D"1(P"H/4+_=![XQ
MFK":)ID=E:V:6,(MK2198(@ORQNIR&'N"2: +RNK$A6!*G!P>AKA/%%Y+J7B
M&73[8ZE)!IML)KQ+:^%E$A?)5GE#!SA58X' ZGTKK-+TF#2C>O%CS+VZ:ZF8
M+@%R .GT51^&>]0W_AG1-4OUOK[2[:XN54)YDB9)4'(![, >1G.* //O#][K
M/B&U\&6$FK7L/GVUWJ%W)',1*]N&V0JSXY)$B_-C/RYX/(73;W4+DVFA1:K?
M1V.H:Y>Q1W37#/.+:W4YC61B6RSJWS9R%S@UZ19Z-INGR1/:64,+0VXM8RBX
MV1 Y"#VSVJO<>&-$NM,BTV?3+=[.*0RQQ;>$<DDL.X.6/(]30!S/@BR0>+_%
M5U%>SWMM;20:;;27$IE9 B&21-YY;#RD<DGC':JWBG47O=9U,1G59++1K<?:
MA;ZA]AABD*^9N+J=[G85XQM'N37<Z=I5AH]NUOIUG#:PLY<QPH%4L0!G ^@_
M*J=]X4T#4[][V]TFUN+F10CO(F=X' W#H<=B>G:@#@ENM<U7PWX;+7-SJ%Q!
MIRW>J6%K?-:74BR >5('7;NV[6RN1DUW'A.[BG\'Z?>#4+B]@>#S5N;I=LK(
M<D;\=P, GOC-27WA/0-26W6[TJVE^S1"&(E<%8Q_!D<E?8\5JPP16\$<$$21
M0QJ$2-% 55'   Z"@#S/3[B]'BC3[B\U'4&BU.^>73M1M;PRVES 0SK \!($
M9\L8W!3RN<T+KM[<^ =-<:E.FH>(M8"VS"4[XX7N2<)SD*L*]NF:[BP\*:!I
ME_\ ;;'2;6"X&[:Z)C9N^]M'1<]\8S3;/PAX>T^Y2XM-'M(9DE\U'6,91L$9
M'I]YN!QR: .0M&?7+*77K[Q'?:;<S:L]I81Q3L(H@DQC6,P@[9&?82=P/WNP
M%8U_;W,^A>+?%,&I7\%W=:L;?3EMKAHEW(Z6T;$+C?EE/#9&.W)KTR/PQH<.
ML-JT>EVRW[,7,X3G<1@L.P8CJ>IJ==$TQ+&"R6QA%K!*)XHMORI(&WA@/7=S
M]: +JLIRH<,R\-CL:X[68;O7O'L.CQZG>V>GVFFM/=K9S&-I&EDVQ@L.1@1N
M<CGKZFNCTW28-,GU">+!EOKDW$S!<9.U5 _!5'XY/?%68[*VAO)[R.!%N9U1
M990/F<+G:"?;)_.@#R#3]2\0ZCH]AKP>\BO;Z]1;.235@MN%\S @\C.&.P$$
MD%LY.15_6K^\N_#GB;Q*VM7UK>VE]-8Z;;P7!2.-D?RU5HQP[.W)W X##&,5
MZ!;>%=!L]6;5+?2;6.^9F;SEC&0S?>([ GN1R:RM>\!Z7JU_:WT%G:0W0OX+
MJYF,?S2K&=V/]XE5!/IF@#,@UR71[CQ;?WNH226>B6=O:IYLA*M*L)D=L'JS
M&1!GJ<"L*UN-?O;BTTB[.HW4.FZ/;7%WY6I_9))9Y0Q9WDR&*KM( !QG.>U>
MA7GA'P]J-]/>WFCVD]Q<)LED>/)<8V\^^.,]<<5)JOAC0];FBFU/2[:ZDB78
MK2)D[<YVGU7/8\4 <(MSKFJ^&M"MTO&O[M%DN[FRMM1,$]W:%F6)UF3&2!L)
MY 8]34&E0P>)?$/A$1ZGJMS;VUO=ZCFXG:.5 )!%&C[3\S*6D4MU8+U(->B:
MGX;T;6! +_3H)C;@K$Q7!13U (P0.!QTI8_#NC0WEE=Q:;;1SV,1AMGCC"F)
M#_",=N3Q0!SWQ)M4U/2](T=I)D&H:M;PL(I60E 2[YP>1L1NO?!Z@5RNHVN;
M7QYXB&I:E$ED!8V:P7;QNTD$("LS@[G/F.PP3C.<@FO4=2T?3M82%-1LXKE8
M)1-%Y@SL<=&'H>336T33&L9K%K&$VLTQGDB*_*\A?>6/J=W- 'GFN:A=W']H
M232ZM/!HEHD5Y)!J L84N!&'=LJ=\C89>"-HZ $DTN@VEUKOBSPM/JMW=27F
MG>'X[R<I.R S2L N5! R0L@;CYN,Y%=O>^$O#^I7TUY>Z1:7%Q,NR5Y(\[P!
M@;AT) X!/(JU'H6EQ:E#J,=C"MY# +>.8+AEC'1<^G7\Z ,+QI->SWWAW1M/
MOI[*:^U#=+- V&$,4;.X_$A1SD<]*XK4(;V+PYXPO;?7-9\FRO\ [)I4?V^3
M<L^(T+%\[G'FL?E)*C!XYKUJ2QM9KV"\D@1KFW5UBE(^9 V-P'UVC\JK_P!B
M:7]E^R_8H?(^T?:O+V\>=OW[_KN^;ZT </J&M:K:^(=<\,VM[*^IZC);?8&8
MY^SQO%B64#LJ^4[8Z;F [UZ';0"VM8;<222") @>5RSM@8RQ/)/J:P-%\/74
M7B&]\0ZS):3:G-$MK#]F0A(;=26V@MR26))/T Z5TE !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444AR0<
M'![&@#SV;QMKQTVYUFWL=/&F0ZK]AB5V<RW:>>(=R8X4Y)Y.<X/ ZD\5?$"Z
MT2[U7[/<Z&D>FQ[_ +-/,TEQ<D+N( 0_NO0;@?4@"MR#P7;P>']#TC[7*T6E
MW4=T7*C,[H2WS>F7.[\*SKOX>27-AJ.EKKL\6EWMVUVUNMNF[>TGF,K/U9<Y
MXX.,#)'% !J?BW6SJ6J6^EVEC%!INFQWMS/>ESY;L';R]JXS\JCN,9[\"J\/
MCC5[:31[S6;*RM=.U&PFO7BC9VFMTBB$A9B< YR!C'&1R:VKSP=%>6/B6W:]
ME5]>;]]*%&8T\M8]@]MJG_OHU-J/A*QU346GNF8VYTR731;@8"I(1O(/8X51
M^% ',:+\1Y]1U'21+)I,D.IRB,6=K(S7-IN4LI<_=;H V ,$]36Q\2I+AO"#
M:?9IONM2NH+*)=^W=OD&X$]AL#<U<T?PU?V%W:S7_B"[OX[.(Q6T.Q84P1C=
M(%_UC8&,G@<G&>:F\2>'&\0/ITB:A-9R:?<?:H6C0-^\"E5)!Z@;CQWSVH Y
MZ_\ 'E[X:_MFWUVWLY+FRAMYK8VC,B2^<[1JC;L[2&4Y/ISCC%6?#'C.;5?$
M/]DW%UI5Z7M&N5GTPOMB*LJE'#$_WP0W&<'@5/)X$BN;&]-YJ<\VK7<\-RVH
MJBJT;PD&((G0*I'0YSN;)YK6T?1KRQNKB\U'5[C4;J953E1%%&JYP$C!P"23
MDG)/K@8H IZ[K>J0>(M+T31K>UDN+N&>>:6Y+;8(TV -A>3EG QW]1UKFKG7
M;OQ&FB:3=QQ17R^(6M[L0,?+=;4-*S+GG:=J<'UQ6C<Z'K&I_$+4=5M;V?3!
M:6,-G;3& 21S!BTDORMUP?+Y!X*]^15VU\!V%K+9'[3<2+;6]U$V\C?+)<%3
M),S#^(X/;C=0!A_\+$NQJ]HBRZ+-!<ZBED+*VF:6X16?8',BDID?>*XX'&<U
MJV?B+Q)K(.J:/IUC-HZWAMTBDD*W$\:R;'E5B0J@$,0ISD+U!(%)8^!)[?\
ML*.ZUV:YM=$D5[6W%LD:D*C(N_'WF ;[W'?CFI]-\%R:=-:P+K5TVD6=RUS;
MV*H$PQ8L%>0<N@+$A>.V<XH YRX^*N3=7UK-I1L;:Y,*V;R,;NY17VLZXX7N
M54@Y ZC-:6L^,-:73_$&JZ3:V7]EZ,98G:X9O-N'C'[PICA0IX&<[BIZ=:T+
M#P7/I[PVL6O7BZ-;W)N(K&-%1@2Q?8TH^9HPQ/R\9Z$D57OOA\UY!J-@NN7,
M.D7]V;R2S6%2=[.'==_78Q!X]^I'% &AI+1>#_AQ:2W[/LTW35DN#U8LJ9?\
M2<_G5*#Q%XAL[W1'UJSL(K76)O(2&!G,UJYC9U#,>'X0@X"X/K72ZQI=MKFC
M7FEW@8VUW"T,FTX.&&,@^M847A"[FNH+K5==GOI[.%X[(^0L:PLZ[3*0/OO@
MXSP.3@#- &-;>-M>N=/TO6!8Z>FFWVJ+911EG,TL;S%%D4]%PHW8.<X/3BMG
MXBWNHV/@J\.E3+#>W#1VD3DD,&E<1@H1T8%@0?:IX?"%M!8>&K)9W^SZ$RO&
MFT?OF6)HU+>GWBWUJSXET%O$%G:Q1WK6<MK=Q7<<@C#C<AR 5/4=_J!0!Q;W
M.O0^+M5GM#I^=#T6&WGFN#(8@YW2L%4'))4)R3QCOFK%Q\27D?3;2.73-,NI
M]-AO[J3478I$9!E8E52"S=23D8&.N<5T,_A".;2?$=E]NE5]=DD>:<*-T:M&
ML>T>P5<?C3+SPC.-3EO=%UF;2FN+:.VN52!) RQY",N[[K ,1GD=..* +_A3
M7#XC\-VNJ-$L3RET=4;<NY'9"5/=25)!]"*XR/7KO35\7>);>'S?-UA+!7=7
M>."&%5C:5E7YBH8R$@?I7HEA9II]A;V<<DTB0QA \TA=VP.K,>2?>N:MO!4N
MGZ3IUMIVM7-M=V4\T_V@H&6=I69G$D><,,MQSD8&#0!1G\9:M:^%)-5:+3;J
M/[5'%%J-FS2VQA;&9F127 4Y!7/7OBI8/%VI_8=,9X]-NGU#5([.VNK.7?#/
M"5+O(HR2I55<8)/(J6V\#3:?#'+I^N3V^H"[FNY9A"ODRM* &#0C VX5<<Y!
M&<\FF1_#_P"RP64EEJTD&H6U_-?FX-NC(\DJE''E\ #!XP>/?)H CU_Q_P#V
M'>:U&T$+1V+6EM 7D*>9<3!FPS=%55VL3C.,U3M_B-)%;ZT;B?2[]K#36OXY
M]/+B,E<CRF#$D'.W!SR#T&*TU\ 0KIUU%_:MVU_-J:ZHE^ZJ7290JKQC:5PN
M,8 P2!BIYO!TU_IE[;:IK=U>37LL+3.5"1JD;AO+2,'"@X()Y)SR>F !(;/6
MM7MK+4==M[6)K.07L%E:ES)O$; *[$XSENF".V3UJIX.\6ZIXBNHS*-,DA:(
MFYAMV>.XT^7C$<J.<MGD;@!RO3%=3J^G+J^DW6GM<3VXG0IYUN^R2,]BI]0:
MR=)\,3VGB!M<U+4_M]_]E^R(ZVZP@1[@QW 9W-D#G.!V S0!S'QC:ZNM&L-*
ML9&CN)7GO,J<';;P/)C\7\L?C5'XEZU-XATJTT'2IF2.\-J]U)&<']^ZK#$#
MZG+.?]F/_:KO[WP[!?\ B&'5;B5F$5E+9I!CY0)"I9L^N% K&TKX>6>F:?H]
MK]NFG.GWJWLDLBC=<NL9CCW>@5=H ']T4 9'B'X@W.A3:C]EET0P::XC6Q,S
M27,X& <%"1$<G # GCG&:C\97_\ :,WB.QA@6.X/V+18KA7;>QN'#2+C.!A7
M!R!GWK5/P\D.G?V5_;LXTI+T7D=L+= 2?.\TK(_5USGT/3.<5H+X+@%\MR]Y
M(Y_MAM6=2@^=_+,:)]%&,?2@#"C\37$%]*^D:5;27NHZX^F1AY7 >*WC(:0G
MG&THPX'3L35D>-=6MGO].N+2SN=6CU*+3K0VY9(97>(2DMG) 122V,YQQC-:
MFD>"X-*GT>7[9),=,2ZV[D \R2=PSN??[P_X$:Q_$'A[^R[6.6%-3GFEUB34
M_MMC")9+61E(7]U@ETV_(1Z<T :VBZWKDWBZ[T'5;>Q(M;-+EKFTW@.9&(0;
M6)V_<DSR<X!]JBU%FOOBKHMF&(CT[3KB]< \%I&6),_@)*C\!:5J$$^MZSJC
M79N-3N4\K[6BI+Y,:!5W(O"9)<A>P(SSFK%[X3U&3Q/>:YIWB&2QENH8H&C^
MR1R@*F2 "W3EF/XT 2Z_>JWB?0=+^QK=,?/OS\Q#1^4@"D8(!):0#G(K"T3Q
MQJ^JVEQ=,-)*16DLMS I=)M.D5<A)D<[G'494+R/3FMJ;P<]]--<:AK%U+=2
MZ:=/^T0JL+H#(7+KMZ-]P>GR#UJK/X#EU%K^?5M:DN;RYTV33%GAMDA*1/@L
M2!G<W ] .< 9H M_#Q=4_P"$(TZ;6)EFN[E/M18%BP$GSX8DGD;B/0  =JP;
M#Q1>RZC;KH^F6AN-;U"])DED?;Y-O^Z$K<GJ53@#!Z<9S7=:?9S66DP6<ER)
M98HA'YPC" X& =HX'TK%T#P9;:#<Z=/'=23&QTTV"!U SN<.\A]V('Y4 3^$
M]9O=9L]0_M".W%Q97\MFTEL&$<NS'S ,21R2,9/(-8NI>--2M+[Q!<1VUHNB
MZ$Z"YN)"QDF/EJ[1Q@<;OF R>!D=<\=+X?T6/0-*^Q),T[&:6>25Q@N\DC.Q
M/XMC\*HGP?9S>']8TBYFEDCU6XFGFD&%96D;(V_[N% _W10!A>'_ ![<:CKV
MFV-Q/I%P-15\1:?(S/:,J%\.3PPP",@+SC@YI_AOQKJ>LZCB>/34A0R?;;(,
MT=WIX7.UI Y^<' !*@#GC(K7@\+7LWVDZOXAOKUY;5[1/) MEC5ARX"]9.GS
M'IV YKG_ !%X1U6+1;N_.HS:MJD&G2V%@$MEC?\ >@(6<KDN1P>P')Q0!-IO
MC'Q#+8^'=7U"PL(M.UFX2!88V?SXQ("8Y,GY<$ 97L#G/89Z?%7[21J%M-I3
M6!NA"ECYC&\EC,FSS!CY0?X@F#\O<&NCTOP4UE/I8O=6GOK/2%QI]L\2H(R%
MV!G(^^RJ2 3C&>YYI-*\%SZ6;.T37KQM'L9?,MK%$$9')*H\@Y=%SPO&<#.:
M (AXB\2:I+?7>@Z=8SZ?97;6HBGD*S791MLA1LA4 .X#.<[3TI/"EQJ^H>,/
M%-[=7$+Z?#<K8V\:[LJ8U#$C)P/]80W')7T%3V_@N2VNC%'K5TFD?;6OA8H@
M4^8SERID')CWDG;^!)'%:7A[06T!=0C^VM<Q75Y+=J'C"F,R,68$C[W)Z^@%
M '*^(/$&H:7X\O+QY8WT?1=*$\MNF[=)),Q5%ZXWYCP"> '/K6O;:YK]EKVD
M6.NVVGA-6$BQK:%]UO(B%]K%N'& 1N 7D=.:=?\ @B'4K[7I;C4)OLVLPQ))
M"J*&B>,#8Z/[$9P1C)-6=/\ #5PFLPZOK&JR:E>6T30VW[E8HX0V-S!1G+G
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MKMW8E3^9KI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(R2RD#)P!V Y). *YS7_ !U$GA-M0TLS171U&'3S'/;MYD4C2*'4QXR2$)(
MSGC&:G\4V&LW>O63Q6]]>:0+=U>WL=0^R,)]PP[L&4LFW(P"<>AKF]/\*^(]
M+L]%D.E1W$MOJ]WJEY;"[#;B=T<01W.6.Q]P+8^YR030!V,?C?1S8W]S<FYL
MVL'2.>WN8&68,_W $&2V[/&,YIO_  G.E1VM_-=Q7MD]A$L\\%S;E)!$QP'
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M,!BI^4].*Z;P_INHR:_JGB'5;=;2:[CBMK>T$@=HH8]QR[+P69G8X!( QR:
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MZ_*BGGWK#\-^#[U+C1+>]T6XM+?3 CRR7.L37$;RQC"&"(2%5&>?G48' 7N
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MT:#5-1U-+<V[0O/J%L?/6(,TA?\ <   @;=HR .N: /=);F"$$RSQQ@$ [W
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M\JSN%WHTQ"\$\$\\9Z_C7FGBFST[2KSQA)I^GVT4%CX=6WD58AB2:9V*L_\
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M1110 4444 %%%% !1110 4444 58M-L(-0GOX;*WCO+@ 37"Q@22 # #-U.
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M+4[;4+[6+_59[2)H;0W?E@0JV Q^15W,0 "QR?S-=%M7<6P-QXSCFEHH *3
MSG SZTM% ",JMC< <'(R*6BB@!&56&& (]"*6BB@ HHHH 15"C"@ >@H"JN<
M #)R<#K2T4 %(%4$D  GJ<=:6B@ I-H+!B!D=#Z4M% "!0N< #)R<4!5!)
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MW8&[&,XYI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **Y75/B-X7TC4)K&YU!WN+<XG%O;2S"'_ 'V12 ?:
MM*?Q5H=OX=7Q ^HQ-I3;=MS&"ZG<P4<*"?O$#IQWH V**S=;\0:5X<L?MFKW
MT5I 6VJ7R2[>BJ,EC[ &LS2/'WAO6]233K6^>.]D!:."ZMY(&D [J'4;OPH
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M8W@[_H8;+_ONC_A8W@[_ *&&R_[[H ZBBN7_ .%C>#O^AALO^^Z/^%C>#_\
MH8;+_ON@#J**Y?\ X6-X._Z&&R_[[H_X6-X._P"AALO^^Z .HHKE_P#A8W@[
M_H8;+_ONC_A8W@[_ *&&R_[[H ZBBJ&DZUINNVK76EWD5W KF-GB.0& !Q^1
M'YU?H **** "BBB@ HHHH **** "BBB@#A/BY_R)4?\ V$;3_P!'+6QX^L+/
M4? .NPWT:-"ME+*"P^XRH65AZ$$ T_QGX:?Q9X>;3(K[[%)YT4RSF+S-I1@P
M^7(ST]:P[OP-X@UR'[%XB\927FEN09[6UL$MC, <[6<,3M/<#&: .:\3^)(Y
M?AIX-TO5[LPMKL=L;Z4ABWV=55Y6X!.6^4?\"-:/P[\1Z2?&GB+0-+NEFT^X
M?^T['",@7?@3( P'1L$ =B:Z^V\+)#XS;Q ]P&2.P6QL[58MJVZ [F(.>23C
ML, 8YHUWPQ_:VO:%K-O>?9+O2IF;=Y>_SHG&'C/(QGC!YQZ4 8OBK_DJOP_^
MNH?^B!53XES7MOXB\%3:?9I>7:ZA*8X'E\H.?*/&[!Q^5=3JOAS^T_%7A_6_
MM7E_V0;@^3Y>?-\V/9USQCKT.:J>+_"MYXBN-(N]/U9=-N],G:>.1K83@DKM
MQM+#UH 72=7\776IPPZGX4MK&S;/F7":HLI3@X^0(,Y.!U[UL6%G?6U[?RW6
MI-=03R!K>$PJGV9<8*@CELGG)K!LM#\9PWUO+=^,[>YMDD5I81I"(9%!Y7=O
M.,CC/:MZPM=0M[V_EN]2^U032!K:'R%3[.N,%=PY?)YR: +]%<]J_CCP_H5^
MUCJ-W-%<*H8JEG-(,'IRJ$?K5'_A:'A'_H(7/_@NN?\ XW0!U]%<A_PM#PC_
M -!"Y_\ !=<__&Z/^%H>$?\ H(7/_@NN?_C= '7T5R'_  M#PC_T$+G_ ,%U
MS_\ &Z/^%H>$?^@A<_\ @NN?_C= '7T5R'_"T/"/_00N?_!=<_\ QNC_ (6A
MX1_Z"%S_ ."ZY_\ C= '7T5R'_"T/"/_ $$+G_P77/\ \;H_X6AX1_Z"%S_X
M+KG_ .-T =?17(?\+0\(_P#00N?_  77/_QNC_A:'A'_ *"%S_X+KG_XW0!U
M]%<A_P +0\(_]!"Y_P#!=<__ !NC_A:'A'_H(7/_ (+KG_XW0!U]%<A_PM#P
MC_T$+G_P77/_ ,;H_P"%H>$?^@A<_P#@NN?_ (W0!U]%<A_PM#PC_P!!"Y_\
M%US_ /&Z/^%H>$?^@A<_^"ZY_P#C= '7T5R'_"T/"/\ T$+G_P %US_\;H_X
M6AX1_P"@A<_^"ZY_^-T =?17(?\ "T/"/_00N?\ P77/_P ;H_X6AX1_Z"%S
M_P""ZY_^-T =?17(?\+0\(_]!"Y_\%US_P#&Z/\ A:'A'_H(7/\ X+KG_P"-
MT =?17(?\+0\(_\ 00N?_!=<_P#QNC_A:'A'_H(7/_@NN?\ XW0!U]%<A_PM
M#PC_ -!"Y_\ !=<__&ZZ;3]0MM5L(;ZS=GMYEW(S(R$CZ, 1^(H LT444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &-)KR
MMXC?2;:(2"U@\^_F)X@!!V+[LV"<=@,]Q7,1>.O$%UH7_"2VGA:*;0BAF4"^
M_P!*:$9RXCV;<X&=N[-1>&M7;2? >N^*WLY;VXGU"[NIHHS\Y5)3$ /940?@
M*Q=2N]'\-PV^K> ?$<;R7=S&%T&*=9X;K>XW!(^6B;!))& ,8P* /2X=5>YU
M.WA@@C-G+9_:6F:8+(A)&U?+QG!&XYX QBI[?5],O,?9M1M)\OY?[J96^?&=
MO!ZX!./:O*/$LS75_P"*-2DD>/2WU:PT>]F4D>7:)AI^1T4M+@GTS5F\N_"X
M^(=MJ&A)8F'P_HUU>W,ED%\IN D:Y7@D R?3- 'IYU?3!/# =0M!+.2(H_.7
M=(0<$*,\X((X]*+S5M-T^6.*]U"TMI)/N+-,J%OH">:\H3PU::?X"\&6)M8S
MJVJZC9RSW+(#,#GSY"&ZC 4CCU]ZI^(=9M)]-\6:Z8_#UN[236A@OHWNKR5H
M@8U 4N!&#C( ! !W'/- 'J>K>*=/TC6])TF9T-UJ4C(B^8J[%"EMS9/0XP/4
MG%:WVNU\J:7[1#Y<)82OO&$(ZACVQWS7F>B6%BGCW0M/OA;RW&C>&H0OFA3(
M\S$<C/)*K$3QTW5AQZQ977PBMM*AO(I=7\37Q$L43AG0W%SERX'W<*=O/>@#
MV.?5-/M1FXOK6(84_O)E7AN%ZGO@X]<4'5-/&H"P-]:_;2,_9_.7S,?[N<UP
M%GI5OJOB#QGKXL(;R:Q*V&G12QAU1X(0QVJ>,[W(SU&".YKD-)M5O_#&@V,6
MK:#)J&HW$5P);>T>74%G#"1W=O,R"I!#,0 !Q[4 >\U4MM5TZ\N9;:UO[6>>
M+_6113*S)]0#D5S_ ,2;FYM/ &IR6LDD3$1I++']Z.)I%61ACT0L<]NM8%U!
MX?;Q7X1L/"D=CYUE(]Q/+9;2(K01,I#LO9V*XSU(S0!O:7XOEUSQC?:5IL%C
M-IU@0D]U]L_>,Q0-\D84Y4$JI)(Y/M4^O^);RPUJRT/2--COM4NX7N,3S^3%
M%$A +,VUB>6   /X5E_"ZPM!X:DUJ*TABEU6\N;H%(PI$;2G8H([;57BH?$5
MUX9UWQ'<Z-KL[:/J.F!)K#4!=BWE977YFB?C@$;2#D<=* -*T\87<,&MIKND
M?8+S2;4W;^7-YL,\6UCN1]H_ND$$9''6M;0M>MM9L;1FDMHK^6VCGFLEG#O#
MN4'!'!XSC.!7F5WK6I:QX#US19-2&J0W&J0:18:JJ!?M22,@?IPQ4%QN'!Q6
MSJ5IIGA_QUIW]F:;'''H6AWE_*EN@#S [452>K$[7//4\T =_P#VMIHU#^SS
MJ%I]M_Y]_.7S/^^<YITVI6%M*(I[VVBD+K&%>55.YONK@GJ>P[UXA<+!<Z=X
M:L[:3PY&^K:I;3B.R1Y[N+,@E9VN&?.X8()(R>0*Z6.P6]LO'?B^&S2ZU19[
MB/36>,/Y7V>,(K1@]&WH3D<G H ])35-/DOVL$OK5KQ1EK=9E,@'NN<UD+XN
MLD\2:KI=V]O:0:>D :ZGN @>24,VP XZ* >O\72O--&L8;B'PIIUEJGA^6X,
M\-XDNGVCO=_)AY'E?S#MW#*L6');&.U6Y;;3I/!7COQC=64-U<WUQ=16DDT8
M?"+^XB"YZ991TZ\>@H ]:N[^RT^W^T7MW;VT&0/,FD"+^9.*RO$?B2+1/#O]
MJVT:7QDDABMXTE $S22*BX8 _P![/?I7&V%OIEAXU%AXFGM5BT?1+6/3EO74
M1D8832KNX+955)Z@?6LG1HQ?7>A6-O$8=+U#Q+=:K91;=H%K"F5(7^%6D(8#
M_:% 'K%UJVG64WDW-];13^69!"TJARH&20N<GH:S=&\46M]X4TW7=3:WTM+Z
M)952>X  #<J-QQDD8/XUY3>7.AW/PLU>>_\ LL_BO5+R6)T?!N8[@S%$4?Q(
MJ#;CH,?7G2NHQI_CG58KN^T"VMM'T^UM[%-:A9P(/+R[Q#>HY8%20"?E H ]
M=:ZMTBCE:>)8Y" CEP Q/3![YK(3Q-;2^);'3(&AGMKZTFF@NH90ZL\3J'3C
MCHX/7L:\\L=%74;3P5X=NF\ZQN+JZU=X!"T*K H)2/822$S,!@GIQ74W-I;_
M /"SO#VGZ=;Q00:5875S+'"@1$$I5%&!P,D.?P- ';T444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-[V&WMTNY+4>8XRS*[*,#N6"[@!S@U'X.TNYM+C5KZZM[^%KV6,K]ON(Y)I
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M;^-;C^S'AEUC38XK:*5X][.('78<,0"&;'7'O0!T]]XET73+V.SOM4M;>X<
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MJ74#22JERLCC;'\H50#R6R<D >NYXM\-:CJ6MP'3XU-CJ<2V6KG>%VPI('#
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MSPR0R2-&80!#'&8YMS9"J4+<!LAN.: .^K)F\4:%;ZC_ &?-J]FEYY@B,+3
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M =?>>-M,M]5ETV&>WEN!IK:A&[3JL;J 2!NYP" 6W= .>:O7'BC1;&2VAO\
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M\R2,V2PEA\VW>CD\$C[IP>F5C\/ZI?>(8-8ETQK:";7H[TVLCH6BC2T>+S'
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M6YY2K,N67: N[;E0"Q(/:L_PUX8O;'6]$O)[":***#47D%Q/'*\4DTT3*"5
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDN$',C,H!7.5Y4 $\$G Y!K*UCQSH>F>&[G6K;4+*^BB=85$%W'AY6. F[.
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M@"\/$.G6ZQ1:I?6-A?-'O>UENTW)A=S#J,@#G..G-7GOK2-E5[J!6:)I@#(
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M/+0_[L81?PH VCJ-B+X6)O+?[81N^S^:OF8]=N<TL5_9SW#6\-W!).@):-)
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M*ZF1"?XE4G/;KCM6K7D$WA_4SJ.H6=Q%J37=QK1NHI(-/1E*>:&23[21\NU
M 03GY2 ,&O4['48K^6]CC25&L[@V\GF+MRVU6R/48<<T /&HV)OS8"]M_M@&
MXV_FKYF/7;G-":C8R7SV27ENUV@RT E4R*/4KG(KSC^SKVU\9 V>G74F_6/M
M$L%YIX>-%8_-<172@;?E)(1BQ_AQ45CI-U_9VB:0FC74.O6>J+<76H-;$)M$
MA:27SNC^8I(P"3\V"!B@#T*^O=,O+;4+!I;:[=('\^S$R[BN.0PS\N>F3CK3
M+2^T?2=-T^V,EEIL;Q*(+5ID4 8^ZN#@_AFN"T[3S'X7L](/A:Z.MVEE<QW-
MVT)15D,3JSK)C$QD8C@$_>R<$5GZOIFJSZ=>V!TBXCFDT6"WA\G3//>Z80G*
MM*V4BVL2,8![C)(H ]2L]7BO-9U+35C=9+#RM[G&&WJ6&/IBE35H ]V+IHK5
M()C$KRSIB3"!R>#QP3P<'Y2>F#6!X/L[RWU?59[JWFB6:VL0K2J1N98<,.>X
M/!K&N- N;SQ,3<Z;)+:'Q0+H[XLH8Q8;0_IMW@#/K0!W;:OIB6*WSZC:+9N<
M+<&=1&3[-G%6$N8)&C6.>-S(GF(%<'<O'S#U'(Y]Q7E][H4UK=WDHLM0M(XM
M;GFM9[2Q%RD:O!$"3!M)=&;>,J,@YY&35G1O[1T:[T#4[[0KB.%;"\M#%I]F
MQV%IT>,M$"3'O5"<9PI."10!Z#)JNG1+&TE_:H)#A"TRC<<XXYYYX^M$6IZ?
M/>O917UM)=1_?@292Z_5<Y%>>>$O#MR=2T2?5=&8?9M,NL+<Q B*9KH,HR<@
M-MS@^F<5GZ+8:I)K'A6=]*N;5K6]D>[@BTLPQ6FZ*4$>:V6ERS#Y@2IZG'%
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MV!?W#M<(R+@95"$)PO4#CM0!U_B/Q-!X>^P1& W-W?3^1! )4CR=K,22Q
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M8T*YFLXM&-NT4=BTS6]R64L6B4%@648W8_AP<9H ]/FO[.WV>==P1^9C9OD
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M9[5Y9X<T'48+S1+6\CU :E9W[37,BZ8J)U;>YN2,.K@] 23N' QQ/!X8CL/
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MD49DD=40=68X _&O&KG0+JQTNU7[#J;7)TH0+#=Z6+V*=0\C+ X3F%@& SN
MP1W6N\\7VE[J/PUOK46;F\FM$5K:'+D-\N5&.3CG\J .C@OK.Z65K>Z@F$1*
MR&.0-L/H<=*H:AXFTC3M$GU=[V&:S@(5G@D5_F) VCG&>:XKQ3X9G&IZE'H^
MD%;.33+42PVT01+A8[G<\0Q@%C%N&/0X[U3U[2CK*:Y>:-H-U#8G3(HFA>Q:
M!KB99@PVQ, 253<,XYW8&<4 >IFX@6V^TM-&(-N_S2PV[>N<],>]9M_XDT^R
MAT^<3)/;WMT+9)HI%**2K-N)SC V&L[Q9;0ZIX*"QVE]Y+-!*L=M /.B"NK
M^4X^;;@$QD9(!&,UR%MH]YJ4=I#=:0L]D/$$$YG_ +-:U^T((&#220-]W#;5
MW8 ;T]0#TX:C8M9&]6]MS:#GSQ*OE^GWLXI/[3T_[*MU]NMOL[YVS>:NPX!)
MP<XZ _E7F^IZ;=6%]J<<&C8T^37DG646#W"0+]D0&5($QOS)E<\@$DXR*J:/
MX=N;J\M8;_2;B6R_X2:2Z(N;(1H8C9$+(4 VJI?MZ\'G- 'JG]HV/VB*W^V6
M_GRKOCC\U=SKZ@9R14TLT4"[II$C4G&78 9_&O(+WP[?+J&L64D%^+BYU036
MC6NEJX\O<OE,MR1B,(H P2,;3@'//=^-]-;5M.TRV^R-=1?VK:/-&$W#RQ("
MQ8?W<=<\8H WH]1LIK1KN*\MWMESNF652@QURV<4+J%D]JEREY;M;O\ =E$J
ME&Z]#G'8_E7G.K:#-;Z[J,L>CRR:-'JUG=SVL$&5GC$!5F5 /GVOY;$ $G;W
M(J*70WU75S<P:+/'HEQKEI,MM-:F,'9#())6B(!522@^8#.W)ZT >GVUU;WD
M"SVL\4\+=)(G#*?Q%2UQ6FZ+JMOJ'B6'29DT>*34XYH7:S\R.1#;1!MJY4<N
M#DCN#78P+(EO&DT@EE50'D"[0S8Y..V?2@"2BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH C2>&1RB2HS
M@!BH8$@>M#SQQQ&0L"NTL,'[V!GBO(?!EM976E>#QHVESP:I!,9;Z[-HR#R2
MCA]TI&'#$I@ GH.FWBUHCW$MCX&TH:=J"7.E1RQ7OF6DB)"XM9$ +$8.3T()
M'3U&0#T33]?LM3T"'5X"WDRVBW?E''F*C)O (!X./>ETG6HM8@BGAMYXX);2
M&[224* 5D!(7@GY@!SVY&":\OT'3(/['\+P:3H=W9:G:6$@U61[)X25-LRE&
M8J-Y:4H0 3TSQBG+I&I'2=KZ==O;C2-#6[@$+;I8HY)#/&!U8A>JCG!QWH ]
M>BECGC$D4B2(>C(P(_.D,\(E6,RH)&R NX9..O%<]X6&DM=:G+HND36-I(T>
M96A:".=PN"4B8#&!@%L#)]<5P=];V-W-XQM;;2IYO$4VK 6-TEHS;'"1%6$H
M&$"'+')'!]Z /7C-$LRPF1!*PR$+#<1ZXI#<0AF4S1AE!8@L,@#J?I7CU_H]
M\^LZM'="8:I-JWG6DL.C--,8]ZF)H[G>%5548()&,,".>=*Y\,6C:)XBO;K3
M+E+N;6Y&^TPV0FE$(F5@2C#,D.5!*#.1D@4 >GB>%H//$L9BQGS PVX]<T">
M(QK()4,;#(;<,$=>M>36MK*UI UWHZ2Z#;ZR)KLV>GRPI=H8"!*;9LG:LFS<
M%&"1NQP:E30TU+5K7R=(E7P[+XA6:"VDMF1 @LY [^60-L;28Z@ D]/FY /5
M/M$/D>?YT?DXSYFX;<?6J5SK-K;:AIEF=TC:B[I"\>"HV(7))STP#TS7F]YI
M[:<US9#1HTTT>()9(GGL9;BWME-NA#"",C>"Y< _=#$GK3O"6GWL.JZ3NLKF
M."'6[YUS9-;HL;VWRL$/W%))P/4XZYH ].FN_)O+>W,,K"978RC&R/;C[V3G
MG/& >AZ4LU_:P03S//'LMT+RX8$J,9YKD?'%G=7.J6+06TTJKINI(3&A8!FB
M0*..Y/3UK%/A:WM$T);71503:!=17NVV_P!8^R$J)>.6W;B-W.<T =SHFOPZ
MSHUOJC6\EC#<X,*W3Q[G4@%3\K$#(/3.?:M1YHHR!)*B$G #,!G_ #@UY9I^
MEZ;I;::?$&@R3Z<V@6T5M&NGM.L4_P QG4HJG;(V4Y(&<$9XJ/2?"]S,3)K>
ME//=6WAJ)+<W$?F&*3S)RJ@G/[Q5V#CD?C0!ZH;NV <FXB CQO)<?+GIGTIT
MMQ# @>6:.-6. SL #7FNC>#=-75/":SZ##Y/]A2&\\RVRK3?N,>;D8+_ #28
MW<_>K'MK2<:=H=EJ&D!?*TCRTFN]*FOF8^8P,*1@A8V "G<PR01V% 'J=UKM
MG:ZA)I_SRWB6CW8AC RR*<8&2!DGH,U=2ZB*0&1A$\P!6.1@&SC.,9Y/TKQV
MTTJ:+2-/:[TFY-]+X0FM$D:S9G$ZJ1L+;?E;;D#.,]!UQ5ZYL+:.+6HM<T2Z
MO+VZL;=-*9;)Y2%%NJ^6C 'RF$H=CDKU!^@!ZL\\,;*KRQJS': 6 )/I]:>6
M5<;B!DX&3WKR>\\+S76D>,Y]4TLW>K+ID"P3M#O8S+:C)B./O>8.J\Y ]*[C
MQ+I]QJG@NXAA!-\D*7%OD<^?&1(G_CRB@#?,B#=EU&W[W/3ZUDKXDLQ<VMK.
MDUO=7*3R1PR ;BL3!6/!(YW*1SR#[''G.GZ9K%]KML]Q87:6GB:X34+T2H0+
M86\KNB/_ '2R?9TP>NUJFTS2OLU_X:N;W29=X75X?,-HS%'>Y#1;B%)4$;R"
M<#D\\T >D:-K%IKFEVE_:L0EU;QW"QN1O574,-P!.#@U=EFB@C,DTB1H.K.P
M _,UYKX7\.)I,7P^N+;23:W/V1UOY%@*O\UODB4XS]\#ANXK4\=#S-9TB.6P
MA>W$<S?;+C3Y;Y(W^0!!"A WL,X9NF"!U- ':O<01Q^8\T:IC.YF &/7-0WM
MG9ZG;&UNHTFB+)(4)[JP93Q_M*#^%>7>#/#GVR^T6+6=&>2VM;+45$5Y:82-
MC=KL&PC:/D)P/3I48@U;P]X:T"_L+>6._N89M#,;J0T>^1C;N0><(P_)Z /7
M0ZE-X8%>N<\4B312.R1RH[)]X*P)7ZUB7^E1Z=X!N])L8V9(-,DMX4499L1D
M#CN3_.N&O_#%U96&EKX<TXV=_/X<O(9988_+9IBD)02-_?+;\%N<Y/K0!ZFE
MQ#('*31L(SA\,#M/OZ4J312LZQR([(<,%8$J?0^E>2:O86EY8W7_  BFA75G
M$F@7L%Z@L7@+LT8$41!4>9(&W'C..>?FYZ*U\/MI?BJR.AV<.GF70Y4DG^S$
MQF421%/, *[FY<\G)YYZT =Q+/%;IOFE2-,XW.P _6L?5_$]KI&IV&GF":XF
MNU>7,3(%BB0J&D8LPX&\<#)/.!7)>)(-1_M73(-;AL+MEMYB-0_L:>ZB!+*/
M*6!78*Y SO8G@$#O63X?\-_:8/#G]I:&7:'2-2AD%S9\HPGC\I2"#@[=VT>F
M<<4 =G!X\MI?#[ZY+I.HP6(MOM2._E$R1DKMP%<X)W9P<=#G%=%#?+(UWYD;
MP);2^69)2H5QM5MRG/3YL<XY!KR*?0;N'PI;06VE3QL?"4<;QQVY!,YDC+*0
M!]_J2.O6M35[>XCO=5%QI0DMI_$7F_:+JSEN(8E%G$!(84(,@+ J"?E#<]0*
M /0[K6K"SN-/AEG4MJ$IBMRO(9@C.>?3"G]*NB:(S&$2(95&2@8;@/7%>.Z1
MI?D7.G7-[I$KVMMXFF=3_9;1A(I+7Y76+!*(9"I]CUP1P:%H]]'J>EQ77G)K
M<.IM-<O%HS"0C>Q=GNBX5HV4XXSP0 ,C  /4]0UNTTZZLK>0EY;NZ6U58R"4
M8HS@MSP,(?TJ2_U:STVYL+>YDVR7TY@@&.K!&?GT&%/Z>M>8:5IUO'+X2MWT
M2Z7Q#::D7U.[^Q..2DN]WFVX=68J1R>W3%==XVLX)=1\+7MQ8&ZAM=4S*RVQ
MF,:M#*H) !(&_P OGH" >U &[H^N6>M6BW%N2F9)8Q'(0'_=R-&QP">,J:GM
M=0CN+1)Y4:U+L5$<Y4-PQ7L2.>W/<5YOIWAM;72-%OXM(,>J?\)'))-.(")A
M$UQ*"2<9V%"/;!%+X9\."\UC0_[6TDR0VUE?NHNH"424W@*'## ;:21WQR*
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MV8W93&1GMA<C;B@#V)F5%+,0 .I)H+*&"E@"1G&:Y[2M%-Y\/K;1=4-Q()K
M6\QN5 EP4Q\P!(# >YY'6N#CMM:\1>'-5U"\MIIKJQ$&D/%%]^XCAF4WA3'7
MS,%<=]F.] 'K27$,L?F1S1NF<;E8$9],TXR(I(+J",9R?7I7DVK6,=V=7N_#
M.CW,.E+:VAFBBLG@$\T=RLA*1E0698U8$@<Y YQBI-?C;Q-?Z[-;:=?R6-PF
MCQ*TEK)'YJK>.9"H8 X //''7IS0!ZK'(DJ!XW5T/1E.0:;'/#,SK%+&[(<,
M%8$J??TK,U*UBTKPG?V^E:6C)#:R^38VO[D.=I.Q=N-I)/4<Y->2G2]2FD/]
MAV8C>70KJW)L=)EL4#GRBL1=R2[X#X)(P?<F@#VV.>&56:.5'"$ABK X/H:%
MN('@,ZS1F(#/F!AM_.O+]3L](O+-O^$?\,WD5G']D_M(1V<D F@68%H?*('F
M,%W$X!.,KGYL5)?6VE3W-M=V'AZZ3PY'J22:@BVDBQW!\AU5Q;XR51_+W$+R
M1GG;0!Z:LL;JC+(K*_W2#D-]/6AIHD!+2( ,Y)8<8&3^E>5Q0-8ZG!K-KIMY
M!X=AUX3PQ):.#'&UF\;R+$!N5#*WIW)Q@TZUTLZYKMK)=Z3<OI\WB6YN&2ZM
MF4&+[%A'96'"E@,9[\'GB@#T:ZUJQL[G3H)9QOU"4Q6Y7D,0C.>?3"G\<5==
MTC0N[*J*,EF. !7E::+#8:KILDVC/]@L_$]SY:K9EUABD@;:54*<)YI4Y P#
M@]JZGQO;B670YKNTEO-'M[TO?P1PF7(\MPC,@!+*KE21@]CCB@#J3<0B(2F:
M,1D9#[A@CKG-/!# $$$'D$5Y1%H$>IZS9JNCRCPW-K[306LULR1A!9.&<QD?
M*C2C@$ $GI\W/JL44<$*0Q(L<4:A411@*!P !V% #Z*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBFNQ6-F"
MEB 2%'4^U %?3K"TTJPAT^QC$5M;KLCCW%MH^I)-600<X(XZUXKH2[]?\-7M
MK8Q6TTDTPO$M;.;[3'N@E.RXN'.'??MX('(R#@5K?#Z&*Q\0VD%I:PW"FR=9
MKQ+.6TN(B"I"W2DE))"<_-UR&(X)H ]5) &2<"D) &2<5P'C Z)_PG^BC7[<
M3V7]FW9V20F6,-YD."Z@$8ZXR,9([XKE&L;X+H_]LK!'HHMKD6B:MITMW''F
M=C&KHKJ5?R?+"ELG (&#0![62!UJI:6%GI\EV]M&(VNIC<3G<3N<J%+<GCA1
MTXXKSGPUX?6^US0O[8@N+V.UTAI(6O+=H]KBXS&2A9L,J8 W$G'7!S5'P]X1
ML&M/ S7.D[GN8)AJ/F1G,P\O<JS9^\H8+A6X&!B@#U&_U6#30SW*3+;I;RW$
MEPL9:.-8P"=Q'<@Y QSM/I1;ZO975\ME%*3<-;+=[-I'[MB0ISTY(/'M7D[Z
M///HRV!L)9(8M,U^"&%HBP7%RGDJ ?95V_08IUQ80*\T_AW3E@OKKPN(]/EA
MM#&QF4R"0*<#:^W ['I0![&"#T.<52_M6V_MQ=(^<W)MC<@@?+L#!3SZY->2
M0V%RUIJ7_"-R)DZ2Z30Z7I,MH'.Y.'9Y6)GVAP,#=R<GI72^%X-"'Q",_ARP
M:WL?[(*2,EL\41D\U>,$#Y\=>_3/2@#MO[6MO[<;2/G%RML+DDCY=A8J.?7(
M-7J\[\40:$?B%Y_B.P:XLO['5(V>V>6(2>:_& #\^.G?KCK6&;77=+TO2;5E
MN5N_$M@FF3%SF2"16^5V_P!H6[2Y/7,0H ]2UC5;?0]'N]4NPYM[6,R2;!EL
M#T%7<@$ D9/05R_CFR$?PUUBRLX6(2Q:***-23@#  %>?^-P;F]\0RQZ?!%J
M5O.AMV>RFN+QU54(DAD!"Q1]>F1PV>30![317D?B&PU6'6]0LK."X-KIEPWB
M2W9%.)&^0^2/4EOM!Q[BNT\(RBUTJT:]66/4-:EFOS&T;?+N.X*QQA2J%%P2
M/NT =17.7?C&U@OKFUM--U34C:-LN9+&W#I"V,E221N8 C(7)&:Z.N"T/6;7
MPA'J6E:TEU#<"_N;F&1;:207:2R-(I0JIRWS;2O4$>F* .STW4K35].@U"PF
M6:UG7='(.,CZ'D$'@@\@BK1('6O+-)6;PYJ>AZKJ]O<6=K<MJDK1^4S_ &8W
M$T<D<;!0<$JIX]<BH?#6B1:SJ>@?VKILKVZ0:K-Y5S$RA7-ZI3<I[X)(!],]
MJ /6>@R:R];URWT.SAGE@N+EKB9;>"&V4,\CMG &2!T!.21TK#^(4B#3=.AF
MLXI[:6]42R7*N]O" C$-*B<NN0!@X&2"3Q7#Z9H<%]%#;W6EP7%M%XI4PI_9
MS0Q+ ]LI;9&^XK&6&>N">: /2=/\50:E=S0P:;J7E17#VS7+1+Y0= V\9#9P
M"A7.,9(QFKFD:Y!K=M:W-K!<BWN;2.[CEDCPI5\X7.?O #)'N*\\T?1(].O-
M+-IIBVP/B+4]_E0;/W8CN5CS@?=P0!VY&*S;:.ZLO#4!ETVYF3_A%=-@DC_>
M(!F9P^[:-V%!RP'.T$=Z /7=0U.TTNQ:\NY=D"NB%@"WS,P11QZLP%6LC(&>
M37AESID$MOXB1;"SFTX1:=<HMCI;PVY*W#"5D1BVXB,X9EZCC'%6=:LGGU36
MC(\,-Q+)&='==(EGN5A\M/*^RN)%5,-G*X&#G=P: /:LC.,C/I5&YT:QN]5M
M=2N(W>XM ?)S*VQ"01NV9V[L$C<1D FO,V@6T\=B9+5+^^?54+QSV4D5Y$#A
M2\<Z$JT 7+;6XP,'FNN^(4BIH=I'+9I<02WL:2M,':")<,=\JIRZ9 &T\$D9
MH ZP$$9!R/6C<-N[(QZUXQIVEF[<Z>]J&TUO$L$BQ6]E);0-$;4[BL;$D1E@
M0><-D^N*T+C2X=/U*[LY[!E\*V^OAY[5(285C:S0J=@',0F.2 -H/7H: /2M
M/U6WU.:_BM]^ZQN3;2[ACYPBOQZC#C]:NY&<9&?2N,^'4%I#!XA_L^VEM[!]
M7=[9'C:,%/)AY4, =N0<=L8Q7+ZK;0D:XDME.WC)]39M-G$#F01^8/)*28P(
MPF-W..&SUH ]<JI9:E::A]I-M+N%M.UO*2",.N,CGTSUKS2_O##I^KZ*T-V=
M1D\217"1+;N?W)N8G$F[&-NT'G/7BJ%SI6F0+JMN;9+*2/7Y)I/-TLSVKH4;
MRO/48W1G+;2"0K8Z9H ]>DNO+O(+?R)F\Y7;S53*)MQPQ[$YX]<&H)M5MH=9
MM-*;>;BZAEFCP/EVQE V3Z_O%_6O+DBU:XTK35TG3FLKB.PUB*T\CS!&6.SR
MWCW_ #(K'E5/3MQBHY;2R>]C;P3I\]M?+X>OHV9;=XB)R(M@8L!^^R&R>O3/
M:@#V($'.#G%!(&,D#->7^!K2./Q+:2:?+ D:V+K=QV>D2VJDY7:)VDE;,H.<
M<%OO9.*E^(UI;R:Y'/.L,K+8%(X-0L'GMY3N)(B>,[HYNG(!)!7'2@#TLD#&
M3UZ4N17B^MP7-WJ5U/K4$5HLVFVWV"&\TZ:]EB/E_.D+K(NV829R?O'Y3G%;
MEAX.@U_5-<37()9[O[!:017<\>UXY&@*NZC)"OGK@GD#GB@#T6\N?L=JT_D3
M3[2H\N!-SG) X'MG)]@:FR,XSSZ5Y+,FKZ[X<U76-2LYX[V!;33(XMAR6CFC
M:>11Z,_&?2,5>T^'2X]8E_M73;N;Q1_;3O'+%$PE\DRGRV$G3R!%MR,XX(QG
MB@#TS(SC//I5:YT^TNKRTNYXMT]FS/ ^XC864J3@'!^4D<UY%X6L;Q=5T4W,
MT4>OI>,VH>3I,HN6^]YGG3M+M:(]C@C[NT<5V'Q#.G_:O"PU6)I; ZHWG($+
M@C[/-]Y1U7.">V,YXS0!VV1C.1CUHR,XR,^E>2VVB6^JZKIUM_9\C>&9=;G>
MUMWB98_)%H<_*<8C,P8@=#]"*CNK&VB@U&W%A,/&(U4_8)E@?>L7G#R2DF,"
M$18!&=O# \T >H:IHUCK*P)?QO+'!*)5C$K*K,.1N4$!QG!PV1Q4]I=B[LHK
MDPS0>8N?*G7:Z^Q'8UP=MIMZ/&*>&F@E&D6M\^M)-@["C<I%GID3L[8]$%8.
MBVEE%::1_P )783S6/\ 8J)9*]N\FRX\R3S   2LI4Q;3P>#CO0!ZII&JVVM
M:/9ZI:[Q;W<2RQ^8,-AAD9'K5[(%>&V]A.EAX?764M8].30($MUU+3);M%FR
MWF *CKLEQLP3R1TQ@UOZ/X>-YJR3:Q!?W<]IX<M3!-+#LF6427!!"EB!,!MZ
ML2">3R: /4@0<X(.*K:AIUKJMD]G>Q>;;NRLR;B,E6##D$'J :\Y^'<45GKR
M6]I:6TT1T\B6]M[.6T="&7"7$9)1I3EOF'S?*W8U?\<:==RZ]!;6L4S6_B&W
M33;QX@?W:I*'W$CIF)YQGUVT =U=7/V5(V\B:;?*D>(4W%=QQN/HHZD]A6=%
MXFTV>>QBAD>3[;<3VT3!, /#O\S.>@!C89[UYOI]IJM]96E[J-M.+FSU/3=*
M 9#EDMY1YDN/[K,QY]%%&C>'M,N+G1-+?2$$4&NZD;R VQ1",3&+?P R[=F.
MHQ@>U 'L .1D45R_@>T-A8ZK9)"T-M!JMPEM%@A4BW @*.R\G&.*X2^@U72=
M4FDAM+M[7PE=-=0)&I_TF*YE#%5_O%(FD7% 'JO]K6W]N-I'SBY6V6Y)(^78
M6*CGUR#5TD 9)Q7F.C^#;:ZU^U@U_3DO#_8:R3^<FY/M$D\CR'GC<"QP>H!X
MJIIR6[V/A67QC:RW&F#0D11=0-+&MU\N[>N#\Y3&"P[-CF@#UHD 9)P*,C.,
M\UY/H7AW^UK_ $Z'7=.FN+1-)NS!#>HS;$-S^Y#AOXQ$1C/(^M6?"&CC3[CP
M/>QV<D5Y=Z7+_:,Y4[Y6V1L!*QY)!SC/3H* /3Z*X/X@6U]%>6=SIL4KR:E#
M)HLS1*3Y8F(*2GT"8?G_ &JY.33-<E\/ZK#'#<I_8:1Z1"?+=VEMQ<!I74 A
MG!@6$8!!.& .: /9P01D'(J@^CV#ZW'JTB.U['$8HV:5BJ ]2J$[03T+ 9QQ
MFN/\ VR1:WJ<EC-;G3V@B4QV&F/:6OF@MRH>1LOMP&P /NY.:QO&<$</BV^O
M%M$OKS_1S#9W5G)YLFT#'V2XC.4YZ@CKDG@YH ]+T_5K;4I;Z.#>&L[DVLN\
M8RX56./48<5=R,XR,^E>4ZEX?A>P\7:O_9S-JT6M(]I<>63+& (.8SU ^]G'
M7G/2LWQ'FXU74;F+3X(-2@U>(H39337I1)4'F+-D"*(J"0 "N#CJ: /7]1L+
M75M/N-/O8Q+;7$9CECW%=RG@C(((_"K*XVC:<CVKR34?#\O]A^(=2MK-A?2Z
MY(EQ,87D<V7GJ74*I#-'@9*J1D;O6N@^']LL.IZO)9S0-I[K"%CLM->TM1(-
MVXQAI&RV-H;  X7J<T =K%<^;=W%OY$R>3M_>.F$?(S\I[X[U5UK6K;0]--[
M.DTRF2.&.*!0SR2.X154$@9)(ZD5P7B/3I;[Q)J<,EO,]M-JNE!MH8!DY#\C
MMC@U4U;PS9+>ZEIT6CQ?V='KVER0VXMP8D#F,2E5Q@ C.[''7- 'JL$OG012
M-&\3.@8Q28W+D=#@D9'L34F1G'>O(=0L[=(M7@-A-_PF)U,G3IEMV\Q8_,'D
MF.0#"Q"/ 89"C# \U)>>&K>?1];O'L)#?W'B1(C,%;S/LYO8B0IZA< MQQU-
M 'K.X<<CG@<T9 (&1D]!7DFM^%+&VM_&SV6D+&UH()=-6*(@02>6I9H0.%8L
M!DKR<<U2\8YN;_79X]/@AU*WO(S"SV4UQ>,J;,212 A8H\ GC(X.>30!ZNFM
MVLTDR6R3W#07@LYO*C)\M]H8DY_A 89/O6CD9QD9]*\IBT^WM-=OX;;3_)NC
MXKMYY#';E2T!12K;L8*[M_?@D^M1:5;0A=#2*RG7QDFIJVI3F!Q(4WGSC))C
M!B*9V\D<KCI0!ZYD9QGGTH) &3TKRG1- BL=-\):I#8-'JCZO(ES<;#YIB;S
MP5<]=G"X!X'%=)\0I(_LVE07%G!-;2W?[R6[1Y+:'",098T^^"> #@9P>PH
M['(QG(QZT9&<9&?2O&M$T5=3ETW3;ZR,FFKXANCY(M'MX?*-H67$3$E8RQR
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MC;UR.!Z57EL[F*+2K:_%O'H-M<:E"BZE:27%NC+<D0AU5E_Y9@A"V0.<<D4
M>O/IMK)J\.J,A-W# ]NC[C@([*S#'3JB_E4EG="\LH;GR9H!*H;RYTV.N>S#
ML:PO <4\/A*V2:::5?,E,)E@:$B(NVP!69F"@8"[CG;C-</X4\.V^L?V3#K6
MGM<0Q^&8!Y=PIVB3S).<'C>!T/49H ](FUVWB\10:(MO<S74D/GNT: I#'D@
M,Y)&,E2!C)XK4KQ6UTF_GTMM1M[&8ZTWA*U/V@1D3F3+J^&Z^88QCUZ5-KL&
MG266J_\ "&6LL5@=#G6]^SPNB--NC\G@@9E \S)^]CKVH ]DS17FU[X,T?\
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M/O'=ZCK0!I:OJD&BZ1=ZG="0V]K&99?+7<P4<DX]AS52\\3:;8Z[IFCS2/\
M:M2#F JN4^49^8]LX./7!K1O+2*_L;BSG7=#/&T4@]588/Z&O*-/L=3O/"VI
MZQ=6TW]I:*+2WMPR'=(;+YY"H[[V:1?>@#U"PU:VU&XOX;?>38S_ &>5B,*7
MV*Q /? 89]\U>KR'4+&\&B>&[F]6".POKBZO]1%[:O/"LLWSQ"5%93@ E>>
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MCW\CD#&>:X?Q)I$5CKVL6DR6=I9I;Q+HZ/ITT[HNSYA;%'4+)YFXX'/W><4
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MB:\E-J&6TCGN7D2V##!V*3QQQGD@<#BM8W]JNI)IQE'VMX6G$6#G8"%)].K
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M!M,9!))8G(+$\ 5V/@V&RMO%?C**.8_:SJ:NT3W#,1&T$1#;23@%BP!QVQT
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ME D7<F"<C()!Y!^M/*(R%"BE#U4C@UY+]OM)[>_?Q#K=U9SV^E6LFF8O7A+
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M[4 >FWVKZ7IS31WD\<6R-99 R' 1FV*3QZ\5+;W%AJ,L[0F*:2VE:WE.WE'
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M*GW4(/=0">^:8U^1H6GFRUVZU-]2T*ZEU%);HS 8@R)-I.(R'.S P/FP02*
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M\45T8E"F$.)"F<2[I"RX8$?+C% ':?VCI$NLSZ/NBDOB@EGA$1;CL7.,9P.
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M,*7/J<=:\RN=433/"_V_2?%%]>:E<Z2;B1'F-RO6/?/@Y$13<V , ],'%/\
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M2"(@@Q[1M(/48KRY=0DMK?19='\07NHW6I:?<27B-=&;I;LXE5<_NB)-JX4
M?-C&:V-(\1#4-9\&6\&J"X,^DS37:)-NW-LAVLX!ZYWXS[T =G%IEA#%Y45C
M;1Q@%=B1*!@G)&,=,@'\*G,,3.7,:%V786*C)7T^E>:>*Y+\W/C:\BU?4;<Z
M18PW%G'!<,B))Y;,25'# [1P<CKQ1J][-X9O-7MCJ^K202Z9:S;VN \BS23M
M$2C/\L8;(!Z*O4 8H ]&MK&TLEVVMK! ,8Q%&%XSGM[D_G37TVQDN'N'LK9I
MI%VO(8E+,/0G&2*\LM[_ %F.[\16]C=S[],MK348[4:H]Z2RO(9(R[ 'YT4
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M@F8G(X88)^4=ZZ3Q+J=R/#>A2&\>TAOKJVBO;J)MACC=220W\&Y@JY[;N,4
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M/RI]% #)(HY=OF1J^Q@R[AG!'0CWIIMH&$P,,9$W^M!4?O.,?-Z\<<]JEHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
,0 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>cybin-finalproxyformasm2001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cybin-finalproxyformasm2001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0?!54# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ1;_ +/>M1Z5?_;&-C=O=-M*E)C$<KM/3 V_7KWKGOAE_P F]^-?K=_^DZ4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO;6?R_OY) $YZ<].:\<\ > O!^J?!K^T-0L[>6YN(9Y+B]<_O(64L!AOX=H
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M\-WTD$NIVA&JV\ ^5=Y!(/\ O<$CW_VJ /H-?'7A5K![Y?$&GFTCD$33B<;
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M:"W4(@/FD!@HX&0.WI0!]!5X7;>*/'?Q&\7:U8^'-=LM#LM,E,:Q2(#+(-Q
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M](\0VK7.CZC;WL*G:S0N&VGT(ZC\:HZCXY\*Z3J7]GW^OV%O=@X:*28 J?\
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M\8>%[;0;RZN8;>WDC=9(=NXE%*C.01WKI+.V6SLH+5&++#&L8)ZD 8_I4U%
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M25 AE:,2*RJ2=K ]1R1^)JEINBV<%M=R3?9)HKH+O$486(*N<=2<\DG.?Y4
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M7T)S6AHWG2:WJ4\DK?.D)\KY2%)3/! YQR.M7[G3=,NY@;BV@DD1!PP&=N>
M1W'UXJ2"*RDN&O;<0O*R^6TL9!R!V)% %JBBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML!DB*56('X&N(^)]K]A^"VJVFV)?)M(H\0QB-!AT'RJ/NCT':N*\.>%[R_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF;#^9NY.<G& .W/6@#W*BO$X_BEXDN[^XU*RA:>RAU$VHTJ+2IY&> -AI//
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MUM)&@<KU.Y<$#/7\N<^U^(>NS?#7PEKKO;?;=4UE+*X(B^4QF213@9X.$'-
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MSR+%-&[1MM<*P)4^A]#7A=SXA\1^+E^&FJQWUO9S7T\X*"$M'YT;,I<KNY!
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MW/,N?F<GELY.:UK37;34/#,>O6FZ2UEM?M* \,5VYP?0]JI0^*XIH/#$HM7
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M8DN4 P Z\YXXXQQ6/<?%>WEA\/G1=$N]4FUR"62VA218V#1G#*V>!@ALG/\
M#WJ/4/BTEA=7H&@7$UKIGEKJ<ZW,8-N[ ;E1"<R;<X)&.E &WJ?PYT'4!I[0
M&]TV>PMQ:V]QIURT,BPC_EF6[CZ^I]:DA^'WA^VLM&M+>WDAATBY^UVX60Y:
M7NSD\MFL*X\9P:=XI\3WBRWUW;V&D0WJP></(92,@H,9#$=2:MZ-\2'U+7]&
MTZ\\/W>GPZU;M/I]S+,C^:%3><JO*\<C//(X&: .ETWP[8:7KFKZO;"7[5JK
M1-<[FRN8U*KM';@U3OO!&BZEJ>J7]Y%++)J=HMI<*9"%,:G(QCD'('.:P?B5
MXJUWP[?^&H-'LFG6^U!(Y=KH#+S_ *D%ONEO[W;'6L%/'>N:-XM\<N=+O=6L
MM.-O,T0N41+./RBSXW=2>N%'.TT =KH7@+2]"U5-3%UJ5_>10?9X);^Z,QAC
M_NITP/UKJ:X+4?B="DVFVVBZ1-JEW>Z>NI&(SI (H&QC+,<%CG&T4Q_BG:W$
M?AQM(TBZU&37HIFMHDD2-D>/[RMNX&#G)SQ@GF@#T"BN<\&^+%\6Z?>3-82V
M%W8W<EE=6TCAS'*F,@,.".>OUKHZ "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *BNH3<6DT(.#)&R GMD8J6FR2)#$\LKJD:*69F. H'4DT <Q
MX7\*SZ$;'[3<QS_8=)ATZ'8I'*DF1N?[V(^/]FC0?"']C^*=;U9[E9HKXC[/
M#MQY"LS/(/?<[$_@*N:=XRT'5;Q;6TOBTSQF6(/!)&)4'5D+* X_W2:;IGC;
MP[K%S;V]AJ2RO<@F!O*=4EP,D(Y4*S =5!R,'(XH PM-^&T5MX,UGP]<WID&
MH292<)S%&@585P>NT(O'?GUJ]X?\*WNGZS'?WD>AVZPPM&L>F:>L1E8XR[,<
ML.!PJG')R35ZT\;^'+Z\BM;;4E>260PQMY3B-I!_!O*[=_'W<Y]J?-XR\/V^
MIMI\NHHLZRB!SY;F-)#T1I,;%;D<$YYH K:QH>LR^*+;7='O+..2&S>U>"ZC
M9ED#.K9RI!&-H]?3O6)+\.'1+"\2;3[W5(9;F6Y^WVN^"Y,[!W^7.4PP&TC.
M ,'.:WW\6:?IYU!]5U&SBAAO_L<1C5\AO*5PCY'+GD\<8P.M4M6^(FCV7A^3
M5;)VNA'>0V;Q&*1'C=W4'<I7<N%)89 S@ =10 S3_!=S:RZ//+<V2R6>H2WL
ML=I:+!%AX7C"(%[#</F;)./H ZT\&3VWACPWI)O(V?2+R*Y>0(<2!"QP!VSN
MK0\6^()="\$ZCKUE&DLEO;^=$LRL%;IC(X(Z^U<UX;\2>-M7GTR:YD\'BRN@
MDDD<%S*;@(P!("GC<!VH YZ87CV=KX4TR\=K>+5XF2PETZ1;F.-;D2$22;BG
MEJ 6#@<@**],\5Z+/K^@O96L\<%P)H9XGE0LFZ.59 & (.#MQQZUC:C\2?#P
MAU&UTS6+-]5MH)W$4R2;$:('=O*KD $?CVS5F;Q[H6CZ'I-YKVJVD$]_;),H
M@5W#Y4$LB@%MG/4CZT  \+7<EGXJ2>ZA\[78P,HAVQ-]F6$]>2,J3]*R;GX?
M7$5\]Y8KHMS)<6D,$XU.R\[RWC38)(SGN ,J?0<UV]AJ%IJFGPW]A<1W%K,N
M^.6,Y##VKRC2?B;XLUZ-M3TK3=#NK1;@QMHZ7+#450-C<02%![]* /3K+2%M
M?#L6D22^8JV_D/*D2Q[LC!8*H"KGDX KE]*\'Z];W'AI+_5+&2ST E(5@MV5
MYU\EH@SDL0& (X''7VK9U[QQX;\,30P:SJL5I/*N]8BK.^WU(4$@=>3QP:VK
M.\MM0LX;NSGCGMIE#QRQMN5E/<&@#EK7P9/;^&/#FDF\C+Z3>17+R!#B0(6.
M .WWJHOX)UM--AT*VU2R71;>_CNXMT#&<HLXF\HG=C (X;&>!QU-=!XFUZ?1
MUL+2PMDN=4U*X^SVL4CE4!"EF=R,G:JJ2<<G@=ZK6M]XJL=26WU>UL+NUEAD
M=;NP1XQ ZC.V178Y![,#U'([T 8EU\/+@7NI"Q.B_9M0NGNFN+O3EFN;=G.7
M"$_*PSDC<.,]ZW[;PW<VL_B26VOQ;OJK(T$B1 FW*P)$#@_*>4SC&.U4_"7C
M_2O$6GZ2DMU&FJ7UNLAA2-Q&9-NYT1R-K%><@$D8.>E:$7C3P]-J4=A'J ::
M28P1MY3^4\@R"BR;=A;((P#GB@#F/^%<WES_ &M+,^DV,][I<^GD:9;-$DS2
M ?O91GDC' 'J>:S]?EG\/7VNV=AJ#6LE_:Q[X9=.DF:>40B/=;,C8)(55(8<
M$9Z=>O\ ^$UTK3[1YM7U*U0M>7%O#]GCD;=Y;E=N,$EQQG'&<XXK:N]6L+#2
MCJ=W<I#9J@<RR9'!QCCKDY QUR<4 <_X4\-76ES:=?W,BJZ:#::=)!CE7BW%
MCG_@6/PK'B^&\UE;Z1+"VE7MY96C6<L>H6OF0RH7+JR]U8$GUR":Z:#QIX?G
MM+VY%_Y<=BJO<B>&2)XE;[K%74-@^N,5)I_B_0=4EN8[74$+6\7GR>8C18B_
MYZ N!N3_ &AD>] &)#X,U'3H]*O=/O; :M9&<./L8BMY4F(+($3!4*53!Y/R
M\YS6QX5T2]T2VU#^T+R*ZN;V^DO'>*,HJ[@HV@$G@;?7I6?;^.[#4_%.DZ5I
M4J3PW<4\LK/%)&P"!2C)N RIRW(R#C@U+XFUG6K/7]$TC15L!+J*W#/)>H[*
MHC53QM(Z[C0!!<^#)Y_"VOZ0+R,/J=]+=))L.$#R!L$=^F*;>>%M;BEUJWT?
M4[."PUF1I9O/@9Y;=W0(YCPP#9 ! /0^O2BT\7W6EZMJ6F^*VT^ V=K%>?;+
M0OY7ENY3#*V2I##U((.>*T3XX\.BRM[L7[M'<,RPJEM*TDFW[Q6,+N(&1SC'
M(YH QI/AYL%V+*^$!46!L&9-_DO:@A2XR-P/0CCC-)>>!]3\02:Q+KVH6F=0
ML(K2-+2$[8#'(TBM\Q._YB"<X]/>M^?Q?H-O8V=X;\2PWH8V_P!GC>9I OWB
M%0%N._''?%)'XDM+N_TUK/4+)["\M9[@,=V]PA0;E/W0!N.[=SG'H: .?C\#
M7TT&H)<_V%9F?3IK.-=-T\1[GD7;YCL?F&/[JG')R3Q5W6M.ETMO"NIC,JZ1
M(+>Y*C_EE)'Y3/CT#;&/L#Z41^/M/U#Q+HNEZ3.EQ'?-,9'>*1#L2,LK1E@
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MZNK>%IO*VLI91W&X#<N>XR*D\">(+GQ5X*TW6[N***>Z1F=(L[1AV7C))[4
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M;B"*.V*3R["2B.V<8&>W7^5R#XJZ79^(_$&G>(+NUL8+"YCBM65'9I%9<EF
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M<Z;XD 8;QC. 2 "<=LY'I4,GQ,\&Q7HLY->MUG,Q@*LK *X."&.,+SGDX!H
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M<:CHNN>&/$WB:6VT"?7-!\1J&E2TN!'/!)M*L.2#@Y/(Z<?CZJJJHPJ@#)/
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MWC7D!,'=EL\@CK[<UF:=;:UK/@[Q=X;TSPXUW_:6O3JM^)$$<1$B$^9D[AM
M!! .<^W/MNI:EHO@GPW]HN MGIEFJQHD2$[<D!54#W(%7K#3-/TF*9+"VAMD
MFF:>01C :1NK'W/% 'F,FC^(/"7BK7KN'P])XBM]8L;>"*6.1 8VCCV%) QX
M1CR2/:F>&_ VN:%J_P .TN(3-'I5M?"]F1P5A:4$JO7)Y;;QZ5Z[D>M(64$
ML 3T!/6@#Q.U\$Z]%\)=#THZ2ZZE!KBW<T65W*@D8[R<X^Z15S5_#_B :O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "LWQ%8SZGX9U;3[9MMQ=6<T,3$XPS(5!_,UI44
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M@32+RUME2ZO;""2YFZO*=F1DGTR0/0<5V*Q1HS,J*K-RQ QGZT\    8 [4
M>4ZO:K>> ?B4ES"LUPM]<N5==Q&V*,Q'\$"D5/IV@>&/$7C6\ LK&]TN/0[0
M6R( T(!DGR5 XR,<'J.<5W\.DPV^MW6IQ.RO=Q(D\?&UV3.U_K@[3Z@#TJ\J
M(@PJJHQC@8H \*MI9+RW\*G7+C23IIT%?(;70S6[3AR'[@>8$"8SSC..]>G?
M#P2#P9:![HW46^7R)/+=!Y6]M@ ?YBH'"D]5 KIGBCD38\:,G]TJ"*?0!YO\
M8K6WM_ ($,$48-_:@A$ R!(,=*\>UK3KO[+XGT:X0_8?"<,ZVA/;[1<H5_\
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M\(4'Q'N@ISP-+A'7KWJGI'PL\1:#IT%AIGQ NK>V@#")%TV([0S%CR23U)-
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MKLV@<>7MW9[8Q[5O^++B_P#!US%>:9%(X\5Z'%8*J?PWBA$5O;Y'X]P:[4^
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M:#X#\8F,QGXDW90]5.F0X/X9H XG6)=%_P"$'@3P]_:Z^#AX@5=3=B^PV_\
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M )_+3_P%;_XY1Y6I_P#/Y:?^ K?_ !R@"[15+RM3_P"?RT_\!6_^.4>5J?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *I1
M?\AN[_Z]H?\ T*6KM4HO^0W=_P#7M#_Z%+0!=HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** *6J_\>D?_ %\P?^C4J[5+5?\ CTC_ .OF
M#_T:E7: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6FJK8IN=(+@$9R."1G'Y4 =-16#XB\7:1X=M;G[3?V:WT=L\\5G)<*CR[5)
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M*M+83-&6^T,MNRN%)'S?-UQWKN-,U2UU>U>YLW9XDFD@)*D?/&Y1AS[J:NT
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MNJZI:Z-I[WUZ[) CHA*J6.7<(O ]V%,UO6K+P]HUSJNHNR6EN 9&5"Q ) '
MY/)% 'ENFZ=J<&[4;S3]4N;2V\3F^F2:SVS31-;!%F$2*,X<AMJC(P<C(-;&
MH,+W5+'Q!;^'+Q-*M=6\^Y_T9Q-=?Z.T:W'D%0_R,5'3<0,XXKM+KQ)I5GX8
M/B.:YQIGV=;@2A2<HP!7 ZY.1Q[U>L;V'4M/MKZV8M!<Q+-&2,$JP!'';@T
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MX!$C0,@@!8#>2Q4X7(^7/I6(WAS6KKP\MK%IUSYO_"(Z= T;H4WO'*S20Y/
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ML-CE,Y4C@ ]SQ79^"=/DTKP;IEE)'<Q-'$?W=R5,B L2%;;P, @8'3&*WZ*
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M;*)%D0N$ZD9ZXX!/TH \RT*&:VT?P9K1U#4)M0N=5-G/+-=R.)(<3*$*D[<
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MQ,DI6&$1;MK*RA>"#NWD\U+?-93_ /">7NH:S=6^HZ=-OM$6^=/LI^SQLA1
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MW#B"&.(.YD8(H7<Q.2QQU)/4U)0 4444 %%%% !1110 4444 %%%% !1110
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M[6_AF0W[6<%Q]IATQ[IFM(I<YW+']??% '3:UH&D^(K1+76+"&]@1_,6.49
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M>O>)-7O_  UXPTI[^66.#2!=Q74VFO:2%6+JZ;&P2#MX; ZGKBO0I?!NER:
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M:XM&9LB4Q*JQN5*J2K-SS@J/>NDU7PO;:GJ2ZE'>WVGWWD^0\]E*$:2/.0K
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M3KSS%B9D=6B;8Z,C!E93V((!K*C\#Z<;F[NKN[U"^N+RQ?3YY+F?)>%CRN
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M]G:4,'W8\O=C< VW.,]JT/LWB%M0AO)?#\LS0W;W<22ZRK(CM&8\ %.% +8
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MCHVK6$FGRQ^%V>:RGFN5EEUE6:6652KLY*<D@GTQQ4'BG3/%.O:-J=FN@O\
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M'YT +12;U_O#\Z-Z_P!X?G0 M%)O7^\/SHWK_>'YT +12;U_O#\Z-Z_WA^=
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MC>O]X?G0 M%)O7^\/SHWK_>'YT +12;U_O#\Z-Z_WA^= "T4F]?[P_.C>O\
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M=V\#'0=.N>*W;?35T[XN:?=W6B3-'=^'HH8KA+,NJ7((R6;'RL%7&3SC [T
M=QH^N:9=^%+?7=6M],TN.3<'#7<,L288J/WJ_*<X[?3M6BM]X??3EU%;K3#8
MN0JW(DC\LDG  ;IG/%>)Z3HM_8>$OAY?:QH5]>:1ILMY]OL/LK.\;.[>7(T1
M&2!UZ<?C3=4T#4;WP7XRN=.T.]M=)U/4[233]/\ L[*X56Q)((QRH;@].@H
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M%#>7E"@!']S!K2\.Z Z:MX/::QO'MH1J<Z?;+8(8/,:,IE1Q'G+%5."!QVH
M[F+5?#,]U;VL-]I,EQ<IYD$22QEI5]5&<D<'IZ4][_P]'JBZ6]UIBZ@WW;4R
M1B4_\ ZUP-KH#VWA>T$.E/'<+XM\_"VY#",7A ?ID+Y>.>FWVK(?2;\6>HZ+
M>SZH-1GU62806^DAS*3-N2=;@C  7:<E@5VD>@H ]#\3^)- \,Z=>RRG3I;^
MVMVN$L#*B2R@#/ Y/XX-;SP6,4!GE@MHXU7<S.J@*.I)->5>(X%M_#7C;1[W
M1KV[U:_NIKBU,5D\HG1@#$P<*0-@&,$@C;TY&>[\;M.G@F]\C3EOW(C!MWB:
M0;=Z[F*+RX49;:.NW% %[3M0\.ZNLK:9=Z7>K#_K#;R1R;/KC.*R6\6>&WUN
MTL;672[FWE@N)IKN*>,I;^5LR&QP,[^Y&,5P=]I^KZUJ6M_87O+XW/AZ2".X
M.G&RCE82H3$F0"25) ))ZG!X-= BZ5XB\;:1]BT2[BLETJ[M+MY;!X%56\L+
M"=RCD#=QT&>* .VOY--LK8N8['S6C=X8Y72/S2JEB 3VP,D]AS51M8\/6L5D
M-2NM(LKF[B62.&2XC^;(_A)QN&>,CK7#Z7I6L7>GZNNJ6MP7T+29](LBZ'-R
MY#9E7UW(L(R.Y851U&UFL;4-$E_;WD^C6L4EK<:2U[;:AMC($7RC=&P)*D%A
MU!QWH ],U+4O#FCO&FIWFEV3R_ZM;F2.,M]-V,UG7OB30=-\1'3-0&GVEO\
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M^5?WNE6LF0-D\L:')Z<$]ZX"[O-,CUSXA6<^DW5Y=WS10P^59O+Y^;6,+'N
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M87OA_51,=/N=-NQ <2_9WCD\L_[6.G0]:;9:GX;U%;AK&]TJY6W!,YAEC<1
M=VP>.G>N+\:Z!>W6KZK#H]@P\[PZT($*;%D*SJ?*R.,E-P ]Z;J,<7B75;,^
M'=+NK=;;2[R"Y>6S>V #Q!8X/F49._!P,@;?>@#O9)=&ABBEEDL$CF0O&[%
M'4+N)![@+SD=N:H^&]7T7Q1H4>K6,-OY#E@RG83&0>C8R <8./<5R&DWK:IJ
M?@*VAT[45_LZ&2.^:>RDC2!_LI382R@$Y!'&1T]1GH/AH#%X'L[.2WGM[FT9
MX9XYH&C(<,3QN W#!'(R/?B@#>$FCFV@N0]B8+@JL,H*;92WW0IZ'/;'6JT6
MJ>&I]3;3(;[2I+]20;5)8S*".ORYSQ7'Z+HVHQ>*TT66SE&CZ!-/>V<C#"3&
M4?N4!/'[O?,/;"USMF+^['A91:W$+VVK0RSZ=;Z.\,=B"S!MTK@ECEN2#SDD
M\4 >DWFM:'$'BLI=(NKQ'0-;FZB0JIE$;,>O0DC'<C;U-6;C5/#5IJ2:=<WN
ME0WSD!;:26-9&)Z84G/-<&FA21?#RY,>ENM_-K_FOB ^:R?VB#N/&=NQ0<],
M#-9'BO\ M&\TOQ19Q6=Q;W#WKNFGVFD/(UP%8;9VG((.0-WRXQ@ <T =])XI
MT5[[6K"SAT^6\THQB2.6XBB5]Q7<<G. NX Y'WN*U[K4/#ME?Q6%U=Z7!>2X
M\NWEDC61\],*>37 >);:9KOQQ:QV%TT][]AN+<I;.5E1?*5\,!C((Y&<\$XX
M-.U".*TL?&FDZCHUY=ZIJMS,]F8[-Y1<HZ 0XD *KLX')&W&: .[O=4\-:;-
MY-_?:3:R[@FR>6-#N(R!@GK@@_C6D+*T(R+: C_KF*\\LO#\_F>,O[1L3<74
MFF6T F>+=YS+;88*2/F^;T[XKJ/"^H)%I>B:-<).E^-(AG821L!@*JL"3_$"
M1D=1F@"[J=[H&C1I)JESIMBDAPC7+I&&/MNQFFW.H^';.VCN;J\TN&"2/S4E
MDDC573@;@3P1\R\^X]:Y?Q7<W,/C2'$;6<)T_:FH1Z6][)*Q<YA7&53  /(.
M<^U8O@K1;@W'@O[?IDZ_8[35 PN+?'DN9TVYXPI*YQCMTXH ],M4TR^M8[FT
M6TN+>0;DEB"LK#U!'!JJ-0\.MJITL7>EG4!UM1)'YOK]SK6;X%LY+'3=5@>W
M>WC&L7IAC9"H\LS,5*C^Z0<C'%<3':N?!EMX8&E7@\41ZBDC3?9'"K(+C>US
MYV-NTKDYW9.=OM0!Z0-0\.F\>T%WI9N8U9WA\R/>JJ<,2.H ((/I6))XLT6;
M4+BUTJ+2]02+39K[[1'=1B+=&RKY;-@A?O9+$\>E<]/X<GF\(>+&ATIGO)]<
MEG=/*Q)<VZSHS*I/)#(I '0_C5?7C!KFI:_=Z-I%Z(W\*75MYQL)(?-DRNV,
M!E!+ >W? Z' !W]SJWANP5/[1O-(LY&"Y2:>-<%AD#G&?;UJ74=0\.Z.D3ZG
M=Z79++_JS<21QA_IG&:Y33]$$VM>*9KK32_FZ3:0Q/+#G=^ZDW*I(YYQD#VK
M#LI+^TCT6"YMY]/9?#UI$+E=)>[GN&VG?"."L94XR&&26YX% 'H]UJ'AVQCB
MDN[S2X$E4/&TLD:AU) !&>HR1S[U,)=&:S2\62P-K(P5)@4V,2=H ;H23Q]>
M*\X\"Z%*]]X4_M/2I<6FA7,9%S!Q%+]H0 '(P&V[L>V<<5;L=-N1X^_X1<Q'
M^R+"[?74;^'$G^KC_"8S-_P 4 =Y?3:+I<0EU"2PM(SG#3E$!P,GD^@!-5I=
M5\,P36L,U_I,<MTH>W1Y8P9E/0J,_,#VQUK-\6::-2\2>$5DLS<VT5_+)+F/
M<B8MY-I;L/FVXSWQ7$:QIEQ::CXLLKUK]%U*7-M!:Z0+D74)B541)-I"%2",
M$@+U[YH ],O-1\.Z?>Q6=[=Z7;74V/+AFDC1WSP,*>31?:AX=TRYAMM0N]+M
M)YO]5'/)&C/VX!Y->;:_97&G3:@D(U!KZ>QMTDL[W2_MMOJC)$% #H,QMD;6
M^8 'YL8YK3=XM,O?%*>(-#NKBYU5(VMEALWN%FC\A5\@,JD JX?@X^]GWH Z
MP:MIJ^(=2TRYM+6WBL;:WG:YD90K>:SJ!R.,%/7G=5C6-0T31+&[NKP6B?9K
M=KEXCL#E!QP#CJ<*/<@5YI+H&N0Z#K%K<6=S<7L>@Z2C;%+&22*1VD53_$P
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M\.Z1K.K.^GRB^82VE\X-T\4BK'&TR[&<JI;.,;BF>: /2K#4[34_M/V20O\
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M+5[(7-].)+665Y)[N1Y&?9DD-G(!(S@8')XYH V(-<TZZOK6S@N-\UU:&]A
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MU;.;4M4\*^&X4NY;ZXBLVU"ZTR2_EMIKBVD8^4PF'4H!C#'!ZDC@T >M@!0
M  !P *6L/P;<17?A#3+F"ZO+J&:'S(Y;TYFVDD@,>Y .,\YQG)ZUN4 %%%%
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MD0[NW(QUYJY!XIU_39=&N]9EL;BSU2RFN6@MK=D>W:.'S<!BYWY&0>!SCZ4
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MWU#2;&ZA@XACGMU=8^WR@CCIVKB9/%7B>3P]#XHMYM-73KB^C@2R>W8ND+7
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MIMSH.CWE@;&YTNRFM#(93!) K)O))+8(QDDDYZY)KB]!\5^(KP>%=2U!]/\
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M=0*C3L)Y'V87'D[<;<[]H+;L]?;BKOBXZYH]E?:N?$$Z:@]R(](TZV"F*7)
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MP%V[@$CY+DYR.>N* +.J>"DL])O7LH[[5KVZNX+J9Y+M8[C?'@"2)\!5< #
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MMH-1CU/3;=T;9%)Y9CEC8#HC DC'0D\5VW]GV7_/G;_]^E_PH_L^R_Y\[?\
M[]+_ (4 <K<^'/$E_-!JUQJ-DNJV=V+BSME5C;1IY;1O&6P&.X,26QP0,#CG
M"@T/6]:U3Q1'<3VD6J0:CI]Y RHQ@W1(CJA_B(XP3UR<X[5Z/_9]E_SYV_\
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MI'%&8UC3/).#G)QDD\"M_3M&ELO$^MZJ\J-'J"VX1!G*^6K Y^N:T/[/LO\
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ML1CS?M,;!K>3RA$60*,,"JKP<8([CBNO_L^R_P"?.W_[]+_A1_9]E_SYV_\
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M(K;AGR97=E<K@[7#[3@YQFNK_L^R_P"?.W_[]+_A1_9]E_SYV_\ WZ7_  H
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M+J#P_P"#].:YA,FAS0R3, <2!(7C.W\7!Y]*Z;^S[+_GSM_^_2_X4?V?9?\
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MW!)8W#J2.XRN#[&L"]\*:UKQU.ZU>XL(KJ;2+C3+2*UWM&GF@;I&9@"3E5X
MX /7-==_9]E_SYV__?I?\*/[/LO^?.W_ ._2_P"% #8+%%T>+3[@+(@MQ#(.
MS#;M/YUR$'AWQCI^B#P[8ZMIHTZ./[/!?R))]JAAQ@#:/E9U7@-D= <5V/\
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MR-.MM5TZ\L6OK6_M9[1<[IXIE:,8ZY8''% %NBLB;Q#92:+<ZEI5S9:BD/\
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M3::NHVC7ZC)M1.IE _W<Y_2FG7-(6\6S.JV(NG+!83<)O)4D-A<YX((/I@T
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M  W XSD@8]Z +M%5+#5=.U5'?3K^UO$C;:[6\RR!3Z'!.#5N@ HHHH ****
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M%!)Z#FO$+3Q._BOXAVM]XATC78M/LKI5TBQ33W\L.3@3S,<<C.0.WYY]PHH
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MHJMY%S_S]G_OV*/(N?\ G[/_ '[% %FBJWD7/_/V?^_8H\BY_P"?L_\ ?L4
M6:*K>1<_\_9_[]BCR+G_ )^S_P!^Q0!9HJMY%S_S]G_OV*/(N?\ G[/_ '[%
M %FBJWD7/_/V?^_8H\BY_P"?L_\ ?L4 6:*K>1<_\_9_[]BCR+G_ )^S_P!^
MQ0!9HJMY%S_S]G_OV*/(N?\ G[/_ '[% %FBJWD7/_/V?^_8H\BY_P"?L_\
M?L4 6:*K>1<_\_9_[]BCR+G_ )^S_P!^Q0!9HJMY%S_S]G_OV*/(N?\ G[/_
M '[% %FBJWD7/_/V?^_8H\BY_P"?L_\ ?L4 6:*K>1<_\_9_[]BCR+G_ )^S
M_P!^Q0!9HJMY%S_S]G_OV*/(N?\ G[/_ '[% %FBJWD7/_/V?^_8H\BY_P"?
ML_\ ?L4 6:*K>1<_\_9_[]BCR+G_ )^S_P!^Q0!9HJMY%S_S]G_OV*/(N?\
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MHJMY%S_S]G_OV*/(N?\ G[/_ '[% %FBJWD7/_/V?^_8H\BY_P"?L_\ ?L4
M6:*K>1<_\_9_[]BCR+G_ )^S_P!^Q0!9HJMY%S_S]G_OV*/(N?\ G[/_ '[%
M %FBJWD7/_/V?^_8H\BY_P"?L_\ ?L4 6:*K>1<_\_9_[]BCR+G_ )^S_P!^
MQ0!9HJMY%S_S]G_OV*/(N?\ G[/_ '[% %FBJWD7/_/V?^_8H\BY_P"?L_\
M?L4 6:*K>1<_\_9_[]BCR+G_ )^S_P!^Q0!9HJMY%S_S]G_OV*/(N?\ G[/_
M '[% %FBJWD7/_/V?^_8H\BY_P"?L_\ ?L4 6:*K>1<_\_9_[]BCR+G_ )^S
M_P!^Q0!9HJMY%S_S]G_OV*/(N?\ G[/_ '[% %FBJWD7/_/V?^_8H\BY_P"?
ML_\ ?L4 6:*K>1<_\_9_[]BCR+G_ )^S_P!^Q0!9HJMY%S_S]G_OV*/(N?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M /7H_M8_] Z__P"_/_UZ -&BL[^UC_T#K_\ [\__ %Z/[6/_ $#K_P#[\_\
MUZ -&BL[^UC_ - Z_P#^_/\ ]>C^UC_T#K__ +\__7H T:*SO[6/_0.O_P#O
MS_\ 7H_M8_\ 0.O_ /OS_P#7H T:*SO[6/\ T#K_ /[\_P#UZ/[6/_0.O_\
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M[6/_ $#K_P#[\_\ UZ -&BL[^UC_ - Z_P#^_/\ ]>C^UC_T#K__ +\__7H
MT:*SO[6/_0.O_P#OS_\ 7H_M8_\ 0.O_ /OS_P#7H T:*SO[6/\ T#K_ /[\
M_P#UZ/[6/_0.O_\ OS_]>@#1HK._M8_] Z__ ._/_P!>C^UC_P! Z_\ ^_/_
M ->@#1HK._M8_P#0.O\ _OS_ /7H_M8_] Z__P"_/_UZ -&BL[^UC_T#K_\
M[\__ %Z/[6/_ $#K_P#[\_\ UZ -&BL[^UC_ - Z_P#^_/\ ]>C^UC_T#K__
M +\__7H T:*SO[6/_0.O_P#OS_\ 7H_M8_\ 0.O_ /OS_P#7H T:*SO[6/\
MT#K_ /[\_P#UZ/[6/_0.O_\ OS_]>@#1HK._M8_] Z__ ._/_P!>C^UC_P!
MZ_\ ^_/_ ->@#1HK._M8_P#0.O\ _OS_ /7H_M8_] Z__P"_/_UZ -&BL[^U
MC_T#K_\ [\__ %Z/[6/_ $#K_P#[\_\ UZ -&BL[^UC_ - Z_P#^_/\ ]>C^
MUC_T#K__ +\__7H T:*SO[6/_0.O_P#OS_\ 7H_M8_\ 0.O_ /OS_P#7H T:
M*SO[6/\ T#K_ /[\_P#UZ/[6/_0.O_\ OS_]>@#1HK._M8_] Z__ ._/_P!>
MC^UC_P! Z_\ ^_/_ ->@#1HK._M8_P#0.O\ _OS_ /7H_M8_] Z__P"_/_UZ
M -&BL[^UC_T#K_\ [\__ %Z/[6/_ $#K_P#[\_\ UZ -&BL[^UC_ - Z_P#^
M_/\ ]>C^UC_T#K__ +\__7H T:*SO[6/_0.O_P#OS_\ 7H_M8_\ 0.O_ /OS
M_P#7H T:*SO[6/\ T#K_ /[\_P#UZ/[6/_0.O_\ OS_]>@#1HK._M8_] Z__
M ._/_P!>C^UC_P! Z_\ ^_/_ ->@#1HK._M8_P#0.O\ _OS_ /7H_M8_] Z_
M_P"_/_UZ -&BL[^UC_T#K_\ [\__ %Z/[6/_ $#K_P#[\_\ UZ -&BL[^UC_
M - Z_P#^_/\ ]>C^UC_T#K__ +\__7H T:*SO[6/_0.O_P#OS_\ 7H_M8_\
M0.O_ /OS_P#7H T:*SO[6/\ T#K_ /[\_P#UZ/[6/_0.O_\ OS_]>@#1HK._
MM8_] Z__ ._/_P!>C^UC_P! Z_\ ^_/_ ->@#1HK._M8_P#0.O\ _OS_ /7H
M_M8_] Z__P"_/_UZ -&BL[^UC_T#K_\ [\__ %Z/[6/_ $#K_P#[\_\ UZ -
M&BL[^UC_ - Z_P#^_/\ ]>C^UC_T#K__ +\__7H T:*SO[6/_0.O_P#OS_\
M7H_M8_\ 0.O_ /OS_P#7H T:*SO[6/\ T#K_ /[\_P#UZ/[6/_0.O_\ OS_]
M>@#1HK._M8_] Z__ ._/_P!>C^UC_P! Z_\ ^_/_ ->@#1HK._M8_P#0.O\
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M+SI5C^Q7B;CC<\6 /KS5Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVU["FBQ.J7$8<*V]1D9[X)KC[BZ_L#PQX\TRPA@GTG3];MTLX;A!-'&7?YU
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M;9>(+WQM!K>J:?:6-M#ILMH(X[GSG,C21MG.T#;A#COQ[\==0 4444 %%%%
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M;NW5DC)P#77T4 <:?A=X7.LG4?L]QM-S]K-F+E_LQF_YZ>7G&?T]JM?\*_\
M#YU+6+QX)I%UA"EY;/,QAD)P2VSLW YZCMBNHHH Y/0_AUH&@7IO;=+N>Y$)
MMXI+NY>8P1'^"/<?E%3#P%X?_P"$.A\+-;2-ID#;H@96WQMN+!@XY!!)KIJ*
M .3MOAUH=O9ZG"[W]S-J4:Q7-W<W;R3LB]%#DY 'M73VUNEI:PVT6?+A18UW
M')P!@9-2T4 %%%% !1110 4444 %%%% !117+?$50_@34D;[K&)2,]094!H
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M>$/^@#:_^/?XU2\.Z18:'\0M;L],MDMK8Z99R&-,XW&2X!//L!^5 ':T444
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M4-(U/4=4U2WMH;FYCCB7R[^XNW*KG.YYFZ9/  X'<T =M1110 4444 %%%%
M!1110 4444 %%%% !7,?$/\ Y$>__P!Z'_T<E=/7,?$/_D1[_P#WH?\ T<E
M'3T444 <Q\1/^1$U+_ME_P"C4KIZYCXB?\B)J7_;+_T:E=/0 4444 %%%% !
M45S_ ,>LW^XW\JEJ*Y_X]9O]QOY4 8/@#_DG7AO_ +!EO_Z+6NCKG/ '_).O
M#?\ V#+?_P!%K71T 5M1_P"09=_]<7_]!-97@?\ Y)_X;_[!=K_Z*6M74?\
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M&>#0!ZS1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% ',/_R5.'_L"R?^CTKIZYA_^2IP_P#8%D_]'I73T %<O_S5,_\
M8%_]KUU%<O\ \U3/_8%_]KT =11110 4444 %%%% '+^+?\ D*^$O^PT/_2:
M>NHKE_%O_(5\)?\ 8:'_ *33UU% !7,>*?\ D8/!_P#V%7_])9ZZ>N8\4_\
M(P>#_P#L*O\ ^DL] '3T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %5K^PM-4L9;*^MX[BUE&)(I!E6&<
M\C\*LUS?CZ:>W\%:A);7$UO+^Z42P2%'7,B@X8<C@F@!G_"N?!O_ $+6G?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MRNL<:*6=V. H'))/85C6OC3PM?745K:>(])GN)6"QQ17D;,Y/8 ')-6/$O\
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M)&T?0\Y$9'&?O<UK7'A7Q#;>/'N-*T>XCBEU@7D@NC;W-FR$Y:96;$D3]?E
M)!Z&@#U9]>T>/55TI]5L5U%ONVK7""4_\ SFHY_$NA6UT+6?6M.BN#+Y(B>Z
M17\SCY<$YSR./<5Y-?\ @K7Y;;5] 7P\)+Z_UG[=!XA\R/$49D5PQ.=X90"N
MT#N<>]GQ#X$U2_T7XA&+1UEO]1OH9-/<E-[HI0DJQ/R]&ZXH ]DHI!T&:6@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .8\(_\A/Q;_P!AH_\
MI-!73US'A'_D)^+?^PT?_2:"NGH *YCP?_Q]^*/^PU)_Z*BKIZYCP?\ \??B
MC_L-2?\ HJ*@#IZ*** "BBB@ HHHH Y>W_Y*GJ/_ &!;7_T?<5U%<O;_ /)4
M]1_[ MK_ .C[BNHH *Y>R_Y*?K/_ &";+_T;<UU%<O9?\E/UG_L$V7_HVYH
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M9> -%O[+5/$>KW.F?V1:ZI<126VG%E)B")M9V"DJ"YY('I0!W-%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!S#_\E3A_[ LG_H]*Z>N8?_DJ</\ V!9/_1Z5T] !7+_\U3/_ &!?_:]=
M17+_ /-4S_V!?_:] '44444 %%%% !1110!R_BW_ )"OA+_L-#_TFGKJ*Y?Q
M;_R%?"7_ &&A_P"DT]=10 5S'BG_ )&#P?\ ]A5__26>NGKF/%/_ ",'@_\
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M^- %BBJ_V*+^]/\ ^!#_ .-'V*+^]/\ ^!#_ .- %BBJ_P!BB_O3_P#@0_\
MC1]BB_O3_P#@0_\ C0!8I&4.C*W(88-0?8HO[T__ ($/_C1]BB_O3_\ @0_^
M- '.0?#O1+6WCM[>XUJ&&)0D<<>L72JBC@  28 J3_A ]*_Y_M>_\'5U_P#'
M*W_L47]Z?_P(?_&C[%%_>G_\"'_QH YYO .D.I5KS72I&"#K5U@C_OY70V%C
M;Z9IUK86B%+:UB2&)22=J*  ,GD\ 4?8HO[T_P#X$/\ XT?8HO[T_P#X$/\
MXT 6**K_ &*+^]/_ .!#_P"-'V*+^]/_ .!#_P"- %BBJ_V*+^]/_P"!#_XT
M?8HO[T__ ($/_C0!8HJO]BB_O3_^!#_XT?8HO[T__@0_^- %BBJ_V*+^]/\
M^!#_ .-'V*+^]/\ ^!#_ .- %BBJ_P!BB_O3_P#@0_\ C1]BB_O3_P#@0_\
MC0!8HJO]BB_O3_\ @0_^-'V*+^]/_P"!#_XT 6**K_8HO[T__@0_^-'V*+^]
M/_X$/_C0!8HJO]BB_O3_ /@0_P#C1]BB_O3_ /@0_P#C0!8HJO\ 8HO[T_\
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MO3_^!#_XT?8HO[T__@0_^- %BBJ_V*+^]/\ ^!#_ .-'V*+^]/\ ^!#_ .-
M%BBJ_P!BB_O3_P#@0_\ C1]BB_O3_P#@0_\ C0!8HJO]BB_O3_\ @0_^-'V*
M+^]/_P"!#_XT 6**K_8HO[T__@0_^-'V*+^]/_X$/_C0!8HJO]BB_O3_ /@0
M_P#C1]BB_O3_ /@0_P#C0!8HJO\ 8HO[T_\ X$/_ (T?8HO[T_\ X$/_ (T
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M (0/2O\ G^U[_P '5U_\<K?^Q1?WI_\ P(?_ !H^Q1?WI_\ P(?_ !H P/\
MA ]*_P"?[7O_  =77_QRKFD>%-,T74)+^V:]ENI(O),EU>RW!"9S@>8QQSZ5
MI_8HO[T__@0_^-'V*+^]/_X$/_C0!8HJO]BB_O3_ /@0_P#C1]BB_O3_ /@0
M_P#C0!8HJO\ 8HO[T_\ X$/_ (T?8HO[T_\ X$/_ (T 6**K_8HO[T__ ($/
M_C1]BB_O3_\ @0_^- %36] L/$%O!#?"?%O,)XG@N'A='"LN0R$'HS#KWK+_
M .$#TK_G^U[_ ,'5U_\ '*W_ +%%_>G_ / A_P#&C[%%_>G_ / A_P#&@# _
MX0/2O^?[7O\ P=77_P <J2T\$Z19ZE:WXDU.>>U<R0_:M2GF5&*E2=KN1G#$
M=.];?V*+^]/_ .!#_P"-'V*+^]/_ .!#_P"- %BBJ_V*+^]/_P"!#_XT?8HO
M[T__ ($/_C0!8HJ!+2-'#!ILC^],Y'Y$U/0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<D@*"V,GOQ7+6>CZGI.HZSI5WX(.M7%_KC7T&H2[/L_E,P(+R'+*R 'Y<?\
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MLS20Z7JMG>R1HKNMO,KE5;H3@]Z#XAT9=/N;]M5LA9VTAAGG,Z[(G! *LV<
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M *K6>G6E@]R]K D37,QGF8=9'( +'\ !^%6:* "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *B:78QZK)JB6L8OI8A
M"\X'S,@.0I/IFK=%% !1110 4444 %%%% !67I_AS1M*U*\U&QTZ""]O6+7$
MZ+\\A)R<GZ\XK4HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O/-%\-7.H:;#I6JVD
ML-K%:7JOO'5[B9P"/<1AC_VT%>AUB+XQ\.26SW":S9O"CK&660'YF!(48ZG
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M^M6]GK&DRZ;>7=U>ZA8W2W4:@Q,J);+(Q;/!!A?CKTKT&#6-.NKPVD%[#)<
MR#RU;)RA ?\ [Y+*#Z$T/K&FQZ7_ &H]] MA@'[2S@1XSMSNZ8SQ0!B>+=.-
MUJ?AJ\&GF[6SU$M(5B#M$K0R*&P>P<QDXZ8![5SWAO1;FWN_#4:Z)-9ZEI[2
M'5[]XPHN 8G5OG_Y:[Y"CCKC;S@\5V/_  E>@?V?)?G5K06L;B-Y&D "L1D
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M;1;S5(;^&[BM0I=87!;YCA3]#V/0X.* ..ATC4Y/%.GWG]C/;S1:S+-.T5F
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M22RQ1N"Q"?> ]2#P?0GG%,C\:^'FM[:2;5;6!Y[?[2(Y) &";2Q)]@%;GVH
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M1D'H<4 4? _G7FC2:]=0F*YUF7[88VZI&0%B7\(U4_4FNFI%544*H"J!@ #
M I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,@_B5F7#+DCYER.1ZUH1>+="FM+JZ74$6*U"M,9$9"JMPA 8 D,>%(!#=LT
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MM45(YS$94:20@;P/E;:X(]U ]ZLZA\4/#-MX9U'6K*]6^6Q"[H(P4<EON\,
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MAC_H8M)_\#(_\: -NBL3_A,?#'_0Q:3_ .!D?^-'_"8^&/\ H8M)_P# R/\
MQH VZ*Q/^$Q\,?\ 0Q:3_P"!D?\ C1_PF/AC_H8M)_\  R/_ !H VZ*Q/^$Q
M\,?]#%I/_@9'_C1_PF/AC_H8M)_\#(_\: -NBL3_ (3'PQ_T,6D_^!D?^-'_
M  F/AC_H8M)_\#(_\: -NBL3_A,?#'_0Q:3_ .!D?^-'_"8^&/\ H8M)_P#
MR/\ QH VZ*Q/^$Q\,?\ 0Q:3_P"!D?\ C1_PF/AC_H8M)_\  R/_ !H VZ*Q
M/^$Q\,?]#%I/_@9'_C1_PF/AC_H8M)_\#(_\: -NBL3_ (3'PQ_T,6D_^!D?
M^-'_  F/AC_H8M)_\#(_\: -NBL3_A,?#'_0Q:3_ .!D?^-'_"8^&/\ H8M)
M_P# R/\ QH VZ*Q/^$Q\,?\ 0Q:3_P"!D?\ C1_PF/AC_H8M)_\  R/_ !H
MVZ*Q/^$Q\,?]#%I/_@9'_C1_PF/AC_H8M)_\#(_\: -NBL3_ (3'PQ_T,6D_
M^!D?^-'_  F/AC_H8M)_\#(_\: -NBL3_A,?#'_0Q:3_ .!D?^-'_"8^&/\
MH8M)_P# R/\ QH VZ*Q/^$Q\,?\ 0Q:3_P"!D?\ C1_PF/AC_H8M)_\  R/_
M !H VZ*Q/^$Q\,?]#%I/_@9'_C1_PF/AC_H8M)_\#(_\: -NBL3_ (3'PQ_T
M,6D_^!D?^-'_  F/AC_H8M)_\#(_\: -NBL3_A,?#'_0Q:3_ .!D?^-'_"8^
M&/\ H8M)_P# R/\ QH VZ*Q/^$Q\,?\ 0Q:3_P"!D?\ C1_PF/AC_H8M)_\
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M "BBB@ HHHH *X72/!FHV%A<032VK/)H2::I5F(\P-,2?N_=_>+[\'BNZHH
M\\NO"&OQZ1JFEV0TV6+5(8/,FGF=3"Z11Q,  AW*1&"#D8)/%7AX9U>PUY]:
MLQ9W,PO+F1;>69HPT4R1#.X(V'!A'&",$\UVM% 'G6M>$?%&K6UY;S3V;B[L
M/(407DUK%!(=^XE$7]\/F&-Q'0Y'-2:AX*U:[>ZVM;;6GL[R+;=RPLTD,8C:
M,LBAE! )#@Y!Q\M>@T4 <%9^$M5L+R'6;>WM/M\=V\IM9M0N)O,C:(1_-/(&
M.\8!&% Q\OO6WH6CZGI_AF]M)Y;6+4;B>[G5X<O'&TLCNOW@,XW#/':NBHH
M\OE\!>(+R&8S26RS2:-<:>6FU&>YW2R&,A\,@")^[/RJ!U[]M?4/#&N:S?/J
MUR-/MKVW%L+6".9Y(I##-YI+L4! 8\# .WKSTKN:* .)NO#&LZ@NJZHYLK76
M)I+::RC21I(HF@R5WOM!.[<RMA>%..:JW'@6\M)-+GL&^U/;6!M)U.I3V)=R
MV\R[X>6RQ8E2.X(Z5Z!10!A>'[2ZT>"TT4VL*VEK8Q_OHF?;YN6#(H<DX  (
MRQ//..,\AXG\":]JM_XR%E)I_P!E\06ELB/-*ZO%)#Q@@*1M().<^G%>F44
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MG(/.*CM? 6O^'WTB^T,:/)=V^FS6%Q;7$DP@7S)/-WHQWL<,3D'J/3H/3Z*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M 7:*3(QG(QUS6-9^*=+O[BRBMI79;VVENH9"NU=D;(ISGD'+KCB@#:HIK.B
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MS@>9XK:Y5SA03S@G .,9J3PIKW_"3>%=/ULV_P!F^UQ>9Y._?LY(QG ST]*
M-FBO+K3XJZQJ-FVM:?X.FO/#ZW'DF:WNU>YQNV[_ " ,_AG\<<UU<'CK1KCQ
MO+X52=!>QVXE+-(H#,?^6:C.2P&6(QP!0!TU%8]KXL\.WMQ-;VNO:9/- K/*
MD=TC%%7[Q(!Z#N>U9WAOQ_H/B31;S5H;R"VM;25DE-Q.BF-02%=^?E#8.,]:
M .IHK,B\1Z'-I9U.+6+![ ,$-T+E/+#$@ %LXSD@8]ZKMXR\,+#/,WB'2A'
MXCE?[9'A&.< \\'@_D: -NBLZ^\0:-IEE#>WVK6-M:SX\J::X54DR,C:2<'C
MGBEGUW2+6&WFN-5L8HKE2\#R7"*LJ@9)4D\@#GCM0!H45RFO_$/P_H?A*;Q%
M'?0:A:HXBC%I.CF60_P YQGN>X )Q6E<^+O#EE!;3W6O:9#%=+O@>2[0"1?5
M3GD>XH V:*;'(DT22Q.KQN RNIR&!Z$'N*=0 45G:SK5IH=FEQ=>8QDD6&&&
M%"\DTAZ(JCJ>#] "3@"LEO'-A;P7[:A8:A83V5M]K>VN8U\QXLXW(58JPSP?
MFR,C.,T =/135=7SM8-@X.#G!H5T==R,K+Z@Y% #J*H7>KVMG<Z= Y9VU"<V
M\+1X(W"-Y.3GIB-OQQ5UG549RPVJ"2?3% #J*QK#Q1IFI3VD=M(Y6ZL5OXI&
M7:IB) &<\@\CC%:[.B8W,JY.!DXR: '452UC5+?1-(N=2N@Y@MDWN(QEL>PJ
MVKJX.U@V#@X.<&@!U%-61'7<KJRDXR#GFG9!)&>10 452L=5L]1MYKBVF#10
MS20.S#: Z,48<^A!&:N9!&<C'7- "T5BV?BG2[ZXL8K>5V6]MYKF&0KM79&Z
M*V<\@Y=<<>M;#2(BAF=5!. 2<4 .HH) &3P*KB[5KX6JQ2MF,OYP ,8P0-I.
M?O<]/8T 6**H:IK%II&ERZA.S/!&5!\K#'YF"COZD4[4-5LM+L'O;J8+ CK&
M64;OF9@H''N0* +M%075U]F2-O)EF\R5(\1+G;N.-QY^Z.I/I5'2->@UJ>_2
MVMKA8;.=K<W$@4)*ZL5<)AB>"I!) ]LT :M%)D<<CGI[T@D1MVUU.TX;!Z?6
M@!U%&1G&>:3</4=<4 +136=$4LSJH'4DXQ2Y''(YZ4 +15$ZK;C7(])^<W,E
ML]RI ^78K*IY]<L*1-7M9-:.E(6:X%N+G<,%=NXKUSUR* +]%98UZW?4KJPB
M@N9)K6>*"4H@(4R)O#=?N@=34VDZK;:SIL5_;;Q%*751(,-\K%3Q]5- %ZBF
MJZ.6"LI*G!P>AJLNIVK:O)I8DS=QP+<,F#PC,R@YZ=5;\J +=%-1TD!*,K '
M&0<\UR6J_$.QTSQ!=Z*FCZWJ%W:(DDWV"S\Y4#C(S@Y_2@#KZ8(8EVXC0;22
MN%'&>N*XV?XH:$FF:/?6MOJ5^NK-(EM#9VV^7=']]2A(((_'I5Q?'FG1:#>:
MSJ5AJNDVMJRJ1J%H8GD)Z!%R2V3Q0!TPAB7;B)!MSMPHXSUQ0L4:%2L:#:,#
M"C@5R6G?$;2KZXN[6XL-5TV[M[5KP6VH6OE/+$HR63D@_3(/Y&FZ)\1;77I;
M,6?A[Q&+>[(\N[DT_$.#T8ON(V^] '8+&BNSJBAGQN8#DXZ9IKP0R,&DBC9A
MW9037*Z;\1M$U34=/LHH[R-]0FN(('EC 0R0_?4G<<'T]:;J_P 2-%T:?5HI
MH;Z8Z7)!#<&"(,#)+]Q5^89/KZ4 =;)%'*H62-7 Z!AFG*BHH5%"J.@ P*P-
M!\5C7KR2V&@Z[I^R/S/,U"R,*-R!@')R>>GL:Z"@!JQHA8HBJ6.YL#&3ZFAD
M5R"RAMIR,C.#3J* &NBR*5=0RGJ&&13J** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *\ LO#&IS^&?#]G=Z)>,@\8F:X
MADM7X@)Y=@1]PCN>*]_HH \1U[PK=O<_%*"RT27[/<V]E)9)';$)*ZH2QCXP
M6!)SMYR?>J&HV%VVI>&];CTG4+;1UT8V?EKHHN&@G#G?N@(^7?V?'.:]]HH
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M=5N-1^*K0Z9>RK>VM@MJ4@9A.50;@F!\V.^,XKV$W]L-373C*/M;0F<1X/W
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M>:?:7/\ ;9T30+Q-+N+2WA@@ALWM=]]YC;)44J"FP;"TF !@=<8KU2B@#E?
MMI<V.FWEMJ<$HU=;IS?73J=MXYY65&P 5*[0 /NXV]JXRQTBTL);:.]T&;^R
M;75]0:]@33G9"SR,;:0H%_>($R 0&"Y7ICCU::Y6&XMX3%,QG8J&2,LJ84G+
M'^$<8&>^!4] '+>"K%H]"O89;.2#3IKR=K.TN(RI2V8\*4;E5)W$*1P"!@=*
MX_PGX7L[NX\-VU]X?_T>RT^]CN8[FQ*1BX\V'&X,H#$KG!YSCCIQZS60_B33
M8_%4?AMY'&HR6OVI%*':4W$?>]?E/'H* /+ET>_C@T4:K:O_ &;#ITMO%'=:
M/+?K%()GX,:D%"8_+"L1T! ([]C<Z??#X+WFGLEY<7IT>:-8Y8_W[$QMM4J"
MWS8P,9)_&NBM?$.G7OB*_P!"@D9KZQC22==ORJ'&1SW./YUJT >7:_X:DL9)
MX-#TUH(&T0K(($V>:QGC,B;N/WCH&')R<UE:K8:=J&HZY::#H5U:0RZ99!K=
M;%[8N?M7)$94,,*.6Q_#[9KUZ]LK;4K*:RO(5FMIE*21OT8&JNE:#IVC-,]E
M#()9]HEEFG>:1PN=H+N2V!DX&<#)H \]\3>%[>WD\16]EH(_LWRM+N$@@L]T
M;.EQ)YI10,%O+ !P,XQZUUOB>W:[TO1!96LC1+J=E)Y:0D;(Q(I)*XRH ZY
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MI.J$Q.K$XVOT)XSCT(/>K5 '!>%K735\=7=WHFC7&GZ>VF1QEFL7MHVD$C9
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MFE5 P7\L#.!G&/6O0M*T#3M&>:2RAD$LP422S3O-(P7.T%W); R<#.!DUI4
M<QXGMS=Z/HHL;61HEU.QD$:0D%(Q*I)*XRH ZY QCFH_ FC0Z3IFIHFFQV9E
MU2\.T0"/?'Y[^7V&5VXQVQC'%=75:_O[;3+4W-Y*(H0Z1[B"?F=@BCCU9@/Q
MH \QATG5[A]7T"R#(?#=K=)IDF[&Z6X0F#![&.-BG_ @:AOM'AU#3YX/"NA7
M=D3H%Y;7JO9O;^;(T8$4;;@/,DW;CN&<<\_-SZ+X?@TRT74+;3;>6'RKMEN#
M*69I)2BMNW,26&TJ <]!@<"M:218HGD;[J*6/T% '%Z+>G5O'-O>P65_%:QZ
M,86EN;22$>9YJ$I\X'('X>F<&L7QAX?U:]U[4--T^"<6E\JZL+A%.Q;F&)D5
M">F2ZVS8[[6KI['Q_H]ZEG*T&I6MM>E!;W-U9.D,A?[@WXP-V1C.,UT5O=+<
MF<"*:/R93&?-C*[B #E<]5YZCWH \RBL7GETK7O$.CW,EA?W%W=WEF]JTQ@D
M81I;&2( D[8HRO3Y6;MUI^D)<:'J>CZE<:=J$6DJVI16T26DDCV\4LD30JT:
M@LH(C? (XX!QTKU&B@#QR'2-<FT51;Z=?0W#Z-?H4*%'RUXK^7GL[)NQS[BN
MF\+VNFCQU<W>B:+<:?8'2TB9FL7MHVD$A. K*/F QDX_E7>TA. 3SQZ4 >>:
MCIU\_BZ[F2SN&B;7-/E#B)BI18,,V<= >">U8NA:+K]A9S&6WN);N]L+R'2I
MC"RG39M\A"D=%$F582'&2,=-M>L6ER+RSAN5CEB65 X29"CKD9PRGD'V-34
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MC-&FTXQ\W!/0$A'('?:?2M6@#S^3Q1?^*8M6M;'PQJ4%B-+F#7=];M#(9BI
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MV689(4G KN* "JFJ6RWFDWEL\0E66%T,9&=V01BK=175Q'9VDUU+GRX8VD;
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MO+#(/+8DK&2<A6)I)8O(M+'2KRQ3[#%?:DL+ZA%-/;QHL^(T\I?OMM/R9(
M.,UZ^"#THZT >/Z' IL-$_X2FRO;C2X[:[BBC:UF81SBY8+NC&YE;RPH3.<8
M(!S6;9Q3W&F:%)J+1_V0=,?R#J-G-=*)_.?=D1N")-NS!.3P<<YKU#Q+9:3)
M<Z?/?M>PW$TPLH9K.XDA<^9SM8HPRORYYZ=JVK&RMM.L(+*RB6&V@01Q1KT5
M1T% 'E9T"?4+2\.K17MY-;^%HC ]S&R/YP:<ABNXXE V]RPS[TNJ:1J-A:7
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M\TI0EF ')+,2?QKH[[1[+4KNSN;N-Y'LY/,A7S6"!^,,4!VL1C(R#@\C%7J
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M>^BN&5665X1%/Y<;,>0N5B"YX'RXK)TZRF^U6DUEIJP&;2;R.Y6UTR>%E<Q
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M[@F=O&<#&3TJS0!Y+K&EP1+X@MO[)G/B,W"C0YX;5SY481!#Y4@&V-%(.X9
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
D !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>cybin-finalproxyformasm2002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cybin-finalproxyformasm2002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0?!54# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%9GB-F3POJSHQ
M5ELIB"#@@[#0!IT5\HVM[X>B^&T>ICQAK,/B\!BEM%=2$%Q(0HQC@;<'.?\
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MLEM"9#L\I RJ<9Q_#^E8'AV^\+W":DWBC5_$RWJW\JQBQED*>7QCH#SG=^E
M'U-17$:9J7]A>"=";PUI>I:U9W$X0&XE(FBB=F8R.2I) /&..HKMZ "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7E'Q$_P"2O_#O_KM-_P"R5ZO6'JWA/3-:U_2=
M:NQ-]KTIF:VV/A<MC.1WZ"@#@/C1;R76L>!;>&X>VDEU=46>/&Z,DH-PSW'6
MD\.P77A?XV77AVWU;4;O3;G2OM1CO;@S%9-P&X$]^#^?TKT'7?"NF^(KW2;N
M_$WFZ7<BZM_+?:-X(//J.!0?"FFMXP_X2@B;^T?LOV3[_P GEYST]: /$]&N
M/%>L_!&T?3=1NKB[.KL+A#>^7/<0CK&DC'.<D<#GZ]#TWPNU:WA\77NCS?\
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MXMWV2*"#D*W8D?+GWKT#PMX(T7P;)?MHT4L0O61I5>0N!M! QGGN>N:B\3>
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M"Q+>7<7-T9&8%=N&SV S@#&,UU>J:79:UIEQINHVZ7%G<+LEB?HP_H>^1TH
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MVC:=?7<]O#:7!B3S$7?N8#[V< >W..M=#?:\=:\#>"+?4M6UR34+^(LUEI
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M?U'PQI>@R&\CM]+??:313[98SR?O8]_3L* .KL[=;.R@M%EDE$,:QAY6W.P
MQECW)QR:GKG=/\%Z7IOB&+7(GNGOH[%+ -++N!C7&">.6^4<UT5 !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB^V6L-P(])C9%E0,%)$0)P>^"1^)KS_2]*L!^SEXHO/L<)NAJ0"S% 74"2$
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MI;2HIA9MXVEL$@ C=CU!KC/#FHZMJ]KX[TBWATC4;TZ6S?VSI$&S[0Y7 C)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *\<TS3/&/PNUG5K?1O#W_"0:!?W!N8%AN!') Y['(/8 =,<
MY'(KV.B@#R+1? 7B#Q'?>)_$7BF.+3K_ %FP?3[6T1P_V:-E RQ'?A?_ ![I
MG%1>&Y_B5H^A:5X3M/#$-M-9RB.75)YEDMS#DG(4$$G!'0YXZ<\>Q44 >6#1
MM=T[XV:OJ(T6:ZTC6K6*V-W'*JB !%#$@\\;3Q[BN?T_2?'?ACP7J?@*V\+K
MJ"7)FBMM42Y18O+ER"S*>01D]<?IS[G10!XIJ/@;Q-H%YX .B:>NJ-H4$QN2
M95C1F;YBH+<C.6"G'IFIX?!_B'QOXD\2Z[J^FG0X[S26TRS@ED#N6('SMM[
MC]?:O9** /GS1? .J21:1HE_X%E\ZVF O+^YU:4VVQ2?GC1)/O>P'X<\>A>&
MO#VJ67Q>\7:S<V;1V%[% MM.64B3:JAL '(Y'>O0:* "O/M#T#5+7XU>)]<G
MM&33;NS@C@G++AV5(P1C.>JGJ.U>@T4 >$ZAX6\9:)#XN\+Z5H'V^Q\079FM
MK]9U5(%<_,'!YX'';IGFN^M+R]\'7G@WPC%8I<6<]N;:6\\S!5XXBQPO4@[2
M<]LUW%0-9VK7J7K6\1ND0QI,4&]5)R5!Z@$@<4 9'C.[URS\*WDGANR-WJS
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML4T^E>9)&CA@K,@) ()! )Z@URNK$GPM?>!,G-C-<LX[_88D\^+\,O#'^#4
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MF6VD[>BDXS3EUO5(-?MM&N+P7OV37XK7[7)#'ODB>T>7:V!@.IP-R@<8]3D
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MM(X &C+J;?8_F'! &&W$KDG!%'Q-LI[OQ#X>ELU+7ME;7M[; =3)$8'"_P#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6VU4_P"D(C8_Y9K'A?[HVHM0:AX*TK4KJZFDDO(H[T*+RW@N&2*ZP OSJ/\
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MCGI6O10!C:3X:M-)O9+[[3>WEV\0A$]Y.966,'.T=@,\GN>Y-;-%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M445P4LNNZ5KVB0S:[)>ZI?W3&ZT]$3[.EM\VYU&T,H3Y0&)Y/'.> #O:***
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M@$[F8\#!Z^U4X?&,MWI45Q::)=R737$UM-;LZ*MN\1(?S),[0,C@C.<CCK@
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M?I<T5SIT<$KP03QS>8DLFP;2I^\"#D'';UH [6BN)N/'E[;/J4,OA>]%QIL
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@!#G!QU[9KBO#OA?Q+HNHRW5QJ^DWCW4WF7EPUA()Y5SPH?S<* .%
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M*_>=>N0,C(ZC(R.:9%XXTKRYWO8KW3A#:O>@7MN8S)"N-SJ.<XR,K]X9''-
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M7WIAI)'F\UI.#@98GCWZU%_PG$,/B/5K6[ADATNQT^"\^UF,X(??G/.<$*H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*R%$#/@JKL ."1G/ YK4E\7:'#JATZ2^Q.LJP,WE.8TD.,(TF-@8Y'RDYY%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %>_@:YT
MZZMT(#RQ.BYZ9((KC?"&B:M::CI%UJ&GFT%GH*:=(&E1SYB.O3:3P0N?Y\UV
MEW.;:RGN %8Q1LX#N$!P,\L> /?M6;)XHT6TMK=]2U;3K*66-'\N6\3@N,@
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M35+:[\/V]]IM\@TGE[B?5/-M]RQE 8(PQ/.>C!< D<UW9U_1AJ2::=6L1?2
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M;RSJCS8!.%!Y.2,=* .&UCPCJW]I^(DBL;^^@U>7S8FAU/[/ NZ-8V2=-P)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 9VOPR7'AS5((49Y9+25$11DL2A  KB]'\/7
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8/RX&#7KU% 'D=SH%K_8/B'6$TT'54\1>9;W7E?O447$>-C=0N"W3@Y-=?\
M$2V@N?#T"W,LD42WD3F3[+]IA7&<>?'D;HLXSZ':>U=;10!Y%HZW,TVBI8Z?
M;6RPZQ=^3/9QR+:S%K*3]XB/]Q=QVX'RY!QG-0:5%HL-[X#BATV:WU^.\VZE
M+);.CF3[-+YGFN1AV+Y(.3QDCBO6-4U&TTG39KV_DV6L8'F-M+8R0.@YZD5E
M:=X-TW3;VUN4FOIQ9AA9PW%RTD=MD;3L!_V20"<D X% '#>'M M].T+P'J-O
MIPAU)]0VW-P(\2F-HILJ[==O"C!X&!2>$?#UKJE]H,6KZ8MS;Q:'+^ZN8MR!
M_M'&5(QG!.,^M>MU5U/4;72-,N=1O9#':VT9EE<*6VJ.2<#DT >4:-;6D4&@
MMXJL);G2(],E@MEGMGG2.83,""H!PQC"!21T! KJOA\LI^%L"V"O'*1=BW$O
MWE;SI-N[/?IG-:WB73=-:VDUR\OKZP%E;2-+<6<S(WD@;F! SGIGID=JM))I
M'A7PU"4_T?3+9$5,!G(#, ,]222PR3ZY- 'G6FOH-GX>M6L-!O[CQ%!I4_VY
M;9'AF\SROW@G?@EF?A?O')RO3-95O'#%?&6PCTU+=] OHYCI>GR01@[$*I)(
MQ/F.,,>0".<]:]QJ"\M(K^QN+.<$PSQM$X!P=K#!_0T >3Z2VF)'H5SX7TR=
M[BVTJ=M42")XI)5\C*QR/@9D:7:5/)ZD<50T>*3^VM&DT*'3H;B33[N(_P!G
M6,D7ER&'*)-,Y_>/N&>0"""3UKVBTM8[*R@M(01%!&L: G)VJ,#^5-@O(;BX
MN8(]^^V<))NC91DJ&&"1AA@CD9].HH \AN(?#S>![B#2M(NAKBZ#<QWCQ0,C
MHYB^87!."[%^@.XYR1QS6E/X=M;_ ,0>*;2&TBM]7N+&TNK"X\C:QDC&[<'Q
M_P ]%CR,\XKU2JNHV(U*PEM&N+BW$@ ,MM(8Y%YSPPZ4 <OX#N)-?6^\6SP-
M"VI%(;>-QS'#$",?C(93^(KD]0B@L_&\\\-K#?WKZO$_V6ZLY([U.5&^&X0X
M:$+\V&&W (/I7JUA8VVF:?;V-G$(K:WC6*)!_"H& *9!J5K<:E=Z?%(6N;18
MVF3:1M#YV\]#G:>E 'D;Q:9IUO?Z?_8]E'N\1S-</=6SBWACQ(T+2J@'F(>B
M@G:"0>.*K0V-G_95R]_86\NG6OB>";Y=-:*%(&BCWLD3;BL9.?4'KWKVB"\A
MN9[F&/?OMI!')NC91DJ&X)&&&&'(R.HZBK% 'B,UE<OJ=^EW<6T.NOK!>!ET
MB26^V>;F)HYO-5?*\O&> H7<#SG-C7+73#8ZS#J5A))XH;6A)%)]G9I3#YZF
M-E?'^J$6 >< @CK7JDOB#2X9!&UTI;[8M@0JEL3LH8(<#C@@^G-:5 %:WOK>
MZN;JWA=C):N$E!1E )4,,$C!X(Y&:LT44 %%%% !115>TO;:_CDDM9EE2.5X
M69>@=&*L/J""/PH L4444 %%%% !1110 4444 %%%9MYX@TNP%R;BZ4&UDAB
MF"J6*-*P6,$ =RP_/- &E1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%9J>(-+DGLX8[I9'O)I;>'8I(:2+=YBYQ@8V-U]* -*BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *\TOM4T^_UKPK>:3?130)J/DKHGEJC
M0MM='E*KAE9 6)#?+@GC)!KTNJ).EVVKHF+6/4KI&91A1+*JXR?4@9'Z4 6+
M:[MKU'>UN(IT1VC9HW#!74X93CN"""*FIL<<<0(C14!)8A1C)/4TZ@ KD_#W
M_(_>,O\ KI9_^B!75LP12S$!0,DGL*RCK^A0M8R?VA:*VJE?LK*PS<],%<?>
M'(Y]Q0!YQX>L1IF@>$M6MKJ\6[N=7-O+FY<QM$[R@IY>=F. >G49ZU!]HN+S
M2=&,^J0S-MOV:QOM1FLQ,!<L ZS+P74# 5LX!SQ7K4K6-L%BD-O&(U:94; V
MJOWG ]!D9/O[U&8=+OM-BE:&TGLBOGQED5DP1NW#MWSGWH YV+4VO/A'+J-O
M)>(QTB5TDN) 9LB-L,7&,GC.X=>M<FEY;6]MILF@:S<WDMUHMU+J)^VO,<+#
ME96!8^6XDP!C'4CMQZ9<PVNO>'YH(9PUG?VK(DT)!!1TP&7MT.13]/TJSTZS
M6VA@C \M8Y'V &7 QEL=30!YQ;V=K:_\(I;:GJ=]'IFIV3W5W-/J$JBXN]D6
MU6?=\HP9&"@@$KTXJI-JFI)H2-H%_=7FI0ZQ<0:&C2F5;RW &\.2?GC7Y\.2
M<%5YYY]9FM+:XM_L\UO%)!@#RW0%>.G!XIRV\*,C)#&IC78A"@;5]!Z#@4 >
M82ZX/#>CZ)XCL+R^U*SN;.6SF6X=F=[LY>,LN?E<R*\9';<!T KK+JTN-'^&
MUQ:W&KSPW<&GN)M1PTKI)M):3 R3AB3QT'TJ]J/AZ/4K^QEDN7CL[:<7+6<<
M:!)I@<J['&>#SC/) STK9ZT >(WUR!X<\0Z5O'F/803>;8ZJ][;,/.50X\SY
MHY#GID@A<]JVO$8NO#%[K5KH]Y?QPOI,-Q*7N))FC/VC9)*I<DAA&6)(_N@]
MJ]%FBTG2;&626*TM+0L#*2BHA)( SVSDBKOEQ^9YFQ=^W;NQSCTSZ4 >1^(+
MB'3H]9M_"NJ7-Q:?V!/<W/E7KW AE5D\MPY8E693)T/(7/:I?'6NVNJ/K<&G
MZE'=6R^%KF1U@FWQ[C)'@G!QNP3[X/O7J5O9VMI&R6UM#"C'++&@4$^IQ38]
M.L88S'%9VZ1D$%5B4 @]1C'?% 'E'B^2QNM,\='6]4FMK^UA,>GV_P!K:,>2
M;=2FV,$!P[EP<@^G&*ZSX@[!\+KPR2M$GEV^Z1>JCS(\D>XKJKN"P9XYKR*V
M+ ^4CS*N<MQM!/KG&.^:L/&DB;'163CY2,CB@#R37=0DTE=<C\(:G-<6:Z5%
M-<2"\>X6"1IE4N')8JQB,C'']P-CUVO!3S1^*Y[:"^L&LC8"62UM-4GOP'W@
M+)OD0!"1N!&[+8!QP37;V9TY);FSLA;H\+ SQ0@ JS#(W =R.:='#8Z9"QCC
MMK2)F&XJJQJ6)P,].22!0!YGXYN_LGB#5+M]16:.TM8I#:KJ4EE<VO!.^ 8\
MN4M[CJ-OM3M3U2:75]2CN[VZMM&DURUBO',S1&&%K-6"E@1Y:M)L#8(^\?6O
M39K*UN)HYI[:&66(YC=XPQ3Z$]*S?$=E;R:3-/)J3:4L+"XENDVA<*,'S PP
MR8X(/MZ"@#S4S0SZE?:?I.MWTNF'7["W1XKYWVHT1\R-)-Q.W.1P>/P%2ZY/
M?:(=;TK3KN:/38]6LDD-Q?2J((98LN/.^9XT9PH)'3<>F:]$T/PY!HZW,DDS
M7EU=3+-+/+&J\JH50JJ %"J !CWYJZ;K3'ENX6FM3(KI%<*Q7.YP-BM[D$8!
MZY% 'E8O+RUMM0M3JL$>C?VC9177V'49[@6<;EO,'GNJE5;]WD G;N)XS72^
M"8]-A\:^*XM*O&N;5([, FX,P0[9<J'))('IGC)';%=K%9VL%L;:&VAC@((,
M2( O/7@<4MO:6UHFVVMXH5P!B- HP.@X^I_.@#S35IKJ[UZ^L3?WD4+^*;6W
M(AN&0B(V2LR @Y )R>,<G/7FNE\(1FQUOQ/I44T[V=G=Q?9TFF:4QAX(W8!F
M).-Q)QGC-:IUK0#";HWUCY?E&],NY<>6OR^;GT'3-7KBXL]/A>[N)(8(V90\
MK$*"20JY/N2 /PH \CN=.L9-4U*R6YFCGD\86XD1+MQ(L9A0@CYLKDEAN&#V
M!X&)]<GOM$.M:3IUW,FF1ZO9)(;B^E400RQ9<&;YGC1G"@D=-QZ9KU@VEL9S
M.;>(RD@F0H-QQTY]J<T$+"0-$A\T8DRH^<8QSZ\4 <7X!DN!J&MVWVRSELX6
MA\NWM;V:[6W<J=X$LB+P1M.T$[3GID5R.NW^IR:IXEGFU*SLKVSO/+LY)]5G
MBD@3:OE%+9(V$@;.>Y;)':O70MGI=B[*D-K:PJ7;:H1$ Y)XX% M[*\>"^\F
M"9PH:&<H&(!Y!5J /-=6U">/QN;;^T;Q/#SW-O\ VM)&[;+>Z(.R)7SE$<^7
MO '&5'&\UDZ[K6;JYU2SN7BGBUM+=);G6'%Q\LZH\:6RKL$>W=]XY*\G)->R
M&VMS')&8(C'(2SJ4&&)ZDCO49T^R::28V=N99  [F,;F'H3CGI0!YY!<Z;-?
MZG>:SK5];:S!K9MX(8+I@ZQ^8!"BPYPRNA!/RG.YCGC(U_AK;V5KINL06TI:
M6/6+U)4:=I&3$[A<AB<97!]^ISUKKVM+9KI;IK>(W"C:LI0;P/0'K3HX(8I)
M)(XD1Y#EV50"Q]2>] 'DL5C)<:=IFHOJ>J"ZN_$L]E(ZWTH'V<SS(8@ V ,*
M.0,CL1@5)<W::<;_ $+SKU[<>(/L]K%)J301[?LJ2F.2<[G"9+$ <DX'3(KT
M]Y+"&YM[-S DTI>6&(@ L5P691[;AD^]+/!83LUI<16TC39D,,BJ2^, MM/7
M&5&?I0!Y'IMU<7UN-,&I2K:CQ5'; 66H2RA86M=S1K,<.5W;O3VQQ5Z\BFMM
M0O-!M[^_BL(_$EG"@6[DWK%);J[H')W!22>_&>,5ZDMI;*1MMXA@@C"#@@8!
M_ <5$TE@-06U8P?;)%-P(R!O8+A=_P"&5&?<4 >6:Y/?:*=9TG3[N9-,CUBR
MCD-S?2J((980S@S?,\:,X4$CIN/3-1%[UX;C3H]6C2R?6-/@\O3=2GN#!YC$
M2H)W53AEVG:"=I)Z9%>OM!"PD#11D2C$F5'S\8Y]>*9%96L$*0PVT,<2-N5$
MC 53Z@#H: .?\3O;>&_ -X(Y+Z.W@B6)'AN#YR[F"C]Z^2/O<L<X&3VKS]+V
M6VO_ !#80ZM#I<!T=9F:VU*>_2"3S=NYG(#*2I ;;T!#9[U[*Z)(C(ZJR,,,
MK#((]#586^GV,:*L-K;H?W2 *J [C]T?4]N] ''> ;Q1JVJZ:4Q)%%#,?LVI
MM>VOS;QE&<;D8XR5/8 _7F?$UG9C4O&L*W$D=W->Z60!<MN"-+!EU4GLW0XX
MZ#'2O5M-_LWR95TQ;98DE>.06Z@ 2*<,#CN",&IGM+:24RO;Q-(0%WL@)P#D
M#/ID T >6>)7O?#,WB2QT6ZNX[;[%87#&:[D?R ]Q)'-(';<R?(N21G&-V,B
MMGP0\\?B:^M8KVP>R%G'(UK::E/?".0L</YDB +N7.5W9. <=Z[TQ1EV<QKO
M9=K-CDCT/MR?SJM9?V;#+<65@MM')"09H85"["PR"0/44 <#KEB=1U?QO+/>
MWZG3K&*6S6&\DB6&3R7;> K $Y4=<_J:Q?$&L?VA!>R27#"ZM-)MY&EN=7>T
M6*1XBX:"*-<R,21R3U 4=Q7KTWV6%))9_)C1\+([X ;L 2>O7'XTUK&S>:.9
M[6!I8UVHYC!9!Z ]A0!Y6XGURUUF\N]0OR]KX8L[R 0W<D2K.T<S&3"D ME1
MUXHU&74]#@^TZ1=WTM]>>&)[R7S9WEWSJT.) K$@,!(_"@#H,<"O5UMK=%*K
M!&%9 A 08*CH/IR>*<(8U96$:!E7:I"C('H/;@?E0!YMX.EF3Q7:16NI6$EK
M-8O)/!;ZM<7YEY79*2\8$9R2.HW;NGR\2^-+VWG\3RV$KX^S:>LS_:]7>Q@C
M#,PWH(U+2/\ +@]AQC!)KT"WL[6T+FVMH83(=SF.,+N/J<=:6:SMKB6.6:VA
MDDB.8W= 2A]B>E 'DFAZA::O<>'E\3:Y/'%+X;CG*R7SP++*'(+L0PRP'O[]
MN':3>P:EJ&A0^)]9N8K:31YI(Q+>/;BXVSD1R.05RWE8;WSGM7H%WHNC1:_!
MJ%X8 T\*V$-M*J^6S!FD&T$?>X;\C3M0TG2CK]OJFHR1%I8?L$4$X4H[%]XP
M#U;Y>* /,XM2U;4#H-MJ%U%)I[V5Q);OJ&IRV2W6V=E1VD12780B-@#_ 'BU
M6H]4>\T[0K&_ODOY#;7,ZRRZO+9VDD2R[59I/+$DKJN #C!&6[@UZQ<VMK=0
M>7=6\,T2\[94#*,=\&H8TTW5[*UN4CM;NV*B6WDVJZX(X9?P]* /+/#7G>)D
M\(6M_J5]);O;:H9!#>2IYWE7*)'N<$,VT8P3SQSU-3Z+?_9/%MC))?G43=ZC
M/ MS;:C()B?WG[N>TD& J8QE<8V@]^?3FDT^VO88&-O%<RK(\2<!F (+D?FI
M/U%(J::@;542U&^/>UVJK\R8SG>.HQS0!S'BR6&3Q5H>GZK>26NBSPW#L5N&
M@6:X79L1G4@_=,C 9Y([XKF--:76-4T;37U*^FT8ZCJ$5O(EVX-S;HBE 9 =
MSJ&W '/(7J><^HE;/5+%&9(;JUF4.NY0Z.IY!YX-2B"%?+VQ(/+&$PH^4=./
M2@#FO QD&EZG9O/--%9ZI=6T)FD9W6-7^5=Q.3@' R<XK@-$TG3KJ;P[IR7$
MXQKVJ+<I'>2>8NWS\*3NW+E0,XQD$DYR37LR1I'NV(J[B6.T8R3U-1K:6R2F
M5;>)9"VXN$ ).,9SZXXH \BO;O4+5(](CNC_ &3'X@N;5FO-0EA78(@\<33@
M,X4LQQZX"YKL_A]+<O8:G')>V]U;PWK);B"YEN5A7:I:,2R*I<!B>1G&=N>*
MWKB]T96N+.YFL\F2-)HI-O+R'"!@>['&,]:OPPQ6\2Q0QI'&HPJ(H  ]@* /
M(H[VW%E?WMMK5S+XDB\1RV]O;&]<G;]K*^2(MV"AC))XX&3GY1B:9)H='UG6
M7U+4$9_$$MC<W NY +6R^U /M&=J8&?FQE03R *[VQTG2?#,$UQ-)$#+>2R_
M:9PH96GF+; WIN? 'N*U)YK*R5$G:&%;F7RU5L 22-GCW)YH \UO;C3;*X\0
MV>GZS>+HL6G0S>;;W;SM;WAD8(L;%B2S87Y,X/''S&F6=YK$GAC4=8O[BZ7Q
M-I5]'>:A8JY5$B0?ZM$!(*-"68'NWN./3HK"S@A6&&T@CB5MZHD8"AO4 =_>
MJ>MZ.VK:?-:PWDE@\X\N:>"-#(T?(*Y8''!//4=J ,CPKJ:7%G/KE[>A(]9O
MB+!)I,#R@-D2H#W<(7P.3NKJZKP6-K;6EO:Q0((+956%,9"!1A<?058H ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX;T6_L;>RN=+M)+:V_U$?E "+C'RX^[QQQ4=QX5T"ZM;2VFTBS:"T!6WC\H
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M9F9-YZLJDX4G/.,9H \]T>_UJSN+C3;?4D-QJGB*ZMUN)8 1 L:,[L!GEB%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUC"[1@D'G ZG-,U7PVFH:C#J5KJ-YIM_'";<W%KL)>(G.UE=64X/(.,C)]:
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M,H77S&8;7'&TD8P2.HYKIM3U\Z1X@L[6\6./3KJVF<7!)RDL8#E3VP4WM_P
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;QEF52^9-N6VDA5)8@=*+CX@Z%;00W$LDXM[FR^V6LOE\7(R!Y:#.3)DJ-A
M/S#WPZ]T?6[3Q%>ZOH4E@YO[>.*>*]+J$>/=M=2H.>'(*G'0<BL67X=7<VG:
M;IYU7RX='MP]A*BX8WN=WGN.FT'@)SPS9[4 ="_B^P@M]7ENX;FV?2H$GN(I
M57?M=-R[<,03D%>OWE(]ZO7^LP:;#82W4,Z"\N([9?E'[MW^[OYXYPO&>2*X
MS6=.?7/'>B6IE3[3';JVMQ0JQB,<;++$-Q _Y:YP.I5F]*[#Q+I+ZYX>N["*
M18KAU#P2,.$E0AXV/L&530!GP>.=(N1>>2+AWM=372V0(,O*S!<KSRN2>?\
M8;TKF+OQEJ2V%Q/97SR(F@ZE>H\UNBMYT,RHA(&1@9(QWX)YK0TCX?S:;K^C
MW[WD;P6EHGVF( YFNU$@$OTQ-)_X[Z57'P^OQI<MI]LMM[Z/J&G@_-C?<3"1
M6Z= !@T ;WBO6KO2/ -QJ]O)MN8H8GW! W5E!^7'/!-)_P )Q86Z7O\ :=E?
MZ9+:VXN?)NHU+RQEMH*;&8$[B%V\$$C(YJSXBT.ZU?P=-H]M<10W+QQJDK@E
M5*LISCO]VL#5_!.I^*A?2ZY<6,,[V:VMJELK21KB5)2[[L$Y:-!M[ 'DYH Z
M/2O$<>I:A)IT^GWNG7RPB=8+L)EXR<;E*,PX. 1G(R,CFDN_%.G6+:T+D31G
M2(5N)\J/GC92P9.><E67MR"*R_"WA272-8FU&;3M$L";?R$BTV(DME@69G90
M<' ^4#'N:D\2>$7UW7],OH[E(K=,1ZA$03]IB1UE1?P=?R9J %NO'5I:M=,-
M+U2:WL54W]Q%$A2T)4.58;MS%5(+! V*JIXZ$&M>(%OK29=,T]+<P3QJK>:9
M!\J@!B69RPV\#WQ27_AC7%_MZRTNZL%T_6W:262X#^;;,\:QR;5 P^0N1DK@
MGN*J:I\/;B]_M2SBGM/[/NH+,P^<K,R2VQ&T.O1D8#GD'F@#9/C>QMH+XZG8
MW^G7%I$DS6MPB-)(CML0IL9E;+?+C.02,XS4.C^)+[4_&]UIL]C=V$$.FQS_
M &:Z2/=O:1AN#(S @@ =>"#WK(C^'D\UK?DVNB:3<2)#]F&GPEPLD4HE#.Y"
MLP+*HV@  #J36]I&DZW_ ,)5<:WK#V"[[)+1(+1G8+M<L6+,!G.[TX]^M $V
ML^*ETB>YC71]3O4M(1/<RVT:;(D.3U=UW' )PN3^=5[CQQ9I<M%9:=J.HI%;
MQ7,\EI&C>5'(,H=I8.V0,X56-9/B7P1J.NZOJ<K?V==VUY L5N;XR,;$A2I*
M1 ;6R?FR2ISZXJKJG@#5+ZRM+?9I$DL-A#:Q7K>9%<64BIM+QN@RXS\P5BO/
MUH [77M<M?#NC2ZK>),]O$T:LL*;G)=U08'?EA64?&@WK!'X?UB6]6'S[BT1
M(O,MXRS*I?,FW+;6(5220.E7/$.B3ZOX:73([A3,);9S++_%Y<J.2<=R$/XF
ML+Q%X'?4/$D^LVUCH]^US;)#)%JBMB)D+;70J#G(;!7C.!R* -*7QO8N+?\
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ME$,>)Y5SF,?/D'Y6Y8!?E//%6T\<V4MG T6GZ@]_-<R6BZ<$3SQ+'RX)+;
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/N,9 .35BX\&ZE:66FQVVDC[1!8F);C2]3DMY8)2[,5+.Q\R++9^;)SGCG%
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MNE8+W4VL3SQ,5C**882^%)S_ ! !02 #70>-]#U35+2UNM!DCBU:U9TCDD.
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MBQU2U\5VNOZ=9+?J+)[*:V\X1NH+JZNI;@\@@@D=CSBLO0/"FJ6.O:9J5XD
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM08IY)2.3>9$;=DLXXQC/SG-6K3P[J$7A+1;7["5N8/$'VR5>,K']J=MY_X
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M"8/L,A)_N]2202!S74^'O,\)^# U[82B9M0FW11[=Y\ZZ8(W7!X=3USCWXH
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M)]3AB2[9ANW*QC^\@!&"W.2<5V5 !1110 4444 %%%% !1110 4444 %%%%
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MMJ\:7%S#"TIVQB20*7/H,]:\IDDTMM;\2)K6@337]QI=I''!':O<[7,)S"K
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M$7BN-M(FEO+[0;62V;[&S&1D5_, ;;]_)3C.3QQQ4>M6:SZUK-Q+%(NG7]G
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M,-D!LY!"YR. #U);RU>Z>U2YA:X09:(2 NH]2.HH%[:M=-:BYA-P@W-$)!O
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M&]@XSCG&">_./!9LIT*ZFA>UTQ-"CM4$^AR7*QW*L?/4QX!1F^7YL?-@X/J
M>R3W=M:JC7%Q%"KL%4R.%#$]AGJ:J:%J\6O:+;ZG!&\<<X8A'QD88KV^E><:
M5IT.DS:1)XCTV^O--_L<V]L+FP,S0R&5F*-&F_83&8U&>R8Z\5V'PZMI+/P#
MI5O+;2VSHCCR9E(=!O; (/?&* .HHHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:0GY[K!EC(7^ DK)'M[?*.U=#?3:QX=^&%U<M,]UK-IISS/(_P ^9MI8G'<
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M^T^?@X\K;NW>N,<U:1UD170Y5@"#ZBN)BN9[+X%Q75M*\4\/AM9(Y$.&1A;
M@@^H-8]^=1OO^$NNCK>IP'2["&>T2WN"BI)]GWEB!]X$@<'CKQS0!ZA1573)
MWNM)L[B7'F2P([8'<J":M4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<AZNO'#'U'->>V_B_P 0:HFBV"/>B:2TGGNKC3;>%I93',81A93L4<;FP#U
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M<8Z8IO\ 9]EMG7[);XN%"3#RQ^]4#: W'(QQ@]JLT4 -1$CC6.-55% "JHP
M!V IU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY'W=O0]:=#XJU.PT#39+2WM].L)9+TS7:V$UW%$Z7#*JE4?<N[YF+$D9STH
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MB8-RG<S;@.,-QG)X%2ZJFLR_$Y$TBXL[=O[&R\EU$TJC]\< *K+R3WSP.QH
M[BBN#L/'\HBM+W5H(+>QGT^YE+1Y)6XMG*RH"3RI4%EXS\IZUUNB3W]UH=C<
M:G%'%?2PK)-%&"%C8C.WDD\9Q^% %^BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN-Y@B<88)P.2 !N.3QUK2@T"RM[[3[Q/,\VPLVLX<MQY;%"<^I_=KS]:U**
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M'QQG ^8Y/ YJ_?\ A>SOA8NEQ=V=U8QF*"ZM9 L@0@ J<@A@=J\$'D UMT4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>1R%.UP H.2&R./0GI23^.X)];\,P:2UO=Z=K4-W*+K+#;Y* C ^N001D8H
M[*BN,L/B-HL>A:9=ZQJ-K'=7T#SQI:1S2+(JM@[!LW'Z8SU["K]QX^\,6VCV
M.JOJJ-:7^[[*T<;NTNW[V$4%N,<\<=Z .DHJE;:M87FD+JUM=1S6#1&99TY4
MH!DG]#Q6-I7Q \+ZY?166FZM'/<S1&6%?+=1( ,G:6 !([@'(YSTH Z:BN$T
M3XFZ5+X,T?6]>GBL;C4ED9;>%'E.$9@2%4%L  $GH,UKZEX^\,:3#:376JIL
MNX?M$)AC>;=%_?P@.%]S@4 =)17-:CX_\,:6+=KK5%VSVZW2&*&24>2>DC;%
M.U3ZG%/U7QWX9T6:"&^U:*-YXEG38C2 1G@.Q4$*I]3@4 =%16?JFMZ;HNFC
M4=0NEAL]R+YVTLH+$!<D X!)'/3FL;Q1XSL]%M-1CM;NT_M&Q6!YH[D2>7&L
MD@5=S(IY.3@#^7- '4T5SMQXZ\-VNM'29M2"W8F6W;]TYC65NB&0+L#'(X)K
MG]7^)]MH O#>K;S^7JZZ=&MMYF44A2S293[R@YPN<\ &@#T*BLZQUW3=2U"Z
ML+2Y$EU:QQ231[&!19!N0\CN!_C6C0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUC8K%_K/W0&#G!^M2^)]'T[XP&U;X>Z?:6HTO<+WS85MMWF8V8VCYO\ 5O\
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M+HW3Q2?.I4L_R[<KM&WKR<G XK3L/B#X5U*2Y2VU>,FVMS=2&2-XQY(ZNI8
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M8M:G3$TM[5[6'4)K>.&X=BQ<D O*G. A.#CG%=C>_$CPEIU_-97>KK%-!/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ:GA"WN)89(G-P8K,3X8$8R2IQQFJ6C?#WX;^)?)>\\JXU^YB$]] E^PD$Q
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MG:&W=ONK)(!M4\]SQWQ764 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ)H-MIUI+#$8;R"<F4G!6-@2. ><"NFHH \\\;>#)-5U/6]8FE8V4_AYM/\
M*MXS).)!+Y@95X##@<9R>E<?X>76/&'BB/S)X)UA\.SV+316<T$<+OA5#F09
M+GJ0O QQ7N=% ' V?@.^MYO!C/=6VW0].GM+C;NR[/$J IQTR"><58\%:!XI
M\,Z'H^C7$^D/:6;RI.T7F%Y(B,QE<@ -N)SGC&,<UVU% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;QP1.LPV>5DD@CH>:Z^?7]/^)/@S3_!_A=7BU^*&%Y)9D\I2(U ?YQR>?SH
M\J^('A2/P5XNN-$BNWNDBCC<2N@4G<H/3)]:Z+X7?"ZW^(5IJ4\^J2V1LY$0
M!(@^[<">Y'I5V3X ^.IG+RO8.Q_B:Z)/\J]9^#7@/6? MCJT.L?9]UU)&T?D
MR;^%# YX'K0!TGB[P1%XL\&1^')+Y[>-/*_?+&&)V>V>]>:_\,TV'_0RW/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG[G-HKY'_ B36'JFIZ_M^W->ZH]E#IMO+YNDRPN]I(8]S// V&<'@^F!T[T
M>I+<0O<26ZS1F>-5=XPPW*&S@D=@<''T-25P7AF-;KXDZYJ,5_<313:;82H,
M@(X<2D';C( QD#/&XU9U'^T;_P")#6":M>VMA:Z9#>&WM2H\V3SI!AB03M(7
M! QGCTH [2BO(="U[Q3>V>B:^RZCF_NXQ/\ :+JT2R:)WVF.--^\,H^[QN)7
M!SG%3W&HZQ-X.'BL>(;RWNY=36$V8*>2D?VH1>4%VY#!1DG.<Y[4 >GVM]:W
MIG%M,DIMY3#+M_@<8)4^_(_.I);B&!XDEFCC:5]D89@"[8)P/4X!./8UYI=:
MEK]Y]O@L[J:7R]?N(6M;>YC@N98%B4A8F?CY2=Q'!QW%5#*VMW'A(-JNK^=:
MZ[/;2K<HD4\1$$CA'QD,P7 W#J&/>@#UJBO'T\0>*KRRNM?@34EDCU"2.-7N
MK2*Q6-)C'Y3J[A\D#&XX;<>.,5UOA==0U+Q'KU_=ZQ>-!9:E+:062E1"$V(<
ML,9)RW'/&/K0!V=1M<0I/' \T:S2@E(RP#,!C) [XR,_45Q/B>]NKOQ+)IMC
M=:W*UO:))):Z5Y,(A9V;$DDTC '(7A1Z$G.:P?#UQ>>(-=\ ZO>ZA<&YFTF[
M:7RRJJY1X@20!_%GG'H,8H ]0FOK6WN[:TEF1)[DL(8SU?:,MCZ#FI)KB&WV
M>=-''YCB--[ ;F/11GJ3Z5QGC*SEO_&/A"WBO9[,O)=[IH,;POD\@$@@9Z9Q
M].:YF^2]OULK"ZU>_D_L[Q<+*&?>HD,9B#@L=O++N(!QTH ]9BN(9VE6&:.1
MH7\N0(P)1L [3Z'!!Q[BI*\B OM+MO$<ECK5W;2W'BN"T,SE6$:OY 9L$8SA
ML<\8 K4U:ZUS2+_6-!TW6I)V:QMKFWEOIT62)WF,;1B0C&74';N!PWM0!Z34
M$E[;PWD%I)*%N+@,T4?=@N-Q_#(_,5Q7AJ:ZU$ZQH=QJ.O6%ZL<4JQ7HB:>W
M5BP+QRKN5U8J1STP?6I=7U)K?6?$6LQC>VCZ<MG;+_>N)?WA7\?]''XT =A9
MWMOJ%L+FUE$L+,RAQT)5BI_4&IZ\YL]/O[+Q1'HD.K7L5AHVBVDXMK8J/M$H
M>4'<2I)#!.0,9R/2LKP_KGBFZM_#^MO_ &B?[1N(A<FYNK1;-XY#RL2;]X91
M]T8W':00<T >MU7M+ZUOA,;69)?(E:&3;_"Z]5/N*\P;4=8F\)6'BK_A(;R&
M[O-4ABDLP4\E8VNA&857;D$+U.<G#9ZU/<:EX@O4N8K2ZGF":[>126MK<QP7
M4L* ;5B+\$*2"1P<8YH ],DN(89(HY9HT>9BD2LP!=@"2 .YP"?H#4E>3QRM
MK>J>#6.K:LTMMJUW;2BY1(9HV6"1MD@ (+ 84L."">YJO:^(/%5[8?\ "0Q)
MJ2N;]D DNK2.Q$0G\ORBK.'!P,9/S;O;B@#V"BN,\++J&I>(==O[O6+QX;/4
MYK2"R!40A J'+#&2<MQSQCZTW4([[5OB+=Z2-<O;&RATF"X6&T959I&EE7?D
M@G "C(Z'C- ':T5Y9H>I:WXKU+0K:?6[NTB;3)[B=[,(AN'BN!$K\J0 P^8X
M]<=*!JVL?\(6OC;^V[K[8;L?\2_Y?L^S[1Y7D;,9W8_BSNW?E0!ZG17FDVMZ
MFGQ&/A8:R1ITETMP;O'SQL5+_8MV,9.-X.<["1UQ4J:YJW]I?\(B;R7^U!K'
M_'QQO^P8\_=GI]W]UGUH ]&HKRH:AK,'A6_\4?\ "07<MS::M-#'9DIY+1BZ
M,8A9<9)*G@YR,KCIS>U+Q#J4'@?QK>K?.ES8ZC-#;2<9B4&/:H_[Z_6@#T>J
M]O?6MW/<PP3I)):R"*=5ZQL5#8/X,#^-><>(=5U?3M;U34;F_P!272K6X01W
M>F/#-!:H%0NEQ </G)8D\\,,8Q5>]M[])?B+K-EK5[9O83_:((K?8$:1+2)L
MN"IW X QTZ^M 'J]%<UXFUV[TSX>WFM6H1;M+,2(2,JC,!\Q'<#.?PK \13:
MAX.TJYGMO%4UU<36RA(;X)(RL9HT:X3 &%429*X*].G< ]$HKSC7+G5/"EY+
M96VMWM\EWHU]<?Z6RO)!+"BE9%(48!W8QTR!BH;:WUJ36?#=G+XHU1H]9TV6
MYO,&,$.@B(\H[?D&9"#CL/7F@#T:\O;>P@\^ZE$<9=(PQ[L[!5'U+$#\:GKS
MC0KZ[UV#PWIM[</=2P7]Y//*X&Z2.UE>*,MCC.]HC[E34GAZ6_U71=*\2WGB
MFXM);^YVR6K[/(*L[(($7 (<< -DG(.<]* /0R<#)JO8WUMJ5C#>V<RS6TZ!
MXY$Z,IZ$5P.B:]JVI7FD^'9;M_[0TZ:X_M>4  R)#\L>?^NGF1O] :R/"9O]
M#\%^"=3@UJZN!>SV]G+9N5,)CDR,*H&0R8SG.3M;/L >NT5Y59WNMIX>TOQ)
M)K]]+-+K8M&MFV>28&NS"5*[<DXYW9SGVKU6@"M!?VMS>75I#.CW%J5$\8/,
M98;ES]1S1:7]K?&X%K.DIMYC!-M/W)  2I]^1^=<QX<(7XB>-(R0'9[.0+W*
M^1C/TR"/PKE8KJ\474>GZG)8KJ'C66V>XBVDM'Y)# 9!&2R8!]10!ZU17F&H
M:QJ^E:K?>&X-7N'A>_L(([^;:\ULEQOWKN(P3^[&TD$CS!UXJ/Q+JFL^&FUO
M2;+6KJX"6%M>03W.UY;9VN!&5)P-RL.0#Z&@#U.BN.TD7^D^/GT>35[V_M)]
M,^U_Z859DE64(2I51@$-TZ<<5V- !1110 4444 %%%% !1110 4444 %%%%
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MKMIIZ6VKL8HOLCN7MI?+:14?=PX(5AD8Y'2DLO&5U=>&?">J-:PB36[F&&5
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M:/H=GIENV];2W2"-G[[5 !/Y5E^&/#]QID^K:GJ0M#JFJSK+<?90?+550(B
MD G@$DD#EC7/Z?XR\17/@Z#Q%>0:'9V]YY7DM/<LBP*<AGD+8ST&%7GG&>]9
M&J^--7U?POK,5G=6'VFPOK%/MMF9%CFCED3[H)R.>#R01F@#OM.\'Z!I5^M[
M8Z9%%.FX1D%BL6[[VQ2<)G_9 J*'P1X;M[\7L6DPK.LWGH=S8CDSNW*N<*2>
M3@#/>N?F\2W&EZUK%M;Z?;2:M/?65DC&5Q')+) &+-G.U54-PHR<#N<T[5/&
MNL^'[?5[;4;*RGU*SMX+J V[,L4\<DOE$$-DJP.>Y'(/M0!VMW86M\ULUU"L
MIMIA/"3_  2 $!A^!/YU7GT'2[F'4H9K.-X]2YO%)/[[Y0G//]U0./2LG2-:
MUD>*9="UJ&P\QK(7L,MF7P%W[&1@W4@D<C&?05O:@]U'IUR]C&DEVL3&%)/N
MLX'R@X[$XH S-2\'>']7OGO+_3(IIY$$<A+,!(HZ;E!PV.V0<=J;>^"_#VH2
M))<Z8C,L2P':[J'C7[J. 0' ]&S6)+\18AIUAJ$-L'@;29M5OER=T*(H 0?[
M1D)7G^XU31^)/$&G7FEKKMGIZP:J'2+[*SEK>41M($?=PX(5AN&.1TYH Z-=
M"TQ-835DLT2^2$6XE0E?W8Z*0#@@9.,CBIQ86JZD^HB%1>/"(&E[E 2P7\V)
M_&N:M?%US<:'X/OVMH@^NRQ),H)Q&&A>0[?Q0#GUK3UG76T;6=(AF2,6%Z9H
MI)V)!CD6,R+[8(1_Q H 2'P=X?M]4&HQ:9$MRLIF7YFV)(>KJF=H8Y/(&>:Y
M6\^'MWJ6K%[N#1A"U^MV]]$CK<.JR!POEXV*Y"A3(#DC/'-3Z#\0+O7++2T.
MGQPW]Y?/#+ Q/[J!8O.W_4HT0^KUR%QJ!NO#%Q<V\9M8Y/ [RI#'(S",[ST+
M$DX]2<T >K7?A71+V&2*XT]&62Y-V65F5A,1@N&!!4XXX(IC>$- ;38=/.FQ
M_9H)_M,:AF#"7GY]V=Q;DY).3FH_$.M2^'O!%YK$42S26EKYHC<G#$ <&N=U
M3QKJ^C7EGI.IR:)9:C<QO=--(TC011 @*N."[DD]P,+GVH Z67P=X?FU0ZE)
MID1N3*)V.YMC2#HY3.TM_M$9K3M+"UL6N6M85B-S,9YB/XY" "Q_ #\JXFP\
M>7^MPZ;9Z9:V8U2[FN8I)9&9K=%@V[I%QAF#;TVCC[W)XHU?QOJFBOI^F:E#
MIFGZG<M,S7$\K-;"*,@!U"_,2VX84D$8.3P,@'3ZEX6T35[X7M]8K+<>6(F<
M.R^8F<[7 (#KR>&R.:1?"FAQKIJIIT:#3'9[/86'DECD@8/0G''3@<5R=IXO
M_M]]"9K2VDNUUB:R\Z.1_*#K;R.)4Z%E(P,-G&3W -:%IXYENK+0\VL:7ETT
MYU"(DD6JVX(G([\.%49_O"@#8UO3M4NM2L;S3ETOS+0.4>\CD9D9A@[=K 8(
MXYK!O/">MW]K<VUS!X;>*YN1=RCR;@$S  !P1)D'"@<8K/T;XGR:A=Z3)*VF
M/;:I.D2VEN[FYM@_W&<GY6YP& QC/?%:7Q-AO;NPT2RMS;FWNM5AAGCGWXD!
M)*J=I&5R.1]* ,W6O .MZOYS,GAU'NKF">[Q%/B?RF!PRER#D+@\ D=ZN0>#
M=7@TZ[L%M?#36]YC[0)8;B1I<=-S-(6..W/';%6&\63Z=X-UZ_BLK=3HMU)9
MPQ*3L98RJC/?H?TJOK'B'Q-=S>*[;3(]/M[/2$9#<2-)YS$VXD!0+P""W4GN
M/3D 2'P7JT%A>62V_AUH+P*+GS$N7:4+]T,[2%B!V&>*N-H'B1XY8V'AXI-=
M+>2 Q7'S3*596/[SL47CIP*P-*N/$LOB'P^MK)8R7LOAH/+)<-(8P/,3#;0<
MLY& >1W/M5J3XF2FPT>,C3["_O5N&GENW=H(?)D\IMH&"Q9AP,C SF@#<73/
M%::E+J"MX=%W+$L+R^1/ED4DJ/O]BS?G69;>"M5L]374+>T\-)<)(TJ8AN"D
M;MU94\S:K')Y !YJ*W\?ZKJEMID&E6>GR:A=W\]@\DDC_9\QQF3S%(&XJ5P<
M=>V>];_C"[>R\%O/>V\-Q*)+598U=U0N9HP2""&P"<CZ<T <?=?#OQ'?7BS3
MIX8647<=XUY'!,))'60/RF=JDX +#DC/K6S=>$-9O86BG@\.$-<M=[EBN$<2
MM]YPPD!4GV(J/4O&GB"VMO$6IV]CIQTW0KMX95D=_-G555FVXX4@-WSD]AW=
MJ_CJ^L?%%QI@_LNT6&2-8(=1=XGO595):.4_(,9*@<G*G.* %/@[5SI]M8_9
M?#8M[6?[1"%AN RR\Y?<),DG)R2><\TUO!6JOJO]I-:>&C<F;SR?)N-AE_YZ
M%/,VE_\ :QFJ=UXDU[0]2\<7[?9[R&RN;2.VMF9QC>(@ "3@##DG_:YZ5TVE
M:SK/_"2IH>L16'G_ & WC26A?;GS=@4;N>GZT 4O["\2?9+^TV^'/(U!G:Z3
MR)\2EUVL3\_< #BL:\\ :YJ.N?VA>?V!(JV,5E'&$N$V(C.< JX."'P1D@X'
M%:-AXSU?7$TNSTRULH]0O$NIY9+@L8H8H9O*'R@Y9F)'<8YJ-M0\3R>.O#4%
M[';6:O:7AN;9)6=)"CQC>,''*E2N1D;F!H O6^B>);6Y@N+=/#44L%O]EB*6
MTRA(L@[  ^ ,J/RJC_PA>K#5?[3^R>&OM7G>?GR;C9YO_/39YFW?_M8S[U!X
M;\2:CJ&EZ'I7A^QL;:5]+6^F:Z>22.&,N45%&=S$E6Y)X [U8B\;:UJ%SI6F
MV.GV46HW$U[;7?GR,T<$EN5!*XP64YX'!Y'(YH E/A?76LY+0P^&S#)<_;&'
MDS[C-NW>9NWYW9 YS[=*9!X>\7_\)5/XAFE\.B\:U%E'MAF($0<OG.0<DD9'
M(&!5>Y\?:G:Z.DES;65K/%J4VGWEZRR26L!C!(<A?FPW &2 ">376^&=5FUG
M1(KV=[&1V9E\RQG\V&0 D!E/;(YP>1TH XG2?A[K.FSFZD3P]/=_;);L221S
MD;WD9PVW>%+#=@$C( '/%6K[P+J.IWMQ=WEEX:EFN.9LPW 60XP&*B3:6Q_%
MC/O6A;^,KN>UL+;[+"-8FU9].G@!.V,1DM)(.^/* 8?[ZUEVGBN6P\+:;+:_
MV1I<-Q<WBM-J%RQ1"D[@!5+;W9CD\' Y]A0!/>^"]6U#47O[JU\-R7$A5I/W
M5P%E*_=+H)-KD8'W@>E77T'Q(\.HQ,OAPQZEG[8OD3_OLH$.?G_N@#CTK2\&
M>(I/$VA->S1PI-%<RVSF$MY;E&*[EW<@$8.#R*Y!_BL1)->H^F&PBNS;_8M[
MF[>,2;#(/X<]6"8Z#KF@#=&@>(Q--*8_#3/-;+:R[K>9@\2YPA!?!'S'\ZI6
M/@O5=.CN([>T\-;+B+R)1+#<2YB_YY_/(<)_LCCVIFI>-O$-K!K>HVVG:=)I
MVD:B+-XWD<2W )094]%QY@ZYSST[Z \3ZY8WFLV&I6FFR7EG81W\!@G,43*[
M.NUVD^[@IDMW'8=* *5EX+U?3XKJ.VMO#@%U";>4O'<NS1'C9N:0D+ST! K0
M71O$Z7%G<*/#HELHFAMV\B?,:-MRH^?OL7\JP&\>27L&NZ=<RZ1JL*:)<WJR
MZ<\BQG8,-&QSSG</F4@_3BMKPA.9O%FO$ K&;+3F6/<2$S&_ S0 MCX?\1Z9
M<-/9IX=AE964L(9SPSF1NK]V8D__ %A56'P=J\&K?VG%:^&ENQ(TP;R;C:LA
MZN$\S:&.3\P&>:W/'=W'8^!=9NI;=;E(K9F:%G9 X],J01^!K(U7Q3XB34/$
ML>F6>FFVT)$D=KEWW3@PB4J-O"GKR<]1QUH CTSP[XOLM:U767E\.B^U/RQ-
MMAF956-=J@'()[DY]?85%IO@?4]'NX;FPL_#4,L (AQ%<%8\C!*J9,*2.I R
M>YJ^OBC6M;O9H/#MI8@6MG!<S&^9LN\JEUC7;T^4#+'/4<5D_P#"0WVE>(-?
MO9+4)/)+H\+VTDFX0F8[' (X)&X\C@XH U%\.^(5TZ*P$?AP6L4XN4B\B?"R
M"3S WW^N_FNJL].MK&2YE@A2.6ZD\ZX9<_.^T+GGV 'X5S?B'QG+H6I:K;_8
MTG6TT^WN8@&VM)++,T2H3T R%Y]S7.ZS=:W:^);Q]=AL9DC\+7\JK:/(L<N&
MBRA!.X$=-P/1N,4 =OK/A+0M?N8[G4M/26XC38LRNT;[>NTLI!(]CQ6?K?@F
MPU'2]%TJTM;6#3;"^2X>VVE59 C@@8_BRX.?7G.:RX_$OB"XGN['1;+3$BT[
M3K:Z+73R'=YB,1& /]P_,3QZ'/%BS\7:OXBELHM M+*-GTN#4KAKUG(7S@=D
M2[<<_*V6[<<&@#=B\*:%#I-QI:Z;"UG<MOG23+F5N/F9F)8G@8).1@>E-M_"
M&@VUC<V<>G(8;IE:?>[.\I4@KN=B6."..>*/".M7'B'PQ::I=VR6\\QD#PHV
MX(5D9<9[_=KE+?XA7G]N:;:SRZ)*MY>BTDLK.=I9[4G=M+N"4)X&1@=>,XH
M[TV%J=2&H^2OVP0F 2]_+)#;?S -6:** "BBB@ HHHH **** "BBB@ HHHH
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M)+,0$!YP1R.02,<C-7-0\6:7I=QJ4-V\J'3H(9YB$R")6945<<EBRD8QU(H
MHW?@V9KO46TW7KW3;74I/-NX(%0DN0%9HW(S&6 &2,\\C!IFK>!HM3GU5EU.
MYA@U2P2RN8=JOG9N".&;YL@,>_-:6D^)K?5-0DT^2ROM/ODB$XM[V,*SQYQO
M4JS @' /.1D9 S6)XD\27>F:UK4!O6M;.TT1+Q9(X%E:.0RNI8 XW<*."<4
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M<B..V$\S*I)^[DX Z_04 8</@R>PLK2'2]>N[1X//#;D62.599#(0T;<9!.
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MFYC)(8(<DC.,@D#('&:V/&/B.[\.PZ4UI92W1N]0BMW$:!B$8\@98?,>@[4
M5+7P$FF66F+I>K75K>Z>L\<=VR+(9(Y7WLCJ1AAG!!X.1]:GA\&?9KS2+V+5
M[QKNQ:<RRRA7-R)F5I P(^7)48VXP.*6]\>:;93WF;349;.QD\J\OH8 T%NW
M&0QSN.W(W%00.];&KZS::)I9U*ZWFU5D#O& VT,P4,>?NC()/IS0!S]KX#_L
MRVTS^R=8N+.\L;3[%]H\I)!-#NW .A&,@\@C&,GKFK6F>"[/2[O2[J*ZN))K
M(W+N\N"UQ).5+NY '.5[<59U7Q;I6CW5W;W;2AK2V2XE*1[@ [E(T&.2[,"
M,5D:MX^%KH>M21:7?6VK6-@]Y':7L*@N@&!)\K$% <;L-D#MTH N'PA)!YTN
MG:U>65S)?S7VY0&0F0 ,CH>&7CC/(/0UH>'/#\/AVPF@CG>>6XN'NIY655WR
M/U(50 HX' ]*SE\:1I#90_V5J=UJ,UJMU+:6T*EXD)QN;+!0"0< $DXZ5NZ7
MJEIK&EP:E92^9:SIO1B"I]""#R""""#T(H S(/"=E!XSN/$RR2&XF@\KR3]Q
M6.T-(!_>*HBGV6LR'P"+"33[C3=7GMKNS6YC$K0I(&2>4RL-IZ$-C!';KFK=
MIXYL;J\L8CI^IP6U_*8K2]G@"PS-@D ?-N&0I(W*,U#;?$/2[F6W*V.IK:3W
M?V);U[<"$3;R@4G=GEAC(!&3C.: -3PWX?3PW8W%JEY/=^?=2732SXWEG.6S
M@ =<GH.M9D?@J6W=[:SU^_M=(>Z-T;*$*I5B^]D64#<J%LD@<\D9 -9WBOQ_
M]CTC46TBVOBUM<I:_P!H"W#6ZR^8JLF2<]RN=NW/&<UUNM:Q:Z#ICW]WYAC5
MTC5(EW.[NP554>I8@4 95QX-MKC2-9T]KJ4)JE]]MD< 91LH=H]OW8_.FZ_X
M*M/$-QJ,UQ=3QF]LH;0B,#Y/+E:56&1S\S<@\$"I%\96:6LLMW8:C9217,%J
M\%Q" P:9@J$$,5*Y;D@G&#5/QKXL.CZ1KD-B[QZG8:>EZ',89 KNR#KU/R-Q
MCTH ;-X%DOKFYNM2URYN;BXTR?3&Q"D:)'+CE5 X((SR3G/L*L2^%[JPMM5G
MT6_DBU&\M[:".1E7$9A!4'D$8()SQ].:?%XWL";I;JRU&QD@LWOE2Z@"-/"G
MWF3!/(R,J<$9&0*JQ_$6PFFMX8](UII;R$SV*?90#=H,9*9;C (/S[>"/44
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5]PQ , 2=!UV@C//2@_#J\A^U::ND:?=P3WCS)J%Q>R@+$\A<J\"XW,,D#!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQK@<CG/8C@]NE:=EH4]OH?PV6VL'M[FW0"=U@(: M9R!B_'RY<C.>_O7IE%
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MEL-.&KN"8YVB3SVP.2#C<<#OV%(/"OAX74UU_86F_:)FW2R?94W.<ALDXZY
M/U&: //+QKZ#1/%VOKJVI"ZM]5ELXC]I?R[6W,L:NP3.W*JS,"1Q@>E:^FZ?
MI^C_ !6@CM-1N)H_[ FD=+F\>?RQYT/S[G)(#8SUQQD=Z[Q+&TBCGCCM852=
MF>95C $C-]XL.Y/?/6J-CX9T'3 XL-%T^V\Q&1_)MD3<K8W*<#D' R/8>E &
MG'(DT22Q.KQN RLIR&!Z$&G5'##!:6T4$$<<,$2B..-%"JBC@* . .@ J2@
MHHHH **K?VC8YQ]LM\^=Y&/-7_6?W.OWO;K5@D#J0.W- "T5%#<P7'F>1-'+
MY;F-]C!MK#JIQT/M1%<P3O(D4T<C1-MD5&!*'T/H: ):*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCYLY_"NU^)&IZOI]OX>@T;4#8SZCK,-E),(EDPCJ^>&!'! /X4 =M17B.O\
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MSBZX!((YS]";OA?Q9JU[I]AX@O/%D,EU>BZ)T VZ'+1[ML:;<.K#:"2Q.<T
M>NNZQHSNP5%&69C@ >IJ.WN8+NW2XMIHYH9!N22-@RL/4$<&O%O"WC#Q3J1M
M)KV\^TVNIZ==33QW#V86-E0E3#&C&0J"-I#@^I[X-$\0:O>/X3T@>)(]$M+S
M0&N9'BMX$!E#G&T%=J\#H!C /&>0 >VEU4J"P!8X4$]3UXI:\)T;5]6\2>+/
MAWJNHZNT,LL5[&62-%2;RGVE@"/^6BX4XZ8^7&:[SQUK6HV_B+PYH5IJHT>V
MU-IS/J&Q&9?+4%8UW@J"Q/4_A0!V%_J5CI5L;G4;VWM( 0OFW$JQKD]!DG%%
MUJ5C96)OKN]MX+0 $SRRJL>#T.XG'->%ZI=ZMXLM= M[W63,MKXK?38KR.WC
M*W*JI*3[2"I(Y&!\I]Z[3XPV$MUH?A^&.\>"(ZQ;0LBQHP8LV Q!!^[@X'0Y
MY!H ]&AGBN8(YX)4EAD4.DB,&5E(R"".H-/WKO*;AN R5SSBO&]9\9ZMH?AS
MQW"FLI'=Z1<6T&G[HXE95(3.%VX.?F/0^W2JVHWFJ:/XN^).I6NMRI=6VFV\
MT,9CC.[,;,N 1T3G\^<T >W45Y+JOC?4QJ$\=AJR,D?@Z74B(U1MMR,;7/'7
M';I[51O=>\6V.F^$8'UN\N9?$*-=33016T3Q 0HPAC,F$&2Q)+')QQZ4 >T5
M#/=VUM)#'/<11/,^R)9'"F1O1<]3["N8\$:UJVI>!EO]4\JXOHS*H>"2-Q.$
M)"G]TS*&. " >#FO,;/5]0URZ^'VK:CXB6_N+[5&E>P6.-1;$!AA=HW  <'<
M3SC\0#WNBO%-,\;>();70_$#Z_'/<:EK'V&;P^(8P(8S(RX&!O#* &R3W&??
M5\-^)=3U74(-4O\ Q?#9-+K$MC_8CVZ,NU20L8Q\X?@'<3CGIVH ]6HKQVP\
M=ZO-H'A<OJZMJ%YXF^Q72[8][0"1P5*XX&-G( /3GFJ9\1^+YHK:_C\2R1BX
M\5/HBP?98BB0LS -]W)9<#'..!G/.0#VZBO$;SQGXHT^RN=(&I3W,J>)#I@O
MQ' LPAV!@HW;8PY.0"<?RJTGBKQ;+H^CVIU007,WB3^S#=C[-/(T!0G]X(RR
M"0'J!CH/7D ]C9U1=SL%'J3BEKP3Q'?:W>Z5-I]_K\[C2_%D%HETT4:L4."K
M/A0,H<GI@]ZU-4\7Z_I/BV>6[UN>71K>]AMQ-8"VGB"D*"DT7$@<D\L#QG@<
M4 >SU#<7=M:F(7%Q%"9I!%$)'"[W/15SU/'05S/C_4]3T'1;;6["9EM["[CD
MOX0@;S;8G:XY&01D-D>AKBG\0:OJMKX=UJXF1[34_%<:6,,MM&WE6@#JI&5R
M&;:6W=>>"* /8:*\8M_&VLR^-=)FM-9N[K2K_5Y+$I-#;Q0E!D8C0$R_*0/G
M8C/''-=+\2/$.L:;JWAW2-+DN($U*2?SIK;R1+^[4$(AF(0$D]^>.* /0J*\
M=L/$?BS6KGP=IDFM+9/J/]H)<W-J+>8RK"%*,"N]%;J" < YXZ5!X9\5>*''
M@_4]1UYKF'4[VXLKBV-O&J;(]X#Y W;LID\X]O4 ]IZ#)JG!JVFW1MQ;ZA:3
M&Y5F@$<RMYH7[Q7!^8#OCI7D?ASQIK=YXTT #6+N]TK63>#_ $F&WB1UC1BI
MCC0ET (Q\YR?2H/ MW+?:M\-;F81"1].U$D10I$OW\<*@"C\!0![?17F7Q)\
M1ZC8ZJ=/TG5[RVN;?3)+]X;:*!5 !P))))C]W((V*I)K.M?$/B;Q'JFCV<.N
MR:<ESX574YV@MXV+3;\9&Y3C.1D>G3'6@#UZJ::KITEO!/'?VKPSR>5#(LRE
M9'R1M4YP3P>!Z&O)M)\9:]XA?PO:77B%=%2YT>2_GO%BB_TB9)"FWYQM  &X
M@8[].U#P#=23^&O",,4?VDZ;!J>L/$O1W61XXA^)D?'TH ]THKQSP[XNUUKK
MPC?2>)(]5.OR.EUIBPQ@6PVD[DVC<-F,'<3FNE^%%WKVM^%;?Q!K6MR7K7BN
MJ6Y@C18MDC+G*@$DXH [T.I8J&!9>HSR*6O"3K&K>%Y/B#?VNL%[D:K%!^_C
M0K"'*#SR,9^4':!TZ9KMO"6L:DGCK4?#DVN#7K**PCO%O2D8:&1FVF,F, '(
M^8=\4 >@5#%=VT]Q/;Q7$4D\! FC1P6CR,C<.HR.1FO(_&GBW7]&\7:E,-5F
MCT6Q,'_(/^S3?9PP&X3POB0ECG!## QBH]>\5ZGI6J^-Y=/G@M?]-TRW%Y]F
M3-O'+'\TC'&6QVWYQF@#V:BO#]8\9Z_I%KXVBL?%/]IKI-K9O:77E0DJSR /
MDJNUC@X_^O7:>&[[6[3XC:IX>U+6)-3MUTZ*]1Y(40QNSE65=H'R\=#G^>0#
MO**\SU[Q?J&F:_XXM6U-(([#1DN;!'"#;*4;D9&6^;;P<UBCQ/KNI:K:V4OB
M[^R(V\+V^IF0PPYDG(RQRR]#U('IQCF@#V5F"J68@ #))[55T_4]/U:!I].O
MK:\A5RC26\JR*&'49!//(X]ZXN/5-1\3? Z74[F9K2^N=*DDDDC0<X4Y(!&
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9A2-I# ^IJ[8:SXJT[P'HGC:^\0W%[ \T$FHVI@C5$MF)1BNU<Y&58\]CVH
M])U;2O#=UJ-G<ZO9:7+>EQ':R74:&0MU"H6Y)ZG JMXH\&:1XIL;N.YL[5;Z
M:W:W2^-NKRQ C'!//<]ZX&#7=9U(>$=7O95:+5_$#O;0RP1DP6NUA&H)7()
MW;@<_-UI_A;Q3J>HI9:W?>+5CN[J[N(6\/FW1A\A8+$N!O5L*#N)/49]P#T%
M?"6ARP62W^EV-]/:6RVR3W%LC.4"XQD@\'GCW-37?AC0+\6HO-%T^X%HH2W$
MMLC>4HZ*N1P!Z"O)_"'C7Q5J%WIE[<:G&\6HP73SQW<UJD,116*M$BMYH"D
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M.2]BO7M8&NH5*13F,%T4]0&Z@&J<WAK0KC3%TR;1K![!6+K;-;H8U8DDD+C
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MC>9E5PB-& V0>,8JUJ&MZG,?$WA ZXVM07)LK2VO"J!D:Y;;(A* *?DW,..
M* /5H=(T65([B#3[!T:?[='(D*$&5A_K@0/O$?Q=?>GQZ'I,1B,>EV2&&9IX
MML"C9(WWG''#'N>IJU#Y*+Y$)0"$!-BG[G' QVXQ4M &;/X>T6YM+FUGTFQD
MM[J4SSQ-;J5ED/5V&.6X')YJU8V%GIEG':6%K#:VT8PD,*!$7Z <58HH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQLS/_K?L]NL>_P"N!S3+'PWH6F3)-8:-I]K*A8H\%LB,I;[V"!QG S]*U**
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MM1TBPN[B+B.6>W1V7OP2,TEYX=T34+^._O='L+B\BQLGFMD=UQTPQ&>*TZ*
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MMQ'<RM%HL:-+)']TN0_S8Z<]JL6OP^UFQCCCM/$&E6Z1S?:$6+P]"@67!&\
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MEOYBHN3NE;E0-P.%Y/T!IO@75KW4/!DUS+-]LN(+FZBB;S1)YBI(X0;P!OX
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&>VM;F'11.4M5GMX8U(#-@(N1CDL0/0M6I8V4&FZ?;6-K&([>WB6*)!_"JC
M'Y"O)[Z;4KFUN]-DU']PNH:48]M]]LEMI'N5!/F% .0%(4YP0>Q%:FH:E<Z-
M<ZMHQU34Y8OM]I%:DSKYN98RS(9G^XIV'YN2,X')% '=FWT?3;V&?[/9VUU<
MOY$<@C57D8@MM!QD\*QQ[&H=*ET&^OKR[TI;*2Z20Q7,\$:[BP/*E@.>1Z]J
M\YT^_NM0OK2RN;MY8[3Q.L,)%Y]H:-38R,5$N 6(8M]#QDXS74>!(I=.^'/F
MVIFN9\W,D:2N7RPD<!1Z D#\2?6@#KKBSM;HQO<V\,IB)*&1 VS(P2,].*JZ
M5>Z1J]M'=Z7);7$$.88Y8E!"],A3Z=.G'2O/K.^EG@\/?9_$5Y?S:S:3'48O
MM .P>0SF15'^JVR!4P,?>P>:V_#MPFA?!FQOFN;E5AT5+@R >:\?[D-\H/!Q
MV!X_"@#K;33;&P:5K.RMK9I3ND,,2IO/J<#FEN=.L;V6*6ZLK>>2$YB>6)6*
M'U4D<?A7D5SK^K:<NM0P:C<(1X<GO5$FI"[D6560+)P,1DACPI(/MCG9UZ]U
M7PS=:E;6NL7LL;Z=!<237+"0VY-P(Y)5R,* C,V/NC;TH ]$N8[&*"XDNDMU
MBE&)VE"A7'3YB>OIS65JNF6?B*SO=+M[X0(9A'J2VZ*6E4H,QL2.,H4YZXQ7
M ^*G"VFM:5;:U=WNF16MI=/*]UYA@E-P%QYG7#+\VTGC;D8!J6\BN+)?&>M6
M&KWR/8W]NT"QS9CDQ;VV2X_CW @'.?;!YH ]5"*$"!0$ P%QQCTIB6MO'Y6R
M")?)3RXMJ ;%X^5?0<#@>@KRN^UW76UC5KA;Y+>>TU5;6"*74-B"/<H5#;A"
M7\Q3G=G/S<$8KK?"275WJ6MZA=:E>3^7J%Q:PV[R?NHXU<8PN.O7GT.* -G[
M)HFJ1M;&TL;J.RE\LQ-$KB&3 ;&".#A@?QJU/I]E=.KW%G;RNJ%%:2)6(4]1
MR.A]*X":]U*_\1#31JEW;P2^(YK9C ^UO)6Q$FP'L-PSZC/'-06VH7DFH6FB
M7^M7D.G+J-_ ;LS[)9/*V&*)I>O1G/J=GUH [Z._TB[NU2.:UEN)1+" ,%F$
M;;9%]PK'!'J:&M](T;39$-O9V=D[!758U2-BY"@$ 8.20/QKS7P\]Y=06>F:
M;K,VV\;7"EXC#,CBX7RY3@8)RQ/'')JT_B?5-:T:\UF&::TCM6L+%H5. +EI
MXS<?7 94_P"^J /0ECTK0X$\N&UL8I'2%1&BQAF9L(O [LV /4U8DLK66*:*
M2VA>.<YF1HP1(< 98=^ !SZ"O+=1NOMZVUW?:W.NHCQ5#;?V<9@$5$O%"*(_
M]P+)NZG/7!Q6E!XFF.G:5;OJF=0?Q+-:RQ>8/,,0N)0$(ZX"!/PQ0!W\-A9V
M\,,,-I!%% =T2)&%$9P1E0!QP3T]34:G3]<TQ7Q;WMC<*&7<H>.0=C@\&O,M
M-\1WD_B'P]=P:A=/;ZG?RQ,+F^4F:+9(>+901&%*KSD,. <DFNN^'ES / V@
M6IFC%PUBL@BW#>5'!;'7&2!GW% &KJ2:!I^DQV^IQ:?#IWF+$D4\:"+<3\H"
MD8SFK<^EZ?=6B6EQ8VTUM'C9#)"K(N.F%(P,5P_C**X\2^)5T2#36U"SL+-Y
M+I%G6/;-.K1QG+=U3S#_ ,"4UT'@[5[G5?"<3WPVZG:;[2^7.2L\?RL?QP&'
MLPH V9],T^Z>%[BQMI7A&(FDB5C'_NY''X4-#81M]G>*V4W*^7Y951YJJ/NX
M_B &>/2O*K>]UJ+P_P"#V?5;VY_MN#S[N6>_^SY<1*R1K)M.S.6.!@MLZ]<V
M-.FN;[6_"UQJ&J&1X[F_@@DBNRPD"XV*6VJ';JI('S;>] 'ISZ=8R3><]G;M
M+M5=[1*6V@A@,XZ @$>XI#IM@;\7YLK8W@&T7!B7S /3=C-><V7BJXN=%\'(
MFK^9>W&FSR7BK*"[.EL3EQV(<=^XJ33+;4;EO"%O/X@U=EU73YKR\87&UG81
MPD*I ^106)XYZ\\F@#T*/3;"&]DO8K*VCNY!AYUB4.WU;&34_DQ^<)O+3S0N
MP/M&[;UQGTKEO#NI:BWP]GO"[WM_;?;(XC(,M*8I9$3..I(1<^M<5I^NZTNG
M)=+JRR-=:-<W,V=1^T,SK%N$B($ BVMQC('.,$B@#U6?2--NH(H+C3K26*$Y
MBCDA5E0_[((X_"IFM;=S(7MXF\U!')E =ZC.%/J.3Q[FO/4M]9%S:6%IKM^]
MSJF@S76^>7<$N4:'8ZC'RC,A!4<$51OO%VKZKH=WK]A++:V3RV>G[2_EB$LP
M-PY8@A2"XBW$':4)H ]'2/2M$CB2.*ULDFD6%%C18PS$G:HQWY.*LBTMED$B
MV\0<,7#!!D,1@G/J1QFO+4N[^2ZBM+FZ2:WM]<T\Q)]M-V\3-N+*TFT9'"D
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%G?!!>6D%P$;<@FC#[3ZC/0U(8(2[N8D+.H1CM&649P#ZCD\>YJ2B@",P0M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
$* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_1.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /T7Q2T4
M58[#EI:;^-.H#4=3E'>FTX-0&HM.7I3:<O2@-1RY_"EH'I104*M.I!UXI: %
M%"]Z.:%H =2^M)FG<4 (,^E+12U+ 2G#Z4<^M'-(!:**7I0 ?A3J*3- #A]*
M6FK]:=0 44'GO2^] "4Y:09I5H 6E_"CK1@T 'X4OX4M% !TI?PHYHP: #\*
M/PHP:.: %_"BCFB@ I5HI!G%!+'T44HYH$&V@9H'2G4 %%%% "K11Q10!R=%
M+GF@U96H#BG444!J.&<4Y:8#3EZT#'4X&FTHZT /!I:;3J '+2TU:=0 9HHI
M5ZT **7--S\U+0 X4M(M+4 .XHR ,DXJO<WB6JEF.!^E8\VL-+D@?+VSP/RI
M.2CN"3>QM/<QJV-ZY'N*KR:M!&"6DX_V>37,W%\\C_,YQTX.!UJHUVL9^3KC
MZURRKVV.B-&YU9\16R]I#_P$TW_A)K,D ED^JD5R$NH"';RH(/=CU_.HVU3:
M>>IY Z'Z_2LOK5C98<[B'Q#:S<)(LG?C@U/+JUO!'YDDBHGJ37!)JIWC'0]S
M@?A3KN>"[C"/)@CL6 _/FE];T!89MG7Q^)X9B"A^3."?_K5=AU))<$-BO,KB
M5[&'<CM(@Y)&">.WTYJO8^.H_/$9N5#CC8W%9QQFMI&SPNET>P1S!^]3+7&:
M3XH@N !D9/&[/%=/:W23*"K9_&O0A5C-:'!.FXE[MFE&*8KYP#3ZU,@I:**
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M$RV2PR><'GM7A5*SFV[GJPIJ*L='I<0:0E@,D8SGOFNH)2UA!&(Y&7"Y/OD
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M)-%.PZ_(W)QWQQ['/YUZ<:JE%(\25)PDR_9HMO?%-JF.8$Y R/;]#[U:=59
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M]U9+;:#JSF\)%M^Y=EDSSE6QCI_*M[X2Z]J.CV\^FZQH^(_LBQBZB8,L[("
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M7[9? KQEH_C;X4>&K_1K_P#M"UALHK65WXD26-%5U<9X8$=_45^).EW .H(
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MA9KDXMBG_$UT>\DP5BESAD(QD G'S$X&ZKOCC]HD?"FXTVUOM,O&DO)9(H3
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MIC<>E1LV15L8]W^7-4[AF:.380'*\9]<<5)(W'6JLC'U%(#\7OBQ#=V?C;Q
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M?3TIY;=QV] <"F!@I_3%9:F@GZ<\4#Z=.*1AVSCFE&3DD\]<4Q>I7G_U@XX
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M6TZ>LW2[VCK@5^)OAFXD\'^)=,UO2V5+_3YDN87.2!(K @X] <#IVKZ3T_\
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M <XXY% [%5E^4$'Z^E"HVXX''KBK#>6IX^M07%V(E.WTSUJ &7$RV\);^+'
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M)0<9P< CCM^&:1V+*!U.1Z?X5&/F7<3P>G/Z4\N6X VC.1^7]* %$A60$(O
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5/4R;S3YK"9EBDVJW/!HHHHNP/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_10.jpg
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M&O8[JS:/AFUZ1<_^(]._3+!R[:;8]?C>>.GE5V/_FV]E^T<F   YR(@3
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M'Q^CIRR.1Q=OB55;GHWU.U[(^@!(DO39*QEVKMGZ7,Q=MCT]H;//D"G1K./
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M1<LWC>N*5X\K"E5,3^>L5+=]C)HP(S9OVQVOO/I:MG]$ P#P*6;$"0
M_%/I"9ROOA;;=CP>XZ;,CC9=^L?ME9O%C25J1,'2]:)L[?;1JMNP&#QV3LQ9
MNCU6;WDNO3X]VR,<29+^W9(AY]KM^V+QVB=BU.1%T?'>AZ)JXVY1N&S#N*%$
MS;BU=-VHWZI'#!HY,5:NW13/)R=RONE$3@  _G5&G       P#^U_\VW8L_>
M9V+6O"51KV7WN+9HU;CBUHKIB*5,C;;1KM>(>&3>^G2\N6&G\:8DZ;/3QK^/
M.>>OV!&]!D^**HVZ1H$[Z\:E!<K'E84K1MF:K6+D^.E_/Y'S]6S_R 8 X%/(
MB!,      /A0A]Y^.QUP/OG4LS%I^OQHU^V!*%6I27J=;-'R3:)ZTQ[1?<"$
M&#=]>2Q9NR<=<+I"79+T66OC[I=BU>9G8LK<M=%OQ/1HV+Y_W%ZU95Q?HD84
MN+-V-&C=*X:/F1J;MNZ*UUY_(SW!&@  /BDC3@      X$,E(Y277WDMUJS?
MFEZA?DNI6G%5X4IQ4ZG:Z8"SSY I,6_Y#L--25).M"FO91OVQO )"Z)9IT%1
MI%SCN/S6BG'M;56C1N/.,7/NDGCFV7WI7X   (!/RH@3      !XC[???CL=
M<+[XTBLQ;]&JZ#/PH2A?NVW<4*)&%"I3/RHUZ!Q]ADR.1^:OCQ6;GL[ZJ$:2
MI/]6:[?MB]E+M\60<7.C;NM[HVBYQG%]\1I1O$+C:-]C4$R9]5CLV?MLO'7@
M8'JB-0  ?!PC3@      X#TRUZCO>GQO]!HP*DI6:AHWE*@>UQ:K%F5JM(UV
MO4;$S(6;LCZDD20I6RU<_7CT&3PYJC;N%K?<42>NN:U*%"Y;/UIW'1 KUVZ.
MUU[?[UIU   ^$2-.      #@/=[8_V:L7K\U1HR;%K6;=XM;;J\=-Y6J%:6J
MM(Q[^HR*<=.7Q9)U3V9]0"-)4K9:M?G9F#IW;?0>,CDJU.\4!>ZL&S?=7BO*
MU6X;]PT9&X\M71/[7G@Y',8) ,#',>($       ..W3H4#R_[\48]?",J-FD
M2Q0J4R^N+%PY"MW5,&JW[!/CIB^/==OWQ<9=+V5]0"-)4K;:M/OEV+#SQ9BY
M:%.TZCXT2E9N$=<5JQXWEJP1Y6JWB;Z#'HKMN_;$6V\=R/O9:LD) ,!',^($
M      !2!PX<3 <GT^<LCE:=^T?1<@WCII*UXM;2]:-1^_XQZ*'9,7?9]G3
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MZ/' A"A9N7E<5ZQ:W')[K6C1\?Y8M'QM///<OGCKP(%L_PH  $ ^8L0)
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MILW?$)WO&Q,5ZG6,JXM4B:H-.\:#XZ;%VHW;XL#!@]G^=0$ @"PPX@0
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M9'W0(DE2KK1BX],Q:]&6Z-!W=-Q0LF;<<D?M*%NK=8R:,,.($P @1QEQ @
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M!PQ]:$I<6J!\_.V6<NF(LUO_\5D?LDB2E*L-&#4S;KZC3OIS.:EG_U%&G
M.<J($P      <L"0T4:<DB3EEXPX 0#(,.($     ( <8,0I25+^R8@3 ( ,
M(TX      ,@!1IR2).6?C#@! ,@PX@0     @!Q@Q"E)4O[)B!, @ PC3@
M    R %&G)(DY9^,. $ R##B!     " '&#$*4E2_LF($P" #"-.      #(
M 4:<DB3EGXPX 0#(,.($     ( <8,0I25+^R8@3 ( ,(TX      ,@!1IR2
M).6?C#@! ,@PX@0     @!Q@Q"E)4O[)B!, @ PC3@      R %&G)(DY9^,
M. $ R##B!     " '&#$*4E2_LF($P" #"-.      #( 4:<DB3EGXPX 0#(
M,.($     ( <8,0I25+^R8@3 ( ,(TX      ,@!1IR2).6?C#@! ,@PX@0
M    @!Q@Q"E)4O[)B!, @ PC3@      R %&G)(DY9^,. $ R##B!     "
M'&#$*4E2_LF($P" #"-.      #( 4:<DB3EGXPX 0#(,.($     ( <8,0I
M25+^R8@3 ( ,(TX      ,@!1IR2).6?C#@! ,@PX@0     @!Q@Q"E)4O[)
MB!, @ PC3@      R %&G)(DY9^,. $ R##B!     " '&#$*4E2_LF($P"
M#"-.      #( 4:<DB3EGXPX 0#(,.($     ( <8,0I25+^R8@3 ( ,(TX
M     ,@!1IR2).6?C#@! ,@PX@0     @!Q@Q"E)4O[)B!, @ PC3@
MR %&G)(DY9^,. $ R##B!     " '&#$*4E2_LF($P" #"-.      #( 4:<
MDB3EGXPX 0#(,.($     ( <8,0I25+^R8@3 ( ,(TX      ,@!1IR2).6?
MC#@! ,@PX@0     @!Q@Q"E)4O[)B!, @ PC3@      R %&G)(DY9^,. $
MR##B!     " '&#$*4E2_LF($P" #"-.      #( 4:<DB3EGXPX 0#(,.($
M     ( <8,0I25+^R8@3 ( ,(TX      ,@!1IR2).6?C#@! ,@PX@0
M@!Q@Q"E)4O[)B!, @ PC3@      R %&G)(DY9^,. $ R##B!     " '&#$
M*4E2_LF($P" #"-.      #( 4:<DB3EGXPX 0#(,.($     ( <8,0I25+^
MR8@3 ( ,(TX      ,@!1IR2).6?C#@! ,@PX@0     @!Q@Q"E)4O[)B!,
M@ PC3@      R %&G)(DY9^,. $ R##B!     " '&#$*4E2_LF($P" #"-.
M      #( 4:<DB3EGXPX 0#(,.($     ( <8,0I25+^R8@3 ( ,(TX
M ,@!1IR2).6?C#@! ,@PX@0     @!Q@Q"E)4O[)B!, @ PC3@      R %&
MG)(DY9^,. $ R##B!     " '&#$*4E2_LF($P" #"-.      #( 4:<DB3E
MGXPX 0#(,.($     ( <8,0I25+^R8@3 ( ,(TX      ,@!1IR2).6?C#@!
M ,@PX@0     @!Q@Q"E)4O[)B!, @ PC3@      R %&G)(DY9^,. $ R##B
M!     " '&#$*4E2_LF($P" #"-.      #( 4:<DB3EGXPX 0#(,.($
M ( <8,0I25+^R8@3 ( ,(TX      ,@!1IR2).6?C#@! ,@PX@0     @!Q@
MQ"E)4O[)B!, @ PC3@      R %&G)(DY9^,. $ R##B!     " '&#$*4E2
M_LF($P" #"-.      #( 4:<DB3EGXPX 0#(,.($     ( <8,0I25+^R8@3
M ( ,(TX      ,@!1IR2).6?C#@! ,@PX@0     @!Q@Q"E)4O[)B!, @ PC
M3@      R %&G)(DY9^,. $ R##B!     " '&#$*4E2_LF($P" #"-.
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MIE^K;+^^'U7RNDV<L3@]9?.*JV],KTY__X@S&:0F)Z].G[?J\.LMZ1\9<0(
MD&'$"0      .<"(4T>R9'"97)'=O<_@N.;Z6^*<<\]_SY7:/_C13Z-4Z0K1
MX]ZAL7#ECO14R8\;\B7_?OGZ/3%CWNIHU.R>N.*JZ^,O?[OROS_B[#LD_G;9
M-?&=<[Y[U$:<*S?NC6ES5L:] T=']3I-XNY*-:-6_1;1\_[A,7?)IEB[[>._
M7MEN\LRET;QMM[CJVIOBI \9<5YU[<TQ8-CXF/78NGS_N4C9R(@3 ( ,(TX
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M^ZA1MVG4;](V6K7O$8-'3DK'E"LV/'G$OA?^W1%G<MKJHPO71Z]_\EHFK]/
MX0_'I!F+H_^0<=&^\[WI/ZN1]_V0?!U:MNN>OL:39BZ)Y9_@<TI.@DVNJ']D
M]HKT_7;JWC\:YKV_V@U:I!\O.06U7N,VT;[+O>E@>.JCR]-Q[89_88 L_:L9
M<0( D&'$"0      .<"(4T>BY%3-9(37Z_[A<='O_AA?^M*7X]ACCST\W/O:
MU[\9E_SY\FC<HF-Z6N>_^W'2J]4W/!D=NMT?=Y6O'@^.G1XS%ZR-&VXN',=^
M[G/_M.1J]Z(E[DK'ELE)H-/GK8ZVG?K$C05NBS/.//L#CT].#>W3?T3,F+\F
M-NQ\X9^..).Q9C+X2P:LEUUY77S[.^?&R5_Y:GJ5?#)>_>.?+TL'E&,FS_W0
MS__!L3/B]W_\RT<^]]]>?$GZ.4^=O3P]F7/BC,71K$W7N/*:=X:2[W_\=\XY
M+QW2WE:\=/J\DL_Q)Q?\,LX\ZVMQW'''QVFGGQ$_^O$%4:Y2S1CXX,,Q9_'&
M(_:]\.^..),!9S+*O?ZF0A_Y=4A>I])EJZ2#UQ*WWQV_OO#B])\=?_P)Z<?Z
MP0]_DI[2F@Q8/\GGM&+CWIB]:$/Z?5OZ[BKI:WGF66>GW[^?^]QQ\84O?#%.
M.>74N/"BWZ?OMT??H;%DS>YTR)GM/W/Z[&;$"0! AA$G      #D "-.'8F2
MDQPGSUH:C5MTB!_^^()T*/B__WO,X>'>N>=]+VXJ6#0Z=.L72]<]\1]]K'7;
MGH^'IRV, <,FI .\1:MW1JM[>L8UU]^2?IQDT'?,,?_XV,D0+QEP)O^^7>>^
MZ0 R&>\E8[SDY- V'7O'K45*Q4]_]LOTL5__QK?BDK]<EIZNF3QVR=K=__0D
MSN_]WX_RWG>!J%R]03JT;-ZV:WK:Y157WQ#GG?_]^,8WO_WW(>>EZ5#POD$/
MI2/2=Y_(F0P:F[?I&E=?=TN<=?;7/S!\_,U%OX][NMS[SDF06Y^-QU9L3T_V
M3$Z)3-[OM[Y]3CIRS#S^E%-.B_._]X,H7.R.=/#8HFVWJ%V_95STNTO2YWSB
MB2?&Z:>?F8Y#D]-1!SXX,7V_&W:^^!]_+_R[(\[D1-5D,-NL=9>X\IH;XYSS
MSO_ VYYRZFGI,#7YG.[I>E\Z4/W='_X<IYYV>CJ\3/YO,E9-!I?)]\?"E=O3
M[Y</? ]MWY>.CH>.GAK5:S=.1\"__-5%\=N\KT\RPKVE4/&XXZY*Z=?GQ!._
MD(Z0?YKW?HN5*OO.J:AYWQ?9_C.GSVY&G   9!AQ @    ! #C#BU)$H&14F
MP[SD=,QD4/C^\=T/?O33*%VN:MP[</01O;H[*;D2.SG%,3DU\[(KKHTO?_FD
M..ZXXPY_[--./S/^\K<KT\'C]+FK/O#VR8F-R?-*!GK)"97)8+)QRX[I2'+-
MUN<./^[#1IQ)7_G**7'>=[\?=U>LF5Y=/F_IYO2TT);M>L1?+[LZOOFM[QQ^
M[-E?^T94JEX_QDR:&XM7[SK\OM.33//>)KD6_F>_^,W'CC@S;Y<\QVIUFL3O
M+_EKG'#"YP\_/OG?)Y_\E2A2_,X8/F9:3)V](GU>Q4K>E??O_S% 3<:<YYYW
M?CJ<3*Z77[OMN?_X]?AW1YQ)R5@VN>Z^6^]!Z=?N_6_[E:^>$C<7+!:=>PR(
M&?-6IZ_G'7=5CN^>_X.\U_WD]WR_-6K>(29.7Y0.=M__'%=N?"KO>V9#>A5[
M\MHE0\UD^'OA;_\0]1JU24>MCZW8%A6JUGW/]U(RV+WNQD+IZY3M/W/Z[&;$
M"0! AA$G      #D "-.'8F2$67[+O?&S;<6^]"3)'_QJXNB?M-V,7+\K%B]
M^9DC^K$W[GPQ/54Q.1VQ8=['2$[ 3$[3S'SL+Y]T<OSH)S]+3U9,1GWO?_O,
MB+-\Y=KI]=S)*8[)"8WSEFY)KU'//.ZC3N+\_@]^G%X!GGS^<Y=L2D>#R77;
M0T9.CNJUF\3/?WGAX>>2#"O_])?+T^O7'W[7<TG&BVNW/1_]!H]-OU:?=,0Y
M=O*\J-.H=?SIKU?$"9__QX@S.;'R>]__8?KQD\]O\9I=Z4F756LU2D>VR;@R
M>>[)E>%GY[U>56HVC,DSE\22M8__QZ_'?SKBG#9W5?3N_V!Z(N;[W_:,,\^*
M*C4:QJ092]+1:?*Y)=?4_^5O5[WG^RXYQ;-,N:IQ_^ QL7#EC@\\Q^1:^N0$
MUN0$SN1$TF3T^OF\K]]U-]X:@T=,3I_;JDU/1[,V7>*'/[H@3COMC/3]_O1G
MOTK'OOV'CLOZGSE]=C/B!  @PX@3      !R@!&GCD3)*"ZY?CP9$YYZZND?
M&-]=_(<_1^>>#\0C<U:D8\6C\1Q6;GHJO1Z]::M.Z7 R,[0\X803XO0SSDJO
M/!\UX=%T*+CY7>/!Y$KV/@-&I%=S%RQ<,CV5\MVG9&;ZJ!'G'R[Y6]1IV#I]
MWYG')N//9-"9C!4OO?R:PU^'SQUW7'KE]Q__=&DZ!'S_B''PB$GQJ]_\[A./
M.,<_\EAZXN3?\C[&YS]_XN'')Z=__OZ/?TVOC\\\-KE"O&6[[O&[W_\IO1[\
M'R>)?C5*W'%W#!S^</J<_]/7X3\9<6[:_5+,6K V';-><?6-'WC;9)R;C&4S
MCU^X:D?TN'=H%+_][CCWO.^]Y\33ZVZZ-5K=TS-]?=_[,5Z.00].C)L*W)9>
M.9\,.(_/^QY)!K:ERU9)QZ&9Q_;I/S)NS'M<,@).1K(7__$O4;E&_1CVT"-9
M_S.GSVY&G   9!AQ @    ! #C#BU)%HTHS%4:%*G?C-A;]/1X'9&'&NW[XO
MO0)[P-#Q<?5UM\2IIYV1#O2./?;8^,(7OIA>E9T, )-KN%=M?OKPVTV8MC!J
MU6\>E:K52P>1@T9,2@>A[W___\J(<].NE](3.2<\\EA<<T.!PU^'Y,KNY.KN
M"W[^J_3KL6S]GO1Y9]XN&R/.9&AY<\&BT:77P)@^[X/7S?^KY8<1YVFGGQ%_
M^-/?TF'N]+S7^Q]?@^=CV;H]T;%[__34U5-..2WO^^-SZ??L=\__OZA6NW'Z
MFF0>GYP*VF? R&C3H5?4SGM?G7KTCV%CIJ4G@&;[SYP^NQEQ @"08<0)
M   YP(A31Z+Q4Q^+VTM7C!__].?QY2^?]('QW>_2$>> >&1V,N)\[J@^E^ES
M5T7I<M7B^S_X29QT\E<./X?SOOO]N+MBC?0$S$6K=N8]]N5T1#ATU-3T!,[D
M^NUD1)D,]-;OV/>!]_NOC#@S)2=;)E?,O__K<<ZYYZ<G?B8?Z]V#TFR,.+_T
MI2^G@\GDZO#DFO+_].N?'T:<)W_EJ^G5YV4KU(@ICRX[_/B5&Y]*/VZ]QFW2
M]Y5Y?'(5^X6__6,T;M$A5FS8F_4_3\KMC#@! ,@PX@0     @!Q@Q*DCT<>-
M."^Z^))T4)B<V+EFZ]$=<<Y?MB7:=.P=-]Q<.!TSOOMTQM]?\M>H5:]Y>AIG
M,FI<MNZ)],KLY*KUN\I7CX>G+TI/T$RO7'_?^SV2(\YO?^>\=$B87$._?,.3
MAQ]OQ'ET1YP+EF^+H:.G1IERU>*,,\\VXE2^S(@3 ( ,(TX      ,@!1IPZ
M$B57DI>^NVI<\/-??^AP[]<771S-VW2-<5/FQYHMSQ[5Y[)\_9X8,6Y&U&[0
M(AV5)E>8)V/+Y&KUT\\X,ZZ_J5",F30WEJY[(KUJ^YZN]Z6#P8I5Z\7<)9L_
M\OT>R1'G-[]]3E2OTS3&35T02]8^?OCQ1IQ'=\0Y8_Z:]!K[ H6*QZFGGF[$
MJ7R9$2<  !E&G       D .,.'4DFC9G9=1OTC8=$R8G7KY_?'?!SW\5U6HW
MB2$CI\3*34\=U>>R=MOSZ6F<??J/B+]<>F4Z)#SNN./BV&./C1._\(5T=-GK
M_N$Q>N+LZ'[OD&C8K'UZ,F.[3GW_?LWZA[]?(\Y/5GX><4Z;NRKO:W)OW'!+
MD3CEE-.,.)4O,^($ "##B!,      '* $:>.1',6;XPNO0=&X6)WOF<@F.G_
M?O#C*%6Z8O3N/^(]UX<?S9*KVXOD/9]O??N<^,(7OWCXN?SH)S]+!Z?)P+%<
MY=I1L6K==, X9-24?SK@.Y(CSN0YU:C;-!UA+C7B/-S1'G$^,GM%M+JG9UQ[
M0\'XZBFG'G[\&6><%;_XY87I]\6*_]+WI_11&7$" )!AQ D      #G B%-'
MHL6K=\6#8V=$E1H-XIQSO_N!\5TR?+SNQD+I*8CO'BT>S9*18+W&;>)/?[TB
MSCCSK,//Y1O?_$YZ$F/!(B7CXC_^)1UZ]ATP,KUJ>^VVYS[R_1W)$>>WOW-N
MWMNTBLDSE\2R]7L./]Z(,SLCSN2$UM//."ONKE@SEJY[(NM_GI3;&7$" )!A
MQ D      #G B%-'HE6;GTY'>:WOZ1D__=DOX_@33HACCCGF\$CNS+.^%A?]
M[I*HVZAUS%^^-3;N>NG?^CC)Z&_CSA=CW;;GTS'CAKS__5&/7;AR1_09,#+N
MN*M2G'/>^?\8^)W\U?CACRZ(G_ST%_&M;YT3-Q<L&F,FSHE5FY[^I\_K2(PX
MD\<?<^RQ<=[YWX\F+3O&S 5KWW.]O!'GT1UQ3I^[*N_M[XL;D^O43SWM ^^_
M<+$[8L'R;?_T^THZVAEQ @"08<0)       YP(A31Z+U.UY(KR(?,&Q">LKE
M.>>>'R>>^(7WG'28##EO*U$F'IZV*'WLOSKD3 9_R4F9R<F5,^>O2:]+7[)F
M]T<^?M6FI]+18S)<_,D%OSC\7(X__H3T%,9D]'?A;_\0E6LT2,=]R>?P_E'A
MNSL2(\YCCSTVOOSED^)7O_EM=.LS*+VZ>_V.?8<?;\1Y=$><\Y9NC@?ROD=O
M+U,QO4+]_>\_^=Z=\/<K[O_9]X)T-#/B!  @PX@3      !R@!&GCF239RU+
MKPG_ZV57IZ/-XXX[[O#@,2FYVKQWOQ'I"93O'B]^7,F@+ADASEF\,<9.GA>#
M1TZ.@<,GI/__1[U-<IIB<LKE \,?CC_]Y?+XPA>_&,<>^[GW7&F>G,*9C (?
M6[']8Y_#1XTXD[%DK?HM8N3X61]XOM/GK4Z'@9F/><())Z0#RV3@F'P.[_\8
M1IQ'=\297)4^:>:2J%&W:?HU2D:U[_[^O/3R:Z-/_Q'IZ_9AIW$F(^)D@+QN
M^_/O?=Z[7DI'P"LW[DT'H,F .'G,OWOBK'([(TX  #*,. $     ( <8<>I(
MMGCUKG3,F PYD^'A::>?D0XY,R.Y'_[X@KBS;)6X]X'1Z=#MD[[?9#RW:-7.
MZ-SS@2A3KEHT;]OU8T><R4 P&=:-G[H@[V-63J]//^FDK[SGN52OW22&CIZ:
MGN[Y<<_AHT:<%UU\252IV3"&CYEV^+') #"YEGO(J"EQV977'_Z87S[IY/C=
M'_X<E:LW2)_7^S^&$>?1'7&NV_9\.K)LG_=U^>G/?IF>BGK,,<<>?KM?_.JB
M]+49]."D].OU_L_MT87K8\2X&>D)J^_^/EN[];GT>W_TP[/COD$/Q;@I\_,>
MLSE6;7XZZW\F]>G+B!, @ PC3@      R %&G#J294XC'#)R2I0J72%^=>'%
M<<:99\?G3SPQCCGFF/1TSM]<](>H6K-1>FWU_&5;8_GZ/>E(\]WO)QE!)B<9
M)N]KT>I=\<CL%>D@LF+5>NDHLD'3=C%J_*QT*/EQSVGVH@W1IF/ON.'FPG'V
MU[X1_YOW/#[WN>/BMQ=?$IU[#DBO9G_W,/*C^J@19S(&+%KRKKAWX.CT_23C
MO]5;GDF'?*WOZ9F.)I///?D:?.><\]+!88_[AL6C"S<<?M_)$# YM3$Y-?27
MO_[M!\:+R;"SU3T]XN'IB]+WG7F[<5,7Y'TMVL=?+KWJ/2/.9.SXVXO_%*T[
M]$J_EDG)VS5MU2E^G?>^SCK[Z^\9<5Y^U?71)._?39R^^-]^[=_Y'%Y,AZ4-
MFK6/2Z^X-AU)OO]S24YI3<:XR8F8'QAQYGT-9N2]'O<-?"CO.=WPH2/.-GF?
M4W**:_+U2DY0[=1C0!2Z[?;T:YMYW$DG?R5^_).?IX/?*;.6?>"Y#GQP8EQ_
M4Z'X[OG_%R>>^(7T]<F<SIJ<QMF\3=>\[\TML7KS.U_K9*2Y;-T3\>"X&>DP
M-GD=,N\K^9P7KMR1CG*3\6HR'$V^[LDX./G^SO:?27WZ,N($ "##B!,
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M>\\O^WZ,&#\W7AL](T9-G!_3YZ^-Y>L_*O<]$?FR*'$" %"@Q D      "5
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MQDY=]"];P\29R_-$SGON>S1J-VB6)[FF<F_:QV)YMB)*G   %"AQ @    !
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M*MO?=*S\7<WNBQUVW"GVVGN_?+]'G^@<2U__X!_^SHC\;Z+$"0! @1(G
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MO%?ILW_3[T9:7WK.J02[XXX[Y<FE'3KURM^_E8Y2EW**$B<   5*G
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MN:]+BC?I^S%VZN(8,6%NC)Z\(*;/?SV6K_^HW-<E\F51X@0 H$")$P
M2H 2IXB(2/%$B1, @ (E3@      * %*G"(B(L43)4X   J4. $     H 0H
M<8J(B!1/E#@! "A0X@0     @!*@Q"DB(E(\4>($ *! B1,      $J $J>(
MB$CQ1(D3 ( ")4X      "@!2IPB(B+%$R5.   *E#@!     * $*'&*B(@4
M3Y0X 0 H4.($     ( 2H,0I(B)2/%'B! "@0(D3      !*@!*GB(A(\42)
M$P"  B5.       H 4J<(B(BQ1,E3@  "I0X 0    "@!"AQBHB(%$^4. $
M*%#B!     " $J#$*2(B4CQ1X@0 H$")$P      2H 2IXB(2/%$B1, @ (E
M3@      * %*G"(B(L43)4X   J4. $     H 0H<8J(B!1/E#@! "A0X@0
M    @!*@Q"DB(E(\4>($ *! B1,      $J $J>(B$CQ1(D3 ( ")4X
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M      !*@!*GB(A(\42)$P"  B5.       H 4J<(B(BQ1,E3@  "I0X 0
M  "@!"AQBHB(%$^4. $ *%#B!     " $J#$*2(B4CQ1X@0 H$")$P
M2H 2IXB(2/%$B1, @ (E3@      * %*G"(B(L43)4X   J4. $     H 0H
M<8J(B!1/E#@! "A0X@0     @!*@Q"DB(E(\4>($ *! B1,      $J $J>(
MB$CQ1(D3 ( ")4X      "@!2IPB(B+%$R5.   *E#@!     * $*'&*B(@4
M3Y0X 0 H4.($     ( 2H,0I(B)2/%'B! "@0(D3      !*@!*GB(A(\42)
M$P"  B5.       H 4J<(B(BQ1,E3@  "I0X 0    "@!"AQBHB(%$^4. $
M*%#B!     " $J#$*2(B4CQ1X@0 H$")$P      2H 2IXB(2/%$B1, @ (E
M3@      * %*G"(B(L43)4X   J4. $     H 0H<8J(B!1/E#@! "A0X@0
M    @!*@Q"DB(E(\4>($ *! B1,      $J $J>(B$CQ1(D3 ( ")4X
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MB(A(J23]GR?&S5@5[3KUCRNJ-HZ*MS2+VLT?C4'#)\8?3.($ "A)2IP
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M/HTQTY?'HQW[Q1U-VN7)UU7KM(H'G^@28R;-BG_[]_\H[Q\)   H DJ<
M  !08M*IK>O>_%6,G30K6C[<,9<X+ZW<,&ZJ=5]TZ3,V%JU^+U:\\7&Y%V!$
M1$0VU:0"Y])U'T3_D;.BSCU/Y"F<%UQ?-^K>W2Y>&30JEJQ8&W_XPQ_+^T<"
M  "*@!(G      "4F#2)\Y-/_RW6O?'+>*Y;_[CNUN9Q1=5&<77UIO'@TR_'
M:^,6Q.PEORSW HR(B,BFF@6KWHTQTU?$T]U>BRIU6L?E5>Z**ZLUBC9/=,G3
ML'_[_D?QGW_^<WG_2   0!%0X@0     @!+UQS_^*5X=,3%J-W\T*M[2+"ZZ
MH5[4;?%D/-WUM1@[?:4CU45$1/Z!I'\_IR]\,[H/^/_LW0G4U/5U/_ZDV=HL
MW9+\DC1ITI@T39JF:9IF:\S6Q-VX[RB*^P;(*HLL@BP*BJ"XH;BPB0B(XH(H
M8 04!52031%$5%P0!$$1P?OW?IK'OR5!?$0<9GR]SKD'?)Z9[WQG>@Z3<_O^
MW#LAVO88$/LV:AW[-&P1C9J<&9</OB&>>WY%.5 !  !)B!,      #Z@<@+8
MS%GSX\IA-Y7UKKE6_= 3.D2+SA?&\)NGQJR%RV/>XR]6/ RCE%)*54O-?V)U
MS%F\,FZY:U9T/N_J.+))U]BCP6EQ5)/.T?NBP7'GW??'JM5KA#@! 'B3$"<
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MS(\^ T;%*6W/BWV/:AW[']TZ3FK=(RX;-"H>7?1$O/SR*^70!   ;$J($P
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MQ2EMSXO]CCX]]CVJ99Q\>H^X^*H1,?>11;'VY5=BPX:-E?Y*!P"@"@AQ @
M    ?V+CQHVQ9NW+,6?!HA@U=D(T[]BGK%7?Y\A69>+8N9>-C#%WS(SI<Y=5
M/%"CE%)*O5\UZ]'E,>[N.7'ID-NB<?OS2X!SS\.;Q;'-SXJ!PVZ,^Q^<$\M7
MO%@"G(9P @#P3@AQ @      ?U8&4%:M7A-SYB^*BZ^\/DYHV;U,&MNW4>MH
M<L;Y90)9!CGOG;4T'G[LA5CPQ.J*AVN44DJI;5%S%[\8T^<\'>,FSXE+!M\:
MIY]U:1Q\?/OX_>'-XLC&G:-'WRMCZOVS2H#SU?7K*_T5#@! %1'B!
M_JR<(/;::QOBA16KXI[IL^/RP3?$"2V[Q6Z'-BF3QXYMT3.ZGC\X!H^^*^YY
M:$G,6_*B(*=22JF:J_QN>V#^LS%JW/UE$O6I[?O$@<>VC3T:G!8-3CXCSKUX
M<-P^Z=Y8^M2S)<"9TZP! ."=$N($      #>5@92ECV[/.ZY?U8)JAS;O&N9
MR+G/D2WCF&;=H_.Y5\60,7?'Q/L>B0<6/!OSEJP2YE1**57U-?^-[[/9C[T0
MDV<NCM&W3X]>%X^(4]J>%P<<T_:/$S@[Q9F]+XM;[YP2BY<\%6M??J727]D
M %0A(4X      .!MO?[ZZ[%NW:LER#GEOH=BP*#1<6++[O'[PYO'W@U;QN&G
M=(X69UX8%UY]4]PY;4',6KB\!%\J';Y12BFEWFWE882'%ZV(>QYZ(JZ\[HYH
MWW- '-VL6^QS9*O8\_!FT>#D#N5@P[B)][P9X-RPP01.  #J3X@3      !X
M1]:]^L>)G--G1?^!(^*T,\Z-0TYH%_L<U>J-/\^(9ITNB(L'WQ)C)SX8TV8O
M+=/+YIO(J912JHHJPYMS%JV,F?.?B=LGSXVK1TZ,=CTOC\-/[A3[OO%]MU^C
M5G%BZQ[1\X*KRPKU#'"N6?MRI;^B 0"H8D*<      # .U(F<KZZ/IY_867,
MGK<P1HZ=$*V[](N#CF\;>QW1//8_NDU9KWY6W\%QP^W3X]Y92V/NXI45#^0H
MI912[[3F+UD=,^8NB_%3YD6? :/BI--[EX,*.7USOT8MXX269\450\?$?0_,
MB:>6/1<OO[+.!$X  +:*$"<      % OK[WV6KRXZJ68NV!Q#!TU+CKW'A!'
MG]8E]F_4.O8^LF4<V[Q[].Q_;0P:=5?<=O?#915MF<IIQ;I22JGML#*XF8<.
M[GOXJ9AP[X(8/G9J]!LX)DYMUZ>L3\^)TX>>V#Y:G7E^7'KUR)@V\^%8ON+%
M6+?NU4I_)0, 4 .$. $     @'IY_?6(US9LB-4OK8TGGGHF)DR>'CWZ7AG'
MG-8U]F[8(GY_>/,XY(0.T;1#W^AUR8@8?O/4,I7SX<=>*&MJ*QW644HII=Y:
M&>!\8,%S<>,=,^/"JVZ,UETOC@8G=2P'$_9H<%H<=M(9T:I+OQAU\\1XY+$E
M\<+*5;%^_6ME0C4  &PM(4X      .!=R?#*JZ^NCR5//A.WWCDU^@ZX-IJT
MZQV''-^NA%X..*9M64-[9I]K8L"P<3%RW'UQY[T+RJ2SN8^_*-"IE%*J(I7?
M/_.?6!4SYST3=\]8%#?>^4!</7)BF2)]6H>^<>B)'6*W0YK$ 4>WCF.;=XUN
MYP^,X3>.C[F/+(JU+[]2#C(  ,![18@3      !X5S+$N?&-RG6R.95LQD/S
MXO+!-T2+3N?'OD>UBET/;AQ['MXL#CBF331LW"5.[W9I]+]F;-PTX<%XZ-'G
MK%=72BE5D<KOG[F/KXSQ4^?%5==/B(Z]KXPCFW2-@XYK%WL=T:($./<XK&F<
MU+I']+YH4$R:,CV>>?Z%6+/VY=BX<:,)G   O*>$. $     @*U2PIP;7X_G
MEJ^,:3,>CFM'CXL>_:Z*IF?TC@8G=8C]&K4J8<[#3NH8IW7L5R:=96CFQCMG
MQMW3%\6,N<MBGLF<2BFEME'53=Y\8,&S,?7!)7'K'V;'L)LF1Y_+1T>;;I?&
M44VZQNZ'-8V]&[:(@X]K6\*;G<ZY- 8.O3$F3+X_ECRY+#9LW%@.+@  P'M-
MB!,      'A/Y'K9M6M?B:>?>3YFS7TTKK_ICCBCQT5QY*F=8H_#3HM=#VD2
M>Q[>/ X\MFT)S'3J?54,&C4IQD^9%[,>75Z"G)4.^BBEE*J]JIN\>=?TA7'=
MS??$V1<-CQ-;GU,.%Y3)FX<VC9T/.C4.._&,..V,<^.*(6-BZOVS8O&2I^*E
M-2_'^O6OF;X) , V(\0)      "\I]:]NKZL5Y\S_[$8._[NN.3JD66BV8FM
M>L0!QYX>>S5L429S-FIZ5K3M?EGTNOBZ&##L]A@ZYNZX8?R,N'WRG+A[QJ*8
M/O?I>'C1BIAG[;I22JEW4"6LN7AES)S_3$Q]\/&XXY[Y<=.$!V+XV*EQY8@[
MHL^ 4=&QUY4EP+GO4:W+Y,V]CV@>QS3K&FW.NC#Z#A@6U]]T9TQ_<&XL>W9Y
MK'WYE4I_I0( \ $@Q D      +RG<EC9A@T;2Y@S)Y@M6O)4_.&>!^+2:T;%
MR6W.C@./:QN['-SXCY,YFY4@S4''MBNAFG8]!\3YEX\N@<[;I\R-&?.?*4'.
M2@>#E%)*;?^5 <X''WDN)MWW:(RX]=ZXZ)J;H_.Y5\>I[<Z+0TXX(_9KU#I^
M?T3S-R=O[GM4RSCBY [1J_^@N&WB/3'OT<??^-Y:&Z^L6U>F2YN^"0# ^T&(
M$P      V*8RR+GTZ6?CWAFS8_B8\=%WP+71MMN%<4++[G'P\6W+)+1=#VY<
MPC4-&Y]9PC;M>@R('A<.BPNNNBFN'#$A1MQR;YFF=OODN7'G/?-CXK1'XP_3
M'XLI#SP>]\Y:&O?/>3H>F/]LS%JX/.8L6EFFL2UX8G7% T5**:7J7PN>^/^G
M:C[\V LEF#E][K*8-GMI3'UP29G6?-?]"V/"O0MB_)2Y,7;B@W']K=/BFE&3
MXI+!MT:O2T9$AUX#HVG'?M'HM&YQX+%M8]=#&L>>#4XKWS6-FIX9S3J<%V=?
M<'5<,WQL3)HR(Q8^OC16OKBZTE^9  !\  EQ @      V]3&UU\O$\W6K7LU
M5K^T-N8_^GC<<L>4Z'?Y\&C2OG<<<D*[,A%MYX-.*1,Z=SNT2>QQV&EE2N?>
M#5O&44W/BF:=+HBNYP^."ZZ\,2X=?&L,O.[.&#+F[AAQZ[2X\<X'8MSDN7'7
M],=BVNPGX\$%S[T9Y*QT$$DII53]*T/X^>_X0X\\']/G/AU3'E@<XZ?.BYLF
M/!@C;[LOAMTX.:X>.3$&#!L7_:^Z*;I?,#1:=KDHCFW>(PXXIDWL=42+V*-!
MLS)Q,P\)Y'?,3@><'/L?W3J./JU+=.MS10R_X?:8\="\6+5Z3;S\RKI8_]IK
ML7'CQDI_90( \ $DQ D      +PO<BWMQHVOQXH75\>CBY;&U/MGQ>A;)\65
MU]X4?2X=&EW/NSQ.[W)!G'SZV='PU$ZQWU&MRN2T?8YL%8>>V*&$<QJW[Q.G
M=;R@A'7:=+\LSCCGBK(J]ZR^0^+LBX;'N9>-C+X#QT3_J\?&Q8-N*1/9E%)*
M55?EO]_Y[W@&]_M</KI,UNS6;VAT/N^:-_[='QAM>UP6K<^Z.)IWOC":G'%^
M'-^R9S0XJ5.9LKG[H4UCGX8MWOCO,^*$%MVB1:<^T>F<2Z-W_T%QV:#1<>T-
MM\>==]\?L^<MC&>>>Z%\-]F:#@! )0EQ @      [ZL,S&S8L#'6KW\MUKVZ
M/E:N>BF>?N;YF/[0O+CQMC_$15=>'^V[7Q3'G-8E]CSLM-CMD/^=HK;+P:>6
M29T9[-SUD":E=LLZM&FIW0_+.JU,\2S50"FE5-76'_\MW[U4TS?_K<]IS77?
M :7>^%[8Y>"Z[XG&L?LA3>/PDSI$J\[G1Y]+AL1U8\;'E/L>BL>7+HOE*U:5
MJ=#Y_9,3HDW>! !@>R#$"0      5%2NL,U5MCD1;?["QV/:C(?C]DGWQH@;
MQ\?E@V^(\RX9$EW.'1!MNUU8)JKE"O93VIP=Q[?L7M;B'G%*QSCTA'9E3>[>
M#9O''H<UC5UR/?N!I\3O#CA9*:54E=5.!YY<_AW?_= FL=<1S6/_1JWBD./;
MQ>$G=XA&3<^,XUMT*U.;F[3K%<T[]HDV9UT8'<^^-,ZY\)JXY.J1,6S4N+CE
MCLDEO/GPO(6Q]*EG8_5+:^/5]>LK_94'  !_0H@3      "HN+IUMO^[<GUC
MF=294SI?6KLV%BY>6H(X-X^?'$-'W197#!T3_:\<$;TO'EQ6L+<]Z\)HTKY7
M'-NL:QQV8OO8[ZB6L<>A36+G@X0XE5*J&FNG T\I <Y]&[:(0X]O%\<T[1*-
MVYX3IW>](,X\=T#TZC\H+KSBNA+T'W+]K3'FMKMBTI09,?>11;%RU>HR;;-N
MTF:I\AUC9SH  -LG(4X      &"[E(&;#.&L?'%U+'WZV7CDL2=B]KR%\<#L
M!7'? W-*L/.NJ3-C_%WWEHEK8VZ=%"-NO".&CKPM!EUW<UQU[4U*U62=?]FP
MZ'3.I642;8:5FW4XK^+WI-1[6V/+O^-#1MX:(\:,C]$W3RQ!_IS2/''*])@\
M[<$RM7GFK/DQ:^ZCL6#ADC^N2W^Q3-L4V 0 H)H(<0(      $ 5>?R)I^..
M/TR++KT'Q,X'G1I7#Q];Z5L"  #@71+B!       @"HBQ D  % [A#@!
M  "@B@AQ @  U XA3@       *@B0IP   "U0X@3        JH@0)P  0.T0
MX@0      ( J(L0)  !0.X0X 0      H(H(<0(  -0.(4X       "H(D*<
M    M4.($P       *J($"<  $#M$.($      " *B+$"0  4#N$. $
M *"*"'$"  #4#B%.        J")"G    +5#B!,       "JB! G  ! [1#B
M!       @"HBQ D  % [A#@!      "@B@AQ @  U XA3@       *@B0IP
M  "U0X@3        JH@0)P  0.T0X@0      ( J(L0)  !0.X0X 0
MH(H(<0(  -0.(4X       "H(D*<    M4.($P       *J($"<  $#M$.($
M      " *B+$"0  4#N$. $      *"*"'$"  #4#B%.        J")"G
M +5#B!,       "JB! G  ! [1#B!       @"HBQ D  % [A#@!      "@
MB@AQ @  U XA3@       *@B0IP   "U0X@3        JH@0)P  0.T0X@0
M     ( J(L0)  !0.X0X 0      H(H(<0(  -0.(4X       "H(D*<
MM4.($P       *J($"<  $#M$.($      " *B+$"0  4#N$. $      *"*
M"'$"  #4#B%.        J")"G    +5#B!,       "JB! G  ! [1#B!
M    @"HBQ D  % [A#@!      "@B@AQ @  U XA3@       *@B0IP   "U
M0X@3        JH@0)P  0.T0X@0      ( J(L0)  !0.X0X 0      H(H(
M<0(  -0.(4X       "H(D*<    M4.($P       *J($"<  $#M$.($
M  " *B+$"0  4#N$. $      *"*"'$"  #4#B%.        J")"G    +5#
MB!,       "JB! G  ! [1#B!       @"HBQ D  % [A#@!      "@B@AQ
M @  U XA3@       *@B0IP   "U0X@3        JH@0)P  0.T0X@0
M ( J(L0)  !0.X0X 0      H(H(<0(  -0.(4X       "H(D*<    M4.(
M$P       *J($"<  $#M$.($      " *B+$"0  4#N$. $      *"*"'$"
M  #4#B%.        J")"G    +5#B!,       "JB! G  ! [1#B!
M@"HBQ D  % [A#@!      "@B@AQ @  U XA3@       *@B0IP   "U0X@3
M        JH@0)P  0.T0X@0      ( J(L0)  !0.X0X 0      H(H(<0(
M -0.(4X       "H(D*<    M4.($P       *J($"<  $#M$.($      "
M*B+$"0  4#N$. $      *"*"'$"  #4#B%.        J")"G    +5#B!,
M      "JB! G  ! [1#B!       @"HBQ D  % [A#@!      "@B@AQ @
MU XA3@       *@B0IP   "U0X@3        JH@0)P  0.T0X@0      ( J
M(L0)  !0.X0X 0      H(H(<0(  -0.(4X       "H(D*<    M4.($P
M     *J($"<  $#M$.($      " *B+$"0  4#N$. $      *"*"'$"  #4
M#B%.        J")"G    +5#B!,       "JB! G  ! [1#B!       @"HB
MQ D  % [A#@!      "@B@AQ @  U XA3@       *@B0IP   "U0X@3
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MQ D     4!E"G%!;A#@!  " >A/B!     "H#"%.J"U"G    $"]"7$"
M %2&$"?4%B%.    H-Z$. $     *D.($VJ+$"<   !0;T*<      "5(<0)
MM46($P   *@W(4X     @,H0XH3:(L0)    U)L0)P    ! 90AQ0FT1X@0
M  #J38@3     * RA#BAM@AQ @   /4FQ D     4!E"G%!;A#@!  " >A/B
M!     "H#"%.J"U"G    $"]"7$"     %2&$"?4%B%.    H-Z$. $
M*D.($VJ+$"<   !0;T*<      "5(<0)M46($P   *@W(4X     @,H0XH3:
M(L0)    U)L0)P    ! 90AQ0FT1X@0   #J38@3     * RA#BAM@AQ @
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MY<\++[PP;KGEEGCLL<?BQ1=?K'< ,T.;CSSR2+EV5K[?IY]^NE[7V!I"G
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M;]VZ]?\)G-8WQ+EHT:+RN_S,FC=O'J-'CXYERY;%FC5KWN'_%=Y[0IP
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MK_>@@PXJFYWR@'T>E,\@9GUEWSD/RX\;-ZX<P!\Z=&BYI^V)$"?4%B%.
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MY"<_60[CYT'Z>^^]]\W7R'YR]I5S_7M.\LR0YZ!!@TKP-'O U4"($VJ+$"<
M  #;5#;ULO%VQ157E(!D-NTR9-BQ8\=R^KENDN26+%FRI%PC&X-?__K7RTGL
M#()F@R[7VV2(,1MO>5(Z Z.M6K4J:WRRR9=!R9S,F8_9U////U]6\60P,U?K
M_.I7OXI##SVTA!^7+U]>GI/WEW_/IEZN/M]OO_W*Y,Y\/]G<RY!JOO:69( T
MFX Y$337P_?NW3OZ]^]?&I YY7-+GV.NB,_@YJ]__>OX]*<_'2U:M(@9,V:4
M &A^!GEJ/-_'3W[RD_(9Y;JB_(SK$S!]IX0X 0   &#[\&Y#G!EL[-Z]>^RT
MTT[E@'L>7#_AA!-B[-BQ6WSNTJ5+RZ3-#WWH0Z5R>U!N,,H^:AX\SYYG;@RJ
M^WT>M,^09VY*RI[PYLR>/3LNNNBBTH/-'FC>TRFGG%(V->7SLO][RRVW1,.&
M#4NO^< ##XRKK[ZZ/"]#GG/FS"F31'?;;;?R61Q\\,'EOK('7&?UZM6EUYN/
M:]>N773NW#FF3IT:*U:LV.[7J-<1XH3:(L0)  # -I6GGS-<F$W$'_WH1Z49
M^.___N^ER983,.LF26Y)-M9RU4Y.K\P 94[8S,F>&>3,G^>4S2>??+*$-7/=
M3@9%<V)G@P8-RGKT#%K^N;!H-O;RY/?(D2/C^../+\W$KWSE*^4$=C8Z\[H9
MY,R_YTGQ/ &>$SASC7K7KEU+B#17F;]U1?O;O8=<F3Y\^/#R6MD@O?_^^TOC
M<DM!U@QQYHKWMTXT/>B@@\H]Y37R=[GN)^\K3\Q___O?CP$#!I250%L*B+X;
M0IP     L'UXMR'.#%JV;MVZ'(3/:9J__.4OX\PSSRP_WY)-0YS9,\T#Z'F@
M/Z=M9I\V#\S7_3[_/F'"A!*2W-PVHK1IB'.''78H*]YS U'V8?.0?![XS_7G
M=6O<,^29&Y2RCYLKW;,_G.'/SWWN<^5Q>:@^>[!ULH^<?>:<T)G]Y>Q?Y\^R
M1_MV][8]$>*$VB+$"0  P'LNIU)F4VSRY,DE9-BD29/2I/O'?_S'^,A'/E+"
ME1GH//GDD^.RRRXKP<0%"Q:453>;D\V]_'V>B,XIGKD.)\.,N2XGFX/9;.O;
MMV^9/IF_.^RPPTH3,9MQN4[\I9=>VFP#+G^>S<&<OMFX<>/2K,R094[=S(9A
MAB'S[RU;MBROF:O7\[_SOC,DN25U*^%SQ="($2/*?7;JU*F\7D[1S.;C.VD.
M9N U3YKWZM4K=MYYYW+*/$_&YTGQ_%FN3\\3YMG@S*;MI$F32D U@ZKO-2%.
M     -@^O-L09P8?LP^:S\L09QZ,[]&C1^GK;LFF(<ZO?O6KT:5+E]*_S2F7
MV?O\^<]__N;O\]JY:6A+-@UQYG5_^]O?ECYR]E&SSYJ]WIRBF1N5]MUWWW*P
MO6W;MJ6/FY]#OO]==]VU]$^'#!E2>K#9)\WGYM_K-A[E%,X,?6;H-*^9?=0\
MB)\'YJ=,F5)^-WCPX%*Y8C[[K=F?S8F=[V2[U+8DQ FU18@3  " ]UP&&_-T
M<Z[[SN!FGGC^U*<^5:9P?OC#'RY_?O*3GXS/?O:S96KDB2>>6!IA&7+<G PY
M9F,LUX;/FC4KA@W[_]B[[^ NL_/^^[_))'$2QS.))W%B9V(GCF-/[#C.>!S;
ML9TX]L2[=!98>N]-O8(014*()D07'=%[[TV(JH*$!.I( DGTCNBB[>?Y7F<#
MSZ;L+L+ +:3W:^8]\61!2/RAPWWK.N>L=,.A=M7/M[_];7WC&]]P_]<&,.W*
M]<F3)RL]/=V]3'R9DS)ME[9=]6-7\=C+1AO6M)>7W_G.=]S5Y/:_[>6?#5_:
MJ9UV_8Z]V'N9ZW6>7Z.^;]\^MPO<3OFT%X!V@JB=DOFRN[OMZ[?/,S,ST[VT
M[-&CA[[__>^[:^/MZ__QCW_L3N>T(5%[R7CITB7W=;^)W>,,<0(       !U
MPZL.<=H[2GN?:+<>V>;[US'$:;_7WDTN6+! /_WI3U_[$*>]Z[1WGC9,:3<P
MV6F:/_G)3]S78+_6KG6W P3L[\,&+TM*2MS[6?L]]H[VT*%#;M@S+B[.W6QD
M[YIMN-/^NQU.8 .<=IU\>'BXVS!O']?>$=N?80<*V)7P]F[8/A<O,<0)U"\,
M<0(     7CO;B6R[EQ<M6N1V<G]6-M1HIV7:%3TO<ZKE\Q,Y"PH*W*F6$R9,
M<!_#7J#94*>]*+33/^V%X+5KUU[ZE$MC+^KLNO.4E!3W.=GN;?N8]K'M?]M@
MJ%VM8Z>&VJF8+\N&+VU8TUY VM^)#8': *<-I-9VQ[9]CC:<>?SX<?>QGG^.
M=JJIG<AI+R"?#W"^B6O4GV.($P       *@;7G6(TZX\M\WLW_O>]W[K(4[;
M9!X?'Z^,C R777_^.H8X;8.]#5/:4.@G!R=M(//LV;-N$-4&,NT6);NU*"0D
MQ+TCWKAQHWL':^^J[9VJ;<BW][KVWM=N<YH_?[Y24U-U^?+E%S<IV6"H'39@
M5[#;*9[V]V@W/EEV.U/GSIW=NV+[7.SV)QOZ_+S# ]X4ACB!^H4A3@    #
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ME+[VM:^YOZ=ITZ8I,S-3#Q\^K-7G]+HPQ G4+PQQ @    " 6F.($P
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M'V/.G#EN&-6&3.WOV$[KK*ZN?JG/[75CB!.H7QCB!       M<80)P
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MY]^R94O]^9__N?MO-N!:7E[^4M>\OPD,<0+U"T.<      "@UACB!
M +QA5X_;B9-VY;<-4MJ)F'_Q%W_Q8HC3!BS_\S__TYUF:4.7=J*D#7-^'CNU
M<O;LV>Y$3CLYLV?/G@H,#%1 0( [F7+0H$$:,&" _/W]%1T=K6W;MJFJJLH-
M4'X:.P7SXL6+2DU-55Q<G/KV[:MNW;JI=^_>[@IX.]W2/GZ_?OW4M6M7]V?;
M"9KIZ>GN][X,.V73/O>E2Y=JTJ1)[L^QDS/M:WZ9CV&GAMJ)I<]/XPP)"7%7
ML7?HT$']^_=7KUZ]W$FG;=JT<9_[M&G3W FC-J!JO]<+#'$"]0M#G
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MA2%.      !0:PQQ @       ( W&.($ZA>&. $     0*TQQ D
MWF"($ZA?&.($      "UQA G         'B#(4Z@?F&($P      U!I#G
M      #@#88X@?J%(4X      %!K#'$"        @#<8X@3J%X8X 0    !
MK3'$"0        #>8(@3J%\8X@0      +7&$"<         >(,A3J!^88@3
M      #4&D.<         . -ACB!^H4A3@      4&L,<0(       " -QCB
M!.H7AC@!     $"M,<0)         -Y@B!.H7QCB!       M<80)P
M  !X@R%.H'YAB!,      -0:0YP         X V&.('ZA2%.      !0:PQQ
M @       ( W&.($ZA>&. $     0*TQQ D         WF"($ZA?&.($
M  "UQA G         'B#(4Z@?F&($P      U!I#G         #@#88X@?J%
M(4X      %!K#'$"        @#<8X@3J%X8X 0    ! K3'$"0        #>
M8(@3J%\8X@0      +7&$"<         >(,A3J!^88@3      #4&D.<
M     . -ACB!^H4A3@    #X'!]]])%J:AZI^LY=7;]9K<M7;^C"I:NJ.G])
MIRO/J_3T61675JB@N%PG"DIU/*]8F3D%2L_*T]%C)W4D\P11O6O"C"5JW#%
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M9MF-?GN/%BMQ[@9U&C!"S3H'Z[VV@]6J9[AZ!,9HT:JM.GO^LAOD?)T8X@0
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MB.AMMOM(H9*6;E= ]%0U:N^OIIV"U+;W$,U?MDGE%>=TJ_K.*[V798@3
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MGD9.F*WWV_NI:><@=?.+T8SDK=J?<4JY)5<\?Q@C(B*JJ^67WW"#G(O7I6I
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M)B(B>MGL9:$-<J:DEVCR_(WRBTI4BVZAZM _2I%Q,[1A>ZH[!?O9,X8X 0
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MZWJ(B(A>M8^O5:_6UOVY[F5AYX$CU+AC@ :$C]6<)1N4<3Q?#Q[6>/U/ @
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MN++:\P<K(B*B^E))U1T5552[JWOZAT]0BZZA[H=T(R?,44Y>B:Y>O^5^D <
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M$A$1O>%LK3V:6ZGQ,U>KJU^,VV#?)WBTUFS>J]R"4PQQ @   'A[;#@D,Z=
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M;TO3B=*KGC^G$A$1-81R2ZYH_:YC&CMCE;KXUN(._:(T9O)"=Z4Z0YP
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MD[=H^X$\Y9=?]_PYE8B(J"%D&R=V',S7]$5;U#,PSFVL&#)ZNB;.7,(0)P
M ("WYTA&KN(2%ZAWT&B]UVZPHL;.<T,D=B*8UP].1$1$#:7,_//:DN);DZ<N
M5XMNH>HR:+B&Q<_4SI2CJGG$$"<     U#?E%>>T8/DF!45/T@?=0]4O;+SF
MKMBEO4>+5'#ZAN?/J41$1 VAO/+KVIM6K#G+=ZEW<+S;6!$X+$$C)\QAB!,
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MN[.557!1Q975GC^G$A$1-82*?&NN'6RS;E>F!@V9I":= M5AP##U"(QAB!,
M  # V[-IYP%U&CA,+;N%NB'.B;/7ZEC!!>67W_#\P8F(B*BA9#N^<XHO:];2
M'6K5,\+M^&[7=X@6K]ZF!P]KO/[G @    #@-3M14*IA8V>J=:]P-6KOKZ 1
MT[4]-<]MKB^INNWY<RH1$5%#R-;<DZ77M"4E5WY1D]6H@[];FSOTCV*($P
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M2X>/G_'\N92(B*@AEI)Q2D$CIKU8ERV&. $   "\-0QQ$A$1U9T8X@0   "
MAH$A3B(BHKH30YP     /,40)Q$14=V)(4X     :!@8XB0B(JH[,<0)
MP%,,<1(1$=6=&.($    @(:!(4XB(J*Z$T.<     #S%$"<1$5'=B2%.
M &@8&.(D(B*J.S'$"0   ,!3#'$2$1'5G1CB!    ("&@2%.(B*BNA-#G
M   \Q1 G$1%1W8DA3@    !H&!CB)"(BJCLQQ D   # 4PQQ$A$1U9T8X@0
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M$$((18\(<0(      ,0&A#@10@BAZ!$A3@      B"B$.!%""*'H$2%.
M  " V( 0)T(((10](L0)       1A1 G0@@A%#TBQ D      ! ;$.)$""&$
MHD>$. $     (*(0XD0((82B1X0X 0      8@-"G @AA%#TB! G      !$
M%$*<""&$4/2($"<      $!L0(@3(800BAX1X@0     @(A"B!,AA!"*'A'B
M!       B T(<2*$$$+1(T*<       040AQ(H000M$C0IP       "Q 2%.
MA!!"*'I$B!,      "(*(4Z$$$(H>D2($P      (#8@Q(D00@A%CPAQ @
M  ! 1"'$B1!""$6/"'$"      #$!H0X$4((H>@1(4X      (@HA#@10@BA
MZ!$A3@      @-B $"="""$4/2+$"0      $840)T(((10](L0)       0
M&Q#B1 @AA*)'A#@!     ""B$.)$""&$HD>$. $      &(#0IP((810](@0
M)P      1!1"G @AA%#TB! G      ! ;$"($R&$$(H>$>($     ("(0H@3
M(800BAX1X@0      (@-"'$BA!!"T2-"G       $%$(<2*$$$+1(T*<
M    L0$A3H000BAZ1(@3       B"B%.A!!"*'I$B!,      " V(,2)$$((
M18\(<0(     0$0AQ(D00@A%CPAQ @      Q :$.!%""*'H$2%.      "(
M*(0X$4((H>@1(4X      (#8@! G0@@A%#TBQ D      !&%$"="""$4/2+$
M"0      $!L0XD0((82B1X0X 0     @HA#B1 @AA*)'A#@!      !B T*<
M""&$4/2($"<      $040IP((810](@0)P      0&Q B!,AA!"*'A'B!
M  " B$*($R&$$(H>$>($      "(#0AQ(H000M$C0IP      !!1"'$BA!!"
MT2-"G        +$!(4Z$$$(H>D2($P      (@HA3H000BAZ1(@3       @
M-B#$B1!""$6/"'$"     $!$(<2)$$((18\(<0(      ,0&A#@10@BAZ!$A
M3@      B"B$.!%""*'H$2%.      " V( 0)T(((10](L0)       1A1 G
M0@@A%#TBQ D      ! ;$.)$""&$HD>$. $     (*(0XD0((82B1X0X 0
M    8@-"G @AA%#TB! G      !$%$*<""&$4/2($"<      $!L0(@3(800
MBAX1X@0     @(A"B!,AA!"*'A'B!       B T(<2*$$$+1(T*<       0
M40AQ(H000M$C0IP       "Q 2%.A!!"*'I$B!,      "(*(4Z$$$(H>D2(
M$P      (#8@Q(D00@A%CPAQ @    ! 1"'$B1!""$6/"'$"      #$!H0X
M$4((H>@1(4X      (@HA#@10@BAZ!$A3@      @-B $"="""$4/2+$"0
M    $840)T(((10](L0)       0&Q#B1 @AA*)'A#@!     ""B$.)$""&$
MHD>$. $      &(#0IP((810](@0)P      1!1"G @AA%#TB! G      !
M;$"($R&$$(H>$>($     ("(0H@3(800BAX1X@0      (@-"'$BA!!"T2-"
MG       $%$(<2*$$$+1(T*<        L0$A3H000BAZ1(@3       B"B%.
MA!!"*'I$B!,      " V(,2)$$((18\(<0(     0$0AQ(D00@A%CPAQ @
M    Q :$.!%""*'H$2%.      "(*(0X$4((H>@1(4X      (#8@! G0@@A
M%#TBQ D      !&%$"="""$4/2+$"0      $!L0XD0((82B1X0X 0     @
MHA#B1 @AA*)'A#@!      !B T*<""&$4/2($"<      $040IP((810](@0
M)P      0&Q B!,AA!"*'A'B!     " B$*($R&$$(H>$>($      "(#0AQ
M(H000M$C0IP      !!1"'&BI'3UQ__:N:_^8<?/?&?;]WYF*]9^9',7K;()
MT^;;L-%3;>#0<:Y!P\?;T%&3;<S$V39]SE)[;\5&V[#MH.TY?,8_>^+"7^RS
ML]_;_F,7;//'1_V?%[_]]:Z.7==]][W5\6,,U]39BVW[GN/V^;D?[-)W_[K-
M>?J?[?WDK"W]8(M-FK$P,!\3;/K<I8'WZF/[Y,35B#_'VY'FYO/S/]C>(^=L
MW9;]MG#9!ILZ:[&-&C_3!H^8&#^?0T9.LM$39MF46>_YO*]<O]/G]_#G5^S,
ME9_MV*EO[*-]G]NN0Z?]STY>^LGG+=+WAU"TBA G      ! ;$"(\\8Z_]4_
MW7=;O7&W>TX3ILJ7G!+O20T?,\U]OB4K-]N6CX^Z%W?AFU_LX/'+-G_).ENS
M:8^=N?*WB-]'I'3RXD^V:/F'R7JD$Z<OL,T[C[AW>_&;7^W8Z6_< YX\<Y'[
MO>''R_O3LSCPZ<5;]E0O!,ZO<R<WEI0DSU5C&CMICGNO\F*W[#IV[9DG]IKE
M#VM-O+MXC7N7X><;-WFNS5GX@7U\\&3$GQ/Z_77EA__X]\3:S7MMVIPEM[P>
MQTZ>8\M6;[5=AT[9F:L_1_Q^T)T3(4X      (@HA#A14KK\_7_<P-NVY[@;
M>NT[]K!7J[]N3Q5[SA[,F=O2IT_ONO_^3/9 C@<M?X$GK6RY2M:X:1L;.&2<
MS5N\QK;O^<S#G!_M_=R-M9'C9KBI>OHNFZ<*$%:K62]^C.$J5;J<39@ZSTVZ
MLU_^_;:N=?6'_]K"9>NM1>NW[-GG2EGFS%GLQ?(O6:=N_=PHCO1SO!UI;C1'
MNK^^ T=:_4;-[?D77K3'\^2S+%FSQ<]GMNP/6-Y\!:QDJ;)6O58]>[M+'YLX
M;;Z;ND>^^,HV[?C$ILQ\SXW1H-%[)3!OD;X_A*)5A#@!      !B T*<-];G
MYW^T!4O76]=>[[C75_3I9RW'@[GB/:G<N1^V%TJ7MZ8MV]NH\3/<BSMY\?_L
M_74[K';=-ZQ[G\%VY(LO(WX?D9(VTS=HW")9C_29XB5MQ-AIOOGZ].6_>J"S
M_=O=K43)TN[WAA\O[T_/8MFJK;?LJ9ZZ]).?.[FQI*3[,V6R'($Q%2A8R+W7
MYJTZV.B)LSR$=RHP]O#KR=/61O0:M>M;UFS9$YWOR4)%[977:MFL>2LB_IS0
M[Z^+W_[+OR=Z]AMFI<M6N.7U6/#)PM:J72>;O6"E'3WY5<3O!]TY$>($
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M^X*FYCWW>)LBM:52*W15.+C9\Z[;LM^KE)8N6\$-7[5)(L2)4,HBQ D
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M'^W]W#WMMAVZN6?^Z&-Y_+G'K9DT]D".!_TZ;3MT]4(9*HIPH_.B.!'B!
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M4CO?U>;'=TE?,V?U_+3^M"->(5R%=+4#715/M=YU7H6'0XU+A((BQ D
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M6;-Y,0157FT9F'<%F#5G^KU#WX>JTJF_T_>E*M7J^:I01:2_YZ-=A#@!
M ""B$.*,36D'L\RDAQ]YU$-HX<:" G+CI\Z[Z^/03F#M9*]4Y=4$U3B]G7JC
MYMX:)*YB8=P.>@409?9,G+; S409:#))9="&GSNY$.<SSS[O 589IJK8&#Q>
MAIW:O\A,E0D2/%[&B\P3F3"A;<6U4U@M;V0BW6R(\]!G5[S%DLPR53L-'B_C
M^8WF;6WZW*4)VM?/7[K.=Y*'GU_&I PZ[?"]U78Q.EY5.-=O.^"&>%(F8)'
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M"(CGR5? AHZ<[,]9ZTAK;MGJ;=ZR76%;509]H4P%Z]KK'2] $.GO^6@7(4X
M     (@HA#AC4U>^_X]7(HRKPI@FD;'P>X4X58U01IR,F#1ITR8P=U2!4@'/
M8#LDF:X*R<F0ZC-PA!NG"@"JU;;"C.'GOM40I\ZKRI/:]1[:)D9&<(F2I3U
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M]4Q5S"&60ISIKU66'3IJ2J)SJW*IUK(JE<I+#WY&;=4GSUCHSUEMW=5Q3.M
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MB9_;#4*<V1]P8S[\,S+6YBU>:VTZ=$U@WJGEDWY0&!'XS/Z0G? (!46($P
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M8+V=]1@M(4Y)WTGZK23TO/J^T#O3_NWN_KT0.@^:%P6,(_V]_6<1(4X
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MN86*>CN:"]_\ZNOE3C]S[:H>,&2LE:M0Y3>'.$--9!FDX=<@Q(G^B"+$"0
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M/$@::J[^T4.<,IP4HE2ETP=RY$QL0A=\THVZ(U]\F>"^[Y0(<1+B1$F+$"<
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M[NT?/_M=8,P[K7Y@32C<F3Y]^I@+<0:E@AQM.W2U[-D?\)!W\'C]QE"C5OW
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MZ]U-=&]7?_;OL%V![QE]QZJHA[YW5-A!UU&'JTI57O,UWNZM[C9KW@H/C*H
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MC&C]@"!C5)_3_-:HW<#RY"W@QJ7"H84#]ZH@I\+"FM<;!:#1GT>$. $
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M*AUHY[G&\TSQDAZ@3A58\ZH8H7=09OW@$9-\=_:YK_YY6\\:_3%$B!,
M " V(,294.$A3ODI\H%>*%O>NO4>9 N6KG<O3QO2%>Z3]._:3*X IRK*:3.R
M.J*4JU#9JW#*<SE[]><$7J*J!\JWT?'A(4YY,EU[#G2_YJ*W'?ZW!_?4T44;
MW1.'N_*Y)R3O2%[/J4L_!<9SV 8-&V]%DO"DGBU1RD.9\M""&Y=U3VH=_T".
MQ"'.!W+D]&!5]9KUW%.L5:>A^T>AE1^3"W'JGN5[*<BH5M[AY\Z;KZ!O3):W
M]NF9Z^M.OFR=!DTM;_XG$E1(E&<JKTN;T$,K=]Z*%'239[=L]3:K6BWQF!1,
MDQ=:KV$S6[3\0P^Y7K@-[W/]M@/69^ (]U+E<X<&!9\K6<:#F7IFDC;P=P^L
M,U6"E+<;NH%;WM^049/\607/K:J*ZK@D_SHT@*MJD9FS9+4\>?.[!ZG@;:>N
M_=Q;U:;MFPUQ:FVHBY#\Z:2"D4V:MW//]6 2W8D2S_M_?'UJ,[U"JN'G4[!3
M53>U@?^<BA(H0'KE;][-2FLP_'A5EI3ONO7:>E.W)U5X;-6N4Z)CY?<J /W.
M\/'QQTORM;6>Y:UJPW[P>*TY/9]BSY3P>:\;6 OU&S>W,N4J^K.XDR'.8*CX
M\&=7;'3@_N,VV.=/\CVL^EIM+]J05,MR?4_H?99?7Z!@8B__Q<#WT?BI[_K]
MRT_7=XI"E+I>Z+T'O_=Z]!D2_QUT_1K_"CSK2Q[D;-2DM3WZ>%[+&%@'P8YJ
MC^7)YVM"%55U?KT[^J[3NZ;O%\V3_'D])\W]P*'CO"N7WKE4J5+Y=570HTK@
MV8X8-\-_6TG*R_^SBQ G      !$%$*<2)*II_^PUP[841-F6:.F;=Q<*/AD
M87OXT<=]1Z:J%S9\HZ6;4Q.FSO.=[$M7;76]MV*CA_>T8U>[FV4 JB6.=LRJ
MC8="D+?R'_TRP;0[5$:.@H1J;S-PR%C;^-&AFSZ'#,J77G[-3:W'\^1SPU-A
M5!E5)4N]Z&W39=0II#EEYGO6H7,O#]FIY8E,UC>:M?6_DSD7.G:94JHHNG35
M%@^KRBQ*RIR203<I,!^;=QZQXV>_<X-'9K/"J)K3T'9$,@:?"UR[5=N.OK/_
M_74[W'!1"#:T/4I0VLFO7=ASWUOE%1I]A_1MMC=114Y5)I!!VJ%C3V]3HUWC
M:A?S^.-Q\Z==Y]J-JQ;HFAL=*R/H_;4?><!6NWUE *G2J<**.E;':>>N0K!)
MC5$FI8*:6C=J!R/SZ*&''[%77JOIIKF>D4Q!/2^%>66$Z3EJ9_3468M]S,%S
MR9!4^QO-]9R%*]TXE'D?/G]:US) =5Y5(U# ^,KWR5>(32G$^7+5FM9_\!AO
M.Z]W0>/JT6>PCU-_KQ\<5&FA78=N'A:6,1@\MP*TVH6M +5:OV>\_WX/+GOP
M,TM6JUCY53?AM0/Z/"'.F! A3@      @-B $&="*=PG/TY^R).%BUJI,N7<
M3U$ 3QMY^[XSRC>8JZ*=/"EY4=/G+O/-KVW?[.J^U?.E7_1-VCW[#K4E*S=[
M."]X?H4!56U1'4^T45E^8W@5/(69Y.F]NRBN(XVZI\Q?LM:]3H4G$VT6?S"7
MMX2>.GNQ;=AVT .EXZ>\ZW\F/S7\> 4$%=J;/G>I;^36^;5YV3?W/EO2*U$J
M2)KZ6K<:54%4RW:-22$L=7WQCC;/Q'6TB0M?I74?5\$OW9O"9 I\*;3WX?:#
M-F3DY"2#>SESY;97J]?QC=-K-NWU@)?N67/\8H4J'A35)N/0>Y5W^G:7WO;!
M^H\]='OY!GY:J%354:VQ%3J4?ZQ0KGRP\#$%JPIJKA5:U89S>7*[ V.[E>J?
M"B >^NR*39NSU!HV:>E>JORVX'44ILP7F%=M9I</J_4D/T]>M.8\M *I/-SG
M2KY@+=MUM/E+U\5YL;X!_ZJ-GSK/ Z>JR*KGH.=Q7YHTEC5K=O\S^<8JC#!Y
MQJ+ LQOH&^6U:3M5JM1^K.ZW0>,6WJ9;H4UYI_*>U>TH6'"A8N6JB>8I7?KT
MOGY[]Q_FZUQCN='\R/O4/,JO3*I@@/SPUNTZV<QYRWT]*@2X<-D&;_<=&IP,
M2NM/WJSF5\=K_<P(O(L*$R<::[KT_JR;M>[@OQ_H/=?:E/__5N=>O@%?ZSY8
M55+SK;4G7UHA1[6-'S!TK#5KU<'RY(OK8*2Y4Z$&=4#2NE>U7-W_S?KC5W_\
MK\^W*HGJG9&GK?,7?ZZ4GS<IKU^5:6O7>\-&3YSE06?-D;I\R5.7]ZW*FF]V
M[.D50\,_7^2I8M:Z?2<;-V6N_U:BL*?N2^%9W4OX.Z#?#_3;2[#2:=R8XP*G
MFF_YY1I+L<![\F#@O<R0,:.OZ6<#XU? 4X%<A3W5*4O=M_J^,](F3EO@:U=K
M2Y5PY<6KB(6*)?CW2-JT7HS@E< S5&&)C8'O,D*<A#@!     .!WAA GDF0"
MJ)*A F7:H;EA^T$/(';JUM=-PM(O5O2=XC*\9*PHY*A*B/HS2>&[UP/'*5BH
M';K:G:Y=W#+^9!+))+V5D*&"?3(.%;13F$T&KEJ7*TQWL^>0:?IJM=I6H."3
MUKAI:S=G94+*F%3;\/*57G'C\:EBS_I]*:0HQ1F]0]R@U5RH=7CHV!5(U7W)
M-,U?X(DD=U!K!ZU7"BA3W@-X,G8T+ZHF(,-'9E.H<:C=LFK-(R-/\RBC1B:.
M*@>D39<NT?EE]BF8*@-;1I/,KQN%$&]&"O*JNJI,)\V=PJ0*9.H:VETM$TC/
M72:ZUH#F34:9QEFV7*7 7+_N%0P4O%2;(+74D0$I<TCF8W+54[6S6\:=0K<*
MKK9YLZM72M7Y\^8OZ.WD]>]/%"KJUY>YW#DP]S*BW/0+J0BK?U>H4P9^M9IU
M/< I4S,IXTUS^UJ-NC9LS%1;MV5_7*759.;F1B'.^P//0N';>>^M\=WZU6O7
M]Q9$"IO*1'OXX4?MY:HUO#*KJCRHQ5%H&%-SHS4E8Z[6ZPV]"H+61[; NBI2
M]!EO0[1ZXQY_+JI6$.GO"G3W18@3       @-B#$F5"JA-CFS2Y6]*EG/&PF
M;TF;814H4B4Y^8.57ZYFS[]0UD.)"CW*,U*U0[5K;M6VDP>3Y&EITZXJSH6&
MD.11J@)=OT&C_'.JGAC:QEG2_Y:GI]">6HVOW;S7VU:K.E]2838%]QY^Y#$K
M6_XE'Z,^H];=^K/0(&!\(#!C1O>KZC5JYMUNU!E'H:KE:[99ZS<[^W5563,N
MR);;*XIJH[2\+ATKCW':G"56LW8#][<4LE2%R:)/%?<PH,*D:I^L*G[RS3IW
M[^^>FGS'\+&D39O6'LR9VWT];<17AR %)^7Q>>OJM&D3!,QTKPK8R@MNTJ*=
MS5FP\J8ZW$@*V.G9*,PG_U4!Q\Q)C"E855!SK<">O-5Z#9O;L-%3_?YO=BW)
M5U;85\&\Q_/&=9P*?=:ZAL)K6CLZ1M4'Y0_GROV0WV>H;ZM_U_S)#U5(;\&R
M]1Y@52!8U0J'CIKBWGCV[ ^XCZT IT*H:J<^=O)<6_7A;@_>:5VJ<Y7:V.L9
M:PP9 ^M!OJN'YCXZ[&%75465]RR?45YQ:)7/^+!Q8$S9 W_^U-//NG<X-W!N
M/??DYD/G:];RS<"\/Y%D2W?]F=:ENBHI%#IBW'0K7_%E]T]#*YC&>].!YZ/C
M&S1N:9-G+O(YU#N55.MU!5;UK+4.VW;H:O,6K_5N57H_%=+5)GR]\RK$("G\
M7/F5:KX6%?I40%3>K=:GWC.]GUKW6B/RCA5J5CA8Z^/R388.];V@^5;8484H
MM"9UKQIG:,OV4*]?8].U561 WS=ZUU7<0(4QY!O7KM?8_?JDO'SYQZJ<^6+Y
MREZT0>M-E6T56$[J.TA%'>0OZUT/';?[]U?_[A6&52Q"X7(])UU7:UQA6/V[
MJL/J^T!MV?4=JH"YUNSYKW]Q7UKA4_U^H^JBZLBF=?O M?6D=NU:UPJ8TTZ=
M$"<      /S.$.)$24FA2U4'7/+!9C>;%$"38:F=Q3(I5.$R5&JE(Q-&.\(7
M+%WGK4$43).1]UO^8U]&XZ'CE[URH<P,!0-E=H7NGD])VLW;9\ ('[<J)*J2
MH7:9JBVUVJ/(=-,._=![4&!QR*C)]L'ZG7Z]I':;RIC9N?^$WVOX/(1+K>FU
MNUQ&R;C /.J:,NN2.[[FZPU\'C7FZK7JI7A^/1?=EP)^5WZXO1!G4,%62\<"
MY]2Y97C*9'WS[1YN_JCM>Y6J->+'H!W6"DRJ78MVT:NZI8*E,@Y#6YRGI!,7
MXG8_R]#LU7^X&_/!:^AZ"A.KQ;J>SV+?87XET3DT;CTW[8I758.4YD_SK.>C
MT*K"E,F-[48A3IFXJNZP?<]G;OQI#6DMR8!5(%CWH58[R]=LMZ.GODYT;F]G
M].7?;<O'1]V0UBYV?:Y._29>T52&FDSWY"J9HC^?"'$"      #$!H0X$THM
MD57%4M7Y5J[;Z9N\Y8G(9Y0_U>^=4=:T97OWH5X.\:;DH73JWM\]J75;]KEG
ME%0+;IU??J?\&WDO-_*,U'Y<03:U1N\]8'B*'I/&\,ZP"39R_$ROPIG2\:IF
MJ0J0NC_Y9_+$9BUXW[KV&NC>JWQ!=432/2NLI7'+%U+P30%5M7!7>^ZJ@7'*
M-VO2HKWU[C_<PVSRL52)\MBIKWU3>TIC4>6^X6.G>><EA;X4JM,<)W>\_&&%
MQU2I\4:;HD,E[TO5 U,:2[ATCPKVCI\RSS?;W^Q:4I53S9L\.[7D3OK\U7Q#
MNH*NFNL4?=ZZC;PX@+I2:9.VUICF6)YASWY#?5.^KB7O5P%$5?;<L?^$=W32
MQNR=^[_PL*:\7SUCK;$:@>>L8Q76TV9X^81![UE^8DICTCI1NWAU!CIX//GB
M!ZH:V;%;WQ3/I[$$*U/>R,,./5[OIH)_*3_+!KZ>@[ZNPH@*5<\.K'MUA=+?
M2PJ;#AHQ(:Y5?."9ZWM P5:-JV>_8=:P22N?.ZU1>=4#AX[UO].Q-[L!7IZ_
MOE>F!)Z10K"WNBXU!G6JTK/__/R/[OW+TTWI<RKPH+F2CZX6\S<Z5O>G3?_A
M8[_ZPW\]B*GO#KV#Z@[5O'6'N._%5VOZ=T*=!DW\=PA]UP7'&'KO9Z_^[&.6
MYR\O6^LV^%[/6?B!_ZXCKSP6O6A"G       $%$(<:*D%*S*J!WJ,@2TDU4[
M/-5:7 ;'YH^/)-"V/<=MUZ'3;I:H=;B,0AF0'N#\#?^Q'S0D5=E3.]UE3,J<
MN)5*A KT*4BH<2ODJ-W1,H>TNUWWM/M:BZ#0>U#(4T:GS"%=+RFCXN*W__+=
MX[K7\'D(U_; .67J*7SZR8DO ]<\[2WKDSL^;AY/^9A#QY:<?+=^X-RW6NGT
MA@J<1\\MV&+JV.EO_%XU]H_V?>Z&H@*'P3'HWS56&9&J@JG*FYJ_<SY_-Q_@
ME8&D5D3'SWQK^X]><),S]!J:RX\/QCT?K^Z:1.A2XY9YK#6H9YG2_&F>_?E<
M_NL-P\8W"G&J$JM,5;5QU[K2=?4<->:MNSYUTU6?5XN>I'Y T'-3%555?-5Q
MND?-L=:)UJBWY;E!)5/TYQ,A3@      @-B $&="R1N2KZ0JB@I<ZG^K5;%\
M1F\[?NR"A]'"O2EY*'L_.1O?*OA\,CZ*AY>^_'M<,#0%WVW+KF,>-)-G)'\Q
M10\P, ;Y9_J,/+*4CH^[QQ_C@U+RQ'2/VI0N[U5>FP)NNF?Y7,%.-.Y+7OG9
M/20=HV,U%[JFQOG9N>_=&U,84#Z4-CNG-)8=^TYXZW'-G\ZAMN<WFA_YPVI?
MK;#AS?I5\KXT-RF-)9%7&AB'O%*-[68#HY)\8<V;O-.DO.PX'77_46M'<WTS
M/J_F\_/S/_BZU+U?#,RQ?%!=1UZVKJ6UH%"N_.BXUO;_]F>L?U?;<]V//[=K
MS]F//?6UK_.X;EEQWK,*'-S,_/AS/_O]#>='H3U=)\5U&3A&]R._5!O6;^9X
MK=N;.?>VW<=]/0=]7:U1W:<^+]]9?R_I'=>[%%S+FC_]SA"<9ZU7S9W6J+QJ
M/1/W\F]A [R.TWSK&>DWC5M=EW'O3-QO")>^^Y=[__)T4_J<QJNYTOL:^AV6
ME'1_^HTDR?=)WGU@#O7<=?_N1U_[7@RN0<VIONN"8PR]=\V]QJQYUF?U&7^O
M ]]+"G#&_ZX3!?^_\'N+$"<      $040IPH&B630:UIM!/ZE5=K>FN52(\)
MQ:YN%.)4FYJ1XZ9'?(SHSR-"G        +$!(4Z$$$(H>D2($P      (@HA
M3A2-6KUQM_4=-,K;P:C-ROHM^R,^)A2[(L2)?D\1X@0      (@-"'$BA!!"
MT2-"G       $%$(<:)(Z,R5OWG[F/5;#]BL^>_;TE5;O V*6L=\^9?_V9Q%
M'UB=!DVL_^ QMOC]3=XJ)=)C1K$K0ISH]Q0A3@      @-B $"="""$4/2+$
M"0      $840)XJ$#AZ_Y,'-MSKWLD)%GK;7:M:U?H-&>07.JS_^ST:.GV%%
MGRYN X>,M4.!8T]=^FO$QXQB5X0XT>\I0IP       "Q 2%.A!!"*'I$B!,
M     "(*(4X4"6W>><0&#9]@E5^N9FG3IK.\^0I:U6JU;,RDV7;LU-<V8MQT
M*U>ALDV8-L_.7/W9+G[[KXB/&<6N=A\^8PN6KK,:M>LG#G%FRVY#1TVVB]_\
M:E=^^$_$QXK^^"+$"0      $!L0XD0((82B1X0X 0     @HA#B1)'0T@^V
M6,,W6EJ1HL7LWOONL_OOSV0//?2(M7FSBZW?=L#&39EK;3ITM26!XZ[\\%^O
MSAGI,:/8U9:/C]JXR7,]=!P>XLR:+;L-'#K.3E[ZR8.<D1XK^N.+$"<
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MO))LGKSYK5'3-C9YQB+;=>ATQ,>._K@BQ D      ! ;$.)$""&$HD>$. $
M    (*(0XD21T-FK/]O1DU_9DI6;K%?_8?9FQQ[6O'4'ZS-PI$V;L]0V[SP2
M..;O=NG;?T5\K"AVM?_8!5NV>IL-'37%FK7J<$.U[=#5QDR:8ZL^W.UK.])C
M1W]<$>($      "(#0AQ(H000M$C0IP      !!1"'&B2.CJC_^SR]__Q\Y]
M]0\[>?'_[,3Y'^WS<S\$_OTG.W/U9[OXS:]^C!3IL:+8U:7O_FWGO_JGG;K\
M5U^?-Y+6\.DK?[/S7__B:SO28T=_7!'B!       B T(<2*$$$+1(T*<
M   040AQ(H000M$C0IP       "Q 2%.A!!"*'I$B!,      "(*(4Z$$$(H
M>D2($P      (#8@Q(D00@A%CPAQ @    ! 1"'$B1!""$6/"'$"      #$
M!H0X$4((H>@1(4X      (@HA#@10@BAZ!$A3@      @-B $"="""$4/2+$
M"0      $840)T(((10](L0)       0&Q#B1 @AA*)'A#@!     ""B$.)$
M""&$HD>$. $      &(#0IP((810](@0)P      1!1"G @AA%#TB! G
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M55NO^CX,61^?_?E9F[OX0P]M,B:%ZFC&\K3NT,.FSEGNQ@W5U)$&)T8+QLV
MH>.M0I5:]E+^5[W"OMC;[_BHG$4K-MJ1L_]U_4S+7R'"CES;QWN.V9A)<VS\
MU/E>S;WCLY-QT2'T9M'QBQT9AH^=;F\6+V4UZS3T<3J,-?HM1EY)4EJD$*<0
M0@@AA!!") 8*<5X?$6(D+#5AVD(K5[&ZA[.6K-SLP:;D?#."772OFS!U@8<Q
M&7U\RRVW>$=%NBERG.CWX%42]F(L]JCQ,ZU1T[:6_Y6"=O_]#WI +EOVG.Y=
MAD%)?+Q83\_A' BW$BSM/WBL=>C2V]9OVQ_S^Q6ISX]]8]U[#?;.HIFS/!S3
M$"?WBXE"["6\PRHUZMF+N5^RAQYZQ*<Z-6S:QN_]AYOVNJ_\RW[ZIX^O)E#+
M^&PF0?%ZNKW>>>==EO.%W,'>Z& SZ6CZ&UT3]_V3?2?=1WZY0,&$#'%&:^$'
M&SU@RZ2HZQWBC ?M._*UC9DXVYJU[&@UZS2RCEW[^IXDG!WKQA0WDQ3B%$((
M(8000L04A3BE>!1&ZJ[/SUCWWD.\JITNG'1OW+GO5(KO"3MP?O+921LZ:JI5
MK]7 \N8KX!7UY2M5]R FP4>.2^=%7AMI8&!N$>3$W&!,4(LVG7TLT0LOYG%S
M!Y.'JG4Z<O[6)NSY[Y,Z2=)!H';])FX&$E)5B//7B;5BM!95_MS/VO6;6MT&
MS7VDT8WLDB!)OT8*<0HAA!!"""%$8J 0Y_417A]A-8K J]:H[Z% .A'BI247
M7OKRS__V8EY"72W:=/$ 86HASG ,..&]C_<>LT7!>PE)T6GQR:>>L?OO?\#R
MOO2*O=>XE8]OYK6QGIYSZNM_V.9/#MF4F4NL>:M.UKAY>Q_Y'.O[%:EX"G'B
M&](]D2Z&Y2O5L)S/Y[*7"Q3R:4UTV5SQT2=^[PELXBM?VD\__-M.!VM]Z-0/
M7CR^?.W'-GSL-*M=K['OJ3QY7_:.GK]EB).]QQAO]GCAUXLKQ!D(7[]]E]Y6
MX+4BO\L0Y_$O_V8;MQ^TD>-F6IGR5:Q<A:HV<?I"#_/R71CK\[M9I!"G$$((
M(800(J8HQ"G%HW9\=L)F+UQC5:K7M4R9LEC';GWML\-?>35T2N]A- GC40@Z
M5JU9WY[)FL.R//2(O92_@+W?=ZBMWK [3>8?QSEV[J\^,JARM3I>+9TAPVW>
MT;-KSX&V9-5F#WPRHOM&KT/8@?/HV;]X@'7@L/'V4KX"/N:=L> *<5Z;,*\P
MY.G42H=6#'NZ$M"Y(=9=$B1)(4XAA!!"""&$2 P4XDR?PC'J'ZS=[B.YZ<+9
MN%D[&S]EO@?M4GO_FHU[K%?_$5:T>"F[Y98_7C7$&2V*A"D6[]"UK^7*D\_^
M^,<_VIUWWFFO%"ADDZ8O\K!G+*;Y(+RMT">E,V3+MEVM8N5:5J=^4UNU;F?,
M[UNDXB'$R7H1<OOL\ 4;-'QBTLCM;#GL_@<>M'?*5+1^@\;8IAT'TWP\1L7O
M.7#6B\9+E"IK;Y5XUUJU[_Z;ACA#T3GVS;=**<09B'!ME_<'N,?_>PQQ\GUX
M\L+?_3II:%&P\!O6MN/[-GO1&K_&>.@.?#-((4XAA!!"""%$3%&(4XI'T0FS
M5KW&5K)T>2M4Y$T;-7Z6FVGGOD\Y.'GTW%^\PV+G'@/LE=<*VR.//F[Y\K]J
M]1JVL 7+-[AYFQ;S%$.#8.2V/<=LZNSE5K5&/1]]D^6AA[URNNO[ SU0>>3L
M?]_P=2 HRG53-3]FXARK4;NA/?;X$U;JW?(V;<YRA3BO471BQ; DE/MLUAR^
MST9/F&T;MQ_0>DHQET*<0@@AA!!"")$8*,29/M%YCLZ(PT9/M8)%WO2P&ET4
MUVS<[?^6VOO3$^+$8Z0#Z)192ZWP&\6]D^>MMV;PB3Z#1TQTS^YJQ>@W4OBG
M!#@)<S5MV<%>*_BZ%7GC+84X4Q!>,-XK]YV& D\\^8P]\NACEN.Y%_S<MNP\
M[%[BKUG_$]X5\8 -'S/-)TTAA3ACJ]][B). )GMOZZXCUJE;7WNW7"4K_G;I
MX)YW]'U X%UCU5.70IQ"""&$$$*(F*(0IQ1/P@"EDAT#-?MS+[AQ6I\0YK+U
M*;XG-"CV?G'>!@P;[]72CSW^I(<NRY2O:H.&3[!/KC*&/251-;WOZ-=N'&;.
M\I#==MMM]H<__,''Z7 ^N_:?OOS<O_G)@Z28C[L/G/5_WW/@G!T__[=+(VPP
M4#D7S#^,O,T[#_EK&;<3&3#%4#GW_<\>/&6\^^B)L]UH?2G_JW;777>[L=FS
MWW W_]9NWFO;/SWAGXM!&%E1RS4P(G[WYV=LZZ[#7C6^?MM^UX;@\S_>>]S7
M+6F\_$_)CGEBQ-2IK_['7T-%.@8UHX'V'?G* Z:8XI]^\:5]O.>8CVS9'ASS
M\V/?NE$=!F)Y#=?"*'I_?[ &A]S\3+GZ-UP#7[?@VOC,+<$U; RN@35A_?AO
MUIG/2QJ1]>\T513[.07[#),_:[;G?-P58]4)QF)HQ?HYD!);"G$*(8000@@A
M1&*@$&?ZM._(US9[X6IKTJ*]/?-L=GNC6 GWRO"LZ$29VOO3$^+$MV)D^MI-
M>ZW$.^7<,T19LS]G/?H,=>\ML@"<UY_Y-LD[)#06^ESX<IPK?A0>WL[]I]SS
MVKK[B'MHA\_\>,G[])'=IW^P3P]]Z1-E\!7I^!GY&?A=^&\+EV^P]_L.\^+X
M!Q_,[('$=\M5\2+FT!OD&,<O>HEX:IP?ONSGQ[_U\^/S.5>\N>0\0XK/&2O.
M>6^_>#[K+WIVFW9\X4%6SI5C\>?D HPIA3C7;=WG?A^?S3'P&_$UW0^\Z*>R
MEJQ=>KH+LF9XHC/FK[3W&K6T%W._Y!.9G@KV0JG2Y7U2U+4>FW/?MN>HS5W\
MH?49.,I]QZN%0=U;#O8,TZBX7E_/T,<-UA7OE7N+C\RZ)W=/HI52B#.IBVW2
MO6.OA9\3"L\87YS]%!G\P]_E'ESV^N#<\+OYM\BQW;YOO_O9_>F#)Y-\84+7
M7!OW+NP8RY[#<][^:7"/@W,+/7/V'^MQ]MO@'@?G@$?-&K&/?$\$K^>U&WR_
M'?37\WSP+"6W)Y(+<:Y:O\OW$N?PZ:$+WM2!<V"]"?;RC+!&=+@\GTQSB4O/
MSC<7GYU@S[(6EYX=7[\K[Q/OXQX<]?U]P:>2<0U<2_@,<9\^"9X;OL\X#J]/
MRU[G]1.F+7"O.T?.%^R--]_VB6.<3ZRZ ]],4HA3""&$$$(($5,4XI3B280<
M/]S\J35HW,KNN^]^'UG3?\A8-YQ2>H\;'F?_XL9KK;J-O5,E0<<GGGS:&C=O
MYV8;Q_VUYX(YBNDS;,PT-_ >>#"35]47+%S4NKX_P$<UA:_%S,(\6KU^EX]L
MPGSLU*V?]>P[W-9MV^]FU9I->SV,R1B3:C7KV[OE*EOEZG6M1Y\A-F_I1QY4
M#(^'H8(A1V?1ENVZ>M5L]AS/N^F:(4,&RY0YBW<%+?1Z,2M>XETWX,9/7> !
MQT@##Q..C@#=>@VRFG4:^EBIMTN6<;&VC!/O-WBLCW\BB)E<AP#,-PRK12LV
MVM!14]Q([="UCXT<-\---\RZ 4/'N?%5IGP57_.)TQ:Z\82AB$F'\859A#'>
MN4=_:]^YEYO)*57_8DAA?K$&=$]@_%"'+KVM>JWW_#,PQ\N4J^*=25GGB=,7
MN2G*N:;%P P#HIP3YGSN//G=R,1DQYR,]7,@);84XA1"""&$$$*(Q$ ASO2)
M(ND.7?K8F\5+V;-9LUN%RC7='TQKQ[GTA#C#$!;^%QY;&.+D/ B*<>S(P![G
M1+AJ]8;=-G;27.O8M:]5K]W ?<\#QPE^G;0ILY=:^RZ]W3.L7:^)'V?)RLWN
M41)F(QA&8?G 8>.M>>M.WC62$&OX&?B)A!]'39CE$XYRY\WO1>X9,V;T$-_C
M3SSE8<G0&^08A,5\#+./$__*?=E),Q;Y>3#M:$QPKES+B0M7>H;'SOW5"]BG
MSE[FWF35&O7M[5)EK7292EX$SQCW 4/'^[6V;-?-0W31QT@IQ(D?B*_)>C'B
MO''S]CXBNG392CXUJ4?O(>[#$K!+SU0=@JOXCP1><^7)9YDS/^03F1B!WJL?
MONZ^:SXVYT60<^6Z3WP:$/<],G0;+8*,*S[:X5YTDQ8=K$IPG>&]P@O%>^W5
M?Z3O 0*1:?$P4PIQ<C_93]R[VO6;7/J<4(V:M74?^Z-@/Q%R#8^'E\K^O.SU
MI<I8NTX];5KP;WC%X6MY!@^=^K-MVWW49LY?9;V#<V_8M(TU:=[.PY,$.-G[
M'V[>ZYXS76-YAL-[S#2L%1_N\& D0<YPY/VR-=N"9V""KQ'G\LZ[%:U<Q6KN
M.2]8OMZ#T%\FXP\G%^)DO7EF.(?!(R99_4:M_!Q*E:Y@E:K5MA9M.MN4F4N\
M.0*!R^AC7GIV#EWP1@M\=[3KW"OXG.!^3Y[G?W?RJRL;!G#M!*A9!SZW9=LN
M2?L[>'983]:@4M5:UJ9]=^_FRG.);W\N#7N=[YT//MSNZY'SA=S^/<#^YEGB
M-Y18?V_'NQ3B%$(((8000L04A3BE>!+&YYB)L[V;YA__^$>K5+6VCU:G6CNE
M]V!04C%+-?/K1=^Z9)IFRY[3>O4?[L=,SF1)JZ;/6Q&<3T4?N_W'/]YJ6;/E
M<'-HXO0D0Y>@(E6^;K*-GNI5VZ\7?=O>>+.$E:M0S4.=5/!BU#5OT]FOC=%*
M!#$?>O@1[Q* ,;IRW4ZOT,>,(<!(]?*\I>OLO<:MW,CDM1A,K,N]?[K/GGXV
MFSW_0FXWX @S\MD8.IA'QR]6#W..]8/S(;Q9)%B; J\5\=<_]WPN7Y]\+[]F
M)=\I;YV[][>YB]>Z 1A>-V87X5/6=MZ2CZQGOV%^/\)K(VB+43QI^B(WEO.\
M](K=??<]]D*NO&YPS0C6#6.- "?GT:I=-P^C\MZBQ4K:B+'3DS74PLX$=.M<
MNFJK7Q=&+\9TT>(E+UW#B\'GY,F;WX]5][UFOF\(E&*\IK4RF9 LIO9+^0O8
M P]D"M:ZI:\!G0W24\4O2>F10IQ"""&$$$((D1@HQ'EM<N_HFY]LZ>JM[GDQ
MS0>O"Z^*3G]I/4YZ.W$2JF(<,\'%2YTXL^7P4"+A.3H&AN=*UU ^#S\,'ZW
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MR1>757YS# PX.ALT;]TYQ??3<3,I@/K+6'5&"['NF%6$2;E&1L=3[4UE<[-
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M)$F5)R-.  " JL&(4Y*DRI,1)P  D"DC3DF2*D]&G    %6#$:<D294G(TX
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M2:H\&7$"  "9,N*4)*GR9,0)  !0-1AQ2I)4>3+B!   ,F7$*4E2Y<F($P
MH&HPXI0DJ?)DQ D  &3*B%.2I,J3$2<  $#58,0I25+ER8@3  #(E!&G)$F5
M)R-.  " JL&(4Y*DRI,1)P  D"DC3DF2*D]&G    %6#$:<D294G(TX  "!3
M1IR2)%6>C#@!  "J!B-.29(J3T:<  ! IHPX)4FJ/!EQ @  5 U&G)(D59Z,
M. $ @$P9<4J25'DRX@0  *@:C#@E2:H\&7$"  "9,N*4)*GR9,0)  !0-1AQ
M2I)4>3+B!   ,F7$*4E2Y<F($P  H&HPXI0DJ?)DQ D  &3*B%.2I,J3$2<
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MR<OB>.G/Z9 SZPLG29*J2B67'T31N=LQ>=Z&^*IAY_0FX5<-\F/&_%5&G
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M^\%S<:ST9N873I(D595.GKL=>XY?BM'35L07#3K%5^4U;M\W%JW<',^\B1,
M "#GG"F[&(/&SHJZK7O&1[7:1>O"4;%XW<$X</):^EG7K*]3)4FJ"B5?2#IT
M^L=8M'9_-"\8%A_7:A]U6_:(IAT'&'$"  #OSM;=AZ-3G[%1N_R")!EQ]AXY
M.S;L/A.'SUS/_,))DJ2J4O+PQ.9]I3%TXN+XO'Y^^G!%V\)AL6+]CGCN39P
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ML>W@V<POI"1)RM7V%UV-16OW1\_A,^/S^OGIC<(N_<?%VLU[XNG39UG_\P
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M9OD#X_/Z'>.;[[I$_;;]HN_HN3%WY:[8NK\L'7.6&'-*DMZSDK/KY+G;L>U
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MA^J3,R(Y*WY]^BP].]['>[-&G    $"%)6\>_+AV^Q@S94'\]//M],V#
M  #\^9(A6^LN0]-/22<C-N#]9L0)    5)@1)P    ! -HPX(;<8<0(    5
M9L0)     ) -(T[(+4:<    0(49<0(     9,.($W*+$2<   !084:<
M  #9,.*$W&+$"0   %28$2<     0#:,."&W&'$"    %6;$"0    "0#2-.
MR"U&G    $"%&7$"     &3#B!-RBQ$G    4&%&G       V3#BA-QBQ D
M  !4F!$G     $ VC#@AMQAQ @   !5FQ D     D TC3L@M1IP   ! A1EQ
M @    !DPX@3<HL1)P   %!A1IP      -DPXH3<8L0)    5)@1)P    !
M-HPX(;<8<0(    59L0)     ) -(T[(+4:<    0(49<0(     9,.($W*+
M$2<   !084:<      #9,.*$W&+$"0   %28$2<     0#:,."&W&'$"
M%6;$"0    "0#2-.R"U&G    $"%&7$"     &3#B!-RBQ$G    4&%&G
M    V3#BA-QBQ D   !4F!$G     $ VC#@AMQAQ @   !5FQ D     D TC
M3L@M1IP   ! A1EQ @    !DPX@3<HL1)P   %!A1IP      -DPXH3<8L0)
M    5)@1)P    ! -HPX(;<8<0(    59L0)     ) -(T[(+4:<    0(49
M<0(     9,.($W*+$2<   !084:<      #9,.*$W&+$"0   %28$2<
M0#:,."&W&'$"    %6;$"0    "0#2-.R"U&G    $"%&7$"     &3#B!-R
MBQ$G    4&%&G       V3#BA-QBQ D   !4F!$G     $ VC#@AMQAQ @
M !5FQ D     D TC3L@M1IP   ! A1EQ @    !DPX@3<HL1)P   %!A1IP
M     -DPXH3<8L0)    5)@1)P    ! -HPX(;<8<0(    59L0)     ) -
M(T[(+4:<    0(49<0(     9,.($W*+$2<   !084:<      #9,.*$W&+$
M"0   %28$2<     0#:,."&W&'$"    %6;$"0    "0#2-.R"U&G    $"%
M&7$"     &3#B!-RBQ$G    4&%&G       V3#BA-QBQ D   !4F!$G
M $ VC#@AMQAQ @   !5FQ D     D TC3L@M1IP   ! A1EQ @    !DPX@3
M<HL1)P   %!A1IP      -DPXH3<8L0)    5)@1)P    ! -HPX(;<8<0(
M   59L0)     ) -(T[(+4:<    0(49<0(     9,.($W*+$2<   !084:<
M      #9,.*$W&+$"0   %28$2<     0#:,."&W&'$"    %6;$"0    "0
M#2-.R"U&G    $"%&7$"     &3#B!-RBQ$G    4&%&G       V3#BA-QB
MQ D   !4F!$G     $ VC#@AMQAQ @   !5FQ D     D TC3L@M1IP   !
MA1EQ @    !DPX@3<HL1)P   %!A1IP      -DPXH3<8L0)    5)@1)P
M  ! -HPX(;<8<0(    59L0)     ) -(T[(+4:<    0(49<0(     9,.(
M$W*+$2<   !084:<      #9,.*$W&+$"0   %28$2<     0#:,."&W&'$"
M    %6;$"0    "0#2-.R"U&G    $"%&7$"     &3#B!-RBQ$G    4&%&
MG       V3#BA-QBQ D   !4F!$G     $ VC#@AMQAQ @   !5FQ D
MD TC3L@M1IP   ! A1EQ @    !DPX@3<HL1)P   %!A1IP      -DPXH3<
M8L0)    5)@1)P    ! -HPX(;<8<0(    59L0)     ) -(T[(+4:<
M0(49<0(     9,.($W*+$2<   !084:<      #9,.*$W&+$"0   %28$2<
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M.N644T("0>@L)_:H"Y0X142DDD VI#'$55==%;F)2R^]-&H+Y )*E1>)@Q!
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M!N4<B"7%=-FJ#Y0X143DCPSK9Y;K(-> %,D&#/(<39HTB?5_].C1,36CF%H
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M)\0G= *EP07/SH86Y%;R/*5.)U/B%!$1$<F/$J=(9:'$^3\.(T'H1D5G!Q(
M)"@8;9I)G'2Q(.& !,'KB ^%"@X4*[*ND_Q(Y]PD+-A52M&&@P0%NT+Y0<^.
M2XHGA43)K-LF72_8><IG2010&*+H0H*":S#FC"0&[Z'PPGF+A6X8= QA) GC
M8BF6, :NV$X66==0$D 4?Q!0*"8A;5)0VGGGG:.HQ/?!:P@@)(SJ8M29$J>(
MB-0EK/=TB: #%MVRD0H9A[7RRBM'K+#PP@O'>%1&@K-Y@@X+O7KUFMU5NSI8
M3UGWD!KH;L5&![ILLX[3V9,UDUB!KE><$Q&#9#]20C;BM#HR03+;3,(H=D:E
M(S@0+W -) C.2T&#=9Y.$<BAQ737X/S(GDBA2!0(&6QT8=18H6[=&=EX,F(%
M"B)L="%^X?NED$&\@-C*N'6>G8(,<BK/7<SHV7)0XA01D=K ^I3E ) @6,?(
M(]!1>LDEETP++KA@C,SD[UMMM56L\?S>9G-%31L:,Q&2R1JLO<@$2!&LZUR#
M31ZL[ZSMY!?8B(DDP'UDXT5K.C?WS*;*'CUZA$A07=Z"[I_D38@OBAU5SO5Y
M+](GP@+/BQR*!%),)RP@KB ',G7JU,B;<"]T#B5>(&Y +B47<L())\0F$#;4
M%#.!I"[(E3C[W3\BO?'V^^GK;[Z;*]<6$1&I+>0-^*U-;$%]@;AEQ1573(LM
MMEB:?_[YTS+++!,;48A;R%&PCE,CR#?N/(-U.^N:R?K?I4N7R#T04[!>$[,0
MPQ 'L7:3"V%3!N>M*8>2>\_$$L0DQ"WD.LAQ<'_D4HA;V"!*ET_>0[V%^RVV
M,04;9^B:22Z%'!"36-A02KVD6*BA<)\\?\>.':,N0LQ&S$)=A-B-6 :QE3BP
M%$%4B5-$1$0D/TJ<(I6%$N?_./P0YX<YXB/C2ADC5M-!X:#8KA&(#HPLI7L%
MNT#Y@<Z/=810DB-(F ,'#HP1K'3M*A9&IF5CS=A]2O*#G;(4,DA6D&2@(QC7
M+E5VX#[8;<HN6R1,A-&:DC/5D25LZ Y"YP[D%#IW9/?(.!8*0 BF=25D*'&*
MB$A=PCI.%P4V-[ AHU",0"&"CA(4"HI9UY$;D"?9T$#Q G&"\]"-@B0_&S+8
M5,&&C&*[7&80*]!- ZF4\U L(?Y@':;0<>FEE\9ZCTA9RD8*OA,*&(@DR)>(
M(G3:*"6.R7U^Y$_B#830[!XI:E#0H?,%<0AR2WV-4<]0XA01D=K ;UK6= K_
MB .%8@9$!H1+NB\5TQV*M1JQ@!B#R1P($>0OV"#)VH[8B0Q S,+&AWRC2*N#
M]R)]TMT263/+6Q"/((?R;ZSW"!:E2 Q93F#HT/_+WGUX57FFZQ__Y\ZD3)I)
M-/;>145Z5T $Q8;81>RBV!$[Q2XJ(%W WGO76).Y?ON^D9S,''XS@5&0[?>S
MUK5RSEKG&&3O[/?9[WL]][/#?R=V_\*NZ?;O:^\] /O[VYK -LF.'CWZC\F@
MK:>3M&X^M;7%QSY&O=6?2YPK-Q:JONFB'CYB$B< H'NP>_)VW]Z&+-CU]#^M
M7>P>@JT7_LII6E:(M(T<=HRY/7?IUZ^?ERQMW6)K(%O'6"G43D5KS^E<=E^@
M]=ATVQ!J:Q3[\VS-8C^CW>NP-8?=8VB=>-Z>/]M^%EMOV+T(^[EMP^M?'6SQ
MK^S?;QM>[20VN]?1^C/:AA0KSEJ!T]95?^48]5:4. $  -I&B1,(+I0X/W/V
M9=D*D?8%W29MV=%>_RXV >.O'N5I_W=6HK "B$W;LAL7=K2'_7NL6&$E2[MA
M8L6']I036H]ILS^WHJ+"RQUV#*K]V?8_V[_+=G':O[N]6H\-L5*'W6RQ*9GM
MN9G0RF[6M.X\M9*J326SFQ.M/Z/]SO_J3MB_BA(G .!#LNMXZ]'G=O/^/ZT1
M[)@N.P+,2A9_9:IEZT1.N^[:IA*[5MJ?8^L$FRYAUWC[\^QZ^5>G7+:RZ[F5
M.*Q@:3^[;9QHO0[;SVG_/OOWV@.0OSH-J_5W8C^+32BU!SBVCOE/1ZK]N[^_
MK6=LO6%_5NO/: 45FZ1E:Q%;AUC9XV,=H]Z*$B< X+]EUW2[;MGWW_^T9K!K
MGDV7M#7&7]E,T3J1T]88=IJ('6MJZX76:[O][[8QPOX\^_[>GFN[_=_:O0,K
M7-H]"KMO87]V6_<M_LKZIM6_WA.P^Q?V=VC/S_;GG]%^MU:(L'6-_9WM[V[K
M)5M#7+QXT>_M?,RIW?^*$B< H#NS>_)VC;9-$'8]_4]K%[N'8.N%O[)1Q+Z_
MVY]O]S+L&8#=Z[!_AUV[;0UDZQ9;S]BZI3T;3UKO1]C/8<\^;(UB?U[K,QV[
MUV%K#KO'8/<ZVG.?POYL^UE:CYBWG]M*H!U=6]B_WWX.^_W^^6>T#3_V9]LT
M]/;>YZ'$"0  T#9*G$!PH<0)! E*G   H",H<0( @/:@Q D  #H3)4X  ("V
M4>($@@LE3B!(4.($   =08D3  "T!R5.  #0F2AQ @  M(T2)Q!<*'$"08(2
M)P  Z A*G   H#TH<0( @,Y$B1,  *!ME#B!X$*)$P@2E#@! $!'4.($  #M
M08D3  !T)DJ<    ;:/$"0072IQ D*#$"0  .H(2)P  : ]*G   H#-1X@0
M &@;)4X@N%#B!(($)4X  - 1E#@! $![4.($  "=B1(G  ! VRAQ L&%$B<0
M)"AQ @" CJ#$"0  VL-*G!NV[]?8Z.E:O6DW)4X  /!14>($  !H&R5.(+A0
MX@2"!"5.  #0$90X 0! >[QZ_49;=I4H;/(<K=^ZCQ(G  #XJ"AQ @  M(T2
M)Q!<*'$"08(2)P  Z A*G   H#U>OWFK;;L/*GKJ?&W8?H 2)P  ^*@H<0(
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M7"AQ D&"$B<  .@(2IP  * ]*'$" (#.1(D3  "@;90X@>!"B1,($I0X 0!
M1U#B!   [4&)$P  ="9*G    &VCQ D$%TJ<0)"@Q D  #J"$B<  &@/2IP
M * S4>($  !H&R5.(+A0X@2"!"5.  #0$90X 0! >U#B!   G8D2)P  0-LH
M<0+!A1(G$"0H<0( @(Z@Q D  -J#$B<  .A,E#@!  #:1HD3""Z4.($@08D3
M  !T!"5.  #0'I0X 0! 9Z+$"0  T#9*G$!PH<0)! E*G   H",H<0( @/:@
MQ D  #H3)4X  ("V4>($@@LE3B!(4.($   =08D3  "T!R5.  #0F2AQ @
MM(T2)Q!<*'$"08(2)P  Z A*G   H#TH<0( @,Y$B1,  *!ME#B!X$*)$P@2
ME#@! $!'4.($  #M08D3  !T)DJ<    ;:/$"0072IQ D*#$"0  .H(2)P
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M@A(G  !H#TJ<  "@,U'B!   :!LE3B"X4.($@@0E3@  T!&4. $ 0'M0X@0
M )V)$B<  $#;*'$"P842)Q D*'$" (".H,0)  #:@Q(G  #H3)0X 0  VD:)
M$P@NE#B!($&)$P  = 0E3@  T!Z4. $ 0&>BQ D  - V2IQ <*'$"00)2IP
M * C*'$" (#VH,0)   Z$R5.  " ME'B!((+)4X@2%#B!   '4&)$P  M <E
M3@  T)DH<0(  +2-$B<07"AQ D&"$B<  .@(2IP  * ]*'$" (#.1(D3  "@
M;90X@>!"B1,($I0X 0! 1U#B!   [4&)$P  ="9*G    &VCQ D$%TJ<0)"@
MQ D  #J"$B<  &@/2IP  * S4>($  !H&R5.(+A0X@2"!"5.  #0$90X 0!
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M [LNV/7!KA-]1\7[Z0^VD7!>SD9M+BS1\=,UNGCE1N Z\\J+G " CJ'$"0
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MO4N39ZT,K!,R]<O(^/?7FY _ICQ_VW^2!H5,5NS4^=I26.)%SL=/GG7U)1,
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MV'[,\VT. ,"5RLZC29G[-&3\0I6K&^F*-10NWU@=>HU00F**=N\[2$MUW[
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M]GIZ\(W# IRV".3 >T?4-V:RWJX4ID)E0U2V3J2&3UZJI,Q]RMQ^S//M# #
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M^NS\J$+]2,6,F_6U!;VNF;UHA0:,F*(*]2)5IG8;M>HZ7&-GKM#&K .>?R
M (*!E=*>OFB].O>;Z-I4E*H1H:[]QVA)?*+V!]B-C2^^^-*MF$W+\DTVNL>H
M:(6F*EHQ5/5;]M*,Q1O<9V%E)@  !<=6;UH5[^B8&7JG6G-W'BY3LX4FS5KB
M%G]\^-''7D\7OG98<&+&_#@U;A6MTK5:JD35YNKDF_M8N[4-&2PB!0"@H&S(
MV*L%*]+4KM=8%2H;HC*^\W#]YEVU8/EJM_CCRP"MXOUCC\-'CVO9RO7J/G"<
MRM=MX[J2U0SMZN94JY*W*WOG24(*  #\ '8>S=IY7.-FKE"3J/XJ5R?2%8!H
MWJ&_QDU?J)PM.[V>#C N&+OV'M2<):O4/GJX2E0-U[LU6JAN\YX:/'ZA"^3R
MK < @!\F=\\I)6?MUY#QB]2P96^5])UKK1IG5/>AFKD@7KM]Y^)SQS7CIBU4
MCX%C7>O6<G4CU2YZC";-7:U-V0<]_S    0#:]<U>]E&]1@R354;=W(G;KMH
MGK-XI?;L?\^CR_>O']9^;-^!0XI;G:S0J#ZN<H5=V#?O-,2U'N.!!P  !<L]
M%-EQ7#$3EZAZTRZ^>4.$JVPQ>/0,9>1L<VU" W&<.OV!AH^?HU+56[C5IB5K
MM-3 L?.U=O,NWUSHJ.?;%0" JU7ZMJ/:D+G/A17?+!NBPK[K^!*5PS1IYF)]
M]OGG^N*++[R>)ER6L7O?08V<.%>-6O5TU2_*UXM2AS[C-67^.FWD60@  #\*
M"RHL2<C4D'$+5;]%+[U1IJ&J-&JGMM'#M'Y3AM?3 <8%P^XC]1TV676;=745
MRNT^DSVGLN=5&71< P#@1V'//^;&IJCWL)FJWJ2SJWI=HVE'10^9J.PM.\X[
M-U\S=.Q,=>@UPJW K=B@G;H.G.PJ:6W.?<_S#P( 0##(V'94"U:DJN_(.>XB
M^9UJS=2JRR!-F;-,N_8>\.CR_>O'QY]\JBT[]FCNDE7NP8=-,JHVZ:1._2<J
M+C'7\VT) $ PL$H($V:O4GC[02Z 4*QRJ*('C]>:I-2 :T]FU;T^^/ C[=RS
MW[50RZ_B726D@\;,B'?MX;-WGO!\FP( <+7*]LT;+,@Y=.)BE:W31L4JA;DP
MY] Q,USWC],??.CU=*% QW]]<Q'K*I*[=9=Z#!RG"O7:G TIV*(8NY=AV\?K
M_00 P-7 %IXFINUQ0846G8?IC3*-W/..>LV[:>F*1'WRZ6?NO,SP=GSYU?QH
MPZ9,M>H\2&5KMU(AW[YJU+JO)LQ)T*KD;53A! #@1V+//U9OVJ%)<]>H4:LS
M1;)*UHA0BTX#M2$ETQ71LDXI-J[I/62".SF7JM%"54(ZJL^(69H?G^H>I'C]
M00  " :VHG')ZDP-'K](M<*ZN8H0S=KWE57+WKYKG\>7\^</:]&:GKW5M6RM
MU[RK[[TV4TAD/PT8,U\)&[=[OBT!  @&=B-]UI(D=>XWT:W<+%JQJ3KV'J'%
M\>L";@&(W7RP-N]V,Z)MCQCW *=$M>:JW[*7IB]>3Q5O   N SO?3IR3H'H1
MT2I5LY5>*]5 W0>,U:;T''>>OIJ'A3CM@<CFC#Q%=!B@PF4;Z_72#5UUL-G+
M-[KG(#F[3GF^CP  N%ID[3BAY,S]ZMQ_H@L&FE(U6VC&_#B=//V^[[S\N=?3
M@Z ?5HG= K7QJY-5.[2+6^#S6LGZ:M$E1G'K<Y6V]0CW:P  ^)'8.35S^W'%
M)>8IHE.,FQM9M?+:X5T4MSI)I][_0)]_?J9+RC6=>H]06%0?O5.UF:HUZ:S!
MXQ9HZ>HLU]K5ZP\" $ PR-QQYJ0]<NIRU6G>0\4JA:I1RQZ*&3=36[;O\?AR
M_OSQ_@<?*2DE4\,GS%&MT$XNA!'>8;"&35JB-2D[/=^6   $@YS=IS0O+L6U
M1;4%($4J-%54]Z&:M7!%P"T L<H.5H4S-B%)+3L-5*&R(:K4L+U:=Q^A^?&;
M/=^6   $BYE+DM2ZVPA5:=1!KY:LK_;1PQ6_)MEWG@ZL!2 _]K" PL'#Q[1L
MY08U:ME3A<LU48FJS=6B<XR6KLER%3$(*0  \./)W7U*:5N.J/_(N2I7)U)%
M*X7ZSKWA[IE"WK;=.G'RM-?3@Z ?5JQCWX%#+EA;N4%;=U_IW>HM7/!V7>KN
M,_.C #B6  "X6MC\R+(45IBC3*W6KD-(U9!VFC8WUCW3L0R&C6M:=1ZH!A%6
M]2M,-4.[:L3D98I?GZ>,;<<\_Q    0#6YFZ:N-VC9^U2O5:1/LNF)NX@&3?
MF$G*V;+3VZOY"\:ITQ]H56**^@V;K&J-V_LN["/4LLLPC9X>YR[NO=Z6   $
M [O@7[0R70-&SU/=YCW=!;^UWI@T:ZGRMN_V>KIPWOC\\\]=^](YBU<JO%U?
M%2[?Q,UW+("Z;$VVY]L2 (!@87.'7K[S;[V(GGJM5'W7G6OVHI4N3'$U#VL7
MGY&[71-G+E'-T$XJ6C%4E1MU4-<!D^DH @!  ;%G'J.FQJI!BUXJ7;.5WJX<
MIAX#QVGENDW:?_"PU].#H!_'CI]22GJN8L;-<JW4K>.:=7KI/VJ>-N6\Y_GQ
M P# U2@I<[][IE,GO(=;7%J^;AL-'C5=B<GI.GK\I#M'7Q/2NJ=J-.VHHI6:
MJG9X=Q<@L?1GUH[CGG\   ""0?;.DTI,VZ-I"Q/5L'4?%2[?6)4;ME6W 6.4
MD;/-X\OY\\?)4^]K^<H-KNV:O<=2-5NJ7:^QFCQOC3:D[_5\6P( $ PLQ&D!
MR)A)2]2@96^]Y9L[A+;MHU&3YRD[;X?7TX7SQF>??:[4S#Q-G+E8C5M'ZZT*
M3172IJ_ZCYZGV,1<S[<E  #!PKIO#1PS7PU;]7'MU&UQA2T R<S=[O5TH4#'
ML>,GM7+M)O4=-EF5&D2YQ:B-(_MKR/A%2DQC,2H   4A>]=)S5BT01UZCU?5
MD(ZN<(5UYY@\>ZFV!-CBTV <5H5S4=Q:=>D[RC<W:JZR==JH6<<A&C,C7JE;
M#GM^_   <#5*R7G/93+;=!NI<G4C5:IF"W7H-5QS%Z]RYV8;U]0([:3R]2-=
MY8YZ$=$N0)*4L=^5R?;Z P  $ QR=IW2INR#FAN;XAXDO%DNQ'?1W$KMHH<I
M+7NKQY?SYX_C)TYIP;+5:M]SF"K4;:,RM5NKZ\#)FK4L6<E9^SW?E@  ! ,+
M<5H'C3$S5BBD33\5+M=8(:UZ:LCHZ0&W ,1"G!M2,C5LW"S5CSC3^CVTW4#%
M3%BL%1NV>+XM 0 (%K'K<C5LTE(UB>KO0IQ-(GMKQ,2Y;K'%U3P.'CJBZ?-B
M91W)[ %)V;J1:M][G";/7ZODK .>[Q<  *Y&.?F+3R<N4?T6O5SABKK-NJKW
MT(G:G'%USSVNA+%UQQZ-GC)/86W[N"JI51MW4O?!4]USGO1M1ST_?@  N!JE
M;SVB!?&IZCMBCJHUZ>S.P2&MHS5BPAS74MW&->7KM5;)&A$N,-*@92_-6;9)
MFW,/N4")UQ\  (!@8$&,M"U'M#@ATX4:"I5II'>JA:MEYX%*R<CU^'+^_&$5
M+&;.CU.+C@-<FXVR=2)=.[:%*]*T*>>@Y]L2 (!@D+OGM%9MW.["!TW;#G37
M\[7#.BMZ\'AM#K"YPZ>??:;5ZS>K;\PD]QZ+5@I5BR[#-';F"JW>1 M3   N
MEQ5)6]WY-[S#8!?B;-"BNP:.G*;DU&ROIPL%.G;O/:@AHV>H9M..[@%)E9".
M&CAV@9:NR5(:E:8  "@0=M]B7>INS5J:K/#V@_5&F88J5Z>5>ZZP9D.JOOSR
M2_W7ZTE"$(_T[*WJUG^,JC9JY[J[6*&OT=/C%+]^B[)V4.@+ (""8!W1$S;M
MT/C9JU0WHJ<[!U>LU\95QL[,W:8O?/.C:XI7"571BDWT>ND&:M2ZCQ:N3%?&
M]N/*W7W:\P\  $ PR-MSVE7 CDO,<P]37B_=4$5\Y^;0J-[:E!98#U..'#NA
M2;.6N':H)6LT5_EZ4>H_:JZ6K\W6YKQ#GF]+  ""@<T=UF[^ZF&(;^Y@"T"J
MAK13A^CAKNIE((U//OU,<:N3U:7O:%4+::]BE<,4%3U:4Q<FN@<Z7F]+  ""
MQ>I-.S1EP3I%=(YQ(<XZX9T5/6B<UF_*\'JZ4&#CO__]K[9LW^.;(XW0VY7"
MW)RI=GAW3?FJ"B?=R   *!AVW\(J.EI0(;+G*#?W>+-LB*HU:J>E\>O<@D\+
M<C(N_[#Y45)*ED(C^ZA8Q5"]4;JA*RZR<*45ZGC/%1WQ^O@! .!J9.?8U*U'
MW#G7NJ183K-PN1"7"4G:G.6>I5SS9KE&ODE3([WNFSQ9&S9;@9JSZZ2;7'G]
M 0  "!9VTEZ9M$W-.@[1:Z7JJU"9AJXMJIVP VD</GI<HR;/4^WPSBI1-5P5
MZ[=S[5 3DK>[$N!>;T<  (*!7:\G9>[7HE7IKJJEJVA1M[6KXKTN.=WKZ<)Y
MXY-//M62^'6*[#9$E1M$Z>W*X>K8=X+F+M^D#1E[/=^6   $"UL\,7O91K7N
M/M(%*:HU;J]V/6.4D)CB]72A0,;GGW^N$R=/*W%CAB(Z]%>1"DU=)<ZF[09H
M?OQF96P[1D@! ( "E+WKI)*R]JOGD.DJ7:N5BE8,5?FZK35E]E+M.WA8'WSX
MD=?3A: ;%@XY=OR4%L>M4YWP+BI2T3<_JA*NJ)ZCM3)IJS*W'R<C @!  ;%S
M;-;.$XK?L,45NBA9HX6[5U&O>5??N7FM=NT]H&M>+5E?^1I']E=<8J[G;QP
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MQPL  ,$@8]M1M\AEV.2EJA':526JAJMAR^ZN&B<A3@   @0A3@  X ]"G
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MXP4 @&!@Y]STK4>U8$6:&K7NHT)E&JEXE3"5JAE!B!, @$!!B!,  /B#$"<
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M@3$(<0( $#@(<0( $, (<0(  '\0X@0  /XBQ.G]/@  (-@0X@R,08@3 (#
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M @  ?Q#B!   _B+$Z?T^   @V!#B#(Q!B!, @,!!B!, @ !&B!,  /B#$"<
M / 7(4[O]P$  ,&&$&=@#$*<   $#D*<   $,$*<  # 'X0X 0" OPAQ>K\/
M   (-H0X V,0X@0 (' 0X@0 (( 1X@0  /X@Q D  /Q%B-/[?0  0+ AQ!D8
M@Q G  "!@Q G   !C! G  #P!R%.  #@+T*<WN\#  ""#2'.P!B$. $ "!R$
M. $ "&"$. $ @#\(<0(  '\1XO1^'P  $&P(<0;&(,0) $#@(,0) $  (\0)
M  #\08@3  #XBQ"G]_L  (!@0X@S, 8A3@   @<A3@   A@A3@  X ]"G
MP%^$.+W?!P  !!M"G($Q"'$" ! X"'$" !# "'$"  !_$.($  #^(L3I_3X
M "#8$.(,C$&($P" P$&($P"  $:($P  ^(,0)P  \!<A3N_W 0  P8809V ,
M0IP   0.0IP   0P0IP  , ?A#@! ("_"'%ZOP\   @VA#@#8Q#B!  @<!#B
M!  @@!'B!   _B#$"0  _$6(T_M]  ! L"'$&1B#$"<  (&#$"<   &,$"<
M / '(4X  . O0IS>[P,  ((-(<[ &(0X 0 ('(0X 0 (8(0X 0" /PAQ @
M?Q'B]'X?   0; AQ!L8@Q D 0. @Q D 0  CQ D  /Q!B!,  /B+$*?W^P
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MKV>??\&]/ZOX^9.?_$0OOU;853_U>IOBZD2($P  ^(,0)P  \!<A3N_W 0
MP8809V ,0IP   0.0ISP5/;.$UJ?NE/3YZU0X_ V>O&EUW7WO??KE[_ZM6NQ
M;4&YPD7?<4&^,9/F:=FJS>[KSP3Z3IY]':O,:*' Y:M3-6/^2D5VB-8;;[ZM
MN^^Y7S_]Z4\O:XC3@H'6FKO8.V5<,+ @0IQ9.XYI<?Q&]1XXRH45;[KIYXY5
MGPP);>TJ4]IV\GK_?I.4[/V^?;7";8^''WG\HA#GG^^X2^^4KJCN?6*T:D..
M<GS'BH4OO^E82M]R6,/'S53EZO75J&E+5SW3CBW;7KF[3I[WM8M7;'(57 L5
M+NY:MO_ESKM=5= >?8:YD'!:WJ%SOOY,T#AV=9H+S[:*ZO954/AV7?^SGQ'B
M1($BQ D  /Q!B!,  /B+$*?W^P  @&!#B#,P!B%.   "!R%.>,J"<K,6);@V
MV,_]\T7==---+G1I;K[Y%CW]S+-JW:Z[9BU<I8U9^[[SZ\Y9O$9MVO70JV\4
M<2W-WWZG[&4+<<:OS71!P!(E*^CW?[BM0$*<.;M.*G'S=DV?%Z^Z#<-=2W5C
M;;[[#!KM6I9;JW"O]^^W[7NKOMJIQP ]_N3?+@IQWO77>U6I6EW7)CTQ];M?
M+,Q<L$HMH[JZJJPCQ\]RP<L+O\:JN%HHN'Y(A/O9%L2\Y]X'W'$R=O*";]SN
MMETM?&K;W?:G!8X)<:(@$>($  #^(,09O')VG7!=*I:N2M'\98F:O6CU)<U=
MLM8MDDS*V.VNC[ZIZT%2^FXM6+[^&U_/K/!=;UN'!%M$=_D_^TFWN'-3]GZW
M#5)R#BAOSZ4_$RZ_/-\QEK'MJ#OF[!C]MN/I4JSK2-;VRW^, 5<[0IS>[P,
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MJ=?-#W&V[]+77:=>SH5M%N"TGVG7?79]6^3MDFZ!I55PM,X*A#BO/(0X@<!
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MBG<72N(,CQ\E<2H4"H5"$3Y0$J<B),!HQMF*$R25AR3H@*$(J1%50Z^C.RG
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M")*]_?XU:=[65*A47:J017U7[?_C%T8T@00.$M-9QQ"ZX+O)]PWUXU _3ZB
M0C;$RVS9<_JM\H1  (DM$F>P_7WESG=";"2V@_\=GZXWSN7UZ_I;5V+#SW9,
M\=_GLN/FJD.1W.#;)GS]M)7D N)'M)'C\;EGRI3%Y+"_HY(=*N_L+R'J0G1C
M/^=5Y21V@=! Y^[]),9%G,;[+%R3F 'SZR=/S$[Q[N#.HU_,D=/7A1C,/,N2
M-9O$,OQ5=6/ND&CST4<?R]SE.U3?[FNIBD;"6K#:A-C-E=O?23R6?>_678E/
M7")6TZEK;YGKQ'R(87ECYQ+K+%]9A#ZP+T(]'N$*)7$J% J%0A'&4!)G> .%
M&!00,,B\Z@@.@SX?&T-9+EC Z<I&'64^,N?)DH?<Y.X-,7+5QEV2U?6CQ_$.
M\0^E"#+?"21TZ-)+LNDA5/)[C,>X2)P8%QB_.",>1,KKX^ G@Q#G1?Z"1<3H
M_?##%*)^@.H!S@R(IUZ5B=/64$<) A(I993B(G'2=N[7J]^0&&WB/F2BT6;4
M1.EWU#9Q_$*$\QY7H7)U,V+,U* Z4T)!XJ3/"4*AA(A208W:#421%,,(AP/&
M$$$8B&TX0V)3'E429V"LWK!+2H9_EBM/G"1.@@N4-D,I%^5+WS9R#<B+!XY=
MBBJ?0LET5#&8*^XX" VI[#M!, ?%&.;RW>]^E[F-*@KD<6^)-8B2*+W@.$2]
MU]M^RKB@R#MTY$0)0"4UB1.G)<_#&*&PA1,BAWVG<=XQ+@094>.8.6^%*5FJ
MK#CG:#]D54JO0U9UUX*<2=M0!>4=X)VB[W$"\AU@[E."@V?DF[CKX%D)^*"V
M0LDX)7$JB5.A4"@4X0,IQ?OC?\K>AR2O<A6JR#XA@]VWDC#3H7,O2<@B8, ^
MB6"8UQ90)"V4Q!GZ,5 $%]C+V&K[CUX2A2?GM_CJT1^$_(?_ OM@[>8]$FPG
M& \V[3@L1,]S5^Y+@AK*6O%12N+ZV-R7K#T(^6S+KJ-1U\0?@NVRQ]HV^'&P
M[?R5*<2/P3'NO$#8N/V@V#Z4G.9;&=\^@6C _0_8]M&>=5OVFE7V>I!.N.:^
M(Q>$D$ BG2MQZLZE'\Y>OB?J4]CD@=J&GPR;%1\(UXWK6:BX@EU\[^D?I7T$
MM>,Z9X-M*VK-]#>)R*Z-^-ZP.8^<N2[/Q[BB((FO@P1K$GF?):"_(,E"!,7^
M9KZ0C!BL^4E;(0@S1S=;NRBN9WX5T ?X*=R]\?WQ;]1C&?= YZ%<AL+<H9-7
M19$.'P$^M_C>%U(NB:[^YCF)R =/7#&;[3O(?59&SD/F#SZ TY>^D:1T5>!\
M^Z$DSO#X41)G!/!#;MQ^2!(,2$; M]ZZ75?QY<Y>N"KJ^[9T]5:)R: F1U((
M @HMVG24> 9Q#4CRL8DIO.U R(-UDU@"-E]<)$YL1.)$))H0WT!-FKA24$B<
MUIYD;X-R(3[VP9^/%=^V;YOP33/>Q+9(:$&-D..IT$45"<07\&'G_"R/Q)KJ
M-F@B9%W(F,31G'@)R0?X[Y>OW6[:=NQFBA8O%>U9E,2I()Z"RCA^D65KMIFA
M(R>81DU;2_S-=UXR=R 5D_1")0&^/?A+2(AY]#QX,3J2:*D^,'#(:(G1L#=+
M[+4>/O]+1-+<O.6F2X]^IGREJB+(H23.A$%)G J%0J%0A#&4Q!G>8--,]A-$
M)6]&G</H\=.3O UL]BG-@$'H)2VA3$ 9+A3L,"+=\01/<1;/L)OH@H6+"CG*
MD3&]Q\1&XJ0$,DY[W[;@!*9,-(0W%"#=\63OHQ*)(Q9#UAU/ (#2$@T;MY2L
MQ+A(G #R%^6[?-L$@6W8R(GFQ(7;XORGM 8$UD4K-HJR@#N.^V!L=^S:.Z@J
M"DE)XJ2T%*6C*37PQ8'3$G0!$/O6;-HM2A6H74 0A+Q9H% 14?V@C!@*G 2?
MXKJWDC@#@X!'/?L>Y!%#^KTX2)RQMQ&G$^5?"(#QGA%$1,T6IQ!_\SV^3OTF
M\@[S?J)$A8%_[-Q-&5N^.[['#['C]^)/OB3.?TD@$!*PUW$6;!(GY%$"-'PW
M&C9N87+ESB>9T[R;)4J5,]/G+HL68$/AU)%CDR5+)NH;9'H2)'+'$)3#@4"&
M*4XNUX8\^0J(\@JE:[SE YF?9+&2&>TEN2J)4TF<"H5"H0@?0*:".#1@Z"A3
M&06NDF4D*$$0C-]#[- RZJ\?2N(,_1@H%(KP@"NG/FO^"E%I)6A^_9L?HOFS
M% I%<* DSO#X>==)G,0?OO_EOT7%&]\J!'[\F<00\#/BU[_]X"57!K\N_EQ\
MO+WZ#16U[<Q9LIH//OC0O/?^^R)8$<RXPYL&Z4]KSQ&_H#)37"1.=QXB(YV[
M]Y7^AU09#!)G5)O^_&\1 D!EO7GK#C'C+^G2R^\7+-T@"3GXL#F>A <2$!$%
M29_A9;PK=9J/S&>Y\HK*.O.#8[V)"Z<N?64F35]@ZM1O'.U9E,2I\()8$H1G
MW@?(CC'(Q7:>E2I307PEQ&]<3"EH][=SEM@*B320T1'CH?H9%0Y?]=I\,U&"
M;].AJQ!1E<29,"B)4Z%0*!2*,(:2.,,;\Y>L$T6X#S[\,(K<];I)G,C<4P:I
M=;O.L@%V]V9C#$%JSJ+5YHF'Y(0*'L0G%##Y^\+E&R3;T4NN2BR)$^(<)9%:
MM.YHLF3-'G4\AC<JF1 .O:6^0D'B3)8\N:B$8I!XR7>OBJ0D<5(R(5VZ#'(M
MB(.4+P-D!%>I7ML4+E)<%(P*%BXF3J+A8R:+F@$D/,;Q83RR\I3$&1C!)'$6
M*59"E"50CL1Y%!>)DQ(\9%;R?O(NA#.)DR#7G0<_2Y8E<Y(R'_036<J4'2*;
MVNO,\I(X.2YSYJS2/J^3@')X9+OGRU\PVO-"0">C&4*FM\2?DC@CWV<E<2H4
M"H4BC,$^G;T:>XUMNX^+"AC_/7+ZFOR>P)R647_]4!)GZ,= H5"$!U $/7/Y
M&TD<))!-%8F(LM[_#'G;%(JW#4KB#(^?=YW$B>\4=6M\P)1/IY(7RHLUZS0T
M2U9M$3*2UP>*7Q>U.>(R^%0G3U]HJM6H&Z4@^:Z3. '^Z>M?/Y.*2?$E<:(&
MV*OO4%.D6$GQ*P>5Q/F7_XNT0Y^9SMWZQ$GB1*R XU'-1OU\Y+AI$A-[&?=)
M;M+8-E+UBNI3Q'Z\5=!0_YPQ=YG$H+SEVY7$J?#BA?WVG+MZ7Q0YB37Y$W<A
M/CMQVGQ1*7<QI6#=_RLI[7Y-$I80S2A9JES02)P0FU' 14R'*FU*XDP8E,2I
M4"@4"D480TF<X0W*9GBEX'V!<8?!^O-?DJ[T#Z3(4Q?O"&$4 Q@#$E70U*E3
M2P8H9*\;WSR7[$>,U:M?/17)?9S1*'@2,/6]9F))G#@T*"G2R1K"WNPJC--&
M35I)J63*<KGC0T'B=,"Q0MFN8(U#4I(X(TIKIS:??IK9Y,U?4/HV9<I40GSS
M'I>_0&'3JEUG,?IP@&#4Q;?]2N(,C&"2.%',A6#KCH^+Q(GC$-*U.SXN$B>9
MP;SK7B+GZR)QWK?OW:D+=\1Q!:G8'8\#LW29"O*.'+=MQR$'QDR<*09[5B%\
MOV?;D\)DRY[#S%V\1MY[U$^NV>\0&=AITJ21]^DE&;:DE,?S;;.2."/?9R5Q
M*A0*A4*A2""4Q!GZ,5 H%*\'D"8H0P]9$WO[PK6'4ED&?Q6V-*2<]5OWB8(6
MI=1)Q/1-EE0H%,&!DCC#X^==)W&R)NPZ<$82R:EV]6&*%.+3;].^J]ESZ%S
M\U@;2&H_>OJZ&31LK"E?L9KYY)/T2N*,!+&B]IUZQ)O$>>;+NZ;?P!&F1*G
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M$*80Y$J^B\7YD?@],5D6+\Q;O%9R'7Q?XV:MQ9G/.0Z.B6.C_#QP:&QQ_G"
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MEC;MNYG"14L(/$PU*ZJOL="$:E67;GPI;IR^G!\!Z0  Z0/D*'KW&R;7COP
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M DX"A0$PXEH'&$=,EHIG)R_>,0^__G,T)\JGW_V/5-&Z<>]; >R<WQ,OQNB
M\M"XUN%6"&3I'>_$K*%+][YFSL+5DK? $9-C FHDST/^)$N6;.;3TN4$G"*.
M/7CX>+-LS3:I?C1EYB*!)G/GR2>0*/ @,!; %CD87_%RW!>)IW)<Q+J!UX#8
M /-P%MVZ^[@ KDV;MY7\%\>0*7-6*1O/]Q,#Y[WZK0]'SC<!XB1&31O1ON2K
M@ K=9AKDP!HT:2&+0-QY+W\0IP/)X8P)D+AEUS&! G%\]>23WI&^ <2( R*
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MCT2W>[#AK2^__:L\8'E1[=Q_6MJ1ERQM&]O*')5O/96RP=_)BX;V#*0_LA*
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MRHI[+.U%WL_9WA_$6;]1,[-QQV%Q4@<@=;8/!.($T-RP[9")Z#-$KK6[7^)
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MZ&L K>ZRZN^^^ZX ;8Q#>/<!VWYE^YH#4SKM2M_H'C'0)TSX\2=YI4P$01E
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M'#G7;MXK$WF"?RU=[=A_R&B!,G<=/.MQIG4%$KQ%0(KG(>-\SHUQ-+ X]R
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MO73S2.EZB->W?62Y??!28OS!5W\R7_WX-SG?Q[B/VH=H;SMP^.CC3^S@H:A
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M@CB!)V$? /6 U]Y^.X7Y#WO^SO9-FK<Q!XY=$CB38^C<O8^<FT*<\5-20IR
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MQ 9QPFX0?_"5<Z>MND4,D'-S.YT"Q +0P9VD<8&/M"NY?T!'-_09B. I8!.
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M&3ENFHP1,:1B+!C?OL38#19BMI12;RE&4.YSX3MP.^1<**%.-5K<"FO6KB\
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MN+8'NN,<[S_[5:IWPE7 -F!"Q'L(\R;*@..D=_#$5:D<"93J./=A*@(; /-
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M=<"WE"E320!DVNPE=L)W0U:H.ON]]^07<]3^SA_$2<D0]NVLTB2(L__8)9E
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MP'6X8Q(T!YITRAQX3^8 #<N4JVCJ-6PFDT5@0DI5,ZF>-7^EK$)MWKJ#P(0
MG+Y6KC+A9F*&RR:0(C ?K@L$[@E",&$'H,-1<,VF/5*R@NT(HK!2LKH]1H(D
M' /?PVK,VO4:28!!RG3?_%(FZ,XYLN*29,*259LEN2#E,KQ*:J.\^0J8^G:?
M3%99'8L[)1-/ BF;=QXU@X:/D_9A-:>X?I8L+8$&RDH 'W+^'"L3>\Z/XP*D
M8QM6L.*V.7OA*IFP7[CVR$[JG\A*6U8E C4"?<8$+?/*N4V9N4@ 059]\F_*
MM[!:U/T98#TF[P1$F"B/G31+OA>7R1P^8$("#)P# .F6W<<BG2V  P<,&2/G
M@0,DUYQVKE._L5QSW$%]B6 )UQ\X=^FJ+>:$[1=<1T!8!^(DL$5P:K!M)UQ5
MYR]=9_O>-/ELRS:=3)UZC4V%2M6DW6BOM9OW27 AT'Y]^]$/\GW39B\5\)%5
MG;A; J7Z*HGS_OL9)?B&JRMM-GW.4NG3?#<!%U;@TM]RN<K71P:STF<0H)95
MT5Q_CIN@ T&CM#[<; EF ;+.6;A:[C_GF D:DL!B53#]@E(P5>QQTR^Y'UEY
M30")>P&W3@)U*];MD, , *<'"OV7K)JFCW$>]%56BM-/^%[Z-RN?66'^]*7C
MK"IY2R%.E4JE4JE4@4@A3I4J_!3*$"<Q%R !%F_ZJB""2]C@$>-E?H^K5;#;
M4J4*5RG$&?QKH$H:B?G KQY#"<PFQDZ:+56BB*/ZBM4[PK2!N"MQ;$PFB(<?
M.'Y)H$(WC.A\QY*5F\74 E,%9Q_$]LFM '"RN-]S'#]);'[C]L/R&0PIB/,2
M[W7V%RC$"3A'">N>O0>)48:3\^'81XR=*G%E9UMOB),V(!\R:OQTR0&Y]_DJ
M($[B[3L/G!:#$3=T"+0Z;=82<4>EM+N34R*/0LEWC#%H5\!9OH=S6+9FFVC]
MUOUB@ "\RC[9YM3%N^**6;9<)?/..^]*'H4<6(<N$6;YVNWR_<YW>T.<P(BX
M;I*G8%^XDLY>L$K&+9@O8/B!JRK&%("<@(\/OOJ3N%EBV$!.AW&1^SL2JE"
M.,F+5:I2PPP;/5G&CL[VY(#HR[0?U>+(PP#+DG>A/<D)W7692M >',L&>[Q
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MEC9OU<%DR9)-2JQXVFD<E4CN5*A4W2P+V1KP:U*IOE8IQ*E2Q:R ]EY]_+N
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M+2*\-G6:M *=4'+3M;PH#N>X6Z]<MT/F3;A> 9< <B9)FM04*5I"()I-]MF
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MX->F4GVM4HA3I8H9$>RF/.?%FT_%%0J $[AO_98# O YK\.AL4KUVC).XMQ
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M34S7G@/,Z@V[Q:WSS<_!/2=3J8)-"G$&O@]4,2. 3$!"-@D QQ'?9AR-ZGW
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M-@'+2%@Z);8=D<PEAMYWX$B3)V\!DSIU6@'; /QPLL1ET %'65>RQC]RZKH
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M6<:4+EM1W!@ %&?/7RE.F3A; C6ZG[^O$.>/.'!^^*NY<N>%6;%VNQDT?)P
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M,7G&0MDQ[<M[5:K8D$*<*I5*I5*I_)5"G('O U7,"#@.0!!XDXV1)*&!\=@
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M!;H=.FJ2J=N@F>DW>)19N&R#.7OU8?AKR3D]?O-G<^G6<[-IQQ$S8>H\N8<
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M 8921KQW_V&F0J7JTA?<CW7J-PF'.#DVI;DY1TJM<UX8DF3,E-DD3YY"<D
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MZ9=5ZW8*R^/^>L#>4/"Y>JA!A_WO\M5;S>5;GWYG<-@$M.W<K:\X2>+>V7?
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M%Y3LA&2AB%,GUTGP X=)=C825"EG%]ZS%JP4AU 6=P0@@![Y;*!-RIA3>IV
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M,(;K??GCWS_9?<<"ZN2%NP(L<JS_\W^^$9"S:\_^9L_A<Q(HXG6\!U"3,A(
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ML)32H _F+EYM#AR[)*4R<')W;3]WX<0.D,MU\EZ W4#?WRJ5JQ3B5*FB5\0
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MO0YG7>Z ?7P>8!]EM@$%@0<C:[= 0IS.ZQZ]QACM@MP_!0L7-0D2)A0NA&O
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MU99!%."1AR]0)1,&W)T6+%TG 7XF-!GMH/?--PD$K&1 :6K?SV!Y]NK#".?
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M)AL<>^6Z'3+XL*L$*+1MAVYFW]&+,B&)ZCYY9B>B !KT%4 KSJ6 J$P@='>
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MSIVV>'2!BHE[AKDD#F8X<6$4\EKF&+'OY*Y2^2*%.(/C1R'.Z!$0%:Z P'\
MF)\+<?*>VO4:"0"5*%%B4ZMN0S-EUF*/T)PW.9P%8"FF3$!MBU=N$A#QA8NC
MG[MB$N(DML"XR&97& =O$"?QE8LWG@@3D"=O?J\0)SP"8"#EL^<M7B-N?XD3
M)S8%"A61BBK B@Z8&;%]_BG58#?M/"SC-27G&:=IF\/V>' EG%^2)$F$'2$^
M1/Z(SW_C 0AD8^:L!2L%DJ-\-,8AM#=55#WQ&_[(7X@3XROA.FS?P[$0RR&F
M!!B<OT AN188CBV[CDJL"KXBLE@5H!^<"?=0H"'.$Q?NRGU!=5;<9:?:\Z!R
M+ ZC0,I4MIF[*$1,R$Y>O"=MYVTC#15@N7<FSZ"OR_W>UPV;B>E+:%]'/ ?Z
M&@,WVI7[N$JU6O(]@./!),;A50!-85[2V7:'5\&EE?B@I_D@[<_[8%X&#1UK
M"A4N9LJ6KR1EXW<>."W'==T4'LP0)Y7K%J_8)$P2/%&>? 4D5AH:&]5QQ5<I
MQ*D*2A&,8'<"+EDEOB]CTJ1))R7'AXZ<:*[<>>'W\=PA3G[' Q$:G$$&.#%9
M\N0R&>+AU:1Y&QGP>>"Z.W)&!7$Z.V0)K%!"'.@2UR9*BS-A<C\W!E*</]DE
M B IMLKVH<9@X^R41 RZM^S#F]TR&3)DE(&!P1;@\=&K/WD<2 !%F13ML(,K
M@QD3G"LN%M#L,&%!C\,(#]+B=N(T<-@X 3U= 4HF0H"BV$[3CLXY,DB[?A[7
M#>B NRB34QQ(0P?<;?+[=QXF*@QV@*Z%BA27"9XWB//@B:O2CL6*EY*^8L+B
M:=<1[<[DHU+5&C(H J4"=G*\J.X3)F> ML 9G#OW'0DJ2ISY\GZ5*B:D$*=*
M%3/"87G?T0NRL /89XPCN,V"2%T*5$C<*^Q<[,;]-V;WH7,ROZA<M98LP)^\
M^0^_@F\J56Q*(4Z5ZO/$,Y^ ,\%*2B_ES)5'=HZOW;17 IO>W@=\1Z"5DNL
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MA28X:S.'C9DXR^;ND>.FV=_1S8I$-\GU<A6J6NX"T2@N0L3LB9?$\GZ0M$?
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MCF/^80Z.5AQBW<E^^_\L-T'RE?F,>0V7SR;-VY@XDV,35\=P@?E]T8HMEB]
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MMF+7K"JGI;=))^%S]MJ/MXDID\)$-'?Q.DNH$(Q(FS:M>^GE3.Z==\M9X)^
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M6)V3.$ TR ]4I.=C\\QUD#C G9*  E6>_GD0X&_7L:>)06FADAH'SCO.R9N
M5FW:XR;-7&@;?\Z/JMG4OI[D!XZ;5)-6J%S='$MIR4)K\EGS5EH[#2;'7=Z?
M)'K:=.AF01:",C.L]?NY.XY)DHI@"96AB#2Y3MJI$9BBPIBV'R2)UGH3*HFM
M,9_,=AV]<::%'>U*F& 1Z_I5IQ>L3<LE"U+ASHK+)X$6JFS;=NANP0<F;H(L
M,&'J/%>E6FT3BW+/I\Y>:JU;SH>UROZ?!49X/0$0@C(XI^*X2M5LK+\'(KZ1
MB%,((800T2 1IQ#1P5Z7"O*QWIZT]'L5K. 2QTN<FJ@H3^GU!(-)PM->D[UN
MIBRONG2//9;0::/_,!."DIR)E(Q/"F( ! H4>9+4IXB1PE0*'Q$'TKX]Z6ON
MEX@3@<F6W<=,&( ((9*(DWO(/:#(\[6LV4QL@1"2& AQFM!C(N*D12CWNU"1
MXG>(.+E'-[[_]ZW[]7-%G 3Q.2\*0".).(D34#",6#6G-_:T)Z7 M$O/ 6[K
MGN-V/N'&CH UH@=B'H@O*" EIK%\W0Y+S*5T;L1A2KS]K@E4TCSRB&O1NH/%
M0E+CXBG$O48BSMB/@8@?$/T1IR:NCFD%;I=ITZ9U;[]3QDP*4GH]\7;6*O='
MQ/DG]^FBM39?L@;Q19P%$7&NBBSBI,,6(E3F7%S*(QV?ENK//)OAGHHX:>DX
M>L),F\<[]QA@>0$*(C@..04,,&BYCO$%.86LUO[],5?*.[ZM?XZ'+V+Q19P)
MZY^*-F^G]CZ29R O$4G$R7J(]1C7R9J1]5M);SU&84ARQ1Q^)SKNXZNOO6''
M9XSHH$8+>=XWTFM9K_&>Y+4H-GK4^\Q1A%*U>AW+P<7Z>R'B$XDX@_&0B%,(
M(80(#A)QBD"#@._HZ:_=I.D+K44(3HU]/QYI+<W")2*H)B10P6:5UA"X6D;F
MD"4ZHCTG7^E_\L)W[HMSOW5?7OX^65<-!(C\^U=7?["J3H2-5'WZYT& 'E$J
MCI.AE9S1GM.9*]][Q[AIP7[4[]%4%?"^Q\_<M I1VG5LW'[([A\6TP0Y+B9:
MN2,6Q46$A OGSO.I8K@8)CADPDOO^;P>8>VV/<=O'9M6:@A#N?\D>J@X\BLG
MJ"3E-211KB6ZB_#>7"/GR;_M.O"E'8,QI.T,22R.Q>>%(!APG@1VN+_<<^XO
MP9'0-BX^?EOZ70?.N'H-FUMP"!$P+= 0KL;Z>R#B&XDXA1!""!$-$G$*$1WL
M.=FK+UJQV56N5CMJ$6=".\Q_V;Z7HE/$EAE?>MF]]'(F2_@CIJ0@D3WG-ZEH
MJW[XU%43 =*.G1:9=)?(DZ^@[4_W1F@#=;]$G%]>_H,Y:2*<B"3B]&,%="%I
MT;JC>_R))]PCCSP:4<1YZ>9?K<4IXH,"A8K>(>)$,,G>G_T[G4=^KHB3PMM.
MW?M;3"F2B)-8 K&#D>.FN:(E2IF0YN57,KE*56I:YQ'.YT88=Q1$*IP+XLO7
MW\AN@HA9"U;9O0B]YDA0@(QH%.$+;JL4J#(&=U/<*\3/12+.V(^!B!]PJ^'W
M'@=K6C\BQLR0X3F+1Z?&$9'"@Z+%2YH#X[UNITX.@_.JVZ"Y=:I*:*?^N"O^
M=O+MU&,IXL1$@]P"L?V]1\Y;7H!U! ).<A#SEVXPQW1$E<S7K%4>?CA-3$6<
MK(]XCWZ#1IFKZBN9L[@:M>M9$0]YC$C'92W)6@D!,,5'W!_&B#4(ZS/6;9%>
MFU3$R>LX/]S>$>[&^GLAXA.).(/QD(A3""&$" X2<8I PP:>#3>BS0:-/W1E
MRU=QS5NVMV0#+HVQ/C_QZX  !D)2'%((EKR1/8>YD"Y;L]V$NK$^/Q'?2,0I
MA!!"B&B0B%.(Z" 9CC 2-TY:J*=_ZBES522YC; SM<<A&<\Q1HZ?;ETH:,F.
M@U7M#QJ[R3,76R$B8DN*(&^&B#G9CR+P1#")\]+L!:M=AZY]3*SXTLNOF,"A
M5;NN)B;DM:&%GPFNE0DB5-P@<7)"!(+#5,^^0ZR(DH+/I.=*N\VAHR:9:#7#
M<\^;Z(+_IYB3&(S_/,291T]?MV/3=C3C2Z^8$]?@$1.MXP@B"40HB!8IKFS5
MKHM[X86,)@AXUCN/]IU[61$K;F-^X2E%F8A/NO08D-#.],GT+ON;N4SH@+,8
MQ:(('\YX]P-Q)?OT#^HWM1;M"2*2TB8 X7XBVH@T'KZX=O:"5:YNPV;V7K0<
M98QQ3>6>W1H#[WF,#>+9!DU:VOCC?LIK^@P88:(+"DH1>(2VP./:>O8=ZHUQ
M0Q.:<+U\!BA*32I("0<B5P2_B'#2/_6TZ]Y[D(E30L= B%\*B3AC/P8B?F#>
MI_@#T5VQ$J42A8)9;2[$!"&EUR]9M<T$GP@A'WTTK<W/18N7\N;RR6'-%J*!
M]0A"0M8(F;-DM<*&C!E?=I6KUKZM8U601)RAKZ,0@CF>=<*BE5O<)]/FNX%#
MQUFGM^JUZEFA2_KT3YGX-98B3M912U9OLS7?&]ERV'76?+^^=2M+C?'(?&\O
MA0-\MNPY[5H0= X9.2G9ST]2$>=O?O,;XW7OGLR8NSSFWPL1GTC$&8R'1)Q"
M""%$<)"(4P0:$A(X+^!:0?   6>9<I5-8'?PB\LQ/S_QZX#$#U6JDV<N,M>4
M=\M6LL %2:;4N&<(<3^1B%,((800T2 1IQ#1@]@/D1XBO)=>>L5ER/"\RYD[
MKYO^:>H3VM:R\\:?S65RS">S7(,F'[H<.7.[W'GRNTI5:[D>?8:X):NVFN Q
MU$$29TJ*!TGLLR=MV*2EM;;,7Z"(Q3\^'CK.1 MTP4CH5/&3 !1!(4)'G*=:
MMNEDXL,GTS]EPH@V[;N9\#-<82*NDUPK8@O$@X@OFK7\R 2DH<Z=-TQ@^G=S
M]7SRR?3>L=.[EU_.9.U*UV_]W)X_:OQTMWS=3K?WR#ES"Z4-.8Y@B#X1HG;O
M,]C<G1"(SENZP=J=TNJT>JVZ+E.B^.2YYYXW 6J#QBU-@$(+= 089RY_;^Y9
M" UPQJ3M9\[<^<SQDV,F)U2ALP<"$X22.$R]F/$E>SW'&CIZDHDM_><2>Z*C
M!X(+WTT5]S$$KB6\ZR$&17M;OQ,+[TN<BO;VY2I4M>OLV+6/G1/=41!)A&N_
MGI2^ T>9L!0Q2Y977S,A+<=/C0!4B'N-1)RQ'P,1/R05<3+'YLJ=W[5HU<'F
MZ)1>SSS9N%D;ER=? 1,9/O_"B]X\6MA;,XRW(H.?<VZG+_[.A)FX=",.Y=SR
MY2]D@D:$D?[S@BCB9!WVV=X3)K;$)9O6Z;09;_U15S=\S!37RSNW"MXZ -$D
M]RV6(D[>8\["-;:F8?U&40<&)@.]^YG<_?-)*N(L^4X9UW_P&.\]#D1\C42<
M(HA(Q!F,AT2<0@@A1'"0B%,\$."*017A\#%37=7J=5SS5NW=RO6[S(WS;MJ/
M"^%#D BQYIR%JUWG[OTM&87+"&W:8WUN0H!$G$(((82(!HDXA;@[2/PCHL/)
M"M$"H@&*21'L(29([7%P@$+(.6'J/->H:2MSRBI7L9H)%'L/&.[&?C+;Q(^X
M40)"49Y+FT_:?K]?KXFU5FW4K+4)(]9N^=Q:HX;&/A!OTN*;=IO$1G@>0D)$
MA^G2I;,_RU:H8L+"\9,_=:LV[#91)(E[VHLCRD0H@%@4$2$"1QPNV0\C)/W,
M.W]$C?[[39NSU!4O^:XY?#[[; 83+O8;.,H[SAASY5RY89>Y;")B[-BU[RWA
M!X)+1 \(2H>-F6("SM'>/<4IJFV''M9&_>EGGC4GR@0WSL8F6EVZ^C-S^YHU
M?Z5KW[FWRY/W+??TT\^82('CEO#.!4'&U-E+W([]IV\3Q=*B]BMO#(@A^86:
MM'9'5)KFD4=,2/&^]SXXIF[=?<R=OOA3<I)[NGG741NCN@V:N4*%B[NW"A;U
M[F55BQ,@-,$ME/&;.FN)M4!]_X-&KE6[SMZUKS%!#L*<E#XC_CEVZM[//?30
M0]Y]S>Y]1JJZF7-7Q/Q[(.(7B3AC/P8B?D@JXGS<FZ,0%C;TU@VA0LE(;-O[
MA>O=?[A[MVQ%*]Y(G_YI<_+LVFN@%4#\G&( BEJZ><>A"(4YG\(6A(^L4_8>
M/G?K>4$2<5H[]5/7K.!BV.C)MD9@'J_7L+FM(T:.F^96K-MI<W?]1BU,_/K$
MDT_&5,3YA?<>K">:M^K@7LWZA@EQ*83I/6"$.9BG=/RD(D[.#Z$JZYA(KY&(
M4P01B3B#\9"(4P@AA @.$G&*!P)SM/ 6\^NV'K#6%VV\C3@;<MIJG;_^?S$_
M/_%@@C,&0;.#)RY;VS(24?T'C[9D$<&:6)^?$" 1IQ!"""&B02).(>X.6E@C
MJB293BOTEU[.Y 8,'N,.G[H:E:N5M=J^^1=KC;YVRWYS:^S8K:^KUZB%"3H1
M(.;)6\ $CI W7P'W5L$BKDSYRB8XZ-Y[L(DZ>"WMROW6W*'.CL1($$@L6[O=
M-6[6VD2 ""T>>?11]_###]N?M#-'^$ ;<I+\B!00->(*^EK6;/;OZ1Y[S)Z/
M0R4B21PT$6*P/Z:=JO]^%#GB:%FE^OLF$*45*:*3CSKU=',6K'9[#GUE @J$
M ;ARMNO8T]JN(RA!U$%;<MJR(OADOTW+=.(YW!,<+U]\\26[!SWZ##97*D2G
M"#YQ(N4::+F. !/!8]K$<WV%<\V9VT0LYT/<0W$0V[[_I E0N!8$G+A]/IPF
MC;T>T09C2]M1W$B),_FOY3XCYO4%#CAV<=YY\Q?TWBN/W<L<N?*8R!9A!H6@
MHR?.M&M&Q,IG"(%M2I\1_QPI4.:<2I4NY_I\/-)M"!%W"/%+(Q%G[,= Q ])
M19R/>O-V!F]>KEBEAC<O?9[BZXEE,Z\SCR*(1,1'40;SRM'37UNQ0&H<H</!
MVN/#-AW="R^\Z![SU@G,F;AU,S_S;_[S@B3B/'WI]U9DT;9]-V]^+^_>*UO1
M]1TXTBU:L=FZ;]&>_.RU/[K5&_>XIBW:!4+$B7,W;N,(3EG'L;[B_K$&8QV2
MTO&3BCA9K\R<M\+M.1PY'BL1IP@B$G$&XR$1IQ!""!$<).(4#Q0$Q4FJ#!L]
MQ?7J/]R2(;L.?&E.G3>^_W?,ST\\.! <PLUDQ_Y3;M;\59;@:=6VLP5/OCC[
MK25?8GV.0H!$G$(((82(!HDXA;@[KO_NG]9B>\PGLUWI,A5,)(A(;^/VP[>Y
M-:86Q #$*A XS%VRWHT<-]T<LA")UJK3T%6O5<]XOVXC<X7"*6K0\(ENP;*-
M)NPXX[TVTK&)?YR\\)T)#/H,&''K6)% K+AD]3:W<,5FUZ9#]Q2?CX#RW+4_
MWGH_6K+S7K1.I]T[0@2$#1.GSC/7442)B$40KQ[]\H8Y<B+(;/IA.^]:&[A&
M35N[+CT'V+4A;N5Y)\Y]:S$='#F;M&CKNO3H;__.'AT! GOS5NVZI'BNXR;/
MN:VM.@Z7^X]=,'%EC=KA7\/]QQUTZ,A)WOF?NN/^(DC%!0N'4=J[M_ZHFZO;
MH/FMU^.2BDAERJPEB:WNO[E-_)$2G!]B&,8>42KBW44KMZ1*M"'$_4(BSMB/
M@8@?$%D>.'[)G"%QPJ:@ A$F3M8(#5-Z/6Z;M%UGKL55.VW:=%84P!RU<OUN
M$UNFIJ@@%&+ES*$;/CMH<S=MU!%/4LB "^>.ST_=MC8(@HB3]1#GM&774=>Q
M2Q^[?X6+EK#SQ^62\[CR[4\.V;AT-V_9/A B3IS;:7U.,0I%*=SOU]_(;N='
MO@O!97)"W*0B3MYKW9;]EC^+])JD(DX*7)YZZAE7I%A)^[M8?R]$?"(19S >
M$G$*(800P4$B3O% <>UW_[1@ HX4;'!)5E!AB(-!Z(9<B.3P'3@):M FK5G+
M]M96!;</@CNT8HLVT"7$_4(B3B&$$$)$@T2<0MP=[ $119#@1U2'BV2+5AU,
MD$B+SFB/]\V/_[5D.06").I/GO_.1!6T-=]_[*+;?_2"\;GWWP=.7+)D/RU,
M>2[[55X;^=C_L_;JB!?9U_K'B@3'/G?]C^9"A8@RI>>?NO#=;86R[)%Y+_X>
M]R\$ %P'XM;+W_S5?9W8ZOWF]_])B-M<^<&NE>=QK;R&O3;7=NV[?]CS.";.
M6=Q;GN?_^^5O_F;Q'?X[->>*@/1FB/B#^W;%^QW$X0JQ9-C7>>?$L1&G\G[A
M/@NTDT>@@I"#YR*V\5]_\(O+=M^_O/0'NR\(@*-Q/-NX_9#K-WBT*U^QFGOJ
MJ:>M!?U1;XQXOUA_#T3\(A%G[,= Q _,A<PMN$>6*/6>N2$BY"Q:O)1;N7Y7
MBJ]GKKODS;\X;.-\C2CRX8?36#MN"D(V?'8HV75$I'/"M1)1)6)(Q(L(*'$1
M7[A\L\V7H6N#((@X62_M/7S6'$W?*UO)!*TXCO<?/,;M\*X%869HC#]((D[6
M.GP&*(C)_U;A6VZJ%2HGN+%ROV_^\)^(QT\JXN2Z.![=[)+[W(2*.!'_OI$M
MAQ6WK$C%YTZ(^X%$G,%X2,0IA!!"! >).,4#"<D -IM39BYRL^:M=&LV[;4$
M I67-[^/O+D5@H020:8#)RXGM+:;.L^JB0F0D3 +E\ 1(I9(Q"F$$$*(:)"(
M4XB[ Q$>"7R$!WT_'FEB@ _J-W6]^@\SA\Y8GY_X];!@^297MV$S5ZU&'5>^
M4C43GURZ^5<3YL;ZW$3\(A%G[,= Q ^(Z2@<6;YVARM;OHI[Y)%'3<2)"'+%
M^IVI/@Y.CH@;BY5XQZ5_ZFF7(V<>5_/]!F["U'E6S(#(,:5CF-G!MW^S? OS
M4<.F+5W.W'G=\\^_Z,I6J.+Z>&LBQ)U)7W>_19P3I\YW9<I5-@%E4A$GYTRQ
M!<4E.)?V&S3:Y2]0V+V8\25SX1XU88857"1][XV?'3)W\!RY\KK'GWCBEHAS
MWY'S[N*-O[@;B>Z7/T?$R>L97XIT:G_0***(DVL\=_U/;O'*K5;4\6R&Y]RC
MCSYJKIB39RQRGQ^_%';\$'92/#)MSE)7\ITR)DC-Z5U/?^\>D!OCWR)^[KQU
MQMXCY^R:N;><VUL%B]IU\EF*]?="Q"<2<0;C(1&G$$(($1PDXA0/)#@VL,EE
M,[QBW4ZW9-56$^'1<BR:%E8BOB"(PN<&P2\!DG&3YEB5*8X:.(40R) #IP@:
M$G$*(800(AHDXA3B[F'/>.'K_S/'J2X]!KC*U6I[U')+UVR/^;F)7P_FNE6@
ML&O<K+7[9%I"2WIB$=&X>0IQKY&(,_9C(.('?N\1#.[8?\K5K%W?/?'$D^Z1
M1QZ)6L2)(<':S?M<^\Z]S;'R^1=>-'%DF_;=K  %Q^N4YA8$E+B%K]]ZP#7[
ML)VY6;[@'>?-'+E<S[Y#3,R(\W32U]U?$>>_W>29BUVEJK5=UC>RWR'BM-;O
M5WYP>PZ?=;/FKW(?=>[E<N;.EZ*($X?+.O6:>L=\T\29OHAS]\$SWC7^WMPQ
M?[:(TYO/<6%'^%K#&]M((D[[#'C7L6W/"=>B=4>7RSO_].F?,H%IQV[]W))5
MV\R5/.GQKR<:5(P<.\UERY[#%2M1RC5NWL:<X\F9)3?>O);/!9W)<%M]XLGT
MYM[*FG?+KF,Q_UZ(^$0BSF \).(40@@A@H-$G.*!YOSU/UE[+#;%0#LKJAAC
M?5XBF!#$H-7,R0O?68!D^;J=YLA)8"7:%C-"_%)(Q"F$$$*(:)"(4XB?!]T;
M:)D]=_$Z2]Y7J_&!FSAMOK7:O*!VU^)G@.O:[D-?F>"EY#ME79\!(RR6=3JD
M-:P0L4(BSMB/@8@_B$LCN,S^9DYSTGRK8!$W>\$J=Q9'Q52X,]-1"B'GG 6K
M79/F;5SQMTN[5U[);.Z>O?H-M;4,8L8O+__!C"]\L20"TJO>GN'TQ=^[?4?.
MN5GS5[JN/0:84/&-;&^ZTN^5=ZW:=;:B%MPNPSE"(J)$E(AHDY;<SSSSK,N=
M)[\)2LG7?)WH:ND_GV-P'OT&CG)/>\_-D.%Y$W_V'YS@('DMQ$&2\_MTT3IS
MS<SE'?/))].[N@V:F> 2(>?A4U=-=$B1S>R%:^R8%$<\_<PSKDBQM[U[VM4M
M7;W-VHOC,'K@Q"6W=?=Q-WK"3%>N0E67*?-K+FVZ=':_<5R?-GNI&3X@"N4\
M:(6^Q'M]PZ:MK,7Y"R]F=/GR%W2#AT\T827W+M*88!+!ZQ<LV^C*>N_%^[SZ
MZNNN:HTZ;M&*+9:'"&U+?^S+&V[*S,7>M;9RKV5]P[V2*8LK[8U#M]Z#W)K-
M^VU\KYOQ1((#)\=>O6FOZ]2UK\N>(Y>Y?;).W;[_9(KF%->^^X>-&5W)<&]%
M'%NE^OMN^)@IMCZ)]?=!Q"<2<0;C(1&G$$(($1PDXA0/-&Q,V5C3/@,0<,JY
M0"0'GYFO$P-5"#H)?LCQ0@09B3B%$$(($0T2<0KQ\TAHJ_Y/2_J/&C_#-?OP
M(]>[_W W_=/EUM4AUN<G'EQV?'[:C9TTQW7M-= U;-+2S9JWTEW][N^WB3F$
MB!42<<9^#$3\@2'%T%&37/E*U=U++V<RP>*(<=,2VGO?_$N*K_?CW*Q9<.3L
MW+V_M51'#/CZ&]E-V/GIHC7F^(Q0DCGGVS_^SP25%!9LW7W,39NSQ 22B#=I
MRUVR=%DW8/ 8M^&S@R8@O)%$C.F#>R<B3T2HN'?B)HJ[)HZ3N#U>_N:OMXD*
M<?/D/'#-1+":)DT:ES9M.BN8.?C%%3/K\)^+V)3N65UZ?FSNGKAAOO-N.=>Y
M6S_WR;3YUI4-5TP<)1%?3IV]Q)4H^:ZU(\_PW/.N>(EW3!RZ</DFMVS-=IMO
M$7K6:]C<A)LO9GS9>VY:.^]J-3]PS5JV=Q]U[&EB6.[[WL/G3%A9\_WZ)L+$
M31.74YZ#T)-[%VE,<//<D"B4I#4ZU_F4=[U<!^WJ,9<(%8$R%B>^^L9-F;78
M%2U>RIX+"'('#!GKUF[9[R[>^/,M!T[:QR/0K56GH;5"9TU!\1'CFU)^@_?%
MU *!:,'"Q4Q(:RZ>B]>Z(Z>NQ?S[(.(3B3B#\9"(4P@AA @.$G$*(800 48B
M3B&$$$)$@T2<0MP;$!]L_.R0B05(HI.,7[E^ESOVU4US48KU^8D'!QQ<<0.;
MOW2#Z]%WB!LRXA,W==82<^&,];D)X2,19^S'0,0?B 'G+5GOVGR4X,:9S0-G
M2-P2O[KZ0ZJ/PYKEBW._=0M7;+;6V/4;M3 WS@:-6[KNO0>YOA^/M'7,L-&3
MK4 %X>C'0\>Y/A^/<%UZ#K#" L2,K;WS&#9ZBEN[>7]$!T[$@IMV'+$VZ*W;
M=35GZ0P9GC-1) Z;18N5=!V[]C41Y 9O'86@D=;@%#%TZM[/Q)BX6_[F-[\Q
M$"LR-\Z8N\)MWW_*>]_?F?@3L>3,>2O<!_6;FC@T;[X"[KVRE4Q(.6;B+"NN
M6;KZ,[?KP)?V/HA)$6AFRIS%9<WZAJM0N8;]W> 1$^U<@6MNWJJ]M1!_^NEG
MW"N97C6W3)XW<MQT-WW.,C=_V49[#?<PWUN%K,T]//[XX]:"G/L[S7O>#G/2
M_DG@A%OFKH-GK+U[UYX?NTI5:KHLKV9U#SWTD$N;-JW+G/E5NQ9:O>,BBI/I
M-3.7^(^)*Q&X]A\TVH2C""R+%2_E_7<#:R,_9.0G;O3$F29:91P[=>MG=.LU
MT,[WG#FW_C,5GY._>?=TI3F<YLG[EG>O7G6]O<\;YQVN=;L0OP02<0;C(1&G
M$$(($1PDXA1"""$"C$2<0@@AA(@&B3B%N#?@9D3'#\1WB 4Z=.EM?Z[:L-L$
M!K$^/_'@0-O712LVFVBF5=LN)J X=_U/YJH5ZW,3PD<BSMB/@8@_Z!*%&! !
M88%"1=UK6;.YMAUZW&ICGMKCL&;!O9(V[(=/7C5QXY"1DTQD6;EJ;6L%CM 2
ME\KGGG_!_GS^A8RN0,&BKGK-NB9,G#)KD?MLWTES>T14R/'".3ON/W;1G"#?
M>;>\B0!QR7SXX30F5GSXX8=-H(F8LT2I]TR<B9LFXD5<*7E/GL]S?1%GNL<>
M<\\\F\%5J49;[ZDF<.1]*8"@W7R_0:.M]3="SF>]:T#(B7@1ATW68]Q#_OQT
MT5K7SKMW;Q4H8@)-W"RSY\AM+=''?#++;=MSPHHG<.=LVZ&[>_F5S+=$G!3K
M\&\(,!LV:>4*%BYNYX13Z&^\<WTH$<Z=OT?PRIAMV_O%K?N"@^>X27-<Q2HU
M7?8W<[G'GWC"Q)]<(Z_EOVD+7[!0,;O./8>^LFOTQP\A+HZJ.(MV[-+'VKYG
MRY[397SI97,!11"*\)+W[M9KD)TKCJT(@2.-55)P]!PU?KIW#RO:L7%>16R+
M #2E5NQ"W"\DX@S&0R).(800(CA(Q"F$$$($&(DXA1!""!$-$G$*<6\A*;]Q
M^R%KQ3E[P6IKX4FB_^3YW][6#E.(I"#..'3RJO?Y.6Q.:[,7K#(!)Y\?B25$
MT)"(,_9C(.(/Q',($!'N(:;,7Z"PB0C'3Y[KCIR^'O7Q:*V.6SBML7$3_W31
M.G/>[-EOJ&O9MM-MM/ZHJ^L]8/BMEN0X6N(.F=)[("[%67K@T/&N0Y<^=QS7
MAW;F\Y9L,'$E[X$;*(Z7D9X_8NQ4MV+=3BN>\>\-!0^K-NYQP\=,,>$FKI2X
MB2Y8MM%]?NRB.84B8.2:]QXY;P43@X9/<!]UZF771]OPR3,7F;,IZS8$CP=.
M7#(A)PZE_/OH"3/M/?QV[Q.GSG=]!HRPUX<_U\XFX%RY8;<W1E_?NB\4_JS9
MO,_.#R?.2-?9N_]P:Q5_XMRWMSF=WOP^P9&3Z\>YE,*A[GT&VS6W:M?%NZ:>
M=LZ<+^.U^^!7)KA-C0.G_]G@L\9]S)$SC[5W?[]N8[=\W8Z8?P]$?",19S >
M$G$*(800P4$B3B&$$"+ 2,0IA!!"B&B0B%.(>PO.1B3(2?QOWGG$! )+5F^S
M_TZ-V$'$+T=.7[//R]S%ZTPP@GCSTLV_N*__\*^8GYL029&(,_9C(.(/UAB(
M^O<>/F>"R#+E*KMJ->NZ7OV'NWU'+]SU,1$VLG:Y^MW?K84V!2D(_I+"WR.
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MU&(<.^^"O:>LI(-%3$HN1L:FI5!A*\?KUV_0WCV$Q,Q"7++SPYX3%KA@&XC
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MO,MK6V#I&H*#!G8R'M78,00)6>6H:!R6&S-:?R B(J+M2(U K>L8QXW;#7*
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MN6CLF98B%&YP$!$1_7E#TZOH''Z$Z+02&%KYRJV*O:<LX>0;+2_,XU-SVZZ
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MOW;Q5ET<U#MT=_\(5E;7F4/\PU"=PE1#BM:N0?B&)T/?S!-[=-^S.KLPL@E
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MCL6;&L32\BIZ!^\C)B47!_1M9 _B7[KG<]K8$TY^";(',3#YE#D%$1'M.*I
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MM5JKUEW%A>) !&3OO3<)&\(,,V&&O</>>X4]PP@DC$#86S:(#-O//^\/7GY
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MN>Y"G !^W*HU&RRL05L?Z:CF00"XT80N\M OP.*7KK"1XT^.6Z_5I(,5K=C
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MG$"P$.($ H(0)P              0/ 1X@2"A1 G$!"$. $
M (*/$"<0+(0X@8 @Q D              !!\A#B!8"'$"00$(4X
M     (#@(\0)! LA3B @"'$"               $'R%.(%@(<0(!08@3
M           @^ AQ L%"B!,("$*<                P4>($P@60IQ 0!#B
M!               "#Y"G$"P$.($ H(0)P              0/ 1X@2"A1 G
M$!"$. $              (*/$"<0+(0X@8 @Q D              !!\A#B!
M8"'$"00$(4X              (#@(\0)! LA3B @"'$"               $
M'R%.(%@(<0(!08@3               @^ AQ L%"B!,("$*<
M    P4>($P@60IQ 0!#B!               "#Y"G$"P$.($ H(0)P
M        0/ 1X@2"A1 G$!"$. $              (*/$"<0+(0X@8 @Q D
M             !!\A#B!8"'$"00$(4X              (#@(\0)! LA3B @
M"'$"               $'R%.(%@(<0(!08@3               @^ AQ L%"
MB!,("$*<                P4>($P@60IQ 0!#B!               "#Y"
MG$"P$.($ H(0)P              0/ 1X@2"A1 G$!"$. $
M (*/$"<0+(0X@8 @Q D              !!\A#B!8"'$"00$(4X
M     (#@(\0)! LA3B @"'$"               $'R%.(%@(<0(!08@3
M           @^ AQ L%"B!,("$*<                P4>($P@60IQ 0!#B
M!               "#Y"G$"P$.($ H(0)P              0/ 1X@2"A1 G
M$!"$. $              (*/$"<0+(0X@8 @Q D              !!\A#B!
M8"'$"00$(4X              (#@(\0)! LA3B @"'$"               $
M'R%.(%@(<0(!08@3               @^ AQ L%"B!,("$*<
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M4:*$]>[=VY8M6^9!SDNE@*J>TP$#!EA86)@_MPJ-7@F$. $
M (*/$"<0+(0X;W!JM%0[I$**TZ=/]U!EF3)E[,,//[2''W[8JE:M>DD!2U$#
MI\*3"G JO%BC1@TK5*B09<J4R0.2"D=^\<47EB-'#BM7KIRU:M7*XN+BO*WR
MVV^_/>=V%0K5_FI?^_3I8_7KU_?M9LZ<V?<W0X8,OGV%1;7=Z.AH#WJN6;/F
M1[>G *<"JKKOJ*@H*UVZ]*E]#(5-%0HM5:J4AUD5QE0 4X_O8IX#[>_RY<L]
M4-JT:5,+#P^W$2-&$.($              ! FA'B!(*%$.<-3L%)!0M;M&CA
M#98*,#[^^.-VSSWWV&VWW>;!QF^^^>:2MJGPHL:<#QHTR/+ERV?//_^\Y<^?
MWUJV;&FC1HVRV;-GV_#AP_T^%<!\__WW3[54;MFRY9S;U6AV-7!V[][=]_/C
MCS_V%DX%)!76G#!A@HT9,\;#G0IT?O[YYQX4'3QX\/]L2V/4CQPYXMNK5Z^>
MO?GFF[XO%2I4L-C86&\/K5NWKGWYY9?V\LLO^_T-&S;,=NW:==YFS].? S6&
M#ATZU+)ERV;5JU?W4>\;-VYDG#H               #2C! G$"R$.&]PV[9M
MLRE3IG@PLDF3)I8U:U:[]]Y[[::;;K)?_O*7/EY<P<6+H6"D6B9W[-CA04@U
M6+[[[KOVXHLO>B!RQHP9MGW[=@]!JOUS_/CQ/E)=C9<*25:K5LWFS)GC[9@G
M3IPXM=U0J^7JU:NM?__^5K)D27OJJ:<\J-FL63/??P5-]^[=Z_>M\&B1(D4\
M'/K88X]9G3IU+#DYV4>;ARA(N77K5@]6YLR9T^Z__W[+GCV[M6_?WA(3$_VV
M"IQ6JE3)GGWV6;\_A447+5KD]W,A>IQZ+&W;MK4\>?)8FS9M_/[TV/4\70F$
M. $              (*/$"<0+(0X;W#'CAWS4*)"AVJ)5.CPZ:>?]A;.2PUQ
M*FRY<^=.BX^/]P;/1QYYQ-YYYQW?AAHR-6)=]Z?;*<R8DI)BG3MW]I9.M77J
MM@J3*G"IL>DAH59+;4.CTM6,J7"F0J)+ER[U_==M%/S4]C7V7*V>"D_>?OOM
MEB5+%M]N0D+"&8];^]FQ8T</>]YWWWW>PCEUZE1O U5+I\:P]^[=VULZ'WSP
M02M<N+#UZ]?/VTLO1-MNT*"!MWQVZ-#!9LZ<Z8_I8D:QIQ4A3@
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M?OUZZ]NWK[W^^NL^QOV]]]ZSA@T;GA&4U.>JA;-\^?+VT$,/>6NG6CC5MJG
MY=D4EM2V6[9L:>G2I;.__O6O]L033_A_[]NWSUM O_WV6V_9##W6!QYXP#IU
MZN3A3H4\-?)<?RY<N- R9LQH?_C#'^RUUUZSL+"P'PVDABBLJ7U5<+5FS9K^
MV#2R_DJ.40\AQ D              !!\A#B!8"'$B3.H>3)?OGP>PKR4$&>H
MN5+MF&JVU'CRN^^^V^K7KW^JW?)<GS-^_'A[]]UW[8X[[O 1[ 4*%+ Y<^9X
M$%-!RL3$1-_N9Y]]9O_O__T_#U-&1D;ZB'*%,<]%C: OOOBBCT+_[6]_:Y4K
M5_91ZVKOU&CS;MVZV1=??&&//OJHAS@UVCTT[CUDR9(E?K^_^]WO[)___*=5
MK%C11[B?3>/<]1AGSY[MC9Y:"HDN6+# '\?/@1 G              ! \!'B
M!(*%$"?.D-80IX**6[=N];;,VV^_W6ZYY18?0:Y&2K50*HQYME#;I0*;&EG^
MJU_]RN\S??KT/M9=]ZM0Y:Q9LWP<^K///NO;5EMGGSY]/)"I;9^+;O/^^^][
M,%3[DS=O7ALU:I2M6;/F?T*<?_G+7WQ?%<34?89<;(CSX,&#'E;5?:K=LW;M
MVK9RY4H/F9X>"KV2"'$"               $'R%.(%@(<>(,:0EQ*HRY9\\>
M6[Y\N8]2_\4O?F$WWWRS-V"J#?-"%)3,E2N7CU/7??[K7__R%LL-&S9X.%0C
MWC-DR. ?5QA3?Q\Z=*B')D\/7)Y-@4WMSPLOO. !T<R9,UOW[MU]'+JVJ]'O
M18L6M>>>>\[NO_]^;_?<N'&C'3ITR(.7NHV:-3_^^&-O 'WKK;=\1+J:04-T
M.^V#QK_WZ]?/MU&]>G7_NYZ3GQ,A3@              @. CQ D$"R%.G"&M
M(<Y-FS997%R<Y<B1PW[YRU_:;;?=9H\__KB')B]$C955JE2Q?_SC'_;[W__>
MQ[''Q,38BA4K/% Y<N1('XNN8*BV_<DGG]CHT:,]<*DQYN>B<>L1$1$^JETA
M3GU>5%24+5RXT!L\ITV;9@T:-+#77W_=Q[\KH*E J<:M:[MZW&/'CO4V3P5(
M%>942'/5JE6G[B,T1GW"A D>&*U0H8*-&S?.UJU;=]Z6T"N!$"<
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M1QYYQ)YYYAEKW;JU)24E>?-FB$;(UZ]?W\+#PZU;MVY^G]KNA?;M2B#$"0
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MX_OV[?/'U;-G3W\^]=CNOOMNW[;&Q2L4JL_7Z';=_G(@Q D
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M%O03&EW=H<>R<N5*OUWHBA"=;"BP&CHY&3QX\"7OT]D(<0(
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M5=:Y<V<?^:Z3@4\^^<3;2#46_O2PIZY,48CSD4<>\<=S,6'7"R'$"0
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MU;+6K5M[ ^BY*,2I*TPTQCT4XM2^GQ[BU'9/#W&JA900)P
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M@I4K5\Y/0E3MW:5+%P^#*D"J@[R>3^W[;W[S&WONN><L3YX\?D7'3T6($P
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M=E'MCZXFT8F 0J>5*E6RH4.'^DF#3D;T=P4W;[WU5G]NU/1YL0'3\R'$"0
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M^]AUA3ZK5JWJ39\??OBAU:Q9TQ8O7NPCUR]VFNWE1H@3"!9"G$! $.($
M         .#&D]80YZ1)DZQ$B1+>7GGSS3?;.^^\XR''"X4M%5Q4@Z7:*D,A
MS4<>><1;,5>M6N5+(<FWWGKKU,>U;8TN5^/E^=HK$Q(2+#HZVK[XX@L/<:H)
M4Z'*V-A8'XE^J71_APX=\NT.&## GR>%.-6X&1(:HZZ63K5X:KR\0IP:N:Y0
MZ<J5*[VUM%2I4G;???=9A@P9;.# @;9Z]>HT[=/E0(@3"!9"G$! $.($
M         .#&D]80I\:-UZM7S]*G3V^WW'*+O?GFFU:K5BT?%WXN"D4>.'#
MEBQ9XN/%0R%-C3+OT:.'[=^_W]?4J5/MO??>._7QM]]^VR9,F."-E^=KKU1;
MIL:R:X3Z[;??[H])CTVMH<>/'[^DYT5A435V;MJTR9M!JU>O;JU:M?+6SHT;
M-YZZG?97S9H*H;[\\LL^.KU*E2HV?/APV[IUJ^W>O=N#G&HI?>"!!SST6J-&
M#7\\:OJ\&@AQ L%"B!,("$*<              #<>-(:XM1M.G;L:)DR9;);
M;[W5 XSERI6S\>/'G_-S%,#4F'*U:FKD^2]_^4O_7 4?%8X,B8^/]S;-7__Z
MU_:K7_W*7G_]=6^Z5"#R?.V5&N5>N7)E>^.--^RVVV[S\*?&M,^8,</'HE\*
MA3ZW;-GBVVS0H($W<&H?-VS8X.V<(;MV[;*)$R=:6%B8/?'$$_X\1D5%^7AU
MC5O7=O1GY\Z=[>&''_; J@*L"H8JT'HU$.($@H40)Q 0A#@!
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M&N.NYU&?OWCQ8G^\IP=,'W[X84N7+IVWCRKH>;[1\%<2(4X@6 AQ @%!B!,
M            @!N'0HL:;SY[]FP//#[QQ!-VQQUW6(8,&6SZ].D>0+R8\..J
M5:M\C+E&GX="H%%14;Y=C5S7?6@I[+ADR1(+"POSMDJ-/5>8<_CPX1YR5-@Q
M1/>KULZY<^=:R9(E?42Y0I\Y<^;TEDR--E=KICY'^ZF@I<:5:WRZ I\9,V;T
MD>:+%BTZ8[OGHOO3OBIXJ>"GPJ :HZ[Q[6?OV]D4(%VX<*&'45]\\45?:B/5
M?NHQ*P"Z8L4*'SNO@*D>AX*N>LZT[U<#(4X@6 AQ @%!B!,
M@!M':'2X1IFK[?+..^^TFVZZR=Y\\TWKU:N7-ULJV'@A"CFJ=5.CQS7"7('+
MCS[ZR#IV[.C_7^V66E.G3K46+5KXQS1Z7:'/KEV[^JARC1L_?=RY_JY@I=HX
M%78L6[:LAQ^U[08-&MBT:=-\Y+J:+!4B56-FKERY?-__]K>_6:5*E7R<N0*6
M"JN>C^Y+S9\[=NSPQUVF3!EOTE2[YKIUZWS?SK<-?:X>I_93 5B%.+4O;=NV
M]7W3?FB4>O[\^>V>>^ZQ=]YYQULXX^/C?W3D_,^!$"<0+(0X@8 @Q D
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MV^?-I7J\H<>O?=3(]KU[]_KCN-1]O-P(<0+!0H@3" A"G
M ,%'B!,(%D*<0$ 0X@0               @^0IQ L!#B! *"$"<
M     $#P$>($@H40)Q 0A#@!              ""CQ G$"R$.(& (,0)
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M         /*?$2?D%R-.R!-&G           ^<^($_*+$2?D"2-.
M (#\9\0)^<6($_*$$2<         0/XSXH3\8L0)><*($P         @_QEQ
M0GXQXH0\8<0)         )#_C#@AOQAQ0IXPX@0         R']&G)!?C#@A
M3QAQ @        #D/R-.R"]&G) GC#@!         /*?$2?D%R-.R!-&G
M        ^<^($_*+$2?D"2-.         (#\9\0)^<6($_*$$2<
M0/XSXH3\8L0)><*($P         @_QEQ0GXQXH0\8<0)         )#_C#@A
MOQAQ0IXPX@0         R']&G)!?C#@A3QAQ @        #D/R-.R"]&G) G
MC#@!         /*?$2?D%R-.R!-&G           ^<^($_*+$2?D"2-.
M     (#\9\0)^<6($_*$$2<         0/XSXH3\8L0)><*($P         @
M_QEQ0GXQXH0\8<0)         )#_C#@AOQAQ0IXPX@0         R']&G)!?
MC#@A3QAQ @        #D/R-.R"]&G) GC#@!         /*?$2?D%R-.R!-&
MG           ^<^($_*+$2?D"2-.         (#\9\0)^<6($_*$$2<
M    0/XSXH3\8L0)><*($P         @_QEQ0GXQXH0\8<0)         )#_
MC#@AOQAQ0IXPX@0         R']&G)!?C#@A3QAQ @        #D/R-.R"]&
MG) GC#@!         /*?$2?D%R-.R!-&G           ^<^($_*+$2?D"2-.
M         (#\9\0)^<6($_*$$2<         0/XSXH3\8L0)><*($P
M   @_QEQ0GXQXH0\8<0)         )#_C#@AOQAQ0IXPX@0         R']&
MG)!?C#@A3QAQ @        #D/R-.R"]&G) GC#@!         /*?$2?D%R-.
MR!-&G           ^<^($_*+$2?D"2-.         (#\9\0)^<6($_*$$2<
M        0/XSXH3\8L0)><*($P         @_QEQ0GYY84><CQ\_B;OW'L3G
MUV[&N8N?1^GI"W'\Y.GTA]2>@R=BV^[#L6G[_EBS>7<L7[<]/ENY*>8N61>S
M/EL3,Q:LDO*NH>/G1,WFW:-*HRXQ</2,K'\\TF_1S$RS,S_'%R[?&$O6;(U5
M&W?&^JU[8^ON0[%K_[$X</1D'"LICY/EY^/,^<MQ)7-&W+Y[/[[^YG$\>_9]
M?/_]]]D^O@       ("_T#>/G\2==!MR*\Y=O))N0Y+K@0>/GHP]!X[']CT_
M;$-6;]H5R];^L V9EVQ#%J[.^K5-Z;>L_\AI4:E!IZA=T".&3YB;]8]'JLB2
MG^%S%JU-MR%+UVZ+U1MWQ89M^])MR.X#Q](S(-D)GBH_GXZ8DS/BSMT'Z9GQ
MHFY#<G[$F7Q1DZ]K\I_/GCV+[[[[+M.SN/?@492=O1A[#Q6GOTA+5F^)F0M7
MQ?CIBV+8^#G19]CDZ-QW3+3L.B3JM^T;51IWB?=JM8DWJA3$__JHJ23I!>SU
MRBWB[6JMXI/Z':-6YE]&FW8<&.U[C8H>@R?%H#$S8NS4A>F!OFCEYEB[>7?F
M\#Z>#CIOW[D?3YX\C6\S9TAREOSAV0(       !DUY_:AB0#SE.GS\?>0R?2
M;<CB59O3ZX'CIRV*H>-F1^^ADZ-3G]%1T&5(U&W=.ZHT[ASOUFP=KU=ID?5K
MFY*D7]=KE7Z_#6G0,>JTZA7-.PV*#KU'1\\ADV+PV)GI/G#FPM7I-F3=EKWI
M&5%ZYF(ZY'SZ]-OX]ML7;QN2LR/.Y&N7C&V^^/+KN'KC=OINBN0+OC[SA5^P
M;&-\.FMI#!DW*WH/FYS>&KA#KU'1NFAH^HO6J+!?U&W9,VHVZQ:5&W6.#^NV
MSQS2;>.-J@7Q:J7F6?]&DR3]NG[W2?,?AIS56\?[==I%I8:=HEK3HJA3T#,:
MMNT3S3H,S)P%PZ)=SY'1I=^XZ#7DTQ@T9F9,F+$XYBY>%VLV[4[OV%E2=BXN
M7[T1#Q]]F1[@+\*!#0       /GFV???I]N01U]^E3Z)-;E!2_+TU>2&+?.7
MK(^),Y;$X+&SHM?0R=&U_[CT!B_)]<!F'0?^?AO2*VHT*TJO&R;;D'=JMDD'
MG+8ADO3BEFQ#7DNV(37^:1M2/=F&M.P9#=KVB>8=?]B&)&="N@W)G!')CG#2
MS*69LV-#Y@S9DYXER9F2W*7ST1=?_3#LS.%M2,Z,.']8OGZ?OI,B&=0DMS=-
MOH#)R&;?D9+TL;FC)\^/CKU'1XVFW>*=ZFWBU<POV.\^:9;^PKU:J45:LL1]
MK7)!VNM)55JFO9%4M94D*2]J^=//]]=__S,_[?=G0=+OTC/BAY+19]5&7:.P
M^X@8-F%.S%^V(7;N/Q;G+GX>]Q\\BJ^^_N:'=V/\P9TZ 0      @(KUXYTV
MD^MRR?6YK[]YG-YXY>*5:['GT(GTKFHC)\V+]CU'1K7&7>/M:JU_?^W/-D22
M7KJJ_.7;D.2_)WO"ZDVZ9<Z043$B<Y8L7+$I'7->N'PM[C_\(CUS<G4;DC,C
MSB=/G\;U6W?2NZ,ESZ]?O&I+3)V[(D9,G)>N99.[JC5NUS]=U;Y7LS#>JMXZ
MWJO=+BHWZAKUVO2+)AT&1XLNPZ--]S'1H>_$Z#IP2O08.B/ZCIH3@\8MC&&3
MEL3(J<MCS(Q5,7[6&DG2"]C8F:MB]/25,?S3I>G/]GZCYD;/S,_ZY&=^Q\S/
M_K8]QT9!UY'1I..0J-^V?U1KVCT^J-LAWJG1-E.;J)IYH=>PL%^T[3XBN@^:
MF#YB(;FS\X)E&V+3]OUQK*0\?8=?\D8"        H&(]?OPDKMVX'<6E9V/+
MKH/QV8I-,77.BA@^86[ZE+W"'LDVI%]4;U*47M][NWJ;=!M2I7%1>OVO28<A
M/VQ#>HQ)KP\FUPF3ZX7)=<,?MR&CIJZ(L;8ADO3"EOP,'STM<S9\NB3]V9[L
M_WK\?AN2[ +;I-N0$>DVI%Z;_E&U2;=T&Y*<&<G3NI,GNB9W:V[;8T3TS)PM
M0\?/CLESEF7.G(VQ>>>!.''R3%R]?BL>/WF:[6/Q)UD=<?[X[HKDD+Y]]WX<
M.EX:GZW<%/U'38\F[0?$Q_4ZIBO:'Y>SR7]/5K;)@/.CS)^KU;)WM.PV*GJ-
MF!5#)GZ6.8B7QZ?SUL?L93MBT=K]L7++T=BTNS1V';X0!TJNQK'3M^/DA?MQ
M^LH7DJ07L-*+#Z+DW+TX=/):^K-]TYZR6+7E6"S._,R?LWQG3%FP,3W,ATY:
M''U&SH["7N.B0=L!\4G#+NG9\6;F#$G>H?'#N=(\[;U:;:)!FSZ9@WM2S/YL
M3>PY>#RNW[R3#CG3VVGGV+LO        X$7QXYTWGW[[;;H-N7G[7NP_4I(^
M.:_O\*GIS;P^K-T^7JOT!]N0*O^T#?FX?J>HW:I/M.XQ.GJ/G!U#)BY*ASV3
MYVV(.;_?AB37"Y/KALGUPX,E5^/XF3MQRC9$DE[8DFU(\=F[F9_IO]^&["[-
M_*P_FO[,3W:!D^=O3&_D.&32XG0WF-SP*QES?MR@<WIVO)%N0PK^:!OR09W"
M:%C8-_H,FQ+SEJR+?8>*XU;F3/HFN3MGYHS*]C8D:R/.Y+'IR2-LDT?9;MM]
M*&8M7!T#Q\Q,[XY6KU7O^+A>AW1L\V;59+#9*6H5]([FG8='YP&38^"X!>G=
MV&8LWAH+5^^-%9N/QMKMQ;%AU\G8O*\\=APZ%[N/7HS])ZZD0Y]CY;?27]CD
MD"Z[]##KWVB2I%]7^>5'F</Z892<NYO^;#]\ZGKZLS[YF9_\[-^R_W1LS!S>
M:W<4IT/^Y "?M71[^DZ-P>,_BZ+!4Z-5MU%1MW7?^"0YO*LEAW=!?%BW?=1J
MT3U:=AV2'MC).S#6;]T;96<NQMU[#],Q)P       /#+),.8>P\>Q9GSEV/S
MSH,Q8_ZJ],9>K;L-BSHM>\5'Z3:D9;H/20>;+?M$BRXCHLO *3%H_,(8-VMU
MS%RR-1:NV9=>_TNN R;;D"W_;!N27#?\IVW( ]L027J!*[OTZ*<A9_*S_="I
M:_]B&[)A]ZGT3%B1.1L^6[LO<U9LBW$S5\? <0NCZZ IT;)H9-1IU2<]6]ZL
MUBK>RO11W?91IZ!GM"X:%OU&3(VI\U;$QNW[,V?4E;A[_V&Z9\R6YSKB3-:J
MR2>;W-TL.:1+3U^(]5OWQ> Q,Z-^Z][Q?JW"]!GUR?/LT]N;9OYWY49%Z>VP
MD]NACIBR+.:MV)TYC$^G!W#RBY7M;QI)4FZ7O$ [4GHCMA\\FXXZDT%GSV$S
MTL<L5&_6(]ZOW3[>KM$VWJCZPQTZWZ[1)JHW+4H?M[Y\W?;T40[)W:*__N9Q
M?)L#[[X       " 7)9<2TN>RIIL0^[<>Q GR\_'FDV[HO_(:5&O5:_T4;?I
M-J3J/VU#DD?A-NLX-+H-GA:CIJV(^:OVQ+8#9]+K?*4&F9*D_TW)CO!PZ?78
MNO]T>E/(Y"FNW8=,C^:=AT6UIMWCO=KMTCU(LDM\-7,&)6=1S6;=TAM]K=FT
M.TK*SJ5#SG0;\MT/3VU]GI[;B/-9YI#^^NMOXM:=>W'@Z,E8M')3C)@T+SKT
M'AUU,X=T<A>T=S)?J.3Y],EH,SF8AWVZ)";/WQ#S5NR*Y9N.Q(9=IV+GD0OI
M(5UR_EYZ1[9L?P-(DG*[Y*PXF3DSCI;=C#W'+L6FO67IN_069%[X35VX*7V#
M0/>AT].[/5=JT"4]BY(W%=1LWCV]._20<;-B[I)UL7/?T;C\^8UX],57S_VP
M!@      @!=!,N#\ZNMOXOK-.['W4'$L6+XQADV8$^U[C4KO?I9L0Y(13?)$
MUF:=AJ4#FQ&3E\:4!1MC_LK=L6+3D?3)>[N.7DBO[YVT#9$D_04E9T6R)SQ2
M=B.]8^>F/:7IT[V3LR4Y8X9/7I+N$9MV')K>G?.=&FWC_=J%4:M%C_2,2LZJ
M!<LVQ)Z#Q^/S:S?CBR^_>JXW^/K-1YS))_/XR=-T]'+QRK4X>/1D^IC:MMV'
M1^6&G>-W'S>+UZNTC'=K%D:EAEW2 >?@"9^EB]@=A\_%B;-WO*M"DE3A)7?H
M3,Z8W9D7@,D=.I,7AZV*1D7UIMW3NW.^4;55^@[ Y!$.S3H,B%&?SHNMNP[&
MZ7.7XM[]A_'X\1-WY 0      (!(MB&1;D,>//HB+EZ^%GL/G8@),Q9'JZ)D
M+-/QIZ>R)G?=K-2H:WIGM.3&7LEUNF2PF5RW\PAT25)%5_K[;<B.P^?3/>+0
MB8NCH,N(J-:D6[Q7JUUZ5^CDC/JX?H=HT6E0C)NZ,';L/1)G+UQ)S[3D;'L>
MTY#??,29/#[][(7/8_/. S%ESK+H/FA"-.TP("HU[)3>[2RY-7;=5GVC8]^)
MZ=W0YBS?E3ZO?L^QBW'L]*WT5J?>52%)JNB2LR4Y8XZ?OAU[CUU*[_:<'-CC
M9JR.HD%3HV'AP/3 3LZJ3S(O+!NTZ1.=^XZ)<=,^BS6;=T?IZ0OQS3=/GLMA
M#0       +GLR9.G47[N4FS8MB\FS5H210/&1>-V_:)2@T[Q3O+(])IMHWZ;
M_M&Y_Z?IX]+GK=P=ZW>>3)^DEUROLPV1)/T6_;@-27:(R9FS;F=)^N36,=-6
M1I<!DZ-^V_[IS2?3;4B#CM&HL%]TZ3\V)LY<'.NV[$EO]/7TZ;>_^3;D-QEQ
M)G<F^_$6V3=NW<U\0GMCT)B9Z0#FU4K)NRL*TEN2?ER_<]1OW2]Z#9L9TS_;
M$EOVGX[B<W?=>5.2]-PKNY0\=OU^[#IR(>8NWQD#QLR+QNT'1^5&7=-W!";O
MOGBM<O.H7= C>@W]-):MV187KUQ/[S2=O&'!F!,      ("72;(+>?;L67SY
MU==Q]?JM6+5Q5_0?.3WJMNJ97E=+KJ^]4[-M?-*@<S0L'!!]1LZ.64NVQ?:#
MYZ+XW#UWWI0D/?>2LR?9AB1GT>REVZ/OJ#GI3;Z2)X@G8\[D[$KVC?5:]8J^
M(Z9DSK:=Z1GWQ1=?I6?>;[4-^4U&G,F8)7G,[-'B\IB_=$/T&CHY:A?TC _J
MM(O7JQ1$M:;=HV77D3%PW(*8L7AKK-Q\-'8>.A='RVY&Z<6'WETA27KN)6=/
M<E@G[_3;??1BK-E^(N8LWYD^QJ&PU[BHV:)7O%FM5;Q7JVW4;-X]NO8?'U/G
MK8B]AXK3(>?3;[_[+8Y4        R$G)-B2YN=>AXZ4Q9_':Z#YH8M1JT2/>
MK]TNO:Y6O5F/:-U]= R>\%G,6K(]5FT]%KL.GX]CY;?2FWO9ADB2GG<_;D.2
MLRBYR=?JK<=CUK+M,63BHFC38TS4;-$S'7*^7[LPW89T&S@A9BQ8'0>/GHHO
MO_HFOOWNM]F&5.B(,WF7Q;???A=W[CU('Z$^=\FZ:-L]>89\4;Q:J46\ESFH
M:V0.Z0Y])L;H:2LR!_3Q.%)V(UVW9OL72)*D/^S4[V^GO7[WJ9@T;WWZB/4Z
M+?O$!W4ZQ.N5"])'K#?K.# FSUD6Q:7GXN;M>_'DZ;?I.R\        @7_WA
M-J3LS,68N7!UM"X:%E4:=8G7*A?$^[7;1ZT6O:-3_T]CW,S5L79[<1PINQFG
M+MB&2))RJ^1L.GKZ5JS=61SC9Z^)S@,FIS?Y>K].^WBM4HNHW+!S-.\T**8O
M6)6>>;?NW$\?KU[1VY *'7$^?O(T'C[Z,G;L.QJC)R^(PAXCHE*#3O%^K<),
M[:-MC['I>'/AZKWIH],/GKP6)S-?"+?(EB3E6LF[+Y(AY^'2&[']T-E8NN%0
M3)JS+CIG7FPFCWQ(WD'X4=T.T:+SX!@R;G:LV[(W;MRZF[[;\'O/5@<
M "!/??/X2=R]_S"V[#P8(R?-2P><R3;DO5J%\5'=CM&^]_@8.V-5+%J[/[8=
M.!.'3EU/1S)EE]QY4Y*46Y4EVY#,&96<5=L.GHG%ZP[$A-EKHT.?"?%AYDQ+
MMR'U.D2KKD-CV(0YL3ES]MV^>S^^_OIQA9ZM%3+B3&X3FCP^_?-KM^+(B;(8
M-VU1U&K1/?.)M(\WJK:**HV*HGFG83%^YNK8O*<L#F<^Z6S_ DB2]$M*'K.^
M\_#YF+9P<_JFA.3.TF]7;Q/OUVD759ITB<%C9\6./4?BW(7/TR'GMQZO#@
M    0!Y)MB')@//2YS?BP)&3Z8"S5O,?MB%O5FL=59MTBY9=1Z4W1MFRKSR.
MEMW(^C4^29)^2<?*;\:.0^=B\KP-T:IH9%1KVCT]XSZHTR[SWXMB^,2YL>?
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M]0]<DJ27H2-E-V+J@DU1V'-L5&K8):HTZAQCIBR,/0=/Q*T[][/]NAX
M ( 7V+T'C^)H27E,GK,LJC7I&A_6ZQA-.PV-\;/6Q.%3U[-^K4R2I)>A R57
M8]+<]=&F^^CT;IS)&RLFSEP2Z[?NC5?6;MX=$V8L3O_@)PVZ1/L^$V+JPDUQ
M\.35K'_@DB2]#!T[?2OFK]P=/8?-B.K->F3.XTXQ>.RLV+A]?UR_>2?;K^L!
M      !X@=V^<S]V'S@>8Z8L2&\F4J5Q473J/REF+MD61\MN9OU:F21)+T/)
M&R?F+-L1W0=/2\_BY(T5(R;.BT4K-\<K"Y=OC.$3YJ1_L'*CKM%UX)28M71[
M^FC7;'_@DB2]#!T_<SL6K]T?_<?,BUHM>L7']3I&WQ%38]7&77'U^JULOZX'
M      #@!9;<-&33]OTQ:,S,]&8BU9IVC^Y#IL7<%;OB6/FMK%\KDR3I92AY
M2NO"U7NCS\C9Z5E<N5'G&#!Z1LQ<N"9>F39O1?0?.2VJ-.H259MTBU[#9Z5W
M SM2>B/K'[@D22]#)\[<B>6;CL30B8NC3LL^\6'=]M%MX(18O&I+7/K\1K9?
MUP,      / "^_S:K5BQ;GOT&OII?%2O0]1LWC/ZCIH3GZW9%\=/&W%*DO0\
M.EI^,Y:L/Q@#QRV,&IFSN%*#3NG9G#Q2_94Q4Q9&]T$3X^/Z'=,_.6C\PEBZ
MX5#Z%V7[ Y<DZ66H^.S=6+WM1(R>MB+JM>D?[]<NC(Y]QL2\)>OBPN5KV7Y=
M#P      P OLTI7KD3REM6O_<?%AG?91IU6?&#9I<:S8="2]V4BVKY5)DO0R
M=.STK5BYY5@,G[PT:A7TCH_K=8@NF;-YQ*1Y\4IRN^P.O4:E=_VJW;)WC)JZ
M/!V2'#]].^L?N"1)+T,EY^[&AMVG8N*<==&P<&"\5ZMMM.DV+)*[99^[>"7;
MK^L!      !X@9V_=#5F+E@5A3U&Q'NU"J-^V_XQ=N:J6+NC)+W92+:OE4F2
M]#)TXLSM6+>S)#V#Z[3J&Q_6:1?M>HZ,?B.GQBO=!TV(5EV'IG?]JMNZ7TR8
MO38V[C[EW1:2)#VG3IZ_%UOWGXYIGVV)QNT'Q]LU6D>3]ID7SU,71OG9B]E^
M70\      , +[/2Y2S%IYI)HT6E0O%NS;31J-R@FS]\0F_>61<FY>UF_5B9)
MTLM0\L:)S?O*X]-Y&]*GM"8W^&J>.9N[]!L;K[3K.2(:M^N7'M0-V@Z(:0LW
MQ_8#9].[@F7[ Y<DZ67HU(7[L>O(A9BS?%<TZS0TWJK>.NJVZA5#Q\^.4Z?/
M9_MU/0       "^PTC,78N2D>=&P;9]XNWKK:-IA2,Q:LCUV'#H7)\_?S_JU
M,DF27H:2-T[L.'0^9BS>FCZE-;G!5_TV?=(;<+[2M./ J%W0,SVHDW=;S%V^
M,_8>N^2@EB3I.55Z\4'L+_X\%J\[$ 5=1\0;50JB>M.BZ#MB:A27GLWVZWH
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M4)+M#UR2I)>AY,Q-WG&Q=?_I:-=K7/SCQ\W2.V2W+AH:AXZ=RO;K>@
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ML<W[RJ-5MU'QA[M-(TY)DG(D(TX        JFA&G)$FYDQ&G)$DYG!$G
M    %<V(4Y*DW,F(4Y*D',Z($P      @(IFQ"E)4NYDQ"E)4@YGQ D
M $!%,^*4)"EW,N*4)"F',^($      "@HAEQ2I*4.QEQ2I*4PQEQ @
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M        *IH1IR1)N9,1IR1).9P1)P       !7-B%.2I-S)B%.2I!S.B!,
M     ("*9L0I25+N9,0I25(.9\0)      ! 13/BE"0I=S+BE"0IAS/B!
M    H*(9<4J2E#L9<4J2E,,9<0(      %#1C#@E2<J=C#@E2<KAC#@!
M  "H:$:<DB3E3D:<DB3E<$:<        5#0C3DF2<B<C3DF2<C@C3@
M "J:$:<D2;F3$:<D23F<$2<        5S8A3DJ3<R8A3DJ0<SH@3      "
MBF;$*4E2[F3$*4E2#F?$"0      0$4SXI0D*7<RXI0D*8<SX@0      *"B
M&7%*DI0[&7%*DI3#&7$"      !0T8PX)4G*G8PX?Z:3Y^_%T=)KL7S=[I@T
M_;-8EOG/W8?/QO'3-W_S?_:6/24Q>>:2&#]E_L\V?=[*6+A\2^P\>/HW_?P/
MG[H:Z[<?B6ESEO_)CV75QOUQZL+]?_'7'\E\[78<*(M%*[?&^*D+8FKF[S%_
MZ<;8MJ\T3F7^WF67'F;]USBI_/*C]&-:L&Q33)O[IS_/BFKIFIU_]#VT=>_)
MF#SK3_]:)]]_!XLO1_&9VUG_6BE_2W_>E5V//4?.Q>9=)V+?L0L_^WNT[.*#
M.'GN;FS:>3QF?[8VILQ:&A.3GX]K=V5^/IZ)X^4WLOZYY&M&G        %2T
MEWW$F>P%BL_>3J_);]AQ+-TWS%RP.CZ=L2@F3%L8$Z8N3*^)SEJX)A:OVA[K
MMQV)?<<OI%N2_<<OQJY#IV/+[N+T/TO.WLGZYY.-KU_R=4B^+G,7K_\7>X?D
M6O*L!6O2W<.!$Y>B].*#]+KTMGVG8LZB=7]R)_'9BJUQY-357_SQ'"RY$AMW
M'D_W'[]VTS%QVF?I)F?>DHVQ9,V.6+_]:/HY%F=^?7_N&OJN0V=BYOQ5?_+O
MMVC5MMA[]'RZ$TF^7MG^-5-N5G;I01S*?/\F>['%F>^9Y/?3IEW'8_O^LLSW
MXH9?_'T\9?;2]*]+?C^4G/NGGTU[CIQ-?Y;-R'S/3IBZX&?_VN2/)YNT3;M.
MQ*&3G__3QYGY_DU^#Q\OOYENG9*=2/)Q3IVS+-W5)7_=I.F+TNU5\GMP]:;]
MZ:XMV9XEFZ=DA[)B_9[TY\6)T[?2[<GAS-\_^7F0_(S8L./H3_NHE_GWBA'G
MO^A1^DV4#)6:M^X4?_.?_C::M>J8'M;),/&W_N>/'#\C_O:__+?X/__UO_O9
M_K]_>"VJUVH84V<O^\T^AN3S7[?U4/0:,#+^[K__PY_\6-IU[A7'?F:XM7'G
ML?1?;&K5:Q+_^M_\^_AO?_\_XZ-*-6/<Y/F9P_9:^ILQ^[_.7Z2'[+C)\Z)2
MU3KQ]__C'__DYUE1-6K6-O,]5/X'O]8SX__YKW_W)___R?=?\L,J&==E^VNE
M_"WY%^!DO)G\B_*049/3 [GD9WZ/)O]BFOR+PZ#AD^*-MS^,__K__GW\A__X
MGZ-I0?OT7TRW[R_-^N>2KQEQ @      4-%>]A%GLA=(!G;)L*C?D'%1JV[3
M^-UK;\?_]9__2_S;?_\?TY)KHJ^_]7[4;=@B>O4?F0X,DRU),H1*QDO#QDQ+
M;VJ5#/VR_?D\[Y)!5_)U2+XN[WU4]5_L'9)KR:^^\5ZT:-TYO>'5B3.W8_/N
MXA@S:4Z\\WZE/[F3J%&G<7K#L5_Z\:S<L"\&#)L8E:O5_=6;CN1C_A__\%I\
M^$F-:-BT3?0>,"K]')/Q[L]=0Y\^;T7\XZMO_<F_7YT&S=,QW<Z#Y3ESLS/E
M7LG0<M6F_>E>+/F>>>^C*C%HQ*28.&UA?/!QM5_\??Q?_]M_3_^Z@<,FQ('B
MRS_]<Y*;==5M6!#_\+LWX]_\V__PLW_MO_EW?Q/5:C6,P2,GQYK-!W_Z:Y-A
MY8DSM])=R*@)L]*=R/N9C_/O_OY_QM_\I_\[_?O]Q__TM^GV*ME@=>C:-]VU
MK=MZ./-S]ESZL[-585'Z\R(9OB?;DS5;#J8_#UJTZ1Q]!X]-]U')_S>YP5BV
M?TVRE1'G/ROYQDO6S<E!^\;;'\2_^E?_1_H-7/3_LW<>[E656?N>&12E25<!
MD2Y([[T+TGM'>@?IO0K2I/>.2%&4+B * BI%! 4$1$&L4[YOZC?CS/S^@/>W
M[W6RP\[).4G0A$3R/->U+C$Y9Y=WK[?D>N_]K+E+;?).Z?,ST7?NUML6 R6>
M>=;ESI/7_?:WOW6_^<UO+ H5+N8:-F[F5FW8F6+7P-L/M,'2U5M=\U;M79&B
M)=PCCSP2>PU^]!TPW%PWP[\/;3U^RFQ7HU8]N_8<.7.[4J7+N>FS%UN'OG;[
M+ZG^G DZ_BO+-[HZ]1J[DJ7*N">>R.?*E*UHX"K/O'FK#A:-FK2PW^?,E3MB
M._!S8$S_\\^W:&NP;0WO&;*PRU^@H,N8\1'7ID-76Y3XY^>MG7:=>KAGO&,_
M]-!#\8[;N7L?<S"]'_"P(OT%BT1<.(]_>,7^N)@]?X6;[$VD.]X\:L!F^.=Y
MRX+\?7',%/?4TX5=ML>R>_WA4=>X:0LW\^4EYEB<VO?TH(8@3DF2)$F2)$F2
M)$F2)$F2)$F2)"FYE5XA3I@0. <<X'"/@VWHVK.?<0%-F[=Q+5IUL,#8IEVG
M[JYKC[ZNSX#A;OBH26[*C/ENVDNO&'3$OBG?7;WI=:OLFMKW=;\#]\!W/_C,
MV!78AL)%BKG'LF>/Y1U@;8#":#\8$D"U<Y?ON&VO'W(]>@UTI;S?L><<SDDT
M]I[#SV%S<%/E>?)LGFO:TI6K4-D]F:^ RY(U:[QS<&W\'AZ&9]Z@<3-7I5HM
M,RDK6NP95[Q$*?O_5FT[V_%6KM_ACGC7A)O@5S_<A3EQ'.S5;XAQ(9DR9XYW
M'M@1*O%^^,E-09R*.&&NEM_\S:!PW'YG+UAA &<7KR]A[+=V\QMFQ(7I('VB
M4I7J[NE"15WF+/'S^9%''W5Y\CYN[%'=^L^Y3EU[N1'>^$1_N!IPM3WT[CDW
M;=9"]T*?P3;>\7GZ!\Q3OOQ/N?(5JUI_&#MIEKEJXL;)> G C)ON6P=/NGFO
MK+;KHX_1?UJU[>1:M.YHT=KK+QTZ][3?#QDQSHV=.-/&2V#H<9-?LOXT9L(,
M<_)D#/[@PA=NP[8];MC(B6:*-W':RV;$1YM<^>I/Z=*14Q!G6#!PXD0W8\YB
M5ZMN0_?PPQD-[.OV0G^SE$WI\T,;G_(F%Z JWC"H6+F:RY APWV%.($;@;B.
M?W3%K?2N ZB43IM4B!.'218UQ8J7M,\!*.;*G<?K=..-G&9B2^WG[-\G$&>]
M!DT,FJWM/>]1XZ89S4X.G#ASU8(%!6_6,/'FS!F_'?CYXI6;8S_//;ZQ_X1;
MOG:;&SU^AFOL#5[9<^2,!W%"D#-(,A!GSIQ%$*?BO@8 )_V7,@ =.K_@+9[[
M>9/Q2U$A3JRN>3N"/V" -S-D>,CKVP_;FQ@LO+=[WTOM>WI00Q"G)$F2)$F2
M)$F2)$F2)$F2)$F2E-Q*KQ G3 B5"H'KV/M\NE 1,Z6JU["IFS)SH8%3E I^
M]_1G;O_1#]W6G0?=G(6K7+]!+UI5U:<*%G;Y"SSE*E:N;C]+KQ G@!40&JYZ
M\!+ 6\5*E(P*<=[YXW\,!H-_@,D8/'RL*UJL1+)!G)1AQG40F'/?X0_<^"ES
M7-T&3>QYA9\C=Y['W?C)L\T)$)?0G6^]8PZ!.!!B\/5HIDPN:]9L+E>N//:L
MZS5LXF;-6^8.O'/&2D#[YZ3\\]'W+QJ8]L23^05Q*I(4OJLE?6?YFFVN9Y_!
MKDZ]1JZ2-Z8,'SW);=UUT !*JJH"F^/F.N/E):Y-^ZYF(A<OGW/G=96KU3+V
M"/[CZ,F+9MQ'?[@=<+6\_O5?C?O@]_!O?/ZI@H6,>:K?Z'DW><;\6+=A*VW^
MW3\L;^'8<+H=.F*\.6X6*5K<E2U?R<#V3=OW>OWB(W/M9-Q\8]][;N7Z[6[4
M^&G6;S OQ#B0,;9&K?JQ$.=MX]+^87#T_,5K79?N?>VSN)#"G!WW^N;M=.C(
M*8@S+$@"$H+DAZX'H&2PQ55R^=K7;!*Z]>-/*7X=+ 8F3)UCI<@S!%P:[P?$
MZ0=EO($((:3SYGTBR1#GEAW[[<V),F4KF!-GIDR978&GGG:CO<Z(Z]_E@%UO
M:@9OAC @ IP"S$)U8^=[_K,[WN!UURWTPM5OO=_-M3<MH-?#VX&?O[[WW=C/
M\^;%96\0P^*;@6_,Q)E&K/-VSME+=TM.W_KQ7^[&G;_:0)@UVV.".!7W->C?
M+%ZQK"Y;KI(WKC2WMXBB09Q^*0'R&"@9D!/(G?QG@<W".[7OZ4$-09R2)$F2
M)$F2)$F2)$F2)$F2)$E2<BN]0IRW?OB7>W7703=PR"A7KGQE]^BCC[JJ->JX
M0</&NFUO'#;'.?9+84=PL0,X>NO0*0.-VG?JX4H^6\9ER_:8N>(!7Z57B-./
M+[VV E0<-&R,@5W1($[_\X!IP%XS9B]RSY8IGVP0IQ_P&M=N_]E*/G?MV=_@
ML?!SP "]LFR#P70\:XS(,.NBA#7N@K@2PKD$/]^L95NK4(D9F@^WW?[Q)V.(
M.!;5+ 5Q*I(2,&? BTM7;35P&!ZM49/FKEO/?L:" 6 &*QQ_ZHU)VW<?,6@2
MCBT\S^"QJ!I,]54 3/+S3@+Y]L4W?W>7;OQHIG<-GVOF.G1YP9PPJ28,Z(DA
MF/]9^M.1$Y]8CL.J9<^>PZZA6<MV;MGJK38^PE>1WX#4<"7'3EWR^M\N@]QK
MU*IKG-7CCS_I*E>M&0MQ^L=G[(2+@LG":!&'4'BS12LVF@$B &EZ<N04Q!FA
MLTR:/L^2G(D7"/'AAQ^V07KJK(7NXRO?NAMW_I;BUW$0&]N77G$-&CT?I]3V
M_80XZ;0'WSWK1HR>[/)Z'2JI$"=O*O"60OU&3=WO?O<[^VZE*C7L9W18!H34
M?LX$@\BZ+;M=S]Z#;'!Y_\SG,?;7_XHS@=XKQ,D XE/CM ]@*&_P3)FYP'WR
M^7=Q/L=Y<'W-)HA3<9^#-X(8TYH\W\J<=IDPL>*.!G$R6?,FR(0I<UR)DJ6]
M[^2QA3>6UTN]_L-B-;7OZ4$-09R2)$F2)$F2)$F2)$F2)$F2)$E2<BN]0IR
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M/O_.G?+NG3Q@O+D?8T1*AR!.29(D29(D29(D29(D29(D29(D*;F5'B%.X"&
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MWEA%?H6W#PLAW$=Q5ATU?IKE*\^%Q1#C&R!R]5IU;;$+U%FV?&5;+-'NC+&
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M,* +*]8@U$6R?';S#T8] W@&DX( NJM=-P2L'3Z>>*?""KM&K7I&&0<!R^2
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MR_;&WP DTC:P%T6+/Y/L$.<[IRZYI:NW&J/V2R%.^D47+W=@0H(&:!AK,7;
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M? RHD2 Z(#22!Y"3B0M D>->-]?+?]L@R[7P\^[>1,$;&0"<.%0R20+LT=F
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M ^P"R+P<8U &/,E>=9-FK<W$"W.M\MXQ,=V!8X'U /)B3YF]9?;<$]M+ANW
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MPS )AQ(GPR13'K_^4T*-@7.5^U8I5KQ4G$$S1\Y<4KYB%9GIO$CE1HB1UL?
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M$OSP-<NA,U\<2IR$$$(((8000@@AA!!"""'$;"AQ,LD1%#E")]8KMR*T6N'
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M[CW38SQ^G; ,^JD2)R37\.>_:4EOE!:_>.V!G+UT.SK^P7J\2S="M7T\5K/
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M&&9+G%CY ?$0 [2E.FBAPD5UA4'@W2@]'[:#K'?KP0NM&)DE2U;)G3NOKD3
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MDAD;C,$8F]Y[4^\%(8DJ(21Z%UUT$$U4T8L$DE"O@"@RO1?3P9][OC\A!WO
MQO:!<P3OU_.\GQD/LC@ZTNAWSO/__G^___+??O<;ASAM2-(6.AM<S%RTQ@W;
MV4Z7MB#:W_T;O_&;[ECT;KT&N!TX=QXH=XOS\XX:;YK(MX' /@,"]7NV*Z3G
MW_^E7_J7;C+?%D3[I?X/_]A"[[W?UFU__<=_\J=NM\6!0\+<W1CV(L)];L_"
MT+B#Y%E-G+[0[9KY6__A/^H'/_B!9P'Z,_4?$NIVAGQVQT[;:MM>2-BB^0N_
M\'^YA:IS]WX:[5E0;3C0_CP^*=7]TF_1ZB/]5\_S8XMFTUT#/_$\'ENH[47$
MC@-E[DZ+KWZ--JAJ@Y"V^-EVX'_PA_]#+3Q?B]U%8,_]5Y\7V_W2_G=[(6)#
MN?_S3__<W3EC=U_4?64GTZ]F=VT,2T[3WWB^=AO@M(7:[J"P0<[),Q>YNV]L
M2-,6<OM^VXNYW_QW/W1W<]B+&=MAM%6;3Q05/\K= 6-W7=AB;3MCVN+<]+/Q
M#__TGM*G9+H_?_;.DF>SQVD[@-I1]$."HCU?]__K!EA_\9=^R0V-VE"H?5_^
M_B?OZ;V6'^JG[WZ@'WG^V5Z@V<_"),_W<$]^]<_MWOK5LE9N<2]0[;';BZWW
M6[=SWSO;4OUY/W-$7Q=#G            / VACC)6]DU<+L6/F!HF/[C_],X
M$V ;-MGPXS?]NVX'R9KS;J?(08&1^M]__6,W9/A-0YSV[^PMJ-7RM;D:/WFN
M.G7MX_D[_\ --]H.G#9'81M^)8[*T,X#%6X&Q 9.OWJ=W_ZYL++!#4D.#8EV
MI[3:3HJV,Z0=KVZ;:?W)C_Z7FPNQ^1";$['':',%77KTT[(UV]WLQ;/#H?9W
MV4R"G;IJG\,V[[*9!AN@G+=DG3N)U#UOIVZX0=3!@1%NWL/^3OO:;0.JD:E3
M-'OA:C<T:1N0#0Z*U'NMVNJ/_OA';E#0-M#Z_3_\(_VMYVNTP55[GFP#L1<-
M<=J\ASU7_0:'N'F,O_BKOU5<XEAWNJT-.W[UX^TQV@!CZ[;M]8,?_*):MF[G
M!CYMH/1%WTO;8,PVYK+CRO_RK_[.?1]^P_/U_W]_^==N8-(V8K.OW^8NPJ,3
MW29J?_*C/W,[=MI\B.VP:<^QS<?8?(8= 6_?9YL#2ILT1^^W_MAM<&8;:?VF
MY_O<=V"0FQVQH^"?]WCL>VLG\=IS:'_?G_[97[CO[;_\5__*/8>__9_^LSL9
MV(Y;M]D;VYSKK_[F[]U&:C;D:3\3]G-==>+GGY^O9@.[]K-G/_LVE!H>D^3F
M@)ZW8RG1BV*(DUY)-MBW+#O7W2'PEW_U8W=<MRV:MH7VGORJG_MX6T1L(;,=
M&6W[Y;#H)'W2J8?GE_G?N&.UFP;U?O\/_X?Z#P[U++3I7\KNR(@>-DJ!87'N
ME[GM7FD+L@T+_MW_^4<W<&@+I T=VJ1]\7-VX/SBL3^=R,\[<MPM"O;WV8Z<
MMN6W_=*UK\5>,-APJ4WWV^+S3S][7WWZ![C=,>U."1N<K#AN@Y(GM7+]+C<<
M:8_!7BC89+\M#/;BQ08_.W?OZX8R;<&T+:KM2'';RKOE!^W<+W?;1=06"?N:
M@B.&N1THQTV8K93TF>[. MM]TQ[7O_DW_]8-<=J";L^'?3X;F'UV0/2+Y]OS
M8L".9[=%UUXHM/0L2#;X:O]<_,SVX4W9"PZ[0\!VJ;0%UNYP&#YBO'NLW_2S
M8,_%/,_GM>^-?4]LETT[POQ_NZ^]G]O9U)X?VX73O?CPO#"SP=7?^+?V-?V&
M&Y#MVJ._XA-3W?-K'V-'E=L":@.Z33\;MJ.HO3BQ'5_M^VP_2\\;M+0%UG9L
MG>EY@6 O M]M^:&[F^7?_?"WGB[V/_2\./@=MRWX7WA^_NS%6/=> Y7N>4%B
M=P\=^88CVRV[H^CO_OZ?W M3VU757CQLWU?J=BW]NN%/HN?%$"<
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M[?S(\_VPF9>FS<AL1TX;'+6YDY3T&6Z'3)O%L+F97W\Z_&@#E78"KNW2:4/
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M&!JG-3E[W6Z%#+M1<\I^7HNKS[H%>L+4^6K?J:>"PN*4D\L.G.3=&.($
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M%=0J.V>O&X";.GN)FUCW]>,B>IEL!\Y-.PJT8.D&-XAL_\D0,KVJ&.($
M      " MS'$2:\S.T)]_=8#;O#-6KUQ-]?8J=FTO[#.;5 W8^YR-XB<L^.P
MV_S+UX^+WJP8XB2?9$=-VR*=5WQ<N?M*M7UOB1N,\_7C(GJ9[$Z*PV6GW.#Q
MEEU%[C]9H.E5Q1 G            O(TA3GJ=59VXJOR2$]J55^FRDR^YQD[-
M)9MOVIU?J=S]I=IUL$*'RTZJYM1UGS\N>K-BB).(B,B/8X@3
MWL80)Q$1D?_$$"<1$9$?QQ G            O(TA3B(B(O^)(4XB(B(_CB%.
M            >!M#G$1$1/X30YQ$1$1^'$.<            \#:&.(F(B/PG
MACB)B(C\.(8X 0          X&T,<1(1$?E/#'$2$1'Y<0QQ @
MP-L8XB0B(O*?&.(D(B+RXQCB!           @+<QQ$E$1.0_,<1)1$3DQS'$
M"0           &]CB).(B,A_8HB3B(C(CV.($P           -[&$"<1$9'_
MQ! G$1&1'\<0)P           +R-(4XB(B+_B2%.(B(B/XXA3@
M '@;0YQ$1$3^$T.<1$1$?AQ#G            / VACB)B(C\)X8XB8B(_#B&
M. $          .!M#'$2$1'Y3PQQ$A$1^7$,<0(          ,#;&.(D(B+R
MGQCB)"(B\N,8X@0          ("W,<1)1$3D/S'$241$Y,<QQ D
M  !O8XB3B(C(?V*(DXB(R(]CB!,           #>QA G$1&1_\00)Q$1D1_'
M$"<           "\C2%.(B(B_XDA3B(B(C^.(4X           !X&T.<1$1$
M_A-#G$1$1'X<0YP           #P-H8XB8B(_">&.(F(B/PXAC@!
M  #@;0QQ$A$1^4\,<1(1$?EQ#'$"          # VQCB)"(B\I\8XB0B(O+C
M&.($          " MS'$241$Y#\QQ$E$1.3',<0)            ;V.(DXB(
MR']BB).(B,B/8X@3            WL80)Q$1D?_$$"<1$9$?QQ G
M    O(TA3B(B(O^)(4XB(B(_CB%.            >!M#G$1$1/X30YQ$1$1^
M'$.<            \#:&.(F(B/PGACB)B(C\.(8X 0          X&T,<1(1
M$?E/#'$2$1'Y<0QQ @          P-L8XB0B(O*?&.(D(B+RXQCB!
M    @+<QQ$E$1.0_,<1)1$3DQS'$"0           &]CB).(B,A_8HB3B(C(
MCV.($P           -[&$"<1$9'_Q! G$1&1'\<0)P           +R-(4XB
M(B+_B2%.(B(B/XXA3@           '@;0YQ$1$3^$T.<1$1$?AQ#G
M     / VACB)B(C\)X8XB8B(_#B&. $          .!M#'$2$1'Y3PQQ$A$1
M^7$,<0(          ,#;GC?$N8\A3B(B(I_TW"'.%AT#9?W,\P]!PR9I^X%J
MU9RZJ;J&6SY_P$1$1&]+M:=O:D_!,45ZWC3_K/T0O=<A0(&QXU104N7K]_4
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M\F.7??[ B8B(WH8J/6^.=^37*G-YK@9&CG-OGFVG[)D+U^CHB09?OZ\'
M      ! ,W;L1(/F9*U5\+#Q;F!D0$2J9BW=JMR#-:ID@R\B(J+74OGQ*]KN
M67MG9FU1G] Q^JA7I%N;$]-FZ9WQTQ<K=O14?=(W6CV#1BAC3K8V["I1Z=%+
M/G_@1$1$;T-VM\76_96:OGB3^H>GJ&VO"(4G3=3"E9M4?^J,K]_7 P
M    H!D[V7!66:LW*VK$9'W4*T)]0\=H\KSUVK2G3!7'K_C\6AD1$=';4-FQ
MR]J\MUR3YV]0K^!1^KA/E%N;4Z<NTCNVRY?MQMFQ?ZRZ#4W2V*G+M69K@4IJ
M+_K\@1,1$;T-V9OCG-UEFC1OG7O3;+MCQXZ>IF5KMWG>5)_S]?MZ
M    -&,-9\XK.V>7$L?-= ,CO8)':MS,55J[O<@-E/CZ6AD1$=';D&VJN6%G
ML3)FKW&;;;;O&ZV$E)F:G+E"[V2MWJ)Q4Q>I\\!X=1D\7$D9B[1LPT$=J3GO
M\P=.1$3T-E1^[(K6Y1[1^%FKU?OIW19):;.U=O-N-9R]X.OW]0
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MB(CH;>A(S7G-S-JB@+@)^J1OK'OS/'/!&A665.O*U1N^?E\/          "
M9NS&S=NJJJW7PA4YZC8D01_UBE+_B!1-GK^!4UJ)B(A>4X<K/M74!1LU-"9=
M[7I'NTTWYRY9KUW["_7.T1,-RMF^7P,CQJAUMS!WI/J("8NUMZA>M:=O^OS!
M$Q$1O<G5-=QR"_7XF:O5?6B2/NP1H1Y#$[5D]1;5U9_6K=MW?/V^'@
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M\?D70D1$]"9F-TKL+CBFA6MVNQLH6G4-4:^@)(V=-%]E54?= .?G#'$"
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M-ZFZAEMNH9ZZ8*/ZA8W51[VBU+%_K&8L6*VBTFI=N7;#IV_B 0
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M;T+VYM>.I-A^L$JQ8V:[1?J#KB$:$#[:;9=]Z_8=/7KTV*=OX@$
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M9[:65AR_HE5;#FGTY"7J%3Q2K;J&:%#D6$V<O4P5U<=]\J8=
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M(B)J+E6=O.YNA!@_R[.V#HC3!YY%VFZ42)F\0#OW%^C,N4NOY<TX
M    8"Y>OJK#Q56:-'N9/NH5J59=0O1QGQBE3%NNO++3JN"D5B(BHI>NKL%V
MX;RNO-+3&CMUN=KWCU.KKJ'ZI&^TTF=DN5TXSU^\\MPU^;E#G+9MMOT+&[?M
M4T#L.'?4JVWK&3)\BI9LV.\&.=F-DXB(Z.6R&Q_RRQJT+O>(8L?.=G<RMNT9
MKC[!([1DS5;5GSJCF[<^>Z5OP@$          (!GV6S(V0N7M29GEP9&C%:[
M7I%JV3E8D2-G:,7F?.T_<H(-OHB(B%XRV\'Z8,DIK=YR6!$CIC^=#8GPK+%C
MM'+##IUL.*M;G]UY[IK\W"%.VZ[3SETO*JW6V$GSU"<X6:VZ!*MGT$B-G)2E
M55L.J;+^FL^_<"(BHN:0;9>]<5>))LS)UL#(<6K1*5!=!PU3S,@IVIM7K/L/
M'NKQX\>O]$TX            \*PG3Y[HX<-'RBLL4W+:;/4*2G+7L?J$CM&8
M*4N5O;V0#;Z(B(A>LJH3U[0^]XC29JY2O["Q:MDY2-V'#E=BZBSE%Y7KP<.'
M;NU]GN<.<38Y>?JLUF[:I<1Q,_51SW!]W#=& R)3-67^!N65G%(%QZH3$1%]
M;96>1;JH^IPREVU7\+")ZC@@WMT8$9D\20M7Y*CZZ,E7\9X;
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M^F4W)114GM&B[#T*39RB+H,3]%['0+7J&J)VO2.5.F6AVX&SX>P%;RRQ
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M]@-5FC1OO7H%C_(LSI%NC?ND3Y3Z!"=ISN)LU1T_I:O7;^KSSS_WYO(*
M        ^ 6[#G;CYFV=:CBGA2LW:7!TBCKTCU7+SD%JW3U,W88D*GW6:FW:
M4Z[\L@9WG<V.I&4VA(B(_#5;HVJ>SH8<*F_0UOV52I^]1MV&)NG#'A'N^/1/
M^D:I;TBR%BS?H).>-?#ZC5M>75^].L3YX.%#??;97576UBLG]X [4K974++:
MVS;:W<+4+VRLAHV;IVD+<Y2]K4#[BT^XZ54;D/'U-X.(B.C9:D_?4M7)Z^[-
MY8:=Q9J]=*N2TQ=J4%2:/NH5Y>ZRZ#)XF!+39FGE^EP5E56[ <Y[]^][<VD%
M            _,K]!P_=(&=9U3&MW[I78R;-5\_ )'W<)\H-NPR(2%7B^ 6:
ML7BSV\GL8,DIM]$7LR%$1.1ON8V]3EYW:]7ZW".:F;59P]/FN[7,UK3&V9 $
MC4B?H^Q-NU126:<;MV[K_OT'7EU;O3K$V>3APT=N5\ZMN_*5E#9;_<)&N?/@
MW^\2K#8]PC4X9KS&3EVF%9OR=*#XI([4G%=E?>/=%[[^QA 1T=M=T\Z;);47
ME5?6X(Y[L&,?@A,FZ:->D6K9*<BM9]T#ABMJY!2MSMFI\Y>NZ.Z]^^S "0
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MV3G8;8_=OE^,VWDS>?P<S5NV03OW%:BBYKC.7KBL6[<_>ZU;9 ,
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MEJ_;KAW["E145JWJHR=TXO09M^OSU>LW=??N?3U\]%A/_.3."@
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@K[JY0G\Y(OW;^/\!X0IOQN8-I7L     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_11.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5!=2>BBBO8/'"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?A^*T;F=CYDN#D;CV_  5Y6$YY5.9['K8ODC3Y5N=11117L'CA1110 4444
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MT<6/AN:\9-LEQ)M&>ZKW_$DUZ:/2O>PL.6FGW/G\5/GJ-=A:***[3D"BBB@
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MJIQ4$SPCX_Y_X2:#/3[,F/\ OIJ\IKZ%^,G@:Z\1PP7MC$9YH4\MD7[V,Y!
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M3N884MX4BC 5$4*JCL!4M%%?0GSP4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** //_C-_R*;?[].^#/\
MR)T7^\:**X?^8GY'?_S#G?4445W' %%%% !1110 4444 %%%% !1110 4444
G %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_2.jpg
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MB+9:(7,"-7!70ZMC='OV"-9J-/CS\[#^U,2Y./LGQT?NS+D35M&NUQMW] &
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M[L.'#^_>O7_[\.'AX=W;-Q]N;]Z\??L./P2(AI>/1B,D4OQ@KE,#VA!&\9.
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M'Y!PU^V[!\T9O>$01#,LP^[W)XOE?+GIC\;+S07H1M"V6@[&(Q6N3)4-VQC
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MY+ 2J^=LGHV\B78PF2ZW5_WQ;+;:++<7PRDZZ_%\9G9M"WYIV!N,^A.':'-
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MC%0WG T'TW\FFJWU+!,XZW>,CJZ :+:I=@R9<$UOVZ8D\I0DM/"I5GBJE(C
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M53+\*C 2_FBR0!PNVRP5,[!UR*I(FE_^\7>@V\'^J]V=YT";WW=TYC\Z/3E
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M[T5#_G0BG(P%X]% ,A4]#_K(N&<YAX)3JS<K,&NH!E7-%]+)="P8/D,(!=1
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M2)OI*,C"XF4ZJV6B:BJBQ0):V"/Z]N60NTHF6CQ6HU/Y3$2+^[5DT,J$S7A
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M1UU[NX]]DR6Z)'T$&@\'HWZOUVHVJY5&I=2L%&M%LV+I%F1,AN2Q))V,XM&
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M![58<B!S #7 64\$HA%U(MFBTQTVVR!B+3)2P_Q-/-RE4C4L5LW:4,L&2]E
M*>NKY *E=$"/'@#4K)B[E/15DUXP:$9PIQ0_*,7WS>B>$=T'F;%=,VHKMFU%
M-HW0NNI?4[W+NGM%=2W+ATO"P7,0L_>8V+R'K=_);=PF-N^0FW?PM1_32S=
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M^!VF,OIEH)\I8.4P!#4^V6/C72;>):..P,39BG8(B*6A5@YQK9'Q@@!JU21
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MOVGG3\K*U! N*]I97CJWQ#-3.-;8N0(YCCK5N6- F$R=Z*PS$X_BI\$>FQS
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MTXY+RLB>:#\'0JG,D4*#G &P# 9G!G^"EA=I1T<Z Y;-B:(+C3O2^5-+.K/
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M(,>O =IF,MJ'9!.-1F6N*G>D<<>ZO2D*%<1*1[IZ8NKGP#(;9R>&AI8OB^^
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M4ZF!/H;:>ZZA*MR/]3'1%KI\A P:^DUL"0L5[:::RARD:4#8@,WU60B>!&C
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MEDQC20Q/\P)-4G@B&?.' VZ_5Y+EO_V0?6F_4/OLB 8>K=MMU6N(:/,9NDP
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M-I_/VNUJIU.=ST9'B_'IR1P,&O1'"W!A<V#6?(:V<SJW"H# N#DX _L&7P+
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M:P)B#CR:<WD=>#3 F7/PV0RM:=+VAH'<5(3@B4V$S)!-3W@,;>J4&/!HP [
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MT*?2/B^B+19S(-IDTCLZ&K9;U7ZO>6)O37?V"8!'<R*GLZSIH,T^>^/=L4*
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M20*(MLUY=GC/KN#9$[WMJ+\M^=L17T<"HOGV6#EIBD T7R?B[T;)02PTC-%
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M-H+:R,==3R?1&5+Y>8"N 45"<[0E+=*/"EB]"-\1P:,Q@+:NR U%9B"&Y#I
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M3+1[.^XOHDE1(1H3&288C0FQN)A,1>$)413,6AX5/5/E<@Y 5BOE2[DTQAF
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M?I9+N5JU4"EF*L5LM9@K9E/Y= (F$#;1\?5J"=4*=AO]UFYW!_5Z+,?XJL0
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M<6L35D7<M ;N#(0N6C>M -1PW@3%# L1W:R@F0(QJ@EY/]I56CW):F8#Z.3
M9$@YQ2AGF*UI:G,JN#D=W)KU*^;]R@6?<IY0+OBU*Z1%Y??8 WXW&R)YFJ+!
ML'D<P8#/Y7(XG7:OUVVU68%?&&HP 1G-)JO=IC<:M :=SF@ '3<4NK?C?B0:
M_"M*,PPD4( :RX6322F?26:3T4H^E4U*$#D!9^#.:J4\( S<&;9I8-D0XTK9
M1C963XF52#@?]N9)>Q[^0H:<]; +(N<VZZSX#"W6!=H)V9N,N\5Z0 "UGHBN
MLVL+1$L$_+D[$M&1?&W)UT1O?$=;.M I MR- [,,S[%3@R?,CXB&G-J(:%E)
M7DJ+W<[%43.B_-%YJ2.G]E><Y5$U '"&5],@@>+ZP'CWQGXBNA]'O6I[$1ZK
M([!--KP3#L(3/J*>:'+C("SLSC#7T)P+=)E@APFTPOX[B0:3W2"Q'?" 4RNC
MH^G6$D -^ 5^C41[;L<JD>#13%FW+FU3Y&R*DDM3=FF+'BTP+NO6IIWJM!7M
M1P.BQ0PK,<,RAIJH01X-$TW43D=T,SQ 33D)-HU23 #.&#7XLDD0KYKCE+.T
M8B:LG ^KYBG-(JD"J,V3NB52N^+6K+JL>L)I(0E'P.<.47Z0V^6PV2Q -.":
MO(AF!8H!PA#%=%J51@U<@_=&DT&I52NTQQ[M'H_[E&@P,-$XGDDDI'0ZELG$
M<MEX)ATM%K*%?":731=R:;R.-N@T@6[E7+J03NP5<_6T5(EQ)3Y8"'OJK'>7
M\P'.R@%;WF<&5?S6-D?LT4 T5Y,AVIRWQ7K;G ]?_H0NZ!2)CN#I1HA.!&*I
M2][G(7?C )8EZ/T4=Y#F]I/LOESWE(D&V1.")W@T=#_F/H10B)\00M.H4<?-
M7.PFX"R7E)6Z@0YLRC>A%.1.&^#"LNCE39"\J^/O$FT4.<&@)>/[R*-%^H+0
M%X6A)'8%MLV&6W0(GCV1[T=8!+5(>"#2 Q%5"7H\0 T]Y>4S/U8+ITY4'_ B
MA8B=H+OFLU>\MK)\^&G<Y;$:<,A"1Z- )3_B79$PIFVJC$U=<AN*'E09R+G0
MO>L9ER[M4"6L6W'31M2X%C.NQ(RK$=VBH)D5U#.2;A[%3^U,1#\K:&<9Y35$
M-+!FFU.\9I[>F@YOS7":14ZSP*I!2ZQFB=$L!U6+X-0"VA6O:LFA6+1K-PBK
MUN<P^SU.K]L>#@7=;J?59C:9]6:S7F?6V=U.C1["IMYL,FG4"H->H]8J=0:U
MSJ %J&VHCHEVC\?]2#1<'X#?O-W=79:GX_%(+![)Y!/I7"R9EDJ%+. LG\M4
MRX7=>@6=?&I4P9TURKEFO=2MEW:R\8I$%SFRS!!5VE4BK9 ZMQE/A7*62%N#
M<@*_ &?;E',W[.[P?O@(@M2)@B?OZW+>+N_I18B^1'0A@48\\MX."J5+H%6:
M!Z+!\S CR!+EPYY8TO5,[" E':2BA^GH]4S\1C9Y*Y^2-Z"-^FW<Q/<2%'/H
MAI1Q?S0@5R9U T FL^Q.X4+!>&,:NC8EEAA&$-0&HK@O14 00M$!=8$;1H1!
M3!C$A6$,BQM&&=R5&U<\ 6%WUCIQ90!7/+<#3E3N)-$Q];N(5@LZ0?CL>MEK
MK7BM1;<IBVZW,Y0)2\ECAH]8.;<Q[=0E;,J895,RK4O&-4F_+&H7>?4\KYZ+
M:,&CS4?T\Z)NGM?,LJII$*.8896 N25&,<\HYSC=,I)VF=>N@ECM:DBU1&F6
M*=V:6[%@7KMF5RX21H5%O>$PZRPFG=EDL%K-#H?5:-(JE>MZD]8NUP<L-C/@
M3+&UKE9MFBTZO4$)$[U6I=-ICXEV;\?]2+3Q +1%)!YPEDQ%LX5D+"FF,K$\
M\"R5*!9RV_4J9AD8-)CLUDJ]O<9N*;.72U0B=)[V ='*(4<EB-;1T&6ZI*T*
M( NY]F@/)AH\.X"PT?7IZ'D7T091;U<B@&B#>&@?B);BP:/MI]B#- LXNYF7
M;A?D(^NX)T<FBOI!'@G=&B7O/KN-#D*-VJ7A;K>?E_(@U*L6;ST[PAD "YW]
MO&,I;;S5%GNWPV3B9C)U&(L#U(81A+/#6!35"B("DB3?;I<0]^-8/)+$8J)A
M00AM,3Z@&*@M,PYPMA-TH9/J05=#OD(%=]W 1!NWY0"HW4DTP!D\80Y0&\EC
M*1+FG,>8MFOC%L68:!'=$D MHEV4=(LQPY)D6,1$ YL&DF$W+^E76.4"JYIG
MM4M(FB5.LX*D764 :MJ5@&;%N35G7)ZP;,XYM>O*E5FS3J%5;RD5FUJ=QFC4
MJ=2;TU-7U]97+#:KP^5T$RX-^O+F^L:R5J_4:C;5BC6]6F$U:H_7T>[MN*^)
M!O^<2C$1'_9,9F+1A)#-)3/I)!"MD,]6*Z5J,5?.9^")Z@/E?*V0*<;%>C)2
MBW%%ELP%''G26@LYD4%#UX-;$=THQS9EVPT[]V@P:YZNX$5)4_"-Q/MZO*\O
M0@CU=$5W7_9H7<G?BP91N[0DAXEVF!EYM!O9",;904K$'@U=%I5/'FE$M%%S
M(9EH-XZZW8)90[<'R!MH 6?HM,#13C2 U_BD^@WY.-1HJVTB?B.1!*+M2U$@
MVC BRI)Q!@8MPO<EOA_C!U$L^;).B>D)(;Q);5\"OR83#:P9>#0P:[1W-TSL
M4.Y&P%GSVZM^U$=H9,=DC7O;8J*5",N88G@"SZK/!D*D(RP%KSGCU"5MZIA9
M&3-O1@UK4<-J'%4)UA(F5 :-&I=&1-/,"YH%F7=+$=V*H%D4P*EI%I'4BZQZ
M&<3KUEC=6D"UZ%4LNK;FK!LSAK4I\];BTK5+JPM3DU<OS<Q,S<W-K*PL*=4;
M"_-3ERY=V-I4Z/4ZF]-NLILU1LV6>F-S<T6UL:396-%N+*N6Y_K'1+NGXSXG
M6B\2%:+Q2#0&$N,)9-82\2BXM%(Q7Y'7SHK9%-BTG5JY7LH5,[%*.E:-\]M)
MH<P'TF T*$<E8 .B[7+>6LA=#MIW:,\V9=^C74W&W>9&M<ZQ^J*_+_@'$3_@
M#!.M+;H[:!TM,(B&!PD6;4E+T! \ 6<H@:;0Y0-WID[,,E0!0)*;"]V9.O.9
M&S+4;N:SXTN>KLLXPPMG([-VI(-$#'LWW*X6B 8X.XC&QD0;B".<_7VB2>A&
M*'1_RE&A (C69OT ,M 8;7LRU(!H8,'&[1ZQ[DJ=F&CPG>B;"0O8-'@"SN C
MO$=71GG-69<^9=<DK*JX106HDO2K,2.J%:"*@6EEY-%D:P9$ YP)&B#:JJA=
M$76K=Q&-U:PPFM41T13S]JTY[=*$87UN?6YR<6;BW"<?__E/?[QPX=S,S+75
M]<7UM<6K%R\NS2TJ% J+W6QQV1Q>N]D*67-=M3RC69A2S5Y=NW+^.'7>VW%?
M$PT" K!,E 11X@%MJ70T&A. :! Y@6C%?!8,&M[&@4J?Q6PUGV[D4K5D9#<=
M*7.!M,]:8PC 695RU,/N!NU!AP<88B?D )QAJ('NA!KX-?!H0YEH'<$%P;,E
MN-HB9,] 7PKU8PQNRR';- 'YM20GYTWI1C:*4^<=.$-$0T)GT4<-'=%M=049
M:G(WQX-T K7>SJ5O')U\PA<,7S]R;0 R/,>MMU$S;BF*!40#G&&B0?!$V5,2
M!M'1.II,-&X00^MH2.,#GK@Q-VYFR_AV('Y"\$1=TCPUTH%[HHT+ OC6NSM5
M1KO2K'72 0C#*VB8:/"R0ECECD.(:/C2]81-+6J7 541_8JD6XZ"#)AH"\B1
M:19X-1!M6=! ,ET3M:L1_3JO7\$2=&L@1KT<5B]#ZB35RQ[EHE.Y8%,LF+>6
M@&AG3[_WZU_^],2)QW_ZTS?/G/EH8O+2[,S$E?/G+WUZ;G5Y2:51:@PJJ\-H
MM6C,JC7=XI1ZZJ)J\OS&A8^.B79OQWU--/CEBR6B%!T21#8B"8FD%(N)8-"
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M P 'X",=-5D5G[5$F$OR/MN"&_5*.R*:/F'5 M%$S5K"K(P9-]FM!4&%B@#
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M$<E=$;UL<-X:6D$C<AY;QF4I>!WPC%ET@EX94JSR.D7$J!;TFZQZ-:Q8#&Z
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M7@7'K1 :A#R?T3 1BSF<-KM>)2.CI/!^([K?CNIQ(KN"Y"$_:<@XTJSM+#5
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M83]M-,2 A9EP#WG(B>TRH[M<E+'UC/9[:9UH_P/]ZT<]>?Q8R&(;E H6 <?
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MIWE"H_:()08Z0T4D\1%PRM @"3* [.F =[?"N]I0?1WPKE989QLPJK>+,#2
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MPO=T#M75]U36=U<V]->W#C2V]-36@?K66U_?V]@PW-D![>ON;VP8:&H:Z^R
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M&VEP#1VAI".9R,'6JH(SQX_LV;5G]\X]20!0VW?NW+5GQ\X]F[9LW[AEQQ;
MKJT[-WVS9>LW6[=\NV7C%]]\_M_^9>-7WVS^^NND;3OV;-FR=]N6CJ(L!6)
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MCH:)J!0-AV,0"E4<GI8OHB$Q(+&V5]=WUK?TMG8.=?9B(&-,%%[%Y%H%$KM
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M[9:=7V[8^ODWF_[XS;=_^/*+_^OS/X+QRPT;O]VXY=L-6W=LVS-47Z/#0[7
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M\L__[9LOO]ZR:=N633NV;=S57)"OPD+5.)@*-RY#)):_I'36X9M*.?U-&O0
M']("+;P*+\I!%&8#X\N+2-6EI)HR85^[8JQ?#ALT8A ^!C7$8?O83"^;X>.P
M@R)10"B,R&1^L<0G%+LY? N--J%4NCAL PD?$//=/&98QI_42*9TXB6;ZF[
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MX'65EY-VMF6E3.OX-UR*%:MHV2)8,H$LS%TV\V;5C"D%=4)."8A0OQ+M$]0
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MM:>-TEHO'^JU8: ^*C8FI-YP*-<\Z@6K>%)!C2M8#CZK/C=W_X;-NS__,OU
MD@P#NQURO[NY]-/=:Q_N+?]T:_'':]/O5B8!VE[.Q1Y-!>?<UJ&F^I1#@-T[
MCR<?*LW,K,O)) UTZ&EH+1&FQ(Y86+B G#-M5<6-$K^"XY$PP(<0D;*G%'Q
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M;P3MOTCM$>T?JLWU4MPDF[0I%UW:DA\9MZHN_^GM^V^[[;G[[A8U54]3Z'S
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M-N6"0[W@T,VCFCF+<@Y13QFEH"6[;LHHR1E&)O7BB1VB)>6"F*PW*NL-C_*
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M-9->3*56)B92).'6:(VB04%M_9^?>?:E^Q^\_NG9@%:_0)(%'SF%HO,XONC
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MS+#L0U<I6YY@[HV1P?2BVJN45I+"++H>3D"C7/"1I5!H'0Q:*  48X@&J3-
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MK\WJC3,6&V/$+/8I&YY#[1G$FC);LC9TTHI.FI ID_7[Z4[<O>CR+/OHM4
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M^1Y]_/>#V=EOD*6=XW?&RG=+\$\<!_+N9 I?IW.WXLD;H>B-4 1$6_=XD6=
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M7F426;A>KB)O42E5'A1+7Z>SMZ*QZ_X@Y*K7O^IT+UJMTP9]02).\-EA%BT
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MI^G_/@.B!:[%O=>0Q>?.9:]ER6U:M!NN6'1S!N642@(%#=I9EDM-L$A^\FB
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M<SK<!3N^US)T4==W7G+A"^;9CS[XV;,[=^W\R8ZF;?7_BF@P=3:":%U(F@]
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MY&FU+"3D!/BLL)#KYS!<=+*?1?-0R?KA >-(GYTX["2-ND@CX%J8@8]SR!E
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M,PI.4L).R[A%C:1B4$Y:M%,FS9Q..:D0%X7L')]9D0F -G!M&N4LPV?&F.0
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M\(DI/C'))<28F AM,,P<\! OF@?/FH?/VS"]=MQ06LH?-RC1ZY6*<;-ZVFF
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M9A?1[B?:+K ^8].^.K73U(G7WZ(2W#-$0SA#1$-0.R8:DK.7G0L)V317M&.
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MFW7E 2C]\KV4S-N)J3?BDJ[%)EY%#3,B@8^9(>'IP6'I06'I_B'@R])\@](
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M,WMFN7TXO'"<H2GT$OX\'X(V (Z!W*N<NZX6KJKX\Q+ZM( ZS>N:X76\9[>
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M%P]_5\] %_<  )RG5ZB7-^ L#&[<"8AH3FZ(: XNB&@(9\X^V)^%9&T#@(8
M&Q:7=$.K&\3W#?[R1(/W\>[]3$Y!641<AG]H0GA,!O K,?EF4@KH5D+2#52L
M'Y\5&W<E*B8S(@J(DT0.C//RC?4D1WEX1[H2PYT]PIP]PET\P]V(D>Y>D9[>
MT=[^0+3D\*C,F+BKR:EW4M/OI&7>3<M BD^^&9-T/3+^6EA,5DA49F!X>F!8
M>D H6+,TL&9^P:D^@9 TDT&804O"\R8 "_&+$(\*:(E(;O I4,PKSH40@]]C
MC\<X$R(!:@[N8:<>#80VK6S(<&/G'N;F$QL<EO#F9?80CS[&;/W :]]0]&VJ
M&9MZ_H9)MC4@/1I5[I@DA\/J/9,"4M5'I6">3P>WLJD2+4O8:S+.1P4'B+:M
M$4/JW-7+(75NJ,4?-;(MG6+/J/HTI/U^S/C#^, /XZ;O1@>.!O6')OVZ7/I1
M*5N1BA9%TDV%9EVJ7&0+ &H?J)Q5ANA HM^7#FSP5!^YRDVN;D<T\$GW;ELY
MNJT=WQUXOS<XO6>:VM".;6K'MN5#.Q+@W<"!:NA -;@M-7P4J%<YTG6.?).O
M_,B2;3*D&WVB=:I@J8<[U]X_VT:?ZV+,=O2/-W0/5K=.ME*F.WOG>FBS/=2I
M[MXI2L]D3^<HX*R]T=!:JV^I,7;6FKKKAZE-$_3.:78O[M$@=0+.T/(9AS[+
MHD^S:2M2'A -04W,7%'PP*G-B%#%[ 2K:ZR_S=!5*ZDK%-7F2^H*I/6%LH8"
M0U<YQ$QC3R6 S-2+#)JVNU+95B)I*!36YK'+L_N*GO06/ )UY3RF%C[O+W[%
M?IL-.!.4YX@K\Z25^?+*7$GY:U3T5_R,45LQIAW<WOSMSJ<_CB[\.J^*XN 5
M]G-SVY^=N_B-N?T)SIPA=>(>#<?9:?;\B4?#==*W]N1H)[;*AI53X-T? W !
MSBSM$-'PE5GLV#GIO(4G9M 0T<P1W;!VM8AN^'@!]!1&-P2UTU4VJTNHU2VR
M;)AKNVB+"R/:R;O"BT4PJ&%.S0YW>:C-$2Y$-YMCM%E!,CWQ:/CLY&.;9NN.
MQ<\3HCDAHMD[DQU<R(YNODC(=ODYN_D#T=P)09ZD4,"9AU>H)S'$S3/(V3W
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MEW ]/NEV8LK=A*0[4?&WPJ*O!45<"0C/# B_# *B(6L6B"K.<*C!C9<O,H"
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MSB$"\%;.N K&<<:M "":E2C $J'F_XL@TS^!YW,P1 6#AD3C2<(!9R".<QA
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MG,P0HLUT*B]WJ:YTRJ<U31"Q3N$F;--T4_WINJJ)ZM*1ZN,#-<7]-<>Z*X]
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M&#,BC)S]>2)2@:1;06.K!>";3ST:RGL#X( MU<29YT0.$+02HG'$2+0%.%M
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MF9QX?OK4IZ=. M0 9\BUB?%G)T_ $7X*:)L;&9D;&H;P$XA&*4:=&@4<A*@
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M)<+23AW1="S#SH[,I@&9HD)&0V%*FH$I37/]Y74T3/358Q;%%CVAD:8^U!;
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MR0P!-]AQLZ]M;K3G]H 6?-S<6.^3R?X'([WWQX<?3([.G1@#P<FC4Q./3T_
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MHK&_96X'5^CF!EO-BAL"(#;89&5 ^H\O-L&=!'W]AD3[XHLO<@N*>*)5X,Y
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M-=#U '/*, ,#MRQ'AV_T=#V9'+_3WWNKM_MV?^_=H3Z &NW^>&^H[^Y@+YP
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M!(J56W0*,@:DXO]G(8W^;_P'1*MO5 K=5G-))AK8-'-;5_B3X;]IYHXFUJX
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M#'S&OL+\QLPTP%E=>AIPJD^3UY&7U9B=V)B;5)^5T) E ZO+2 0A!OXCB"_
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MN3HKJ3HCOB8CKC8CMCHUJAI<SL1P(%I=2GA=*A*M@5A]\O9ZV;8ZE&FAH-2
M:"V)&^H20ZKBMY+=PYNJHE9I=P=KM@?*0_U3UGK$+'79$N#B,]_%SMG7P7>]
M3-7\V>G;-X=&[PZ^ *(-CHQ?'7AU=6CBS.VQGVY/?''^>6W?][ZK(N;R'=^;
M*S8PDAI@.R<F!UAIID\T8)PQS\:$F#'7UIAKPQ4X$J(ASI!H G!"&:)A,[G
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M=38IW6AW*GQK>AR-_C8H*[% #X=T3^492/+4-E#L&&Q@Z>VP**3IR!?7<</
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MTSH]:8\ZJ=?7&W&A-\.'!1Q"#8=>N./<,1RFB&M3WIUC_O8LTW=FF\XVL##
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M>3TE!11J?64(-6J ,^R4*@>9!AI-U:4&=::DX3, V<$R%1A"K03H)N\NS,:
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M2C3J;X+RTI=@] P<@#IC629FFG"F,@/DPSO(S&$Q306(R4)>$&N8^@17U(H
MSC9(;!W -?4T%KMS3(%HX(0"T;SYIM2\*-'HLLX!?3S]'_Z[=NWZ^LT19$K/
M5/$Q1^1,NF>MC#DV/*&]T Q_4V+25#%#FOU6*D"?:'A VF5)W\84R_X!T71U
M&XR)S;STXVA8.4V?11H&T.B/(Q,?Z:0Z<-T9/8P?&K19/<C4GF0>=5O3*>:(
M32O:H!6V[$E=A9I.V3G@?E)BOK0N3W]@+YUB1#ZR&&@"1@6V04(@1D##T
M<Y!)1$%4FL,BB3W\$9#Q<X1H;\_FSYHCY EL%BX,6KUN1T145D9V=5'%P:*Z
MCRJZ?Z@Z?%%[Y$KE1[>T[_]<<>1LT_L7CG]]^YM3 ]]]=^_4=_=/GQK\X8>A
M[TX.?7-RX/O30Z?./_O@ZWLMARXD*+I7;Y<O7Q^W)SPU.28].T:FC(K-V16N
MW+=/$QM=B%"+T";% M1:%5F=!;F]A8INM;R[,!>A5I)_H)S*-#7806W1X0J
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MY,CC4Y1QL<I(]#W+$^*JDI.:LG+:<G,Z%+G=!8H^\$"+%/TE\OVEBH/E>6#
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M)Z/W1T:!:/='QD&@ <YN#X[?&!@_<>5)FKK):L%B$XGC7!,+$RZZG#Q"-*[
M 22;(?:HDU%H0JS 8-K.]8A&X<6;/@B(00\P2.3$$SF"W..0; .F%$"RB9T%
MXOE\M&FH8HDFT.M=9\]34+(7H%XC8HK5: )=61E%&!C<'52IT5@;=4CAF(:
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M^ZT-O>9ZG:E.9VKN,]=U66K:S)5:8UY59_BSK+>^6._L-7&,TM]9@X,9@5F
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MI]NQM"<63?.>K?%!G"'11!*,EBX< []H#<,Q!<XP>,(>1M%]>(#:/]AC_ )
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M90Z03/M367F15MOXNX-H\,0WEJW@!1I'-)):I-&PAQ1/-$=7;Q<%5]9/GX1
MG_^>:,+'3Z] WX7+R!"BR5D#2*7O#)7?3(*:TGN6$MYW9@KO()G'=-[8"%%>
M:1/12+XI6)$'>?[X@?T"PGZ%9<*/%-AH92;V[03CIJ:S>B9F2NQ8*\YWH[9"
MU)J-@]H+B>8H#;1S]A6(-F7VLE5?(]%NAF=',J*EI"/1LO.Z@&B@T8!H)96V
MZGKLW0H(:.TV=O=;2*-U]9MT_6:0:2T=QJ968Z/6!-*L"0V)5MMNJ^FTU7>9
M6[H,';I^75=_7X^YJXO!KLF26V:X&=FX]U3:\2NY$7':Z/CZA^%IQW<<V[SL
M/^M#%WP[=]:.17-_?#-XS]NA!]Y=='39DI,?O'GRPS<N_N>]*ZL_OKSZX_,K
MEMU<_<GM;SZ_\]U785N^OK5]0_B.K1'[]R>>_SG]=F1A?%IF8E'$T\HC9Q(_
M6GGNC4_.SO_LTISEE^>MOO[ZAEL?;KOWW=&XNT]*XN+RHIZD1#R,?? @^OKU
M\*LW[OU\[?[%G^^>N7CW]+GP,Z?OG#U]Z\*9\,OG[]^X%'GS\N-;5YZ$7WT6
M=BGJ_)%;:U?O])L8; <"S1EW.7'F.780&DHTP0@Z+ORH% %G0Z06 0X?HQR$
ML^%$PW0*7MP)B2#.+/.#C(@F%4H%1"<"$0TT&JP*(AJK]AO0:$0TT&@ -2(:
M^,M@(^T]__HOEY='J\"G=F5;G.1CT5\H8[V&1$2;S.=U"IGJZ'Z" ==DZ,UP
MJYI-SZ#:9ZJ&9JVQ>($F&!]3PQU/<DLIC5;ECU!C,BU$$X"!-JH9H-T#(AIK
MRT'U\"*OLZ6UJ:T-P?3[H%967O':M-<UOK/8['C*686W [ RB4:<.LG\[5R\
ML4#'WMW!V<M9'CCP&0PV M9PB@VQX<^B X(:QS(1T51>,Y0^(J*QS6 ^4$4-
M_LE8D@>&_Q@0^:[<C&@XAHNN)"I?+C0@A,E>B+,A#U#P%0583PN_U"=([CL3
MC#@E&D(1I$!^#1CKUHTFW$-Q-.P@BDE_G-?I*!M+3>A>L?<8(PF8&/3VRF\.
M' &-=C<[,KHJ(5F+1,ONR,K391?JL@JZ<PL-Q>6VJN>L&W6'J45GZ-9;>O2H
MT7H,:+H^*_J>G>!^FEO:+=HV2W.KI:G57-=N>]YI:^BT-'<86CKZV]I[NG7&
MOFY;;[>M6V=KU%J+GIOOQ3><O55XZ$+&Q;"26[<++QQ_N./+'S:^N>S;A?.W
M+9JW_?6Y.Q<'[UT2<N#-!4?>671TZ>)3'[QQ[K-WSB]?>F[Y.U=7?G+SZU77
M-JZ^N/&KL!^W1QX[E7X[HCPAO[:@J;RX-3PB]\RMG!U'HY?^Y^2;R\\M^OQ2
MZ*HK(5]=#?WJTD=;;FX]\NSRS90;UZ.N7HFX\O/]Z]<?7/DY_-KUAU>NW+]T
MZ?ZY"_?/GWMP^=S]*^<>W+CX"$%V+?K.E:=WKSV[>S7VUN6GYX_=7KWJ!\_
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M@BO[P/ C])CNHIGHZCZ9VQE@QC*AN4IU$=3H'HYH(+"5?.4'$]Z86TA)(8)
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MY,<GE,0GEL;%E\<G5";&5R4G5"+(DBK24RLS4JLSTNHRTNNR,ANRLQJSLIN
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M:?51P;3!C8EFA7?I38"4$$V$B-:KTJKX-$3CAMT;$>U0D5=K;=7Q']+%W>A
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IX$T>WLMKXJ\AI,^:^($$>/EB#OP/<=U;^_+*[$8     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_3.jpg
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M3V-20B"PJ*B(W1RU6T)64]!IMYI,%*662%&+6B"6\8228TF\1![*88 DN >
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MM!YX!'E-JS,"C'""!,<$*(0H!X\123" &BY7DDK:H#-9C!:/$_R02:NF 4F
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M4I0>JBC(&!T^]?K5 7,!2[;M_6F(1=*GH1^N?M/9WA+V^X L"@RG25K"-(R
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MVJR;(DF-2J6E:;U68](9#!JM@=98='JS1FM4TPZ#P6,QVXT&E\7LL5E]=DO
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M8T.EV9-5^0LGP"*5[[167>RHN])5_W4O!+=6P!#4M<&_D#30\6Y&TE#WC=.
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M7R:6J@DB9#671 (M62E#);ES=25+]:6 I.VVZ@N=]8"D2YVHG?15=^-W/2U
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MYXTQZ*S/!3<@N %(??>9][W6'8]YRV6*+5/:<AN^VC6?K:H5J^R]43ROX<^
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M$-]L!S[SEL=F1*/1):7DXN) :],B&K7%IJVI9?]:_1"W2+];Q9%TS76^MQW
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MW&M$6MF&4;EMT6Q9U%^,BJ]&10Q)&U;-9E0;%LT7D_J+6?/-JMMP&-?,FC5
MDEZYJ))^U"F7E-(YF?"=0@2VZ+6$/R7DS$CXLW(1."80(.F]4KJF5P&23KS.
MRQAQAOO@"FP"0P1(@H!VZ+&?0HX+NB_[D%CWUU 8KA<1WQD"(.]9G^^LSW\:
M@1L_Z!Q"7U\ @5' <^SW0,H#>%W ]X:]/_J\%P';9<A^&7:<!ZP@N %"743
M-+D0?]3O.H>\YK><^,QP/0_:D,_VNW<\EF]>EQZ/(5668W/NS! H^RSAOE1U
M/#2$'$P2=TF_6<61=-UU=GHP-3F,);XF=C_KZ@PVU%HKRUPMC<:V%FY]0T%J
MVOWTS,Z*"AN+VB]B/I>R7LDX$U) $F]"Q'G%9T*, B0M*O@?->(UG?0SXH\
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MG+,BB*B@KOU=PC<F[O.O4UX!G.JGWIHU:;'!8?6OGF>,=XRYX#8!)*UXS2L
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M+9<<AJMN\U67<=T#M2D]"#J@U;>@ZV78#6#T*N2&.I62H<U4>#,1!$CZ[9+
M%?#HOT@*.!Z[K1LV_9I.OBP7SHOY%2Z]P*9<=UGN!=P/0/E=MUW6BSK5LDYU
M3JLXKY-?,B@VG.:G/ONK@!.\%=2364A\J:0_EU/0%M]4Z$L^\;68VBTFO]=R
M^W/E?R[,_5J:_CE?>QWQ;0 D :/D<WZ*^'>3H=U$:"?F_Y:._"@F?Y8S $F_
M:Z^8 FSZ6<W^J&0@),T")$'/L]VMIG>K&:AJV>U*<K.8>%^(O2O&/DZF 8]>
M%",O2]$GF=#E@"-CT5@YM+Q<^CB5V;IXZ9^]^AE)AUIU)!TR??_^_?V;@D$]
MJU6O:+5G=29VWP"IKX\,&Z&AQO5\AH7'< E828TTIY84M)(%AV'):5QV&L^:
ME!?M^A6'_H;;=-MON^>WW_/;G@1=S\.>EQ'O"W -NU_'?&] 1;UOPIZWH$)0
MO8MXWH1<;X"E\EDW[(8;)O4EC619)5X0\:;YK"J7L:Q3K%GU:R;]FE&_8M!>
M-NB6U,IIJ7!2RI^3"R[I%.LF[4.[\97/";+AVYC_3=S_'/I9@8^IR(=H:#,6
MWDR&OE>RGW/QG4(":D2HYMZ&W.M:.93= JX/(>\6X&/$\RGJV4D$OF8B$)+^
MATI5R"Z!' >\TMY,[DLMM3]7_#:=VRZGMDOI[7)FNYS>KJ2W:IF/!\[H63;T
MIIIZ5H@^2/L?%V(K46_&JC:Q*3F-XG&Y_)^GS^M-28=<=20=.OW<VWNRO)22
M20L*65@HI \,X/IZ6!@$%X\V"CA:.LG*8_C$G+A"4#(JYR DF<[:#9-J\9)9
M?=EI6',:;GC,M[S6VQ[KX[#G:=C]-.1^%+#?]YB>A.P'4]V^UQ'7ZS# D/MM
MQ/T^[GL>M#_U6V]9-.L6[:I!<4DKN:25K:CD"P)NB4DM<1ES4M&D@%?E<:>$
MPEF%8DZEG%+**E)!5<Q;5$DNJJ4WC)J[-N-=N_&1U_8DX'P1]KV.!E\#'J53
MF\GX(Y=UW:"YHA#?-FH>.\WOPYY'%MT]H_J)R_HJX'H7\;T/>S=COLUX8"<3
M^9J/[Y=3/\JIGU#+4N9'+7NP4P0ZA&1W*KT[E?U4BG\J)G8G"SN3N2^3A=VI
M(N#1)^C,_^3+0O1I%GH\]_U,\$[">RWFG7(:4V8-&#&_1+!Y\SIDD>I(.MRJ
M(^DPZI^][T^OKH6U*BN/RT' T7W='#Q&0B/KN$P5E6A@TTPL<EC"+1J4%:-J
MP6Y8M!L60()S0,^V7;'KUES&&Q[+NL?R , (?/X#KOL^ZUVO^6' ^C3L>!%Q
MO8RX7D5 H'._"KN>^"SW7(:[3OUMN^ZF5;MJ5%PQR*]:M-=UZDMR28W-3)()
M608]1B3YD&@'#&Z!P]TD8EK(+RNE):F@)A/.RH7G-;(5H^JJ27W;:;[OLS\*
MNI^$ R\3B56#,87'1>!C*30\BT-6R;@;&MDCJ_Z^0?DNX'CFM[]/0''O4R+T
M(>X')NM]PK];2'PK'E"IFOYQL%D$VD8["5(;<$.)K].YETG?NTQXJYR&>B\K
M4*/39C7]H9IZ5TD^R89NAUVWHJXUOV4U:%L*./)6'8BZ*BJ^Y'?\J"__'P75
MD71(]?/'CZT/[ROQ"!N+0@WTL7!HDTA@$G -;(::1C2S:3&%J&C2EHWJ&;MA
MUJQ9L&@/^KF-EVW:5:?ANMM\TVVY&X!.YM[PV6^[S?>#MD=AQ[.HZV7<\SSL
M?!D#@<[]+.AX[+="/+)I;MFUZS;MNEU_RV&X9=??LYI7U:IYD2!-(7G@""\"
MY47C7"B,>G24TMA ;6JTXC I,:\HY=?DPBD )H5P22N];-)<=YANV$V7#)H:
MEZ-N;;/U]18IQ#D>>Y[+/"_DK,J$-]62YP[CQZCW?3+X.1_?SL<^)D,?DL%7
M8?#[.#]E([N%^+=R<N\ 1M F6^AX-JB^S>2V*\D/N2CTU.]*9J>6WZD5 9*V
MI_)O*_%7Y?B37&C9IKZ3\M]*>&\D/-,><T@M"<A%8CSRVKGY/X>XKD.I.I(.
MM?;W]V=*6?A@#Q6-,(H%2CK5R&9JR,207!*6BS-Z5=&DJ1K5T\ K 20=++VM
M./17#N+;FL-PW6FZ&W""6G>;[X7L]T/V1Q'GLZCG*8#1P8.5'@<<ZW;M39L:
MU"V']I93=]=CO.<QWW;H;U@-JP;M1:5BFLN-8W&VX5'3Z)@%@;!A,48$7#(T
M(!SJTV,0+C(^RJ;E^9P"EUGDT*<E_+,:^;)>/2\1SO X-1KU')=S6ZV\J9!=
M%O"7N>P5B?".00ORVF8RN)4)[Q3B7XJ)S[GH5C[Z+N%[$_=^S(2V<M'=4G*O
M!F!4_+U]!%KRKR1W)U-?IS,[DZFM<N+K5'ZGF@5@VJYDORY6/TREGQ<C=Q+N
MM9"EJN%?B[MNIGQ7\V&W@)FW&.DCP[?65O\<W+H.I>I(.M3:W=F9JQ8)\#'T
M\(""PY2221HZ34^GN01<-X\5E@ES6D7-K)TV:^;-FF6G<=EAO.0RKK@,5QSZ
M58?^FNM@JCO@N!NPWPU8@5%Z&'8\B?RWO?MQ$ 0ZVPVK^@9 DEU[QVV$PIW?
M!E+>@5$R73,;+JM5-18K0Z9Z$4CMT+!Z:-@ F["BL58<SD+$6<EX*Q'CP*-B
M+%I)R)F6\N>5D@6E!%#I@D:YIM6LZ_4;)N.&V7A1*%CB<L[QN=<TBD<NVYN(
M'T2VS_G8=B'VN1C_4DIN%^,?<Y&M8OQ#+@SPM%-*?"VG0'VKI$%JVS_(;H!'
MWV9S7V>RNU/9K],@LF4^E5*?RID/U<S+4NQI*7H_$UQVZZX$K=>3GF6?:=9G
M\DO8);O%*1$_VKCSY^#6=2A51]*AUN;'#^E8"(^8&.WIYN )4AI52B+910(#
M@VKG,@)B?L&@+N@4.96XHI4M6'7++M.237?>85AQFU?=YNL>\S6GX:;+=-=O
MW?"!*XAO5D"EIU'WXXCKKM^VX;.NNXPWG?J;+N,=G_5^P+'AL=YV66Z[S.MV
M\[K-=$6KF>'Q\@QFB$!R87 ZV(1V%*:?0!J0* N18*<2K62<!8_RT8EI#KTD
M9%?$W$F)8$8BO*!57]9HKJ@T*VKU>;ELEL=9EDO7].IUL_ZAQ_8A%?Y<3  >
M?<I'MPHQX'JV2O$=8(5F\N#F,[2:EMPJQ &G(#8=G/P//9ADOOAE"FK.WIW.
M[DQF-\NIS7)F>S*_.95_48P_R(2NANR7 ]:K<<_ED'TEZLJ;Y#8VV2OA>Y2R
MKU^^_#FX=1U*U9%TJ/7]^_<+9Q<E7.Y09R<5A6*A,708S"+@&U@,,XOJ$7&3
M6D5&IR@9566]HF90+#J-LQ;MG$5[P6U:MNG6W*;K;A-@S;V [7[0<C]DN1>P
M +MT-VC="-ANNDVW_+8;;M-5A_ZJPW 36J>SWSIX/-PUA_FJQ7#5;#BGE,_+
MI#D6RT\@VK%X(QJKFD *^H:$0R/BL5$U&F&C$NUDG(].CK-I62XSRV,6!%Q0
M>1XW2:=-BB05'K\F%,R(A< WK9KT#WVNIR'/A\SOIQ(DH<;K$L2CSY7D5B6Q
M,PER66:["M6'?&RGF@%_"@K8J-U*8G<JLU6);U627V>+T)1V.?6AG'Y?3C](
M!A^FPP]RT;6P:\JDO)8,K,2\BU[SI,M@99,= D[ J-OYO/7GX-9U*%5'TF'7
MRL4+7H=SK+^? )N@PQ%T^(2!SS-RV38>R\*F);3RN$J25DOR.GE)KYBT:";-
MFII)>=9AN.@Q7W$9UWW6.P$;P-"&WW0O:'X0L=\)VFYZS=?<QFL>\YK7<MUO
MNVS3'93^G%YUP^=<<]HN&'5+&M6,5%3B<W,\3IS%MF*PHH%!R=BX&([@C8[1
M>_O80T/"L1$=#FTE$=PT2HA!#]/);B+.3R,'6'07A:B9&-.CD&8DTCX.FY)*
MEO7:58MQW6EY$0ULYN+;^<3G0N)],K29B^U6,YN%^"OH@9>!]^ F%_M03GZJ
M @"EMLHI "Q@E[:+ %BI3Z7X9BG^928/ON'S;.E=.?6^FGV0"MV,>F_&?>OI
M\*Q#7[-I;A1BTT[#?,">T,L-'&HU&=G9KB/I:*B.I,.N_?W]J7(9((F!Q5(G
MX"PDPB3BJ^@4.Y]MY[.\8IY/Q U";4K"@EY1-"J+!D75J)RS:B]YK5?<YAM>
MZRV?[5[0ON$S/HC8[H;L-_V6%:=^R:):=NC/6C45A: LX]44HBF5=-EJ.&?2
MSZJ54PK9@EY;E(CR(J&/2K'@\;R!?DI')Z&C'=?>@6IK)_?VXCLZ) B$<'1,
M.@'383%&+$:#G.#V=/$'^_E# RH,DCLZQ!L=ME,I;CPNR^<5A;PEG7)))5TU
M:MYFXF^3D<UL_&,Z]C&7V"JF'P5=#P+.)S'?ZUSL12[V!@2WZ<+N7/G+5 Z:
MPRXG0.W4H(EMX))V )*JZ2\+U;?EU+MJYF$V=BWLNAKQ7$\%SX6<!;-BRFW*
M&14+(6?1;M!QJ-/YY)_#6M=A51U)1T#Y=!H+FT /#3.0"!X.HV8S5'2RB4,/
M:V1:*M[*H7H$+)^0G=')<P9%3BNMFI0@OD&G=+M,EZRZZR[S_9![ T2VD'7=
M9[[LT,X99$49KZ@49B2<G)175HI2/$9-+:^IY%DA+R?DY\0B)P%OP^.\#+H"
M-J['X^1H-+&[&]7>RAH;IP^/X+NZ*0/]G/%QWO@X8V@0W]'.&AX2P6'4WAX^
M;)PU.,@9&:'W]U-Z>A0(N)=&";,9&2&G(A=.RX17+/J+.N4=E_UE(@3J6<S_
M).9_G@P]3@2>)$-/T@>]10'[HX3_>2;\>3('O-)F,?8Q']FII;_4TCM3N2^S
M^=V%\H=:]E4I^20;>9B+WTZ%K\;]YP/VJE4=D?.6HAZ?A)TU*7-6G9"$KA42
M>_6M;4=$=20= 5U?714Q6=B1$0&1(*&0%'2*CDW7,RE>F5!-PMJX= >/Z>(S
MHBI15B\OF905HV+&JCEG-RP?Q+%;/OMMG^VFQW#5";[4S.LE"2XY(V$'6&0O
M@QCA4$,L<I!%30HX,2XS)>!'V>RD0*#'H"T4L@:+$8R-\L?'Q1@TMJ>+.- O
M0J/XL F )TI_/[F_#]?;,]'6.M[:0AH:H@X/8;HZN1,PP"G!^(1@;%P&1VHP
M:"N9$&#3$T).G$O/"=@+&L4ELV%1*;MF-VWXG;<\]JL.T[K?<2?BO6PWK(=<
MZV'W58_Y43( >:6IW,Y4]LLD-*L-_-%6+052V^Y\>6NV\+Z6?5Z(/T@%;B4"
MMU+A:PG_^: CH>1G38J<5>67<X(R;D0CY1&1JY?._CFF=1U6U9%T!'1S;54E
M$  DB2ED@"01$:=ETLP<II%%U]')7JG SF-:V%2W@!V6"T%PJQA54Q;-K%ES
MWJZ_;->M^VUW O9K;L.*0W?1H:O(N2D!O:*5!=@4)Q478%%\=)*73C;CT!8"
MUDVG^)AT(P8EA4\PAX> %4*UM9(&^K'=7;"F9DK_ &=TC-330^CI)O;WH;LZ
M$1V=/<>.P]L[R4,CZ)Z>H>;&B>X.ZN"@#D?0P%$.&AU 38&"&PB8BE&7DXFS
M0GZ,3IE22L\9M&>U*A#E+EKTUWS.%9?YO%6W#)WA:[[BLU[W.^Z&W:^*B=>5
MQ,Y\\?-DZDLUN369_C*7WYG+?ZBE7Q9C+\J)A]GH];#KLM]V->$_Z[--V@U1
MI7 NZ$P8I'&]Q"WE*JDXO9!U_<JY/\>TKL.J.I*.@':VM^PZW7!'AY!,DM$H
M+!1<1B&:>1P-G:(B$X!7<@NY.BK!RJ:'Y:*\7E'4*ZH&Q91!><ZJ77$8KKM,
M]T).P*.K7LN\_B"R*80EE3@B9#EH1#^+ID&,:Y 3<MB8#H=6(>%F$EXT,B0:
M@U%Z>@E=/>CV#@9L M;:-M[<0AX<HH\, T@1>WL(_;VTD6%X<^OPJ092[Q"I
M;VBDH076V=ES\@2VLTN#!6\RID)AA..C*@Q*,CYJ)Q,S8E&4Q?00L#;$1%4J
M.F?2GC-J%[3*18-ZS>N8UROGM(HEBW;%9W]63+XH)IYDPS<"EE>EV,YT]CLP
M1[/Y;XNE+_,%@*3'F>"S8NQ1/@HLTN6@XYS?6C8I,EJ)@T,!%FDN[$Q;E&X9
MQR[A"HFH[4\?_QS3N@ZKZD@Z&BJGLZ.=75P"4<-E,Y P.8UL%G!%>(R)PW2*
M^&8V78Y#V3CTN%*:U<JR:DE1+9T&2+)IKSCT:PX]<$FK'M,EE_&L15/32/,*
MH9V$M5,)1@):CT/+8:,& E:-1;,'^AA]O<*Q41E\@C\T)D-@V2/CQ)Y^5'L7
MJ@L$M Y45R]E> C=T<:?@'%'1\03<$);-[5GD#T\(89C"=T#PPU-(PV-Z-8V
M.0)I))"XPT.<X7XM%A46\OULIA6']=$I%8TR*^9'F;2<@%L0\<L2X8)>#7Q3
M62HX;S6<->L6[<8EAW$]XE^/>"\Y=)?MVK>EQ/>YXH^SE6\+Q<_3F:WIW-MJ
MZD4IOI'RKX4<JS'WN:!MT6=)J/@YDS(@XY3=!N"2@FI)0"41DW'O7K_Z<T#K
M.JRJ(^D(Z/OW[XE@9*2[EX) 2FA4,84HIY,M8H&43%#3R086S<9GF9A4OU00
ME@J2"G%6)2EKY;-&U;Q>L6Q17_>8[T4]RS;MI$I45HFK&BD(:WK,1%# MM-(
M&C1"AH!I\#@!;)S:V\L:'I*B4%(44@)#B,8FA# $;WP"T]:.Z^K"MG=0^_KI
M WV4KC8=#JM'HVPDLA:)IK9U<@>&U3BB#(U#MK3B.SMX(T,6$L%"Q&E0,#,1
M:\"A[61"D,WTT,@&-"(M%?DY=#^3$J"1"U)16L!-<)E!&LF*GDCRF!65=,YJ
MF+?JY\W:::W\LLNT'G*^S,?>%A);U?2WN>+V9&9[.O>NFGJ:C]Q-!U9#CCF[
MIFJ2SKD-DW9-0BV(*+@+86=<*PXIQ68>*VXS?=VM]TD>&=61= 3T[=NWF<HD
M&84;[^D3D,D"(EY$PKD44AF5)"/A;4*NF</P2@0!J=#-9X4EO(Q*4M!(IXVJ
M69T<(.F&UW+9KBO*N%DQNWI@D?3(<15\U$8E2<='%0B8"HW2$O#<L5%*7R]S
M:)@[.BJ$P11(I&!T1# ZK,5C&3U=(-!!R_P(N&ILR(R>B''H.2$W)^0!K&B
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M]/7"XT.863SG,E-VB2:^SE-MR$SK$OV*5#5-8U6IM!D^=UXAKHGX<1#?**0
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M__?VT>_?OKKU<AV?11H;:SAVXO2I,PV-S:V-+>U-K4VG&T&U-#3U ._4W K
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M]^YM_#E,=1U-U9%TE+2_M[>SM?7R\<.UI=F%1#"KD:?!!YO'=C"I>A:#B<6
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MJS08BW7ZYDQ/D597H-/9TM-<2H4J.3F%QQ/0Z"E<?BR=DQ@C9-.8)/ 5DRA
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ML^/]D].=@\.=O6T_<$I+ZPM3VS-CZX-WG]575XD2>LTJ@*0[+L,]E_Z>4_?
M;1CR6@"2[KF-]]RFVP[=':?A$DG7K2#?&2 J.2%!/'( 'D'K=)=VZ:;;=--M
M!",4T+S6VSX;R&@0DH!1 DC*=EP*\ CH49X+6"3 HXF*W(FR[*FJW-F:,)+J
MBY8;2P"/+D>@M9;R];:*^28(2:OAU :0M-94 C1?DSM1FO7 9ZO32/6Q,408
M'/FK*Z:TY Z?\V%]Z=*#ZX&I,?_BW+LW;[_X\KO?_?%/2ZO;B2+7LXGEMV\C
M)T]^3A5!TC^DP#OSR=GI[,[!T.IQHK$01I.@Z&H"SX:D*^ 4*8&M(0MM<*;R
M/PAI,)::Q%=&$1-@%&D468RDBG$L.2O%4=%Z;^K%VK8_N']P!*@$QO_1)06V
M_-M@W [L0.<"!$.[>T?[AR?'AZ<7!Z<GX&G */G7-E9F-UZ,KXX,KCVZ<S,_
MLTJ><AWBB^ZAV_30;7B8:1G,LCYP&1]YK(^SK !,#S+-0& "GG/79;KC,D+;
MFL*ZZ= #W7(: + &S)H;=MT=M_E.AODN^$2O#0(09(ML]WW6P1S[PUP'T.,\
MUU"^>[@@ _!HI"0+\&BJ.F^BW/<7),W7%ES""/BCR\DJ<$S-I?.-A8!*ERYI
M,XRDE8:B%Y79H\69=SR6"GFZBLLF(I (@*3TY.[<S.&FVJF!'O_4^,;<S&XP
M\.F+K[_[S>_^\X??NPNZ8R2EQ0T/-@,''SY$#GO[/"J"I']( 22]__#Q1>B]
MM6P S=>CF5H"SPYC6J\RU/@8$X-O@M&D5XFIT401*2$3QY;!24DHNCR*+(HF
MIL IJ3B>.KNR=VQR:6EY#>0R@*2?N:3M[6 829<*;@5V=D!\"_NIE\?G)\>G
MH;U08&=K;6UN9>'YVNS8PK/!Q<&!CBQKLUX.?- #IW'0;;H+S%&FY9[; ) T
MY+4/9ICONX!=,CS(- $]]-@>>JP/P$6 GC^#"0C :,"J&;!I;@!7E6&Z!Y"4
M9;D'.2, II^0]"C7"7CTI# 3Z%F)=Z3$,UH*D)0#8#15E3-3G3=76S!;DP](
M!!@$G!& T26>H'ESV5Q]P4)#X7(3R'%E&RUE@$?+]84 22.%&;?<YA)QLHK+
M(<*1B"M7M,GQ7;F>9VTMX[T]JR-/=S?6MC<W/G[\XIMO?_/#[W_</'B%BC%P
M9>7)NOJ6OJ<[>\?O(XMQ__850=+?O\ W_<>/'T]?OLVM?X"-M>!Y%AS+@>%F
M4D6%3$41+L:&IRL0E'0X,1&&3XU352&9"C0U'486P2D2!"4-04V[2DE3V$L>
M/IU>6=T   *Y# BP"6AG9W<[C*3P;24_4<D?".[N V2=' $F 2B=G.X=[@?W
M@QN!E;7UN965Z879D?F1^Q/7VEL=^CZS^J[#<->IO^DT -/QT&,!/!KV.9YD
MVX< 63),]S.,=UWZQUGV(8_]<:;M4:;MH=LRF&%YF&E]X#;= 9'-90"ZX=2#
M3P<P ACZBSFZ'($Y>EKDN=1(,5#F9&4VI H?U-*&!(Q2[FI+^5)C"6#3=&7.
M8D,QF"^'6TO+K:5K;>67.P" 10(\6JS-GZGP/<ES#=CUA6F)"C8+#T/ ?W5%
M$LOMRLU\UM;^?.#ZPO#PX=;FZM+BQ<N77WW][1_^\.,//_Y8W-1+$%J%^B9B
M4I%06U/?]61E/73^\E5DH\"_;460]'>NCQ\_O7SU[OGFA=[;2DW(I,3[V$D%
MG.0"5G(.@J6/IJN15!F2HD101"B*Z"I9G&BJCP9YC92*HDJ15#F" D9)%"&1
MEVCHO3DZO^+?\/MW=H]V0\>A'>B@V^U@8!.ZO6T'\DH!2- D"$S281A)IZ=G
MYZ=GIX='![O[X#D;6UO+:RNSJTLS2Q.CJZ/#X[UM3295KU5SW:Z[85;?<YE
M3'OH,0][[4^R'4.9E@<N8)$L@$J//7; (,"CQQY(0SXG@!0 TWT/I =9ED'
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M&Y (F",5DJY$TN5HI@I!ER%I2@1-#M 314AAI&;QY 51Q#0$*0T%138Y9*!
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M>/,1T'BY;[+2=]DV@@1<4G4.I,O@5I4[69DS"3)=3?Y432[0I5&Z;'(O-Y9
MNR5;RP&2YNI 9,M;:"@&&?!9B?>^S]9MUE4HTYT)_%0RB0)'H>!(7#1P286S
M]VX^OW-S[M'#Y='Q]>>S:S-+P;7=S=70SM[9IR]__?O?__Z/?_C]U[_^P5O6
MGZAO2##U"FPWA8Z[%%$C(;X$Q?5B8K/YZL8X?2M>Z$.P3)A8'SZ^A!!?3!9D
M4X4NK;MV],7&FW<?(W;IGU,1)/T_%;!%6[OG"YMO[@SO6;-[V6E9:+X1SM$C
MN29<G!U0"<VS8W@.+,]!X+MP8,ZUHK@6%->,8H+(I@%"@9&F1-) (I.A:!(4
M513-4$&K;^148IPM3E-VE2C&T0&MTA%4,8HB0U,5&*H<#:W*25!T"8*E*&JZ
M-SJU.3.]N+"Z-KNQMN#?6MG:6EW;6%O?W-CT7R+ITB(!'KU\^?KBY1O H'=O
MW@,>O7_W$1BEUZ_ E=?G)V?'^X>[.R'_YL;*_$Q@:69I],'<PVMW\]P])N7]
M#--CCV4T&_B@K.&<S.$\S[,"]U@80\^!\0E/@,!DK-@#!, $8>C/@BZ69#TK
MS8)<4KEWJCH'ZA#5%T*JRW\!>/1GKP3X,E&1#36\J_/&*[P3%=ZIRFQP?3$<
MV<*[M\N66\J7F\O"5"J<JLH=*_$]+?+>\]JZ3)IR6:H]CIM,P--16"P"C8=%
MWVMIF+I]?7'HX<S@@Z61T;4PDM87_;L[IP=GGRX^?/_5E]_]^,<__@@9I>7_
M'9=.22HDI=6PM5TISML\;0=?WR$PM9/3BD".0_-=!$$609!#B,\G"/+1/ ^&
MZ\)QK12APY#=]/CY^O'%>V"3/T;H](^L")+^;PKJ%KW_</[N4_#X==^C.8FE
MC,"WHUA&7(P5I#-<C(,L<&.X%BS7C.::T&P]AJ7#<8PXM@E:\N<Y4!PGAJG%
ML+1H)D"2&D57(&DRJ(M$$\.@7XLD!9!"D=-8XGQ6FA=&3,509,! (2AB0"7H
M:= SI>!I<*HDFI2>K"^^.PZRV_SB\N+\^OK"^N;:YM;RZL;JVM;Z^I;?'[SL
M)9V<G)U#"VT7+\\O+EZ^!B0"2/KBTU>?/GWUX?T7']Y_?/7R]<N3BZ/]D_V=
M_1V_/["QO+DTM3;]9.5._[4L1Z]=>R_3-.RS/,MQ#/L@0?8'D*C8,UGJG2CQ
M3!1G0D@J^BN)QDNR)LM\$Z5>, %(F@#SBFS@E<9*L_ZVA30+D!0V1U _NQH*
M=#\MP%5!G:;G51"/@"&:KX6,TG)3Z6)C\4)SZ6)+Z4)3\6Q#X6Q]T6BI]U&^
MN]^N;='*2\5)+@$OE42D 23!4!0$8JBS=?)&_\+CP1</!Q>>C*Q.S2Y/+ZS,
M;>SOG/EWSH]>0W?A_N&''W_\X__Q_6]_IW 58MAZ'#\+$Y=#2B[BZUNB^=[H
MF RL( O'=Y.$V?CX D)\#L 33I")B?7@8CWXV$P\/Q/%LZ%C'6GVVMMC&\&3
MMV>OW[]^^P[0Z>??.I'Z+U<$23^OCY\^G;[^N'CPH>OI1HJE LY6H[@&;)P;
M&>-$<#-PPAQ$3 :,;4-P+#"&#LW0HAAZ--N$Y%J0' N&:\:PC6@6"&[&L Q@
M'MZ.I$;0E4 P !VHC:U D"5,63&6;T234Y%D*0IJ;,N@?0!4,=3G!G,JR&YR
M-%6*B]&5]PX_&)N:>C&]M+RZNKJUL@J0M+FZOK6VX=_:WMD[.#XX.CT&P>WE
MJY<7KR\@3_06(.GCAR^^^O(;0"4P 78)$.K5^9O3@Y>'.\?'^\=;*\O;ZXLK
MLV.!R:>S-[J[W,;;T(J;^4F.92P/>"77TW!&&R_.>E[BG2SQ0"K-F@ J@1@$
MKH/)\[)L0*7)4A^80Y.*[(ERW\1/.P!^0A+4/ J3Z'+U[9)$E_.?KE?FO*C.
MFZ^#-B4MA^]WFVLH6F@J66@L!H'N>57N<%'F@UQGGTW;K%.4B9,S!+QT"H6$
M0&&BD7P2Z6E7V]3M@;G!NXO#0PLC(PMCDXN3<VMSZ\&M@]W]\[WSU^^^_N[W
MO_O3G_[PI]_^X0^+AV<(EAS-L1$$7JS RU'6,*05:&$V&J!'X"4(LDE)Q< B
M8>(@QX2-S<!"UWT$\ 2>FQCO1<>ZHSE&D;WFT>SNS/IAX #ZA5:1M;F_;T60
M]/,*'K^IO3XFU)4@.%9L7"Y:4$J5-/!43:G.:^+,FR+W0*JS1Y+9)\OJ%NAJ
MXN1UG+12+->)8IFQ'#.&:P2F"07YII^0A&)"7@E"4KBCA* J4)"4,)(TT=QP
ME2&'$1,0%!&:*L=0%&B*' /R'44*XAN:JD11E$B2^"HIQ5K<<6MT_L7"TM+"
M_.K*YA*@TII_Y6^0M'MP?'AR?OSRU=G%VXL+D-1 :OOR"^ /OOG^:\"ECU]\
M^O#%EY^^^N+]UQ_>?/GV_,/1[LE^8">PL;JSM1)8G@G-C@XW5US+-#W,MC[.
M,HX6NH9R+, E/2OX"4G3I=Z9<M]4F?=Y:=9,><YT63:X&$85I F I^*LL2+/
M^.7:/[0=">+1Y6+_Y1+;)8DN(?47#P6M[H?W< ,D7::V-1#9FDHA)#46SS<4
M@<\=*_,^SG<!)/4[]4T&1:DTQ26,2:=22'" )'@ZCS<YT N"V\R#NTM/GRR,
M/)M].KHX,;LVM[:]MG-T>+Z^LW_QS7>__N'W%Z?GDW,+FQ=O-=EU2+:9$.?%
MQF7AXG/YV@9B2B%&Z,,*?,2$/+PP!Q^?&QY].($7#\F'B_/B8[WX.!]1F(..
M<>'B7/A8<[PJ]\[(ZNS:UOXI>#\X_?@IXIC^/A5!TE_KW?N/-YXNQRFR 5E8
MTO($:[_0=BU6U\X451,3\G&"7'2L#\7+1//=<+89SC'".08DQX&-R0BWDVP8
M@#! );8)PS%CV7HL!"8-M-S&5*&A39(*%$..I$DP='$4/B6:*HLW5$539'!2
M.HJF0D![D:2(OT0VB@1&E<"!42*+8)14OM+7=/?YY/S*ZL+<TB((;:'%E:WE
MC:V%U<W%M<W@WE'HX.3H_/79FP\OWWQZ\_;+BY< 2-]^_>5W7W[Z\N+L/+2]
MO;D*);W5I=6-E<V=K=#9T?D7[S]<'!\?[&P'MI;69T;WIT>&JPMO>R"C-)QK
M'<JS/(.:1YXIB$>^F5(?1*4R'] 4F)=E [VHR/TKFXJA[/87)/T%1L#F %T:
MI<NP=@FC2W]TN4,2VHY45PAX])-:RN?KB^;J"H%FZPHG*G*'"SUWL^T@6M:H
M)<62%(<@)H5"IJ$PA&A$AEKU_/JUR;NW9A[>GW\ZO#@V/CLR/C\^LS2]$-S8
M.0H=@9?E]?>_65Q=>7#KUO7;#YXL[Q:TWD<R]:18+R8&_%-F(6.SA,862GI)
M-#<#$YL% $049A.$.4!@#I"$Y6?BXCR$N"QLC ?']Q'BL@FQ/A#H,+%N<E*&
MR5=[?VQY;?<L='3R\M6KB&/ZKU<$23_5V?E%<<,UAJB0KVT4&#N8LAI:>BE&
M"+YE7<@X)R'6A>>[<#%.+* /UX:%]AP9T!P#.L:(Y!GA7"/P\TB>"<TU8C@Z
M+$>/YEC0'"N::T6Q32BV 0C!U"*!Z H<0W85ETA-=+!$WJN$-"0E'4X6P\*-
M)#A%#"-!-]]&AT<D50JMNU'34%QE0?O0HXFEQ;D7"W,+ZUM[RVN!U:W _,H&
MT-;._O;NX?[IQ=GK#^>O/[Y]^^6;UQ]W0P<3X\]O7!OHZ>AL;:AOJJMI;6IH
MK*MK;6SN;.VX=?W&R-#0^O+BNU?G)Z?[!\&-@Z47NR.#@X6>^U[SXVSS<)YY
M)-\Y6I !D#17GC=7GC-;YIL&Z"G*!/0!5 )>"2 )C)>F"6BBU#L& EV82I<;
M("\]$2#+8F/)?'TAY(9JH+X2&)^7^T:+,N9J\B]W;$/+;>$CW* 5MY;RA?IB
MD./F:B$DC91D#>:Y;G@L'69UE5)4*$ZQQL4D4\@,-)H$@S<5Y(_V=$T_N/OB
MT</9)\,KDY/S8Y-33R?F)^<"Z\'CP,'WO_YAP1^Z<>O6C=[>P4=CXZNG$GLY
MBFG \S+P? ^&GXG@N=%QWGA#"TU<!N.XL3&9$)($V7A!-BX.^",/-L9-B'5C
M>78<ST7B>XDQV01^#D&02T@HP JS0:)GI?LRR_L?SVSYCU[O'!R_?O,N J;_
M2D60!-7QV45%^Y-8?5V"M9$B*D0+/+BX3&)<!E'@ 98>!=XA^0Y,C!T#K!#/
MAN7:,5P;BFTE"C*!O8>Q;7"6"<.U8'@F)$AM/!-TVC_'C>-DX+E@=&*85BS+
MBF%9T$P3))H*3I(*M164!$<4*1E!3KY"3("34E%D$-\D*+($01*!.1 ,GX*A
MRQ#DU*NDM$1]\=W1U9FYI;F%Q?FEC=DE8'>"\RN;\\L;@=U#X)*.SU^?OWX'
M='KR<F%^^>;-VUT=G==Z^WHZ.KI;6X#:6QH[6IO V-)8W];4V-W1>N?FP.ST
MY.O7%^]?O3P/^4\69I9N=-WT6A_GVD?R;)=(&B_(F"ST+%;F+53ES5;D *]T
MB23 HTLD74Z IBIRQDJS@ "2+OW17U+;Y<[LRX &PMKER21@OM14^I,:2X!1
MNCRK!&BF*F^Z*F^R/&>TU#M4F'DOQS&086XQ*BJ5HGQQJDT0FT@BLC$8)AI]
MIZ5IM*]G9O#>S-##6>"2QB=F1R<FAI[-/X>0=!@X^OZ;7S\;G[Y]^\[0X..'
MPS,WGVS J HLQP*01.![H+XUUXWDN8 _$NH;Z>DE*+83%YL%J(07>@G@VR#&
MA>& ?W$K]"E<&Y[C@%@6 ZW*X>)R\?$%N/@B?'P^BN^.D>99\MJ>+>TN!4]"
MAV?OWKWY&&E^_R]5!$E?[!Z<%C6-Q&JZB"D5:&$F)M9.2L@$CAT5Z\,+<X##
M)\0"A^]"\QQHGAW-M:/8-BS/A>(X\7$^H;*9+VM@IE6"MTTXRXW@@$QGCV98
M2+P,$M>-9SKP+!N.924PK7BF&<LPP&F::(HXBI(F,-=!=\!1Y-$D111%B6 :
M41PS+L9.$F30$K+P/#L^QHI@:*,I<@19C"2+L&QU=??PTQ?KT[/ )RW/+6^"
M!+:PLK4(_K-WN']T>G1\MG]P'-K=GQ@;[^OI[6QK!_ZHKZNKIZ.]MZ.]O[/C
M>G]O7W='5WL+L$N=;<V]7>!*SYV;U^=F7GQX#?+>JP_'>Z_7YR<Z:A_F.4?S
M'1-%F<]+H9CVHCQGKB)GMC+W17GV=+EOMC)OMBI_KKI@MKK@!9B')]"\*C]\
MHC:DR[M&?FH;5>5<(BG<PX8F?W5&S="RVGQC^):W^B+P<+FY%'QHOAZXJM*9
MVJ+1,M_CPLP[.8X^M['9J"R1).>D)ED$<< EL9"(="YGJ+=K8?#>"PA)@S/#
M0PMC8XO/I\>'1Q>F%W;]^R=';R[./IP?G=^X=O/AT,3T\@&)KT<SS 0><#W
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MR>6S!I05"@29-K*OHH(C"T(2R2:XKJ$U-636P)?MMKJVP;[56S8!1LWV[1;
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M ;B+,D#FT.']58-E0V\TH3;B<@/8-WBOZ2JC)+D50[5F>31I(2'3<50&7%J
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M2H5WD"%&JZ*$RH"K3%1EN22E297=09&7T*4%LM1&86(C+B[ I"4@BV@2L&_
M%S0S!<"$IBC $YD4)U"]B $+U"*1]6BH< 2]LAB]#-4]E8(JA]>3@\I DQOB
M2_HPC3E$J<=5I01:43$2X55,C8L(=Q+A+B(,;A";R.RG"ZP .[I6D]LK2+J,
M:>MP&/.Q3I;6SD]J$J9>YB6V$=%UW+A:7EP556D(EJ!,O#"RN*3FVLZ#EQ^^
M_!#XB/WY)^Z7__BO0=*'P,UG=!;C3TO[GSY_?O?QTYM/G^^]_NP]>EQ]?5Y;
MV,R,,%%41GJXG8BR<Z-M_%@K$6/EQE=S8^HC<F_R$VJ96CL[UH7FAS@W$>]F
M)]2PP::E-/&2&WA)]9SX&B*ZBA7I9$6X>-&U;&T#+Z*!%>:F@T&+<&97+>/A
M=AH(;[69I2I#Q%'H63 HY<5,10DF+:*C#D>!TEX=4U:,DPQB2E$@&(F*<)2N
M+F"(\AB!M#0W[@)#PQ)&TYC2"Q<8%X!*YX//G;MP[MSY<U\'@VCZ*ICQ=\'$
MUYCL/!'-5!7R(XP7V/'!: M;$B[,P/C9-"XB$14=%I") LP:JGM*P81I.+D>
M1Q7E4(6YN" />(0+TE$G7+3=!+Q;7%ZIN_-*W]4K70,]U\%\>29&9J;&EA?F
M5A>\2[.((]/ H]&1F3&X#DT/#X!*&NV_"1)I=6%N;<F[B!)&GL ], A4TO3H
M$" )( 7?@O!-3JU.32]/>Q8]TXLSGJ69R;.]K;]__^WOOGU\;V;(B]+5SKUV
MYVZK8P>))M=&BV.[HPKM4&NR^5L=2XW6Q4:+M\$\6U,.'@UBL=ZVV&"?<5=Z
MJBJ]=8Y9M]GCKB#%D7FV&IXTS=94SKC+)QQEP_;24:M^S%H\9M8-5Y9T&0K;
M];JQEK;MN<6UF84UK^]D[^1@]P1X]/S9ZW=OOWQY_\-O__[W__#C[P_V3FJJ
MF_+S= *^A,D@J#0\A,8,HG'.TP0A#&4(KJ$2,:!)*2!" ?%2/4MN9(>6X^I2
M*H CTI%0-L@*<_+CJH1)3H8L"U,:Z'(C4V)@PEN/&@#\1!ERBQR:S- BG;(,
MS6ID65, 22RY 4DG,CM./DD60"E+"=1XH(PI+X/9,=XX&*0PT!5ZIA)&8#D1
M[B;"G)QP)SO,Q0ZO8FF<3(V#%5[%CJPF(MS"^"9V=*,RNT>:>16+K.;$UQ'1
M+GXB:*4KW/@.0<HE7F*+(!$P6H]K*FER/4V>3U?E<[4E'?W+SYY_^/SQWT$2
M.KOFEUK?]%^!I(\?/W[X^/X+B:2/GSX]>_/V]JMW1R_?KS]Z;^\<5:=6TF7Y
M1'AE1,&UK*IY7MI%3F([+Z%1$%?#BW%Q8MSGU=9PPS __2HMRL&,=3'CW,RX
M&GY*"R^E1931(<F\+,ZXPDULY<0U$MHZ(K*:%UG#BZCF::H$D6Y^J)D)8EM9
MR(]SQ98-GA?G!PGS@L2&(*D^1%X: G.@LHRN-&$J$]S0%$9,7A8BU%&$!11!
M'DV(3CVB\M*9$M#Y:3AJ5HMR0!1>)I6?1>'!??IY;K(JH?P\,^)KF@0,PKD0
MXEPP_JMSU*\OT,^?IWQU'@L"E21,8(A3+A#Q@JARACS_*V9L$!'/$F?A?'!P
MF>#.*#R019EDCBD#'>*&#DW*@"]Q41Z-GPL0I/+!XF6BIF["1'3$&Y'R%2-6
M')E[8VCVZM4;-[NO3PP/SH# F9U>75I:\_DV_6NKBTO>Z:F9L=&E68]OS@.(
M >'C&1L&>'FGQ[=6E[?]O@"5UI>]0"7?O&=N$ODUN *8%CV3Z],S:],S*Y-3
M\Z-C2]/3OKF9Y9GID]VM[U\]_L</+T\F^Q9:G'YT#(ECNP4U'D'[_AM11FFE
MR;K6Y@25-%]?Z6VP+#1:02*!7UNHMWKKK#-N\W259:;&/NFLF'97>,B8<@&/
MS#/5E=-5Y9,NTU15Q;3+-&$S3-K+>BM*KE48)R]V/CLX>7AT>W]C=V]C[V#G
M^,&])Y\^?O_'?_SG/_S^GW[WX^]WUO>N7;[A<M0Z[#5FLT,DE *2*!1:,!6_
M0"4NT(4!)(6PHI%-%F:CDC$P7P@K$&4,51E=;@@2E<7H^L(*KPK3:FC2C&!Q
M+@,4-)!+#$@J05((OD2U @ RU%N20'DB(Z8P -?@]P26:%F*P%HMVEH4R$LR
MY"C0@@E:,RG#5 :ZQJK)ZSHGR"?4I71I*2\25)*%I;&R-'9VN(,9YD!)<8V-
M%8&HQ(FJ88./"W<)4SICRR89D0WLF'IN7 ,GMH6?T,:):V:C^UI!0AT_UDU7
ME85(<^0)SHBLYD3]E1+7S7N/WZ$/X;\Q*+_8QW\%DE G>O+QXMV'.^]_/'C[
MZP[/0;+E&C_.@8=7<$CNL&.10&5I:^'/36C=C @K(Z(2B["<5U>$E=S0E@Y0
M0<3&UC-C:]F)S>*,RX+42Z+T+EY2!SNNE9_0Q(JI9FG=Z ?1.VIGA%KIBLH@
M25FPW, (+<4BC,GNT:S&A=BR:VF6P8RJV9S:Q:QJ;Y)M*MDZG6SSI#GGTEW>
MK.JEG'I?FG,VKV8ARSX=6]2M26\.36F @14L+3@GS/D5.^UK=NK71/(%(I'*
M3J)QDX(%J=&9KB!65!"F#,$D013>N6#FUQ<87P6SS@41=$)#AP\ /POC9[#$
MF31Q=D1FW05N:C 7G6J+DR7:J!H D(22W%F8$!$*@LQY@TK*P=G)!!<=]$;A
M)_^*%<<*+8G(;<FP#">77HW.LC5?'KG6,]37VS\\/.R9FO3.SJPL+ON65K;6
MM]96_<L+W@50-[.HOAG4D']Q=G%F8F9\:'9B>'YJ='-E8<,'>FIR>6YJ?7D>
MOH07^.:GO=-C\%UX<M/K79^9!20M3$S,C8VMSLVN+7@!3,<[ZQ]?/OJ'#R_7
M>R][FYVKP*,F5-*-^D8VVT ZK;<ZP;AYZRH]U:9QIV&FIARD$,DCRT*#W>,V
MCSM,4V[KA*MB%*#C- */)N!:98+[29<1"#5A-X[9C",VXX"M_&JE<>Y:]XO3
MNT]/[]\]OGMV=-NWX'_WYM,__Z]__MWO_O#FV_='AZ?3$YX;W;WMK9T-=:W5
MU4T6JTL=&HGC@"1Z, 4[3V$!DBA,%1BW$"*:"AI3F$,3%]&DA0Q%,4M=3J@J
M68IR)'!"#31%"2>IP=)S*(EQTL2EN+B$)LH%245FKT'O '?*V.I*E@H%V5RI
M%".SDW].)50[@A9MX?5 (B-X?Q))"$\L5!D LZ!1GM(N2VZ@R R$QH:#U-*8
M&0"XT$HBS,;46)EA-A8$V(5(-SNJAJ-ULZ)<K,@:0MNLU0VSHNOQR"JP#KRX
M!G9L+1%3@\9_E),3[1(FN+E1J)H!$QEX6@=5:\RNOO;\U?>_??D=4D;_Q^7'
M_S\^_K]"TI_77G_\]/GUQ^]NO_R\</I-1>>4+*N:KC72T,Y[)SNJFHBJ9D14
M,<DK+[:!'5U#Q%4QR?5[+-RJSN\.+>IEQ-9QDQKXR<W"M#9Q>@<15R](:6'%
MU/#BZSBQ;B+2Q@@W4]45$"$P2B)=\IS+,66#B9532=;I&'V7/+>MX,J6I+"+
M%>W$(IU451D8>YI41Y7 N"RF2(HH$AT%QJBLF"HO"I$6$>&HT00_MEZ2TB%-
MN2Q/OQ*1WQU=U)-0VI]0TI.@NZK-;@U+K5$G.J5)CD1]1S _-9@31^%$!S'4
MYS'Y>5P!-U0.C'XP:%D,<2XFS OA9F#";%&T7952?8&3@LX@X9 6#!5#II*9
M[,#J6Q:5F_&SCT.9HV"FELI)EF@K$DJZ(@HO<6,L5'D!19A)*'(,UHX; U,W
M^X>'AD<F)Z>]L_-^W]KZVM;VUN[FQM;6^H9O8<'KF5J:F]GP+<(7*UX/!%!I
M>G0 P 08 A@!F !&$($O U1:\(S[9CS^V=FUN=G5F1D([_C8DF?*O^!=G/=L
MK2U_]^;%W[]XO-S5NM)6LU)OW6JV;3?; DCR-5KFJDU@W!::;)Z:\NDJXRQ*
M(9F7&NV+3<Z96LN(Q3#J,$V .'*73[I-HW;#B$T/5XC)*I.G!IA5-EEE[K>:
M1NIK3I>6WCUY\?#LP<'N\<'6X=M7;Q_??W)R>/K\V<OCH]/%A>7QL<G!?K2A
M^'+GU<Y+5UO;K[AKFQ*3TC&,3<>808"D$*22*$PEA1E*84?#7YXN)$M;)?EH
MNRS*YIB9R@H2-\6XHO"\O$21<TD<XXPMZ!%&UP2+\T-$62SXEA2EL<D,HP'\
M%Z&NP.6HB@V1Z*=:-K0&AYXA?Q7P#D<@0WA"+Y"CQ3@&<FHH08DI3#'%_7A$
M%1W]5!&!:N+()6#XQP#OU&8"=:2P@)$DHFH 3!SXI(!H@H])E#N\N(\7WPSW
MF,;!C'*S8MS,:')2CW$3T?#Z"JJP@"U#_S8LRDB/+,DH:GIZ]R^;-/UBSR_X
MST?2QY\S1Z@=S.?/WW[Z^]V''[IG]O-</?PD*QYEPB/*B2@S*\K*C*YF10+4
M:U!HZSC1#2QM'2NZEA-=S8VMP2)<JMQK427#[-A63DR3(*Z1&P]&&B:$*DY\
M-1.MOMF8$>5TC9$::N7$U$HS.D)SNY(K1V(-_1&ZZZ*49DZDFZ:LQ&"64Y1%
ME?4%RW4<=1E3AO;HD_OU#6B4D/E(U)%6 <\;66CMOQ@BD$7")84T<'""7"HW
MB\K+IHL+T>)+6"4G%OT;A&E-F=6>TO8E8:)+D5H3GM6@3JV6)MIX4:4H523.
M =\'%@RH!#,M)BYB"/,I_%Q52ATZ>!*EHA+IW"0ZXA&YHPVY-GA]+IV?3>-E
M4?F98 R_8L>S(XW)97WA.9<Q9>EY=D((+X;*BZ5R4X(Y*=KTBINCBWTCDR/C
MDS.S\\N+JUN;N]O;!P>')X<'QR>'8+.V-OPKZ[YE_Q)"TMKRW.;JPNK"#.@@
MS]@@H <8M+>Q C!:6T(R"O $-X MT%/+GBF(50#3W,PJQ/SL"ER]<TO>6=^R
M]^Q@YX<W+U^?['F:JGS-SN7:<F3?FL&[65:;;,N-((C,\PUF3TW%N*-TRFD<
MM91XJBMF:LU3[HHQAW'(9H" ^W%G&4*273_F+ 4PC3E*03&-VDW]-M/<Y8YG
M^_N?7GSS^.ZC6Z?W;MVZ=W9T]N-W/YX<G*PNK6ZN;Z[X5N?GO%.3TV.CH_W]
M_=W7;W1>O@9(:FSNS,XM9A)\#(02C76!R@[&P+@I@G$UA8BB\1(Q80H#%=P7
M %D8R@I,:6*@%I&5A,H"- D1%Z@RZR_PTX,D)=&ZFZ&9[4*M,T123$>'8A4R
M93I"6<J4EV(RM+>64*/C)X%*)(S0CDAR=Z2)Y%$QZ?7TR!@J#1@,*H6>+BLB
M\TV K0I,Y4@S>X)D)>@L'!B$J/%N!5A"-FD)662@<H3P*G:$FQ?I1J65X6B>
M9FC=X46]>'A5P!:P8VN8H))B:M@QJ#:8'>=F*$UT03XF+F"IBK@: S?,E&KH
M/'OTZN._.13S%^CF_M.0A*JJR3T@<'G]_L/KCY_/7GQ</OO&V#H:FE-+"RVF
MJ@U$E)T9Y2"B0 W5$S$->$P3$0T\<H,N):+KF-'U!/!(ZV9'NK"(*GE^3T3I
M( 9Z-<K)!;\6#?+52D16$E%61KB%&EK)B@8NU&E+^U-=WDCCL#CS$A'KQD,K
MJ-)"3)+'0"<(EC%!"<N+F3$-RKRK5(D.'7VCLK#5%AA_:"XB:]A@'! P22+I
M7H:*;H%*@"J9GH$V\>L!4J@H#E7KYF.B/'*O4PX5-17)A*LLP<8)+0QFQ5*8
M\116*IV;11-D4'A)="$:$$ T'+580O7<J$VJ((O.3H+Q%UO0%L1.I'(3T8P-
M2.*D8KQ4A"3XS>#R!-D47BHHKR!1IBJC,:6\GRK34009\%EB"%(PM"27"H*+
MRDGG:+)Z/5N#TXM3,[/>A=7EU>WUW?V#H]NW;C\XO77OSMT'IR>GIT?'^UO;
MZRN^3?_BNL^[L[Z\[5\$!H%EFYL<69@>!RKM;Z[NKOL 50"C]64OTDT+LYOS
M\QNS<^NSLQM>KV]FQN^=WUA>7%]:6/7.KRXNKBXMWCDY_.'=JW?W3Q>OM,PV
MV/U-3M3BMMFVBJAD76BH]-2 03.-N<J&S<5#E3K S:2K8L)9#I9MQ&X:M!C
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MD!-70%VC!!/JSB4M(13DD4=HKP#:-, @[1N&JI- *!4@R2/,CROI#9$94-9
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M?"$=A!))@3.4J*)<AJP8D,20ZC!I$2;-1Q@B7Q:@4L"X0?RLE?)I@EQ<B(H
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MDB/7AM(-"#2HS@A#@8P;:B ISL6D!>C 6U1_A$P9@SR@F8[:Q1<PT=%OZ$0
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MWV!A*INHD7#$'@"MM8#1*$I.R$M?P.04*2+9]U'">=]P 5.3_G0.+MF8YQH
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M=/,U=H:LA6HI)/C=P<-T4@__F1#L'?"R>EB9G1)]EUC?P\X[5G3\&C<3/GI
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MLYB2$H:L1F1TH!%0T6EEV2E14=>IM[Y*K?V33EI+$L?N/^/K#R IGER_>'6
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M<'0M";(HOAXE$2/ !(_!<,)+4L5PAP/U  CX)TA*;*+0 W*4W 3 BD92"&J
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M9::JF5"%X1+KXFN=8D,'2+\\\T6:LH4+$$;EH4D_.0<G I AEWO5VSPMUB4
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MQ(]/?WOT\$>J?)PJ'*=:<.,Q>#\;U$X?BD2 I,@:YK;]"6\@M; *+"DT/A=
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MA:A42>:+U!$Y!F!4C[,A\=O]<LHFAJ*>(:OFR&KX\F:^HA54& [.E=721(<
M?83YO47V2XJBO@.\HH/<_*RJ/FE1YT$Q?.R'N-(J)KK<-A.;2JKNB61&L'C"
M0>SKFUJ[WUZ)/UU!G\ED"+TEUXEV>PCR+9G<2JUOQQ(;0)0 E8+A!$ 2<"6
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MQ$&]W J_%$52HR*I64G !TWG4A#KP2CP<GOE$9'-*;94P;*2?C7A*3W9UJS
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M4"IIJ":@%^O*N5J!QY#$W 7@)RDU5<'T1UEH*MJ35G<R04E$J9C%GF"J&S<
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MD.E*,:'D\51+!DEP9;4TB4SP2]UNK#K[]O<3@65/>-$3GB4DBD77:$4CJ\'
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M$HBNN ,+8YZ9^P1)D]'[8PR2[ON()0&2W.A$"457.>%&J$2TA>OP\/FGW9X
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MLVI5+K> ?D-$#YK9-M:"X3J<PR0+;T.%H8F_0^KH1T^BI26CX9S$T86IN4F
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M+&7.B;*X'\!C2))"UC'[1%,=[($(@%!2B,$2:#$U-6/DEJ59I'<6['Q'FS,
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M*UXA,S8QH&D5T;GAZ!;9>S6YA^ATE=M=3YGJ[<Z7<MK>X=O:0$*MC2H,[&J
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MQ14T 4"UO5I^B=9P>LZ5B9=HF"1( @_JG^[JFZ+% &BBHV>D_<5PQXM1@B>
M5/=$6^?$TX[Q!QWCM]J&KS\>N/*@_Y?;W6>NMIZX^/C \=\^/GBJY=,O&C9^
MFNMIBLZJ45B2Z3PJ06-=!EKD"#@(#BS$(DO4$<V.W ,B(CZ8YV!Q6ZSH0^^;
MQ%XE<]<KW?6,I,!1F\21!$-M^1S&FSU*.N%9R[3!5<[\0T*;ATXD?*@7W^6O
M8IOZ;.3-"XL2V. 2N! )JN9@S>Q3.K %(27Y9JMU9QV0.F%7P@572X@6A?A4
MQ&B"*Q3!%7*W3^XJ1^L *RUQCC*AN3C">U1L]XBM!8@%AVDD$2MZD5X4(H@0
MV8K%VO@ +IP^5Q"GKAIE:*,BN$;F]G*A'HF[4!O;D-]R-K'ZJ"&V/KMBR\@_
MN^GVP?C(,*'@X(B_HC0P-O'UKX^4(5XI265[L=2<1]HR./UCD1X;\W(CR03F
M'HD)$@9)VEB,LV&B+5JDINNQ)-Q@4<)%BU3A@?J4D+2-"//10+*Q1V$C#+-7
M=&#82R5!.8%*HE3)"K8C)F>)&A(#,0A0&YD)GNHL5S*7Q27Z1VUEO%T)ZU%B
MK*>0_5<V["6-N0)C6OYF(C*P3&.L!XNSE- EZ\UEM[.6;K^"0^FQB*45\X%Q
MF%I"&P@AD1UF[')GA3JD01^RF7/6N(IVQ=:?(!!4.QNP$0M#$I@*8C%7;S[=
MFV=8O&.)RE$)YV]F78)/)&OLIA<C"4+P@=0 9T@%W-VR3 D;I99\@2(Z0!XK
M4B6(U7%2-1*BA7KT$$F"TF3H#$B3PE\I56%,1Y,7*MQ90G6*RE&<6O65-+0F
M0)TD4*-M5<IS*'T&"SO)<F=L544WBX+RU)8\*0: <1A(;?@%5:SQ][.3#_I(
M@@W3>>D5X<OP%+3;X-C"P"B<B09&%[K[9]J[)YZT#S]\.O#@2?_3]A$B3<2>
M2)T-CD*[,>&&R]&IQ>$)= P-,4AZT3_UZ%GOKY=O/W[:O;B\&FS+"S= $B'1
MRGNMDN@#X"D2X='+UV\A!IGK .I3(Z]YEL3C$0$0T:76SH'6SOYGM)X/TK?M
M7>-,8([=;QV]U3IT_6'_;W>[?[W=??YZV\E+CS[_X?<M7YYKV76D:>-GI;[U
MR06-2GNJ4!<KUB8)U0B)895'#\EJ&%>X:D**OQ0:"GA#9+D=%(:_+D.[4"V'
M<<AJ#IXDA$<%"!9%U1)]_S+L;^2+@O(C2K\5F J4<)?'F*Z"*"KQ+W1RPWX$
M(2).#_S(6#,WD@?11N1CGT"?AE#&7A5>?%1 1 ;N2.6RX#*IVR,/+I<'>Z#+
MW S1V( NG)7<Y6);D35EBSBL0>0HEJ)C&QI0Z/(Q$8>P0OJY= P*E5'T*:)7
MJW)7Z*,;Q>YR+JI.$EQN3MY4L.&G6,]Q>4B]/KHZ,J?N>=][D[?O>2?]35\?
MC+-)WY'5BM+S@9&F V?5897JR$;.7B0T9BE"*O6152)],BW6L;WJ/:)%H[9(
M38H,H[8B332)-2F,MV,%JEB)*D;(A1(DN5-:1&JZ6YP4?"J6/3:9- AL@VP$
M)5D"5:($^@*9W?"Q7[6.Y&='"(EHT1$ETF<R[/";<*\Y3\+QEB&+#*GG>:RC
M/].SXQ<QX:F!=5>RQ7=.LU&C(J9<@$%KGKF\KRXD%?K"$7PF0]9-*<;?\,DC
MJEPKMS0A,ZMH9V3U47%0B<I1+W=5*-]WE63C2RQ9]YW/)"T9]O+*I":/Q%0*
M8P!L\Q'L%DBQ\MC*H=<FT&6%Y^^&::DJCO H4!$MIK=1@YX M!UI,\4(9<40
MCUR71I@>B+,Z2!.I8$?*QZG5QX7F?'\/P>K@[EKK '+?C#DIU<<$0.1<CD"*
M!>P@40>6J9Y 4U%<R:X[;5-CHZ]'1V;&IY?XNC6&-L:7:0V,0+MU];ZDH_UQ
MZQ!!$EVV/A\C[4:W$X=BW0/^*5Q"--)9A$K#XTO](%FOVYX/7[O^\-KU>W,+
M*XO+:$Q:6EE>^6] $J9M5Q!&LCI0L@(\FGL'2=.KD#0RL4"0Q#<!$!YUO,!(
M<&OGR-.. ;8&Z?JSY\-/VX>)RA%NWGK<=_UAW]5[+R[=?G[Q9L?Y:T]_^.WQ
M-S_=VGW\XN9]WV[8O+N\YN/4HF9=2'8@47MM$KKA#5FL[(@Q(PFA4FB#-F$;
MYRSC;=I9_<AO_L?[D7*N6AE,;-C$]>IT-V\[P?;^"T7&(BZX)CQOK]B43TMF
M+:"/O<*.T4OT*\'*EL\4*4>MBI[?74-+[JZ5NFIDSAJ9U:=V5FMBMMA0TBJ$
M"B-^%$)$B>A2!=$%F9N63P9S$A^F<-U>L27?%-MB2ME&XEUA*U0[*S3T4X++
ME8X28EX@7[8"9N$6(M;'BRTY8E<Q%U8EMI?K8S:FU9Z,]7ZKC%IO2-J@BFC6
M1#0XD^ONM8V-KH9Q_]UX- %(8K%(:U^W6GLB"C[B0JNXT!J.7KHE-RBN26K+
M%^D2A01#^D2I/HF/11+!LRT.%$F%T7\B2K">P9Y:C% =)R&H4H8I''G.I&8A
M8T^L]2..)04DL9)MAL2<2X=3H#)>J(QE<Z?)$M(C,-/PS]/R,VZ$1[1@)OUG
M'Z4UTL1 IP YL3C4LP/TJ=D;OA=:_;#EGT%9M<KU/V3U]K7_\B\ZE2&"K1CL
M&D/;]&E#PA+Q=K5S@]3LBR@_Z/(<DAK!DM ,PKM,8'87[@*\P0!.='Q,KH4=
M]NP*+6 38TF8+P&AHU?+$G$A%@K%AOR0G-T2<QYS.$P*4$0)Y.$DA\6Z-+DV
MG6--VZ*@+#1JZ5)D^N1 .JN35K47QWH.N[(^#="FX2^"?4_@$?HA=-!Z/#S1
M.>!#5;(^NMF>LT>@SU0:,L38;O,I>5\$>X6$D-3E^>&WKM')Q8'^R>%QU*='
MQOEI^V5:@R,+?8.O>_IGVT% _-KM6<<H@=3[D$2,AB['7RX3:1IA+FO$D@9'
MWG1VC]^X]?2G7WZ?>36_ #0B=;;L]TA:@?D_F@#8V.WK13BWS;Q987CT)T@B
M\C4P^H9O!2"61!2)(.EIQ]#C-F06T'K2-DBOC;"27MO])_VW'O5<?_#BZMW.
M7V^V_7*C[>S5Q]]?O/?=3S?WG;RT]=#QS5OW5=9O22]I,4<7\I $QP58+1?"
M3,8*XR1M9+,I;2?*V^!'K(JT>NE?3B;244,LDS"_0+D%!L<*4R'!@1P1M25B
M8TYH[GY%2!6"E:SH39$"F(K@2(MR$A^?4\$['ZG=57RGDMI)Y-JG9G-M(G=#
M2,%AD;54XD 6+A=:KPRM4Q*'"JY2N<I5K@K<V>_/#1\ESE4-"+/3F;50"9+N
M4Z!7H$;NK,4PBKU $!3W+RXX,"@AP)01:,^2AE1$%GV=7GW>$+M19,\+=!2&
MEGRNB?Y$&[G!G;KQVMV!T=%_3KO]J;Q-FO&;"[<TT>6*L%I%2+723N]@@2EA
MO="< T#5,^]:?W@D3Y%BP9)4I-$(F.CR'21)-;$"18C,EF.*KA*B83\&"QU,
M_#,DD::@/X_"DBM4(S* .78G8<.;E A4&QSR<:RBK3$'IC\&I)CP2/070(%/
M&^0;R_O698A,F<5;?R0E @'XY_2W]Q_(W_(^0O$LB;>@9$ #"TJUJQ:,&I"T
M7F8I3ZC[*KSR:[G9)[? LX:Y+WE1#F!%)?]"=?P=)*WE!> 6,_-UXS<!F0T+
M\FD)?(/RA/J\\,*#$FLAF[Q-D6H3 F6A@:1_29UI$V1:S)>(]7D2.I-KXTDF
M!^J29"%EB;7'#7$; S7);% K68):.(K?:/7VHU*:F)X-U"E3;,P.*_E2["P6
MTEM-[ZJU6(7CIX3.R7)GI=B87[?]3!\)KJ&9H=%Y J.Q\<6Q\65:$Y/+XQ,K
M0\/S+WI>=K-!W"=$E![WW7O8\[1MN'=@EM"*<(>XU=0,6I,F680))O5'%U&'
M&GK5W3MY\_:S<S_]-CK^$LE(*_]>7%X!12(D8LR(\2/_P.W_!DEC4^!N@V-S
M?%,2$27B1,2,6I^/$E^C]:1M].'3H8=/!^^SUW;S?M>UVQU7;[5?N=U^^7;'
MCU<?G[IX]_A/-P^>O+3KJU/;=QVN;=J>X]OL3/"(M!!N4KS#&1)C/I\/K'3Z
M=)'K]4G;45Y<94:K>VWH":!S%>=&SR0S D3>,E$DN+4A_3R70XHDTASEADQ=
M=(LE8X<0J=FY$FN>A(#)7@1K5ELI2_2"ES877 G+$3<BX!7H?H*1+D&A.J1&
MXBB++#Q(\@J3FZB"5RG#&V2N.AFR ^C^-3([ 1G"E.!> $Y4%U%\1(A9.2\7
M7(=G<]<IW1N5P1M5(4UJEX\^8"(NFLY,<N)N#D]6\YFDFN]%3I\RI$3J+""$
MLN3LTL1M-B5N<:5N_NE:Y]CXY-C?[[K-?[V#)/IYO6,S+;M/&>+KU5&-4F1.
M%7'V4G/B)@'Q?!TI FS?,$-;++ >NB0,8I!$2ZQBWVIB2+C)-'$"+M08Y=.&
M>@F2X#F)OWH<;"=YVP#2(,8\M;V8A(:0(PA+DO&F'!@B1=L16P CM"ECY3*!
M]BXT:>TZJDY8$&[$DOZE3DRN^U9H*>0]E9AS &]R M,E1K[>>0FL"4#>2!>R
MSEJ"BCC.DUZ,%['/GXS>#7N3Q%0657[ 5K1?;BI3.>K DDC&,Y,3UF!)% EE
M C L[/I#K_%75ED201*V_S%^R>)P^00Z]NN4B P%1)N1LV!(EQDS":"%BL@
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MVRI4I/(LR))$J ELD:LYE"8+HRM."ZVD\8LXAP?VV"Y8]\M1HO;W9*(O'+Z
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MK@4'\&!$BS5V\W.Y_M(2#TFX3@_1I EUV0I3%JGUN-I3BI!JA0-&*YRCFNB
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M!$S*(9Q'DR3@PM;)PD6J> 7ZC#(0@:O/$&K]62;^'J7WZDH\$O'K7=F;[DP
M9RC P'-0NB'YXZ2&,VC),<+-CK.5BLU%I1N//A^:'^E_-3VUT#$Q-?3R'20-
MC6'<;(THH6O17U0"4>(-'I]W31(D,=,E9E<RN?3H2<_%2[<(='A(>K.X@C9N
M_Z8;Z^=^L\RK-N)0_.)1B6_IGGE#D 332R)*@*3^-QV]K]IZ9I]V3S_N0A\
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M:Z0$!>K(A-KC,<6[!>IWPNW/+ D&N'SO):[X%X"))5F#(B$>?@V5]%D*0U:
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MY/4O?SS_^8$_MG]Y;,TGGWVP<7O;RL\\6>T2,QK;$J;OE]AJ*M>>4MC*,=5
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MC,@A5B5QAKPX39[06.;+VYA2OE'A+GE?%8A5IW)TI='E*3"I XT%MN>,S!N
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M_0\N 9%\VGR9KH#9N>8"1K&36,"KO:F"XR4"&(5#7@"F<U7&"J6Y6FBNIG)
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M-?+PV>C,Z\BCUR.3J,@FIR!3>O+D3\*@Y\__>O;LS=-GLW3_R=,_8:7T!)8
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MXA%1I-F9Z3<S,V\>S[Q^]O3/IT__I%*.%H'1Y,R;":)(CV;''C(16B6,(
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MBCTMLOAV7>KRC-K=M5N.K]E_-K,>1NF.G(V<IW&A+E_MK=0D-J@#S<:T)=K
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M=8(^D\@71 #0$# Q0<8\*6"0]!:/>-<D)H,LP&X79)-%0EV>MWB=*K%59LB
M 1.;4.7-9.<[XHAI04(!K^HF5 (PR<R\D79(:@D1$O&WG*V6;W*K') F6?*V
MZ-/7(%W>6L64OI401LS-D= M<IQT;.GGZ[6HUGRN3D1;G6DIZ$FJ66!W2$G
M9ZTI_^!GSAM:J/#'2$PQ(@NV._6Y(DQU\3Y\O*\Y"CI>D<1K!9AIR5Q@-UM,
M+<&'<59RL&&IUR>VYX0_7;WE^X'(\\Z^QS?O$@8]?M#S\'[?>&_?^$#?5/_
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M<AZ1 EMOZ%O!=XEO@3';)@9)0*5W7JU('1#HTQ/*5L<2),'QEO]?7@'P5C?
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..&K\     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_4.jpg
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MJ0('90F()F!V ;&Q-IM*TQK+^!19Q#&O0_2*/"1*D&A'.9L-Q%L"P*$V W/
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ML2'6V"X02Q \11,(2J)&&_Y8HHT;^VJA:BR\+*C9S7V;K+)N@L"X&?;-G![
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MQ$S*R1D&S6@10VP.LT5,PE"5L L(XF)9W2%6QJ/%1"P;CW@=HH/ X&(#6T!
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M+)QUW/QIATSLGMY>/U!7Z*A(MN02K854:T6FJ[:BLZ:8#GCA-4HX*E&$0&"
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MIPKL2$ TBT5=BLP!['B^F,_E,^F QQT-^"-^K^Y4-8?@564=W!N&\G:;A"%
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M\_&V='A2?;XK'ZWPR2VIX+RNAH:8=V9+U3$S!Z<W%FN"&@#7CR-QR1[ D8B
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MG55Y@%H^Z(MI<L*MQ!3)QU,Z)" 2TW&[G\)T,\U9CLR/VF(,%B1L2<%>XY>
M7'W9T(RZS)RFW*&=-4L&&LY;//TW,[H6==6T1I3IM?&IE9&%;14+VXNM8;G>
MR];J3'?"G>?(UK!:[6;R"IEDT ABB]@,A4VN =W\B*VHB96Z ] 9Q W,^5!;
M2N&2"N,GC>@*>/6:$=A'HE8*=H%-HVP>L'L,X1<YG:%<N$TE,">)NAG2S5/%
M5+R]OF9"5_M0?^^TB1-F3IX\<:"_O:4EDTI9K6;&W"R&P>QV8V\$:V<6DVC6
M"<C:\0 Q=V^QUINT1ML:-LUT:@ U:\=28Y4.471P'$^2 D6S&,;B6#P4;*JM
MG=37&]8]"L\%W)I/E24"EPA, '<I\#)%"G94IHB0QY5+Q"I2B9-/.*Z\U.U/
MI\I$^X[UVJLO/O?D(V^^\LS=-U_SQ8=OWW;E997Q8%B& (ATYS.S.YJG-=5V
MYY)U(;W@EK,*5^U5ZX-Z 7)HV)O@B!J?5A_QM:6B#;% 8SP(..LN9B%RIMU*
MP>^)*WR88UTHFO-Z>FJ*P+)"T!=WJ6%9@*09%!DOBWL9S.@<M*,>#/63=B]F
M6"0@2(1%XSP2I>Q1 J_U.K(<7N6D&P..Z=6Q^4WI>0VI8P;J+SY\VI7+YIP\
MK6U&9?#DJ:W+9W0L:LN>-:_OJ)[J*3GO@J;4Y)P_SV--.M>?\M2[R3ANL"R&
MVA+$"-<R/);DT*:P5ND4\BH396PAW!;$;)!/?9B!LP"#&D3##*)Y<=1M$LUH
M<<.,T;96KX+1R8#:7#2FT9B"(0J)^E49&-'=TM3?T=[7V3'8V]/7W=7<T%!7
M4]/4T%!94:'K.D1+:\[3Z%8)UHXMB+4%C+E"K[5H$A@TRZ:-$&WW!LFXF4 !
M;3S#@.\#KAD#;L'9V6QPU#6ML:9FL*<'<J7"L2%=]\B&93-'M* *2RN,,988
MH-;5U##8V9:)AE<N/WG\^Z-</U*5B?:M:WAXZ^;-&S_]9/7ZM>]=<]EY?[[_
M]Y>M.GVPI:[:''X1$>EYW>T+^SM;$^&66# EL5FG6'3+=0%WE=<):@C[*KUJ
M:R+4$@]U9A-MZ6A3,E(;]N5T9U,JFO-J"9<2%EB/'4DX'76)2#$<@!B;\;E3
MNBOFE(,BYV-Q)VJ,=3"2IAGN/&;B\X)[0FPANRULM\4(M#6D3<@%F[Q\DX_O
MBBE3"OZ#&N)+.O.KYG9?N'#PRB733QIJF%/I/W%BW<6'#"YLB"WK*:Z8V7Y<
M7_6)DQJ.:,NV!YC^N#(EIP]E704!R3"V*A6K<=) MYR U'OY!&-K"(A%E4EP
M:(+%BAXAH] IE0Q@:)A%@ZPQ&,U+&,_01QF1TYHJ #'3ZBI5$8-H@BECOA1B
M[.W$PI$D BXM'8O6%"N:ZNM:&AOK:VHJ\OFJ8C&?S7K<;D62K#D @*I1D(V5
MY=JL65#6LN.C36E6+P&VV]/!R9XEU7@>S!J+XQQ)2AR7BL7JJBICP8 QH172
M+DE8VZ](% E>42*-W5Z::ZI6+3\%B#NANVW%J2>6-_K\*529:-^Z5J]^]X7G
M'W_G3?!HCS[SV(/77G+NC/[.YGRR+AX*,V2$)=K2L<'*7,$E5FB.G,05/7)7
M*CJI*ML6#S:%]8:PISGF'ZS*]E5D^HO9IGBH.N2M"?NJ0M[&1"3C40,<H>.V
MF"QT51>J8Z&H*E:$_3'5X>?IJ"*Z4:-EW65'O 3J@W!G'VF,-W"VNYTKAB'5
M&C,I'Q@J!&?71&=5A^?71Q<T1$\8K+[DT(%'SEIRY1&3[CSIH//G=\W,:\=V
MY>#FJ9/K?]5;N&1AW_(I#2=.J#YS9NL1K:GC^BH7MR07-24[_&R-T]X==71'
MY((#:]"I%K^8)&T]2:T[X:ER4QUQO3WA;8GK>1<3I?&:@#/(&#V;40<3YHBX
M)@9YTHT9CLQ-V=7=!DTV![X9LSY-KO&[]VTRMJ>SHTY1#.J>6"B8C,5" ;_?
MZ_5Z/, R:T,6:[:FY=3&X<PZL?;9LV2!;*1_8*RA,W?)8LQU1XQ1;"QX/XHV
MU[<D[/9H*%C(9N'H=;L4"*\HRB (C]D!:HHYX%:7'0W%BHM6K7SAJ;^N7'[B
ML4<>^M&''XQ_NY3KAZTRT;Y=;=LV_.Z[;WWPWM\?_^/]-UYUR=-_>G#IP;,'
MFNMB,I>0^1"))12^+NCISB8:P_ZD2%9J8KU?:XL%NM*1IHBO4E>B/%;M<[8D
M0I-J*V:TU#4G(VF7G/>ZZJ*!NAA8/$;';'X6+X;T[NI",>3/!_2,K@48W'!D
M=IN.(QX,"8HD,,)CCL6W^@$ 9"'4%J?1K$C6^?BVL%*IX!UAQ^2<9T%#;'Y=
M^+"F^,E#M7>>-/_FXV;>=^K!CY^[]+E+?K6T/;%B6MUU2X=N.V[Z>7/;SIG5
M<N) \92)U2NF-9XR5'OFC.8S9[2<,%#9&Q8'XO*\VO#"YL2,8F!V37@HYVWV
MLX>TY><W9:?7)!;WUO5F_ .%2$?:7W#Q;2E_SL-# JT*NAH2P<JPGG0) 9'T
M$*B?IYPC'9V&))-HUIA>PZR96S0QYLPD0XB-Q3 ':VP@X.!8PTF)(@=9DJ:L
MM8, 1J.<&F79**U&6]FL"ZQK+*<V"CMR=$]X<X0'1%'.[#DU-IHA")>JII/)
MA+%6FRC2%&L'J!G9TT%@(+!I88_KUT<ON?7Z:^"]<>WO+ID[?>(7Y<U6?M0J
M$^W;U8X=V[=MV_;ZJR\^\]='[KGENL/FS9S05I_SN@NZ%F2) &%+R1SDS2J/
MW!3Q5KC$G,J#->M(A&I\6DL\ .ZL*>H[J*ME?E?+8%6N)1&N\!DL&Z@N=!8R
M*54,L%A(H&HB_IZJ?',FEM;5M%MUXZB?Q<("K:.V(&</4(@7&^E&M/H90X0M
MA-D2+%+OE]K"6DM0AJ0YD' O;L_.K0G]JK_RZ.[<&=.;;CE^YITGSGW@]$-N
M/6[:*U>>^,:URY</55UT4,>])\U[_.PC3I]<<UQ7^H+Y[5<=,>'\>>V_&2A>
M,+_CQF73KEXRM+@Y-K?*?WAKZIB^XM+N_#']U8>TI"=F/<=-:CQV4N/!+;FC
M)C0>TEV]J*=N<7_CE+K,I)ID?U6\Z)=;TZ'>RE13*EP=\>9\6EJ7XRY)I^R:
M,2_5IM.HTVY332GVD4D(UBY-QHH=J'&RAVXHPF)V&L,$A@:BL=;& F-Z-JT.
M@5)94+.X9I@RH)BUVNW(+J4C#XU>0^R^P-BBP9SE'@X&?;KN=#@@E@)D.3LJ
MXA@D4"?/>66Y,IT\;\5I'W[P#WA[_/Z6&XY>?/#PUO(BD3]:E8GVK6MX>/BA
M^^ZXXZ9K#YL_JZ6J4)V*^A@\KVM^$@^3.!BQ=B":6QDL)/OSB9Y,;$(Q71MP
MYS6Q(>QMC@6&:@M'3NJ;4)VK\&I9MUSTNUM2T>94- L?=3L25\3JB+^WJC"E
MN0XL6X F?(3=8T<!9PFG&*!L/L)H=Q\9HF$.I "%<5L$MZ4$I-;#UKKI.IWN
MBLJ'MF;.F-EVXE#=A0O[?GOXX'7+ICYZUN+'SCGB3V<?<<_)\YZ^:-E;-YYV
MQ:*>"^>WW7?J02]<]JO+#^DY=W;S?:<<])?SEM[QZ]FK9C5?NV32$Q<L^]/9
M1YXUN_7H[NSITYN73V\ZMK]XWL*^%7,Z#VJ,+Y_5><:\GA.FMAX_I?6,@P9/
MF3=P[-2.)1-;#NJLGMM151?6)M:F^RN3/<5$9SY6G_"W9F. MJ0F>"E;1&82
M+D=$YD(2&U&%B,P;\]O-C:"L*5:C*Q%Q)M&LS=()N(>FS.V=[#2.,<86+\;0
M6<+<X+T49^/\&FXNRV&-4T-W[T,Z2CT#>68@-2Y&$('G>8:!;PZ!%(CF<;D<
M$$N-\6ND!%1%$0=)ZI(8]7HN/W_5A^^]O</<->K2\\\Z]?BCMFS9//Y]4ZX?
MI,I$.]#:O'DCN#-KBO+;K[U\RO''S)\V--C6Y!78A%..B9P71VH"'G!>146J
MT;6!?+(QI /1)E9F*G6UQN\R#5I@2GWEE(:JAH@?B%83]C;&0ZWI6%50C\E\
M6"!;T_&>REQ'/M6<CH9YTHTB.H8"[&("[4.1 #DR1,.[6X"S.(LF.3!HMHP#
MJ5#0HFKO3ZB'MJ0.;\^>-:?CVF73'UAQV'._/>&Q\Y8\<^EQ[]UZYHM7G/#X
M>4?>==*<9R\]]MJC)M[YFUFWGS#SJ8N._N.JQ0\L/_B5JT[ZY.[S7[[RQ ?.
M..0/9Q[VV0.7O7K-\NN733UYJ.:W1TPZ<T[;D9V9WQTU]:IE,X_L*5QRQ)0+
M%@_=<.+"*XZ9>^&1,\XY;,HQ0\W'36E?.JEY07=U>]*]J+]Q<EUF:F-^J"[;
MG@U-JL^WI((U$7=6%VNB>GT\6!%PQ34AYN0B$FU,>+ ;(SRL13N<9M>!U= F
MF*WRX-<$,_=1)MJLH60$.M+,;Y%H]+A/ ;.L[10,J!F[E%H[71E[E2*[Z68U
MP"'FALW6,#>0,=%*UXT!<>:NH$Z'Z" )3>!=/"O1./QO>^G)Q[=LVFB\.;9O
M/V_%R7]^],'R5/8?I<I$.Z RWZC&7F>;-V\"KOWYX0?F39]<G4EVU53I#)7S
MN4,L$6;H^I"O/1GIR2: 97DGUQ3V=J4B5B]GM5\#@]9?3/?DD^WI:$LBTI:,
MM&<3@#-02G-DW/*$NLK.0KJO.I_UJ#&)#G-4W,&&!<*/(=:(5MU$V%B<!5%;
MBK,E&5O>86\-29/R_H.;4T?W5AX_L?;,.1TW'#?SX55'/OO;W[SW^W->ON;D
M5ZX]Y8,[SGGO]E5OW+#\T;,7OWWKRH?/6O3R5;]Y<.4A+USQZP_N./OI2X]]
M\\;3/WO@DD_NO?"I2XY]]O+C/[G_DG_<?L[]9RRZ^?A9?SA[R2V_F7?ET5-O
M.7'^'\X[>L7<SOM6+;WRV%DWG+C@U=LN^/V*(V\\>=%M*Y9>L&3&)<OFSFW-
MS6I*G[YPZ,B)+<?.Z%XTT#2U(7=05VU?,=Z9"P_6I >JDEWY:'/"7Q5TY74I
MI7%AWICPX"-L?FID%I=FKJUF]218@90W6]DLT2A*H@:-#(<%_LML*;/(-6K*
M1F$W2K21C@+(JKBQ"2E)&-OZT11M[<%L,]S9R#>Q7!L0T)J$((FBQ^UV.9TB
MRW($ 3;-(SEZVUMC?CT9\EUX]IFC"W+ .^3<E2=_^/Z[X]]&Y?KO5YEH!U2C
M;];UZSY?_8]WK[GLXD-F3V_(YSP,E=%=<87W47A6DUKBH?94Y/]G[ZW#JSK3
M-]SM[NX2V7$C"83@;H46"E2AA0JEBI46*(52W(*[Q-V%N+N3$ \)!'>)[BCG
M_=8&IL.<Z?SF3&?./WG[7.OZ]MH[$,K*S?-\.M':W%.O&@OAT=[@II:XJJ43
MK/7@W6:/L!NE5;AIY=,<K<=9F4UQL!ZI58XQZ-WT*GN9&' V?80#F+5QMI:.
M<I&&1ARAE4.,U1#17%;3C'P5-I1IFN *5QT>DB;.EHMSD5#&:GGS771?3W?;
M\N'4$]\M]M^XS'_CI]';OTKS6EMX>E-]\-Z"TYO*+FQI"-Y3Y;OM:L2!DG._
MU 7MRCOQ4_F%+9?V?)UW?'UCR)Z*BUN;P_>WQ1ZY%7<,/EQR[E?XP@KO;3$[
MOLXY\7/.B0UIA]8E'5SC_=.22P=6^_^R/&[?JH!?/P_;\4VQ[Q[_K2O"=ZU*
M/+HQ</NWOEN__OG#:6O>G7C@NP_V?/W>@>\_6KUHZA>S/9=.=?]V_J3W)SBO
MF#O^J[D3/Y@PXNU1=K-&6$VT4;MK1382NK609L;":R&3LH@:*D&)QZ%%720T
M)"(EHI$$M+4L'2VQY)%)3 *>@<?3"7@*'H\1#1V;\)I?;T#MM5!_&;#OI3M#
M5QJ59A();5>.O!KJ7'OU2P'4F-AA6BP&@\?A<%DL)I4*1(/P*^:P)5RV6BS0
M2D5*$6_WEDW7_G!V5'W-Y=?MX?J?U3#1_NUJ;;FZ[(/WIHSVL-5J=$+^2"M+
M+9/NJE$"@)R5TA$JB:>Y>K29:HRYVDG,<]5(1^H4<]P<%XX;"1[-1L0>9:8&
MG(VUTH\RUS@IQ+8BCKU,.-71=J*=Y2ASM8>%UDVK@(_92CDZ.D5#QFM)."TV
ME&G"F18#F1Y$P-FRB:.4+%<I?8).,-U:^H&'Y8_OC-G[V1S_#<LR#J_/.[FI
MX-3FBHO;K@3LNA9SI"YD;T/8OIL)Q^!Z-_ET6]S1UIA#M<&[JP-WYI_>4.&S
MK37Z4&O4H;M)IV[$'[^7?*8E^M#5R$/78H_"%^:>VE@?NK\EYDA#A%?QA=^2
MO=96!NQ*\EI[Z<#:T-^_2CJ\/O?<5O^M7\8?7)=W87OJB5]B#JP[O_&S$VN7
M^&U=&>>U(6C'JCTK%VU:,NO3:2,V+9G]S;QQ:Q9-W?#AG!\63/YREN>22:X+
M1]O-&6&88%".,9/9BQ@&+M%!RK;D48'F0#<U!4%-07RY29&,1A93R2(J242G
M"*@D%@%/Q>,AA%+P. J"&EH/\'K&V1MZ;=:P,0$"9L=0 ]"&'3S*I&+304PC
M!J]MW>NEHPP:G0FB4N%S3 J922)*>%RM3&JI4MCHE0MF3-K[VZ:6YB;3<P+_
M!-ZY/;SIT/^ZAHGV;Q2DB;3DI+:VZ]/'CK'6:M4\CEXDM)9*;&123ROS,9;F
M;AJ%O8P'Y/+0*]U44@.#-MY*/\G.<H:SK9-"Z&FI!9 !^(!<KCJEJTXQU=D.
MX#7&2C_:H!^AD4/\]+#4>5IJ+'DT X=AQB1;">@ZZDM?IL-P9B(:M"U)."<!
MSE5,\E0QYCMKEWA:?3O#=>L'DP]]-2_HE^6YQS=4>/\.++L:Z=44<>#FI1./
M,B^TQAYN2SC6$G/X>ORQ^^GG;R:=:HP\V!1YL#7VR)WDTW 'U)X?\"#M_.,L
M;_C,];CC=U+.W$\[=ROI5%O"B8>9WK=3SE;Z[ZH/][J><#+O[);JX'UY9W_-
M/[^U)NQ@W($UA=[;+X<<* _<FWUF2^;I7]-.;LXXO:4FXFC*\<U1^]>=^7G9
MS^]/_77)K-TKWMWQ^?PCJY:<^G'YWI6+URR8O&+&J*]FCEXZWF6>L\4$2YF'
M5N2NY-OP2.9TG#GX-2I.1\?I&#@-'<UQDYHV8@.T,:E*/D=(I["P_<&I0!\L
M?B(C]DIO$.UUF6AELF, -1"10**#4:, %;&);'\8:B 3"50R!9(IY%,V$R50
M\&OHT!DBD4>GZA1R1RL+1X/9LL7SMZ[]=LD[,UL:ZX8[T?[_JF&B_1O5=OUZ
M6(#OW&E3K'5:&9-A+A8YF^EU/*Z-5#+*$FR7A8-<[*P4>YBI791B1YG 52T#
M3HVUU#I(^8X*,>!LNK/=)'LK:S'/32U[>\Q(@X#EK)+ 5UGRF2,M=.-L+,?9
MF+MJ9382CAF3:"-@&#@D+0&Y,PVVH%*'X<R<@-IN8OIX'==3Q7S'2?W55.<-
M"\;M73[GY/>+ C=]FNJUMO3"UJJ G?5A^X%E5Z,/78L[^C37IS7N2$OLD>L)
MQT&/<WR?YOK=23T+J+J;=@[:3W)\'V1>["P*?IX?T%4<TG;I1'/TX9M)I]L+
M ONK8CH*@^^EG;^?<>%:PHFV2R=;XT_4A!\H]=L!.$L]]E-S[+'L,YMOIIQK
MB3_9FG"J*F1_1=#>JI #U6&'FF)/9IW>DGMA>^3>-<=6O;]S^=PS/WUZ[N?E
M@;]]$[UW7>CV[X__\-&>S^?O^NR=G]Z=O&*JV_L>-O.<])/,I:XRIIV ;$E'
MP[AF)!S03<_&ZY@X#9.HI.+D%)R22[.0BZW42KU,(J!16!C4R'_ V1M$,R'L
M#:*17L(+&^)\Y<N :PPZG4:E$E'T1 49U'2 /(O)0D?'0PB%MPEX-H4D8C.5
M(KZ%2CYUM/N>7]9G1H=L^/:+K-3$-Y^>X?J?U##1_HTZ>>3PT7U[IX\?I^1Q
M)52*JX7E5'<W,Q[742&?Y& W0JNTEPK=U/(QEKI1>A7@;(Q!YR@560M88ZW,
M/"PT(]02#TN-JU;AHD%;/'H:S*S%7 L!TT;"F^Q@/='>"B(G %%+)UCQ64YR
MGB6'I"-AILQDS3#IL6655F2<AYP^3LV:K.<N]32L>]OCT(IY 1N71?SV9<:1
M]55^.^M#]D+2!'Y!P(3\6!NV#]I7(7M&'+AVZ?CMU#/W,LX_R/9^DN=W+_/\
M'7!G6=Z/LGT>9OMTE88"U/HJ(Q_G^-U+OP"F#-C76Q$Y4!7S(-/[67[@O8R+
MMU//W4F_<"_S8JG?]LQ3FXJ\?ZL,V@V ZRP)NY_E\R0O -!6%;J_->'DPVS_
MFRGGK\:?:HP^5NJW.V;O:O]?OPS<\F7:L4UI1S<E']Z KEX_A_[V[9G5'V]?
M.OOWCV>MFC/ZPU%6BUS-IQED:&*=FF?+PJ-U\GC,KS%Q8%K-.21+(4//HVGY
M3!N-TL%<IQ3P)&RFD,'@8KL/_2/4_H@S1*@_Y$I3K]GK#Q"P\U:HV) H1BVL
MT#'->-3OA@TFL)EL 8_/A,^0P*;1)5RV4L@=[63WY8>+_$\>:BK+V[?EIZ;Z
MNC<?H.'Z[]<PT?Z-"@L,F#UY\@1W5SZ)J./S/6QM=!RVLT8]0JNR$G#MQ2)W
MK=)9+O+ >LK<M'(++MU6P :NH75.6OED1QL[F<!2R$%# 4K)1'MK5[U2QZ2#
MH9OIYC3>SF O$Z@(. .'92O@&E@T<SK9C(K7OW)GIH8YMF+<4T&;;BF<;2.=
M9R__8J+MYD7CSZ_](&G_ZMP3&\LO;FL(W0\4NYU\&G+E77!A8--BC[3$';F1
M?.K:I1.WT\\_S/&YFW$>]+0@ +AF(AJT.TI"!JICC!412.7AW65A3_+]'^;Z
M/2T(-%9$=I:$=)>&/<GS?YSG_ZPPL*,D%*!6%^EU*^UL8\R1.QD7C)51767P
MA9'M12$WDL\\R/(UED=U%(>V%X4^R0V\E^[3$'FXQ'=7TJ$?*P/V7@D^4')Q
M>^&Y;27G=V0=VQ2ZY<N#7[RS=_E;FQ=-6C7+_=MIKL"UF5;2269"-RG%@4-T
MY% -5&S5*AEG8%.M>1PPMK8*H9-.9:N66RAD5AJ52B04<]AB+I=%H?P-:J;>
M_C_4&R]-=]!0 ,8NS*ZA.^#=@&NF21X(>:_R*8E(8M(9 AY/(A0PR"0ZD2AB
M,21<IE8JW+I^]=%=VWY9M;*ANO+FC;;A[/F_KV&B_1NU:?VZQ?/>4HO%(AHZ
M]%<O%JOI](GV=G82H3F;;BL6C+4RGV1G-4(MFSG"P4$FT% (SFJIBU8.ILQ!
M+AIMT%F)(:(*/*W,P= Y0415R]RTRO<FCQUCI;>5\,P8-#499R?A.LH%>C+1
MC(+38QY-^YIE.)PM%><AI2\<H?MHE/G2T98K)MIM>W_BB:_GAVY&?6=5?CMJ
M G?7A>QMBCQX ^"5?!J(!J'R?N:%1[F^@"? UO.BH-<"A-W+]GF0[?,XSP]>
M=I>'&RLC>R]'F:#6@ZFK+*RS-!3N]\']RDCL3GA[<0@0#1H/<WP?06+-#X!?
M =X%(/9=CNXIC^@L"FDO#.XI#>^OC'Z<[?>\( CT*-OO>L+)<M\=%?Z[KD8?
M;0CSJO3==25@;Y7OKMSC&Z.VKSS^]8(]2V<<_.RM?<OFK)_GN72T89ZM?+*.
MYZF@3S03CE%Q1ROY]CPB1&\-'F?@4EPT4C=S]3@'Z]EC/$;:66LE8AF?)Q<*
M!$P&0(U!H9!,?'J%+=/UCW=>OX\!ZTW8F49%7[FYET0#IX9B*8TF%8L%7 Z+
M3.*2B3(N2R<3.QG,C^S:=G#;+U$A_O# W+L[O';]?UW#1/L_U7UL.OC&']<Y
M6UO).&PYDZ47"F4TJHK!<--KM4RZK53L;J9UU:FFN]B/L[888]!K:50'N=A.
M(C#C,";86[N9:2P$+#,.?:2%SEFM,&,QU'0*!,]YGA!<54YRH3F':BOFF=,I
M:*MN(=O I)A1"*]Q!BPS$'#65-P( 7&FE?@33^OOIKG\,&/$KH^G!6]:=FGW
MMQF'UI6>WUH;N+LA?#\(B ;6[%;RZ3NI9^]A.'M6%-1>'/P<NP+(@%,F/2L*
M-MT!0>-9(6 NU'@YJA?3*Z*%]57%#%R)!?57Q_0"LP!YEZ.A#; #KL&7P!>"
MIQN\$@L"]@'4>LK"^R]'#U;%=A0%=Y>$=96$=A0&/\[V;4LXT1)S].:E4VUQ
MQUNB#K?%'+T6=;@V8'?%^=_BMJ^\N.;]\]\ONKCJO8/+9O^Z8-QW4YWFV\O'
M*JB3==P9!O$\!_4[3MII!N4D"_DX<[F+@N^D$GM:6TQRMA]M9SW:P<Y*K>*2
M21P*F<]D<AAT*@G-E7U=IH#Y1XK]@7@OZX^6#H]![1],'O@^-*^-S61JE$J%
M2,@DXD5LIJ5&9::031\_^N*Q@T$73L,#T]+<4'OELNE O.'ZW]0PT?Y/=??.
MG?R<["^6?JS@\W52B;O!TE&M%A,)UE*)FDI5TVF.<JF]0C+>UC#)P7JTI<Y>
M+K)7B.UD(AV#:BL1CK34Z[ET<S[3U0PM1U?1*!H&64'&C;,Q?WO,2&>57$<C
MF['(U@*FNU9F)^$8.&0+&MDT&J#'W)F!B+.AX9QXN/%JQGMNNF^G.NU>,OWH
MBK<CMGR1=?C'_),;RRYL;0C9UQIUJ#7F<&OLD>OQQVXEG4(X,_67Y?L#L( ^
M0#0L,(:8_%<[!,GR<(2GRDAHP,O'^0'@O^"E27 3: 5W^JJB340;K(DS<0T$
M-WLJD*?K+H]H+PX%\,&[0_ !>+<J&C18#8"+ZZV([*^,,I:%@[I+0I_G!SS,
MN/ XX\(C2+L03E/.W$\\W19YJ#%H]^7S6[.\UH3\O"1P_<?>J]\[M?+MK0O'
MKAAO/=].\I:5<(*:/EI&&26AO.VH?7^4S70;]3ASQ41KW7AKG9N9VM5<.\K&
MRE:CDC+H,AY7B.;!DIE4*@V<&N:S3(AZ;;O>@-3_"[?^GFCXOS=P>.Q+)"*1
M0BKA4"DB#MM,J;!4JQP,9G.G3YXW;5))03X\.1?/G3AQ>/^;S]-P_==JF&C_
MUSJT?P^50+ W-Y-SV*Y6!BV/*R&3QMG;*DA$-9WJHM,X:Y1S1[N/M;&4$/#.
M"JFK7J4@X:Q%@A%ZC;U:[J21379Q\+2UM%?)+'AL!1$/X72*DPUX-#N9<(1&
M9L5CV(LXD#>M.'0M$9M&BPUK@CNSQ.&L2#@;!LY=3)AK(_UFBN.:6:Y>G[\5
M\-/'Z?O7Y!Q=7W!RXQ7_G;?BC]]./-4&+$L\>3_C NA!UL7[61>!:.#13!GS
M>6'@T\+ Y\7!)H.&B 9H,R7-RLA.DV7#'%PWACFX#]@R^;7>*F3*,*B]-&M&
MX%1EE(ENIE\!B&9"'C@U0-L+ -R5.(#:4'5L7T5$;WE$7T5D#Y@U(&R^?WNN
MW[/,BT_2SS],/G,W[MAM ''$@1J?;5E>JW.\5B=L^S)RTR>^JQ<?6C9CTSSW
M[Z?8S[<53U!2)VE8K@*\ QL_3L.;ZZCWU(GLQ0Q/2ZV32NJH4KB:Z^S-= H^
M%QTC3Z>QL*7L)!*)0"+A" 0P8"0*A8Z-8P+73&#ZQWI--Q/1L)=HVIJI*^V/
MGZ02B1 \92*A2B;5*Q46:I6Y6C%GRL23!_<$>I]]B,U*2TF,J[DR/-OV?U3#
M1/O7=??NW=+BHKDSIFBE$@<+"P678R822JED.8TZRF IIY#-!7P7K=K-3#?.
MULI!)I$0< 8A#XR8E40 [LQ.(74WZ*>[.4]T<3"(^%H.W5+"L^2S9XQPFCK"
M?J1.Y6&A I Y*406'(HEDZ;&YM/J"3@SPLN^,RLRSIZ-&RDF33,7+!]C_<N"
ML5L6C3_VY;R8;2L*CF^H.+^ERN?WEHB#]Y).WT\Y>SL)S2Q[FNN'QBYS?.YC
M4(,&6#,(GB# &0BPU5$:"C(1#6(F"-I=Y>' M8Y21#2 %&)3;?Q077QW1617
M>01 K0^@!LRJB>\'\U45 ]>ANDLOZBX-U<:;<&8B&KQ\47\)"1KP*]3$F8@V
M4!G55QYN+ DQ@A,L"NHN"&@'"YEV]G'*Z4=)IVY%>34%[KQ\;O/5H%UYA]9D
M[/DV?<^W$1L^/OW57*]/IJV;X;S<P^P]9^54'7N<DC%1QW>7,EPD='>%P$G$
ML1:SU52"C(A7<Q@ZL5#"97.I%.H?G!?B$1@T,IE&IU, ="0,=5BOO\FXH4+M
MEQUG+[_J%?5,G6BF2;FOWR+@<"P:52(4J.0RC5RNE<L4 IY>(9LPTFWELJ57
MJA#([M^_[^]]]MZ]>V\^6,/U7ZAAHOV?*BTER:!5::02,X7<P=Q,P6)**21G
MO=9&+E71Z>X&"UN9:*RME:M.K201%$2TL[Z&1;-52EWT&A>]>K2M8925N4'*
M-Q-RK.4B"P'+T]I\HH.-C5A@R66-,E.[J"1V$M2)IL86!NCP"&=FT, BIP,+
M/T9!FV40+QEE^<.,$3^^Y;[KHREGOUV0NG]5^;E?ZP-V7X\Z=#?QI(EH#]+/
M/<[V>9+K]S#+^T'V2Z(] C=4&&PB&E"L':)?<0A< 5(FE@'47@G:@#:X&0T"
M9L$5[G1"8(2 61735QT+%!NH38"K"6<F#=8F .8 ?R_J$A#.&A)?-*>\:$P:
MPG+HT)588WEX;WGX$$31RU']Y>']96$#96']I:$]!?Z=V=X=61<>)IYXG'SR
M7NSA1K_M-\&L7?BU\O2&_$.KD[=_&;K^0]]5"_=^,.&G.:XKQEHM\[!8[*1^
MRUHZTR";J!>[R]@.0J:U@*9GHGV6Y"1T&HN00N22B2P*B4Y!1293B"0RCD#$
MH^W4,+>%QYMV%0*J<5@LD5 HX//I-)KIO5= >[/^Z-$ 9Q0B$1UO3*&(^3RE
M5*(0B05,NI3-%+&8,R:.N]%V_0ZVLU!=S97O5GQR__XPU/[K-4RT?UTW;]PX
M=& ?ATZU,=>KA'P9BR$D$B04L@K\%(>E93/LE'(KF62$F<Z,SU%223(\6K6C
M8])'&\PM!-Q)+@X3G>UME3(=CPF1TU+$':%7SO%P]; T<Q +K/@<"R;=62H$
M:V9:YZ0GXBU(J/M,A\F.1IBL%RQPU'P^SF[+H@E>R^<<6S$O=-.G65YK+U_X
MK3%H3VOXP3L))QZDG'F8>NY1QL7'6=X/,R\^R+SX.,?W 3:.B0UE^INZ_(%B
MX+\ 9"9RF6CU6@ LH!(PZQ77(D&FC\'-@1K$+&CT M1JX@%JKRCVLH':R*PE
M()Q=306<(8\&5\RC#57'#%9%#X#O U5&(%6$#Y2%]A4' =2Z\WS;,\\_2CH!
MNA]_Y&;XOM;@7:U!.TN._9BS_SN VJ7?/KOP[3O[/YZ\Y1V/55,=5XRS63'>
M;OE8VR6C;=YV,ANIXH]0\ ULHH:"UKK+B&A1@8"$9Q#Q)).9(I" 90AG1#*1
M3('LB2P:F8Q'&Z.91C%?%@&;=FO:/>T?P?;*J6'"IH:0\7C(MB(>7Z=6Z90*
M#H6,G3'*D/.Y,R>-OUQ19GJ*JBK+2XH*_O[)&JZ_OH:)]J^KO*QTROBQ%#))
MKY#+N1SX.1&3"#H!#W &5QN%W,5,9Z>2.^DT&C8=G61.PBNH1%N%U%HF&F-O
M.]U]Q%A[:S6;!N_:RT4.*IF[N7:TE;F30F(CY%CQ6,XR@9I(T!+1KHW6+*HM
MAVI)>>G1#"2<FX@XUT;^Z6BKM;/<MG\PY?B*=T(W?II[9'V-[XZFX#U70_??
MBCWZ(.DT$ UUL:>"1SO_*,L;;-KC'#^P9H^PV63/BX([,%_V#!JE86"X &IP
M-3FO'@Q;)J(!L$#&JI@>@-TKP<O>*T"Q. !9[RNB]=<F]%V)ZWM%-  9,FL-
M22B$UB>^:$I^T9B(B 9.#3-KB&N06#&B]56$0_;LKT!.K;\DN*\HL+<PH"O7
MYVG:F2>IIY\DG[P3[74S8O_MB/U-?K_7G-]<?'1MVJZO?+Z?[[5T\I%/IV];
M.&;]+-?5TUT :A^/M/C0W?(C#]M9=KJ1&I$5GZ*FH!6@:,<.$IY'(5$Q6_7*
M6YF:!-2G]FH]P#^6B5;_."\7]T^(1B>3^6RV6B&WMK!02,04 IY-)K(IY#&N
MSADIR>#4'F(=:B>/'AS>-^V_7<-$^]>5G)CH.=+5U<%>KY")&30!F:1@,Y5L
MIH;/T_*X.CY7PV$IZ%1S$5_-HHL). D!I^<Q;95R&X5DBIO+6 =;*[G$6BJT
M%/,MA1P(H>/MK4>::VU$'!6D2R9)341; ^E)."L.R4G(L..2+<EX\&CF>)P=
M ^<IIRURUGX_S67[^U..?CG/?]U'Z?M757MO:PT[<"W\P/5(K[L))QZEG+T/
M.$LY<R\9+<-$.,OV?9CE\RC'U^3.3-/' &<FHIEP!G[M67%(9UE$URLC]AID
M1@Q;2) 6JU^J]TH<"!H]"'"(9=@U8: .:0@HUI#THC$9X<S4!J=F,FO7,^$Z
M5']I\&]$BS 1;>!E]@P!IV8L\._(OO@\X_SSM+./DT[<BSL,"?1.U,%;$?L;
M?'XK/+PFZI>E?JL7^J]>=.*+.3L6C]\P=^1WD^P_=C=_ST7WX4C#.TYFTZW5
MH_526S%3QR8I:'@9@RRB45@$M#,'$3"$EA)@1#-QZ>_+Y,C>O/L/]4>BF792
M,P5/)I4J$0I5,IE4P!=Q. P"GD.C6IOIUW[[=75%N6FJ;6)"W*ECA]]\O(;K
M+ZUAHOWK.G/JA+.]S831HS12L9!&YA&)"B[;4B[50L9DT,"F*>@4&0F=JBLF
MX(%H<@;%6BZS5LCLU$K F9->:R;DCK:U<C;3Z/@L&[G8PV#FI)2J*40EL(].
M5!'P%@RR.15G22-8TG!6-)(Y ;DS1RYNBI[[OIO9NK=&[?YX^IEOW@W;M"QU
M[_>EIW^I]=MQ-63?C4BO.W''P*#=3SX-.'N0>NYA.EID_@A8EN7S(-/[4?;?
MB-9>#$0+>5X<VE4._(KNKHAJ+PU_5AS:61[951&%(%4=9ZR*[;X<W86I!R@&
M_+H2UUT5 R_A:GH)]TWM7K!I=9<&3*I/',0T!%ZL :"6]*(.XUH39M!:T\&R
M#=7&#T#PK(Y]<25V (N?@R#(GN7AO24AO<7!:* @SP_UJ65>,$'M8<(QT+V8
M0]>"=U>=W51P>$WV_N\2?_\\Y,</3Z^8NW_)U*T+/,&I?>IA6.BH?L_-8I:-
M<JQ>XJ&368L8&A9!R40G@7*(>+!I5#P!<B81.V_ %"@1P5YQ#?^W,<U_47\D
MVLOCILAD,H% )1(Y3*98(- JE0(VBTNG"5@,)ID\UGW$+S^NN?UJ2IK?Q?/#
M1T;]5VN8:/^ZCG@=&.%@:ZY6 LY 8B9=R>?JQ"*M@ ]$T_*Y,@I)1B7)J41P
M9R(\SEFG@KSIJ-,XFVD-"JFE3 *1TT+$=;70NUN"=&-M+<UY3!D.!Y'3G$DS
MH"%.O"4=9V"@(4XT8X.(LZ) WB0M'J'[8:;KGB733WVS(/CGI<E[O@.<U?OO
M; C8U1JV__ZEDT_3SC_/N A$@\CY*/W"TVR?ISF^)J(]S0MXGA_XO# 8*-91
M$M99"J8L#(3U^L< U !D'641W95@RF)ZJI %ZZD&?L5V748(,Q&MYTI<5U5,
M)R(:O(P'F3X#C;[:2P,-R0/U28 SDQ#@,(IAV3,1H0V(!JX-,VZ#-4 T-*L#
M3>FHCD'=:I>C!RLC^RLB>DM#C1C1>@H".G-].[(N M>> =223SY//7,[RJLU
M>'>3__8Z[]\J3V_,WO]]TN]HK.#BM_-/?OG6W@\GKY_M]L58ZR\FV,^U58Y6
M<<< U/1R@Y"NI.-E5+R$3N93B#1L$3L9G2?PM\'*/W#J_XM' Y8!T4Q'KL 5
M;!K/=*HQDRD5"F0B(9-,$G,Y,R=-B P-,=FTYJ:FPP?VO@;<</WE-4RT?U'W
M[]_?MWOGF%%N:HF(2R2*Z!0SA4S)XTCI-!67(Z$0I102#X>3D E2,EY,Q#MK
ME.X&"VNE;(RCG8[/4;'HEF*AO49EIU&,<[0#&?ALR)Y:!EE#)6FI)#,ZN#.\
M!0UG0<59D'!F>'2UH>+=!=09EJ*O)CEN>-OSX+)9WJO?B_WMRVROM>5G-S<%
M[;X><?!>PO''*6<1T3*]'Z>?!YP]SKCX)-/[::[O,XQE'6@=4@@:XBP,QJ:_
MAH,Z2L.[RJ.Z*X!BL<;+L7#MO0+AT82J^!ZLT5T-% -F)?367#+67(*7G9=C
MNN&MVDL@:'3!AZ%=E]A;E]A?G]0/7#.I/JFO+G&P*?5%<RI*G<VI0\UI0_5)
M0YAK0[ULJ+LM'J[]EV/Z*L&F00C%Q@HJ(OO+PXW%(7TEH5WY 9UYOCWY_L"U
MIVEG.C+.7PO;=S5X]_6P?<"UBE,;BH_]F']H=>+O7X3]_&' FL4GOWAK^^+Q
MZ^>XK9KA^OEX^UG6\I$*UB0KU60[O8V4JZ0 U @ -1Z9 /&3CG^Y.<=K>/TC
MQ0A_,&XFTID<W9LWL5,+T)$K! *=2F4SF6PZ'8@F%8DD C[$3Q&7(^9R.122
MA,=;_?7*&VUMI@D<AP_L:6IL?/,Y&ZZ_J(:)]B^JI>6JU]Z=\]^:Q:-3^62B
M@$I6BP12L&E<CHQ&$1+P(B)!1,1+J&1H*]DL3WL;![5RI(W!V4*OXK)4+*:%
M5.AHKO.PLY[B[C+&WD;+I*JH1 V%J*62%3B<EHBS9.'-B3@+,DZ/[:MA3<6Y
M"<FSK:5+/"RW?SCUR!=O7US]7N2OGV4>7%-R:F/5A:W-P7MNQQY]E'P:< 9Z
MEG'Q>;;/,S!EF=Z(:#F^"&>%P9W%H<\+@I_D!X),4.LHC7BILLC.<@2UGBK4
M$=:+"1 &_.JK2^JIN=15'0_MWKJDWOKD;G@)F .6U5[JJDGHK$F :T]=HK$^
M"=0+:DCN:TCI;TP=;$R%+Q]$C93!AI2AIE30(+"L$5Q;,D);72*:R%8=VW<Y
M&M1?!5R+ZBV/A.M 9;2Q-*RO++RG,*BK(+"G,+ ;H);MW9YYL2WR8%O$@?MQ
M1V]''JP\LZGB](:RDS^C^+GM\YC-G_JM6G3LLUD[/YBXZ9W1/\_S_,33>K22
MX:Y@SG:VF&1G9L&C*ZEX.0W^@H@2)I5/)9IV4ON3=>S8N06OVR\WO'V]K1#.
M%%&Q'C33)N#P&2J9S&&QV-AQGPP*A46CF6FU:KF,3B0RB02E6*23RZ*" Z^U
MHH/O[MZ]&Q$:]. !VN1]N/[R&B;:ORB?B^>6??R^HXV!1R4!T?@4DE+ E3)I
M$@H9#!K\G @(>!6; 403DXFC;*W!CBDX+!>#N85<HN*Q[?1::#B8Z0!PH^VL
M;912'9>F(.&T-'1T@ J'=L@QI[YDF3EVM<#A7+F4>7:RS\9:[UXR_>(JA+-+
M.U;F'?FQ^N)OC8&0-P\ T1XFG7J6#@;M(GBT=J!8MB^"&DJ=?B:B=9>$(X]6
M\-*C=92 1XOH+(ML+XUH1U"+ZJZ,[;X<VUT%*1+<&1 -+!C8KB0,80G(@M4G
M]S:F],"=VL2>NN3NNJ0N3-WU*<:&5&-CJK$AI?</&FA,?2EH-[R$VHM&")ZI
M0T"ZVL1!1+2$7C!H56A26U]53'=Y1%=)6$]99%]%5&]91"\0#6Q:06!W06!?
M<?!@:6A/7L#3M'./DT\]3S_WX-+Q!O_?J\[]4GKRIX+#:W+V?Y^\?47$QJ7^
MJQ>=^FKN[@\F =36S'9?ZFD]0<>?8"::8:]S4G"M1'1K,4].QDM)!"F-+"#C
MV7@<$X^CX='Q*Q3,;;UR7H0W.M,(J/<?>30RB82ZR["W7D9.*A5]&#N8W73$
M%(O!8-'I$$7%0@&8-1J!(.1PN'"'0-#(9-,FC(?@>?,&.G_GEY_7W;XUO+WM
M?Z6&B?8O*B,M9>0(1X68S\#AP*!)V R5D">B$(4DO(B YQ/P CQ>0B9!WC27
M"$?;VVAX'#N=VEJM-)-)=!*1A4*FYG/,I&);C1*D93-5=**:C%<3L7-/\&@[
M0ST>I\,AF7 V@D>>I.9^/,I\\X)Q1SZ?&[KQT\R#JW,/KRT^N:'6=WM+Z#[P
M+'?CCX%'>Y9^X7F6-^AAVGD02IW9?L_S MH+@H!H'46AS_*#GN0%/2D(>EZ$
M$:TL$B)G5T7,2U7&(EV&C!D/ZJY.Z*E)[*E-PN"5W /NK#ZENSZYJRZY$T &
M+P%AS>D@:'34)H%ZX$Y36E]S!JBW*;VW,:VO*7T *0TTV)@VA*Y@TY+[ZY+Z
M:Q,'ZI(&P 96Q_<#,2_' F%[*J+ZJ^/Z*V.Z2R/Z*Z,QKH5W%X?T% ?WEX4/
MEH?W%8=TY?FAGK6LBT]23E^/V-<2O+O1?WOU^<UE)W_*.?!#TN]?1FQ8XO/#
MNP<_F;9UX9@-<T=]-]5YR6BKV;;*Z3;*,7KQ*)W832LUYY+4=**4@)U70"$(
M*00>B<!$AQRC3;W)V$;>V&H!Y,4(V (I#%XOK1D1.T(%O!@"G^FM5^PC8@>P
M4T@D>)<)P9/#D8A$0CZ/SV9KE JE5,H@D00LED(LBH^. J(]Q(Q_1EKRFX_:
M</T5-4RT/ZO[]^^?.'QPK(>;5B'E4U%?C(!*DC!I0#0QE22FD/EX/%Q!6@%O
M@JO+2!MK#A[GH%./=7'2"+@ ,DNE3,YAZ:4B@U*F%PN5# 8ZPPV/4Q/0?CBF
M?1SUF"Q):+63'1TW4<.>;R__;JK3J:\77%BU..[WKXI/;KQ\?FN=GPEG7K=C
MCSQ(//$X]2PR:-D^(%,/VK-LW^=Y@>V0,?,"GN3X/\KV>YCE=S_3]WZV[Z/<
M@*>%H>TEX-&B>B['0=CLK4KHJ<9TY5+/E41C39*Q-LE8A\Q73WU*5UU*)Z:N
MAM3NAK2NIO3.AE105U-:=U-Z5V-:1SUZV=N2U7<M9^!:3G]+MK$YHQON-&4,
M7,T<N)HQ"&K. +KU-T 43>ZM30(-U"</ MIJ$OO@]ZV,A6_&6!DS6)/07QW?
M71[96Q$-";2[) QPW%44# ETH"QBH"R\KR2DIR"@)\\/;-K]A&,W(@\ U.I]
M?JL^NZGTQ'J(GRD[ODS8^IGOJH5'EL_<_>&DK0O'_33/X_/Q]A^/MG[7S7**
ME=)5R;,64JR$#$L!2P<YE$&4D'!\/#H)%$$-.PF4BHZ)0F>IH(Y_+&."%</6
MM!.00<..80>HF8Z20M8,)5'L8Z\$:*/3:$(^'X@FDT@44BED3[E(S 38X?$\
M!OV3#S]X/2:0DACW]\_:</TU-4RT/ZN;-V]<.'/<Q<'6SM)<QN=P200!)$T&
M34RG\(EX'AXO(!# HPE)1*"8AX.=3B004TB6,HF;K;656H6DDBNX+ 67J>0P
ME&PZFN>!G1^,>M (.#WQ;WD3[1>$QXT2DQ8ZJ5=.LM^R<)S/FO=#-WR2O.OK
MDI,;:WQ^OQJRMSEX=TO8/LB;8-">I)T#=]8.1,OQ;<_QZ\@+Z "6Y?H_S/2Y
MDWKN9M*9FTEG[Z1>N)-V$70OR^]Q?K"):,;+<7U7$@=JP3<E#X +J[Z$= 7<
M&5@S,&6I@+..VN1.8!:T&]-[KF;UM&1W7\WJ:LXP"5[VM^7W7\^'F\;6G(&V
M_$%X>2VWKR4;--"2/=B:,]2:/0AH:\[H;TCKJTLQ$0U^1U!?3:(1<BZ ]3*
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M6QL#$-'NQ!U]D'CR6?KY9Y WL[PQHOFUY_HCHH&%*0B&R/DT-^!QMM^#3!_
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MG\,RU-8RU==3@^N22M+DRZO+<QTLS(R4^7QL<KDZG:(G2]?G,C6(!&-9IH4
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M+<L7PE1/ 8I7/84AR*3 72WM-:]-[(6D"7&L+!H\&D"M5ZJ*V-ZJ^#ZI:A+
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M=S&W/R0^^"W]V>]9?K]G!_04ADJ)!K9%C%Q,LJ0V&8T, L@PH@UB@.O&NM4
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M4=)^--'WSJ9DU)7^!]& ;M@,U>\&3527#*ES %O@.5"? AX- B P10*AKZ-
M]"+W.]':"P>1P*.5BE^6#7:5]'<4#W06#W:52MY4#+^O'GY7*7Y5*NPL$G86
MBU^60EO252SI+)( "CL*16WYHM8\^-,0T=KRT7[?+W*& %L8T08;,_J_$RUC
ML#X-LN<P,F4YP\W9P\^Q/K47.0AJS9E##6E#@+S:Y,'*^&]%D;_GAR*BE8-'
M0R,#TA.7$@W<F11G7_.#^XK",85A\_40T?J+PK[E^(/Z"X(!9[W00% + J?6
MF^WS.?D!!C7/-D2T$Z6W#J:<W11Q:'GH_B5W-CB>GF=Y9*;).DOE.9IT1Q6*
M@R)ALA)ELBK;D(Z;J"IK)F#K<5E*%*(L'B^=P %B8A1#(I&DXP-4;!H'"3P:
MED"I)*) 7EY!7LYIQC0ND\&F4V48= :5K*>ENGCAG!^ON;'ZNS5&M/]<00%^
MZDH" 8>IP&)PB02T.AV/5R#@[?2T#>39ZE2R%HT,2<1.0TF;1+#BLFQ5N<9,
MRE05_@8[\]G:2E-4N"84W!9[4Q=#Y<D"QE(S%7!JBXWXIQ?:G%]LNW^Z\;,=
M"U//;DD_ORW?<R\0[56H9XOOA1=^%X%H[V*\.T*NM05[OHN[^SG3MQLB)_B1
M@K"!TBAA1:P8S3M- "\#&0TT6 5$@^P9+T23U!#@$-IJDT #-4B]*'LFBM :
MSTQ)<_;0BUSP4.)6Q" Q<*>C>+ -$0UP)GE=(4)0@\@)OJQLZ$WE\+NJH3?P
M)H+=T.ORX3<5$C!N725#X.DZBX>ZBH<[BR7M!0#'H8Y"=&S+%P,K 5+MA</P
MAP/IGD/JA,";+6H"DY@UW)PU A1[D8LI!]I#SS.'&M.!:)+Z-%%-<G]97'=Q
MU+>BB-[2:, 9G"80#0Q:-P9T")[?"D*[D2^#R!DV4!+9C_6F(16&]F/=:CT
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MZ$6>E&AB1+0<<&?2U#DBC9P M=:\X>9LX-KH\\SAAC2I01/#O[DN900H7)4
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M@=#X!I@OB,D0/\OB!@LA44; $6@%F$.D ]>&\4L$I,L+%6'63%(<!2R#]\'
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M:=%)QCR9=8[V.^<YSC75LU?A.:@J&K.H>F2"/O8(6R":G;*<.9LZ35UNMJ[
M6I9B1";8RS.G*-(V6FM?7^48?G@-$"WYS);T"SNJ[QVONN/>YG>Q,^#*&XB<
MP9X?HKU_B[__:^R]CS%W@6O=J<^ :*+<H+YTOU]B[OX:]Z CT+/ZWJDLCWU
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M:&WRF6W@T9+/;*FX[9YS>5?%K2/5M]U33KM!ZBSW.I1V9G/X_N5^VQ?Z;%T
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MXD#"50.LQPV<IW5IH%-=M-=H7NQ87NQH+N LH"G*<R@]Z$Y>Y$A&4%><9W7
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M)[T4![WJ]LV'=N_PMK;\\RC9J'^^-HCV=^K=JQ=-^%Q,E-\V1AIOL_/8$(]
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M(:9VMWWM7@>"L]];(-KMEK7['<AVO GIT88U$#=HH!OL PMZ*A<Z(&]20-"
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M[2KYIDNZ7:U$$R\@,*)>LPJT$!U. E(&ERX0K:,2Z55/#7;N"CSB:[-[P'2
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M L[ZL#W"GE0A?@5JH!$]'H!=X)%N3,& :,V 0AL2L;\0#0+=(W0.%'-7:[T
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MU0K6P-MTB/:J%>Y:M;M.@Y9S-F/39>&Z16,"3B1<0#1@67^COZ\!'8>:$=$
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M]IS0@V&!%](.B/;)M]&>=A<KIU=#6JH2;M=*]JI%OF;57@5W7%302TO=U%-
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M:G7N:LUFA1QJ'[,S3[T.A<T&O:=6'0B;D-FW',)-NV#3QM^Q/R/:D@["9CE
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MLG'GJ\5K-1)WLQK"IK_#C.9P-"K\]3)_@WQ!4::+OZ*-O0Q$T\5=J<P*>4P
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M4:>!:)J8L^KH,[;DR[79MQZ5WNLA1/<0H[L(48] TW!ACJ*H^;F#>Z:\F'9
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MR;I1EWVSI>!.:]'=EJ*0K@.BO=!V0+3GU>9G9X8;K0,:THI+N%LM]M1)T)A
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MVB"K8$Q0.BX$4RM?U[,VC>Q-(VO+Q%[7T>&/P;R"L*JEKNEHBTK"I+@XL"-
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MFB[VDCGINC/]=E76W>KLNP.,]$EAP0@G>Y"9,<Q!@YY]:$,.1#0T/L!%XP-
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M<-9:'-->&M=#28/$-"U&^PL!UR!; <CF4"=:68!H^Q:NU\8'K@'1X AY<]?
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M7;SR07'5F(( =@8](L/W\"HZV:4C4MR<CCXN)PR G0'"*(4OJ(5C8MRX&#O
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ME'2GBN%0TM<4]%4YS:&@KRF92W+:FHZ+$*U>XS!+UO1"ATWAJ%$O:@4K)BG
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M>#R53*'1&4&AH1]<N[9I:O_)M4FTE[">/OGHS3-=X8[=T&$.3;YR"*&M 59
M-% 2L+,B6W&:"3M.2@&TM09:UWN9-?K(*Q5&J<;<<A=93[CS>(+/_MR(@X71
MQTH2;_957N^IN-RRYX.>RCMC39_-='RS/@J<^O'UR6\W%@I^.3X+P(*D"9.O
MUT?N3K8!R,#.X)5W)UN_6!T"<OUZ?!:(]O6!$7@]&-EOI^9_.C()[O;+B9G?
MSRR"H*G0=FX)).ZOI^?_?.?0GY</ M0@<OY\=.*+E=[[,ZUW)QH^'JGYH*?T
M2N?>VZ,U'P_ONS58>;VO[.YH[;>K/3\=&GPRWW9_LN'MYKPWZK-6\\-/E"=
MWCQ=F;Q>$-$3X0QV%F=(#Q)@0H28)&-F@:T( GB6G!>G1X9.-*2&::.\&3N"
M>0CH* DF3HJ'3I51"BS8SQ<$:C?L#")GK9NTW<\8N-;J:]SF9W*^(N9P7O!2
MNN](E'.*$<MXU[_NMGU.-):*:%O(VUXAJZE1,&@:D42CTHA$,I<O</?TNG'C
MQHN7;[/^GK5)M)>R;KQUKM[/HC?2>2#*M=E?=0R[/\)Q0.D$:&OT,:]VDQ7:
M2B!^)AC0XO5HV7+^'CL=(%J^C21.C[;/S:0UP'8RT6<U+_+U/7'OM>YYMVWO
M6TV%'PW6/ISK_'*Y3_6>VH&1[PZ-_0NA(&-"TE3=DFAE\-%"S[WI=H#:]X?&
M/Y_O_GRA!_P+H ;4^_GX#,S_=G$-&B:_G9[_Z\G97T_-_7!LZI>3<[^?67BV
M-OC3L:E?3\_]^<8*].^GY[XY,/ALM?^K_;T/9EH_&:N[VEWZ?E?)_>FFFP,5
M'VT<-8=6W?5LH?W^1/VCF>;WV@N!8OOSP@_OB3Z\-V8]7PGIN\1)/T'&]&9I
MA@@PR<;,9&-&ABDG6<:(W\!9E 0?R$-XT7=Z4K<%\S2AP=$ 9PE20JY<)6B5
M3N):5=Z4/B=:C4*GW=^D,\"T.UC>Y".[U5/P>F'(L;W*R02/SA#[%&..B=HV
MU4VZ-XBF>BOMM2VTOVRA;M]&W+F+AL&QR#0JD8+%X"D4.I7.\/+Q^?3>O1>O
MWV;]W6J3:"]EW;WV7DN(W6",HC_2N3/8KB?,?CC:=316 5SK"+1N]I77>9H4
MV^L"T8)YZ 0#>J8YK\Q)/\]*%*5#SC(79I@)]KF9CL7['"M).E.5?KXFZVIG
MZ6<3S8_G.I^M#'P!"K9_\/M#8S^J-IV-?[,^\FBQ][N#HP_FNA[,=7Z[/GIW
MJNW.1///1Z?A2X"Y7R%4GEV"_AO@[,T#?YQ? 2/[[<SB+\=GX-N_?WW\AR,3
M/P+43LR D?UV:O:W,_._GIC^\<CX3T?&OUT?_&*Y^_%BQ\/Y]L]G6^^,U]T:
M5MWI[');(31P[?%\VYW1FOM3C1\/5=WH+3M7G;:6'[&<$WIX3\RQDOCI%+\R
M%X-X WJ(-MZ'C0@3X1,,Z7%ZE"@)42G"1XBPX=J8()Z6#V,7M"]C9P@/$2;0
MBM7!18O16::,,D=1J;T0B-;HH=_J:P1A\_EJ0'N 2;.O8;5"I]Y3_^[0WE-E
M46]4)RYE!BYEA30&V/H+"?Q7_VE9@ %<V[Z5A]"@[MR)W[:=@D*CU1$8!(9,
MHG(Y C0:QV1QDE-2[]^__^(EW*R_3VWY\I_KQ:]LUC]P/;Y_;R#)=RC6O2?<
ML3?, 7HPTGDLUFTXR@5\#>)G6X#5/H4LU9BE%!.4$F*<'C5)QLR6"U)DK&A=
M:H2(5&BCTQ9@.Y7DOY87>;HR[=YXX\>#-9^.-=Z?;/UTO/G'0V.?SW9^O1^,
MK!OZZ4K_X\6>9VM#CU4W(^I]LM1W?[;SR7(_,.L[U<(HI-0I2)=_7ES[\[TC
M?[RQ_S<5XQ8!83\=A= Z_=W!$9"UW\\M@I3]=A(\;N'W,W._GICZY=C$CZ^/
M M'N335]-MWT>*'CHZ%];[<5G*_+/%.3_F9CCNI^9POM=\=4]ZV]TE[X9GW6
ML=*$]8+(E9RPY>S0A<S@MF#;-#->D #KST6%BO!*"2E20HH0$T*%V"@)(5P;
MZ\M4]Z1N]Z+M\&.J^;/4(H2H6 DV29^8(,476G&?[Z'=YR)I]I;U!,M!S9J\
M#%K]C3J"3'M#Y0U>^A-Q3E^M-%^L3;Q8E[)>&+Z4$]8=J<AWDMD0-/]EDRUG
MQU8^&DG7T*1J:-(P>"(:1R?3*20:D\'!XXA@:A0*+38N[O[]SUZ\BIOU=ZA-
MHKV4]?3)D^F2E.%XCUZE\V"4:U^XPZ#2:3S.': V%.72%^ZH.O7I8YYG)8R3
M4@!JH0)L"!\3JTN!U)F@3P\5XF-TJ7F6HF9_FTD5U*+>;LQ?R5%>:2]^NM#U
M\7#]H]G.Q_/=D"N?K0[>FVK]:O\ C&!M3Y9Z[TVW?;L^\F2Y[^Y4*T@<L.S7
MYRL 9Q95C@9]=A'ZMY.S7ZX.0,S\^=C4X\5NL+._G9G_X?4QB)F@9K\>GP0[
M@[ )_6BAX]/)QKL3#0_GVZ[UEEVHS[Y0G_5V2][UWM*[8W6?#%=O'!NH/%V5
M<JPLX4AI_/F:]"/%L7/I@3WA3GL<]:)TR0$\=+  &R$FAFM#P$0'\5 1(ERL
ME!S"1[D27G/ ;/&@;/5GJ@=Q-*)$Z&0#$A MRY1>;,/;YZ(#85,E97XFO2$6
MD#3;_(V[0\R[0\RJ%))JA>1<5?37B_6'"H/?K$]=+XK87Q QDN17$^B89*$G
MTU)[?A"*^9=761IJ+"2*A<$Q\$0B$DO$$.E4IEBDB\,20-9()"J!0+*SM7OP
MX,&+%W*S_J-KDV@O93U]^G2J-+T_2C$0Y3H<X]:O=!I0.@'.)A,\Q^,]1F(4
MH&Q-OO*]]CH9IIP$?9I23 P3XN ?/(S LE !+D)$C)%2L^3"CF"'E>R("S69
M1TL2SU5GOE&?=[$N=^/<>//CE;Z'<YV?3;4"W;Y<Z?]\KO/62/WSVZM!_'RX
MT//#X7'0L=_/+?]^=NEW2)J@9A?7?C^[ ';VQYD%8-DWZ\-?KP]_=VA$E3=/
MSOSX^MBSM8$?#H]\?6#@WG3SG8F&![.MD#<?S+1\-MT,.+O25?Q>1]'5[F+5
M)Z2,USU;Z;D]7/U6<]Z;#=FG*I,A:1XMC7^N::-QGF6NAH S?PXJB(=1B@C!
M?(PO"P$=S$='@J ),9[4G8[8+:Z$5P/9ZF%\9"A/*T&JVJZ1:DC>:\.'O%EF
MK]WH:0!ALRO0K"O(M'.C^\,M>D+-:SQT2IWX)\K"@6@G*J+>;LD\7A%WMCYS
M+"THS\4DU]4BVL) I+Z3]LH65>_8SD:B&6@<41.%4=-B$&DD+$6J8X!!X8D$
M,IW.PF'Q9!(E+#3TUJW-T^Q_W]HDVDM90+13$ST=80Y M(%(%^ 7-$1.T+2)
M>(_GIM;B;UGI8EAH*\XTX\7JDB-$!,!9  <9H0UQ#!\KI4:*2= %UI)^I6(Q
M(^1<=<;IJO3CI<DWNBMN]%:\W5QTH2[GUE#MH[F.3R>:GZT,/)AIOSE0_7"^
MZYL#PT^6>L#7OEX?^?G8-&3/'X],_O#ZA&K1\\SBCT<GOW]]',(FX.SQ4L\7
M*WU?K?9_/M_Y:*'SBY7>QXM=T-^L#SY;[8.8^62IZ\EBQZ/YMH=SK>]WE]SH
M5^W;^&BHZOYDX]?[>WX[,OK10/FIBN2E[-"U@LB9%/^95']@V4B<1Y.?98HQ
MVX>E!1W(PP1RT0$JM*$CM/'A0FP !^%.WNY"> 5P%L!4CY'@H)7:J!0#,A M
MVXQ>Z2BJ=!;#J!(T\+) T_8 X_8 (V!9;YB\SE.GR4^_V=_@0('_HYF*2XW)
M;S:EG:U+.=N8-9#DE^5DG.MFG>?IZ"A@2% :]&VO4;=NI:MKT9 8O#J2H(FA
M$^E:.Y%X-)& (^&P1#0*)Q;I -2P&*Q2J=R\X>W?M3:)]K+6YW<^!J+U1;KT
MACNJ-IU%N0Q$.$+V'(YV'8EVA8<]80[-OA8U[L9%MCJ)AHPH"1%P%L!%)1K0
MP6B"5.D,$RNE14G()8[Z TK%L9*$(WOBUG(C+S<57&XN?*,NYT)MSLW^?>!K
M[W>5W1YI^'RVX[/)UD= --7I@MY[DRUW)EJ^6AW<^$C0_L=+O5^M#7ZY.OC=
MX;'?3LU]=VCT]GCCHX6N7T[//5SH_&2L_M/I%J#8EZJDV??=H>%O#@P\7NP$
M.[LS7O?)2 V,-P<J;PWO^W"@ OK!=-.WJ[W?KO:\UU9XH$ YD>0SG>(W%./6
M'>;8Z&=9[666*><'";!^+*U@/A;^+KX;$_@[0@=RD0KB7UP(K[J3MOK0=X7S
MD?%28I(^*5%*@+R9K$_<:\.K5>@V>.@U>ADT>QN"E_4$F[?ZR]K\97T1%H.1
M5NV!LAI/\9&] =>Z,]]M2[W>EW>MO_!B2];QFM3^9+^* (<B'\<]_FX1UF:F
M#!IMYW;JCIT4=4V2FA91$TU&$9 [$&@-M-9N)$8+1R'2>!P!G<9$H[ $/)%$
M)'MZ>&XN%/S]:I-H+VL]??QHL;;@.=%&8]P@:?:I5@GL5;(6[:KB6HRB-\RA
M+<!ZG\(H5RZ [ G_VD,%V V<8<#7PH1X<+1P;4*,#J780:_%WV8^+?B-VNPW
MZW-/EJ>\TUITI7WO<VN[WEMYK;OBXZ&ZSV?:G^T?@"CZR6C#9S/M]S;N"'1[
MHN7#H;I/IUJ_W#CN?F^J[>/1!L#9G8DF(-HW!X>?+O=\-MT" ?/I4A>DRT\G
M&NY.--P9K_]HN/IJ3^E[G7NO]95]-+3OX^%]GXQ4PWAWK/;Q;,N3^;:KG7N6
M<D*[(YS:@FT!9 V^<DB:)4YZ@#- LPMINP\3$<!%!W)1H4*<4@Q)4\4X#\I.
M$#1@F>J],[8F$"U6@DLV(*<;41-5FS;P%0X0-O7;_8Q[@LS:_8QZ@LUZ0U1$
M:P^0#2J!:)8@:/7>.I=;DJYVIKU>&OS)V-XK/7GO]1>=:L@<2@^J5WKN#7"I
MB0X.-).)L6C&KITL!)*FB<)OU\!NUZ!C25PJ&P^*IH$A8LDX#!&XAD,3*&0:
M$(U((#$9S)CHZ,V=MW^GVB3:2USK'=4]2N>)!,_16+>-M\]<NX)M@6@SR3Z0
M/4=BW6 $WC7YJCZ4(-.,FZ!'C=$A18H( +5(,5$I(@+.0H7X:!U*F@FWW-EP
M.,KM>$G"A>K,\]69[S05W!K8=Z$FZV1YZJW!ZMNJCYZK?:=U[XW^ZGL3+;>&
MZQX"K=:'P<L>+G0#UQXM]MX>;[XY5/?A4.V="9C47.DJ^W"HYMY4\\U!(%?Y
MU9ZR3Z>:KO=57.LM@_F-_HH/>DK7]\2\V9A[<Z#B2B?\RN4W^E3]87_Y]9Z2
MRRUYA_?&]"J=&_PL]GF8E"MD>3;B;$MAJBDG4D(.XF- .;T9FKXL!#@:D#J8
MA_&BJ0'.?!D:7M1=?@SU( XB0H"*E>!C)-AH,296@DW4P^?+6>4.PEJ%3INO
M44^0.;"L+U3>$V+6$6C<%VX^'&W=%B2K]A!7>XAN3>Y]M+_F>&7X^SW9[_?E
MO]-3<*(QLSO9OS[*NSK*OS3,SX1"T$:C=$@4CA:*O%N3K('&JR&)P"]U#&HW
M2FLWBH2C8)%XE"9&2QV%1>/))"H6@\-A"1*QSMJ:Z@.,-^L_O#:)]A+7@8[J
MYD#KR42? :7*R\;BW"%UCFZL#T#J[(]P@F<&E$YM 58U'B:%-J)48Q:86HP.
M.4:BZF@Q6:E-B!*3(D0JNJ6;\EK\K-=S(R_69)VI2'VK(>_=YL(K;7O/UV1=
M;BFZ4)=[I:/T]DC=G='&F_W5[W>77^NKNCE0#12[/=[TT4C]I=:]-X=J 6=O
MMQ=?;B^^.]G\8+;]XY&Z&_V5,'[04WYKN.;1?/O=\7J VIVQNNM]Y1]TEYRI
M27^[)?^]CB(8S]=F'"U+.% 8=4"U/R-T/,F[.\*YP=>BW%6VUU$OWU:29L9-
M,^5$B G^;!38F2\+J7(T#BJ$CPGD(+UHZDZX5YUP6WSH:GY,C6 .(HR'C!%A
M$G0)T2),N$ K2H3*,:&5V0MJ7'6:O/2[ TW[0RV&E=; LE8_P^X0LYXPL[X(
M>8.OM-%/VA]E_E9;XE_/]5UHBKO:G_M@L>Z#D=)3+3GM";[52L^ZN) R99 Q
MF4!^[16:FCIEEQKVU>W8K>H$330!@<6HH[1V:J'4T'@T 8/ @:,!T8!K1#P9
MA<0@-)%D$MG!WO[:M6LO7M'-^G^N3:*]Q/7)>Y=:@VW[E$Y=H78CT:Y3B9XS
M25XSR=Y -(B<&\]X#44Z0_"L]S0%HJ49LU,,&0E2:OQ&Q^I0@&N1VH2(C8[1
MI61;:-=[F(_%>*YDAR]GAAXK3KA8EWVYJ>!\==:%FNRS51D?=(- [;O9OP\<
M#13L]ECC)V.--P=KK_96@KM=Z2I_JW7/R7U99VJR@&*WQ^K?[RF[VET&++LW
MV72I.?]"0\ZGXPT?#E9].%#U?E?QNVU%Y^LR+]9G/]^ =K(R^4A)W'I1U')V
MZ$B\9Z.?Q5XG??"R EL)=+H9-U*'%"+ ^;%5( ,[@XD_&PF"%LQ#>],UP,Z<
M\:^Z$EX#G$4(P,CP<3J$% -*NHP6)\$"T6+%Z&(;7HV+!")GFZ^L+T0^&&[9
M$V+>Z*77%6PZH+1L]C?H"#&N]9(,Q5D]7884G/-HH>*#_LR;HX6W9RJOCU4
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M)L5J$Z*%>(!:&!<=SL.&L%&!3&00"Q7"P<#$3X4Y#5^:1N &RT(YF!".ZF5
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M!:E+V"7%;M5#;K$F[S1#;RGSD'VSTO;7RTL/9NI[PFQ S08C'<'4II(] 6<
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MV'Q[18Z0CC,4<?2%7 H& Q>%2J20<"2D.AIPIJ6!4]\%$SP614*H;AE$?'X
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MEBK$B&"FB$09K<H$.C8UO<E,H-RTMP08PBJDY/2W_'#P+S^95(1)A=CTMP(
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MC*ROV5\8V;.HX,Z.>4"T\?55=[;/O[M]_N#*V5T+<H97E]]NFGMW:\.KEE5
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MRX!H:M;&X 9,H:9Q/4>;</@ HI((2;F$4DCIJ3U'K@A Y (Y$B#74KP11#!
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M7&'1F\Q:$Z&@2(0QJ,T\K9WUCE#LKQ#,]$U[@J3I"YX!B/],"0_*)F6FO16
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M&.#L3:NDK>!E@#.&,$'JU"I=4+!!<XQ%Q=M)7 <EF(G*1#1L_3Y34W!3=^E
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ME5>6E3071)RJ2 !- ZBUUZ6!N/4MS.^<FPEK[F^?=V?+7'"QL365?0L+ &&
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M&T)HL->[>]?.1P\?_A?YVM\DT5Z\>+%C^W:[S0JYDL!QR)@BH?#-=4S@&G2
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M!CW!BMN <2+GXQDWC@JIZ6;ZIP>H0<1 N@<^J7WTP;3''DI_Y &990_>-Q!
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MW@3 @H?0I^7]M>4]:5D,.C1J2\U!DR!" K]@, =]XZTRUV3&R0L\/?T1E8:
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M!M"Z84 W,#66RP9!HY@LCV>$SS<Z.WN*(.:A>-#K&^7WCR;(B-L]',4"DE0
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M AT=H@>,U4:-O-D&I ]XWBF$X>&@)S6#?Z,9\(CBT?O2'K\O_:E'%8 Y^#Y
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M#45WVJ[]<K?MFY[Z>ST-MZ\W0-*\>ZOC1F]+?5W9S9M=?7V=W=U@1DV,0@
M@ !)1$%4J=UW[]VLJ+S6V]=SM:RTJ:6YJ:6ENK;N:NFUTFN5>_;LIVE>$)P^
M;\1N\T+8]+@B-L$G<AZ3CF1(!X1->=*9CH&//OT9O=L6'9(['D!&6B3YN.C4
M4"3?O'8EP][\:* 0"H'88J&A=B%"F.T4YB)1A\7  ='L?+@P.8&PV 4FH,F
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M?Q1'!7&7R=,A34Z%?".3T<<#5IDJI4C,QS-12R\&%V-1V"QR9&NP!=M2Q7P
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M"3RL:\6D)TP2$4G,]WM'I>(_U[52 @NS=(+$X WSX,GV'$-72R@\0A-1>!^
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M]3B#LE#DM\8,,8["X^!H;B< -.1QA""<2ER!P*9Y.N7(,20VI4L%$6^%RB9
MTW0V^M#NX^MOWWEP^\[_SUJ>_Y]_79V=SSS],X7E@X8E4:P)MH11(L& H*FT
M0-D]KA%V<#3&10'1\%R/.]L%=@9)D\@E:!<C$A+"F?/?^@1H-Y@:3[E8'(ZX
M.4 8@(SV") Z8=^0 L R@)I?CT$+FDF9L53>!X0BW:AVA=O&H/Q(HV6 .5('
MM/F-)$<:P!0@'1!*14O) ;P"$ RA90:+H;MCP#O@&C!+R)0J@X )5UV!\@;,
M% 3/S+A9-(PV,UG=!UX&O(-+=.XP')B8")>:F?MNJ-:VA&8"8DXQ%2T#K8,7
M9NZXZ88,V#()='>/YQF#HPW"(P:\252LAE!"_KQXI C59<-15RSA$2 'H5[.
M+,B;F".'R'[4!2S+#+)U.;(PA3.S'K:Y<@@6@PN#J E>%A<Y3,@+I3<NWW1Z
M_^FK7UV=/VW>Q'<^.KG_6&=]6_WUZH&VGO;:IF\&[GTW<+>ALOKLL5/=S6W-
M-?6#W;W]'5W=K>WW^F_W=70VU]4W5%=WMK5^_^!!;U='<WUMS<WK ]T=%\Z<
MN-W=5G/M0EO-C?Z6FH8K9VXW5'[;>JOUTHGZ4WOK3^R\=7!SV\GMS8<W56U?
MVGYBRU]N5_^MO^IO]^J^:SIW?=7,W9^\NNOCWV^<\.LSGWW8O&UQ]?JYAV>]
ML_/CUXY\^E[W@75-.Y9=7#F[>MNRTTMG'5T\\\*&+S9,?7_[O.E[ERS8.'?F
M%Y],W+)T\?:5R[>O7;-JX:+7?OO2K*G3)WWXT>NOOC9O[KQQX\9/FS[]A5__
M^I?//OO\"[]Z\;>_F39C^LG3I^H:&ZIJJH^?.MD[,%#;T-#1W7/[[KWFMLXW
MQKWM\X<-P\\P$D6)AAYD:346 C!!8)& :!RA2[17($V1@HN\Y5.3(HT6?S!E
M8$2,(RV.,.'/#9<Q38RPI)D)D@40/T'< '/@;ASES?XI@3MD!C. 92(#QR.4
M2P>6 =0L-05T4P5TNXW$C*!5)($+*DF%BX2\Q8 PTF-@3BWL+Y/82-A7QA ^
MEO3;1@@NFT9Y?)96R--114QY]2*(F2(;8ZFPKA1$@X\%K'+2 _H&/TE2$_/!
MUQ+1)R4TG3O-,W%GKJ$*^:0G%+!& =&&C S$"K9H6)D[@$9FL$F6BA.>L"P6
MJ'(QY%"*0',S@5^:5((Y R'_6(Y)6GHY, M<S)'K-=12=+^,3@+4X"4,&;?G
MFK@G!)G19XUBZ*0L%:)A:%R:9I)N=R G6R<@9DJ%).KEC M"/L>E#'VD+!=#
MO 7/@JUE5)AZ!0#+:0] KJ2(.,1/W!,&M(E\(4OGX>XP\$N32RUM)$.FX*MN
M1P B)S"7PJ(L&0=-T^4"2RGDR9 N) 0\\-")LP=[^_H&!^\,K0SP?_A77U<7
M\P<4E@M;/@&G=%84<5JA.(T1+5XA;6XW$"W;13M)UDT3-HR O.FBD:81DLX;
M"J-R&$\Z:9TW.5P$.Q,IA<4$T@6")@+($L%\A;-\6@0#6M$&@ S0%C3!YS6)
ML0 6KEPTNRBSUB^*D)F9WJA7,;.LR;^!QI%%BVAE0S3G?(ABD!-)C\RCV>:H
MRQ)V '81/UPVT1@T]% (ZB)Z!SB#:0^:&Y"I3XMF.%&9B4TA;SZPDG!)@*VA
MH;8@99A#]&;6@O+IZ,F9G@1THPW :J&*WHAE#*F)G!= !L$3N ;94Y.#$#]=
M=F9H8FGN"'RH1#@(G6UXAFC#7+8LS)5+0N@6*,U20ED/VS$[[86T) =\2E!A
M-?@%EN=7[-JPJ^I"U<E])U<M6GEPQX&6JL9O^^]WUK?^,/B@LZ'UQP???SMX
MKZ6VX<:EJSUMG;WMG7#5NMW=.]#3]^<?_^7;>_?@[]W9UM;7T]W?TU-WJ^KJ
MI0OGOCK5W]U17UWYYS]^\V"@^W972T]S;5OUU7MM=6?W;^V[=?&;EIL_]M3=
MJSIW?>_:8\MG'5LR8__<#_LO'?A;;]7?OFEJ/;EE_3LOG%\ZY>*R:5L^?&GK
M1[_[:N'$RK5S*M?-;=BVI&GG\OM?[:S>LN3(_$EGEL\^./^3?0NFU.W?<F7;
MVJ,K%V]=,'O3_-F;%RZX?/C O@WKEWSZZ9Q/)J]8N'#UTN6??#3QG;?>GC9E
MZO///;]LV?()[[X[8]:LM>O7SY[SZ=L3WIGX\:3-6[=4U]5V=*-I3ZA_LZOG
M]IU[._?L*Z\839*\SQ?A.2W@BP>\\5BX@,(E1PYI'T&X<FA+BFI\D,,-R@WG
MH<%X=+^6!V&3<,J L&2XO# YUE+B(&6X2PZ8Z20:<(MZ.2TTV1-,/ #4 W)!
M"(7FU5(Y#]/Q8/F8LN>=N3SF5$#*&-S*BXWF*)\N0SY2(75RE%_BP#(BJ>AH
MCT-UV62!@=/,PITZ1P1(E^5VZ,Y<S>/4,:=!XCZ."FMRGBU' @53Q3RO42IQ
M"8Z*1(.C-1D2[AC"!>PKT>5"EH@(= PT#=(H[0FY[5[4(:"79>Y\Y3,DI+8D
M189A/^0?3> A@4V!=OF\%:*0KRDENE8&7!.Y-( L'!@3#HP%=[-EZQ J@8.
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MZ3(WQQHQ7 .B8>XP.!I T#1&\2RJZB'P::]9CGIOA3S2!9^X:-17_E!C4^W
M0.]_>!.MK:6E+)5.^H. ,S+7J9( "26N^P."%M%\Z4!,<-.,G9!Q@7%0G(O1
M&4TB)=Q&0.,P ;0"- U8AME(D52&[G-#,^6@RIE --HM2+2AL%8R5.15P@()
MN<"GL-Z@F828P).Z(85HCP)T$RB3RJPS!A[DUY,1;\'0$N5>%2W.!'C*S+Y$
MTY@R)V)"R!0U&RK^@ZHYD@AM))(X$\PKTT6 P,2@$?^*Q\:S!'H"O!6\')Y@
MSZ9SAN' ,KAN>^P"BQM#2ZA$_$69)53\J!N41(-O&03$(*1=(-=0S@UYP8H-
M(!KD3;2X%&T.?\3)$"KJGR4U^"K$Y.Q'7!X[*S#P<L652X&:41XQ]U'WL'_,
M!:+% VG<3@ND$O.G EJ8=-(<(2JL^MIO7M^^8?NB.0L;*NMZV[KO] W^Z8<?
MP<N^?_ MJ-F=@0$(E?V]O8,# _?NWNWLZ+AWY^[]>_?O#-[I:.^X/3!07U<'
M!U&-L>I;@+/FIL;!VP,W*V_T='6 K-775B--Z^MY<*>_K:FNMO)*=W-=]95S
M?2VU?_[^SM_^Y<%W78T_]#3UW[KTUX&6/[??^NO_0]A[1TN6W/=]^D.F1,39
MF7FIX\TYI[Y]._?K?OWRF[0!BR FD:9T*-&R9=FR)1\%B[)(FQ)I$A((DB!!
MB 1)"  1=A<;L#G-[N3\<LXY3 ;\K=L4;4OG '/JW%-]^][;/=,UG_I^JW[U
MJ_7)HZE+U_[BCU[[@]]\\0N_]OO_VW_WE7_YC][XTF]\^-4O?/#5+Y[_DR^<
M_Y/?.?\G7WS]#W[KC2__^V__W__'=S[_?[WP'WYC[NV7-R^]]_[7OSK^VDO?
M^;TO?._+7YI^[YVWOOF-=[_SG6]_Y2MO/??\QO3,[8N7;WYX:?KFG>L7+KW[
MQEO7+UV]<N'2VV^^_=QWGOO^*Z^^_][Y/_WJGWWYRU_YK=_^#[_[>U_ZM5_[
MM[_ZJ[_^K_[5K_[,3_^"YT(F%)BLZ%E1K=SO6?A/+L'""[2.%@7YK_)NLS*:
MLZIH2ZD.OA8-5:.A6F$$_9:CE3-=$O!D:R6 #/R"-,/O#N-9)IF@>XOA0'NE
MNL"XD&.J&"I"3F+]5OU)U,FB= ].\Q1/N]TGT#]%H=O2I6+>'[ TDH<6A20.
MDDN!TV=K-2;C^'93%<$.M?N$W'5<8N)]T7429PON1+* >MVW!V VXP7G=1*
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MB[E^?/-,0H9J2W=+F1X)QC/6:Y[,.0KOM+?ORR0X4_62772R.QOXD2QJGAN
M:+_W>U_Z@R_]X>7+5Q86%T TT&1M?0V0ND<6;-Z+U=/"X>$^B :-MK2T@ JX
MAH*7H%+;.0)M..+EX\>/H,[ +]"MO:\2CFTFMF&'\[CXKX+:4,=YX*S]*#C0
M:]>OCH_?OGOW",\'T< =(LWB68+9Z2E4=K>!T_7+%R_<N';UE9=>?.&Y[YY_
M[]T;P-*E"W.ST_.STZ#8YOKJXN+<^MK*S,PD%"69/R!?>WMU90E$/CHZ)#'$
M2_/7X*S'[TR.DW7U^%);:YMKBVL/[CU\]]5W2T$Y,'*F:%5RM6:I?[3W-).
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M,"!D3[]D-Z,(EB*:EN&%N:*NF:ED9G!P^/GGO_?22Z]<NGP9_^\/#@^VMK>
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M>:\1[]]N<Y2FBJ[(&MD4SV1%13(D47=LWW4#BF*&AD:>>_Z%-]Y\\X,//X!
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M&?ON<\]]>.'"[3NWX3JG9Z;OX?_VSO;4].3$Y#A8!HVV VT5CZ/A):09!!H
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MM8&SU,_[V7#:WRK";AE$46IJGA*I+=/@7+XFQV8[]P8ZY_62*5-5@3:!,N%
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?UN[O=X<G!N.'_S=4VUC&2@^S\0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_5.jpg
MB5!.1PT*&@H    -24A$4@   :0   &D" (   #Q+L9B  "  $E$051X7NR]
MYW<CUYVN:W7N9D3.!505@"KDG'-@ $F0! ,B(\"<<\[-#.;4S6ZVU%FM5K;L
M\?'UF6B?:WO-S+7O&H^ML4>6'$:V?/^)N]&:\Z67/1[/L61YNI[U6WL5(;(7
MN3\\>E]4P)?^/P(" H(7@"\]_P(! 0'!?T<(V1$0$+P0$+(C("!X(2!D1T!
M\$) R(Z @."%@) = 0'!"P$A.P("@A<"0G8$! 0O!(3L" @(7@@(V1$0$+P0
M$+(C("!X(2!D1T! \$) R(Z @."%@) = 0'!"P$A.P("@A<"0G8$! 0O!(3L
M" @(7@@(V1$0$+P0$+(C("!X(2!D1T! \$) R([@SX;?_.8W/__YS]]___V_
M^]N_/3P\N'/G[/CX>'=W=VU]_>#P\/;9[5NW3A\]?G3W[MWO?O>[/_S1#[_W
M_>__^,<__O###W_UJU^!GWW^GR-XP2!D1_!GP+_]V[]]Y]O??N.-UXUZK4HI
M_W2T&I758M+K=1J-RNFT&XUZG4ZCUVNM5K/=;O7[?4JE4JU6V^WV0"#P\LLO
MO_;::S_YR4\(Z[VP$+(C^(("K/3!!Q]\YSO?OG5Z,]G<I%;)=5JE3JO2ZU0*
M.0Y6I4*B5LG  7@='#CL9G"LU2C<3IO58M"HY4J%S&ZSF$T&DU%OLYK!ER:C
MKJTU-3HZ_(UO?./;W_[V!Q_\*^&^%P="=@1?+(!]0/'\SG>^L[.S;389@<74
M<HE6(57)<*U2IE<KP!1XG!:#UFXV@ .#1FG4JL#WZ( -57*E%#/K-2Z[!;PH
MQT4NFQF\:#7JP'>"'P0O@I\"E@1QT.6PUU17;6]O?^][WP/)D;#>?WL(V1%\
M@?CPPX_^^J__6J/16"Q&N4PB%L,:$-]DF%8AR2C,9G+;S$!SG\K.:M)Y'%:5
M%,,1ODFK BK$A;!4A"APD4$E-VM5!J4,K 4NNQM\JU(*M.<TZTU:)8A]."H
M_V!9H-!NM;H<CLKRRO?>>^^?__F?G_^%"/X;0<B.X$_/+W_YR[_]V[]M;V^S
MV:T*N5R*2W0:C5B$RF02G5;MMEM!(@,-5"+%0(,%756O4:AD8@SA2A">0@@K
M4 3G0T:E7 +S%6+4J)#:M6H=+C;(I'J9Q&72VK0*HPHWJR02/L<@QS08@L,<
MF5!@-^A ,/0#VYD,#I.^I- WOS#_-W_S-[_XQ2^>_Q4)_OPA9$?P)^.33S[Y
MIW_ZI\/#PY*2$H5")I&(<;$(F,ZH-\@DN%:M,NFT2JE$HY""EFK6Z]1*.6BF
MH,]FXIY$;%3*9#"D%@MU$N OD58F-BHD5JW"I,34(KZ$QY)"/"TFUDJ$,H2G
MEXG BU(^VR3'E2A/B4(J#+7I-3:CSJ;7VO7:,K_;;M#H-"JU2MG3W?/5KW[U
MYS__^?._,<&?,X3L"/YD *'(9'*%0@X2G%(A4ZL4*I7,Y;1;S$:#7JM6R$ S
M54@PDTZM5\DU$DR)B4 SU4AQM033XIA+KW=J-%(!I).(S"JI0@1I)(A9*=;C
M?)V(IQ-#&C&JEV R 1?G,8PRD1SFZ' A&'!LD(I4(D2-BS02L5XNT<HPA0@Q
M*&0VL\%LT)IT.K_;=>OT]%O?_.;SOS3!GRV$[ @^;W[RDY_<NGV[LC*DU^ME
M,JE"+I5*<9$0%@GY&J5,JU%A8J$0AG 1@J,",#(Q(D7X<D2@E6 Z*5;L=@ K
MR6 !:*\R 5^)(AC$!MD-*$PCXNLQR"J!]4*6&>/+(8X:A@P8JD8X<H@AAY@Z
ML4 M%,CY;!F?!21HE.$J,:H4(G)4\&D\M.G46IG$H)0[C)FSON6!0&MS\U_]
MY5_^ZE>_>O[/(/AS@Y =P><'Z*W?_>YW1X:'95(I@@"[H6:30:60*4%K!;)#
M("',$XM@3 C#/+9"(N8QJ1"#"DP'8I>00]<K<+E(8-+(Y1B*<I@PDPY&R&2@
M+(:,QU'QN5J$:\5@BQARR1&[!#8!]Z&0CL\R"7D:/M,HXAO%? T"J6"NB$ZR
MRL16&693XF89IA;".DP(5HM2JA0*G'JUTZ UJY4NL]&L5=N,^OW]@_???Y\X
M8_MG#2$[@L^/)T]>5:D4,!\2"1&(QP;932X!<H. UV284(SPP:K3*C4*J4(B
MDHH1F$7G,Z@PDRKD,H#LQ!"30\T5\N@PAR*!N1(^AT_-@VGY<BY;P6$:4;Z:
M2]=#+!/,L:$<%PY;13RC@*7E4IQ ?[C C')U,%LC8.E1GDD$ 16"+QTRL5F"
M6&4BBU2L%4(Z$:05"3QZE54E=1MU/HO!8S:9U0J=6N-QNK_ZWE=^_>M?/_]7
M$?R90,B.X//@HX\^&AX:M%I,0H0O1F$)B&8"'I":4HI)1 @&ZJH0%O*Y?#:#
MSV7RN0R1@ O:JPI'Q3P6PJ1P\K.%;!K,($'47#XU%V;D81RJF)F/,TE 6PX)
MHN52S7R6GDVQ"9@V!!SD.T0<$Y]F1UE.E%D@X1>"K(<RS2C+ +/T J818;N
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M\.DFE&T3<1PBCA/)%%@P;C[%QR?[(5(QE!> <DNAO HX+P3GA)^])=<@RF]
M<AJ1'-!;DV(P>4UH;I,P#UBO49S?( 0VS /? TS7(2'W*F@#2EJ_DCJF9P^I
MZ<,:YHB&/@P.M,P!-7U(QP::&]5#XT;!F%$P;A6/6[%)EVS4C@_;\%Z;9-BG
M&RXTCA:9)\I<TS5%PY6^L=K2B6AP(EHV%"KJK2Q,EKJ[JHJ'$J'VRD!/HJ:F
MV%?B<ZTO+Q/7&W_1(&1'\'_$#W[P@\SCYP0\J1C-?":.0EK@=M16!N.U5=7E
MI96%_H#'&2SP!@O=93YGD=U<:#:XU#(@.[=<!&1GE\!F(=LIYCF$+ ?"<($1
MT#P"FA<"ILLK%N270CE!?DXY/Z="D%6#Y$30W 226Y\Q7792F-.&DSJDI%8L
M-R7*3"N6WRXE-XMR&M#L%G",Y?;)*<,:QJB6,:%GC>M9(QH&F$$5?5S/'C=R
MAG6L83UGQ B-&/CC1OZX63AJSLANRBD%OANQ82-VR;!;-5ELFBFQS01=$T%7
M;Y%UM*I@/%PR&0N.U0;FFFHF&VM&8L&11$5W=: G4M%?%ZDO#Y1YG*\_?9WP
MW1<*0G8$_W5^]K.?34Y.<+EL$.L4F% DX#DMQE!9 &2ZAG!-97%AB<M97N@+
M!0J!Z8(^5XG#7&(W>34*AU3HD"# =TZIP"&!7!C'*60Z40;(=!X!*+ 4'\AT
M_+Q2?EX0RJKD9U7SLT/0U1I!5IA_+0'GU"-9C4A6*Y;7(<WOE)';\;PV#$QN
MIY0$ID]%[Y)3>N64?CEI2$T=U]+'M=0)'7W*P)DPL">,W#$]9P((#E1:(W?$
MP!TV\L?,\+@%&34APT9A1G8.Z9Q',6H53KL5DV[%;*%^L<R^%/+,E+O&RYQ3
M-84S\>!DI'2NKG(B6CH:*5U(1E8ZZSO+?7VUP?'FQ%!]I*6ZPFTQ?^/K_]?S
M6T;PIX.0'<%_D4\^^61F9AI%!&(AK)%+@.Q,6E6)SQT-531%P[%0!0AT97YW
M=6EQ57%A>:&GV&DJMAD*]2JG3&3#!':)P(%#=C'7#-,M$-F)T%T(:*]D/TPM
M%) +>+G%O)PR7G8EE%7-NQH59$60[(@@*\K/J@>-%<EN%F:W2_);L)Q6/*<#
MR^F5D7JD^6 =5-% 5P4#2NNXCC5E8(]K:1-:VIP%FC%#4R;^N($W;46FK/"$
MF3]A$DR8X&F[:,$KFW%BTPYLS )&/&7'9UW223LVZY9-N>5S?O7U,NM2F6VN
MS#9;X9H)>>=C);.QDN7FFJ6FZNE$V5QCU?6VQ/7V^K6>U&);TT13?+@NTIZ(
MM=;%_Y]_^(?G-X[@3P0A.X+_"L!T7__ZUR6X2((+91(AAO!-*GFQVU%=&DA4
M5\9#%4!P 9>CS.^I+"XH]WM+/8X"J]ZKE;L5F%TDL IY=A'/@?'<$KY#Q''
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M^Y\60G8$?P"??/+)G9?OX#@FDTDD8E0J1G5RJ46CLJH5=JW28]0#V7G-1C!
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MG$E2@4S'HZE8) 4M6TW/T=*S]+0L*_VJC7;)3@&Q[H*?>KZ0=C[(NE@+74G
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M5L>O43(KY;2$E)92<&,R;E(IJ-!*JDVRI$X<EG%U1(06"W'2T1Y&22D3Z6/
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M4 T)IB'"9&!OQ0 \-(2/1[+0<#(< @9&,@)*0D#)*#@%#:-@D802. H*P
M!@'@,)C5:FO(-MMM+BH>QZ'@E5QJR**M]+NC#K-/*Y>3T78AP\$C.UAX,PFI
MPT)U.*@!#S43"T'/3X.4<Q'=6OJ(C;\2T6ZFK(<9WW%CY*"V]##M.B@W[Y2I
M5WVB10]_W,;LUI+K%<0:!3VM$U48I:52CIJ!E],P<A911,,S""@<$EH"A8##
MP.(X)!(9A112R4Z5+%WJ:(OZFH.V2CTOK68TZ]DS$=U6C6NKQKD0TXZ5BL>]
MDH6@=J/*>= >.QW(WET:NUJ:.ID=NUB=V9X=7!QJ71]HVL[57@TUW^EKVJN-
M3I2:^DV2U8K2__1W?_OCPU/D+T11=D7^_-&KEWP,$DQV% !0L)@*!HF!*&PS
M2V!4!)1#PC*(."(&"<8Z4'9*F=BL5QM5<HU$)!-PQ3P6V' =)D.IS:3@,J0T
MO)B D!(*]YHH\8 $"_ 0 +<$X.)1-#0*!P4C&YR @.&@4#P40D;!6"0,G8"&
M P XH.P@(%"HJS2XLW<Z-37/93)\-GU5P.F0<<%XE7);$DZ32R[0,/ N"<O)
MI^B)2"4:HL;"U5BH%@/8B$" #DT+2G):VKB5MUYF/$A[3^I#9\W1JX[$C<;@
M:=I^D-!N!B4K/A&8[#K4I'H5M4;'+5/QS!R*CDG2LHA*.D%(PM#0<-2[/PD*
M_E4 $ R5C8R,V2PV) R&A  4!%3#II29E1F_I<ZMKU#S(AQ,MUV\45NZWQQ8
M2AFG _)IKVPI9MBN]^VV)Z]G^Z^7I\X7IT\6IPZF1Y9R+5NY[&EO[8/AAJV4
MLU-&K:.C*_! GUG\U]]_6SQM]S-1E%V1/__F5]__4&.) * 5\OG$$@H,H$(
M-A;)PJ"X))R022-A$"P65:62Z35*O5IN5"FT4C%88T'9F71JA]EDTZ@$%)R
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M><"A(PTO7]S]PV]_77C([O.D(+L"_R,^^NBCBO)$>6E)P.,^>O1$(E0 L4[
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M>"X(%.)11SR:"2MOWB5<]$L6HL:YN&NY/KX&Y,>NW(7UI<*O$U\L!=D5^&P
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M>?&][[_UAW_TQ[T#DRY?OL[DU>C=M,)"L68I8U1H'81$ YCC80Q03\:8X$H
M^'"6+Z"0H /2\0D>F$[$I9_@C.L<YC]%NH\H.^O4U,SV[:O;MV]?7EY:7-S:
MV%"+(TV'S#!P#3 GY&"'_&QNS8^/]!WH/M1RC&"'R7$A>%NI@$=C?)V4\&@9
M)Y!.18&X"VJ8L)J.:N@\K3RIHPIU=*%&EJ^4)%72F!S4'!%C4>8I1?DJ<9%6
M6J@29PQTM4W5X-*W!:V=(5M_U#F1\,X7A.:2P6VE\>W5R3TM9?N:RP^V5A]N
MKSW<7G.HI?)02_G!EK+C756'FM.'&HM/=V0N]I9?["V[-%!]?K ./.R5:;"N
MO:#L3HZT'>IKV-56M:.I;&=+!2B[M8;4]MK"V8K83$5\NCP^51J;2$4G2A-C
M944]F9+GKEX!B?W1[]-F?,QB$W:?F( _3M]\_8WK-^\$HVFC-:PU^%4Z#ZMR
M2.4F*6T02[7@6TF97DH;,9%2(M,S"JM<8:59LX32$V(E1LCY0@E?*!9PR1<
M[X0;K24HGBS8X0)4LOA)@0+":#2/C4TL+V_G8+>\L+ P.3'NM)E% KZ8HYM
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MSA=@ B'<P$,)#B\0B)XVN5JM?G1T?(D+(!U<YV9G1@;[&9F$Y*QK#G9(S?&
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MQ4_YV8WCL7,>%DB'#J] (]WY:)Y[.)*HK6OJ[.H;&9U\ KN#AXZ=.''F]"E
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M"M/]'7W+YR[>>>-;W_GH'X#-^#?$+P+LOO6M[^S>>RP02=M<,;T)#)U-*@<
M:>&J,;B%(E9(;)".0QN2=0Y77$:C@<#<0Z3I.%F'N.9PYP/O-AHU'A_^ (FA
M(2(>DS6*8"?6$919*#' %72<A+*1,FLDK^9)9URN2RZ'.8G<J3/'0_%J6NG-
M)0!.CNQG[D.?RU^FTD>!<8PZQ*C"+%S5@#FX!K6F>#2_GD$+<UZ9PB.AS.!#
MY:Q#I0U JK4AH*'.' />>4-9@S7!:OR<8'3+6 ?P3LK: 7DD8P9,Y_:0X6(U
ML;%OE]L]]D3<<6?+;L .E6@!=B0:-(#6!S5\@9R/2AFD#O[@EE6WMG=/3<^O
MK*X?.'CTQ(FSX&%!U@'@;C__T@MW7H$K)%#O]O,O N-NWW[QSAV4+[SP4@YY
M*)Z[]=+M6\]=OWSN^+[!EFJ?1N9C\)B*+%"3"2414Q!1I2C$@IH3@H$%;QM2
MBJ)*(JX2Y6G(/"614.#Y2B*I%A=HQ,4Z,J45I76BE!HOTY-9G;C"**LT494F
M68U)VNA@6[Q:$'1=46M?PM$?LPW%K!-QZ]8BQXZRX(ZJ\&)E=+FK]HN_\UMW
MW_W@O?O_ )B[#^[UX8?(QC[ZQQ]]^$\ .]!W]]]_]-6OON[UY3L])9Y@O2_2
MYO UHBIJN#''+&!<+H%WH.S0;@I[CH 9!#L@(.HQ3EN<92#B:IL7G8%:^"SH
M/M24YR@S.RNM[FHPMIFJ*8"=.]@(">\?B+7Y(BVAO,ZB[&BT -SQ<$EV[/2Y
MVU_XT[_XWO>^OUF[^'?%)QMV=^_>75HYD"RI]_A35G=29_#3C%G"C1X!QVJV
M!BFY44C(A3@Z5_ QZ5APK_Y@$2%6YS[\B:S#T$$0\?Q*@ *'.23T'E==P</J
MC9:H2NO#1#J"PQQ2=F!@958I;8?TA<O GX*:R_G6)[TC8$5=_E*[IR2'MASI
M((%H@#-@7#!6S=T$@720"DU$H0VI]&%X:+0E@[&:G 8$V!$2\+ *1NED55Z5
M-@BO =@]?C>_Q9F$WP,(3(4V@)KO&#O #I*46\4_@9V6(+5"'#GWIYPLS7_*
MS"+,H90"#;E7;@P]Y@LIBM6G,M4M;5T N]4=NPX>.G;RY+G+EYX!TPITNW/[
MY1=?>#67< _(RST!S$&^^.++<+W#Q0MW7H!7O_(R4/#F<\^<FQWJ".GHL$(<
M4XCS5.)\E2B!T(8RS($OK( D8DIQ7 DO$!6H1(4J,JDB"I18B5J45F-9G:A<
M1U09R!JCI$HOKM"*J@R2>@O5[%1T^/4]45M?S#Z4L(W$S1,)\UR!=;G4OUP5
M[T_Z]HSU??NO_OS^W7L?//C1@T?_=/_^(R =)& NET]@]VN?^QV?KR@<K2M,
M#293(X%8ER_2#CQZ KLG3<4@Z#C8E4-RX$/*#F!GYD8#V+TUQ=DQ4(7<#K/'
M37G.2A!W +O"TF&0<JY  V1.W,$OX8TT)4L'@_D]T<*A>-%@07JPJ6-A><>)
M+W[I*YN\^[?'QQUV'_E>/OWA=][\[L*V];R"REA>I=61QZH]E-Q$<J0#KI%2
MK<N3($@E06XP+I>@:-1:E\'DSZU;Y6"W<:*-D*596S!2RHU1VF@HX5;Q4+&5
M( W!2%:N<**>$HD1EYDQ2"DRK2#K&*7'$\R2-.J/RPFZW-H<EVY?N!*PQ7(6
M%1"6RYQV _=:4-+&JH%Q4:4VAE(75>K" #*E-F)#9Y*!P_4I- $1;>5C8*4M
M&GU0J84O#RJT*%E('7P(YA<Q4:4/&6UY#F\)L$]M"(&^ ]A)* M7G.7,+*DC
M1%IN3G+N4!XT[CAW AF:[HD:34AT%<AS?P?DCFU$SI=@Q:2BL*2\M:T'8+>^
M:]_A(R?.G+D('A8,;(YK+[WXJ9=?>@T![LXKN<P]>>FE5U]ZZ96?Y(LOO?S2
MRZ^\ OGB:Z^\^-S5"WNV3J>]=C\C!J@EP)^R>(&:R%<3"14P#F2=*,Z1+@<[
MD'4%2KQ(392HQ2FU.*,55YME=199M8%L-%/ N#H+76=A&IWJKJ"Y)V3MC]I'
M\ARC"?-DGFF^T+*8]DRE@KU%D6=/'?ON-UZ_?^_!AP\>_>C!@T<?O,_![D<Y
M3?<//_I?'.S^\<']']V[>__PX;/YR89D26\Z.U%4.IZNF,[6;(D7]3G\-0"L
M)QXV9V.!<29'!23W/ V:#C48FXJ-MHS-716,M4"B,9_(VV9,J"-O@W>!6&LX
MO]/NJW7X:IT!\+--7-9%DQV)U( OWN%/=$<*>Q(E/=F:T::V+:^^]AO@:C>1
M]V^)CR_LX/OWC6]\\Z-/N7CWW7>_\I=_U=(VX/85&,TADS5,*T"\Z,02M0B2
M5!-BE5)M5ZALJ"(A8G$1XEWN]!F FL46!B;"3<[8YNH5R,9B"ITQ /FD>X[;
MV:I#;2524$:FXG2S3&X328RDS SH(2B;"-4][3+:KC-&0+L][BQQ@II[G& J
MO>%$G5H/%(L X)1:H%A8P24\41MB>46MP#B5+J[6)^"*4@^PBZH-"5^H1J6+
M<6MY7BEKXPM5C-JG,<9TY@3WAE%6&V&U8191#S#JSR&/4J RB,88,=GS38X\
MG14PZJ,8U'^'I@^(M3BW8W=C2^^3H>TYB2>D>9B,FP>EP'!P]RSJQ<,H-&89
MI2*_,-O:WC,]LV77[OU'CIX\>^X2>%@0<3E!]\K+GW[UE5^"*P(<ASGX\/&3
M#=Z]_/*KK[SRZJ<^]:E77_O4:[_TZ5_^S*=_^5.OO/K\S<O'#S=F"ATTYE?@
M$<"9FBA4$P4J'%1>0BD"T9?3>I )%9[4B))*K%")E^JD +MR UEMDC189$TV
M>9.=:7&IFUS:UH"U,V0=B-J'8_\?>^\=)4=YIGW/3.><NT)W5W=U=<XY]Z2>
M'#1)HP"*) $+3FM[;6-CUEXOMC'&1&,9L,F***"  @B!2!(Y)P,F2:", F)Y
M]SOO?=<S&EB?]WS_@KT>[E.GIJ=[-'3XU74]SQT\9V7Y<_*>)57_>;7 G+QO
M06=EW9]OVOO7]P\</';HZ,DC!S\Y<?#@L?T?'SU\' !WXOAG). <_.SA@\?>
M>/TO\^<M\?FKOF!/*#HCG!P3(L/^^%BZ/#>2FO'EI&*2:H=)Q4(7*#N73W2R
M[AJ0SL86X0A<$T(]F>(DW,AP54#>%.^\';A^Y^\LMI[I#C2 H;YH'T:L+Q#K
M"R<'VGK.%F(#P=1(.#.:+,[,U^;VS;BX=^C"Q>?]Y*[E&]Y^Y]V__9S\\^M_
M?GVM84<J9MY\\ZV''WITY\Y'7GKIE0\__/"##SZ<?>82CD]XA+25"M!LT&+W
M*#56J<(@4YH4:@L60JCMC".H$#=AB7P[33H<KLH+*3*0<!I_TS;6(V1T1O?T
MWNLT[$#-@:8K58?%O0B ':?4>Y0&<(A>#:!-+WA]99>W,)T<!R>8ZVL.H-JR
MQI+901N3!HMJH9+38;8C['SACE"L&S G1M9*B\%F+'3*PF13N1&])6HT!PUF
M'O D4[*4,P4<I!Q9Q@7"+6.BDB+LP/GB;@8(/;(:*"[;X>8L)KN8O69[@''&
MO?Z"C0GI#)Q&YY1A*Y3IW)HO;59 2/5-../"+@,+WZ+#G#NI%F G5^+B0#19
M&I^8N^3\BWYTR4__\_(K?GO5M3?^_B:0=< UB#OO6$Z" (ZP[PO>W7:'2+H[
M[[P+.'?7W7<O6[Y\Y>J5JU<M7[%ZY?([;__3S7^X9O&L8<&J#AI:,F!7;8H2
MI2S8%&!LLV9YSJ[,T^J,39:R2-)F2<XB+5AE99N\E99WNS1]',@ZU3"G'?69
M1OVVR:AK,NX%3;<X*YQ;$,[.><ZIA,YN3_9'N8OFCK^\^XDC^_8=/73HV">G
MCAX]B942!X\=/W+\V#$DW:<G/S]YXK\([(X</G[PP)$''MB1S=;=[B+OZ\9F
M3<D1(3[LC<[PQX82^?%L9;8_UD\\+,#NM,3K8#U8)$N: H"R@P#>V1W N[9\
M93;1>CBC!P-7],B= 7: /."=F'6,R M$!OR1_GKGPFAN))#"^3[1W'@B/QMT
MY>#X=QI]YP^/?^/GO_C]UFT/_5/B_?]\?7UA]]'''[_\\JL]/6/E<E^AT)M*
M=Z92C6*QOUP=BF4Z7-Z,6N>2JR@PI&J=7:DRR)5Z()U28X/0Z&F'*RQ73J65
MB)N).$$53L#J>KQ),F%Z:NR6Q(AF36*$SW\@7,).<&+"L)@JC*0CRL[.Q(*1
MND;O 7&G0<SQ6.J N<$^O=$?C7>"'".P(PDEA'2 'O"GL50_'$&R37M5. ><
M@:R+)GL#D0;ER-G9+.W,T\X"[2S:'#FK,VNF,_G*3),]830'-'I74Y,N&&T5
M,-TD90<RLCD+*$$V:V'2%E1Y<2+N2)#=7I+IHH;0H9,E914&$VA>P8"S,EQ:
MHU-C &]K)\^21"Z.UL9Y9E:)%&!G%>LH9$TMJF:I22R>L_"^Y,3,,\^_X!L_
MN?1GO_S5E==<BQZ6&%@@VMUWK5R^;#7$LKM7P?FRNU<3]MUUYPHDX!UW0=P%
M<F[9LF7+EZU8OG+5BM7WK%JS>N4]:]:LA?_N6;WLCEM^?]GW+VJD A&C-&M3
M L[R%FG))LM995G<H%"D 78V:<8N+U#R"J6H4<I.5MG/:69XM.,^W4R?86;
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M,*=G9&J[3&4SV3R@^,ABG 1$"MHT#;8VDAC,5IYUAL"L-4NP.+0)79N1[$*
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M8C"9'X5+VFG8%6FN".R#6WSAWE+]3(>G%30@!._O%/OE-7S17H!=+#L2B \
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MB;X;8(<)QF+!+*?4.E#<*2DL#E': 7:D0DZJL&(E&39WFNK[9+=[FIIT<+6
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M1V+].MQI@)@^_S(*X5O W(9[[]NX8<M]F[=OV[IC^[8''[@?!=W.AW8]_##
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ML8 3ZK0+=RIHD'[.(L@W.+&S:3"A-C8N43C,5-3A*0K!]DBB-U, ZLW@O#4
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M4A/8UC@]4>L\I]I^5K&VL%!= ,>VKB5PH]@7#]SWC'!J!!X"OKO0NC"6FTS
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MAAV'4P7$J2M\#8YN4'S>NE+CD2DHVIF 7V)CLXG\D)@?E]%9PG*M5V7PPQ]
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M+V*0]S&\B:OM\\6\ ;"Q'4X!]^;X8!? SD8GFYM-5AH;X<'?P/DJ[D -+#/
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M53I;\]7VU@!-+ -D9VC;+C!H#?8X?+T TYB0=2"=+S(72LRE"AO -<XR+M;
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M;"9[Q>;NN'QPOE,07RQ;J),IK4L5UE*/$U>--5LM62C@7K%09)]$7[*X[ Y
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M2\4W1-/K!K.7P?9R&\L4'[ZT4*B=ERJLAU\.Q&;._=0B['"NLBE7V>"/#%E
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M5L(4N=7.3N=@1VV=L&S.*J09&SW19J.+F^1A0WU'D# 'KC7Z.\.I64XZ;V3
MO:TC0+$"I[?5ZNT@;<AJO"P4C:V:'$6CK:#21\<$D_AS!>-RF=QA<:9"\1;9
M6'U":\ZRLJ$VC3OP5FF$MJ]LMJ<MKHS%E;-Z"JY U>ZM4(MC=S62&D62(RH[
MI^9H3?)B@:XO,L#K 1"SE?6N0),2]W4)C3&&BP$/R$[2Y)V()XASKZ+4154Z
MB+X0:PK@$$JA[.P"J5FF=KO]>9'4+)8#=BZE+FRDFKF^FR8SE/_E(S=?_<:W
MON'U;_[&K=]ZX/X_<=@=.GB<W1+R^.;=DT\\"]YQ)PO#^]T[?OC%+WP5RF[O
MWHMKM8;+Y9'+590W+E2JU#:]T6NR!BEO+EP))>KQ=#>3F\KD1NGLB.6=C&!C
M.>S"D48D5KWC>W>>!L[._@6R[O2I%X\>.<72Z* QC\+/ G.G6;R"C.T^*A<[
M=NSXD</'WO+F=P4"5;>_O;SY#7S$#&0=I;#YVMY(#^=MLW,^:;HPGP!+N<3^
MR$RE>7ZQNLT7G(G1,(>U;$MN.1A; "L;W=VI_+(G-/!%I@EPH5DO(,AL;+JP
M(9:<4QNR''9F1\U!+=U'@)W=VVWV+K"SX3L6:N->,5CR6F-&K4_AV"M4-U5;
MVT.Q&2@[/L",-WIP!8:PL5B5UBYHTM5M.Y#+%R%.8<VN?4TT36G#3-FMXP$*
M?%IM[TP7-_(&Q?'L!OP)#-D+O*U3.#G'80>YQ[I=S33ZNQ*Y]:'X'(-=3VL,
MXT)H=9:\P4$@,A])+!1K6QK='>!@.#X5CO8!NW)]ZXT?_/0_3@+*RP>[??OV
MO?'JMRJU=L@Z*OM7V212G7A"*YLT,MB-@W0".MW%?P<[P=]@-T;;><I)'?MF
M*1-W!#NA2./VII5J%X>=9,)(/DMADVNH WN^BO>XY_!2BW.@02 VC$M,*HU?
MJXN4JDM&&\TDYH*.DX[#3F_-59O4H'BU\I^G''/>!2+]:FN+$R[5S[*%81C#
M QO+L\.GH\7+_+$I+NBXIL.R^9I.ZN+9R1:7;53C586R,^))'16*J]I*!G-.
MH;;1Q%2!>%+I5FI]R=R0PXY%[LHTZX!-:0'4DKE9NZ?D\!;YT&M@"TK-XV]X
M DV+HY@I+&B-*9X>2$/_0.'0P,F24<*I:>J,QD+,4'"K-A9WU(:HR9XM-]9I
M*>N8(A6L=(S:V]&2V2#NHHGVA-(EDEMHLH\VC/\54[)3&F/DH__RR>NN?=?K
MKKKF7S_SA3_<^R"X=OC0L<.'3OP][*"PGF&9=SSG[N]A=^&>O85"R>ET3RHT
M(I%2(3?KJ9>ZS^Z.N[P97[ 03A'L6*))%S8V$NN&HV1C0]&F+U!QNM/M[N(S
M^XX#=F?/_@4*#E##L^-YL6!@85VY@64]BFDS$2 ^?OS$HX\^.3.]T>$L%"N;
M2_5MX?1B$ :->I ,J!(FV(-&2V77^L-#?W0:5*(.E\DE;W!ZR_;KD]D-_M <
M 6XE@8-@$8C,KM_R)G]DY [TJ7*6144]X;E ? D8Z@SWXO*C,Q<X[$S4%@4'
M1L\='$122\7:>4Y/DT\:HSU9:T%C2*MT2<!N>N&R0'04C+%FR/@IRALG2^$-
M3[N#(]C8='%SIK2%ET^P)X57I;TY7V2F-=@3I^$[/*N.&G.R2,7:?/6\0NV\
MU8:=C-<TB;'4V)[(+8-N@?@,]0&-4RXQ7&V^MCE3WD3#+H#[4%.A=$LGW59'
M$:[6&Z#Q9M'47&^T.YU;C,2G8HEAN;$56J\_<^%33SWS4A:\0A\O'^SN_</T
ML#?1  "  $E$051])HN/[<($]68_8 </.ZFVC GE'':",2&62"@1C/U_8$>S
M5P1BL8B^>6R,Q!U+M5..B[7^8$XR88:'/3=CS,B5G=H0SE>7;)Z*S0-;U[%Y
M2B(:C6J4*]U:?213F-.;TP;86'O!0G$)@(.U-:?&8?E&=PLK*5N!'2L7H^P3
MP Y7^WQUO9WJ_ZFY"&2=-SKEB0P]U.%GV)^]Z"6PXWMV4 K^\""1F;-[(.@J
M;-6,SJK%#5%9AKAS!C)C(M$:@4BC]0C%ID1NJ#,G5+HXE!UKQKTRE0*'>R Z
M#,4&;"YBP>VON[Q5?ZAE]Y2ARQS>LC?4\E#>/YQ[Q6#-.AB4Z64$VU9O':^<
MP2[#'"L%9'F",5E^8QS6'LIQ%7:L<;$=9A9.=EQFL3C35E=:(#4!=@IM !3&
MKPTDIJ$*_^F]'[[A??_\NJO>])$/?_RWO_FOIY]ZGC!'O#O.%]\[X^(.3I;#
M#C;V"Y__R@TWO'_7K@NRV;S-YA"+%'@'M3JWSN#7ZKU:(S6)4*C<,I53K0N:
M+$FK/>/QE:.Q5@C6E=QKW>TMV!R)5[WF+<=._C>#';SJBR>.GS["="6>&N#C
ML@[ZCK^2 P?H\1,G3O[XQW=F4@V/ISH87>R'04O-4VI%F)..<G>ZK&HB$!F!
M&FQ[:SX<7\@4MW8&EP0CB]'$,AMSPS44+-Y\MKBEV;_0$X3A'9$,)".Y%$HN
M@SO>T/1H_C*KHV:P%C7&',67..Q8.G&MNRN>7<O[@X%T6#I35JE-J0UI7!WK
MG?-9QX%IE[]K<M;H>*9DXX[-BY^EL=D 5KZZS168PGVF[^:]8>KU!/R!:-GR
M9D8ZRK/C<\6PDOGU$'&LYI\6:XA"B@_?#-Z1C4U2LAXH'XB-@-I(9AXVWQ>:
M#L=F7=ZR2&J23KI,MH(_/(HF<3V8"2=F$]FY5G]'.#85B0X3V87>U)YZ9_LC
MCSSV4A:\0A\O'^QN^L2G#28_9)W!'%3K/#*552S3P<,*H-$HI8Y<JF"-F.6@
M@'=2;FP%@O&Q<]%8@4 DD<CY=[+L!(50H)+1AEUZ3,B2^ZD5J'Y";H97E2L]
M9D<FD9TV6G(6ZHD(?==0JD,"D7%2[3+;$JG,-&DW:P;Z#J+&: /XJ&&GT9IQ
M!VKEVC*OLJ >=E;JCV)VE?FD*%[)[Z"A)UV[KPUGX8T,Z3(;&0!SK>%N[E[Y
MIQQY6*!5N;XE')]V>%H6*I^HPX]0_:.3LI3UMEPR-\62!\5BRJ,V.IPYFRL'
M<:<QIB #J:5[H.L.]EF99)TRD]UUJ[OF\K>LKJ;=T[93EV/J$^D.-GRA9B *
M)K8@W_ ]3GJ1++$YV(UF<! /]5:"G=:4I(:@%($EV.$1F[L8C@]4FJA&%YU4
M^2<4+JG<(9'91!-6W$XH',ET5R2S2Q0NA3:D,:==@0[."INK?-55;_O$)S[[
MQC>\^5WO_*>?_.27CS_Q_/Z#1P\=/7GX$-8)+O$ N^>>/?#4D\\]\O 3]_[A
M@5_<]9L[;O_AYS_WY?>^^SW;MYV73":U6KR)2KLK%TOWP_%6,-8()9JX'\],
MQ3/#0*AN=N ?$II06 T&A]GLL#M"9GO29$^;[.&OW'K'D>,OG#GSY[-G7SQ]
M^NRQHWA2:F '60?, 78GCI\Y<IA>QH']1R#NCAPY=O3(B9MN^HS/FVVVMI!)
M3,Q#V;%"B"%I=G\G7]F8+:T_MUL'F38722WB3GOJHD1N V<$UT0LQ GS.-<=
M7>0)T97/'Z-NFM1H)+H4(2;.)C*+E>9Y%GO=9"^=B^Q3Z2O>4&]X,)R_!,Z7
M)ZCC_37:*J"AQIC76TIX#1GXS03E=H02,VQ(([ZM#T0Z_40W, X2K][=[?0/
MH/*8OJ.\8FY=H^GE4N-\W,'C[!'>ZXD*8P>S5\2SZQG[* <%KQ]_((=@!(]0
M^ 64'[K#@T!\Y(M-U3N[(O@G1$=&2WS-F$JB\)J=%1Q7])<FYN%V ]$I7!XR
M12C<830U;'2VM;J[[K__3R]EP2OT\?+!;F9^ P2=V1[6F7Q*K5,L,[+&ZWK6
MR(3RAWD%!8?=&H(=[=D)SD4JF/03B46R_P=V0I4!UW^]1S!.C0  .\F$7J8P
MX[14J+R19-<=H$8Z(!2.(:>WJ='%U@@-LDF'S9E)I*:,U/8Z ])A@71\&6T9
MG%W1>(_A($'JC_H2LR:QU'^QGLJOC21G><JNB]+K^N =6_UP:K;6W4&QUW.,
MPX,\+&OWMCJ#W1XH0>9&64$KC8@G?6>G1NJ9PLS8F&9,,#$F$(LD%HT^%(RU
MY.J@WI(QN\MF5]7J:T.?0@[ SQ:JFW!@4:\!.BU[U,.=372D- 5_K5!=#L:Z
MT'H:0\+FJ5-!.^&8=*C=U^C-7$"U:'R2I!%FEMIY*G4T2!=\+U1 ^8Q<$Z*1
M%+ J2B=DG4AN@YH335B<GHQ*'\(E74%#,!*0MY2%$.ILWW;IE[_TC3=?<^U;
MW_*V;WWKCD<>>XJ:91X[R:<]'#E\DF^?/?\<Y1@_\O"3]]Y[_R]_\>O;;_O!
M9__UB^]\^SLV;=H0B80T&NVDR@S$XP_WA6O!6#.:Z@)VT)OIPFPF3[>I_+3!
M%.#'@%"HD%.5;MSARWSLEB^=/OM_3I_Y,[AVZM09@ S:[<AADG4\+G&,LDS(
M4&/A\6/'3CW__,'++W^=PY$:3.VFDL_T4C Y[X]0:(+OV2VNOW+E4QA;*L::
M 1!CF;53\Z]F^U_D$UG$<YDACWID3B^^&E((!T,@-LWJ%I9"\74T:3LZW1[L
M!L7L'GH'F:RCY"$LO(GXYN'\I38V>(27T_*%[[2Z&HWNSE1^/4PQCN%,8;W%
MU2#8^8=,Q\VX K"Q(W=P"HH2MX =L,MAM^IJ&[T]Y_)1*"#+B\;PRO&'\ %C
M;-K. FMT3%MU<+Z1Y#SU\@/EL>+3N&P#W]7V]GAJ(13N:0PAF<)B<N1,SJHS
MV,4Q0'MYK-M5,K?4&5X0CH_"B4ZINAZ2^6NW?O>E+'B%/EXFV-USS^]#,5S-
M B =EEQE&Y="UCG&A),KL*.L6K%$.DF5L&NDK%J(G*Q$=$[*$>S$HO&)<Y^*
MV4ZV*I&HB2GIA!8L+=G8":-4;I_4^$OU)9.#3"@U8F(#6XV6M$!D NP"X5HT
M/C"8TR9;EM2<+0/5L,J[?&71Y:VL3*)@.W<PN2P%CPKX 1K<4BH6S@%RKZ3L
M.$WBN<5<=2,+T5+:'4\](=+YR(3V1GMPR[K74HJ\S=-D!VZ#BKW"G5"L3:44
M!'VA5&81RZSQ=(^E"F:I1LU9L;#Q\NQ\Z(03E,S%=_%P#N"OL['.CCQU)IZ=
M\_A;9GO1Q<HV[*S#':!,06%W+9Z;]8:;1EL.K-<:2=QQ?0>A!_SY0NU@M*?4
M1N3J@'32+6:8DTPZZ%9F4^O\Z<*(VJ700 S KA7$]3_2GYG9^LUO?N\=;W_O
M-6^Z]DM?_+<_/O38/MJU6X$=%M #205Q!X=+HVWN?^A7O[H;L/O,IS_WMNNN
M7UY:]/E\.IU)I;'9W3E_I.$.E#GOXID!KCW9TGPJ/Y/,3P-V5D=L#>UR".4*
M0RC:2!=F4OGA8'KS'^Y__,SIOYP^O5(UP09-4%R";^'Q.HISL#N!+_W^W@=[
M_85&:SF-JQ=$4W+!1Y%6HAO^I3AI\1]F5:@#6JQA'&1=M;VSUKF 2@M69MGP
MO!/ZM-+:66V?[R8/"]X- U1NM3847PZGEKV1T6CQ,@@WNP<' X5338ZJ 4:!
M-6>'%,+ETTJ]B]M\L0DD^.:6/S(ULW@%=),O/,*GI?I6.I)]75A4< VWWO L
M8&?S=$ H%G6EC<+ W[+MB'J=J4LXG=DCBVQ[CEYP?^;R9)YB%/A!CD)V9[;6
MV85G!.RH:Q[$'6QL?!H0S%<VEVJ;O?ZZ1.8028PV=RF8H-J/4&*.NMA'1CRV
MT^[O"L8&H7@[E9V=6WS5Y[_XK9?BX!7Z>#E@MW___NNN?[?1&N1!6,BZ"869
M])?<1/D6YWHWC8U)Y7(=0YB<]3@!VF128A]Y6 Z[<:'TW!:>"-\I%JNCT:*
MYIF2C3T'.Q.4G<F:R)9FH5;@4BVN*J5B "NVW+C$)E<ZP]&&/]@$[( YKN;X
M8C-KDI7F>INSP&''>]B1C766K2"4&U=:ZE7'SP%..E]T"LL;[J=+ZY*%M<X
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M+^I?0KTY91,ZN4R_TKN)E8NQV)R,U?^OP$Y 59,\(X]@-SEI4B@L*SW9&>]
M.LD$V5A?$-*,*JZ,=E)&T"!.F$='42RU3RB<Z=S0Z2[I32D86#:M8@5Y4'DX
M^:'L;(X\M[%&*Z6>4!R#S7;"T0_8 1\\DYYK.@\EV5$GNW)C*S,^U+^3YBCR
M-#>V <2[L>/JS3!' T"ICX6K8714#/92KK+>Z:]K#&'8<.IG-:X0BC5*C3N<
M;*OU,7IV9YFZF,",^^@7>H*=8GVC+]*SNBM 'C6V\S8H:\\)K-.I,LO*GGB%
M$U4^L7Q &[// &*^NL[M;X)K!DM&;:!9X/A':0TIC2&I,:22F3F+O0#\R=5^
M\$Y*L@YFU@G8X1^KM\1 (IDZ@&/=ZJE3S"XV"D6:7_G*[1_[Z"W77/V6&]_W
MH5_?];NGG]UWX.CQHT=/<>Z +US9/?O,_L<?>_K!!Q[^S:]_=]NWOP?877/U
MFZ8&/9O-IM$8+?8P/"R4'9X"U LGVE!VB>P([T@J/Y?(SKG\-8W>+QR7CZT9
M5VOM[F IFIYV^>JA6/,+7_R/,V?^<OK4GQGLSAP_]L*IDR]RV,'#<FF)A3OX
M]/BQ,]=<\XYR=2:=H^(P4" 0GW6'![PA8"@QW9_9@TL+WDV62#RD_#(V?!H"
MBHLF;F.QN$K"'3 E0%59-/\!O\T7FPZE\3V4LMN=OBB<FF-&=6#W#URA*:>_
M;W$WS<X:1%QG:K>)6B7259#UT2%QQU5\>W!A(KL,D^@-36E-A5QY8R0]CY_E
ML','*7)"0C(T5>WL2)76\W8 '((\0(&7!"G*TTV8Z%NDH@X&09 .O&/EL7"U
M*P.VP;5L>3-$'"\7\3'8 ?3XG;'T0G=JA\X87C.FDTCM6E,&ET]8F7QU"V"'
MQ6$73<TU.MNA["+)8;.S\^9;OO92(KQ"'R\'[+[Z;]\P6D)&>X2-U'')E":I
M7#^IL@J$ZC&!<@U(-TZU$%J=2RA2TU0=@7S-F'Q<*#>;7 )6(4OE$V,BR+IQ
M:@HPQH;L 7]2I=(LIU$5:IH_R_2=5 ;-:)M4>^*I+FOT%-5;2!G9:>Y7T^8H
M3<@](JFM5)VW._. '4A');0L-,%GQ>(V5U[0&Q,Z,TV/!0XH <56 #%M'FB-
M$=P-)6&%<,#QK;J5A9.D/=A-T0 :GTA->/C6#[]6PWCF:YO &AP?K$J,C4QV
M0(N5=)9\J;$5&DUO3DZJG23NP'2!;$)A369Z2AW^!)H<9'%7< ZPZ0=]*+M
M;%!M;Z5\XT#+1HT 8(VIXR.).$B5Q&RY<1Z^DPF3*4]H2&W1H"O=-,$O&!\D
M\W,Z$_UI$'<L>YD\+*L8H><JU-9IC FY-C"A]DI5;O&D2R1W2IBR4VC\L72?
M=0;,0"?ZHJ-H:M[JR'WJT[=^_K-?N>ZM;WO/.][SHQ_^[(DGGSUP],11AA6L
M5=@]]^P!P.ZAAQZY^S?W ':W?.*3;WS#ZWN]CLUFUVHM#D\RFNP%HDUX6*Q0
MO!5-=:'LL#+YA51A(1#M&JU1B52-XV%297;X"['T3#P]6V^M?_C1 Z=/_Q6
M ^Q.'#][\@09V%4/RT,3K![VQ(GC9YY__NC&3;O;O8WN0"=(A%H^!SN2<L7Z
MIFQYF=YBTM%,MI!BFIU?=U4LP\NME@/GVIV#91PHQ?H.'K3E$LD?'[%0YIP_
M,M.?OL@7IFG"7IC<\,@5'+"Y8C1A)U582F3G3;:BS54Q6(M6:NQ.5TI>G3::
MO\)#S5%F+,ZFSEQ,Y]<5:IOMWLZY0,0<WTST14;YVF9 QQV<PFOPA&;XV!V.
MXWKWPDQI"WC'&$?A%&YU6;;=;KQ"ECQ,;4X .ZJ7R*QM]M@0-0:[0((\;(AF
MC,VU!UN5&L\:@6Y2&="9LK@ ^V-3G:F]R=PZUKUYA'^:/SSL]'?%TL-H<E0H
M;_[$+?_V4B*\0A__X["#A[WV^G>;K!&3(Z[4N2@HH3!,* SR29- P'J6"*E3
MDV3"H%#:!..KL),IY#JYG/=]HL9V7-D)!:(5&TNP$VLT-C&U^:1L._SL:L68
MUA!,9OJL7S&4'<U4I-0-?]OIJJLA6)3N5F>]&5*.3<5>U73:<Q.RTX59C2ZJ
M9?<!.SA9V%B"G;N>S"WQ"!U73"N8@ZQC76T!.^XB^?'*-9V3>=AP:M87'5I8
M!SJJ\7+6**/*5C YBP9'L='?"9.B-Z55&M^82$5_W9A8/FGU^ N>8'U2EZ @
MAJ>&<P.PHTTE*G>M=4<['3[:IX._ADQ@)*7<>DIY\;6'LWN]=()!E="5W^'K
MLI2%-L5G_?5B=3VX!MY1D8:1MB;9R@*L.DNNW-RHLZ0F];Q.U@/884D5%)F%
MUO,$0=@:E)W%5?.$A] :1DOVA@]\\ANW?N?=;W_WV]Y\_3?__3N//O;4_L,P
MC'^#'<\^>?ZY@T\\\<R?'GKL[E\SV-UTR^NONJK=:IFM=I7:XO9E05(>H&"P
MHV@LE%TJ/YTN+F:*:R.I*:<W-R&G'CF2"9W-DXWGYG.E]6O77T(!BM/_??KT
M"R=/4@=V2+P7SL+54H4LSSCA"Z\$7[W[MW]87-J6RE!5?RA.E:'^^"RI\F#7
M'^EW1[NI5HS%82&I F$J)X"L6]SP>F9FB2.<'0QV9&F7-EY]3CI1W!,*SD$]
M!TF)IW)KB[6-;#X9]5!QN%MN'\W5Q#%@=]=3N05?N&-WPXAD<#S8W&1LV26S
MGRUM:@_VP%&"(V9' T<(WLI*>SNSL12$]4?)PP*I_M@HFEDHM[:Y:7L1HH_R
MF5>=;+ZZ#2 ^]VJ7B>RQE7V]SM0E[/43H)FX8_7_B?GNU$4<=H'8R!^?!@H9
M(F<JK671A&%,J%.I(D9;&4<:8!=)+>!U,AM+QSR9F-8.<K+Q43JW_J:;_]?
M[H$''[+80Q9[5&,*RC2.":55*C?()HUBJ4;(83=.<R346KA:_9A0O08/0MH(
M%7J=@_5TFEA-NQ.-P]L*6?VL8(RH)]9J'4+P4: $[+ X[,12D]V5#D1J2AUU
MWS7:4E9WV4$A@H[+TS"8$H!=I[?19$GI323K_GZW#K SVM+QS)3.F-"2N"-E
MMPH[8")=6(ZEYSGLW$&JBEU5=F$V*W95V?&T.#K<63?V0GTSC@SN-$V.BM%:
MPF7<1*VE,A9OM3UUH<E6-=H*6F-4/&$DZ2H03RA,<B4-SU;J8B8G=?MAH_9P
M?@ZI+X"[DBK,9\M+%E<)'#2YFF9/RTZ1"H*=-]+/5=;E*LNXV :BTW W3O^
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MM8EU!(&7G!TMO)IS9%7<N0+#4G-S(#X,)4;1Y(P_!/!U0I%!. :=V/,'VIY
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M]OWA;C@^E2W,>D/X\QN G=84IHF:$V:'.Q.,M=/YF49[Z?$G#YU]X:^G3KZ
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M<]]?(&[%#[F2XK6[I*=HV-A<LWN,JMFAHYF/-!5F^CJ(-.VN1C*_&<^L&>V
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M[-Y_R>5V,:K5NP [F<(R(Z/.?Z7&,3:EV8+=^.2D?'R"NJ.8N)L [!0* [D
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M#_D5>(O,<:M8BN<VBO5#OG#7$ZC^Y*=WW7SS+9_^]*???]$EW_[F/S[\\.,
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MD63#"]BU>J<GLNO,L*OM"?7<(>;&ZN\U>V>!=SCG>4<]K]7P,%^30NVT7.4
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MJ0Q!1#H&6\8BE,R.HMZ25&B\I.RF#)/3V&ALQ=2LQ1\J0US(56Z5UDNP,X3
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MJ/,TDJ(FA$AR+9!8#237_?%U";(NLDH+:M&5:&J],7>,G__,S))F5^,/@G3
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M2M!HL<P:5"'>;8TYI;-D34)%D+!OW4AJO;MX+C6ZTJHBM:#RCF9 I-JB0<,
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M6*RM_\F?7O+<B1=O_=G/O_+EK]_YB[L??O2Q77N/6NPIMY>&7I<;^_+5W>X
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M\O3M4C-=AB0\Q%>*:3ZLK4"ZC$9_5('4:&JMMW!N*+K@";8M#K)[PF4)GYW
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MW3.SY?VLKZL7RZX'H@OX%+!O3M:G10MJ5&XR!V&.0XOWF2&*A+ACS1758OT
MN1!ZJ$E&9.Z$;-END"GM"R?7!&J;H=]")PH>2L4"=M',&E=V?-E.(BN$%1=S
M-P'L"K7]-$J"6,\,78(]Q+ 66\(E9>A(D]F-UKS#VP+LG+ZZX"Y;[%F3-64P
M)0"[4*0?C,SIS FG5/6'YGOSY[EQ*85J]C;9\9/''79HD:<WWMAL<5]][NA=
M]]S_9I2\S5]O >P>?.AAIRMB,/FL]@@9V*EMTW+3U"QTAY%L-:'FQN1*E56.
M"!1RC#8>A$Y/3BKD,MTV[)BRFY*KS)"$.U@%W#;I #)H-S9?0L.<G3A#:<(.
M-HLM,#5#-G9O@AW(!<D@4PHRN<@:UP,::"5KVF#-:/216*(]/JYD[6@34U-R
ML]E-)<KC:EZY,BFSR54BE)U#S*0+RWIKDJ:"L6&#5#/,9B3BMMPXB(O8$'],
MV0EL\*A#JH)TH<0\0C_$L&9[5D\K;C'>*:'2!Q-4=Q+<6J2CE?ZM7X6\H48R
MMP@!14,>Z%ED7,PC69,MFZ9FV[12(Y%'Z;A*KA(LCD2YN1NQI(WQ3J 5=TJP
MLG69;B V7VD=Y#X%(LT>PR6=E3($:)DYDE[)5?=:W34[&^3,^RCX"A%>E#\R
M:'0/ZZVT8,?$7<% ,[SC6D-8JP]"+@5B;2@[LY!U^FJ *>LD[_K#U9MNNOWF
MFVZYXF-7?.3R3_ST7V\[_O1S@-TSSYSXSG>N/_/,LQ5*]8Z1B1FY26_R0G>;
MK)2@@+)#& O8>?P-;[!%:W;)@2^$.ZUHJL^&C77#\0'K_Q]$DPOA^#Q;N5O
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M?"[!&-&8$HXKL8268'2O/X7AI+A$-"RU((X@7W-$.3;+) V2F0VAVS :#D<
M7"0E[_6SQ"*%U)ULG343R52:83.WP(Z8UE&'3D71&[+6B"6M:#P7BF9\8=WC
M Y %#9ORAP5)*SI]P 09MY_SAI40@EV>I C*K<%)4BR[T2X)Q]0Z76X"=EB&
M@MYY#K^#O(!"<9!(6?%DGL%:D*:D]662YP(9"WL[+'I8UIA^W6($:;<DT1;
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MP\7>ZU5CK&@=46X(<AT6MEW;*S</FX.+)Q<>^OSG__2UF/*=O[PJ&_OR2_0
MF*/'_^3RV../<U(.V!QH6  [V*)Q=B(#)"@=C:MN#_"R:#0FN#UA+"MQ8(>_
M ].L$;\_%8U*- ^+[G5XA'9<0)AE@,NM>B4"EC:*;1D?N>$DOT$EBP.P.6](
M*I1W0;U&$D#64/$E!8S'A1.6+Z3%F6PPHKA0^29Q-H67#^!\"1P;!GPJ:^\"
MZKF\''$,!;QS$+##UC%:C *O.1CF1-D.AI1(+,ND2K";8>64/H S7[?F4]BE
M00^"JB7>2F1WQ:W5R"UR]F:P>SLI,IJA);H^PG)<E;12R.UZ^PCS)#Q($M(B
M!GI6  %; LC6LP,X2.("FV0IQ;M%[LY=?%"4.Q(:S+53<A>$$J?T1:T397+
MD>$S]_GE4"@W'%^5$5L[)+6Z(J3F0,<Q5"M HNGZ'@/=O5_I> /@)J8 F$<&
MC4;2M=L"%%II3,*1NZS2G>W=RV&!=!/'!@DUCJ28X:T!FJ?S\]'\!I#$;/G
M@'\W.N]^]\]\X/T?!K#[DS_Y\Q>>>_FEYUY^S__^3T5!<CH#B:0NR,4D:S%<
M@17*LM%4TFT .\Q.E";Y\BQ7G *;@Z-86P)W*P'2U5?5QEZUOE]K'K8Z)XWV
M,9DZ=K[>PMO-[G&UA2,6RXV556B[W=%(1,*25Z6E9G'Z&BE>.T OR>*F4#L\
MN?A6(TOZ-#$U@?&RLXSJX=[)@V@)<S9!E<A;$'KKG+T/9.KXPIOAL[)*.)2+
M0B1)31Q;E6-XY-G>?8(V)(':(0A8F3A(8SBO>)POGVR.WI@K@LS?T[(3N!OR
MLCPH4%#!^T#].&,ZG-]%>F"!-=> (I&5G(-/ Q1 -)&+,S8@'3 [^/:+-6"@
M)Z1>E_2<8A?:5-+'HC:L-$YRA24Q"D6/'#JJF H+T-?U+H*=FD&QC/-ZJ(RU
M#Q1S.5G<5-1.BBT$@SQP$4DMQYB\!*1,!PG<)S8$Z$%K%>= UEAX&4#M4_EP
M5/.%E!A;\,6MA-P!AI@N'J6![5KKQ?X#@@I2M\Y)#5&%[7 ?D*Z_>ZW1OC :
MW_[.'WO?_\H.BE=0[^]P^=1G/D?*Z]* =+ _D[2:E>3,))OQ!5@B-K<-$L2D
MDT;]$=UTW0;-14>(8<6)T[_C0C&;XC(>7^JL_Q^Y'@6X2$RAV0EZ4#'K\F"J
M-,7GT]D.:06SR,S#:DJJITC *Q3/"7+5XQ?@GBX/P4>T\Q2\ 0GNSTO5='8
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M!E2A3<$N3CPO >G0Q$EHP$))FP.G!SMD@=RYW-A#YO&C5YT_)(M*3=%;P2C
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M+6;G)Z^-@MU.-,)@+31@JU\*Q4T$.QE1!L[D2O.<73T"L ,40^FZS5&@HPZ
M';:1$9:$OR$%G$B.#(2,T>P&*07 :%><0Z2C 3LX0,"6ZBM0+O$D3M[!,6.O
M>+67:14T-8FB54Z\C$UCH(ZU[&2RON$-\@Y'*!03_5$I)96'DZN<W"'N\#C8
M6\<N_6U,'7;4_NP.C;2X4:&MDV98&H(D#G=W8\CIK &. J*:G0"S T0;S:]S
M<A,PES([0>MA: R[%!;EUDEK>!6$GJKWQ]/3][SGP__BH[_TEU]][*47_^8O
MO_QHI]6%SS@882G8I?A<DLWQ<DDRZJ17#!W8 >QR1?3IM*MK8'.5YD&IML'9
M.LU#H ;5^D&]>=AH'37:.%<,CD;WM-T_;7:.:NT#('I&NN+UAAVN4((M("LA
M!;V4B %P-_I7>I,;6 ](J*Y./(&)'R< Y<GY*V\G&A:[XK,X2@*S%CA\*[\"
MP36:W0E?*,4[M .@5DYXXZ!0/3F^]%:2*T 7.8*P*TQK8&IB'R3GP;D',7MK
M;V - +?JC&ZCTQY(I@BHT$14!\";.OWSO%2.)DQ<SQ$#&#I<5^I+;T")P5[+
M%(&O ;,#Q&QT+X,>I]\./*.@CQ#IY$Y*:)K6%)A=BN3KR+03-(8"9L?)?0#6
M]N"JJ$]5$MG X$9^'Z$V,\F7U^7*+!*10,/N[$08SD;[:ZDC*'V<9HOVU-CP
M$T_DZXUU,*0ZG(S#$0\E;$X=+?9?C\8*F2604T'ND=Q%$]9 -C^A8"=PE6[W
MG"RU[>*\TCA<[]TLEO=X:9C.@Q@_]UN__7NOQ9?OV.7; ;OS%VX P,$A*B56
ML(#6Q1@M&.4=GA#E:WY_#(=AHTUQ%)V7W(A6@#+ ]6)QC@ *)CT18# GX'1[
M_-$8'9Z]M;I#L$-G)X87+4KQ7@5V*3C"4552RX&P K0K%-/#R4R$,6-D$C:
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M71-+)>*Q@_,?FE&FX(]FW $A&,7B.U+'%W,Y(TY,4+BVP(L ]XJ,);\ XAD
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M95P8K0,BABS,&Q \ 1;P+I8P<E;/X4YAZROVS"(3=)!,Q:O CN8NL"HEF52
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M;[SAP7?\^J__SF.//?/RRW_UT8]^U.,.A$,LQV=AV218,\E:L(K(Z(DV:%@
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MTM;2'9<G1:BEGPAGUZN1CEPHN[P%=O!*PEZ_&(J9,9QB4853G<S00;!#9D?
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MH41.-Y?YTH5B[?32[0\^]O@3KP6:[^3E[PIVO_?)3Z<$4U3M.*.'HR*6$+N
MOOE"X;@3NP[<9T%]=RS.>MPX2)P$Q:@5.U;P)AF#8;,N#^L+D(^8?,K>D.P.
MB;Q8RN3Z3H_@I%E:]$K!%"T<'@^ YBW"1=.U'G\XY?8EHPF#D\HR<"NE+R@@
MY?HIH9:VQB!O'1X1[8[/:NCP$9QNIR>22.H@2)TNG-J#S Z?" DCL0!PO8K-
MT>>Z=7$['0$@IX&P9I<G0"K)O#$@6156;@*U(12OIYJ39N\B)V$P6"8]L[PV
M%@A, #,"U#"R.+A$3H](V O)'0'KEFJ.LH4Y0]R<4)LG+%@3$= XR0(HG>'H
M HL&9X489T>QU X]W&%GQFXMJ55OG[!B&^42=LYV6;$'CQ.*J]CM%DA%(YHG
M(#=[)X**N6-XA;0<#)D(G/_F$EC88'('=7S2B$455LR1"CN%N#\=GCY$,H#$
M+@WMB<C8*C)IA9,[S>XY$$0\.E^--=+]GBMC;:UAS?N[EZ_>]M ?__$7GW[F
MA?_^YU\V3#N9TK <70!A;H%$2/$%.#BQ#&"GD-Y8S<3J$U*#,K9*$^)K EI[
M6JPM[<H<.$NQNB'38_?MREZ^A(D+N$.A/#6MMC^$0TX3R;R YE>8+,I5-L<7
MWI@MXKP(.I@&ST9@>440\MB],%O?E\ECNS[%.TQ0V ?I')J@3%8/5%J72#'*
MOF[OZ22+BLP.&>*R/;P,+ EV!6QNM1;H?5] U])\&?O#[,K!8/<:+$L]-W[H
M'[W[C_[T+S[V\?_RV->^_M6O?KW=F0'6=_I'*;X8B6->@K0 B<&(V!L??.+3
M?_3<<R\^__R+SSSSW--//_/$DT\_^>33CSWVC<<>>^*11[[^Q?_^E;]ZX>5W
M_O"[L^9@=W*'ENGS4I7E*JQ00XM_OII,E1),L5A>*%J;QQYJ/-"BAHS$@V^P
M4#FJ-2\*.-VB#@LX$-%<7M'IA7-0#\0RI*2!37)IS-TY$IZ EN :@K8K&PM9
MG15*ZU BXPY*GG F%(>5-M;-A9:>V^7C1N^R !M\=@Z?+6SS&.A0^L/)[4:F
MQZ1,A@$JHZA&<\<C!Q(5V&N!.UO%TU+]PG_\U8]]UU(3]/)W KMGGWWVW(7K
M"';_+W/O'2;9>9UW=N6<\ZT;*MRJ6SG'KJZN[NJ<)@ #8 8  0(D0)%<:R79
MTLIRD.6U K6V)%O)*^UC2]KU!J\5&&Q26HHB*8&D"(  2 0"F %F,+%GNF=Z
M$D!:_F/?\WW5C<&(8?\@]6P]]ZFGIJ9#==6]O^\]WSGG/6+>Z8[;'&$B'35:
M62Q6%XM8N2R"\C+Y S&#P<',G6A.&)^C"*RXO:+7KTSIO6RN:QBA*^W?V06+
M/992VX)4@\HSX=TW@D2<=R3-S&:[V6RY@SM3M)=G=N@--.W0[4V%*.?08Z5,
M@YC4JS0V!;GC\))9L=[H9\RE%Z;340AL-#H8 >W,I(!O$=(KMUALK);XN\'.
MH-?;] 8O7J&<:MH]"3:XI\@<0^E\XEU3Z?Q"M7T8"R"G Q-W0VJ,Y74GLP]1
MN^ZD#V&2C27+[#@DTEPR,T1HS(9(:6X_@YT_Z_5EL2H.1\?<W@QUR%(GW&0Z
M#^L$J@*1F?Q"(-* N N+5#L:$KH(BGWA+.ENG<MFB]I<B7QU0<W-X?=*U-!&
ME0>44L352XQ;:$\?IP9)MF?'*C8F9<:<=Q!'W*$,[W!8)K=QXIW48[!K=?KW
MQ!-=0>F)-%Z2+*%2VBHWXRW7UTX\^-\_^\Q+%R_M//W,<X*D4K-1E"P PH(6
MC%(,&XKF:;E*-,&[B%A'M)[29L0D]<E"SR+HP]*%!Z >\$?-8>7EA#I4<PN%
MRDHJ.Y?*#@$[)=W&:8ES!M%&*%*,8VF1!I(Z:LW>5VYN*1G*$;,4)/6-R;E%
M21M#@1X^]A/<B7.2CF#>ZX0\EJH>K_X(SU?@^42>G(19T0ETZR(^Y?'JXZ1\
M:03B?))&6ZRHY76(._(NS2]M'OE(6IN3DUU9[?W1)_[B&R^]]I6O?/GKSS]W
M]NRY+SWU-373:'56H6J=GB1@9W7$+(Z(RR?]W"_\F[/GKUZ^O /8G3MWX<P9
M2+MSH!X>G'[SK9.G3KWRXNM7MW=^X><_EE'[<^/WRVG #FJ.*LRYPZN?[]G5
M5J0D9%2=3@DJ&)B.):>IQ)KV[+8JC2-1&;*N!%EGM$:G#"&<TDY?VN(6]<S3
MFR9>&0,(5-G,3UHVPF(_$*XIZ6F]1398DDY/.1CI1L4^%*4G4)%3<[7V,5F%
MYJ6M:@IQ:'I&?7G]_5C&G B3:7I,V!/03,Y,H7DT6][(%C>TTM;*QA.G3[]U
M-VA^R+?_3[##>QV(I,*T(*MV9XQ9#=NH \%@-9DGXDC'J*'362*1Q/Z4:YH
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M]D<^^N/A:!*K'4C'RDT N[(@UB(Q2L5"I$2E&K>TPSUXE\X-TCFL52TYW4,
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MA\=J<T^Q/@IF#>\U6H)F&\2=&!6K4K+EH6(1VDKCVW: 5UR9AK@KU]]MJR#
M'<2PN"RE[MSB^R:3/5D'!?TM+#)UAW*(X^1$>T(Z7]8;!.QR4+)\I&RN/,^T
M9)Y*52B"!N\FL$NHPW)C(TB%"&2W%Q(:%B=TKM5L\WE\B5"X@E@O)-:B@ *+
M4I7, FL.Y<-HEFK=>SGL)ND\-G ^EB"M5&UN<8R&R/^V18L_D0[1>D=,#O/5
MU4)C#:=O@M*[BV)RA(!Z9>V^C:T3+D\<NM+ED0 [CS])=<6Q0BA>!.^$1%U*
M4YV=E&KSNA,>P/*$+!@'60?D99G#7;HPJV2G*=F:GI:3W5B\ %EGL@9\X7RQ
MMI+(S%&B&1$ZP0ZZ9DP63,QTOCMSHM8^FB0U1Z-=92+[,I.T"V 6PMM"?4NA
MR0SD;4?]L,RGDZ<FNK,/9LO4-T9?P/1@.D_TI(+DS'AE_0.ERGRI.OOEOWYQ
M]RK A,AT#R"#E,.!![P\&,P"^[[ZU6<0R9X_?V%G9W=GYRJO+V'1Z]N,=/MQ
M*]NSXUMX!P4H%RY</'_^W$LOOCR<6=G8?"3,G$YH=C4S.J,FO\R2E!JO;GU4
M2@WY4.,HI<BHT<+E20?# )DXI;?H:+@SKW)UQ86<)):<3LGM3?B".<KRAZN^
M0,GCU9R>1""8=KHB3!,8(&R(=Q2T^2P.Q1,H!X5N1)Q1M.79Y2=CR;&<796U
M]41N(U,^"MAER@CM'^G/GI!3?4EIQ<5ZH[4:EQMJ=KI0FD^H@T)E-9FEED2J
MC\F,D_GET<+[/O[)S_Y0-^^^*^R^^<JK@ICS^F7F%,(W\@$["QMQ_6XV]B[8
M6<RTM:?368VT;1<T6:)0$\%(+IWM,]@E7-[T';PCR^)Z:\%H"AA8YS\%L/S0
M0]D)@EC4&P,,*R2C'&Y\N^IA._25YHJ?C(\*O*. DICAHC]<P:>EE1:E9,\5
MR+N#>8<_B\/F3CI]*8<O8[++@ER'W+L+=M^] &5R<[I\)%IU9+^,%\EF;%-C
MK]DF($*/QBMNG^H.Y#CL2*-1S@$11+/=/\9;Q-[;>$!%=G)Z"'9PT@5IQXTJ
MYG@V%K K-Y;C4H/#CG=0X$EF0 !EIR&FX[ CJ4NG:2$4P5)//ZI874EFYB,L
M51IF1@,.;PJGJ<7B=GMP6FNTL24WHA!';&,.(2?D#&)/7,;XYV#\")%BXCQ*
M&5L6R5)#2#S1'RT\[ M5..DX\EC>N2LF9E+Y\7#I8<!.QEJMDH=26&AU>DO5
M^M#K5WR!!& 'VCH]LC^4"<9PB19B2C6>K,>3C?UVL6XBT^.I6,X[#CLU3VE9
MK;24+2VHA;E,<4'-C]/9H2^0)MLU1S@0JTS/G0C$FEA4Q%1?5BD7"=@1<]-S
M:GYY9>O#N<JJPL8)48VQ!I"M4I4,*;OQ_/+C/'A/Y"8S.H!^EJD@&[OEK0^Q
MJ3I4/\C+$KD>3&F+V>+JVN8');GQ^ =_XLK5MR]M[U[9N<9AA^@5!P#'N[[P
M))3=7_[E4Z=.O8EG@< ]*C29P.[Z=<2P;]^Z-=FJ ^;X Z[L\+T7+Y#UTZ5+
MYY]]]FNT9[=\/,1L3KQA*CWQ1VM2>I3. Q_+]Q[_22E%$R^CTC36/YKHZLM:
M'1)@-S$THW/893:'0@%M?G1?&,%!(!,((V92G?ZDU:6P"2T!G=Y#6P23ZYJ5
M'T\YILP1JR?KC39#XG14&D7$D91>F1D_$19G:/!V:3U9F, NF=_HS3[<'ST8
M!^GDNIKIE<KS@7 ^I79%N2DIO4)Y7=56:1AC<L0ZM5<SQ2TL2"^]_.K=)/K!
MW;[KGMTO_N*_#(123H_ U@'. CV#G86_!3J=WF P[L.."C0F7T!O#8D[(Q&!
MJNV2:CL0SCD]29;]28(+#D_2YI*IS">@ENKS+$L;-!C]Y,2 P^@U&'P.EQ@5
M\GJ#7X>?8P7O*)YUN*F$ K K5A<\M'L%/45]HZP<%P?M7A5JRV*JYT=(&*NX
MPP '5:[QUBZ'3Y-379TQQ$P*K.3[Q%2=V6R^BV[ON2'H=7A,9IO12--LV1Q;
MFO^M-X4@73.YOC>0Q5_'_$CX7%=6_A:MQY5^N;XQV<A'4,FJ<'$?C+<#0DLK
M+\NI:1KC@&"3IAI3NQAM.6.Y#A=ZPZ.(0*DKELR[R3Z/PEAV('!.YP<TVI&-
MT"9E!]"'BH%P!22JMP\)2B_,2ODH?):FO>&<WN36Z6T>K^1TI42EJ^9G(W);
M2%'I*?/R7%8RDWVZ%HU\IE'SE(1E_L/,NV4:1R#6F)E_$,@+LS V%*,1W10O
M2]2%IF1&O=$#Z0(1A$20.A_!GQG)"&+>%TB&(JK7GX"L<_L2_F F$-'\T5Q4
MJ@A*55"HX Z:CGB7[J:R Y::F,&#M#9,:P#?*%<:0]RIA5&FB MCE-)F<-E8
M;1$(;8=7JC17977(DR?QU$!*TX:=I"Y(-!]R7*QM=68>H/0"E0'2CEL"L,LN
M$]^S"Z.EQRJM(^G""FE VK]CD[-9J6!"&R^N/U&H;RC0("PS.XEM::(%1<?=
MX?%V_Y":[7WN"\_L7H4*N[EW[<9UIL5 .M#MK;?. 5+@'>ZYX3">O\P;7Z]>
MO79M[Z"^Y!9DW6TJ/>%YB9NW@+E;^&E7=Z_O7+EZY?*U[<M7MK<O?>7+7VW4
M9I97'J2, 5-V[A#.AS(90,2[P1A9[T2E+DZ\2+Q/*?YPT>E.&2VQ0%BE!DV3
MPVP-V1RBSY>-"?5<;M[CH>RJS2F:[&&=F=HZ)Y5AY+GK8*:V)I,Q& KEK<X4
MXE9_O!M11I!R8GHYGEP24\MSRS\2BD_3DIE?24 4%S93A4.*MMJ9>; S?4P0
MZW*BE<L/A7C5'\JE,CU?,"\G!J7*5K-S7$XNB$F62U$7TJ5#I<:1_^7?_<>[
M0/0#O'U7V!U_\#$LR$YW]$#6L0XMJUX_V=1G%;EXAK-O\A5&$_^G >&]7N]@
MK101K3!T0UBY%9 .J')ZTS;6^HHC)$ /%_76*+"H-P7U5+ 29-T4Y,T)%8!G
MIFCX;-AD"9NM$8=#<'F26"+*M07\-(\_@\,7R-(1)A=?Q+:EQFI,:;.65?(C
M\88KS!DIA^C/[DG%Y+K>'*$^"LK&6B>"U&+;7\3^]HV>=]@]-/J'[5GP+C="
ML)E@IQ4&T/P>\D'),O@BJ*1,!<@EIP:EVEJ0T8VC)PS!%6_C&<"N4%ME'IQX
MD3S)4 $K>5@:BI4[@\.<93P#2[QF;15XP*IP&ZY &@=G_3YG*0HN-U8I0\)"
M:6BKD-##&H"E B+(9@\%_*F /U>MKD:$AI"DH8B)[+RBCMG%OZADELJ-H^WI
MXPDJ3*/I$]SK24B0<P%T4[ZZ5FIL,O\"LE=A1KAD;R50G]8,_K=8VTBH\TD:
M:C$7$7M.?\H7R7H#*6\P[0NE\< ?3 ?(IC@+O4\N3_%R1*R&XQ4>QD+B)5)=
M*='&?3+55;.##+B6Z>=+\ZEL-Y&=5HMXD3-RJB%*.:,1GX+7XU,;K;4P[9:2
M(3O9NA"C9Z3L'/XT*3V<6WJ<VT^QEOAWC>D!96!][?"/DJ5=89U,Z\BZ;C5)
M1D_4!"(F!O/+[Z=H"^S.C)7L'$O%TAP?WE>[N/YX0AM\^$=_=OO*V]>OOW,3
M FWOULWKMW=WKU[>N7*1-MJH8PR1&03=2R^]<OKT6XAM$</BQF!'G1*\UN36
M+6#NV^^\0P>#W=O7]VY?W07L;N)^>^?:A8O;B&0_]_]\L5$;SLP<(<].VOK
M0IZESSU8=/JTB%A+:Y!UO:C8I\;P:,/GU^PTA" ,X:(W!0 U7( .3\KN3D?B
M=9Q79JMD-,6,^B"9W5+M%UD](G9!+*73^:>F_%/ZL-6IE1N'0=*(-!U/S@L@
M76HQGEP0E/F8,IJ>>S_M&&06%8CBTA8U3N0WY/1"JW=_LWN/(#;)D[V' 0
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M@%V:=1,OKCVI%L;-WMHKKY^_?O._WKCY]MMO?_OM6__U]HUO[>SL[>Q,/$O
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M)K#349!KW,]2XWN=$2$G*E76WD]>)J2BJ1!1!>EPW5::R[@8[)Z$A6 78T8
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M)2LD*JPSZ:8L'G=4/YD^,9%R'G> S]GYSK";,IDMOE!,-5@"-BJ12[@\E$P
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MC]3:]U J5J$:#EXWPP^\X&)]K=S<0* *D@9CK;#0F8@[&I4]7VD?S996(>X
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MMGG%#O8!=MQ'C>@2Y=97C_&SO?&#Q?H9F%U1JE* M6!!S$)XJD93T>L:NYX
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MK@<)JAL3,3M".BQ^+B\E/&!42,7CV3#J83N"\"0C=7.HV;ND62SX<N,@K&W
MDV_"4B+6+A8P2)^HE,)*EMC(2 Q\M(9+?F?"H)@B5O@IJI>BE%K0^V:/:FB8
M*I)[.P&B0@-(RMW:-\#$;*F:RD>)K+='?<B*>%_9;&'O:W7+WC&[W1?\#DGO
M2V8B#?(O@R'&6<9BT'E9,?"BL16.N'!U1[Z8H'$/,&\J&L52M,7>'<5J#@U\
M%PH7F,5*GRK -.XDJW!3(;S!X>R.Z8W$)1*TCDLI*,,.&,<_2 ]HF;V0>@*P
M&RT>UCJG%D#*YRH.;YPM1=QI-UXJ>JK:ZH_.*RT V1I 4&Y1FU31<29JDZWY
M^OAM4)X0B__:U4X8M[CL:[#<OJK:4WQ)[(]"7;N0'Q[7.Y>S]<.25D_FK8SD
M%JD!14V0.]UJF4[7L#N["EFG;[D#2#_3[EI.!S+0C2;4AS>DP@G=!=QWO*"?
M+SHT%>.Y7,&1E):"2>52?V@/4CK<7-W]E!.M.+681*LX%R;')\C88'UX^C:4
M-:4] \(H38S>B)#G@/B#T[?P%O"@3"DX1U[MT*EMK0J_.-J>7+S?&ERR>=\J
MJ%$0D-6QZ#]-C'*V>@P1#9QURVO\#Y#Y8N#Q:/& <BVY3AE?.F7L"OL>=ZWN
MC^^YX0JZV+#ZJMZ&!$EE3>R:AM7,%QQN006\4\O554DJ@XX5I5I)[2H&I.ND
M7#^J-8]DK4OF=*1A[5C2CBJ+3-;A5F$IGK$)W2B7Y#"1=N,IAUV%W&363.(U
M24=WNKI=YU/:! ^B==B\NU1EA!74INEDSTQG#4'@4$#V^/CR_4;W-FG5:*M9
M2]6>*,[,\,A\87OZCE_EMU\Y+C?OU#L/,*KM.W[]XM:#/XUKY>*"4#?W'C[N
M2FV6R=B&@;<9R6K7=!;U]NVK>]_>Z-YO]A[6N_<:_;N#^9-7O^%@]WN_]WM_
MXPM?*!;9S@3<+)E-YZ1T3A/,+IV6V(N<\N8HS+F73Z5DZJ!*GN89>I(]G>+Q
ME*BE9RB@H^YDLAB$73XL+Y>HJ( .)>F@D+RD^^W!.5@,$Y8/DL@$V&&IKP^?
MB(#4->.CP7&K/B 2ND;T81 _Q2*.H &(T*$V-#N/D)NA&%TP+'!)['LE[D>1
MIBX\^/@I$2F9R+%QRU=%NKT/A>JNP2Z65#6'3JNA%^)*G.3 #NQ$!TC)!$L5
M)BB[?T;@';0,V(=BX&I0;IWP4L:V3V>R;%D!A2L\6L0 > FDP_W%G7=O=H7K
MZP.\HPP[)YS7:)]GAV1&.L'O<*]8D\GR$28B" 4V6(""Y<\DHY%,4_ KE=)T
MO>D%DU;_& J+:DNKG(!"U6.78>LB:)S-#U[KTK+\H#7:S<!J'RT>">"@<!YQ
M*-(R49T3<6LGZ^US?':)G)VA[KV!1-YV56AG@)WPL\/ [ ?287CAQ/&&CML-
MRF3D:0<3PQ]Q _*)C>>];IJZ(F22:3E?\A7J/3)0[#XT-7AE?WRWUCK!8J-.
MJ>1]0KE@G"%Q H@'<=@<O@ZI3B!5/1$%(4 ZX3G:'=]=';XF'C,K/'" XY2R
M1PG5M=;%Y9W/ -:!5J"! NF"JK"]PB_<#RO[O='MJ :E?'"#=-C&Q(/A_+Z(
M;XJV9\!BETU*;'_9G]S!*H#PU$#0E'I:S,F$YOH]:N?*@;:]N-[N'4MR!5!8
ME+&%#[!-:M:TVCQI]\YDK9W.A\F\OY<P8PD+%W!O3^:ZH#0)K%@:VT.SLY_*
M!>STXU .?!I+6\,.72AZMM_B5R:X/T&:J8S2I5+%/F^B4 G$[.@4OGP8M<[W
MC]]I]O _[T.]*N94 7%Q%TX$]#\YNG@76(\I[55 .>\V^H\Q:MU[8?WR]J-O
MQ7Y@8UNR.B#U4.BR$I6DR !?D<%"%N7:::-[=__XD[W)LZAQBXHK^O<ZXP?/
M7O^.;S#8_?-?__71<'BSE..)-, NE56(V<4+N9P:3W"V3BP=)T/ZG&F6BT53
M)* PV%'8+I7,,3\2S(ZX'E#2]5MI2OBN2N1JV=/ML46^,22U6,J1@SZSF!VY
M$V#GA%,P.\X$_@#L1,@/H#99WG\Q?L]GD<(#G40BV UU&N-NA K PJ;%(%/W
MAEY8QX)<7H-=D,I8U.5W+Y?/R:F4< 'XJK>/ 3MJ!^[&XGD2PJ(?!<E8(T%Y
MY^3$EZ-3$?(%X),982-,8!=4U[WQ;=4DL?EAL*-P&]4S^.1](MZ"P#MA:H+K
MMCEZ+D3K#=@Q-:87@"F[T8("=L3L=OEZ@MGIUG2R>"3Z=IONFIH5!#/9[J9R
M.GU\>R59*DMR?;:\YY97(556G7(,:P=V +Y:[Q;HFT^^F+ND$T'K@'08S?[5
MV>WW*9)-TFQ+1[J58T[3.P7VS==/(>$!=NF2G:?LDS*&9M5UJPF,TZTV^)WI
M](!E&-=@UP_*T'I@BS./\TXH^Z2ZL)Q&G'H_95(935*JN B:,\)[,<GV8[LZ
M> YN9?HDKNG?B[:<'78(A>6$F\>O?$>U2>X >-X*-B)[QF'?*F#<YOB-1N]2
MO".".<A,?*M*/=7P^NGR:<A&I&3QU"+O$\9Q("/>/G[D@-JY3>]1-3X?4HLA
M_&" ?0 [W#,*$^D#V)')(.#/G_;&EQ2<-=I%F2HC4UF1:Z(+L(LEJ?\4P*[6
MW"]R])G"M7J?=( -9K=M]L[RI5HF'R8R=CSM8 MW_"%;TA:X."S)K=>,3O\H
M6Z0X-=F:I8P8U8 6(773&=TP*R+K^!KL\IC&W<&9'<RO$S:7M@<B?P@(PTR8
MKIZW^G=4>ZY:,PV8ZRQL2N*AV.C^T1NXPHHY]LO'U=;=QN )1JWW,&I<WGO\
M;7Z$CZ^K:F4@;$D*XW$MC*::T:'F3<%^HTNF /7>W=GFS0HY1=]J#>YWQP]?
M>_L;S>Q^\B=_,OEB+50L!;!+I&5<ZSB#G6!P+!^R>*96&R2IMVZ6B1X=ZI%K
M4$'.9 2SHW@6+E\^K]EN(YVS"U+$_0]W/7%$] J8)=@*A[1V%>]B#8ND^0*;
M1[_([$J41ML[N7P+OX$?XZ<Z@M,)DP;,GL[@BCP;K+%"[L1#U1FJ[DAQAB6]
M6^^>6,&4&E\4HU36H5PSL/U8IE14DTG1^?NKWEY2N&Q,'U-4BP]M<I2_$I?X
MM$M+9BC-O5*?94I1@0N!"WP2+7@HD#VJ;T#!%&. _U.EYAB482>.*=B5\Q[E
MH]@CO,<;!!<RE@+AC0/A+W\S&.SHNU"X('="]HI>/^) %@#G>JOAY"ZF+V&!
M1TH6ZU!U!SGJ(TY@35UXY*C5.ZHT2:ARX121.VH>"#';O>55CZ#R0$8$LQ,\
M3GB1BB]O/?@,5C)_"?UX+/(V"&[\3:MW.ZANDI!@>H2_ DXG:9%B5%2S3B;/
M=H=I74_(6 %Y&"Z[>+J5):6;5)=A=5EMK#4MX%9^Q73>EM0Z"#OV,R"=&X'6
MW>D.;YD$N"OQ[[F$=%O#IW^I,[JS.GC582IJ ^G ^,(=9+-1\\GBX+G0L(+9
MB3<E.&RM?8:?=8/U:/ZD/;A;I;YBEQ4J+#N*&B"&U'$MK!ZT^Y=T%@2,^\#0
M=,?F>I,[V-+(+N$#>3OGH_D)A(CN]"6MD2^%U)Y5G.EG7' ?WCX5[F-GUNK[
M8':8MR5L[>Q&I]AC2)QJ^S"9\5)IMRA72FHU%C=TLTUDD-0H%_G$2]A]-;/C
M5V:QM!U+ZWL 4 I&9>*Q8C:KZWJPQ\6=<7:?C">D5-KI],_QIHI:CXNL-XY_
M*#8P4%I*E.O?D<TQY(+ASJUPG]QBJD=V0,RZWC[7S!G CI!K]+#>?USMW"LW
MR [+]<>R&A4*1C9C))-:*N/T1Q>8G^#(]>X=4+EF_S[5WM3.!K-7*BVHX+O=
MT8.WW_VSWV"P^_SG/_]AWI+,Y"6B=4DID2ARTDF&['G!X&+90D%WW3J=TNX2
M[O*\VK.*;(D6BPG:(C!2BF*79&PF!N](-:9@PJ]\X(2SX>QN424)QF[IN_R[
M$N<;MP>GEC\F'Q3.KA#E947R#H#"[2\/GMP(588/6M[B'!.DJ=(X-MD83K7H
M?),@SQLI-AV)UCK'^%N@=:F<3V*!CZMB])^;"5+B7TO&OE K1C?A:4PF"+0'
M9$2_,0K>):F9;"IK^=&(CH/9NU@,CM\1/.'=02T2TIE##"ZQ(),2(BG^%)>%
MOT5@=Q.VPSTN5%3?9^&_VQC$V^<MA*3N\<6;?/K!RO?Z-%: 7;EZU!G<,KTI
M!4T"2$+"*<T=2T8]#N(0*Z9!E.0P*L\I>25:<QV5R"X^ [/CBJO3T>)AHW/A
M70?L1(4L^0LP@JP.7ZVTCFWJ'DMY'C=>3W@-J$%G< &I)5MU<#I)K4@J-Z,P
MZ[+> *?C@!WN>S8K6:">,&J'=+5 ],HSMSSSPXD;#/)T4);>BTGIO"?SD9?&
MWG^Z/=T<ONJ22">RQO\;438K%+BV!G&+ZEN'[91YX&5$WX0,/[Y\M]H^$SC.
MO< _B$@ZP7H\?]3N$XRN#M]LDKW[>9G/J;E1V0EHG5?>0, VN^>B%E!P.A&A
M8]>I=6MPR6 G7%3)0X$,%#R\P6FS=US4ZGDI$N62>]1(3\_D?<ON<&]B4@RQ
MI%T%V*GU$F6J=CC_')_= &_<"B;90B1K]6S!8_6JZF:+6I+2G,04S5'#3\[.
MZ_0/6" +7X\D?S>;R2A<+)"*[Z43!'^%1%*#VJVUL.T=XT^ 0EK^OAL>!Y43
M.SC S"'3P\Z59(Q!ZTQ_Q:<66\V=8AI'M8-6[THU9F'UK-&_WQ@]HF84S:NP
M>GAQ];:NMPI%-YO54BDMD_6@]K _L<_"96M %GAAX]RI'*K.JM:Y.UF^T>H]
M[([NO_?I/_\G#':Q%\ NN0,[TK!D9Y+1-#^?-^)Q,@B(QXO<D! L+Z\I3IP[
M+G(%!; C99H!'^D:U/^0P&YGW0%V4VYL0. +"C"N!UUV W9"Q@ZF5P+U,&[
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MJA6[R2NVPZ'I]U70/7_H5Z>F#][7DM2($[\Q#XU\L2;A^H@8:&7_X/@-)UP
M[.A,E@K:*-!&Q#-8:NY\>_9VU#@DW&?;!;;(WQB,=,"[V>89U.L-7:5[?FOD
MM^I,9XN']>:QK/>!4[.#9T']*&R(F"9;W;7.2>_73Q;KI^7Z(?#T)F8G-"SV
ML'KW!)*"7:.G(KQ(F4;,UH4G,R LG?,_ +N$3MT%Y$HLH<:I?1V$K5VF3.9!
MGK*FZCFY4]![V)-49]09G\>25BRN\Z&M!,C3]!I9FQ!^I>*Q4CPFQV,J)GQ8
M'J12$F,<3W+:W3.:$=*G3UM^/AE7D@D-&C:5#0'9P_E#"%5<$,['QM5;0"HI
MUAC/-'NW3%!C#M7YT0%0NZ164CD38GR^>:8YJ[!^4>_=J[;OEIMG+@2[U6IV
MEY [W#FZ+JMMW<04751:MPY.WZ]W[[4']T#Q=&\N.1/9Q7YYWAX^?OKJ=_?&
MCXY.W_[;/_G37_[REU\&K7_3VT? CKS6L6Z+8';I-)1L@;"?\2Z74[A*+'^-
M=X5X3,)PW68VH\39U)/ZUW#ML6$$%%Y-JNFLERU%.:YAD Q:J+N.J&S!)M2K
M&'@2V]UHAOVJ*>$9M56BUEG-(A]0 /@ZNS/<7>1>IWI2REPSV>EWL7FJ69A)
M8\Y3ZRG@C*"'Y F*;:==U.N4:Y+DPHD].4:%8KETNF1; ;/ZKYIZ$J.^0B]&
M]/"R1#PN4FVX$)AD?H$B@)2ZJ03504FIW)2^<;DUX1V3NTZEN0^(9Y5*G;"Y
M)P!U00/>@9Y0:;<](<9'8$=+@JDK<=CA[#:?5.Q.8P7D,<.E$VIQ.G$=YMOE
MG=B4=[(X.'V;EQ]9YAFT5P/LUA3 \J:*T5+-")]O-J>62I'C3QN]<S [MT*E
MH]0GFS*JR 0I:IS,5J^ )=V0.Z$!Z<L(5'$YWW\*3.'32<JV"ZL$=DY(4<)F
M]\3VAP6B=>6B3$4UHHWL#;,SO)[I#^V0,HHM?V"'Y(9B^'W=Z[EE++"!Z;9R
M!8L3OS/QA%F46[A<DMG3W5%W>+O9.>>0_](K'U@^V8A"<]%_&"TJG7/ F<GY
MAI1[2!A$K<HM\C)8E)NGZZ/7\4#P4T9PTK;T&A=R;+/:/*7C;!/_TGRPO+^K
MMV7:2WY0PC>A?K(Y?.Y1MMV:LAKY4$* ':[Y9/4PK!_@@:@(O*D+Y"#LW(UF
MY,64<>,I()U%3:!2IN.S\7J26B?'$EH\Y=CNQ+('6;*&Q=XP4JQA7N\4M7;4
M7(/-L8"5:/].2)(<<, N&2?.48CO@>7ANT7#*'-= !!0= K$?,ZJ>CF;QW(H
MQ.(2D"X.L*-F+V7=F<[W7Z'](*)/TPZVACN1=>S*8\C_WOB!'5'AH%NF+431
M6MF"$\]H>:DR63[1W8.P>57OWZTT+]V(C.-ULVI8M736Z?2..48/I /#W0:U
ML]-;GVT/'U1:>.46NKB$M^:M@OIY>_#HZ.S3L_5KB\WS^?K)YS[WWWWI2]\8
M^Y.7P8Y*W-.%. A=L@2PBU-Y+"$=1DDR2R63NJ82V-& ?$NGM49CE$B4N \9
M^9TPZJ55/=RCEB@ZV8&40BI0E8#KK9+<&$VOP+94HZT ^Z@2H%O2"?BPO&OM
MHT[O3#<'LMJ1U::BM\C6&&!G=@"4G>$9T&T'=G0$06VP57MLN%/,L,[H2M02
M !T((M5&3JZD"GXR[Y5K\V3&V4L:Y%(-R$O0-()2*!2L7$9C3OH2G'UP22AM
M\$,X2#*6VZKE1'22-E+BN12Y@Y*-:I."1!;SHEQ7X!WI6:T!/NM7%@*J1,1-
M)(Z(R@IP-\W9]4(#&HIS:@%MT'3]";61O29T-\Y.]*#9.[;\\8XA@M\Y9**G
ML5F>'2XVIV]8I.!F6-7B5$%$M=@I?FXYE'R03.>Q'B2M-ET]L,D^A&)>U+2A
M>D(-]"K48*72ONR.[U%0C_6I$PJUN*5V/.'^:/F@/[TK<MRX[0,%^_&\8E/E
M0+-]4)0C52OG)9_,[,A*KP9AJ[L=*J*@"MD.$3IO: 4#TV]; <C+4/<&3C1Q
M@H'M-E,9G?>5;")MYY661#&*H1,NEYLGND7NI/2F6(3BK>W@S%^<7+V'?X:D
MJ[^\B3#RB\'C]C<G;P.YJ(TO()O230CL[(!2@O&)]*:7E?8!9B:!8'F78>-S
M&4E8(ZDN/*" L(O-*R&9#H!1$BL4B(F_CMUE=?C<YIY$/%$IKB*;?9[MG;"V
MA#C-%2& R!(1(!Y/FK&T6>^MKR6M1K402=N)@+R8-IV\W,QA2,VL7"MJ]: V
MX=['$OM9%+F&7>,YR9[A=-2>B7,:BFV5N7%*.DXKE,\N]@J6V\;'09,V+B>I
M#[V=S/N94E6S)]/E*]@P&.DVNC,S:-/%?SXQH^UH_:I7._*K!V"ILM;-Y,.]
M--:4DBJ6QZMGJGU0:=UI]NY$>('=+\JA;3>S6;]0JIZ>O:G361PV@T.W HY\
M-MV\.EH^LZ.MX>^7K(5D+YWR8:US!0$[73U?'[YU=/[^X?FGCL\^_2.?^UO?
M$#W[$;#;VX$=E&R..F338:M(/=%UCZIE">9*%!J@@%W),"K%H@VPHX!H/$?7
M-);-Y729VGI*,=XNN$"5ZKUDK>E'TWIK'V!G6#T)#$YMB;18F;+)>K/U0^QC
MFM''4+66JK<UJROS4.S>:'&;$TWHE.,FGL7T9P01X5=6)?*MH_;;I X*42QC
M8Z2+ 7;+6(*VS5C:B:7M>,9)I V G21YR025QWX$[#[X\H\".]%LC),0<5G2
M6D#%Z@'Y5A4##*[V]1GUJM76 :BK8&?7N+S+2L'CZ>H>GR_3\<M+&3E1'?+A
M6.%2$P%VS.EV!E"-[A$T'=;2C:? ;@_PJ*)KM'B@NU/.A/@@/XY:Y'FK[NA2
M-QO$!6*93%:5M3KXH^B<C47K0:J4C\@EB9KF4:GI=/V*:!'+S&[#61T4MR;;
MSLK!<OLJ0^1A&5J/O97P7?QI?++MWA$V $4#N0L(Z8C9U4IZ57/8^ 1*UH.2
M[0'3=;</I(-T-8,1P,X*1K;7*<D>-:NG@%TAG?<+2ELRAPHE,-UI=LYL;R$$
M-<B(<=V#'(C6Z%UNCM\02">B=3=@9P9KOW8T7#P".#*%(;"C'_=F;K@/7NQ$
MB_GV84&#T)[0FZJ?C)>/J=JINN6R.6*OG(-RYD8$=F6 >U64T^VDO0W<!!9O
M7Q'Q.\8[D+(!D*Z@MHM:BSHF2]"P7B)I)4B-&O&$E<K[W?$QI'J,#BM,/MRK
MTQX931-9/Y6/"M3RM0Y(*FHU+QIR6XFBJ&G-Y60RTQ7ML:C]:9I!#7B7M2GZ
M1&#'^SK6,J9NB8(#6D2,A#2LGDPYJ4*8EQJJ.0:+YQR=M>9,L;A48Z 80.J9
M$1Y,-J]ZU4,KF,MZ.YL+ ,H4+DRJJ5)UC)\JG]8ZM\/:D>T.BU*8*]C%DI](
M.JK9OWWOTP[-0"K&@&BH=6\U!W>'BR?X,J<,BL9,<5:88_7NK5;_3G=T?W/T
M]L'IN\OMV\O-FW?N??/?^_L_^Y5_Z_Z* +O/?2S8)3-*EG,X^:PZ%8]G),GD
M8'PQ ;T6*R632B(NAT$/7R82$I,[BN4E$GE-]8LE]QKLR+7IIIM$H[WOA1-R
M@M8[4)IBZ( PHCGM^>9!ME25]0X&43^1M,%(9_BC/B@A(2-54ZGL>E2B'C0M
M;/5>>:D[0_!'-K.C[HM)(%W2@0H SD(ZQ3-V,A<D<V&*/%J#9-K$_V:859X$
M+QU0?)U@)P[X=^2.=H5X*976O+";RMK"J(KLIPCFPKQ"C1:;O2/ ]$UT4@"6
M #X\WR2>OX.PF\,<\65O?%%N;(1N?8$8[O*QA[-;]&+B=(1T#'D[L"LWCUJ#
M2X-MWV]6NP [C-7A*YK9BI/Q618?GZ16J"JK?H#7 ]2X>0V1N_#:V6*\?%KF
MMF%.=$#.3MQ1C )DP08(LCE^TPGI'/9Z'+O1H>[.BFJGT3[(ER)9C62]K)G,
M[,@+H*58%+D#V-G!@*P!R.BI#XH'U--<R-B!X75EO9),R[R7I.-)!=M84<64
MH!J[Y?:I[<X =G3*+,YA(Z)U)J68K)8'K](Q1;#2J2CX0\S.]%?;\W>BY@G
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M4+*I@ILL>* J1%IE&J(^A(M_">PPYIO[$B<5"N^ &]&*80<3\-87G!%VW\7
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MZ<P /<D4/NLDMBM%K87U#3/$&=751X=TVE [\ZLGG&!\LG_RCE?97@>\#NR
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M]^,I0KH8:%U,C<4ERRKS9:'P,68=G[02D,6XM:EC1QF"O]VLW*,&96H^+XP
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M#'9I!CL)5T!XSR8S%N0SP([:CV5M;DOLB?H*7!9 GE>!?J^PDWLE2Z',G7<
M'FMVU_)' OT!>4+7B^M3(L.H,Y&I1QN&WBH:+3"[DM&5K;X93*N=4\V=7#LA
M[U);><P'LWM^=5\ GT60M*\[\Z)<V2/G_40ZJ\M:I=$&81E9Q)'WG?+6*1]X
MU+V!IF]W?&\X?\A*EHT R MSQ7A'%(^0M'D&B*3H@3>'C!5@)V)V18K954J<
M9W?#[+B9+%@5)D9'L=N*A<^:RSDYZ+Z7*";3=KU[&#4WDM'1',HHI':._D(,
M,+NH=G1X^K80LQ@"[]B4C=YXI74$CG]S,JN3*PQU"-#L(78+;#:]\3EV%V[7
M/3)<3# \&./MXS=@2^B.;UWG,%*W$ J !C/=GV/,-D]N8@4@=.(O N]P;7NC
M*[&O%]4V1DZJDYPOE*/Z&CN<@#EQCQ%+>R#X^1*4.^$:IYX8L81ENT-):9*!
M14*+Q2GY 7M @LPE=WMP*G7CLTW8ARMFZ$*QBF?H@$(W/*(F6+#Q7#RAIJG:
MK ,*-I@^ -,G3@HFZX#BK<R 3"(4>QK5MKK5XIV;?A&[51;2&6^R>(1M#$B'
MCUZF)D%^*F.W>]N2"M;2!1&NM&[5N_?!Z9;;MZN=6R).ISJ4#H$'U,NB>5[M
M7.V?O -Q2@74%'9?<HN"J62,#\_>90>]DZ!*_3SKG=NMP;W]X[>.3MX>4-O?
M9[/U\]_^[2^]#&-?WVWOL]_YFKAJUS> 78I[)-+5L>TR ]^'P Z@INLA7[X/
M@5T\7I"Q;Q?L>)+!+J51;BVO]DS1]ZNSJ+[$1KJS7>.I1JG_)N"O ]+W(M@1
M BIUKK5H8 V$Y04^<D7CVC+J\,8]I\F@;3:>/PBK!YSYO<15$R<5Y.-(T9S%
M<':G(#?362]&17QX4[%$ F!'W85B//[(VT>9'6X?+V/C:9ED+($=.\WNF%TL
MI6?RCN&T^+ "8 >JZP+LTGGJJ U<"VHS<3+SXCW +E,*#8^2[SAWNHR%P0<[
MU^G6>JM-C:!V1[IY@*#>+&%I:1T,O[H.ZP=<-S843LC<Z6+7SVRT('<3K'E*
MO"#AC_6_P-RE?FE<]Y8ONOW1*;=VIA;4E%9*#6B@84G&!C4HV5=8X>[,XT1.
M&3=;V"\W3Z;KIUQF< !DD4G*-;-%"M@![$I:5-2@W\LB9B<$+-,ZZC&FV3W5
MP7RH%J%A:78EZ! L(64*87=\H0(-W;Y.?::'&GN=6^&";#F<^73Y!'BW4Z]"
MQMJ$01S 76[/WA3V)Y1M$ZY-(/YN^@T@->:;!ZI%^RYWL!W^_ZR]^:\KV7H=
MQKGFD446JUBL*A;GF3SS/-]S[MS=MX?7T^LGO<&R9,..##D(D$% ?D@<*P(2
MQ18")'"LR @"1T ,Q IB1'9BV0X06T&"!(HA0$,<6\%[_T6^]6V><\\]?;M?
M:RALL-D\O#R'N_9>>WW3^H3#!#)</@0'Z]'&8'8I<GIXP$0E'N?2AS0WESLO
M:6+Q(H.=\!BP&-S.:'YIN$-AQMX]THE%Y[J,^E9@',-<0$B7*X=!:P,E8N7Z
M&NF(RA5J0;0H22&+])A"<595;2&4NS9CP>;NKCQAGX-4N[O%B0FLUV/.$,"R
M!//04JLZMVNK_NS&CW<XA+7%ZE@TMKQPH4(;+?5J[3M(Q<;/VX8]V#GX& U&
MNJ=NL"*62BNY*#46FX]M.A6:N]G@>CA#1"+N7D79Q63CG6JX2W8KL;EZ=!"F
MYTGO46?\N#][.EV]W#_^%-88G4!@V6+V-@CLXLYEG%VFW4>= ?39A[,7X]FS
M#S_ZV?F*F-V[O_R?_E<__.&/'L+8-[MR?^Y?__;M]Q%7 6Y.Q&OD0D%MM7H<
M7N3<NEN\(U"KU]/"NIOB?;"#<I:JUFEU<AL:E(NMV8WLMP=D5\ZX&\,:K5C%
M<$P81TM\.#L3&">8"^(2MU464;(1-)>ZV1&J 2Y+^'K<<[K>7!V??RK4RFZC
M%KM!:[>!T-(*0NV]@[(:T9_!2@]%6@.R0KP5_@X.P^-Z\^N_<=%/WY0I7E]O
M!3LZ;QGL)&C#L*PV5'HP XYJA7:U?0_L8-J7Y*"L >_"=(GHLP&AE'5PA@>#
M'?J]BUJ1VRCV:["+VEMK>Y]>)#O768.=AGC?XR#91?O*-241&@&OP8XPHA9N
M50D'PWFUN8$DQ-I,4H,2"SH0N1N,#L)H2=,(/3@NF.?L8C2$#[FI&$I$8UBR
M3 \%TJW3+TX??2=D'6,"RK7/3FTJ1B@"%)J;:"S13LR.8$Z8L=R/8EQMC*%=
M7&LK6HU]3-B_M) :S44CV2#V:M;![!HQ"A[80M\D_MYJH^$+G7,>T8<[L*-'
MM.5=ANG>R=7GHFK58_D30BNA=2KT[@?3BS"A8QB:S\3IJA#:0LLZ$><)T]W.
MZ!1*7&CO*WJ9SW%.L%M@L?V,II?>B9QDR!/ 0TI@1[/1&Y\*L+L;PGE'=XUN
M(FB=!EI'2)>OT&,4I5LT2V4Y8 \=6B/F"EXKW20;ECMV0E0]EY=EQ;P%.Y'=
M^<8Z)+#3-9N7-^9.F)_P\>61 YLO.J#8:)-(,[#1ZAV%[1UN6[SAAWMAM.\W
M%KJ=(?@K>XX3\F_)\8<HQ4I ,WQP^NUVGVC=GN/#Z526FV2>;^Z]0T@7=\X&
MTV?]\?,XNZJ%A]5PGZS=P?R9%^XVXI-6Y[H]>-H=/^LC9/&(N.&C)S_PH!\U
M][@3"VY-L'U^_8/A_)W>Z$4/RNSO#:?O8$R>'!U]>GS^!4'D__0/_^E##/O&
M5^[?_0_^K?N3)<!.^.!DU37I@*4# =4A"A*F<3ZHA:)1JR5LMZ*- ]?? 0II
MDS<:6;GBP-2'4KF%?KW0*Z^6Y7IGN*.:B<%I92YWWED?H77(<,]6CW14C_71
M^KK*.G<N].SH_4EWI]:8&7;/<HCH#;B'W@05H#X96704?.+6%^C'WMP@*B>B
M%F3:T*'=&QW7PQG4.A%+ L 5"GFI @-6,'YN#_00LQY<WYS9E<NRH5?7JA)"
M/+9HYXH./=K5U+3(0H%.O4@C8%V6!M!-B\)D(>E116L2_V6A%)BWDDX\+N'L
M/(*Y1-9C28\5<XUWBM4FBZ\63NEU$<_!C^#4ZW$NWG!S_P4:F-4A;LJ59% J
M%M%)LES@F898"!T_2S>8N\U--X#X.+)AB)@79+J)M?HP[>[3;8+*;FLS;-/)
M?,S:=L=DI0[G3V@T4YBQ'*#81IX*HK=PE>X<?43,CL".K&.[/J,_">E'1B#K
M#<D(R(S5[)@L6=/MN)Q]PJG%:$:!;GLUNO4Q=ROFZ&%>)@CNC8^MVLB\U3IU
MT;AC;9+3OF7=D2.WSMUX16X=$ UO(.-H]^BC $)UHGR5^"R]9X$\) =2S[/-
M)V9U3&<#5/]@\Z[A#(@6+,DLC;)]&NY:9%!T!>$^(0TZ:[?F&T]=](68$; Z
M]+%<&6;5%H3[G>'A;1(X(G**V:5!%GW2W45=(YUV6E12ULRN*$=AO%$HU4L2
M1UW1&M'/%VM)AN0UYF4* C5EI8PL OCFH K^)MCE(31;4E5AN BD*].>=:L)
M-_Q$0Q@D9F/[X$\EDMOJ'(L#(XAV&L&&Y62ELDN_JU(Q%.3]<-D9;?FRI]G=
M9G*X?_)MXO6$Z1PK0ZJ@X8R>O_<S[?Y%ETS.\9.T>U%K[A/ V4CCW]W8^[@]
MN"&8&\S>[4U>9L.;M'_)2GF[-\]^X-;F3I408(9L4,C!GNVC!O9[@^E+$<RE
MT1V_&$Z?]0:/+J^_]\[[/_.'?_C_/<2P;WSE_OHO/PA0"&9'.U8RK"::%7%^
M+,X6+GVE1TFI65:3:R>$O,RZ[0[AG>>GR,<IZ'E47V#D\T81M:)NTIZ7I1IK
MU?9<L+DISDD?V:%)>V^ZN+;=D5,=.!X]CBRDSJ)VBKA>-CCDPJDA;V/$-V@#
M<\' C)842$I]46_,&\$B8')71Y'C1+=[\]6YH@9Y^F/05:2$?5.12X7[X/5
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MHA0+53S*LE+UFJ"*!1I%?A$"'U)%<ZHNEQ[+^6+U[.KC&LK=H--7;V[X:&^
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M6L"L.[ C?C=?GJIZ4S"[.[ C:"/#=K$Z*T,<A4 0_X1]263 -G4K6VT_MFN
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M@]"0)2<TM]>;GM::<X%H[$Z!%T6 '8UF"K5A484BP$[\+SW2$H78NI%6S)3
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M+;+!!8KR3'3I9M4:2)NP'X2@1R>[B?@I>X*QMAY^T6\,=OFO"%!\#=B1*2W
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MH]/+[Z?=BS#>=D!T6K+1</W,#X<RN@LDS=9JMKSQR89-#F*R6SMG!';73W]
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MHF*E$;8&G//%]" OUX)N6:FI9D(?@O9:D6@JMD=80_MAZP"E%'?,#@&*8)/
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MBYQ/?,_E[*E C33L;'9&)^"5L++CF1[>4\".S$XU%NZ.8>G<!GVCQ+!X]UA
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F\/SH[LO1K<M__//?-V?J^O5_$>^XZC?S9^,     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_6.jpg
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M?R&!9[F_\'1@9"(@,4V^;0]3;L>WL6=9V;(L[>">)K &6P3>A\83H^)+26R
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MO87]IWS,F:*_4[DD/K@G:Z;,BBFW84#4DE@Q)98,L8S$%5HP.&2>$'A$XTJ
M&F36[P6<@H*D!@'0@LZV +ZPD,.B<-$(.MP0F3QX3F(+*3P)9$,Z6TRF<[>
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MP\7%P6;W3N?]^UQ=79VL;602L=!2+K.UM=QJI["UE@/,[&QM+&52D4C Y?(
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MF@KCM$6QG>7)G>4I^HI40WW68&/.6&/.1$/6A#ISO"YCLBYSMBE_JC%WMJD
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MN=M1^K"GXEX7@M3#SO)['<4+/>4 J8=Z(%<IH.IW6K45 *?^()2IKC?G JJ
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M1N#QR+.'0LX>.W5PAX#'-T='UY#0%J $J@6)@:>R$:'8QED_!L\XY8?V"X0
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MG<L3'<N3[2]'FP%P*V--IA$K(!1< 57&F<$:P!:D/\A]UQHRK]2F7-5D3M=
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ME1VC*5:VF3A5G=)7E]9;FSI8#QX*. 60RIS2Y "GQAM1W+O<G#O7DH<.X$/
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M.K0X&5#55?&HL_Q^>]'=UORK#9F7ZU/G:E,0JB &:C*O@O6K39F'^X8,,%G
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M2=VJI/[JE-'&;.#4N"9SJBE[MC5OMC5WKB7_>D?9'7W5@[[:AX:Z)[UJJ&?
M)N-&"%#@H99'$9O@WI3R7@QH7PPTOT3TT9DXM3*N6YWL7I_N>P-.:K+7B*T^
M=)TQK(YW02T-MJT,M2_WMRP/M:R,MB]!?C0A#VU3U?)BJ.GY0..=MO);+<4+
MW94/NLINM>9?:\H&3LW5I<[6IT&!G_JC@%GPZE5--EBJ\8H$,%-]^6$]!6$
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MQL.>R;@_&_>-!%R#'#4>989#S@'6/L+A_4ZDA]#U.]2]5FFO5=!K$_1AG6G
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M58;2+?BP.:]IP6=9"MH6_-BB'YOQFL8!MGS8A \;99 AEW& -@P[X6'2,$Q
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MJ"2!*T(F,25O<JG: [ XK!.D].(ALWK8HNZWR$8(]0BNG'2H9IVF:3<^QV"
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MV^@)%+L]<PPZX=".8HHQFSICUT[@^EFG==F#%_S43M*_&?9L^L@-'YEW65;
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M<>B:S[S,0'FO(>?5YUETV6/*N9!Y0C=G5\_:Y%F *JQ4&:MXPBK.6J7#1N&
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ME6X2MBVXL26.6 N[5B/NDH?J"?X;5> Q.+D&O$S8N1X@BP%;(6#.L::L0S6
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M+6QD5.MI-79>K5M8;F*'[()R"Z_"PBTW<\I,G"J'L-8C#3F$I19>CG;&3\D
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M5P S4$\)X(=X\(-LV#XN_*"2D*BDI<AQQ]#']^55A"Z-WJWIN1ZZ<+7RXC7
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M/LM:%]!W9MJ >^H.FL[F6+NS3:>SK6?S7<WIII:@L2EH:,NT=N2Y.W(<[9G
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MDU7T%#4+I>?BC$*244RVB"E@0\?# 6"!O&:24(PBD@[J9Y'U8K)!0C&((QL
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M0>L(]]ZH[^BV^'..HRG;OSFT^H,OEFWYZ+VU6_^X>&U+UYF7+J:.SNZ@W\W
MH)"G3G[SQ6<K5ZWY=M=V*?*($7KN-U%/3=)3D@"M'&QH\4PG#^$6HKPBM%>
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M[\ATW^1]?TEX[M)UBV.WO;=JP[O+UP/N1#@5:4A%HM^LA_IMJN?RV$B7"FR
M_2/UWNJ-[\ZTU<'[;RU<-7-#,';!ZDWOK8#:[7]>NG;=QU]\>PJ6&PKW#=Z<
M^.?XJVB^_#]6E%/_V9KZ1^]I;&+B1O]@:6,+WV@]B:$LW_;Q@@T[ 9Y6;?]T
MU;9/EF[>LWCC[D6Q.]]?LWW%ECT#MX=G?\E')J;Z1Z$KZ=SER[EY>0(&C4W
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MIQ?,6;%Q<>S6!6LV Y1$S-2LGXK8J-GFU"RM9CDU2RLH]\V8*5#@4(!3X%M
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M0+5^Q^*8;8O7;5NP;@<@U+LK-X,Q0J79>I%3B\#.L3L6;_S@O=BMG6?/1RX
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MF!1F]<<V'CJN+QVI-E;HBFI5!97*?/B%85L!.PI3A2RW),=8#L=!O\CSX-D
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M4S& 5&=K*-D2P!H);'69L!7+X_FQHHO;?]#JJKWR1H6Q7%>(D%*;JPE))*:
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MW;Y#SL"U=SVLS*\RE(S0%PU#UX]Y?*2G*)H..RQ$)61XRM"-$@;XZ)>D7W@
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M*71#<[3IFMQT;1Z:!K>9 J=06"D-E@Q#R:J-F_[DU/^QE]OC?>B9%Q7,LQO
M*04KY")R"EM=:Q;6:Z#^1)UI *=XIZ>W?(?WU &]GX[3%^D@]5KZ5A\*C>6:
MPAI3Y06FJ@M-M:/?^VK#9[L.;#O>NN5(RXZC5I8S%6L+Q.R!..<4FS&#Y?'
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M<BVR7(O:7/SQ9U]ZSIQ*+V<5I\#I.];<<M%UMP %"#K0)[+UA3(#SL/$M"F
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MW.?(=)EB%01.)=Y\U+Y\GU^*>@ZU+SP:10 )!SFA^"-0*4F=HPY&9\H+2F5
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M3F4IM8J"BET'C@R\A7['K[.'4_7-UK_=^*_<LN'*PJH<?,KA Q,Z(CXM6:1
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M"B6*CI.&(DBIF$O8CU],5>G0[QNF+JH&330H2PN@41=7R<UE"G.9JK <9\S
M7V&< IE& \<T5T;&<M )3^3? 8S0R].;>785MPP=YG^F8X4\0[H*5_'#19*5
MN/",A%;J3)5>9RJ;\?J\UM]W3/W,YI33Y9ZW9)D<G/D"'**6BU'2+%9HF&H/
M2;LF&0%((9G*1SV8HT>JH0A E(-.QSG:^'7H+])7"%M*>E!;<.(Q.GT5YZN*
M:B:^-/?_8^\]P"0KR[3_W>^_ 9B9CI5S[EB=NV=Z>F9 0!%%,2V"$1%=%5D7
MU$5$%Q5%"2(H010!D9R3Q)$\9&9@9IC<,YUS[IX,[/?<SWW.VZ>K9T#=C]#7
M]:_KO>HZ=>I4=775>W[G?I[W"6=<=,7O[WIXU;9N=MGKGMS18T/JK^'4QIY!
M<(K=:(8GMPXA:H%C*S@U.KSC->'4Y*Y</+T9IY1'0SM9OR6WZCF3C6=QBHM]
MX%3;P-CF7O25V3HP>=<C3\6SZ'!%,,E]NG9IJF:)<5'1OL.P.65<Z8909H-(
M8H<^<LJIME1AS2BQPJL%OG8E%*]8PBGS+']E&G<&0[31B!4S:+[Q@(!M&X94
M:O$^4HX\& TK;PA5VME\]GU8DY"))[Z5?!Y 4+D6KUX4JUXDJ@HN5$_,G:P(
M:5.L8#G2_>"<PJ2:UE->K>M"-@E]*)U(+I<62C<'D&(\3$>F.((.R:XPNB);
M/4=M3EG]LOSA0D^X,%9VR_)'>]_#27]SFU.=W=W?/_="(92_A 8:KBIDC4!*
M)@>GIIEMA(A'%X^<DYOSVW#*YPCUI%N*&'+"RW"*!_ I3F+^Q2#*.38E:Y>*
MF(I4+FPX]"/?^]7E9UQ\]1TK5JWO&=J&1#P14SL,I,BIKM'QCI$)-A!EKV-4
MR.L9Y&*? *MU<*QC=+MPJGUX8NL0^F598V"T<V1R= ^4U.1^[#Z#)S,42>#1
MB,8K6)Q21]6@'=4)3EG=KJ9CIGJLA+ZQK?UC&[N'Q>CKGMAYTND_$HT3JVPF
MFT1)I>N6T>@S7BI*JG Y.LU$M(H+=CK\Z#GJB9**>QCYB8%%0!1+X76"/Z+7
M=CA2W<A]?B@M8HH_!_E%C>.\:%'[D$0<%J>@?2QYA;>%0\I>$"S1*#Q]"#95
M-2%WS_9,D4W6HIXC3"%,8Y!^*RV9,-\;S??'?9ELL+S&#S$E;UZ#MY+/HXW\
MS$J?U\[IXS#;M/AXC&4&*JKT7LS#3'$L[1%)%8T7H^6,""L$4CFMO_Q N" 8
MF>^)'OS)SZW;W/J>M?SF-J?:.CJ/_M*_^[7VA2]M3'1(GE3M8DXRPPY#);_#
MC3J;4YSQ?)/9&WP3'F9.#_-"GB<\,4*XJC=GZ@].-QT2JEKXZ:]_^[N_O/R<
MZV]_<D/KML%)S9*9,!:?@U-C[;,XM:%[0" E]YO[1A \)9S2/C1M;-HNBF9P
M;,O <-_$U*1P:C^0VC^G,. ^UYBID>THVT(EQ6'6^*8Y-3;9.2H?DF[^T77M
M?1M[AE=OZZE8>)B((QIZ,C*URT1.HAA>]6*Q?V-VN@P%5!!M9L0PK\?#F4HJ
MHM@2*AECT$@J6O?Z]4ZSAM^Y3[4501/4XE,LUVE^>AX<4KJ1(,[C.>C2LHZL
MJ.?4PK##@VW2J?*RK4ORBX#CO3$AB2<24. E;(TQ=293/:_(7QQ)!<NJ I4U
MX4H]K*PVHJHJ5"Y$1D2"@9%/\_NX03"12L8M9>/)JD>L)?32A9%D42Q1$(WE
M1Q!@5:3 *G2HJ@*15/+0%_F'@UQ7WW[W>]9%]0]#]BWWF;EP6[=I<\O1QP0A
MPNOI9:3HE4F<K&GFU#'SV%Q7.9SPXBPWQ#%4HH;B4SY'U!4?<H-ODH,J_NED
M;4NZ?EFLMB71L.R4LWYYRCF_^>/#3Z[IZ&D?V2'G>8]F\.:(J<Z1T?;A<<.I
MUOY1$SEE<6H0SSIZ((\AP&I@=,O0R/#.W5CIF\6I'-^Y&8A(V&XE&Y-3(ZR(
MH!U#32 ".35CF0_IAQ-MP_#Q;^E'B>&VH:G?WW37@D":OB<HJ=JER9H6NN=8
MMS.6M0*F9(B "E4T!DHAH")"(M%-BB1A$SU6QO1SRBMLVV!RHH=[>&_B+8NB
M8B)9"W\A=2V9ZX?SUS>3A$\9N 1$-%4@.!-1!0(U>_(09"&[>I1A4\2.2,C9
M-N_)XPW(W+&R XM\OD2IOR0;*$<7&?T3,/1,I03:=)S5?FWB0$YY4%D!1W+;
ML,S,?U&1A9$T.!5%,4]7 KDU!=&$*Y8LCB2T_(N%JD)_M,@?*P[&#BSP+?G8
ML1NWMN6>8^^-V]SFU#,OK2I=<EBP4N9TG<]1YU",OFBEY1K(X11GFYG6!EN<
MT\2-29%AN04#)K]#?.5L..'ET^SY6+8Q5;<D5;\L4M7<>,3'OW?N):?_^O?+
M7]FPN6>D8VQ[UY@5,^5THCLY1?^4DU-B_0F2R"FL!EH@&]O</R*<:A^?G'CM
M]3?GU(159RJ74XQ%L#BU<[>14;,Y97U:S3K>-C2&Q,.^H?6=@YO[QHXYX:3B
M:#D#T &IZB58W1,95;TX40U@);3N, ,49 3+&[7#*+155%"EG!(D44PY.<6A
MM )!PMJEBM^\UVY];G@D]X(JV2^<,C_]+ 99/L303#N=- FK&@J(.BM'8444
MK2Y#3U >8 PZ*B;]H;&B1SSQXQD!19!-H\H1:5402L_S!'W)<G]I5ANR8XV/
M1AS+>/*>@QK*.1C_.=M]SI4^U5.E1=&,<*HXGBR*)PMC*/7IBJ6+(JFB(#A5
M%(2[JL@?+?;'"OT1=S"1'TS=<->][TU%-;<Y=?-]#WHJZR-539K6!Q-=Y*Y8
MYF+TF6N:F:QF<)9SVG&.$BX!VY5./%%5>1PYQN;<,.K)L(F8XPG@M=IP-:74
M.17*-GWRQ/\XZ0=G7WS;O2]M[=K6-]XUL;W;-&CYZSG5.]0ZH)P2HT\YI7IJ
M%'JJ;Z1GQZ[)UU&Z\^_FU(@&? XII_HT9FHVI^1S=HV-PXDV/+YU<'13S]"&
MKG[YG \_NRI=UR+6$ ,1:/HIIV#W)518):KAGQ(PT<4>J&B,9A>&RU0Z"8EF
M=NXS(VQ%J*/@%&HDZ._%[Y\;3LJ003*0VJG+?.:I@(I<RAG"(J">+,X'YSM8
MTT;>I[R.J7FR'2FU7D4 .3G%F68VS$/GLWQS_KF(O+:\X2!/=)XOXDN+,JH*
ME62AH31=QJ>EINA$-Y"2B4UR$5*R30%%)66,/EZD54^QEY_H*8%4HC 6+X0-
M*)!*N^4$T4I5MC<]5AB,YP7#(JD6N,-'?O:$S6WO14DUMSEUP>57>C.U$2V'
MX)??+('@$?E=14]Q1AHV$3%FFTSA'#7/<A@8$5(&27R5DU,\P.-(4<8<@H>U
M/EK1)&=L2</!PJE83<N)I_WHI!^=<\N3S[^J55RZQ[>;.N@D%+/DT&%T9)S^
M*09/*:?@GY*QJ6\$Q5N0QP>[3^BP112-.K"V#8Z,[GUM8N_K&#,AY>14C@$X
M-+53.(58!(:DVP$*2.6;&8#N^*BHQ=XY,MDV.+H%@?+#PJGVT1WG7/H'3ZHR
MCKXR+9FZ@Q.VAJ+=%\TND@W<:Z@4'.=HUSX#3'1+T>ACV(%M]%F6.[S7#OO.
M^6L2/10O<E\<DU.TE#\9CS><<H)&]L@\X20Q6#$#J-)WXYN'9BHRS"ZM<<Z$
M&"[G8;^-).M5T[32]<%*;3DC1E^R_%^*@_/]"2%.I+PV"@\Z;#V"2;?E_Y(+
MI#"K2F/0T7*&>**V,C**G"*A""R:?JJG2H1-[F1ID=;20YZ-($SV1Z:MO^(0
MW%7YB%>(Y'G#^9&2^QYY\CT8\#F'.27?YO=_>IXO6247/;\6G/*JVH]J5CKF
MF6WEF9G-AYR[W$_Z.#G%]W$N\!E..8_Q.=8$[?4^95FZ)J2E*5,U2\H:WQ>K
M65Q[Z%$"J;-^?\V*#5O1J,IJ8KP_3@%2,SDULJ%[4,:F_K%MFFR,IQ@".@0/
M^L:>X=Z)R2F[;N??PJE=\)W;2LIP*L?NF[G,-]6-?)W)K0,CFT5,R0=#->3A
MCW[V1%<B&ZM:G*A9(F""N5?5C(XR]*!K7RPVE6$4E7Q%\<KF4(D:=YHWPYVT
M]8SO/%S:J-S7BTUIC1_G\'34K@&07]U&)(4<D!]*F\.<G#)6& D2MC-FC#XR
M]AHQA)U<#<P@68<JR3K8/*ML8JF66-7"J/:(Y&JC12Z$JB,,"B6&Y?TKL8PH
MNN9?74%WHE(T5 1><W J6%:K=A^TE>!).54I)J'LT:D%$X^VGO%,>31:G58>
M991S0R456OLIL\3NTP+J2+5)%@JJHNR0'"^RXQ6*0M$#BX)'??8;[\&JQ'.8
M4UW=W2=\Z[_\F9IX]2+YC7VI*F\2G&+LKY-3YL++X>04^44&&:%$K<3]?(HO
M)[ X^) LXXS4_1:G1#*4U"TK;3@D6-EXQ'$G_,=9Y__IH2=6=_1O'1JSVAW/
MXI00BISJL(V^K0-P &UT<&JK51?!BO!$R9<!,;Z&AW?LGK*5U&PD.=DTIGG(
M<L]6QF-:4QAU$9QZ:J;%E\.IKM'M[<.3K0,CFWH&UW7V;>P>_,OS+\=1\7FA
MJJ>E%%#TG1LE13]Z5)MB43J%%$\Q55@45AQ45016$#6G+,=0T,Z+<@YSI2$7
M9#"(A,>'9E:\"ZO#B%88B4.<$5(&8>9X&S2*+8?-:#%(<_=,P183PVF(R0T*
M)=(J7$$5UBBFUH'N(!+F[3I3/$#-.B%:C7JL9*?\@R*IZ)\"H8RO*J#.+)I[
M3D*98/1BNSVR#-DHCJ& NI45F"@1,[ XFG+I*-) J@(_.KR+I)*?[__GU/_+
M6VM[QU&?_7*@I"Z.RBT6IX0:PBDCUW.&@53 SN_C-N>ZL>/((VX;5/&>PPDL
M0S%N4 XDJY>4U!\L/WFR?LEQ)WWW] LN>^B5C1M[AMJQS#?1-3'1Y> 44:6<
MXH#[B6)*V[4/DU.;;4Y1;8%3 V.;^T;;AB8G=KTV]:;J*8=3]$R!4ZS?LAU]
M9?;'J9F+DH@O[1@>A]'7,[BAL[]C<L\/S[_8%:\0&"5J6E)UR\3TDVT2BI!B
M_ZM8U2*BRLDC0RL&2?$I1B' 'BP1DQ"9;H1(2$,*O+9/RF=+JJ@=!2[;A9$2
M\YL&;?LKX+#LB)N0PW-D]A!)/-B AF_"]^%#0BJL<9M!Q#JA^#TYA6'[JJ*5
M#8@"52..5:5$244K&J-E=7G^Z )OQ%^"93YC\87LKJ**+7E)G8HIU*4BGLP]
MAY-31E()DFQ46=A23@%2;$N#^I\R$J7%HK8B&0_<58@%+?1'A%/ND  T=OV?
M'\P]V=[MVQSFU/.KUU0?\B&1Q CG%;M/.2774LAO.WC/4,FY8;8YRZF,#'IR
MS#T2RAQ#TLWF%$\,9,:6R$5[8;IV:5K,G^RBAL,^>N)WS[SH^MM>:>_>.C#>
M!4Z-*Z?8S=@:7<JI#AWDU%:TPP*G4"S!XM2HS2ED*5N<ZAWNG]R-.NB..L+[
M&[,YA34^Y=307\4I] KL&-8H^3[Y5&A^LVUXXGT?^[0GF064H:3$]&NQ'.>Z
M(4I*((7N,C:G2"@S&*Q@V,00!(ZP1BKHF6Q[J?3W(D?,3TF!DZA>9%KRF0.,
M5C)&'Q]RP\@E Z.HNKKYY\RKR#*CDN"-4@&%/Z&'Q=3/A2AS>^*9/Z0V&J90
MI ***5K>$"FM6> )NR)I9O,93M$\I.E',16 ?[U:?5404,[U/GK0Z8H2&-'$
MXSW=50HLM*)12*E_BAVTY#Y15IPL=\F(EKFBPJF4*YQPP;F>\ 2BQ>',L5_^
MVGO-1357.27?XH.//YE9N R=)C7CUY?,HO1UICI1UX(Y9UL$ADW<UJDS(^2/
MT\@8<;QB,U'&B2=N<-L)*8,JEN(+EHN^6Y2N7U+2M"Q6V7CDL2=\\X>_N.71
M%>N[^SJ&1QG;Z50H*E(F.\;&.\8FVC5X$G8?*D^)33>RJ0\9,SJ$4R/@%/*3
M)[8A$ATI-5L'AL:T^=4X*@CG@FF?PXI"T,$%/D!J/YXIQW*D5;6]?7!B:_^$
MJ+SUW8-R?\=?GD)@E"[J,53*N,]E3,>@VWVQ^-!(*F/N60XI6V?QJ4AY(^H+
M.]R(0;LGD*$)\2&6ONR7"6!^4W*'##+DXGW8-@"-0\H()0,OOIRXX4.^"5]E
MC@S8I?(HZ-!:1O\<7T*,ZI2CH*N-5];[DYEY[E"Q1OE!9%7 AT54!729CR^A
M,1C4#C3465ZM^4E"<8^\B<@E$BH_E'*8?J7%HI7B)85HB9PJ"B?=L;0;:30I
MN7<G2CF\R5(/*JR+(BLK"&<*(B7%8=1[$6VU>OU[JS#Q-*=0V\$QWLLW?L*;
M[KTO7K,(A*(PMCF5%$[I\HJYWG+"F8>\Y]@GIYSTR6'36W J4QW--B5JFE-U
M+26-R^)53<=^[90S+[KBV8W;-@V,=(Z,]:B,^E]S"OXIK/3A/<?A.W^;.:5N
M?LLL;1L8;^T;%QMV?=? EOZQ$[]]NBN>3=<O,_YRCE3=4FQDF]E>-*$9?Q&[
MG(M150987'PPIA^?4I%E*2GS\YEK#[>CFB4C8HJ5\(@S/DL $2Z&."0(0L-M
M@Y'8(J<8'N4\V( L8!=%X#WW!QPYS-QI/F%(Y9C?7H[4P^JC935%H=@\3\23
MJ&!S=G**VXQ]]Z,6%3J,$EOT6QE.44:15C3ZZ(T28%%>R8;<(_X@EA%"R2B&
M8DH51]*R(3L]-J=8%Q3ODZB ,TMXAWQ ]':__#U60L_!J:%!YW@OWP12_0,#
MEUQSG3M5&2JM<\OE)5D9$)--IFFZ*EK5))PR,77DD;FXF<$]!CU&+GD=40CF
M ".O2"4>SX?F2+]>[45,":>2M8M3]4MJEGW@^%.^__O;[G^U:T#L(^,[?TM.
MP3DU@ #.C7UB\?5OZ![8V#NT90!VG\FGV8)(])'A':]-[GEC$I R;43?;#!L
MR@J8VKY[<#OP-)M0^^,4"K'#NS^ZH4< .O3"IO;R18>$RQM3M4MIY7%$LXOH
M31=S#V+*[M7.13WN(:<(+"*)/G6CK8(LY%):'T3<T+28,F>^G,S)FF;"Q8V0
M%,0BY/SHA [W&+Z030&50MS)8T*:!$/B,!N&A_&M^";<,%3B7R<K#;QXW>)G
MX$:T$F\8%?J49 O\X?Q 7&:L<4O%4.E%/E4#RTX9-JDQ:#FMR"F#*D9(<5!/
MF1 J8JL8GO(TQ511,%D4$+,N*;3R1#(NM0%I"7J2Z)MK7%VN>(D[@NBJ^D,.
M[^SIS3WQWKW;N\"I_R=ZK:>O[]0?_]R7J@IGL)KKC96[M2B/F(&QFD5AS2 U
M5SSGC.$\8V-D0QD9)I=XMBO=;'"GX9114H140*_M<F%/U;=D&D1-+#KXZ&-.
M_M$O[GOZY<U](^W#X!$A]7=P:E/?L.&454>A=Z1]9/O$GC>F4,CE]8FWF5/T
M]".CL'=D<\_H^JY^P>4U=ST0JJ@S&HH1"?1,P2>5782(*MO<<W**>*+"@K_<
MD=9G>=#M]&/14Q0I*C<L![F!1;JN):HNH?Q0&J4^9]EN4=O?9/#$\'%BR\0]
M$55\%?^*B3(/VKK,##XDX+C!%_)A4/643KQ:K/]F\('Y;+BL/I3)+O $BH)Q
MN:"&N BH@V)*#3WYM%@?I$.*MF%0FXP:8#GCI!PN<VNQC]8?_%"(DTH!54*H
M8,HM@BN4\J)9'*J V@W?K>IZ\I[>9$6Q8"N>$",Q5-FP>5M[[EGW[MWF*J>Z
M>WN_])^G!<3L+ZT3">V.B@ N+T3GZ[JX7&-53''.&4(1*.CI(-?GLEIOILJK
M89F$#C%D:&4&11.I9.Z=&ZS8#4Z5(N(T4=V<JEV2;EB6K&[YV(DG__3R/ZYL
M[1*^=(WLFU.0*F,3-J>T"?N0+O8-C*)20B\J)6SL&71R"GIJ<'Q3SW#_Q,XI
M6'RO3<SB40Z;IB&U8S?6^'9H&<_M6A1A/YR:&=X)/=6.4(EQ$5/RI]=U](GY
M^:5OG1:M; *;:JPX*0X3FB"<2F31FX]@$E0Q:(,:BJK*TE!R+YPJK?<[ZK=8
M=I\(JQ(Y;^4'18*4RI!IKY"P1JY/6)G5_81+K+()4%!.F2,)(PJ?',00:A@:
M.<6HJ)!2C_PR+S&0BMK%SOF&E%11-?1\ZAU3?Q/$$8<N]M7Y$F7S7 %1.KZ2
M2NRL@#%(&45@T=R3#<8?\)Z.<X9*,;93.27R1Y#$[NU8Z>.BGF"('G3$HZN&
M@MT72KBU%I4[(L!*>A"1 ,'EBI84BJI*57A$4LG;IBMA%<9*"^-E]SWY=.Y9
M]^[=W@5._2]O9%Q;9^<Q)YZD5QNQ^RI=L7*7S2FMESA]D>0\([ P'76-!MYW
MF4^.E3ZBRNFBXH0CQ0@L[N%.(ZE"6..S71*5#9F&@]/UR^2^JN6(+YQRQG4/
M/[&A=ZAM>*)G#&PBI&9Q:EPY-=DQNET3C&=QJG=(M-660<0E4$\)+[;VCXWL
MV#.Y]ZUE%#DUH4DSAE/P3&GEEK^*4UK%I0UY/&.B#3=T#VWI&WONU=;2QH.C
M%0A'$$C)O\P- HNA":9V L,[.2S/NMW(#Y*JO#%<@4HO?N%4:9V\9]0NG>Y+
MU;*8IT8P-%)5!;6X&)64?/,%X4Q$K"T$@M:$D)17@V6U"GG6TE"$%'U21)+0
MS20M<*H$6&1*0PVF0Z(<;.(@F,@IOI9O3F;I&]92!]&F(V6$/F+<Q:L:Q I;
MX(MX4N7^"@0E4#<9SQ0WR"EJ****1I\S^MQV494RU,"3+*,^0B0G1RQ3H,XI
M#>9,H 055O3BV$;\0<(;$TBEW&(S)BN*XJ7"*= J7>E.504U5?;9E:MR3KUW
M\>98[Q,V#<T-/[K<-K5N/>1CGT9V:%D=X)( JH1389E>:-BG,MN^3E))<3)9
MN-$(8^_,EJ)T0AG=9*AD]I@1L/U6<L\2M'A_F;O5"\L6'HIUKIJ6@S]R["D_
M^^63:S=O&1CK' 6/9HNI_7#*1'@.;>@=F,$I55*LH] !H^\M?.<,1#!Z"K8>
MLF1VCZ*KJ-6@83:A<B#5-8J$OLYA,?HF(*9Z(::ZQG=>>NTM\H7'*JV5OK@=
MSRD;-/IBU=!3AE.T^P@@FH'&W .MLHL$5:&RAE!%(WQ2ZE!G]T,>9MF#9;CD
MQ*U6",!-843.TDK9]HJAI+\"9%2Y%J6S+U$&-WA*R15TN*O,) '%- ;*"H:R
M7\)W(*V<]T155(U]^Z\T$C2TI&B[89$GG55G>:U *B\0\Z3+ A663<=A3#\G
MVH*:[N?5,'2"B<_2Z-.(5O4H):"GV!$+G1T0BZ!B*I)RB7K2N',7@(4X*:@J
MC9;RRI&A>%$(AT&(">Q2Y8(J;[HZD,F*C7+-S;=W];Y77%33G+)H-1=N P,#
M+ZQYM6S)87!,EM:"+_*;Q>%)C6:1N\#)9Z8@K\"@22G2W]EX%H*(G$)U/0M/
M1CWQ80ZPC,(R>_#F6OT6?K&JA;&:9A%3R9HE<O_Q+WS]_&MN7-/5WSF, @-B
MW!DQ17?/?CDU;'.J9W!#3_^&'CBGA%.M-J<$4C+ZIO:,OQ6G1K7ZG4F@ :0T
M]!S)QBA\CE2^?7+*"5/-.AYM'QK=*G^W;W1CS_"&KB$1=,=\^23Y?@0WY++Q
M3)%35JZ,W?S*R"CZGJ"G*A9%RM1%588R+^'*A:*J0A5-P3(U^K3O,265U1LY
MHSM5@!C;37['_% :-5@$-"B&J<U=RM$277[ND-*$!*$((E\BM@%(!63F"5/V
M(EK$CK0BB:B5^,*H;2T:845/EH$7E12'44.R$8;TR\[WA?,#43'Z0EGD#'*E
M3T9<FT&04TZZ$5BT^)SK?7I/2(FDRFA:#%Q.\M#RD<=+BD0QQ=*>:$:0)'@2
M6Z_ 'RD*1MT1S>S3WEFN2)INK*)(PI/(^)+E[J1\YDIWO.S]QQR_:=M[)2=Y
M3G*JK[__]N6/1NL7,Q%46.-6/[KA%).S.$@H7C Q%Y4L<&RA*J/E/O<YHL]S
M2.0$E@&9.4;>S2_;HJK*T$<D40M.Q:H7URP[\DO?.N.!YU9N&1CI&IKL&YOL
M=C2_V@^G)MI'I]":0<RK 41X;IC)*=%EJ"^L0U@V]*:!"$9#.8,_R2D&(EB<
MFHDG(Z8,3#5L:KQC:&R;?J1-/4/KNX>V#D[\Y?G5Y0L/B54VQ2N;A<N,Y^2]
M<5%AHV*ZYI213J*M@L*@<NLA_%-:XT5&".E^5LTI0HK;_DQM(*T5T\M$3$VO
MK.4%4_(+AF%\-02T# M_8CJG=+\5WLDI 7)I=LMT^EXY0E@X3T@?QII'M14H
M19EYRD*5[9,R>_AA#*2<>#)##A#K[$"77^C@RU0&*UDX 78BG5/DD4\CSKG3
M^2;D%&4:7>G>%(KAL3L6;3V&&EA[=+A$3$4T.@&%7*P:"4 5E!1"JQ"I$!7S
M,"[#'4]ZT;I&C,VL*UKRR<__>^Z)]^[=YB2G>OOZKKC^E@CBSE$I0<#AX7I?
MO"Q1TQRK1I%\Z'8=?D? E-)*E_E4"ODU5V:V;C)X<D**( LX&FI!E%F^4LQC
M$?^9!B@IL7<6?^33__6+7Z_:VBU,Z1C;WC.QO6]B1D>I?=E]NMXG8@JQ4>@Q
M SV%B 2!U)B,+0/C6Y![C*7 _LF=;V[T&9^4X=285N\<MCG%F*G9D**8<G)*
MJR- XB&)IV=@76=/Y\2NLR[ZG2]3D]!$F40-C#Y:?W1+456!7%KF18AC'%(4
M4[#IRAO"E7"<1\L;4=?%+I!@K#RVG FA<B:^7G/)D>\9L*AL=,7+F7)L>&0N
M1=Q))05Q)-#1#3K(D39,RTXYQ30](HG<(8-(-]DF_N3Z)^_#5U%&&<N1!^M#
MO EQ0WN-_F_(J]*:HG#F(%<((>.RLZQ:^6@M]AEA1<SYU<-E($5#D@\]FB+C
M51>2'3RE,5",*DB4:F/W<@JK B%1-)T?3N2'M"A"*%84BFF0%)IE%2N\W$(Q
M/E0WEB^>#J3+Y%6-AQZY9L.6W'/O7;K-24[U]/:>^<O?@%-:T64VIT*<3#H=
M,05U!OM9(,%./)[-*6Z8;<HK[N&1W$-"Y8Q0&3A5TK@4=E_=DJ./_\;EM_P9
MY:*&)FQ.S2B)^?=S:E"D#3SH$WO?(4YU#*,Y(#FU 96P>M?U#G_PF"]ZT]4Y
MG#)Z:MH,K$)9=*.;Z#77[:8@J($]L ?+FK#>YUCF0_7.,N3W0?GJ:@EUC=%'
M\D.HQ3<=<\ #^"P?4N. <3:DR"/B";+(;JJ./22:+8[P#GH,T<:7$U(T+9GN
M'K#+L?./AJTB?" +H4.X0"65UA0$4PN\,8&+)U7A0Z;Q-*%R%OOHG**'B\.(
M*7+*$3R%* 0?BMD*LU)"*'^F4K05/>OT4N6)DHK$"T)1U'()1%U*);9UT"X/
M\*_;VS%8B&HP)FL7/?ST\[GGWKMTFY.<ZNCL.OZ4TR+5T%-!-NR+5Y!3L9IF
M7/244"%"RA+DF,2D%<D":]&.0G#:=^01]QN%1=O0B"SN-^]&_T6ZKH5K7E5+
MC_C*]W[RR,KU@I6.T<FN">&4&'TSG.@V!:S1,3[>/HK1-FQ'3BFG$)'0.[*Y
M;U2&<*I5X]0[AR?'=[_QE@%3)!0KO5@>= >GN,:70RA61W! RN+4-OG3$%.#
MZSO[-O6/B#V;:5@JE$G5(;PSIG4[+0%EAWIR#R,/Z)FB^WS:2Z4+?)&*IE!)
M/4H/._HUV)%3J.V)@94[7&GD=TS5+HYJ+(+\(G**.CD5=O@BJ8E"JH\@E]0U
M:8ACL48'Q10O>#)A(C;R:-PASDZW^1)Y!Y'G4&3V>E]$(T+E2%[Y=&J!3>Y$
M.<44_=^TY@12\SU1Q"NE*X-HV0 /.B$5U!@%O\8?D%944MSF>Y)3O"]";2DT
M$V5\ICN!(9 2-HF>TN[MJ8)P,E^,.U%5H40AQ51 1K18J[@X\<3>,UJ+*HH#
MPHG"4,(=35]VS8VYY]Z[=)N3G%K^PLK*@S\8$=VDFMSFE%QGRA)H.M2,BNGE
M.@MM8X%76J**@_0Q FJVGB*/G <8;''#O'-45WS2FBL3JUK4]/Z/_?SR/ZWK
M&FX=FNA$=82IGLG)WLF_F5,;9G-J$,%3 ]OW3NS^GXF=HI@L)]3L8904 A?^
M%YSJ&F%3F5%PJGMP?5=?Y\2.,WYYH4OSO37^H)F<(IL8B4XG.LA5,5T0/:YU
MT^FH@I4G8BJ[*%PNVZ*DE%-:'B^$FE,:B !FU4-5E<%]$]#82V.1Y053 :T(
M#/HHJIR<(KS($8X9T08.K43T8/W7]F&Q>)G\IIA%CI<$]6"B+:3M&(QDP_OK
MU))9IVR"12873J. _!EP:IX[DN=/N+4X9["\-@(_&I8%&(Q.S!%5A)2Q^^BK
MXC(?33^**4**GG5UKLN>4M%3WE290 J<TGL4QA-S3^12(.:6H80BIT@H-)Y!
MJV1T],.>4"PO(.9AJN7P#^6>>^_2;4YRZH:''PE6-Z&<BR.OQ87,I@SB8NH6
M(V^&+6<59 23@93?=I.34TX!Q4$\$4E44CR>^_ERH\MT=M;+=5XX5=JP+%6[
MY,.?_^I-RY_<V#_6/KH=9[MMXO6BWL"T^]PYM 2"555JBU9KV8B*+D,RP"E$
M+9%38^V#8R#1+AG[A90,ULR#F-K]VLC./4Y;CV.VN4=".4F*V$[40=>/U#^Z
ML1L2;^OPY*$?/\Z3JC)LHKEG"KDXO>EQV5\)&+%_?4P[8H7P$)H7F(##&W5X
MT8J=E5A*ZT)8UZOWX[NUB!.VU]?X;8N2$@H0-Z22.<P8AL0'.2([&31'361V
M6A23>6)'@=*XXS%R'\\VF9AU<SS_$*Z(MA\]ED4X@CK"J[V)LL)PTA4KD0V/
MR!S(]C)?2JZC)0<4!U!*)5D1KJA#MS[U3ZE5*S-38"2C6@NYB%2W//%FD'<F
MA,IM]6L K0RGM'<#ZFYKV*<6&@XG11D5J&A2AY0.E5%BWPF;R"G9R/.&[(>B
MJN(%_JC<%X426[=MRSW]WHW;G.34'^[X<S#;D)C)J6(MM1/)UB?K%Z.T"[4Z
M+WJV=\/)*6/WL1HZ'^9(*E*,QYN=!G-D'_64<"K3L"13O[2T\9!_/_W'3V_<
MNGE@K!,QZ-/U6ZA3]L,IK3G%ZG?3G,(PG-H,NV^T>VP*V7R U-_ J<&_BU,=
M JEAP)$.LO5: ^O1E:\&R^7,G Y'<'(JH=YT[HE4PJ<>K4+]*5:AXJ)>H$RD
M;E.T9E%0$YBB@@ M#,#OTQ '1$"@-G6*Q07YJN4GR ^E_5K#,\3**@HUPB5L
M%Y"BQ@FQ;Y5MWUD.)OO]#8 ,@V#Z:4UT96A==&9  U](P]/RHUL^]49&-OED
MSHB8BB#:&P/%GDIE^-,5!8'(/Q?ZBN/P)46R#<%*RVL>P.J>?. J&8$2@91,
MLPI%%6P]4LGH,EJ1QE=%BY+"B@@S>3-RS0:G$-69H'%7;,5Y:K,9[3.J:W^P
M <FI/*_<BZ2*R2"MBH*)QJ6'YIY^[\9M3G+J@2=6R,\<U_8-) B<4\AO*I49
M$*MN0HM:V^5).6T(1;11*&FDG$AHA,SE2"JCH8QGBAO$EA-2\OYR"B5KFH53
MB>KFVO=]^*)K;U[?-[QU<+)K=!I,YN2?S:FNL8FV$0M2<%=KK>$9G%*[3SBU
M=5B,OMV3N]_XZSDUMG,/6ETY;+U]!DP9B\]\-NUX.BZ<VCJ )GTLD" ;WS_G
MPH)()FDG'EM^*-LY9<DH#:&RHCUU#Q\&E5 ,/6>Q<#"E%!V #0C,MVJ&7Q,G
M"8NH=@]%(J==;]-BBC/EP':E\P!, &592&T]T$J1I'R!1N, UQQZBB.B[B=^
M-AZ#G]NN/R62$!'%V+9<X#)S7!%DJXB*D2&JJBA>)FSRILKS?*%YNM@7**U&
M]^-*,5=K@W8U]%!9-:M-B9[2Y@Z6,YYX<@*+KBON\=H]EOP:_%FL=?)@<D);
M90HB8*4;#6:@GF0P.H%&'[>IIV0(IQ9X@BB1[A-L1850:/$0D&/BJ]>NS3T#
MW_';G.34HRN>B=4VQY!+5:,7%A#'%2LKC&; J=I%D2J(*6OZVM/=P(7<(:3,
M(*?X%%'EE%'<R7ONY%G!,TH@!>=4@YRZS>__]/%WKWBA=6B\?61'+^J@CSLY
MY016#J<8AFXX988%*;'[!B>VC4Z.T.+;/Z>,6\IP2MNROS6G9B[SV9P:0NNM
M3<B5&114K6KM6O;13_E*$)'@M/(B6G28JHK"B@**>W@O#X50W!;3+UAA_31^
M@13L.WR9E$+\8IUZAPT7Y*%\\_1,6=@24<,U$QM/E#P<1@%Q)I!6?-N8EH*A
M)N);R72*V-3CV_)9U#F0 ^SE/%1&Y]NRRK#"+ER.L"E*FZ)P2I1(?B"&X,EH
MNI#Y=[',@<6>_$#"DR@/R<%E:( <QG]4S]A.=)TI$[-7IFA6!]Q2]%493M&5
M3@UEL&4<5<Y%0+EL%XIY$=&J>+:&LI24^LM9&,^XTD5844_E^P$I&:*GU%T5
M+?3'_O >J/$R]SC5/S!P[_)'THU+Z:U0MR4TD0M=1DK$[$_5R?5<*ROJ9*)_
MRF\GV1,ZY)0Q_9QBBJ+)R2PGO+Q:H8UOR/>4/Y2$<TJ,/K%W%I]TYB]>VM:S
M97BR<W1G+W+Z_C9.B=&W:1^<&L88&.N:V#FVYW5!SUMS:H_5TV$4G)KA._]K
M.*557 2UXUL'$1FO/6^&1/'=^<@*7PDJ?"40D8 *4T8QL3 >MSF<J(*VJD)F
M3!2ML1!Z'BROL\RQ4DUSL8M8@%"V:09\P'Y'I8&HTF%!(.E&Y28[<]->MK.\
MX[K',&N:7'H (07T**$@E/1]"#):<'2W<\3484\9I?)<[AO$P"3"^-H($@EA
MOI$@A9$2B*E@O$",IG"R4(9P2JR_4.(@MT\XY=,$&AE^%"-&D"=\ZKC:H2!Z
MI*)6]=3TDA]]ZGQ(#GHTZ<]&&*LFT">%P@FT^U@XH2B*PG@%^#"6C#*<XJ"J
M,JA:X G0F\Y1X(O*6. )^>.E[WIYS[G'J=;VSN^?_<M4XY*07(M*:KTI= -U
MH:@+1*]<K-+UBQD*R-E,#46F4$Q9IN),3I%!Q!/91/O.P,O)*4+*CWH=F-9R
M?J;JELBI6+WLR(MON6=CS^C6H<F.T:E.<&J&W>?@U+@."PI:)@&E[]"7H1]X
M<AI]&_N&-_8-;AX<'MZQ:]R1M9>3OC>#4]K%;W3W7A0^MWU2^\23L?ATB*V*
MS],Q/('PSN&)+8-(/-[4.[2NHW_;X.3I9_\JD*E-5EN<2FBIJ9BCF"<3_8QH
MHH""XUP,/8V?TD29A1J/KGI',8&>5QD410B5(BX!XB6+RXQ/3N"LO(GE%?+$
M*_("J9 M;8R-%K9#-ZTU.X+&IA799)01S#UV^B"\U&]%%SO>S0$^&HEJ%2Z$
M=*IJ#%6J#,3_945"\+\P<0-B:A6(Q:2< J3":1?JI906>L('ND*%<9BK=+KI
M9P-]Z("G-UV7-2U;C[J)AIY!(4T\(HR+?<4Q4Z&%4>DH@NZ1OX@(STQ1))6O
M'\9(*D,H#J?UE^\-%PBA1%7!^@.J!%+Z,+)RY<NYY^$[>YM[G'KZY35U'_B8
MZ*D@2HA!^\S@5%EMNFZQ6:.A*<%IP6WCHG)*)X,GXY,RSSI19>#%#5Z*H]GF
M3,/!)8V'R*EXY*=/>&35NBV#D^W#4YWC4UT3N7B:YM3X. 8XI0'?J)$PMF5@
M=+- "EQP<*I7.=4_N&UD?-364/ODU+3%IY7S9'M$("7J:?^<LO%D^<YM3DUJ
MLP;Y2!/Z>1 AL;:];VU[[\$?^;=H15.BRDH\=II^W""DZ)DR!J#0*E JAI75
M7881YWJ>VZ[#3"UCT.W^[+I@#VU5%ZB %2:6M?Q\!:&,+YD%:YB7IV+622NH
M(=W 0UL]\:>/.E?K[##@J"ZVT"JT7J6T<IJ3!%8DVQBM;M35R3H1AGS_H%TC
M@9*G""LY&7(*IE\H41A->]-9=RP]K\ WWQOUHD<#IB)HA9=;3BCBR:@DM\9>
M\5D>0);1!J1SB@YUEN5D9A\'F\IX4^4F%5F!E:;7W'#*;8>D$U5PJ NG_ *I
M4(& R1,BL/*44W)_[@47YIZ'[^QM[G%J]?J-S4?]6\FB0] +R\$IN ;$[BNM
M$4Y13YDK:MB*$K:""0QK#*V<VQ19W..VRWCZ[<AU<W# 7E2*5S>7-KV/$9[?
M_LDOU[3W;AN9ZAJ!DNK=/Z>@LR8,IR:V:6+*-*=LGY0N_(ULT)C/GK$=$W:N
MS&P9-8-3>]^8V@.CSRFFWI)3#L^4<LI1MF%=5Y\HQ%L>>$S.*!$7:3C1IR'%
M!3X#*0["RWC-(UDT<4 JG]V<G585(2)@8F"GE3=3"A6CH&D,5S7%:A9%JQK%
MI')%R[ATR]\4W[]-'"=KL+,"$9L,VG0""P]M Y!<HZ$7L?<''5&=1!B!A>I1
ME7(\S+0X3%<K<E@A92$&!E>LM" 0+_3%BNP82T^JHBB2G%?H+XZD-=("TR9@
M+0+  #1ZRF\'1I%'#%F@C#(V((6;<5>YD(X'3C%+AIQ2;84X3XU$CT-D1="G
MSRFC<@:?!<M\D4(AE"6C(*\(K$7+#L\]#]_9V]SCU)9M;1_YW%=$3P6T'*U7
MVZP[.96I;TG6P &!*Z<MJ0RA AJ)GB.CO':=/"*,;VMDE+GWV#$*?)^PQ@0F
M:UI*&P^1TS*[^/U7W7;_^OX1$5,]HY.]X-2^C3Z;4X!"Q_!8^]#8-I82WA>G
M1%*A.'K/\,CVO1.[+"2]!:?V(!Q!#F!IA+^)4U8/00>G-O4."J?ZIO:<>N;/
MY7O.U"VEW4<8&4)1.CF]Z204LHO5[A-)%4)VL960;*XB@ YJ)" >73E5'RVW
M:A+(?4#=[?)MBU1A#@W-0-(GICXF0QF&CUO6G^U'UX!OZR$O+:0;.64LOK"&
MVH6-)TN/D8V$2#D 4< 'ILA,0*LNO-!><-0)IB:8MLP+Q O\L?Q@;$$@BI)U
M\;(%_LB"(K\[5H8/8"D[^3Q60A]]3^01+3[:@_!A04Q!1I%E3C\Z#U:?5!I-
M0]7ZHYCR)-&QO4"L3N54 >OAA1-NE':QJN4YF45MI2G*T2)_M%#9)*JJT ]L
M&4OPZ6>?RST5W\';'.-4;W__[VZYL[3EL&1]B^&4=GPMHQ_=7U*=KI=S!@X%
MQ^7:0A7Y0M%D.&481$X95674$_%DE!3>1-]'Q=3"9.WB3./!D:KF]Q]S_..K
M-K0.CFNU*;'L0*)9>+*&/-L],=$Y-M$V-"YC*[*+":EA'3,YU3W0VC\ROO.U
MT5U[1G;ME2$;LU%%3G&,ZS%#-IYF^\[IEIKQD>#1G^P808ZA!DE,;.D?V]R+
M\C+K>P8W](XN.?+CP;+Z9,V25-U2;7T\ U(&3T92P8FN@9VXKUB(T/,RLJ,A
MR+HKFKBGP!)5@B(6 BPU^BS$8)E/S:[Y6A<A O%2(Y]!:4(-)1L"E"8=T]8?
MGBJM1TY"N= 'KGKF)T2S"T-:0D]?Q1=BS<[Y0L,IQ1.<67(PH*DCB*5)"T_6
M!$,K8\B<PG"J"/XI+.<7^N-Y@1@\V='T@>Y OB_J3U:&RFN#]DJE45($$!U2
M-.N83!,LE<D&GSIE5%#3_8Q5R)>HF!(9I2YS%'4!MFQXI0JBJJ=$6)%0X51A
M "%11ELY;4!C%1;Z+4Z14$25C$]_[DNY9^,[>)MCG&KK[#SA])\$JAL%$'X4
MGY[FE!MQ"27^LNJ2IJ61*GA  SKT<HU[I\7GY XY9=23@9?S61YO2:ITM4Q6
M!"AFFQ)U+6@MTW1PK'[IMWY\[OJ>D6W#*!_<.0'G5/?^[;[N<3EFLF-LLFU$
M4#79BIAOFU.]PP92%J>Z!GO&I\;W"*'V# %5&.24,?2F SN%4[M1NA,'S^*4
M<9SO@U/RD<98 $N;F*+OUIBJ.:STW?3 8R&T)A<--5W%A4M^)K#3*"PRR[+[
MRAJU.U9SM,+24'(2QK+3^7$!1R0:A8\ELNR(2GFJ*%*B%P8!4Y,J-<O_Q5@'
MO9<]=I*PJ!5@2)_*+M+@TL:P'<]EFZ)X$]VPX^QL5+'_(T46@44[,4;GO8*)
M& UPY5?44%G6FRYW13/N:*HH""]/<2">+T2(HO#3@<6!@E *-1+02 9K?!13
M 0V>,BYSNJ+T'\?R'UNW:[P"'%7$&?%$"U$YA=<R(D'/ JM"GL:7EA1HBA^,
M/I3T3+HC:>&4;!2I6]UE.]$]^,S"5D1^%G/M+X L/^HIRZWN#2]<=ECNV?@.
MWN88I[I[>L_\U<6A&BP2"R]\ZD*BW4=.^4JJ4HTM]"DP50)1,PXG.B%E=!/1
M8]23H979,)SB0S\*@=:B@A7UE$9.Q>M:RI<<<=E-=[>-;-\V/ E.J1/]33C5
M)5 8%Z*)DD+UNRW33G2+4R8N84/W\,;NX9'=>\=V:[%@!Z=R?%*&4^-::HJ0
M&MQ7W] <]SD@)1;?*+*F[;K&8ZT([QQC-^:>':^=_,.SY%N*68E[+2@+H55<
MK/Y7=B,LLH"$@E31S+Z8EO2TFP-;MAXA11</.<5M/B2D>$Q^*"U?/@UYI/NI
M%<D_P55%999@R'BIP"D*.AJ>C"\EUXQ!:F];$9M\+4>T:J$&6VFX0[8)%5W@
MG[)R:PQ8N2&<\I?*;"EWB>453A0$1(.$BWRQ!;XH>!&,Y?G"HG2H@S14REKF
MDWO&D1L-)??:15DLODH33L66R'*\45)47ESO\TS'H(N,@G-*A176^\ LE/1,
M"Z%0#R^4U)%F84\B20:!14EEEO^*IB%EW1?Z8_WO7C_W:4[E/O.>O/7U]5UT
MQ1^#-0O#E595ENE83>54H+0ZW;B$ 7AT57!*.8T^TLWPR(W"8,!0CMIR[B&V
M^!(H?\T[P]4>Z3)+92H?^=FO/O3BJVUC.T6,B$KJ>BL]Y>14ZYMR2B E@FMT
MSQMCN_8,VV-D9MF6&9#2CC+D%%&U/Y_4FW,*_0%1O1/]KX16+4=^W)>I4J&$
MD:Y?:O*-G;8>98X*&:B5L%9Q8=4$[<!N48F<,J=ZP%K_LC@5T>;&R9IF$5/R
MG1=&,D%UZ^!9F'L(=^!?B58UH[1>68-R!ZRA7SP$^B!*2XX)HKH>.!5!,"H"
M*?0I33-43@75L151#L*[;[G8[4@%!$FII6GSE)\<%JA^<JTLCG(%+HT#(*<*
MO)$\7TSDS'QWH"B4\"3*O-#I%J>,B4=W.(,2R"E;9UD!G\'2+$V_D-W5G>*+
M@&.$)UUCQ!.+Y+F39?))/&PL*E(NE'*+80@EA>Y8;KC5K1@%XY\BIT HABGX
M(WF>4)XW)*HJ#\M_B%IX_H47<T_(=^HVQSC5WM7]O;//#=<N#.*:8X5!67[T
M6%D![+XJX52TRHJF(:<"CI4^OBI'0''_;#WEE%WD%]\GJ&=70EM@R4C6+?G.
MV1>N[1QH'4+,$3@E>DHMJ=F$LC@U-@GGE 92M@JDD$,WLB].#0LI>B9WC>U%
MD '"-7?MWC>G[.TQ@93&H*-'P[[<4DX\37\>#>SLT/0=+2B*_H ;>T?6=PVT
MC>ZX^]&GN51O6W9+DK4S,ON,%49:D29XJ($(K(R.#E?J>")Q[+/=\O31T#,Z
MBWI*-MB*/5+1&)6A[J1 *:##.L7P.JDL"I8W!N GJD-+-/ST]6'8?4 8%A %
M85C%@W,J*OO+<8#:= O5F8U8352CAN>Q2D:P1 VK6(4K45F<J)@73(J>0I"$
M76DCB$ \*Y+.G:ITH[)X>7$4>;]R5B]P!_(]X6)DSR0/*D(!3U>LU*,-^\@F
M8^CQGB[SX(RJGK#X@J4BHZP(4K[6O$2=Z-.04DF%0NF6-UTVT*-!E%3&@V8S
M2;'X4 \/%E\"\DHE51$R^"QA!<^41E%I[9>8Z"FY1YRZKOT5!F)YGO /?OS3
MW!/RG;K-,4Y=\^>'RI8>GJAK#I37B]U'3EE^]'AY0:3$F\XF&Y90QM/I@.'0
MZDY.&;GDU%!&0'&GDU#<(*?DGNDRJ9J6RF5'7'SK72B0,#@IIWH7PCM-1-(^
MQ$L/],M4Y^AV>*8&QUN'ICG%]3[#*=0GZ!\<V_W:Z&YTLAJ0L6OWZ.[7QM1Q
M/L,SA19^KZ.$R^[7!&1OXC[?%Z>V=XU.=8XPD@O- =6IC\^PKK._8WS7#\[[
MM;^DELYR<LHV *<#$0RGN-,*\JS&AJ6P$(P^'<1D5!6'69_E =PCD$*1J=)Z
MJSPQW$Q-@B1",(P_(:JG+I1%F+BOO":8;< 03ME1G7 _B0U861NK!(;<L8S\
M@@6!9*!LH1\>QL6!^D-]#8='FS^86?KAZ-(/UW[B^-C[/[7LWT^-?/#3AW_S
MATU?_:^/__C"<VZ^*U96ZTW#_N+"G$T3F4)R/:MP)U%3I4@S?O/<P3Q7,-\3
M*@Y$\KSA XM#;O4?^4L$?S7^F?6(%7;P4O&>;G6_'88N[ZSWN2_AO;WD9S@%
M%!9&M)M#0I24%<:)S#X0RO(]J8""#>@*IRBOS'YUHD]S"OXIY-.$D4_C1<QG
M275C[@GY3MWF&*<NO/:F6%U+LJ%%)IG?MMH,IV1.>])5\?J66/4BNJBX@L/K
MGI-33M'$;2[J\:%9"C1LXFL-L(*:?89:+K5R3BXZ\C-??O#%U:W#4^U#VSN'
MI[K_*DYMMSDU]J:<&NH9FQ@7,;7+ZK$^N'/WZ)Z]8S)V[\WEE!A]>UZ#^WS_
M*3)ORBD,-+^"F!K1_E>H?K6A=[#E0Y\(E**?J%G@B]I57 RG2"@Z?8SW1R6,
M99?I,I_E@0YI=K'7D29I"$6+3X9\VWG!E"]='2EGDW?A%%WF<(2#?95-@6QC
M0&L/**UJ0Q5UR.R5EXA(*:E";\=435&R.E"^.-YP6-EAGVHZ]OCXAXX]])0S
MZT_XK\]?\/N/GW7I"9?<\LT_/O"97U[S\P=?^-*E-Y[WV.I3;WCHYW]9]9/[
M7SSOT1>N6[GMDA4;OW_7?<%LO<>N)V5HXD,T)LF%LBV%0>%"--\3G%_L%UH5
M>,,'%'CG>V)>3;[SJ/GF5%*$E*$//>7T6YD%/K^=C<QG^12=4_1,,;./PDJC
MG;'85Q1+N6Q.&7\YY1(YI1UHX%Q78%EY,S@@R%IZ**=7J$6I%GB",G0C$$J5
M][Q+'6CF&*=NO/>!5,.25%U+ !DS8(JQ^P15L!%*JI.-2]%RQMA]QOJS$VB<
M,.(P<BE'4GGM+!E#* XZ,E#+I7Z)OZS^I/_^Q4NMG5IL4R0)..5L*9K#*0U3
M&N\:G11.P<)2S]06[=;'?@W3GJD>V("")XL^.W8-;]\YO&,7'%53.\DII]W'
MN"K@;%^A4@92LS[,!,3=R&3'\%3'\&2;]K/9K!\&.7TC4_<\\5QAO#16M9 9
M?&9ICYQRFGX)3:/A<!J (HBP@>5\R[XCF STN9.H8N:=$5-!M!>U_%Q8.JQ9
MK'XHD4N+M<9>/5HVE-0&DME@IM:=K'*7-OBJ%GMKEZ7?_XGD!_[M\&_^]U'?
M^<7[S[C@ZU?=]<7?W'+!$^M.N^7QBY]>][.'7OKI@\^=^\B:2QY==<D3:W[_
M[(:+'WOIMT^_?,TSZRY]\)E[UFP[]Y9'[MG0<>E#3__PGA5?N?P:GQB T1*N
MLI$L="V1(X!%-%,<3J+P@-A]Q0%PRA,Z(-];$$CY-)B@4,NM^.P</8HR>IT"
M&KU)-M&^H\>*?XYT"]C-1WWJG*+11TY14AEM51!)%D03IHJ+,>N(*HV9LL24
M#CO"DYQ2_Q0YE0\E%5K@\>=Y!54!V?!&4^]6.:HYQJD5+[Q4MO#@1.VB8&D=
M6./@5&&T-#^<<:<K4TU+$ZJG$)J@@7]TA?!\('0,GIR.*D,KLHP'D%F&4P&-
M)XZR@&?MXD2V*=FP]-*;[EJ/ZIV36X>W@U,HY_(6G&(LY9MP2B E-E?;R!0]
M4XPL'YG:OF//GI'MV_LF)L;V[.;2WN3>_Q6GNC"FQ%QM'T:WFQF<ZAGJFMQU
MQGD7'12(Q6L0?Y"J@_N<DBK&""G;Z.-#>19BRJ85\,0J+MJ5C\X@<\UP,@N0
MTMH#\/K5MD =1TH"N"2(R%H8$PV5J9,1RM1YXA7!5+4W6NY/5A8G2A;$RGPU
M!\=:CDI\X#,?.O7L[.?^XZ0K[S[Q\MO.N'/%6<M7??_N%1<\V_KK9];_]/ZG
M?K5\]:\??.F4R^^Y=4W[%\^_ZJ&.WJ//_/6#:[>>?>/]OWO@J3M?W'#6]7<_
MN*7C[%L>>KAG\*Q;E]^QH?/L^Y[\UHV/?^GRFUPE=86A)-608421&ER%&)DB
M%'N*Y_L$4OYY1;X\=VB!RR_"2E08A5AQHJP@BB)YE$*$D9%('(Q!)_Y(0"*,
M9B )93SHY)=7(3C]D:+I_$@J/Q(O#L==Z,O@J#EEEW"9Q2FH+<,RU!W6]3YX
MT+V04?/=%JJ* I%5K[R2>TZ^([>YQ*F!@<';[GV@1#!4VQPNK?.!4]:/Y-*"
M]L(I5[(BU= 2J8+3E^LX$%/:,0FHTJ*11DQ1,1GU1"J9/33]#,@,I^CB!:?J
ME\A?.?@3G[GOV55BJ:%ZU/ D[+ZWX!1Z"],3A/#.04!J2_\,3B%7IF=P77OO
MP/;=0A^KX][V'<."J3?>F-RU9W!R:FAJ^]#V'8.3V\<AJ=Y@S)05VSD+4B;9
MV&'K86C+^(F.T4D0:LBJV: QZ$,;NX?DGUK3UG_XQS_C%6L:OG-KD%,11RT7
M*BEB*XHVR(M#5M Y<H^1*X/RP0U:(< *9*-/&I JLPHGH")"96.FOB64KD3_
M*#00S7IB99Y(J2M6$:Y:["Y;Z*DYI/303T3?]_&6X[_5>/PI1Y_UFR]><N,Q
MY__Q9\M?^<[MCU_R0NM%SVPY^\&7OG/3H]>O:3_APNNO?;G]A/.OO&K%ZM\\
M^-0Y]S[Q<%O/54^]_.#Z38]LV';]R@VK)J=N6K7^J?[AY>T]CZ[O>&)+]VTO
MO/KDQFU7O[#NRB=?O.JI5RYYX)E3;WCX%_<_':Y:E.>/T^[3#NE6;W17).--
ME.6'4_DAM,.#0\<=FE\<6. *'I#OF>\.H7*>&FAYP61^*$4;C5K,<,IO=Q4-
MV%XJ<HJH(HF"NDIHQ!1%&1%&)>5.E"'\76,1BA6:TUXGQ5..I%(G^C3%IH?-
M*;O82U X!?Y"4@6>>OK=:>8^ESBU>O/6CQS_C5@UQ+](?9_C8H+!(F&)LF3]
MXK =\@?G5'D="F#;Z]\!.YK!J"HRR.BFG.&$E-]V5(EA(K9GK+HY4KWPA-/^
M>\7ZK9M%@_2B97'G,'SD/>, T[Z"E6 5=HUN%RZT:A47>*; *53L1!BZ5L[<
MV#N\OJM_<_?@^,[7QG?L'=F]=W#7'A!G<FI@8FILS]X1T58[=X_LV"F6($R_
MW?\SOOMUC5:W/.@YG,IAY32GQB?:T>>&58^U5A\YU3.TH7NP?7C[/8\_KQ;?
M="4\HZJ$2B:JTSBJ1/NP5WN4+1C*FV+*J0C2^IAHB2\PBMIA^,X)?82,BV[*
M-L:J%WG+&UUU!T</_FC\?1]O..9K39\YN?JXDX\YZ[*6DW_RE=_=^<F?7G[&
MK8_\]SW/G7'_4S]Y<.5YC[Y\^NU/7/+4ZC-NNN^'=S]YT:.KOGGEG7=M:#_I
MM]?=NJ;MQI<V7;=RPS,=O7>NZ;SKY?7WK6^]<^6KUSS]\I]?V736=?<^LJW_
MDV=>]E!'WZE7W/[[QUX\]Y;EW[WNH<N>?.GKE]UX\[JVSU_PQZM6;O[\!=>=
M<M_SQUUZ;;3EB/Q PJ5:1ECC5<>Y)Y[Q1#/YON@\?Z2 Y5S\L06>\ *7B*G0
M/R]PY0?BHKGF^^/S?#'A%%YHY[X8-AG=1.G$_006465@Y-'V,WRY,0F-N2?W
MB)E"DZND.Y(Q93QG:"4E%T>Q'9)N]AA.%:%"7E3K)4!,S7?[Q.BCZ?>G&V[*
M/2W?D=M<XM3SJ]<U'OFI>$U3O+HYA'98^*GX(V%$4!A,I@7BIZJMBHO@E-AZ
MI58'RD"ZVJP2$D"&4]199I!0!E)<C?;I@C2=4\F:9E%MJ8:EYUYU_;-;.C;U
MH@VG0*?+]J,;3LU$PY2*J:EV=5<KIT8WZ^(:@K\5533Z7NWH%6DVONL-T@<
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M(K^F\<1<&<V@ML44.*7ETB.VI((-*)SJZ.S,/3/?_MM<XM2J=>L;#CT2#*J
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M!2M(A?=RB=(P/9M3(5%/28&42*I\?Q1<H)Y"=ZE GC=T4&'P_QP 3A4$8FR
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M_T 0R\J %&>:<$KDV((@BCH)IX1!PBF4&%9.J?H(B/003OWC 87"*3N!#FG
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M4C:AS(#%AP N[=1@N<\19:J?0;MOH<SQZ/:?7OP[^1)*&I>IF%JB,9S-NLV
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M/Z?HJ[XGI]0?U,HIP<3$\HW59^B<NE].(;QS;5/&E#K%/B-.72&GYN'"1Z/
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M\J\NPX^NGJD=D+*#1M^6W0=^K5Z86;S27$$]J3M/ U4^3OD;7OG&+=?\JB4
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MT'80'5(-B>0 NP&54*[:6:R(I!(]E<A5DMJT F42$,ZJ=I]NG<N@/\X4<DF
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#0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_7.jpg
MB5!.1PT*&@H    -24A$4@  !=X   +5" (   !1"F1(  "  $E$051X7NS=
MWVM;:9HG\/TW"PKLFHCM:"JM9D=#HQ3KA3$TFIXH"X;&#*@OO'C$#@JT+EHP
MZRVPH;5IO TNN@4U8HGW0G-AU@@&Y4*0B(+L(:=+_>:1K=B);?TXG\]%$9_W
M.4?RD2S[?.M]G_,?1J/1_P$   #@P?V___?__D/<!@   ,!#^7,T\PX   "
M!R2: 0   %@:T0P   # THAF     )9&- ,   "P-*(9    @*41S0     L
MC6@&    8&E$,P    !+(YH!    6!K1#    ,#2B&8     ED8T P   + T
MHAD   " I2E0-#,8#+:WMU^_?AT'     ):D6-',TZ=/W[QY$P<     EJ00
MT<Q@,/@B\>+%B]G0#S_\\.S9L]G0\^?/D_VBMV_?/GGR9%;\\N7+FPQ]=!0
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MZY(L: (    ^6>&BF;PO;V@]\]$;6E^YUBGOYIOM==W0JU>O%NQX70P$
M%$?AHIGYK.2Z>32I^3L]S;9,)I/KAK(M"W:<7U0%    %,V&1S.7EY>/'S^>
MS4^9;RB3KRVZ,I<)0^'+=.;+@J&/C@(   !%MN'1S+OD]DRY="E3GM2DHVG-
M?$>8?$LNQ"L+ACXZ"@   !36YD<SN</#PRNGQBQP<G)RW0V;     .Y$(:*9
M?';,K:*9O%OP@L;      )^O$-',)S@Y.=&I%P   +AOHAD   " I1'-
M "R-: 8   !@:40S     $LCF@$   !8&M$,    P-*(9@    "61C0#
ML#2B&0   ("E$<T     +(UH!@   &!I1#,     2R.: 0   %@:T0P   #
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M.HDF+\[-)R^+1P$ 6%]G9V<[.SMI+)+*_M3L=#J3R23N=M>R1TD?MUZOQPH
M5M7F1S.YP\/#^45,BYV<G%PYOP8  -Z]_]]O]7H]#42"5JOU8 N++BXNPJ./
M1J-8!,!**D0TDR]'NE4TDW<+OJ[U#   138<#O?V]D(4DMK?WW_X9"1,WNEV
MN[$"@)54B&CF$YR<G.C4"P! ,!J-FLUFFH $C49C.!S&W1Y$M]M-G\GN[FZL
M & EB68  .#CQN-QJ]4JE4II_)&JU^N#P2#N]H!&HU%X2A<7%[$(@-4CF@$
M@$4FDTFGTRF7RR'XF-G9V3D[.XN[+</N[F[ZQ+*G'2L 6#VB&0  N-IT.CTZ
M.JI4*FG>D:I6J[U>+^ZV/,?'Q^G3J]5JL0* U2.: 0" *_1ZO6JUFB8=J4JE
M<G1T-)U.XVY+-1Z/P_,\/S^/10"L&-$,  !\X.SLK%:KA8QCIEPN=SJ=R602
M=UL-X7[>[78[5@"P8D0S  #P9X/!(+1K295*I5:K-1Z/XVZKI-?KI<^Y6JW&
M"@!6C&@&  #>#8?#1J.1AAI!L]D<C49QM]4SF4S";:26>]\H #Y*- , 0*&-
M1J/]_?TTRPCV]O:&PV'<;85E3SA]_@<'![$"@%4BF@$ H*#&XW&KU4I3C*!>
MKZ_CE)/3T]/TNZA4*K$"@%4BF@$ H' FDTFGTPD+?U([.SMG9V=QMS4QG4[#
MM];O]V,1 "M#- , 0(%,I].CHZ-RN9PF%ZEJM=KK]>)NZR8LT6HVF[$"@)4A
MF@$ H"AZO5ZE4DDSBU0V='1T%/=93_U^/_W6RN7R=#J-10"L!M$,  ";[^SL
MK%:KI6E%JEPN=SJ=30HOLN\ES Q:W_59 !M/- , P(88C\>GIZ?M=KO5:O5Z
MO?Q>UX/!8'=W-PTI4J52*2N>3";Q6.NOV6RFW^G^_GZL & UB&8  -@$_7[_
MIS_]:1I&_-5?_=7?_NW?IEN"9K,Y'H_C@3;%8#!(O]E2J;1)TX( -HEH!@"
MM9>W5MG>WD[#B 7V]O8N+B[B439.:*RS >V- 3:2: 8 @/4V'H^?/'ERPURF
M7J^?GY_'0VRH@X.#]'MO-!JQ H 5()H! &"]'1\?IP'$=79V=OK]?MQYHYV?
MGZ=GH%0J;617'8!U)YH! &"]A;DA\QX]>G1Z>AIW*X9JM9J>BN/CXU@!P+*)
M9@  6&_[^_N+5S/5:K6X3V&TV^WT5-3K]5@!P+*)9@  6&]'1T=I^A!L;V\7
M^;[1P^$PG) -OBD5P)H2S0  L-[FTX?@[.PL[E,DM5HM/1M'1T>Q H"E$LT
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M<;?F)R6=GY_'(@#NC6@& ("5=G%QD:8&6YJAW(-&HY&>X8.#@U@!P+T1S0
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MW8*OG#(# , G&PP&Z25]J53*KO-C$2LO= MJM]NQ H ;*T0T\PE.3DYTZ@4
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MT0P 4%##X3"]=)SW/_['_XC[L-#%Q44XA]F66$0Q-)O-])V0?1DK /B1: 8
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M4JE4W%^<*X4?GTZG$RL "JQPT4S>EW>^]<P-XY+Y6U^'>V/G9HU^%X^F&P&
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M P 4Q=TVFDF-Q^/L:.G!,T='1[%N(X1;4W4ZG5@!"X6)9OO[^[$"H&!$,P!
M481&,ZU6*U9\AO/S\S E9VL36YP.A\/P/=[)S",*)?3/SGYPK&D""DXT P 4
M16@T<W9V%BL^3VBBL?6^C\:&)1>M5BO]!K-3&BO@!BJ52OI&<O-UH.!$,P!
M(<PWFIE,)K'HL[7;[?0A,K5:[3X>:"FR<QBNJ.^DCS(%='!PD+Z1]O;V8@5
MD8AF (!""&LH=G9V8L4="3>6WMJ@R\ZSL[/T^[(.A4\6&C]E[Z6-23 !/H%H
M!@ HA+ 2YVX;S:2R*\S0*#?3;K=CW1K:V]M+OZEFLQDKX,9"YVPSL( B$\T
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M*S2:6;4E$N/QN%JMIL\P<W1T%.N6(;LJ#@M,5J%-#QML_BW7[_=C$<"&$LT
M )MI-!JEEWG95=\*_D_XX7 8+D>W5N.*-+1E-86!!["_OY^^ZYK-9JP V%"B
M&0!@,X5P8:4:S:1"0YQ,N5Q>^CVJPV*KI=]TG"(([8VR'P2!(% 0HAD 8#.%
M5BDKU6@F"/>HSM1JM27>3"I,.,H,A\-8!'=M.IV6R^7TC7=Z>AJ+ #:1: 8
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ML&5]  ]O\Z.9DY.3- VYO+S\^NNOTV5-:7"S(#3)=BR52K-8)SWL@J&/C@(
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MW3CO5[_Z5=P'8,T5+IK)^_+.MYY9')>$&V#G\FZ^V2[7#;UZ]6K!CM<MK0(
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M\VL @-44[KF[P9=M%Q<7H25PYNSL+-;=0*O52@]2K]=C!:R&^5Y+F5ZO%^L
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M$\T  .LJW(U%HYEY!P<'Z2D*OOKJJ]W=W;@/;(K1:#2?SC0:#>D,L&I$,P#
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M4DD_>3*-1D,Z ]PMT<Q?Y$N-\HDP\_)U27DZD^<X^;_S[6&!TFSUT^+1=",
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MD48SP+H;C49A]E_^:29H!@+1# "PBC2: 3; :#0JE\OIIUFFT6C$.J#81#,
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MRO09V&RB&0!@56@T Q1-O]_?W]^OU6J52J71:)R>GO9ZO;"T<R8KF$PF\1#
M^A/-  "K0J,9@,QX/&XT&NGGX4RE4NGW^W$'8,V)9@" E:#1#$!JP?299K-I
M^@QL$M$, + 2-)H!"$R?@8(0S0  *T&C&8 KF3X#&T\T P"LA'#A<7%Q$2L
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MT0S #9D^ YM!-/-G/_SPP[-GSQ:L8PH)2^KP\##=,1QJ\2@ T.ETTLL)C68
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M!P<W;MSH^EO77SE<>+ITZ=+-FS<_^>03?="%86D&  !D\/SY<_7S!TT?$@8
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M: 8 @-(EWH!&OHY4___>WE[TDRP??_QQ_<+ ^"1.$_FMZ[H.R_^MZ^Q8F@$
M $-QHQD  -;!O@'-7_S%7[SRRBO^EI=??ED64V[>O-GOMZXO7+APX\:-+%^;
M*A=+,P  8!!N- , P,K8-Z 9[OSY\_);U_6K"/W<&XFE&0  , @WF@$ 8)7L
M&]!T=?;LV:M7KZ[CMZZS8VD&   ,PHUF  !8*_L&-*W.G#E3OS"X=>O6RG[K
M.CN69@  P"#<: 8 @'5[].C1N7/G_,N]07[K^KWWWN,+SNE8F@$  /UQHQD
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ML#0#  !Z.G_^O+\TPXUF    >F!I!@  ]/'DR1-_7>8KW&@&  "@%Y9F  !
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MY!M/]4:[U-\( $ IN-$,  ! 1BS-'+.[NRMWZK4_U>+?/B:ZSN(VVJ7^1@
M2L&-9@   #)B:29"/CY3BWZ_2;[ZY&XT$UUGF69I1EH- (")?>UK7_.79G[\
MXQ_K/0   #:&?J_>G1R'I9D(6:!1MXFI#C]9XW^FQO[*DEWJ;^SARXX  ,!4
M?OG+7_KK,B^__/)''WVD=P(  -@8^KUZ=W(<EF8BY Z^ZM8SX4]?J]_&%NY&
MOW:IOQ$ @"*H&\V\^>:;>@\   !TP=),HW!5)?HYFO"GG?PM=NF71P$ H!#J
M1C,W;MS0>P   * +EF;^Y.'#AZ^^^JK[)(NZH4QU]"VD\/M-89'Z4(Q="@!
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M&]JM-\&Y,_D4- MBBL28SY\_]ZX/W1R_DG10=V#O@M.H=:$_,6,/4D^69@
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M%/3^^^]_Q_/=[W[WTT\_U8\I4*>Q^<477^@7T4?^YW_^Y\O7SH'PFSL^_91
MR?S;EX3NW[^OAX?'#2@^9R&&Q'1O_MUO5-4G7UJ!;PX"0PP9F#89JBS-H#"C
M7LP68A,R5L0\LHZ8&X)E4['D3AO^03)ZX]A?_.(7?*)D^?;W]]40JQM.M^6O
M?_WO__[O^I''_=N__9OJ%4WLOUK;W-=/NOK)3WZB:YR#^XY)*'H:G?K]O#XO
MGDZ?)NCA3LGS3[KZ/.M@QWWXX8?Z,;FY-G6?PG-+R?70TQ4",.;\(V.0I1D4
M9A.NV9N0L<H:L^@[BM4[2$TF^ 0U!KJ3K],NV<0QH]_<T>,M]EEN_OR[0-'/
M383?2HA^UT#WC&1WINVQ<]F0F+]>P)H%'/_UE1N_[O7/2*N*6+<?_O"'_@6B
MD_!JDLC]?KQMQD_M23U9FD%A[F1Z:5+TFWFLF_M#L72;W_SF-]+QGCQYHOLQ
MIG4GT_RS<"DQCT^*?Y1XXUCFMP4*[];A[N7I^#_+XN3ZA=V![B3T6/V8 FU(
M3)3(K;#[7_!DPE^(Z(JYD_A-P_^===EB,G?FFV;EA+,TLQ[ND_8??/!!/0C_
MY5_^Y<:-&S_^\8_=)UJ7_$E[/H(.I)/W4>X3Z>[#Y\^?/]=#"UF-<<TV;F)B
M,.X":[#O>^(PS2Y!EA?3F_!*NMJ8SUEL2$RLR9VVBV;BEPVC;PH2Z=DSV4B7
MPD*_:5@EM.8*+BB_GF^:E59F:68])AXPB1]!#]\)\!%T8&PRUMR/4[B/<>IA
MG,_*;L*B%HO=A/;3G_Y4GVMLAD)?3-^9]H4! /@V9 K:D)B_GF_98A/(:P:6
M9M8C95[0KPJ3/X+^PQ_^4!\.0)G<7^/==Q;D-T2_^.(+/:TDNY,P_^C'C,^?
MZ]3/Z+B?JQ!\87XU$F\<6_>'3?A$R9U%#DP &^+7F_%FGID6P\F+$Y9FUN.#
M#S[0,P&P&8J^HYA;*&G=<S+U:PBITD<??21A)8MQH^([H[TN4;>%<C\%*M3G
M\EA$+E'TFSOAP,Q[X]AJS$Z['+_>C/=% # C9EH,)R]U6)I9CQ_]Z$=Z)D"S
MHM_,K^ -0[49[XNJ7C&?/'DB/>'!@P=UMZG[FW2\>D_]X)F$-RIN[;0__>E/
M_4ZN;I7B_^@LWWDL@FLO)_'&L<NY(]*=[F,3   @.WGAQ-+,>KSSSCOZ=64Y
M^ BZ;T/>,!!3](CI[H0BX\)]-X=OY13D'_OZ[G>_^W8O.SL[_W^:^EET=8_[
M_O>_KSME@7[-WSD! , "R$MZEF;6XWO?^YY^73FF'__XQ]Y"RI^$'R?A(^@]
M;$+&:F/>%\T24W[TQ]U=I7X*&:$C_=S RKS__OOOO?>>W/'W^]___M___=^_
M_?;;__=0ZYK%/_W3/WVE?-_YSG=TL./^^9__6?<Y    ]"*OV%F:68]WWWU7
MOWP.U.\QOG/<M[_];7G+X?SMW_[M_Q=XY957](OW0V?.G'GSS3>_]:UOW;AQ
MHZ[ P2%=LZQF>:,[L4W(B!G]X0]_D$52]VN4[HXMNJN5[&C%^(_4I_#<DO%O
M?O.;__S/_WS__??K&6QG9Z>>S5Y[[34]S7E:URS6L3137PATL./>?OMMW:L
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MSI\_K_M$;O+]RIV=G1M''P=+O-517<_Z46?/GJV/<.G2I7H.U'NLPH;$!
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MJ9;P91]DD:LIY09&SJU;M_PU'?FY=V?3;I.\0/)UL+V]O1M'GV6K>X)N5
M & #L#2#LA7Z91^$9FS*3K=)KJNGUQB0[!O?^$9]AA\]>J3;     -A@+,T
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M#TLSG<GWF&9<F@$      "O T@P      ,!L6)H!      "8#4LS
MLV%I!@      8#8LS0       ,R&I1D      (#9L#0#       P&Y9F
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M,,-0X9:!)AZ;2CWM^)>KZ"P4O<H.,=[85*9/E[U[)/*33A"SFG!L*I,E7=3
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M#$Q?QH"A60:F;]1T8L:QZ1LO:=.1)QN8OJ;*#+3,L5FUE0XQ^]BLVDH'6LC
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M,)7PV8>;>&S*\9LBJ-*4 _8PWMB</=UD ]-(.D',*E;#<'2TYDT9FW,E7=3
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M:0; ;-0U&\ 2,#"!96)L @O$P$0N+,T F T7,V"!&)C ,C$V@05B8"(7EF8
MS(:+&;! #$Q@F1B;P (Q,)$+2S,       "S86D&      !@-BS-
MS(:E&0      @-FP- ,      # ;EF8       !FP](,      # ;%B: 0
M    F U+,P       +-A:08      & V+,T       #,AJ49      " V; T
M P      ,!N69@       &;#T@P      ,!L6)H!      "8#4LS!9-6 P
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M^IAOO?56O_Z9)9T2#9M8Y[#MALB2+AK'Z31GRC_E@&?.G G_-M#)].D2B\3
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M2-=*#I)S:08      &!SZ/61CN0@>99F*E9G      # )M$K(]W)<;(MS0
M     " =2S,       "S86D&      !@-BS-        S(:E&0      @-FP
M- ,      # ;EF8       !FP](,      # ;%B: 0      F U+,P
M +-A:08      & V+,T       #,AJ49      " V; T P      ,!N69@
M     &;#T@P      ,!L6)H!      "8#4LS        LV%I!@      8#8L
MS0       ,R&I1D      (#9'%N: 0      P/3^SZ>??JJW 0      8'S_
:]5__]?\ J5M'AM+%E@8     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_8.jpg
MB5!.1PT*&@H    -24A$4@  !D<   +5" (   #U5J%J  "  $E$051X7NS=
M_VMC=[X?_OZ;"X$XC:#1S:QZNZ)%^<$M%6Q-&P^WAN(N5?G@XA7E:EI$L\[>
M>-G8F]7,X$GJD"N8%6$<B ?&J:]"T# (')$PG[-SDC-G7K(U_B+9^O)X_! R
M.B_)MG1T]#Y/O=^O\\^ZW>Z7     # [_M__^W__+-X&     %/OIU3K.0
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M<_.L58<     3 FIUBO2]8-2+0   ( I)]4"    8/9(M0    "8/5(M
M &:/5 L   " V2/5 @   &#V2+4     F#U2+0    !FCU0+    @-DCU0(
M  !@]DBU     )@]4BT     9H]4"P   (#9(]4"    8/9(M0    "8/5(M
M     &:/5 L   " V2/5 @   &#V2+4     F#U2+0    !FCU0+    @-DC
MU0(   !@]DBU     )@]4BT     9H]4"P   (#9(]4"    8/9(M0    "8
M/5(M     &:/5 L   " V2/5 @   &#V2+4     F#U2+0    !FCU0+
M@-DCU0(   !@]DBU     )@]4BT     9H]4"P   (#9(]4"    8/9(M0
M  "8/5(M     &:/5 L   " V2/5 @   &#V2+4     F#U2+0    !FCU0+
M    @-DCU0(   !@]DBU     )@]4BT     9H]4"P   (#9(]4"    8/9(
MM0    "8/5(M     &:/5 L   " V2/5 @   &#V2+4     F#U2+0    !F
MCU0+    @-DCU0(   !@]DBU     )@]4BT     9H]4"P   (#9(]4"
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M^_O[L0X  &:95 L 1DF;OJ^OKU^BZ?O*RLKEFKY?7?)KA^BM5"KU>KU8!P
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M]ZC5:K$(  !NB%0+8!&=NK[L;__V;TNETNKJZM[>7KP#"VDP&%2KU;"?V#T
M )@24BV 1;2VMA:BBGJ]'HO@^?.CHZ,PIZ]8+/9ZO5@'  #73JH%L'"&VVE5
MJU7]DCA+J]4*.\S*RDHL @" :R?5 E@LG4XG)!2E4JG;[<8ZR!F>W+>]O1V+
M  #@>DFU !9(K]<KE4HAGNAT.K$.7C6\YQ0*A</#PU@'  #72*H%L$!65E;R
MP42BV6S&(CA-N]T..T^E4K%P%0" &R35 E@4S68SI!*Z(W$A]7H][$(N,@
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M.%*M4Z395FB)]?Q%:#5Z)E?:2RM=R6@%(C YI[;3TIF;*;&RLA+VSV2/C44
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M\VHP&%0JE;!OM]OM6 <  "-)M0"FU.KJ:CCM-Y^%N7%T=!3F(99*I5ZO%^L
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M<$[#H7"SV8Q%   L&*D6P,0-7\K-$BJXD,%@4"Z7\V^B1*?3B74  "P2J1;
M9)W:3JO5:L4Z8*2#@X.0#KM^* # @I-J 4S6\,HI[;3@<IK-IG<3   9J1;
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M JD6P(5IIP53KM5JA3>I!<(  /-'J@5P,<-=>YPMPQ1:7U\/;]6MK:U8! #
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MX+6&%RF7R^7D\R76 0!PHZ1:W+!NMYL_;4@DYQ*QZ.)&+TA<6UOK]7KQ/BR
MX3-5[;2 4X7+F"36U]=C$0  -TJJQ0W;V=G)GS.4R^58<06C%R1N;6V9H;-0
MM-,"+F3XVY%6JQ6+  "X.5(M;E@X9QA[>R,+$LEHIP5<2+?;+1:+^8.&V9T
M %-%JL5-ZO?[^;.%-R?6CO?HZ"AT[\JS('$1A(L2O*F=%G .K58K'#I65E9B
M$0  -T2JQ4T*9PNE4BE6C%7RXRQ(7$R=3B>\XLF>(,H$SF-]?3T<0*YX51,
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M"@7+J $ KDZJQ62%M6/6T[W6UM:6!8FIX7XTVFD!,ZK5:N6/9F^^R.AC$0
M%R358H(.#@["(+[7Z\4BAB3/TOKZ>GCJ,@NR(%$[+6#.#*\T;S:;L0@ @(N0
M:C%!C48C/WSWO?2%=#J=15Z0J)T6,&>&P_I"H; (WU(  $R.5(L)"J',UM96
MK.!U%G-!HG9:P%P*5U!)E,ME!S< @$N3:C$I1T='8>RN(]+E+-J"1.VT@#D6
M9C$G:K5:+ ( X'RD6DQ*L]G,C]HKE4JLX"(69$%BK]?33@N88X/!H%JM.LH!
M (R%5(M)":-V/7''8O2"Q%:K%>\P:U965L+?U6@T8A' +#LZ.AJ>D;JYN5FO
MUY/#N*FI  #G)]5B(I)!>7Z\GC@\/(Q%7,IK%R3.[E,=YO<E5E968A' [-O9
MV0F'N\S;;[^M#24 P#E)M9B(T.V[7"['"JYF](+$>KT^<PL2AYLHETJE7J\7
MZP#FPNKJ:CCHI9:6EMXT314 X'RD6DQ$6$=F=#XA(Q8DEDJE&5J0V.OUDE\X
M_ F=3B?6 <R+QX\?IP'6669WXBT P+61:C%^O5XO#,W%$Y,S'PL2A]MI:<0&
MS+<1BQ!3]7H]W@< @%=)M1B_5JN5'Y>72J58P;BUV^W979"HG1:P@#8V-L*A
M+V]I:>G?_;M_%^\# ,"KI%J,7^@5D@S<8P43,!@,MK:VPG6U,E.[(%$[+6 Q
MK:^OCUZ!F&QM-IO3_)T$ ,"-DVHQ9LGX.P0K[78[%C$QO5YO;6TM__SG3=N"
M1.VT@(45+JMREF*QF%0.!H-X?P  I%J,W=[>7AB.&XM?OUE9D*B=%K"P#@\/
MPP%PA*F=;PL <+.D6HQ9Z%Q>J]5B!==B^A<D-AJ-\%MIIP4LE.'#X&CE<GE_
M?S\^"@#  I-J,4Z#P2#$*'M[>[&(:S2U"Q*3$[/PRR1G:U,R@PS@>B0?FK5:
M+7\D?.NMM]+CX5G?2226EY>MU 8 2$FU&*=VNYT?>2>#<LL/I\&T+4CL=KO%
M8C'_.R2[RL'!0:P#6 #)(7I]?3TY2I=*I=75U?3;H%ZO%P*O8&5EQ6$3 $"J
M=8I.I[.TM/3TZ=.X@=<)0_"UM;58P0UY[8+$:YM5E_PFU6HU_ +;V]NQ#F#A
M'1T=C9AO^^:+S]FD)MX- &!A2+5.T>ETWGOOO9.3D[B!UPD3<&Z\<Q/!Z 6)
M*RLKUW!V5*_7P\^5?@*,<'!P,'QMC;Q:K98<WN/=   6@%3K%9U.YQ<Y=^[<
M"04__/##^^^_GVRZ=^]>=F.X5R),]?K^^^]OW;J5;<W?=YXDST-^D%TH%*YY
M71OG-'I!8J/1F-P+IYT6P.4D'[++R\OA$)I)/G/K];IL"P!8-%*MEW9W=_.1
MT_'Q\;OOOIL/I_+I54BUWGCCC4>/'F6WY"6/DXPULX L_)1YLK&QD1]ANY[=
M-+N1!8G::0%<T?[^?KE<SA](\Y)C;+/9]%4! + XI%H_22=AC5AXF(53:;9U
M_E1K<W,S_["O_4&S*XRS=W9V8@53IMOMKJZNYE^UO/$N2-1."V!<6JU6J50*
M1]1,LBDYNKI:"P"P"*1:/SE_V'2A5"M=>QA6,N[N[IY5/[L.#@["J-HZB%G1
M;K='?/,_K@6)VFD!C-%@,-C>W@X38/-*I9+NE@# W)-JO92N#;Q]^W;<\*H+
MI5KI#*^PWG#X$>9 H]'(#Z:KU6JL8(HE9T?-9G-R"Q*UTP*8A.1 .N+HG:A4
M*LD1.-X- &!>2+5>L;FYF;;-.BNE>GY:)A6ZQ>?O.UQ\UHVS+DSVV=K:BA5,
MO0DM2$SNI9T6P.3T>KUZO3XBVZI6J\G8(]X- &#V2;5.D4[:2IRZ(/&UF50:
MC:4%IQ:?>N,EI*_:-+A__WX80'_ZZ:>QB!GQ#__P#R/:M?SF-[_YQW_\QWB?
MLSU\^/!7O_I5>) [=^[$.@"N)OGDO7W[=CC>YBTO+__YSW^.=P, N#DQYKBX
M]'&D6J=(LZW0$NOY.3*IM)=6NI)QHBL07^X(-^V___?_GA\W_^I7OXH5S)2'
M#Q\FK^G;;[^=?UDS?_,W?]-L-N-]SC!\BI7<$HL &),___G/O_[UK\.!-R_9
MZILG &!*Q)CCXM+'D6J=(A].Y;TVD\HWGL^NG)@OF+]N\<O+R_D1<[/9C!7,
MH*LO2&RU6N%>E4K%9;D )NW@X" Y2H<C<%ZM5G-1%P!@#DBUSG1J(/7\'*E6
M/@X;OK3B\"VSKMOMAK'RX>%A+&)FC;A"8O(&:30:9Z541T='H<E+\L_7!F$
MC$MR  ]?.^4EQ^1ZO>["'0# 3)-J_>3X^/B==][)YD^EV=/2TM+3IT]?+8RI
M5EH9_IF_8UJ?I6/S-U%K:VLK/THNE\NQ@AGWVBLD9A?8ZO5Z>WM[C49C<W/S
M7_[+?QDJ76,>X/HEA^6SOIQ(%(O%Y A_UO<3  !33JKU4G8!Q%18>YA.W<H7
M_.+G=O+A&HC#\[#R!7,6:27"&H=&HQ$KF NC%R0FF_[TIS_]\I>_C!M^5JO5
MXB,"<%UV=G9&7 DDV;2]O2W; @!FCE0KVMS<'%YUR%EZO5X8&;MV^'P;L2!Q
M!.VT &Y<<AS>VMHJ%HOQ&/VSY/!N4BT ,%ND6J](UP]*M<YO9V<G/R NE4JQ
M@KF3G!<U&HVS%B2>*ENB",#-ZO?[HX_AR\O+#MH P*R0:G$E84G:QL9&K&!.
M'1T=C5B0&-3K]7A_ &Y.K]=+CLSQ8)VSLK)B\C4 ,/VD6EQ>O]\/7_:VV^U8
MQ%S;W]\?T:@E]=9;;U6KU7A/ &Y:M]M=7U^/1^V<U=55US4& *:95(O+:[5:
M^;%OL5C4.VD!)2_Z>^^]E]\3@J6EI4JE$N\&P'0X/#Q<6UN+Q^Z<]?7U;K<;
M[P8 , 6D6EQ>^(+71>X6UO;V=GY/"):6EI)=)=X'@&G2Z73"18V#C8V-7J\7
M[P8 <*.D6ES28# (RP\UEUU8AX>'^3UAF'T#8"8DA^OEY>5X$/]9\KG?:#3Z
M_7Z\&P# #9%J<4G)P#>,="T_7&3)>4Y^?\@L+2VMKJ[&:@"F6*O5*I?+\8#^
MLV*QN+6UY4,? )@&4BTNJ5:KY<>XEI@MN.3T)NP2;[WUUILO.@W[5A]@%FUO
M;X^X'DBR*2F(]P$ N%Y2+2YC,!@4B\7\Z+;5:L4B%D^[W5Y?7Z]4*LG9SNKJ
MZM[>7JP 8'8D'_?-9C-\XN>5RV6'>@#@!DFUN(Q.IY,?U!8*!?-Q & N)1_Q
MC48C--/,6UY>UC\1 +@14BTN8V-C(S^<U3@) .9;K]<+G_[!RLI*I].)=P,
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M8&5EY?#P,-YMEO7[_6SZWM7WKO2%2U^@>;J>)@"<)1V92+48)8POU]?78P4
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MJS.Q)##[(,^NRGQMR_47Y&M/ !;9?_[/_SD_9#I5L5BLU6K)9V*\,W UU@<
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M?/"0KA8   "F@[2WEI:6_#Y6F;FY.=I; (",T-4"    IM_%Q<7N[B[M+0#
M-*&K!0   #P@3=M;FYN;)R<G_E8  %" KA8   #P$$E[:W%QT6]EE9F?GZ>]
M!0#0AJX6    \*"=GY_O[.S0W@( 9(>N%@   (#_;XSVUG X]+<" ,"DT-4"
M    <$^C]M;"PL+6UA;M+0# Y-'5 @   %!N.!QN;6TM+"SXK:PRM+<  !-&
M5PL   # "&.TM\[/S_VM  "0%%TM     '4U:F\M+B[N[.S0W@( =(2N%@
M (#&3DY.-C<WY^?G_596&=I; ( NT-4"    ,+XQVEL7%Q?^5@  :(ZN%@
M ( $&K6WEI:6=G=W:6\! -J@JP4    @I>/CXXV-C;FY.;^558;V%@!@;'2U
M     *1W<W,S1GOK\O+2WQ   !7H:@$   #H4-/VUO+R\O[^/NTM ,!(=+4
M    3,+-S<W1T='Z^KK?QZI >PL $$=7"P   ,!$75]?T]X" +1'5PL   !
M/YJVMU975P\.#JZNKOP- 0 >)+I:     'HF[:W5U56_CU6!]A8 P-#5 @
M *#'U=75P<$![2T 0!UTM0    "HT[2]M;Z^?G1T='U][6\( #"]Z&H!
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MM+3D[N%T<U^X?:^<.#DYL>4Z.SLSMRVMG]VV(-TMR(^#P<"O.( '@*X6
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ML[^_?W%QX3\]@,S1U0(     :'=^?NXWJYJ3-W ='Q]W_2<O 4P&72T
M0 8&@X'?IKHU.SO[BU_\8F%AP1^(6EE9V=O;XR\G EFCJP4     R,#-S<WF
MYJ;;F?KLL\]^=OL!0WGOU?GY^=[>7M._ZKBPL%!LEC=P 3FBJP4     R,;I
MZ>G&QL;2TM+"PL+:VMKQ\;&_QNW7=9V<G&QM;37]0XTK*RN#P>#L[,S?(@"5
MZ&H!     *;6Q<7%_O[^VMJ:W\&*FI^?W]C8.#HZNKJZ\K<(0 VZ6@    "
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M .W0U0(     H('KZ^OCX^/-S<V%A06_B16ULK*RM[=W?G[N;Q' 6.AJ 0
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M)XNN%@      $W5Z>CK&&[B*]7D#%R;IYN;FW__]WQ\_?NP?BXY^_Z8G72T
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M7-WW[-DS^>+V\_-S_\% %%TM      #0E?/S<[^/==_)R8G_&* >NEH
M *!#@\' ;V7=FIV=75M;\]<&:J.K!0      .G1S<[.YN>GVLS[[[+/BOVMK
M:WSC.]J@JP4      #IW>GJZL;&QM+2TL+"PMK9V?'SLKP$T1%<+
M^:&K!0      @/S0U0(      $!^Z&H!       @/W2U        D!^Z6@
M     ,@/72T       #DAZX6        \D-7"P       /FAJP4      (#\
MT-4"      ! ?NAJ 0      (#]TM0       ) ?NEH       #(#UTM
M    Y(>N%@       /)#5PL       #YH:L%      " _-#5 @      0'[H
M:@$      " _=+4       "0'[I:        R ]=+0       .2'KA8
M  #R0U<+        ^:&K!0      @/S0U0(      $!^Z&H!       @/W2U
M        D!^Z6@       ,@/72T       #DAZX6        \D-7"P
M /FAJP4      (#\T-4"      ! ?NAJ 0      (#]TM0       ) ?NEH
M      #(#UTM        Y(>N%@       /)#5PL       #YH:L%      "
M_-#5 @      0'[H:@$      " _=+4       "0'[I:        R ]=+0
M     .2'KA8       #R0U<+        ^:&K!0      @/S0U0(      $!^
MZ&H!       @/W2U        D!^Z6@       ,@/7:U6AL/A[.SL^_?O_0$
M      !TB:Y6*\/A\.G3IQ\^?/ '        T"6Z6F,:#H<SCE>O7OEK
M    H#-TM<9Q>'@X,S/S^O5K^?'=NW=??/$%GT,$      "8&+I:C7WZ].GY
M\^=\\!       *!'=+4:HZL%      #0.[I:XY!/(+YX\<(?        P$30
MU1K3]O:V?$_\HT>/WKQYXP]/A*0&      "0';_-T9QLAZ[6F.1-6X7)?R#Q
MIZ,        @-WZGHSG9#EVM5J2W]>K5J^+_A\.A]+FZ?AL7D=5$H6JB4#51
MJ)HH5$T4JB8*51.%JH]:U42A:J)0-5&HFBA4312JIBDNE+PTNEJM?/SX\<F3
M)Q/^FBTBJXE"U42A:J)0-5&HFBA4312J)@I5'[6JB4+51*%JHE U4:B:*%1-
M4UPH>6ETM5IY]^[=W-R<O%=K8HBL)@I5$X6JB4+51*%JHE U4:B:*%1]U*HF
M"E43A:J)0M5$H6JB4#5-<:'DI='5:N#=NW>/'S^V'RW\].G3\^?/9V=GW[]_
M?W_%;A%9312J)@I5$X6JB4+51*%JHE U4:CZJ%5-%*HF"E43A:J)0M5$H6J:
MXD+)2Z.KU8S] XABPI\]%$16$X6JB4+51*%JHE U4:B:*%1-%*H^:E43A:J)
M0M5$H6JB4#51J)JFN%#RTNAJC6-[>WO"GSH$      " H*LU)OG@(5TM
M  " 7M#5 @      0'[H:@$      " _=+4       "0'[I:        R ]=
M+0       .2'KA8       #R0U<+        ^:&K!0      @/S0U0(
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MH:L%      " _-#5 @      0'[H:@$      " _=+4       "0'[I:
M    R ]=+0       .2'KA8       #R0U<+        ^:&K!0      @/S0
MU0(      $!^Z&H!       @/W2U        D!^Z6@       ,@/72T
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M"8)0@B T( 4E"$()@M" %)0@" U(00F"4"))$+(1NEKYH=H:D((2!*$$06A
M"DH0A!($H0$I*$$0&I""$@2A1)(@9"-TM?)#M34@!24(0@F"T( 4E" ()0A"
M U)0@B T( 4E"$*))$'(1NAJY4=MM8?#X>SL[/OW[_V!::0V!4,0.CRH% Q!
MZ* V!4,0.CRH% Q!Z* V!<_4AT(0&N22@B$(':8[!9,H"-D(7:W\J*UV<>(]
M??KTPX</_L T4IN"(0@='E0*AB!T4)N"(0@='E0*AB!T4)N"9^I#(0@-<DG!
M$(0.TYV"212$;$175ZM(;C 8K-[:V=DY.3GQUQC7NW?OYN;F9NZ\>O7JTZ=/
MSY\_]]J?'S]^?/+DR8L7+XK_/SP\M.N+UZ]?VS7EX?8X*_:\6.'1HT=OWKRQ
MZ\B3%L]EER21JMH)R<NWPI<LY?)J:.X*;A_8:+1?"E,PT2!L!$(.<FMDJ:L2
M[)W"("(IB'@Q[:B749W1'N451-7IX)T(X0KA.J4A]D5A"F:L((3[0&]Z%>',
M[JW0%X5!1%(0D>M2I,Z:3P<S74'$2SWR9.F1PA0\5:%$9H3(T/UM*S*50=C'
M5ITXVNA/P50'X8K<CD:&]- ?1"0%;ZC@-30BL[8V28*0C6CI:MW<W P&@Y\%
MUM;6KJ^O_;4;DOZ4O<S)R58$+,>$FW2QIKT;</^_:B.VJV5;8.X)_$"Z6EYE
MBE?]Q1=?N*>6>^ZYDXU7GW [D='>:4O!!"7R@MC>WK8'IR1B?QQ9ZJH$-= 6
M1#P%4Z.8A[=7GF?/GI7>#<1'>Y17$)'3P>.='2-/EGYI2\$$):H?A/? 8DWO
M=W5MQ7=I"R*>@HE>ER)U5GXZF"D*(E[JD2=+O[2EX!D9BBMR8Q\94F**@Z@Z
M<112GH*I'<1A]>UH9$@/Y4'$4R@.^,A%WGNL<DF"D(UHZ6KM[.SX#:T[*RLK
M_MI-R(6O-%KI3-GNIOM&+7-W3MHCQKN AEVM8N67+U]&'I)*^VHGY-4A9(L@
M4XX;1''CY3[0VU1\M'>J4C#-ZU.4UQ[Y\5)'$M1 51 C4QA93+D*_>YWORNV
M$]X-Q$?[E5<0'O=TB _%3Y;>J4K!-*^/K;8W'9M@@NYH>DU%51 C4XA<E^)U
M5GXZF"D*(E+JD2=+[U2EX!D9BJ?^9*'0M 81.7$4TIR"J1U$Y'8T,J2*YB!&
MIA#I:L5G;862!"$;4='5.CT]]5M9]^WO[_N/J2T^S<@54++WVEAC=+5^_/''
M"=QVMZQV6B-//,N;;.2JYQ7'UCP^ZB[LBZH43),@1%%,][?'.J76>;N@*HCZ
M*5054WYUN;Z^+KT;B(_V*],@A#T=O.7>+X?U3Y:^J$K!M @BG#W#.;<T,B54
M!5$_A?"Z%*FS_M/!3$L0\5*//%EZIRH%3Z-:1=J%D2$]ICZ(\ JFD.843.T@
M(K>CD2%5- <Q,H5(5RLR:^N4) C92"==K>)0WMK:6EQ<]+M3$U$\[\;&QM75
ME:F^\+FD[75Y>>FMZ=V<>=VQ\ Y;5G8?%=YJ))$DLH0.;]_H&"^R"28;*8XW
M]]AUXJ/NPKYH2\'4#D+8X[E^J4L7]DY;$#53*"UFD<7CQX^+JX=<7KR-Q$=[
MEVD0HNH?/[Q9H/[)TA=M*9AQ@RB=/>WHR!N^WFD+HF8*WL$<K[/^T\%,2Q#Q
M4L=/%G=A7[2EX*D9B@EFA)I#>DQ]$-JN/Z64IV!J!!&Y'8T,::,\B'@*55VM
M^*RM4Y(@9".==+4V-S?]5M/$K:ZNFHI_X/+(#4&QS][Q(<>3RSVVJKI:;A^M
M]%:CO221I57</TF)2L\QX4TVI7./71@?=1?V16$*IEX0YOZ165K5^@M[IS"(
M.BF$Q73O ,*[@?BH!ID&8:HOU.'-09A:U<*^*$S!C!6$%#]L*;I=K5_]ZE?/
MG6^:5W4;IS"(.BEX!W.\SJ5'?NG"'DU'$*55M0OC)XO[D+XH3,%3)Y1P1J@S
MI,K4!U%ZIFBC/P43#<*]!77_/SZDD/X@(BG(H6[9%>*SMDY)@I"-=-+56EA8
M\)M,?3#UNEKF[KCQSCWOGP+D+L$[=<.NEOS_S.U5M>J7I9:21-8%VP<L/7\:
MW:7%1]V%?5&;@AD5A!RZ]GZWM*KU%_9.;1#Q%,)B%DML*.'=0'Q4@TR#\$X'
M5VE&X2E0NK O:E,PS8.0)?(0>=177WTE*\C,[D[0LJ1TR[U0&T0\!>]@CM>Y
M],@O7=BCZ0BBM*KNPLC)XCZD+VI3\#0*I>:0*@2A02XIF(H@(K>CD2&%<@FB
M- 6/]#&*(S\^:]]_D!9)@I"-=-+56EU=]3M,$[>XN&CJ?0+15%P'#X,WN+I+
M(ETM>P"]??OV076UA)Q^X:OVBESG'?55H^["OBA/P50'L7W_KR/5+W7IPMXI
M#Z(J!:^87O_=NQN(CRJ1:1#>Z6"%31;3Y&3IB_(43/,@7-MW7YA=>@J$4W:/
ME =1E8)W,,?KK/]T,-,2Q!BEMB>+/] 'Y2EX2D,IG1%&#FDSW4&842>%$GFE
M8.X'$;D=C0SIE%<0I:>#9=L=I657=7<42A*$;*23KM;%Q<72TI+?9YJ@A86%
MT]-3$_2>JI1>!\.#P%TMTM6R:W[]]=</L*M5U4DLO4OSBF/+&!]U%_9%>0JF
M(@BY++J'>OU2EYXFO5,>1&D*)BBF_%CJ]=U;%TOIB2/'(,+3P2H]+TH7EIXL
M?5&>@FD>A.4^L'1F)XCZ2E,PP74I7F?]IX.9EB":EKIJLWU1GH*GM'JE$8P<
MTF:Z@S#!B:-37BF8^T%$;D<W-S?]17=T)I)7$*6G@V4G:_F2_JI9VWF$(DF"
MD(UTTM5JZN;F9F5EQ6]-W5E86)"O?A]/G6M<Z3KA0> NB7>U9'1Q<3%R\1U;
MRVIWK6K*&7F[["Z)C\J2?BE/P90%<5C6Z0\+&RX1I:=)[Y0'$:8@XL4L_<<6
M*S[:E^R"*#T=K-*W#H6G1KBD7\I3,,V#L+Q)]C#X*S_;?#UV;6$*(KPN1>H<
M'OSADMY-1Q!A8<,E+N]DZ9WR%#REH93."".'M)GN($QPXNB45PJF(@@1N1V-
M#"F15Q"1%,S]GE=DUO[I 9HD"4(VHJ*K9:K?WC4_/R_ONFK#?MS47>(>&:77
M0>^V0(XG>WYZMQ3A/83M9U<=@F-K7^V$WMW]M0OY4<I2>O*$198EMCY>#>.C
MO5.5@JD1A%=/5\U2APEJH"J(D2E8\6+&[P;BHWW)*XC(Z6"B_R96\V3IBZH4
M3.L@K,.@\^7-R#6W,S&J@AB9@A5>E^)U5GXZF"D*HGZIPY.E=ZI2\-0))3(C
M1(84FN(@1'CB**0Y!5,O""MR.QH94D)S$/$4Y$?OGSWL:'S65BA)$+(1+5TM
M<_N.K9V='=O;6EA8V-S<;/,N+9>$:GGIEEX'Y<Z@ZE%R#$6Z6K)"^%SM):EV
M0M(TM+Q+F)Q=[@HSP1]1$N$M6GRT7]I2,-$@[-'H\:YZPBMU/,'>:0LBDH*I
M7<SXW4!\M"\9!3'R=)"+?]6=<>1DZ9VV%$R+(-P'EM;9.YNJ\NJ%MB B*9B@
MDL)>E^)UUGPZF.D*(E+JD2=+O[2EX(F'8J(S0F1(H6D-(G[B:*,\!5,C""MR
M.QH94D)Y$/$4O+:&=[3'9VUMD@0A&U'4U4)-.JOMO?UMZNE,P1"$#@\M!4,0
M.NA,P1"$#@\M!4,0.NA,P?,00B$(#;)(P1"$#E.?@DD4A&R$KE9^%%9;6O)3
M?^*Y%*9@"$*'!YB"(0@=%*9@"$*'!YB"(0@=%*;@>2"A$(0&^E,P!*'#0TC!
M) I"-D)7*S]46P-24((@E" (#4A!"8)0@B T( 4E"$(#4E""()1($H1LA*Y6
M?JBV!J2@!$$H01 :D((2!*$$06A "DH0A :DH 1!*)$D"-D(7:W\4&T-2$$)
M@E""(#0@!24(0@F"T( 4E" (#4A!"8)0(DD0LA&Z6OFAVAJ0@A($H01!:$ *
M2A"$$@2A 2DH01 :D((2!*%$DB!D(W2U\D.U-2 %)0A""8+0@!24( @E"$(#
M4E""(#0@!24(0HDD0<A&Z&KEAVIK0 I*$(02!*$!*2A!$$H0A :DH 1!:$ *
M2A"$$DF"D(W0U<H/U=: %)0@""4(0@-24((@E" (#4A!"8+0@!24( @ED@0A
M&TG9U0(       !&\EM+#<E&Z&H!      !@HOS64D.RD91=+7\IND&U-2 %
M)0A""8+0@!24( @E"$(#4E""(#0@!24(0HDD0<A&Z&KEAVIK0 I*$(02!*$!
M*2A!$$H0A :DH 1!:$ *2A"$$DF"D(W0U<H/U=: %)0@""4(0@-24((@E" (
M#4A!"8+0@!24( @ED@0A&Z&KE1^JK0$I*$$02A"$!J2@!$$H01 :D((2!*$!
M*2A!$$HD"4(V0E<K/U1; U)0@B"4( @-2$$)@E""(#0@!24(0@-24((@E$@2
MA&R$KE8RP^'PT:-';]Z\\0=24UOMH@*SL[/OW[_W!Z:1VA0,0>CPH%(P!*&#
MVA0,0>CPH%(P!*&#VA0,0>A "DH0A 8/*@63* C9"%TM<WAX.'/GZ=.G'SY\
M\->H9^?JO5H   O1241!5'M[N\W#ZU-;[>(\G$P%-%";@B$('1Y4"H8@=%";
M@B$('1Y4"H8@=%";@B$('4A!"8+0X$&E8!(%(1O1U=7Z[__^[R++[V[]\,,/
M__5?_^6O,99(WZH8LF^P>O?NW=S<W(L7+WYZY.VQ91\K7KUZY:X@/G[\^.3)
MDYV=G>*_WOK"MEU+=T:>Q=NRNV^N5-5.R*M26*)/GSX]?_Z\&'K]^K6[7.IF
M']AHM%\*4S#=!!&> JK^#4%A$&.G$!FRRX6J",34!.&5VIL1O'7"!/NE, 5#
M$#ITE,+(S?9K6H/PIH"1,?5+80IFW"!&#@F[@JHL% ;170KQT1XI3,%T$(3W
M:X6EYXQ0&,1X*=2Y_I<^4(DD0<A&M'2U_O*7OQ19?A/XPQ_^<'-SXZ_=A-<;
M*GZT1XED[,8?OM]J>/]SA7+ A4>,MYHL"8^>R,X43^T.E;;81/MJIR5].OM*
MBSW_XHLOW/LM]RQU"R*OT58@W$YDM'?:4C!!B5(%$1[;JF@+8NP4XD/%]<$&
M)/<*VAI;4Q-$46I[X2V]X%<]4 -M*1B"T*&C%+S['/DQO!'OT30%$9D"XC'U
M3EL*ID40\2'K\/9N_]FS9P01T5T*\=%^:4O!=!F$R_M=HW?:@A@[A9'7_ZH'
M*I$D"-F(EJ[6#S_\X#>T[OS^][_WUZY-YOZJ246Z6K:-5;KR,/B5OCAZ2O^5
M+&R'>4=/Z?8MKXT5/HO5OMH)E;YVE[V*A07Q>HC>IN*CO5.5@JE1G[&#"$\!
M550%T2:%R%!([IA5A3(U07B\2W']!_9"50J&('3H+H72N:/J)J<7TQI$? J(
MW$#V0E4*IET0D2%+[O9_][O?<3I$=)="?+1WJE(P70;AX;H4T28%3UXW2R91
M$+(1%5VMHN)^*^N^__B/__ ?4X],+9&CQ'9&9<WP+F$8_$H?WDS8(\8N,=5=
MK3H[$S[6U;+::8T\#RWO14DUO*+9VL9'W85]496"Z2P(65]/V4.J@A@[A9I#
MEJIS04Q?$*(H=>E]V,@']D)5"H8@=.@N!>_N.?Y/=[V8XB B4T#5R=(752F8
M1$%$AJ3;>WU]35<KHNL4S*C1OJA*P4PD",/L,$J2%$35]7_D _N2) C92"==
MK9N;F]/3T]_^]K=^=VHBBN<].3FQAT4QN\P$;\:SY#":N55Z, V#7^G#9G/I
M 51Z],1W1L[Y7_[RERLK*Z4[(Y)$EM#A;3.NZD597D&D%>C5QZX3'W47]D5;
M"J:;(.3_(W?/O=,6Q'@IU!P2LH+7B.S=] 4AP@N^&/G 7FA+P1"$#AVE(-.'
M+)&[J=*,>C2508R< JI.EKYH2\&D"*)JJ#@I'C]^7-PRR1DQ\BDF25L0W:4@
MXJ-]T9:"Z3X(,ZH1WPMM0;1/051=_T<^L"])@I"-=-+5^N,?_^BWFB;NN^^^
ML_LCO:29LKZ5W)-Y0T/GUWCW_\W=,>?>3%3-6U5'3V1GS-VCXF=^DLC2LB\J
MLN=>04KK8Q?&1]V%?5&8@ND@"/O_5F3+O5 8Q!@IC!QR^^\ST=]G^C)]09B*
M]^&*^ /[HC %0Q Z=)2"O8F:J7$[/GE3$T3]*: TIGXI3,&,&T1\R/V-H.JW
M@QXI#**+%*SX:%\4IF Z#D+.A=)?>WND,(B6*9CH]3_^P!XE"4(VTDE7Z]MO
MO_6;3'UP=O#>#8$-6P(NIASY'WN^'3KOO9(A*SS.2M_J8J)'3^G.".F:53U0
M)(FL"W;G2Z]<7D%*ZV,7QD?=A7U1FX))&H2[4,@UMW2H%VJ#:)1"S2%1]7'I
M?DU?$'*A+OTG+Q-]8(_4IF (0H?D*<@&%Q<7PW\@U&#Z@C#1*: JIGZI3<&T
M"*)TJ%AHBT]7J[ZT*5CQT;ZH3<$0A YCIQ"__D<>V*\D0<A&.NEJ???==WZ'
M:>)^^]O?.COX?]Q; :]S+&'+]+/M? 'J<-3'KP[+/GYH:AP]X7V)+/G5KWX5
M.2A-4&UMY&P,^\1>04J[@7:=^*B[L"_*4S")@G 7"FV?C5<>1,T4:@Y9VE(P
MTQC$]OV_2^N)/+!'RE,P!*%#JA2\A?+PTAOQODQ?$*)J"BB-J7?*4S!C!1$.
M>=]22E>KJ20IN.*C?5&>@DD=1+S5TB/E08R10OSZ'WE@OY($(1OII*OU/__S
M/T48?I^IA;V]/7]1U+???EO\KN[LX$]LJ.$]@0P)]_U<D4,D,FG5.7J\=;;O
M/@H;>0.A":JM35A8X;W8TM=X>/>YZ_BHN[ ORE,PB8)P%PIM;R16'D3-%&H.
M6=I2,%,7A-Q/A,NMJ@?V2WD*AB!T2))"T[FC%U,6A%4Z!93&I('R%,Q8081#
M[B\1GM(M3)[R()*DX(J/]D5Y"B9U$*4SA0;*@VB:PLCK?]4#>Y<D"-E()UVM
MIO[RE[_\_O>_]UM3=\VL;[_]-N%O;O:6J_2>0")W.\K#:%>K]'TNHL[1X][_
MR?KVM(\T7%M6NVM5UR^O(&']W27Q45G2+^4IF$1!_/2P.U77V;XH#Z)F"C6'
M+&TIF.D*0FX.PI5=I0_LG?(4#$'HD"2%THW0U6JDM(:F(@A7. 54Q:2!\A3,
M6$%$AD3DG[W[HCR(Y"G$1_NB/ 63.HC([[/]4AY$HQ3J7/]+'ZA!DB!D(RJZ
M6J;Z[5W_\B__\J[B75=U#)V/N)N[0\3.,=Y!(*,SM]SOU8J<C8<5'S\T94=/
M9&?"/H*WJZ[VU4[HW=U?>Y$?(V\T+2V(6W_O;C@^VCM5*9C.@I#MV)4CF^V+
MJB#:I! 9DE]@O!14G0YFBH+P3H<JX0,U4)6"(0@=.DHAO!!%[EOZ,AU!C)P"
M(C%IH"H%TR*(FD."KE;<!%*(C_9%50JFXR#"_KL>JH)HDT+-ZW_X0"62!"$;
MT=+5,K?OV/KAAQ]L;^O;;[_]XQ__6/IND48D1<M+W1N5L-T[AF%U5RL^8Y4>
M/54[(_TU;^72A291M1.R?[)!> 5Q>X66]W5F(JQS?+1?VE(PG07A';15[^'J
MB[8@QDXA,F34IV"F)8CKZ^OGSA\:L^S#JQZH) YM*1B"T*&C%$RPY9$WUA,V
M'4$41W5D"I![47=45-V=3IZV%$R+(")#[A;,J-\1>J$MB(Y2B(_V3EL*IK,@
M3/5OLAIH"V*\%$9.TU4/5'(ZF$1!R$84=;6R(P?*Y,]5G=4NSD9MM[.=TIF"
M(0@='EH*AB!TT)F"(0@='EH*AB!TT)F"(0@=2$$)@M#@H:5@$@4A&Z&K-;[M
MNR]W]P<ZIK#:\D]2#^H\5)B"(0@='F *AB!T4)B"(0@='F *AB!T4)B"(0@=
M2$$)@M#@ :9@$@4A&Z&K-:8>/RK\ *NM$"DH01!*$(0&I* $02A!$!J0@A($
MH0$I*$$02B0)0C9"5RL_5%L#4E""()0@" U(00F"4((@-" %)0A" U)0@B"4
M2!*$;(2N5GZHM@:DH 1!*$$0&I""$@2A!$%H0 I*$(0&I* $02B1) C9"%VM
M_%!M#4A!"8)0@B T( 4E"$()@M" %)0@" U(00F"4"))$+(1NEKYH=H:D((2
M!*$$06A "DH0A!($H0$I*$$0&I""$@2A1)(@9"-TM?)#M34@!24(0@F"T( 4
ME" ()0A" U)0@B T( 4E"$*))$'(1NAJY8=J:T *2A"$$@2A 2DH01!*$(0&
MI* $06A "DH0A!))@I"-I.QJ 0       "/YK:6&9"-INEJ&QA8       !J
M\)M*S<EVDG6U        @ F@JP4      (#\T-4"      ! ?NAJ 0
M(#]TM0       ) ?NEH       #(#UTM        Y(>N%@       /)#5PL
M      #YH:L%      " _-#5 @      0'[H:@$      " _=+4       "0
M'[I:        R ]=+0       .2'KA8       #R0U<+        ^:&K!0
M    @/S0U0(      $!^Z&H!       @/W2U        D)][72T        @
J(__O[=NW_C(       ! L?_\S__\7VRA8'[NGJ2B     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_9.jpg
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MF\,B'W_^<'WU \!LJ,0 &=K_T*.A+5Q^]:W-(B&21[YYPYUAD?_@_H?KJQ\
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MWAAJ3+/;B Q.6#9A\80E%!926$YA4?WJZ>?# JNO.0 XX51B !B.T/WJ)P$
M"YM*# ##H1(#0.>HQ  P'"HQ '2.2@P PZ$2 T#GJ,0 ,!PJ,0!TCDH, ,.A
M$@- YZC$ # <*C$ =(Y*# ##H1(#0.>HQ  P'"HQ '2.2@P PZ$2 T#GJ,0
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M9D41.?'YY7._W[AM=SR4>MVF[3YY"X#YIA(#%.>-M][^\MHK0^7XW#F7W/O
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M"]UW[W$)48D!:$\E!LA0X95XHO?NW-"*!WP+<1[YU*=/*:'Y3Q65&(#V5&*
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M/948(&>'?CT1^L-GSKKHE\_]OMDN1+J50Q-O+EZ^)BSIGS]ZL+[6 6!.5&*
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M\-3+]B'+'!*6S6//O!J64%A(._?N#XLJ+*U3EZQ**^W+:Z_\P?T/AT587Y<
M,,]48@ ^Y.C;[_SX@0,;MMZR^.R+JO589+@Y?=GJR[?<^,/]__'&6V_75R$
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M&  Z1R4&@.%0B0&@<U1B !@.E1@ .D<E!H#A4(D!H'-48@ 8#I48 #I')0:
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M:$P.Z16"43 J]?_O=E??U\&#WT 8GY\&O(%PJ@.?PG-;]5/IXL;I.;+Z\!C
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M,0I&124>&8L>F#0* ', Z#$*1D4E'AF+'I@T"@!S .@Q"D9%)1X9BQZ8- H
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MZ5D"T?BER2T4H&Q%*$@S/:%@18,E+MU[4RS%F])C[G5!Q0"6V)X\VP'M[OF
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MHS.T>IKI%6.IMO/:ZB5J6H75;4J*KEI9]E;:D(_!H;PEUM4I],CJR<_KO>K
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M_/.%J]9><.EUQT^>B7,C---ZZ?3;%UWV92GQ;[SY3ACL82&$ M1A$0H&AU"
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MQIMA*@       "P56.+6P!(#      "T"Y:X-;#$        [8(E;@TL,0
M    0+M@B5L#2PP      - N6.+6N.(+7\<2 P      M B6N#6PQ
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MP1*W!I88      "@7;#$K8$E!@      :!<L<6M@B0$      -H%2]P:6&(
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MXFUW[PE3 0      8*GHN"56ZYNPQ#J(.FV)SU;..7X)DY]"/,A;F@*PQ
M     .W2<4NL+V>JM<0Z6%J7JFZRQ,&(:X^?0JR+>.E'\<GV&#G-_WGL22PQ
M      ! BW3<$JNS#9:#]H.E=<=X/G#MB&M#/+#L;KY7E[#6CW*NPDTV3G#H
MJ:-88@      @!;IN"5.K#BM#W73*T[7/NR5Q&!TM!IO_;OI2F*PQ
M .T26L$9I<F(ZI#F5:M6^<3@1<3ZT5O<VK<9&U_XPA>"A\!88@      @%FD
MXY;X;,^OVO->^>/#'_ZPM[NZKW^WL#Y&KATU+6987VCLB0=.)R8A&UAB
M  " =NF()593ZN?W&K_[W>_$ Z]:M4HVR=^21SX&;T[2\=7J@76FL7?(1C"%
MV*>K(=<QU7+\.$\,EA@      *!=9MX2VQN5C/A9L1A@'1TM9E7,<ZU?W;5K
MERZI=?[YYP?+<2GQ%&+/""]APA(#      "TR\Q;XMD%2PP      - N6.+6
MP!(#      "T"Y:X-<02WW3[SC 5        E@HL<6N()5Z_:2Y,!0
M@*4"2]P:1U^8QQ(#      "T"):X-4[\NL02 P      M B6N#6PQ
M .V")6X-+#$      $"[8(E; TL,      #0+ECBUL 2 P      M N6N#6P
MQ        .V")6X-+#$      $"[8(E; TL,      #0+ECBUA!+O.[FN\)4
M        6"JPQ*TAEOB*+WP]3 4      ("E DO<&J^^?@9+#       T")8
MXM8X\\:;6&(      ( 6P1*W!I88      "@7;#$K8$E!@      :!<L<6M@
MB0$      -H%2]P:6&(      (!VP1*W!I88      "@7;#$K8$E!@
M:!<L<6M@B0$      -H%2]P:6&(      (!VP1*WAECBE5=<'Z8"      #
M4H$E;HWWW__K)__G%\-4        6"JPQ&V")08      &@1+'&;8(D!
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M<-5:<2 77?;E.[_S,(.B4;N:/_76W.X#GUI]O0ZEOO?^'[#^%@      #,5
MEOC/__7?^G#X@DNON^6.[ST__WKL3Q!J1;_XS1\VS^W5H=0W;MG!REL
M # X_2WQ&V^^\_GUWQ"_\8]7;CCXQ/'8DR#4N@X]^Y*.H[YJW>977S\3%F(
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M0V$1!P      J @M\?_]?V]<N&KM!9=>Q_N6T*SKT+,OZ?N*3YU^+2CG
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MQ.(31+&%0*ACTJ(>5@(      ,@5+#'*2%AB      #P8(E11L(2 P    "
M!TN,,A*6&       /%ABE)&PQ       X,$2HXR$)08       ^6&&4D+#$
M     'BPQ"@C88D!     ,"#)489"4L,       >+#'*2%AB      #P8(E1
M1L(2 P    " !TN,,A*6&       /%ABE)&PQ       X,$2HXR$)08
M  ^6&&4D+#$      'BPQ"@C88D!     ,"#)489"4L,       >+#'*2%AB
M      #P8(E11L(2 P    " !TN,,A*6&       /%ABE)&PQ       X,$2
MHXR$)08       ^6&&4D+#$      'BPQ"@C88D!     ,"#)489"4L,
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M     , TLT26^+R/?-1LY.$C\W&&6MDNB['$8U>3)?;*S1+;H_C $D^;L,0
M     .!9"DN\>\\CWA(G7**X31UR+/GMP7(1^5OY>/'*2R1]V;(/K5YSM7\"
M&>S2-*WWX*&?Z]QFW21'&_PQYK"66*0GDL3X+$W?Q5^Y^DSY0?1QM]U3D!]6
M]M41Z?+?:[_T53NL>51E[I[[]1HD6WS-<E*[2/G]Y;!V;?X@M5<ETNL/*!NF
M=HOD^N6;VF7[;VU%10XNV>3(P:4N4EAB      #P+(4E%GLC%M3\9],B6V;
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M4Z(=TWRX'L?R6 9=C2P^2*W[K4TLHV]M92 N /X@RS_V\<$GG \E+#$
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M![.R5<\EURG[!G<$+)LX6_T9[0(LFV+G;3J=/B66X^@/(GG&_BHF+#$
M '@F8HG1-,A;XGAKGL(2 P    " !TO<66&)8V&) 0    # @R7NK+#$L;#$
M      #@P1)W5GX)KMHUP#(4EA@      #Q8XFXJ6*^[&'@][6X+2PP
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M8Y!_/NP1^^H?$2M!9O^@6%RQ=\OBI2V=I\1C$988       \6&*4D;#$
M  #@P1*CC(0E!@      #Y88920L,0      >+#$*"-AB0$     P(,E1AD)
M2PP      !XL,<I(6&(      /!@B5%&PA(#     ( '2XPR$I88       \
M6&*4D;#$      #@P1*CC(0E!@      #Y88920L,0      >+*SQ,=>_(\M
M6[?O/_#3>-/BM7O/(Q>OO&3%)SX9;YI:7?NEKQX\]/,XO9/"$@,     @"<O
M2RQ^6/RJ.D#YHZACV;(/R28QBL/:9O7#<H39LL3RF\B7G;OG_GA3]X0E!@
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MPB9[:W&QT!+K$VQSN7*1P=7:@&<OFS:L![3T6DL\R&6K-'W8%S+/D+#$
M  #@R<@2USJ]M"4.YA+7VLA <1[QKN=]Y*.2*$>+KR08_"P9?,K!0S\/GN7*
M5KE:72++UL2VK;66.+ZD)ODOVTEAB0$     P).1)?;CC8--39985YPVOZI+
M6\79O +_J:M#F\F,+;'FT40;(VTI\H<8:<NI\XK]<V,UL9:AUA(/<MDJ+#$
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MJ,-O&%J,5GSBD\%J6YT4EA@      #P96>*R<L7B_1@^'6CUFJMS\,,EEA@
M     !:2ER56;=FZ'5=LVK#QMGQ^#2PQ      !X<K3$*%MAB0$     P(,E
M1AD)2PP      !XL,<I(6&(      /!@B5%&PA(#     ( '2XPR$I88
M   \6&*4D;#$      #@P1*CC(0E!@      #Y88920L,0      >+#$*"-A
MB0$     P(,E1AD)2PP      !XL,<I(6&(      /!@B5%&PA(#     ( '
M2XPR$I88       \6&*4D;#$      #@P1*CC(0E!@      #Y88920L,0
M    >+#$*"-AB0$     P(,E1AD)2PP      !XL,<I(6&(      /"<L\0K
MK[A>?,+\J;=B"X%09R0E7,JYE/:P$@      0*Z<L\17K=LL5N'9%WX?NPB$
M.J/G7GQ5ROF5:V\-*P$      .3*.4M\XY8=8A4>>^I7L8M J#.2$B[E?/VF
MN; 2      ! KIRSQ-ONWB-68>^!IV,7@5!G].#!GTDYW[KC@; 2      !
MKIRSQ'L>>DRLPO;O/QJ["(0ZH]W[#TDYOV_O@; 2      ! KIRSQ#]YXHA8
MA<US>V,7@5!G].W['I%R_O"C_QI6 @      R)5SEGC^Y5-B%:Y:=WOL(A#J
MC*[9L$W*^=$7YL-*        N7+.$K___E\ON>I&<0O/O?AJ;"00ZH".GSQS
MP:7777S9NK^\]UY8"0      (%?.66)AZXX'Q!+OVO=X["40ZH#V'GA:2O@M
M6^]=6/X!     "!K/K#$3SSSO!B&+W[MKMA+(-0!K=]\CY3P'QWZMX7E'P
M    LN8#2_RG__SSA:O67G#I=<=/GHGM!$(SK9=.OWW195\62_S&F^\L+/\
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M@G(.      !P-K;$PKWW_T#7V7I^_O789B T$SI^\LREG[M92O*VN_>$11P
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M/EN]F6GG=Q\2UR'Z^RO7;__^H\PN1NU*2N"N?8^O7'.#%LMM=^_A?4L
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3NTIZ,T'<"0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
